Citrus Sinensis ID: 019904
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | 2.2.26 [Sep-21-2011] | |||||||
| Q2V452 | 441 | CBL-interacting serine/th | yes | no | 0.985 | 0.746 | 0.860 | 1e-176 | |
| Q2QY53 | 438 | CBL-interacting protein k | yes | no | 0.994 | 0.757 | 0.849 | 1e-171 | |
| Q2RAX3 | 454 | CBL-interacting protein k | yes | no | 0.994 | 0.731 | 0.849 | 1e-171 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.997 | 0.758 | 0.807 | 1e-164 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.988 | 0.734 | 0.754 | 1e-154 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.991 | 0.735 | 0.721 | 1e-148 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.964 | 0.668 | 0.75 | 1e-147 | |
| Q9MAM1 | 447 | CBL-interacting serine/th | no | no | 0.988 | 0.738 | 0.701 | 1e-142 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.985 | 0.739 | 0.705 | 1e-142 | |
| Q10SC8 | 456 | CBL-interacting protein k | no | no | 0.973 | 0.712 | 0.708 | 1e-141 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 617 bits (1590), Expect = e-176, Method: Compositional matrix adjust.
Identities = 283/329 (86%), Positives = 313/329 (95%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 6 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 65
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 66 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 125
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 126 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 185
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 186 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 245
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
I RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSEEH VTE++
Sbjct: 246 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKR 305
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
EEQP A+NAFE+IS+S+GLNL NLFD EQ
Sbjct: 306 EEQPAAINAFEIISMSRGLNLENLFDPEQ 334
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 602 bits (1552), Expect = e-171, Method: Compositional matrix adjust.
Identities = 283/333 (84%), Positives = 311/333 (93%), Gaps = 1/333 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKTKI+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A++L+ RILDPNPMTR+TIPEILEDEWFKK YK P F+EK DT LDDV AVF DSEEHHV
Sbjct: 241 AKRLLTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEE P A+NAFELIS+S GLNLGNLFD+EQ
Sbjct: 301 TEKKEE-PEALNAFELISMSAGLNLGNLFDSEQ 332
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 601 bits (1550), Expect = e-171, Method: Compositional matrix adjust.
Identities = 283/333 (84%), Positives = 311/333 (93%), Gaps = 1/333 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKT I+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A++L+ RILDPNPMTRITIPEILEDEWFKK YK P F+EK DT LDDV+AVF DSEEHHV
Sbjct: 241 AKRLLTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEE P A+NAFELIS+S GLNLGNLFD+EQ
Sbjct: 301 TEKKEE-PEALNAFELISMSAGLNLGNLFDSEQ 332
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 578 bits (1489), Expect = e-164, Method: Compositional matrix adjust.
Identities = 269/333 (80%), Positives = 305/333 (91%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSEEHHV
Sbjct: 241 AKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+
Sbjct: 301 TEKKEEQPTSMNAFELISMSRALDLGNLFEEEE 333
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 543 bits (1399), Expect = e-154, Method: Compositional matrix adjust.
Identities = 249/330 (75%), Positives = 294/330 (89%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK+KRRVGKYE+GRTIGEGTFAKV+FA+N+E EPVA+KILDKEKV KH++ EQI+RE+
Sbjct: 11 PKVKRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREIC 70
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
TMKLVKHPNVVRL+EVMGSK +IFIVLE+VTGGELF+ I +GR+KE+EAR+YFQQLINA
Sbjct: 71 TMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINA 130
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
VDYCHSRGVYHRDLK ENLLLDA GNLKVSDFGLSAL++QV+ DGLLHTTCGTPNYVAPE
Sbjct: 131 VDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPE 190
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+ DRGYDG+ AD+WSCGVIL+VLLAG+LPF+D N++ LYKKIS A+FTCP W S A+K
Sbjct: 191 VIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKK 250
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQ 303
LI RILDPNP TRITI +ILED WFKK YKPPVF+EK +T+ DDV+A F DSE+ HV E+
Sbjct: 251 LITRILDPNPTTRITISQILEDPWFKKGYKPPVFDEKYETSFDDVDAAFGDSEDRHVKEE 310
Query: 304 KEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
E+QP +MNAFELISL++ LNL NLF+A++
Sbjct: 311 TEDQPTSMNAFELISLNQALNLDNLFEAKK 340
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1346), Expect = e-148, Method: Compositional matrix adjust.
Identities = 241/334 (72%), Positives = 291/334 (87%), Gaps = 3/334 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS + RVG+YE+GRT+GEGTFAKVKFARN+++GE VA+KILDK+KVLKHKM QIKR
Sbjct: 1 MSVSGGRTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL++HPNV+R++EVM SKTKI+IV+E VTGGELFDKI + GR+KED+AR+YFQQL
Sbjct: 61 EISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSALSQQVR+DGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNLM+LYKKI A+F+CP W S +
Sbjct: 181 APEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS--EEH 298
A+KLI +ILDPNP TRITI E++ +EWFKK Y+PP F E D NLDD+ ++F +S +
Sbjct: 241 AKKLIKKILDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNESGDQTQ 299
Query: 299 HVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAE 332
V E++EE+P MNAFELIS S+GLNLG LF+ +
Sbjct: 300 LVVERREERPSVMNAFELISTSQGLNLGTLFEKQ 333
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 523 bits (1346), Expect = e-147, Method: Compositional matrix adjust.
Identities = 246/328 (75%), Positives = 286/328 (87%), Gaps = 6/328 (1%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
VGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMKL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
RGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N++G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
YDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI RIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHH--VTEQKEE- 306
DPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F DS E V E++EE
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFEN-ADVSLDDVDAIFDDSGESKNLVVERREEG 326
Query: 307 --QPVAMNAFELISLSKGLNLGNLFDAE 332
PV MNAFELIS S+GLNLG+LF+ +
Sbjct: 327 LKTPVTMNAFELISTSQGLNLGSLFEKQ 354
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 506 bits (1302), Expect = e-142, Method: Compositional matrix adjust.
Identities = 233/332 (70%), Positives = 283/332 (85%), Gaps = 2/332 (0%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ P + RVG YE+GRT+GEG+FAKVK+A+N+ TG+ A+KILD+EKV +HKM EQ+KRE
Sbjct: 8 ATPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKRE 67
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++TMKL+KHPNVV + EVM SKTKI+IVLE V GGELFDKI GR+KEDEARRYFQQLI
Sbjct: 68 ISTMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLI 127
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
NAVDYCHSRGVYHRDLKPENL+LDA G LKVSDFGLSA S+QVR+DGLLHT CGTPNYVA
Sbjct: 128 NAVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVA 187
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEVL+D+GYDG+ AD+WSCGVILFVL+AGYLPFD+ NLM LYK+I AEF+CPPW S A
Sbjct: 188 PEVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGA 247
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDSEEHHV 300
+++I RIL+PNP+TRI+I E+LEDEWFKK YKPP F ++ +D +DDV+A F +S+E V
Sbjct: 248 KRVIKRILEPNPITRISIAELLEDEWFKKGYKPPSFDQDDEDITIDDVDAAFSNSKECLV 307
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAE 332
TE+K E+PV+MNAFELIS S +L NLF+ +
Sbjct: 308 TEKK-EKPVSMNAFELISSSSEFSLENLFEKQ 338
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 504 bits (1299), Expect = e-142, Method: Compositional matrix adjust.
Identities = 232/329 (70%), Positives = 278/329 (84%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++R +GKYE+GR IG+GTFAKV+FA+N ETG+ VA+KILDK KV KH++ EQI+RE+ T
Sbjct: 11 KVRRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQIRREICT 70
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL++HPNVV L+EVMGSKT+IFIVLE+V GGEL D I GR+KEDEAR+YFQQLINAV
Sbjct: 71 MKLIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAV 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLK ENLLLD GN+KVSDFGLSA+S+QV+ DGLLHTTCGTPNYVAPEV
Sbjct: 131 DYCHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEV 190
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
+ D+GYDG+ ADLWSCGVILFVLLAGYLPF+D N+++LY KIS A+FTCP W S A++L
Sbjct: 191 IEDKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWFSAEAKRL 250
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
IARILDPNP TRIT ++L+D+WFKK Y+ PVF++K DV F DSEE HV E
Sbjct: 251 IARILDPNPATRITTSQVLQDQWFKKGYESPVFDDKYYPYFHDVYDAFGDSEEKHVKEAM 310
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
EEQP MNAFELISL+KGLNL N F++++
Sbjct: 311 EEQPTLMNAFELISLNKGLNLDNFFESDK 339
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10SC8|CIPK9_ORYSJ CBL-interacting protein kinase 9 OS=Oryza sativa subsp. japonica GN=CIPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 231/326 (70%), Positives = 278/326 (85%), Gaps = 1/326 (0%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
RVG+YE+G+TIGEG+FAKVK AR++ TG+ +A+K+LD+ VL+HKM EQIKRE++TMKL+
Sbjct: 23 RVGRYELGKTIGEGSFAKVKVARDTRTGDTLAIKVLDRNHVLRHKMVEQIKREISTMKLI 82
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
KHPNVV+L+EVM SK+KI++VLE+V GGELFDKIVN GR+ EDEARRYF QLINAVDYCH
Sbjct: 83 KHPNVVQLHEVMASKSKIYMVLEYVDGGELFDKIVNSGRLGEDEARRYFHQLINAVDYCH 142
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
SRGVYHRDLKPENLLLD++G LKVSDFGLSA + Q ++DGLLHT CGTPNYVAPEVL D+
Sbjct: 143 SRGVYHRDLKPENLLLDSHGALKVSDFGLSAFAPQTKEDGLLHTACGTPNYVAPEVLADK 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
GYDG AD+WSCG+ILFVL+AGYLPFDD NLM LYK I A+ +CP W S A+K I RI
Sbjct: 203 GYDGMAADVWSCGIILFVLMAGYLPFDDPNLMTLYKLICKAKVSCPHWFSSGAKKFIKRI 262
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 308
LDPNP TRITI +ILED+WFKKDYKPP+FE+ +D +LDDV+A F SEE+ V E K E+P
Sbjct: 263 LDPNPCTRITIAQILEDDWFKKDYKPPLFEQGEDVSLDDVDAAFDCSEENLVAE-KREKP 321
Query: 309 VAMNAFELISLSKGLNLGNLFDAEQV 334
+MNAF LIS S+G NLGNLF+ E +
Sbjct: 322 ESMNAFALISRSQGFNLGNLFEKEMM 347
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| 255583653 | 466 | CBL-interacting serine/threonine-protein | 0.997 | 0.714 | 0.957 | 0.0 | |
| 224120590 | 440 | predicted protein [Populus trichocarpa] | 0.997 | 0.756 | 0.943 | 0.0 | |
| 225435981 | 439 | PREDICTED: CBL-interacting serine/threon | 0.997 | 0.758 | 0.939 | 0.0 | |
| 147815805 | 439 | hypothetical protein VITISV_010092 [Viti | 0.997 | 0.758 | 0.939 | 0.0 | |
| 154425355 | 441 | CBL-interacting protein kinase [Vigna un | 0.997 | 0.755 | 0.921 | 0.0 | |
| 363807728 | 414 | uncharacterized protein LOC100794566 [Gl | 0.997 | 0.804 | 0.921 | 0.0 | |
| 357493713 | 441 | CBL-interacting protein kinase [Medicago | 0.997 | 0.755 | 0.909 | 0.0 | |
| 62857008 | 441 | Ser/Thr protein kinase [Lotus japonicus] | 0.997 | 0.755 | 0.909 | 0.0 | |
| 224106656 | 440 | predicted protein [Populus trichocarpa] | 0.997 | 0.756 | 0.925 | 0.0 | |
| 357493717 | 338 | CBL-interacting protein kinase [Medicago | 1.0 | 0.988 | 0.910 | 0.0 |
| >gi|255583653|ref|XP_002532581.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223527690|gb|EEF29798.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 669 bits (1727), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 319/333 (95%), Positives = 326/333 (97%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 28 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 87
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 88 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 147
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 148 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 207
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 208 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 267
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEIL DEWFKKDYK PVFEEK+DTNLDDVEAVFKDSEEHHV
Sbjct: 268 AMKLITRILDPNPMTRITIPEILVDEWFKKDYKVPVFEEKEDTNLDDVEAVFKDSEEHHV 327
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP AMNAFELIS+SKGLNLGNLFD+EQ
Sbjct: 328 TEKKEEQPTAMNAFELISMSKGLNLGNLFDSEQ 360
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120590|ref|XP_002330980.1| predicted protein [Populus trichocarpa] gi|116265926|gb|ABJ91211.1| CBL-interacting protein kinase 3 [Populus trichocarpa] gi|118485622|gb|ABK94661.1| unknown [Populus trichocarpa] gi|222872772|gb|EEF09903.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 659 bits (1699), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 315/334 (94%), Positives = 324/334 (97%), Gaps = 1/334 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EIETMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSN+MNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGTTADLWSCGVILFVLLAGYLPFDDSNVMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEIL DEWFKK YKPPVFEEK+DTNLDDVEAVFKDSEEHHV
Sbjct: 241 AMKLITRILDPNPMTRITIPEILVDEWFKKGYKPPVFEEKEDTNLDDVEAVFKDSEEHHV 300
Query: 301 TEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+K EEQP AMNAFELIS+SKGLNLGNLFD EQ
Sbjct: 301 TEKKEEEQPTAMNAFELISMSKGLNLGNLFDGEQ 334
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435981|ref|XP_002271894.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3 [Vitis vinifera] gi|229609837|gb|ACQ83534.1| CBL-interacting protein kinase 18 [Vitis vinifera] gi|296083952|emb|CBI24340.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/333 (93%), Positives = 322/333 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSEEHHV
Sbjct: 241 AMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+ EEQP AMNAFELIS+S+GLNLGNLFD EQ
Sbjct: 301 TEKTEEQPAAMNAFELISMSRGLNLGNLFDIEQ 333
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815805|emb|CAN70422.1| hypothetical protein VITISV_010092 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 655 bits (1690), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/333 (93%), Positives = 321/333 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRITIPEILEDEWFKK YKPPVFEEK D NLDDVEAVFKDSEEHHV
Sbjct: 241 AMKLITRILDPNPMTRITIPEILEDEWFKKGYKPPVFEEKGDANLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+ EEQP AMNAFELIS+S GLNLGNLFD EQ
Sbjct: 301 TEKTEEQPAAMNAFELISMSXGLNLGNLFDIEQ 333
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|154425355|dbj|BAF74756.1| CBL-interacting protein kinase [Vigna unguiculata] | Back alignment and taxonomy information |
|---|
Score = 651 bits (1679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/333 (92%), Positives = 321/333 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKI++VLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIYVVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDP+P TRITIPEIL+DEWFKKDYKPPVFEE + NLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPDPTTRITIPEILDDEWFKKDYKPPVFEENGEINLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP +MNAFELIS+SKGLNL NLFD EQ
Sbjct: 301 TEKKEEQPTSMNAFELISMSKGLNLENLFDTEQ 333
|
Source: Vigna unguiculata Species: Vigna unguiculata Genus: Vigna Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807728|ref|NP_001242682.1| uncharacterized protein LOC100794566 [Glycine max] gi|255638908|gb|ACU19756.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 648 bits (1671), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/333 (92%), Positives = 320/333 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVK ARNSETGEPVALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKSARNSETGEPVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKI+IVLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIYIVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRD KPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDPKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPWLSFT
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPWLSFT 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDP+P TRITIPEIL+DEWFKK+YKPP+FEE + NLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPDPTTRITIPEILDDEWFKKEYKPPIFEENGEINLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP AMNAFELIS+SKGLNL NLFD EQ
Sbjct: 301 TEKKEEQPTAMNAFELISMSKGLNLENLFDTEQ 333
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493713|ref|XP_003617145.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518480|gb|AET00104.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1659), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/333 (90%), Positives = 319/333 (95%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDPNPMTRIT+ EIL+DEWFKKDYKPPVFEE +TNLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPNPMTRITMAEILDDEWFKKDYKPPVFEESGETNLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP +MNAFELIS+S+GLNL NLFD EQ
Sbjct: 301 TEKKEEQPTSMNAFELISMSRGLNLENLFDVEQ 333
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|62857008|dbj|BAD95889.1| Ser/Thr protein kinase [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/333 (90%), Positives = 320/333 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MNQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVV+LYEV+GSKTKI++VLEFVTGGELFDKIVNHGRM EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVQLYEVLGSKTKIYMVLEFVTGGELFDKIVNHGRMCEDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INTVDYCHSRGVYHRDLKPENLLLDACGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDKGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDPNPMTRITI EILEDEWFKKDYKPP+F+E +TNLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPNPMTRITIAEILEDEWFKKDYKPPIFQENGETNLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP AMNAFELIS+SKGLNL NLFD EQ
Sbjct: 301 TEKKEEQPTAMNAFELISMSKGLNLENLFDVEQ 333
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106656|ref|XP_002314239.1| predicted protein [Populus trichocarpa] gi|116265928|gb|ABJ91212.1| CBL-interacting protein kinase 4 [Populus trichocarpa] gi|222850647|gb|EEE88194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/334 (92%), Positives = 320/334 (95%), Gaps = 1/334 (0%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYE+GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEMGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMK +KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEAR YF QL
Sbjct: 61 EVATMKRIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARGYFHQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+ ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGAPADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A KLI RILDPNPMTRIT+ EIL DEWFKK YK PVFEEK+DTNLDDVEAVFKDSEE+HV
Sbjct: 241 AMKLITRILDPNPMTRITVSEILVDEWFKKGYKTPVFEEKEDTNLDDVEAVFKDSEENHV 300
Query: 301 TEQK-EEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+K EEQP AMNAFELIS+S+GLNLGNLFD EQ
Sbjct: 301 TEKKEEEQPTAMNAFELISMSRGLNLGNLFDGEQ 334
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493717|ref|XP_003617147.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518482|gb|AET00106.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/334 (91%), Positives = 320/334 (95%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
ARKLI RILDPNPMTRIT+ EIL+DEWFKKDYKPPVFEE +TNLDDVEAVFKDSEEHHV
Sbjct: 241 ARKLITRILDPNPMTRITMAEILDDEWFKKDYKPPVFEESGETNLDDVEAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQV 334
TE+KEEQP +MNAFELIS+S+GLNL NLFD EQV
Sbjct: 301 TEKKEEQPTSMNAFELISMSRGLNLENLFDVEQV 334
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.985 | 0.729 | 0.860 | 6.1e-158 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.997 | 0.758 | 0.807 | 3.4e-148 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.973 | 0.674 | 0.746 | 3e-133 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.898 | 0.361 | 0.766 | 1.1e-124 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.979 | 0.733 | 0.650 | 1.7e-114 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.967 | 0.725 | 0.642 | 1.9e-113 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.940 | 0.712 | 0.572 | 2.4e-99 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.937 | 0.743 | 0.586 | 5e-99 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.940 | 0.715 | 0.572 | 2.8e-98 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.859 | 0.586 | 0.586 | 1.1e-97 |
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1539 (546.8 bits), Expect = 6.1e-158, P = 6.1e-158
Identities = 283/329 (86%), Positives = 313/329 (95%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 16 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 75
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 76 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 135
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 136 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 195
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 196 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 255
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
I RILDPNPMTR+T E+ EDEWFKKDYKPPVFEE+ D+N+DD++AVFKDSEEH VTE++
Sbjct: 256 ITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKR 315
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
EEQP A+NAFE+IS+S+GLNL NLFD EQ
Sbjct: 316 EEQPAAINAFEIISMSRGLNLENLFDPEQ 344
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1447 (514.4 bits), Expect = 3.4e-148, P = 3.4e-148
Identities = 269/333 (80%), Positives = 305/333 (91%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
A+ LI RILDPNPMTRITIPE+L D WFKK+YKP VFEEK++ NLDDV+AVFKDSEEHHV
Sbjct: 241 AKNLIVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHV 300
Query: 301 TEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
TE+KEEQP +MNAFELIS+S+ L+LGNLF+ E+
Sbjct: 301 TEKKEEQPTSMNAFELISMSRALDLGNLFEEEE 333
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
Identities = 247/331 (74%), Positives = 288/331 (87%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ RVGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMK
Sbjct: 25 RTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMK 84
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
L+KHPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDY
Sbjct: 85 LIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDY 144
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
CHSRGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N
Sbjct: 145 CHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 204
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI
Sbjct: 205 NKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIK 264
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHH--VTEQK 304
RILDPNP TRIT E++E+EWFKK YK P FE D +LDDV+A+F DS E V E++
Sbjct: 265 RILDPNPATRITFAEVIENEWFKKGYKAPKFENA-DVSLDDVDAIFDDSGESKNLVVERR 323
Query: 305 EE---QPVAMNAFELISLSKGLNLGNLFDAE 332
EE PV MNAFELIS S+GLNLG+LF+ +
Sbjct: 324 EEGLKTPVTMNAFELISTSQGLNLGSLFEKQ 354
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1225 (436.3 bits), Expect = 1.1e-124, P = 1.1e-124
Identities = 230/300 (76%), Positives = 261/300 (87%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS+PK++R VGKYEVGR IGE F K++ A ++ETG+PVAL ILDK+KVLKHKMAEQIKR
Sbjct: 1 MSEPKVRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++ MKL+ HPNVV+LYEV+ SK KI+IVLEF++GG+LFDKI N GRM EDEA+RYFQQL
Sbjct: 61 EISIMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA NLKV++FGL ALSQQ DGL HT CG P+Y
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+ ADLWSCGVILFVLLAGYLPF+DS+L LYKKIS+A+F+CPPWLS
Sbjct: 181 APEVLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSG 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHV 300
+ LI RILDPNPMTRITIPEILED WFKKDYKP VFEEKK+ NL DVEAVFKDSEE V
Sbjct: 241 VKNLIVRILDPNPMTRITIPEILEDVWFKKDYKPAVFEEKKEANLADVEAVFKDSEEGRV 300
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1129 (402.5 bits), Expect = 1.7e-114, P = 1.7e-114
Identities = 216/332 (65%), Positives = 268/332 (80%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K RRVGKYEVGRTIGEGTFAKVKFARN++TG+ VA+KI+ K +LK++M +QIKRE++
Sbjct: 3 KKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISI 62
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MK+V+HPN+VRLYEV+ S +KI+IVLEFVTGGELFD+IV+ GR++E E+R+YFQQL++AV
Sbjct: 63 MKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAV 122
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CH +GVYHRDLKPENLLLD GNLKVSDFGLSAL Q+ + LL TTCGTPNYVAPEV
Sbjct: 123 AHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEV 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
L+ +GYDGS AD+WSCGVILFV+LAGYLPF +++L LY+KI+AAEF+CPPW S + L
Sbjct: 181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
I RILDPNP TRI I I +D WF+ +Y P E+++ NLDD+ AVF E +V E
Sbjct: 241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300
Query: 305 E---EQPVAMNAFELISLSKGLNLGNLFDAEQ 333
E E P+ MNAFE+I+LS+GLNL LFD Q
Sbjct: 301 ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQ 332
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1119 (399.0 bits), Expect = 1.9e-113, P = 1.9e-113
Identities = 210/327 (64%), Positives = 262/327 (80%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R+VGKYE+GRTIGEGTFAKVKFA+N+ETGE VA+KI+D+ ++K KM +QIKRE++ M
Sbjct: 2 VVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIM 61
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
KLV+HP VVRLYEV+ S+TKI+I+LE++TGGELFDKIV +GR+ E EAR+YF QLI+ VD
Sbjct: 62 KLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVD 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
YCHS+GVYHRDLKPENLLLD+ GNLK+SDFGLSAL +Q +L TTCGTPNYVAPEVL
Sbjct: 122 YCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQ--GVTILKTTCGTPNYVAPEVL 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+ +GY+G+ AD+WSCGVIL+VL+AGYLPFD+ +L LY KI AEF+CP + + A+ LI
Sbjct: 180 SHKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLI 239
Query: 246 ARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQ-- 303
RILDPNP TRITI EI +DEWF KDY P + + NLDDV A F D EE +
Sbjct: 240 NRILDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGT 299
Query: 304 KEEQPVAMNAFELISLSKGLNLGNLFD 330
++ P+ +NAF+LI LS+GLNL LFD
Sbjct: 300 RDTGPLTLNAFDLIILSQGLNLATLFD 326
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 2.4e-99, P = 2.4e-99
Identities = 186/325 (57%), Positives = 246/325 (75%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+YE+GR +G GTFAKV ARN +TG+ VA+K++ KEKV+K M +QIKRE++ M++VKH
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V L+EVM SK+KI+ +E V GGELF K+ GR++ED AR YFQQLI+AVD+CHSR
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GVYHRDLKPENLLLD GNLKV+DFGLSA ++ ++ DGLLHTTCGTP YVAPEV+ +GY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
DG+ ADLWSCGVILFVLLAGYLPF D NL+N+Y+KI +F CP WLS AR+L+ ++LD
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLD 260
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEH--HVTEQKEEQP 308
PNP TRITI ++++ WFKK + + N + V A +EE + + +E+
Sbjct: 261 PNPNTRITIEKVMDSPWFKK-------QATRSRN-EPVAATITTTEEDVDFLVHKSKEET 312
Query: 309 VAMNAFELISLSKGLNLGNLFDAEQ 333
+NAF +I+LS+G +L LF+ ++
Sbjct: 313 ETLNAFHIIALSEGFDLSPLFEEKK 337
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 983 (351.1 bits), Expect = 5.0e-99, P = 5.0e-99
Identities = 187/319 (58%), Positives = 251/319 (78%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YEVG+ +G+GTFAKV AR+ +TG+ VA+K++DKE++LK M EQIKRE++ M+L++HP
Sbjct: 11 RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKREISAMRLLRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L+EVM +K+KI+ V+E V GGELF+K V+ G+++ED AR+YFQQL+ AVD+CHSRG
Sbjct: 71 NIVELHEVMATKSKIYFVMEHVKGGELFNK-VSTGKLREDVARKYFQQLVRAVDFCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKPENLLLD +GNLK+SDFGLSALS R DGLLHTTCGTP YVAPEV++ GYD
Sbjct: 130 VCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPEVISRNGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G AD+WSCGVILFVLLAGYLPF DSNLM LYKKI AE P WL+ A++L+ RILDP
Sbjct: 190 GFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKRLLKRILDP 249
Query: 252 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAM 311
NP TR++ +I++ WF+K + EE K++ ++ E V ++E + E+++++ + +
Sbjct: 250 NPNTRVSTEKIMKSSWFRKGLQ----EEVKESVEEETE-VDAEAEGNASAEKEKKRCINL 304
Query: 312 NAFELISLSKGLNLGNLFD 330
NAFE+ISLS G +L LF+
Sbjct: 305 NAFEIISLSTGFDLSGLFE 323
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 976 (348.6 bits), Expect = 2.8e-98, P = 2.8e-98
Identities = 185/323 (57%), Positives = 246/323 (76%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+GR +G+GTFAKV ARN +TGE VA+K++DK+KV K + +QIKRE++ M+LV+HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+VV L+EVM SKTKI+ +E+V GGELFDK V+ G++KE+ AR+YFQQLI A+DYCHSRG
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRDLKPENLLLD G+LK+SDFGLSAL + + DGLLHTTCGTP YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+L+VLLAG+LPF + NL+ +Y+KI+ EF CP W +KL++RILDP
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 252 NPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAM 311
NP +RI I +I+E+ WF+K +K E K ++++ D H K P++
Sbjct: 250 NPNSRIKIEKIMENSWFQKGFKK--IETPKSPESHQIDSLISDV--HAAFSVK---PMSY 302
Query: 312 NAFELIS-LSKGLNLGNLFDAEQ 333
NAF+LIS LS+G +L LF+ E+
Sbjct: 303 NAFDLISSLSQGFDLSGLFEKEE 325
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 915 (327.2 bits), Expect = 1.1e-97, Sum P(2) = 1.1e-97
Identities = 170/290 (58%), Positives = 221/290 (76%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+G+YE+G+ +G GTFAKV ARN +T E VA+K++DKEKVLK + IKRE++ ++ V+
Sbjct: 23 LGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREISILRRVR 82
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V+L+EVM +K KI+ V+E+V GGELF+K+ GR+KE+ AR+YFQQLI+AV +CH+
Sbjct: 83 HPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAK-GRLKEEVARKYFQQLISAVTFCHA 141
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
RGVYHRDLKPENLLLD GNLKVSDFGLSA+S Q+R DGL HT CGTP YVAPEVL +G
Sbjct: 142 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
YD + D+WSCGVILFVL+AGYLPF D N+M +YKKI EF CP W S +L++++L
Sbjct: 202 YDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRLLSKLL 261
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVF--EEKKDTNLDDVEAVFKDSEE 297
+ NP R T PEI+E+ WFKK +K F E+ K N+ D + + DS E
Sbjct: 262 ETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVE 311
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2V452 | CIPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8601 | 0.9850 | 0.7460 | yes | no |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8498 | 0.9940 | 0.7579 | yes | no |
| Q2RAX3 | CIPKX_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8498 | 0.9940 | 0.7312 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 334 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-109 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-95 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-80 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-77 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-72 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-67 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-65 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-64 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-63 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-62 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-61 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-54 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-53 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-51 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-51 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-50 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-48 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-48 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-48 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-48 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-47 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-47 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-47 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-47 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-46 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-46 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-46 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-45 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-45 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-45 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-44 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-44 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-43 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-43 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-43 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-42 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-41 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-41 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-41 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-41 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-41 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-40 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-40 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-40 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-39 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-39 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-39 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-39 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-39 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-38 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-38 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-38 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-38 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-37 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-37 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-37 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-37 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-36 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-36 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-35 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-35 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-35 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-35 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-34 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-34 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-34 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-34 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-34 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-34 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-34 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-34 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-33 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-33 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-33 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-33 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-33 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-33 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-32 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-32 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-32 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-32 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-31 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-31 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-31 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-31 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-30 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-30 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-29 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-29 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-29 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-29 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-28 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-27 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-25 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-25 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-25 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-24 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-24 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-24 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-24 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-23 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-21 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-21 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-20 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-19 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-19 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-05 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-109
Identities = 116/260 (44%), Positives = 174/260 (66%), Gaps = 10/260 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ +GEG+F KV AR+ +TG+ VA+K++ K+K+ K + E+I RE+ +K +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRLY+V + K+++V+E+ GG+LFD + GR+ EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G++K++DFGL+ Q+ L T GTP Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 193 STADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPPW---LSFTARKLIARI 248
+ D+WS GVIL+ LL G PF D L+ L+KKI + PP +S A+ LI ++
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 249 LDPNPMTRITIPEILEDEWF 268
L +P R+T E L+ +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 282 bits (725), Expect = 3e-95
Identities = 104/263 (39%), Positives = 154/263 (58%), Gaps = 10/263 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ R +G G+F V A++ TG+ VA+KIL K K K + +RE+ ++ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRL + K +++V+E+ GG+LFD + G + EDEA++ Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G +K++DFGL+ + ++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSF--TARKLI 245
D+WS GVIL+ LL G PF N+++ + I EF P W S A+ LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 246 ARILDPNPMTRITIPEILEDEWF 268
+ L+ +P R T EIL+ WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 4e-80
Identities = 97/262 (37%), Positives = 153/262 (58%), Gaps = 11/262 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +T+G G+F +V R+ +G+ ALKIL K K++K K E + E ++ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + +++V+E+V GGELF + GR E AR Y Q++ A++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPENLLLD+ G +K++DFG + R G +T CGTP Y+APE++ +GY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +LAGY PF D N + +Y+KI + P + S A+ LI +L +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 253 PMTRI-----TIPEILEDEWFK 269
R+ + +I WF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 2e-77
Identities = 98/253 (38%), Positives = 150/253 (59%), Gaps = 6/253 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G+F KV R +TG+ A+K+L K+K++K K E E + + HP +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++ K+++VLE+ GGELF + GR E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLDA G++K++DFGL+ + +T CGTP Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
S GV+L+ +L G PF + +Y+KI P +LS AR LI+ +L +P R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 259 ---IPEILEDEWF 268
EI +F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 4e-72
Identities = 96/249 (38%), Positives = 139/249 (55%), Gaps = 37/249 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG F V AR+ +TG+ VA+KI+ KE + E++ RE+ +K + HPN+V+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V + +++V+E+ GG L D + N G++ EDE R Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 138 KPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
KPEN+LLD+ G +K++DFGLS L D LL T GTP Y+APEVL +GY +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
+WS GVIL+ L P L + LI ++L +P R
Sbjct: 177 IWSLGVILYEL---------------------------PEL----KDLIRKMLQKDPEKR 205
Query: 257 ITIPEILED 265
+ EILE
Sbjct: 206 PSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 1e-67
Identities = 90/279 (32%), Positives = 152/279 (54%), Gaps = 24/279 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
++ G+ IGEG+F+ V A+ ET + A+KILDK +++K K + +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+++LY + ++ VLE+ GEL I +G + E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT------------ 173
+ HRDLKPEN+LLD ++K++DFG + + + + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT YV+PE+LN+ G ++DLW+ G I++ +L G PF SN ++KI E++
Sbjct: 183 VGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 234 PPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 268
PP A+ LI ++L +P R+ + E+ +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 6e-65
Identities = 90/259 (34%), Positives = 140/259 (54%), Gaps = 11/259 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+ + IG+G+F KV R G+ LK +D + K E EV +K + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
N+++ YE K K+ IV+E+ GG+L KI + E++ +F QL A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR + HRD+KP+N+ L + G +K+ DFG+S LS L T GTP Y++PE+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---TVDLAKTVVGTPYYLSPELCQ 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLI 245
++ Y+ +D+WS G +L+ L PF+ NL+ L KI ++ P S R L+
Sbjct: 177 NKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235
Query: 246 ARILDPNPMTRITIPEILE 264
+ +L +P R +I +IL+
Sbjct: 236 SSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 6e-64
Identities = 88/262 (33%), Positives = 145/262 (55%), Gaps = 12/262 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I +G + +V A+ TG+ A+K++ K +++ +Q+ E + + P VV+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K +++V+E++ GG+L + N G + ED AR Y +++ A++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL------HTTCGTPNYVAPEVLNDRGYDG 192
P+N+L+D+ G+LK++DFGLS + R L GTP+Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILD 250
T D WS G IL+ L G PF +++ I + P +S A LI+++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 251 PNPMTRI---TIPEILEDEWFK 269
P+P R+ +I EI +FK
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 9e-63
Identities = 94/249 (37%), Positives = 148/249 (59%), Gaps = 6/249 (2%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
++ +E+G T+G G+F +V+ A++ TGE A+K L K ++LK K + + +E + + +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HP +V + + +++ +LEFV GGELF + GR D A+ Y +L+ A +Y H
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
S+ + +RDLKPENLLLD G++KV+DFG +++V D T CGTP Y+APEV+ +
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFG---FAKKVPDR--TFTLCGTPEYLAPEVIQSK 190
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
G+ G D W+ GV+L+ +AGY PF D +Y+KI A P W AR L+ +
Sbjct: 191 GH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 249 LDPNPMTRI 257
L + R+
Sbjct: 250 LQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 4e-62
Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 17/261 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F +V+ + ALK + K +++ E I E ++ HP +V+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K I++++E+ GGEL+ + + G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PENLLLD+ G +K+ DFG +++++ T CGTP YVAPE++ ++GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 199 SCGVILFVLLAGYLPF--DDSNLMNLYKKI----SAAEFTCPPWLSFTARKLIARILDPN 252
S G++L+ LL G PF DD + M +Y I EF P ++ A+ LI ++L N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN 234
Query: 253 PMTRI-----TIPEILEDEWF 268
P R+ I +I + +WF
Sbjct: 235 PEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 4e-61
Identities = 79/263 (30%), Positives = 136/263 (51%), Gaps = 9/263 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ G +G G+F V A + +TGE +A+K ++ + E ++RE+ + ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59
Query: 72 NVVRLYEVMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+VR Y + K I LE+V+GG L + G++ E R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+K N+L+D+ G +K++DFG + + + GTP ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPP---WLSFTARKLI 245
Y G AD+WS G + + G P+ + N M KI ++ P LS A+ +
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFL 237
Query: 246 ARILDPNPMTRITIPEILEDEWF 268
+ L +P R T E+L+ +
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 2e-54
Identities = 90/278 (32%), Positives = 153/278 (55%), Gaps = 20/278 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E +T+G GTF +V R+ + ALK++ +V++ K + + E +K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++RL+ + +++++E+V GGELF + N GR Y +++ A++Y HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG ++++RD T CGTP Y+APEV+ +G+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +L GY PF D N +Y+KI A + P L A+ LI ++L +
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 253 PMTRI-----TIPEILEDEWFK---------KDYKPPV 276
R+ ++ WFK + KPP+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPI 274
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 181 bits (458), Expect = 6e-54
Identities = 97/313 (30%), Positives = 151/313 (48%), Gaps = 28/313 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + R +GEG+F +V AR+ + VALK+L K+ K K E+ RE+ + + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 -NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
N+V+LY+ + +++V+E+V GG L D + GR + E EA Q+++A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL----SQQVRDDGLLHTTCGTPNYVAP 182
HS+G+ HRD+KPEN+LLD G +K+ DFGL+ L L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 183 EVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTC--- 233
EVL Y S++D+WS G+ L+ LL G PF+ + K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 ------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDD 287
P +S A L+ ++L +P R++ L + K + DD
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL-AHLKLKESDLSDLLKPDD 296
Query: 288 VEAVFKDSEEHHV 300
+
Sbjct: 297 SAPLRLSLPPSLE 309
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-53
Identities = 87/260 (33%), Positives = 141/260 (54%), Gaps = 11/260 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ IG+G F +V AR+ TG+ VA+K++ K + + K E+I E+ +K KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHP 57
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+ Y K +++IV+EF +GG L D + + + E + ++L+ ++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ HRD+K N+LL + G +K+ DFGLSA Q+ D +T GTP ++APEV+N + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIAR 247
D AD+WS G+ L G P+ + M KI+ P S + + +
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 248 ILDPNPMTRITIPEILEDEW 267
L NP R T ++L+ +
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-51
Identities = 90/266 (33%), Positives = 137/266 (51%), Gaps = 16/266 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
YEV TIG+G+F V+ R G+ + K +D + K +Q+ EV ++ +KHP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59
Query: 72 NVVRLY--EVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVD 125
N+VR Y + S ++IV+E+ GG+L I ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 126 YCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
CH+R V HRDLKP N+ LDA N+K+ DFGL+ + D T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSF 239
+PE LN YD + D+WS G +++ L A PF N + L KI +F P S
Sbjct: 178 SPEQLNHMSYDEKS-DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
++I +L+ +P R + E+L+
Sbjct: 237 ELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-51
Identities = 106/340 (31%), Positives = 161/340 (47%), Gaps = 60/340 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKL 67
+EV + IG G F +V R+ +TG+ A+K+L K ++K H AE R++ +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE---RDI--LAD 57
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
P +V+LY + +++V+E++ GG+L + ++ E+ AR Y +L+ A+D
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---------------LSQQVRDDGLLH- 171
H G HRD+KP+N+L+DA G++K++DFGL + RD+ L+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 172 -----------TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+T GTP+Y+APEVL Y D WS GVIL+ +L G+ PF L
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 221 NLYKKISAAE--FTCPP--WLSFTARKLIARIL-DP-NPMTRITIPEILEDEWFKK---- 270
Y KI + PP +S A LI R+L DP + + EI +FK
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFE--EIKSHPFFKGIDWE 294
Query: 271 ---DYKPPV---FEEKKDT-NLDDVEAVFKDSEEHHVTEQ 303
+ KPP DT N DD E D + Q
Sbjct: 295 NLRETKPPFVPELSSPLDTSNFDDFE---DDKDLSDYLSQ 331
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 9e-50
Identities = 88/306 (28%), Positives = 135/306 (44%), Gaps = 74/306 (24%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATMK 66
YE +GEGT+ V AR+ +TGE VALK LD E+ E I RE++ +K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLK 53
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE-----LFDKIVNHGRMKEDEARRYFQQLI 121
+KHPN+V+L +V+ ++ K+++V E+ + DK G + + + QL+
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLL 108
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN-- 178
+ YCHS + HRDLKP+N+L++ G LK++DFGL+ A +R T
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--------TYTHEVV 160
Query: 179 ---YVAPEVL-NDRGYDGSTADLWSCGVIL------FVLLAG------------------ 210
Y APE+L + Y + D+WS G I L G
Sbjct: 161 TLWYRAPEILLGSKHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 211 --------YLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 262
LP D + + P L L++++L NP RI+ E
Sbjct: 220 EESWPGVTKLP-DYKPTFPKFPPKDLEKVL--PRLDPEGIDLLSKMLQYNPAKRISAKEA 276
Query: 263 LEDEWF 268
L+ +F
Sbjct: 277 LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 72/248 (29%), Positives = 135/248 (54%), Gaps = 7/248 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ R IG+G F KV + +T + A+K ++K+K ++ + E ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L+ + +++V++ + GG+L + + E++ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+KP+N+LLD G++ ++DF ++ +V D L +T GTP Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 193 STADLWSCGVILFVLLAGYLPFD--DSNLMNLYK-KISAAEFTCPPWLSFTARKLIARIL 249
D WS GV + L G P+ + + + K A+ P S A I ++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 250 DPNPMTRI 257
+ +P R+
Sbjct: 238 ERDPQKRL 245
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 15/259 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLY 77
I +G F V A+ TG+ A+K+L K ++ +K E A M + P V +LY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
SK +++V+E++ GG+ I G + ED A++Y +++ V+ H RG+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KPENLL+D G+LK++DFGLS + + GTP+Y+APE + G D +D
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVG-DDKMSDW 176
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNP 253
WS G ++F L GY PF ++ I + P + S A LI R+L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
Query: 254 MTRI---TIPEILEDEWFK 269
R+ EI +FK
Sbjct: 237 AKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 4e-48
Identities = 90/276 (32%), Positives = 143/276 (51%), Gaps = 29/276 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G + +V A+ +TGE VALK + K + K + E + K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+++ +E+V GG+ + N G + ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL---HTTCGTPNYVAPEVLNDRGYDGSTA 195
PEN L+DA G++K++DFGLS G++ ++ G+P+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 196 DLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKISAAEFTCPPW-LSFTARKLIAR 247
D WS G +L+ L G+ PF S NL + + + P + LS A LI +
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239
Query: 248 ILDPNPMTRI-TIPEILEDEWFKK-------DYKPP 275
+++ +P R ++ +I +FK+ + KPP
Sbjct: 240 LIN-DPSRRFGSLEDIKNHPFFKEVDWNELRELKPP 274
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 8e-48
Identities = 85/242 (35%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R +G+G+F KV AR E+G A+K+L K+ +L+ E E + L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY + ++F V+EFV GG+L I R E AR Y ++ +A+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +L G+ PF+ N +L++ I E P WLS A ++ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 1e-47
Identities = 86/245 (35%), Positives = 143/245 (58%), Gaps = 7/245 (2%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKHPN 72
+ +G+G + KV R ++TG+ A+K+L K ++++ K K E ++ VKHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLDA G++K++DFGL + + + + HT CGT Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 253 PMTRI 257
P +R+
Sbjct: 239 PSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 1e-47
Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 23/267 (8%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
G IG GTF KV A N +TGE +A+K + + K ++I E+ ++L+KHPN+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA--RRYFQQLINAVDYCHSRGVY 133
Y V + K++I +E+ +GG L + ++ HGR+ DE R Y QL+ + Y HS G+
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 134 HRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRD+KP N+ LD G +K+ DFG L + + + + GTP Y+APEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGGK 179
Query: 190 YDG--STADLWSCGVILFVLLAGYLPFD--DSNLMNLYKKISAAEFTCPPW-----LSFT 240
G AD+WS G ++ + G P+ D+ ++ + A PP LS
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGH--KPPIPDSLQLSPE 236
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
+ + R L+ +P R T E+L+ +
Sbjct: 237 GKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-47
Identities = 80/261 (30%), Positives = 130/261 (49%), Gaps = 11/261 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++G IG G F V N ETG+ VA+K + EK+ + + I +E+ +K +KHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+ + + ++I+LE+ G L I G E Y Q++ + Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K N+L G +K++DFG++ ++ + GTP ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGA- 176
Query: 192 GSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW---LSFTARKLIAR 247
STA D+WS G + LL G P+ D N M +I + PP +S + + +
Sbjct: 177 -STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--VQDDHPPLPEGISPELKDFLMQ 233
Query: 248 ILDPNPMTRITIPEILEDEWF 268
+P R T ++L+ W
Sbjct: 234 CFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 90/257 (35%), Positives = 138/257 (53%), Gaps = 8/257 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG+ A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + ED AR Y ++++A+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 257 I-----TIPEILEDEWF 268
+ EI+E +F
Sbjct: 238 LGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 9e-47
Identities = 84/242 (34%), Positives = 138/242 (57%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ E E + L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L I GR E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++DFG+ + + T CGTP+Y+APE+L+ + Y +
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-V 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I E P WLS A+ ++ L NP
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-46
Identities = 85/241 (35%), Positives = 133/241 (55%), Gaps = 3/241 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 257 I 257
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-46
Identities = 94/279 (33%), Positives = 159/279 (56%), Gaps = 27/279 (9%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV R + G+ A+K+L K+ LK + + K E + V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS + + + ++ CGT Y+APEV+N RG+ S
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
AD WS GV++F +L G LPF D M + I A+ P +LS A+ L+ +
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSLLRALFK 234
Query: 251 PNPMTRI-TIPEILED----------EW---FKKDYKPP 275
NP R+ P+ +E+ +W ++++ KPP
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPP 273
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-46
Identities = 87/242 (35%), Positives = 134/242 (55%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A++ G+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + T CGTP Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF + +Y I P +S +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 5e-45
Identities = 91/270 (33%), Positives = 146/270 (54%), Gaps = 9/270 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV + TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHR 135
+ ++ V+E+ GGELF + ED AR Y ++++A+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK ENL+LD G++K++DFGL + ++D + T CGTP Y+APEVL D Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W GV+++ ++ G LPF + + L++ I E P LS A+ L++ +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 256 RI-----TIPEILEDEWFKKDYKPPVFEEK 280
R+ EI++ ++F V+E+K
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 156 bits (394), Expect = 6e-45
Identities = 85/241 (35%), Positives = 134/241 (55%), Gaps = 3/241 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R +G+ A+KIL KE ++ E +K +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+K ++ V+E+V GGELF + ED R Y ++++A+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I + P LS A+ L++ +L +P R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 257 I 257
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 9e-45
Identities = 100/312 (32%), Positives = 152/312 (48%), Gaps = 29/312 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F KV R +T ALK + K ++ E + V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
S K+++VL F+ GGELF + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLD G++ + DFGL L+ ++DD +T CGTP Y+APE+L GY D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
+ GV+L+ +L G PF D N+ +Y+KI P A+ L+ +L +P R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 259 I---PEILEDEWFKK-------------DYKPPVFEEKKDTNLDD-------VEAVFKDS 295
EI +F + +KP V +N D+ +++V DS
Sbjct: 238 YNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDSVVDDS 297
Query: 296 EEHHVTEQKEEQ 307
H++E ++Q
Sbjct: 298 ---HLSETVQQQ 306
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 87/272 (31%), Positives = 141/272 (51%), Gaps = 16/272 (5%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ R +G G + KV R + G+ A+K+L K ++ K K AE + E ++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L++V GGELF + E E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN- 186
H G+ +RD+K EN+LLD+ G++ ++DFGLS ++ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 187 -DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
G+D D WS GV+ F LL G PF N +IS P +S A
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 242 RKLIARILDPNPMTRI---TIPEILEDEWFKK 270
R I ++L+ +P R+ EI +F+
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 5e-44
Identities = 87/242 (35%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVR 75
+ IG+G+F KV AR+ + A+K+L K+ +LK K + I E +K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + +G T CGTP Y+APEVL+ + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 1e-43
Identities = 91/273 (33%), Positives = 138/273 (50%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A+ G A+K+L K+ +LK K I E + K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + V + T CGTP Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF ++ +Y I P + A L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237
Query: 256 RI-TIPEILE------------DEWFKKDYKPP 275
R+ + LE D+ + K PP
Sbjct: 238 RLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 1e-43
Identities = 95/262 (36%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHP 71
+ IG+G+F KV A+ G+ A+K+L K+ VL KH MAE R V +K VKHP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE---RNV-LLKNVKHP 56
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ + K++ VL+FV GGELF + E AR Y ++ +A+ Y HS
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLKPEN+LLD+ G++ ++DFGL D T CGTP Y+APEV+ + YD
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYD 174
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
+T D W G +L+ +L G PF ++ +Y I P S TA ++ +L+
Sbjct: 175 -NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233
Query: 252 NPMTRI----TIPEILEDEWFK 269
+ R+ EI E +F+
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFFE 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-43
Identities = 90/300 (30%), Positives = 139/300 (46%), Gaps = 57/300 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----QIKREVATMKLV 68
YE IGEGT+ +V ARN +TGE VALK K+ E RE+ ++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 69 KHPNVVRLYEVMGSKTK--IFIVLEFV----TGGELFDKIVNHGRMK--EDEARRYFQQL 120
+HPN+VRL E++ SK K I++V E++ TG +++ +K E + + Y +QL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQL 109
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS G+ HRD+K N+L++ G LK++DFGL A R+ T Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYR 168
Query: 181 APEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------SAA 229
PE+L Y D+WS G IL L G F S + +KI +
Sbjct: 169 PPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 230 EFTCPPW---------------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268
+ PW + +A L+ ++L +P RI+ + L+ E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-42
Identities = 99/331 (29%), Positives = 152/331 (45%), Gaps = 56/331 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+K L K ++L+ + ++ E + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY + +++++E++ GG++ ++ E+E R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-------------------------SALSQQVRDD 167
HRD+KP+NLLLDA G++K+SDFGL +S+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 168 GLLHT-----------TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
T T GTP+Y+APEV GY D WS GVI++ +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 217 SNLMNLYKKISAAEFTC--PP--WLSFTARKLIARILDPNPMTRITIP---EILEDEWFK 269
N Y+KI + T P LS A+ LI R+ R+ EI +FK
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
Query: 270 -------KDYKPPVFEEKK---DT-NLDDVE 289
++ P+ E K DT N DD E
Sbjct: 301 GVDWEHIRERPAPIIPELKSITDTSNFDDFE 331
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-42
Identities = 97/309 (31%), Positives = 143/309 (46%), Gaps = 64/309 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-I-LDKEKVLKHKMAEQIKREVATMKLVK 69
+YE G+ +GEGT+A V AR+ ETG VA+K I L + K K + RE+ ++ +K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
HPN++ L +V G K+ I +V EF+ + DK + + + + Y + ++Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS + HRDLKP NLL+ + G LK++DFGL+ + G+PN
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVV 164
Query: 179 ---YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISAA---- 229
Y APE+L + G D+WS G I LL +LP DS++ L KI A
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTP 222
Query: 230 ------EFTCPP-WLSFTARK-----------------LIARILDPNPMTRITIPEILED 265
T P ++ F L+ R+L NP RIT + LE
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 266 EWFKKDYKP 274
+F D P
Sbjct: 283 PYFSNDPAP 291
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 72/201 (35%), Positives = 109/201 (54%), Gaps = 6/201 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ IGEG V A++ ETGE VALK + + L+ + Q RE+ ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSR 130
VV+L +V + +V+E++ L + + + R + E + + Y + L+ V Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-NDRG 189
G+ HRDLKP NLL+ A G LK++DFGL+ L + L T Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 190 YDGSTADLWSCGVILFVLLAG 210
YD DLW+ G I LL G
Sbjct: 178 YDPG-VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-42
Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKH 70
E + +G+G+ V R+ TG+ ALK + E+ K Q+ RE+ T++ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS- 129
P VV+ Y + +I IVLE++ GG L D + G++ E +Q++ +DY H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+KP NLL+++ G +K++DFG+S + + D +T GT Y++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGE- 175
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKL 244
AD+WS G+ L G PF + ++ + A PP L S R
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235
Query: 245 IARILDPNPMTRITIPEILEDEWFKK 270
I+ L +P R + E+L+ + KK
Sbjct: 236 ISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 7e-42
Identities = 81/264 (30%), Positives = 141/264 (53%), Gaps = 13/264 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+G +++ + IG+G F+ V A G VALK + +++ K + +E+ +K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS+ + HRD+KP N+ + A G +K+ D GL S + H+ GTP Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPER 177
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA- 241
+++ GY+ + D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 178 IHENGYNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 242 -RKLIARILDPNPMTRITIPEILE 264
R L++R ++P+P R I +L+
Sbjct: 237 LRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-41
Identities = 80/242 (33%), Positives = 136/242 (56%), Gaps = 4/242 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ + E + L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L +I + E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+++ ++AG PF+ N +L++ I + P WLS A ++ + NP
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237
Query: 256 RI 257
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 73/253 (28%), Positives = 130/253 (51%), Gaps = 6/253 (2%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A+K + + K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+ Y + + I +E++ GG + D++ +G + E R+Y +Q++ V+Y HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ GY G
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-G 185
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILD 250
AD+WS G + +L P+ + M KI+ P +S AR + R
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 251 PNPMTRITIPEIL 263
N R + E+L
Sbjct: 246 ENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 87/251 (34%), Positives = 138/251 (54%), Gaps = 11/251 (4%)
Query: 3 QPKIKRRVGKYE---VGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQI 58
+PK K ++ KYE RT+G G+F +V A +E PVA+K +K K++K K + +
Sbjct: 20 EPKRKNKM-KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 59 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + + HP V LY ++ +++VLEFV GGE F + + R D Y
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q++ +Y S + +RDLKPENLLLD G +K++DFG + + D +T CGTP
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + G+ G AD W+ G+ ++ +L G PF + + +Y+KI P +L
Sbjct: 194 YIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252
Query: 239 FTARKLIARIL 249
+ L+ ++L
Sbjct: 253 NNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 3e-41
Identities = 92/286 (32%), Positives = 152/286 (53%), Gaps = 22/286 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVR 75
IG+GTF +V R +T A+K+L K++++ K E + L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L + + +++V ++++GGELF + GR ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGST 194
DLKPEN+LLDA G++ + DFGLS + D+ +T CGT Y+APEV L+++GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNP 253
D WS GV++F + G+ PF + +Y+ I+ + P LS R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 254 MTRI----TIPEILEDEWF---------KKDYKPPVFEEKKDTNLD 286
R+ E+ E +F KK PP F+ D++ D
Sbjct: 238 QHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP-FKPIVDSDED 282
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 5e-41
Identities = 88/281 (31%), Positives = 151/281 (53%), Gaps = 15/281 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE--QIKREVATMKLVKHPNVV 74
+ +G+G+F KV A T E A+K L K+ VL+ E ++R V + +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
L+ +K +F V+E++ GG+L I + GR E AR Y ++I + + H +G+ +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLK +N+LLD G++K++DFG+ + + +G T CGTP+Y+APE+L + Y+ S
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254
D WS GV+L+ +L G PF + L+ I P W+S A+ ++++ + +P
Sbjct: 178 -DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 255 TRITIPEILEDEWFKK--DYK-------PPVFEEKKDTNLD 286
R+ + + F + D++ PP F+ K + D
Sbjct: 237 KRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSD 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-41
Identities = 82/251 (32%), Positives = 140/251 (55%), Gaps = 13/251 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+EFV+GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + +R T CGTPNY+APE+L Y S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFD-----DSNLMN----LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D+ N L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 247 RILDPNPMTRI 257
L+ +P R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 2e-40
Identities = 87/258 (33%), Positives = 139/258 (53%), Gaps = 10/258 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE+ + IGEG+F K+ A+ E +K +D K + K E K+EV + +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V + ++FIV+E+ GG+L +I G + ED+ +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 130 RGVYHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLND 187
R + HRD+K +N+ L G + K+ DFG +++Q+ D L TC GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFG---IARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
R Y+ T D+WS G +L+ L PF+ +NL L KI F P S R LI+
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 247 RILDPNPMTRITIPEILE 264
++ +P R +I IL+
Sbjct: 236 QLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-40
Identities = 76/257 (29%), Positives = 130/257 (50%), Gaps = 7/257 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
++ G +G G+F V N + G+ A+K L + + +Q+++E+A + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V+ + ++I LE V GG L + +G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRD+K N+L+D G +K++DFG +++QV + + G+P ++APEV+ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFG---MAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIAR 247
G AD+WS G + + G P+ + KI S P LS A+ I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 248 ILDPNPMTRITIPEILE 264
L +P R T E+LE
Sbjct: 238 CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-40
Identities = 99/316 (31%), Positives = 163/316 (51%), Gaps = 28/316 (8%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++ + Y+V + IG G F +V+ R+ + + A+K+L K +++K + E
Sbjct: 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
M P VV+L+ +++V+E++ GG+L + + N+ + E A+ Y +++ A+
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLAL 155
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 182
D HS G+ HRD+KP+N+LLD +G+LK++DFG ++ + G++ T GTP+Y++P
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISP 212
Query: 183 EVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPP 235
EVL + GY G D WS GV LF +L G PF +L+ Y KI ++ F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV 272
Query: 236 WLSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD- 282
+S A+ LI L + R + EI + +FK D P V E D
Sbjct: 273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDI 332
Query: 283 --TNLDDVEAVFKDSE 296
+N DD+E D E
Sbjct: 333 DSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 81/267 (30%), Positives = 135/267 (50%), Gaps = 16/267 (5%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVATMKLV 68
G IG+GT+ +V A N TGE +A+K I + + M + ++ E+ T+K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H N+V+ ++ + I LE+V GG + + +GR +E R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND- 187
S+G+ HRDLK +NLL+DA G K+SDFG+S S + D+ + G+ ++APEV++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 188 -RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------PWLSFT 240
+GY D+WS G ++ + AG P+ D + K+ P LS
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
A + NP R T E+L+ +
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 11/256 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + +G+G++ V + + ALK +D + + + + + E+ + V HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCH 128
++ E K+ IV+E+ G+L I + + E E R F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ + HRDLK N+LL A +K+ D G+S + ++ + T GTP+Y+APEV R
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIAR 247
Y +D+WS G +L+ + PF+ ++ +L K+ ++ PP S + I
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 248 ILDPNPMTRITIPEIL 263
+L P R +IL
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 81/256 (31%), Positives = 141/256 (55%), Gaps = 14/256 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEK-VLKHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R +TG+ A+K+L K V K K E + E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ ++ K+ ++L++V+GGE+F + EDE R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS LS++ ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
+G G D WS G+++F LL G PF N ++S C P ++ A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 242 RKLIARILDPNPMTRI 257
+ L+ ++L +P R+
Sbjct: 239 QDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 84/257 (32%), Positives = 141/257 (54%), Gaps = 14/257 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A + TG VA+K +D + K + E + EV M+ +HPN+V +Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+++LL + G +K+SDFG A +S++V R L+ GTP ++APEV++ Y G+ D
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPY-GTEVD 197
Query: 197 LWSCGVILFVLLAGYLP-FDDSNL--MNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+WS G+++ ++ G P F++ L M + + +S R + R+L +P
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257
Query: 254 MTRITIPEILEDEWFKK 270
R T E+L + K
Sbjct: 258 AQRATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 83/268 (30%), Positives = 141/268 (52%), Gaps = 31/268 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + I G + V R+ ET + A+K ++K+ ++ +Q+ E + ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV ++ +K + +V+E+V GG+ + N G + D AR YF + + A++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT------------------- 173
HRDLKP+NLL+ + G++K++DFGLS + GL+ T
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 174 -CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232
CGTP Y+APEV+ +GY G D W+ G+IL+ L G +PF L+ ++ + +
Sbjct: 176 VCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234
Query: 233 CPPW---LSFTARKLIARILDPNPMTRI 257
P L A+ LI+R+L NP+ R+
Sbjct: 235 WPEGDEALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-39
Identities = 81/258 (31%), Positives = 140/258 (54%), Gaps = 11/258 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K ++ E G+ +K ++ K + K E+ ++EVA + +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCH 128
N+V+ E ++IV+++ GG+L+ KI N R ED+ +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
R + HRD+K +N+ L G +K+ DFG++ L+ V L T GTP Y++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICEN 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246
R Y+ + +D+W+ G +L+ + F+ N+ NL KI + S+ R L++
Sbjct: 176 RPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 247 RILDPNPMTRITIPEILE 264
++ NP R ++ ILE
Sbjct: 235 QLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 6e-39
Identities = 96/308 (31%), Positives = 156/308 (50%), Gaps = 28/308 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + IG G F +V+ R+ + + A+K+L K +++K + E M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI ++ F +S A+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280
Query: 244 LIARILDPNP--MTRITIPEILEDEWFKKDY---------KPPVFEEKK---DT-NLDDV 288
LI L + R + EI +FK D PV E DT N DD+
Sbjct: 281 LICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFDDI 340
Query: 289 EAVFKDSE 296
E K+ E
Sbjct: 341 EDDDKNEE 348
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-39
Identities = 81/270 (30%), Positives = 138/270 (51%), Gaps = 25/270 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ IGEG +V A + TG+ VA+K K ++ K E I E+ MK KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQNK-ELIINEILIMKDCKHP 75
Query: 72 NVVRLYE---VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYC 127
N+V Y+ V +++V+E++ GG L D I + RM E + ++++ ++Y
Sbjct: 76 NIVDYYDSYLVGDE---LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV--RDDGLLHTTCGTPNYVAPEV 184
HS+ V HRD+K +N+LL G++K++DFG +A L+++ R ++ GTP ++APEV
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-----NSVVGTPYWMAPEV 187
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAA---EFTCPPWLSFT 240
+ + Y D+WS G++ + G P + L L+ I+ P S
Sbjct: 188 IKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKWSPE 245
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270
+ + + L +P R + E+L+ + KK
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 9e-39
Identities = 81/222 (36%), Positives = 117/222 (52%), Gaps = 17/222 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKL 67
KYEV +GEG + V RN TGE VA+K + ++ +K + REV ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV--TGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
++H N+V L E K ++++V E+V T EL + + G + D R Y QL+ A+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
YCHS + HRD+KPEN+L+ G LK+ DFG + AL + L T Y APE+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYK 224
L D Y G D+W+ G I+ LL G F DS++ LY
Sbjct: 173 LVGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-38
Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 23/272 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V A E VA+K +D EK +++++EV M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD---KIVNHGRMKEDEARRYFQQLINAVDYCHS 129
VV+ Y ++++V+ +++GG L D G + E ++++ ++Y HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLN- 186
G HRD+K N+LL G++K++DFG+SA L+ R + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWLSFTA---- 241
GYD AD+WS G+ L G P+ M L + PP L A
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND----PPSLETGADYKK 235
Query: 242 -----RKLIARILDPNPMTRITIPEILEDEWF 268
RK+I+ L +P R T E+L+ ++F
Sbjct: 236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 2e-38
Identities = 82/251 (32%), Positives = 141/251 (56%), Gaps = 13/251 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD--------DSNLMN-LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D N + L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 247 RILDPNPMTRI 257
L+ +P R+
Sbjct: 238 SFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 97/308 (31%), Positives = 157/308 (50%), Gaps = 28/308 (9%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
++ + YEV + IG G F +V+ R+ T + A+K+L K +++K + E M
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P VV+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALD 156
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPE 183
HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 184 VLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPW 236
VL + GY G D WS GV L+ +L G PF +L+ Y KI ++ F
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND 273
Query: 237 LSFTARKLIARILDPNP--MTRITIPEILEDEWFKKDY----------KPPVFEEKKD-- 282
+S A+ LI L + R + EI +FK D P V + D
Sbjct: 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDID 333
Query: 283 -TNLDDVE 289
+N DD+E
Sbjct: 334 TSNFDDIE 341
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 22/287 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLY 77
+G+G+F KV A T E A+KIL K+ +++ E E + L P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LDA G++K++DFG+ + + T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PFD + L++ I + P LS A + +L +P R+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244
Query: 258 TI-----PEILEDEWFKK-------------DYKPPVFEEKKDTNLD 286
+I E +F++ +KP V + N D
Sbjct: 245 GCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFD 291
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 137 bits (345), Expect = 9e-38
Identities = 80/249 (32%), Positives = 141/249 (56%), Gaps = 11/249 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R IG G++AKV R + + A+K++ KE V + + ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++F+V+E+V GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + + T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD---DSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
D W+ GV++F ++AG PFD D+ MN L++ I P +LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 249 LDPNPMTRI 257
L+ +P R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 88/264 (33%), Positives = 135/264 (51%), Gaps = 25/264 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G+G F KV A++ ETG A KI+ E+ L+ M E + + KHPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-----IDILSECKHPNIVGL 67
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
YE + K++I++EF GG L ++ R + E + R +Q++ A+++ HS V HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGY 190
DLK N+LL G++K++DFG+SA ++ T GTP ++APEV+ D Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D AD+WS G+ L L P + N M + KI +E PP L S +
Sbjct: 186 D-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKWSSSFNDF 241
Query: 245 IARILDPNPMTRITIPEILEDEWF 268
+ L +P R T E+L+ +
Sbjct: 242 LKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 76/243 (31%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +TIG G F +V R +T A+K L K VL A +K E + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY K ++ V++++ GG++ ++ G +ED AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSA------------LSQQVRDDG------------ 168
HRD+KP+N+L+D G++K++DFGL R D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 212 LPF 214
PF
Sbjct: 242 PPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 90/308 (29%), Positives = 148/308 (48%), Gaps = 43/308 (13%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+G +V R TG+ ALK+LDK++++K +++ E + + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
Y ++T + +V+++ GGELF + + E+ AR Y +++ A++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALS----QQVRDDGL-----------LHTT------ 173
RDLKPEN+LL G++ +SDF LS S V T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 174 ------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GT Y+APEV++ G+ GS D W+ G++L+ +L G PF SN + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 228 AAEFTCP--PWLSFTARKLIARILDPNPMTRI----TIPEILEDEWFK-------KDYKP 274
E T P P +S +AR LI ++L +P R+ EI + +F+ + P
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTP 305
Query: 275 PVFEEKKD 282
P+ D
Sbjct: 306 PIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 3e-37
Identities = 77/244 (31%), Positives = 131/244 (53%), Gaps = 4/244 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T + A+K L K+ VL E E + L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+E++ GG+L I + + A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G++K++DFG+ + + D T CGTP+Y+APE+L + Y ++
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D WS GV+L+ +L G PF + L++ I P WL+ A+ ++ ++ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 256 RITI 259
R+ +
Sbjct: 238 RLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 6e-37
Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 34/268 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLVKH 70
E IG G V + TG ALK++ ++ V + QI RE+ ++ V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PNVV+ +++ +I ++LEF+ GG L + + D AR Q+++ + Y H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV----LN 186
+ HRD+KP NLL+++ N+K++DFG+S + Q D +++ GT Y++PE LN
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLN 245
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPF------DDSNLMNLYKKISAAEFTCPPWLSFT 240
YDG D+WS GV + G PF D ++LM A + PP T
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM------CAICMSQPPEAPAT 299
Query: 241 A----RKLIARILDPNPMTRITIPEILE 264
A R I+ L P R + ++L+
Sbjct: 300 ASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 81/266 (30%), Positives = 139/266 (52%), Gaps = 4/266 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A GE A+K L K+ VL E E + L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+EF+ GG+L I + GR A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD G++K++DFG+ + V D T CGTP+Y+APE+L Y S
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D WS GV+L+ +L G PF + L++ I P W++ ++ ++ ++ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237
Query: 256 RITIPEILEDEWFKKDYKPPVFEEKK 281
R+ + + F K E+++
Sbjct: 238 RLGVVGNIRGHPFFKTINWTALEKRE 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE R +G G F V R + V +K + E++ K + E +KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N++ YE + IV+E+ GG L + I + ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 130 RGVYHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLND 187
+ + HRDLK +N+LLD + +K+ DFG+S LS + + +T GTP Y++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPCYISPELCEG 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
+ Y+ +D+W+ G +L+ L + F+ +NL L KI + F S R+LI
Sbjct: 176 KPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL 234
Query: 247 RILDPNPMTRITIPEILED 265
+L+ +P R + +I+
Sbjct: 235 SMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-36
Identities = 91/309 (29%), Positives = 158/309 (51%), Gaps = 21/309 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L +I GR KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P R+
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 244
Query: 258 TI-PE----ILEDEWFK---------KDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQ 303
PE I E +F+ K+ +PP + + ++ + F H
Sbjct: 245 GCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDAENFDKFFT---RHPPVLT 301
Query: 304 KEEQPVAMN 312
+Q V MN
Sbjct: 302 PPDQEVIMN 310
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-36
Identities = 71/202 (35%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y+ IGEGT+ V AR+ TGE VA+K + K + + + RE+ +K + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
+++L +V K +++V EF+ K++ + + E + Y QL+ + +CHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL-NDR 188
G+ HRDLKPENLL++ G LK++DFG L++ +T T Y APE+L D+
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFG---LARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 189 GYDGSTADLWSCGVILFVLLAG 210
GY + D+WS G I LL+
Sbjct: 175 GY-STPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REV-ATMKLVKH 70
Y+V + +G+GTF V ARN ETGE VA+K + K+K + E + REV + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKF--YSWEECMNLREVKSLRKLNEH 57
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCH 128
PN+V+L EV +++ V E++ G L+ + + E R Q++ + + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
G +HRDLKPENLL+ +K++DFG L++++R T Y APE+L
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 189 GYDGSTADLWSCGVILF 205
S D+W+ G I+
Sbjct: 174 TSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 78/240 (32%), Positives = 134/240 (55%), Gaps = 4/240 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE +A Y ++ + + H RG+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI 257
W+ GV+L+ +LAG PFD + L++ I + P LS A + ++ +P R+
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 77/256 (30%), Positives = 145/256 (56%), Gaps = 13/256 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R ++G+ A+K+L K ++ K K E + E ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L+++ GGELF + R KE E + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-- 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS + + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTA 241
D G+D D WS GV+++ LL G PF + ++ + ++I +E P +S A
Sbjct: 181 GDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 242 RKLIARILDPNPMTRI 257
+ +I R+L +P R+
Sbjct: 240 KDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 6e-35
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLDA G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L ++T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
Y+K+ PP +S A+ LI R
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 7e-35
Identities = 84/321 (26%), Positives = 146/321 (45%), Gaps = 25/321 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V +G G F +V+ R TG+ A+K++ K +L + + E + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ +L K +++V+E+ GG+L + + + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLND-R 188
HRD+KPEN+L+D G++K++DFG +A ++ + ++++ GTP+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 189 GYDGST----ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFT 240
G T D WS GVI + ++ G PF + Y I +F P +S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 241 ARKLIARILDPNPMTRITI------PEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 294
LI +L R+ P + +W P F + DD + F +
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKS--DDDTSNFDE 296
Query: 295 SEEHH-VTEQKEEQPVAMNAF 314
E++ Q + N F
Sbjct: 297 PEKNSTRRSQSSTTQLKPNGF 317
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 89/288 (30%), Positives = 136/288 (47%), Gaps = 49/288 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+GEGT+A V RN TGE VALK LD E+ RE++ MK +KH N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRL 63
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++V+ ++ K+ +V E++ + D G + + + + QL+ + +CH V H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG----TPNYVAPEVL-NDRG 189
RDLKP+NLL++ G LK++DFGL+ R G+ T T Y AP+VL R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI--SAAEFTCP---------- 234
Y S D+WS G I+ ++ G F ++ + + +I + E T P
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 235 --------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
P L+ R+L NP RI+ + L+ WF
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ IG+G F +V+ + +TG+ A+K L K ++ K +K E + P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y +++++EF+ GG+L ++ + ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---------------------------- 168
+KP+N+L+D G++K+SDFGLS + D
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
+ ++T GTP+Y+APE+ +GY G D WS G I+F L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 212 LPFDDSNLMNLYKKISAAE----FTCPPWLSFTARKLIARIL 249
PF N Y+KI F LS A LI R++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 78/194 (40%), Positives = 107/194 (55%), Gaps = 20/194 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
IGEGT+ V AR+ TGE VALK + + E V + RE++ +K + HPN+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----REISLLKELNHPNIV 61
Query: 75 RLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RL +V+ S+ K+++V EF+ + D G + + Y QL+ + YCHS V
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGY 190
HRDLKP+NLL+D G LK++DFGL+ A VR H T Y APE+ L R Y
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQY 177
Query: 191 DGSTA-DLWSCGVI 203
ST D+WS G I
Sbjct: 178 --STPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 78/242 (32%), Positives = 119/242 (49%), Gaps = 7/242 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVR 75
+G G F KV A +TGE A+K L K ++ E + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ ++ + V+E+ GG+L I + E A Y ++ + Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +NLLLD G +K++DFGL D T CGTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W GV+++ +L G PF + ++ I E P +LS A ++ R+L NP
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 256 RI 257
R+
Sbjct: 243 RL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 79/262 (30%), Positives = 131/262 (50%), Gaps = 18/262 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILD----KEKVLKHKMAEQIKREVATMKLVK 69
G IG G+F V N+ +GE +A+K L K K M + + RE+A +K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V+ + I LE+V GG + + N+G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-------GTPNYVAP 182
RG+ HRD+K N+L+D G +K+SDFG +S+++ + L T G+ ++AP
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFG---ISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTA 241
EV+ Y AD+WS G ++ +L G PF D + KI A P +S A
Sbjct: 182 EVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240
Query: 242 RKLIARILDPNPMTRITIPEIL 263
+ + + + R T E+L
Sbjct: 241 IDFLEKTFEIDHNKRPTAAELL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-34
Identities = 76/256 (29%), Positives = 125/256 (48%), Gaps = 9/256 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y R +G+G F + R +E V K ++ + L K E+ + L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
++ Y + I +E+ GG L+DKIV +E+ Y Q+++AV Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLNDRG 189
G+ HRD+K N+ L G +K+ DFG +S+ + + + T GTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFG---ISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ +D+W+ G +L+ LL FD +N +NL KI +T S L+ +
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236
Query: 249 LDPNPMTRITIPEILE 264
L +P R T E+L+
Sbjct: 237 LQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-34
Identities = 82/272 (30%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLD+ G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L +T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
YKK+ PP +S A+ LI R
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-34
Identities = 72/265 (27%), Positives = 129/265 (48%), Gaps = 12/265 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILD---KEKVLKHKMAEQIKREVATMKLVKHPN 72
G+ +G G F+ AR+ +TG +A+K + + ++ E +++E+ M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R+ + + +E++ GG + + +G KE Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 133 YHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLH-TTCGTPNYVAPEVLNDRG 189
HRD+K NLL+D+ G L+++DFG +A L+ + G GT ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEFT--CPPWLSFTARKL 244
Y G + D+WS G ++ + P++ N KI++A P LS R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 245 IARILDPNPMTRITIPEILEDEWFK 269
R L+ P R E+L+ F+
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 9e-34
Identities = 80/255 (31%), Positives = 132/255 (51%), Gaps = 11/255 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ + + + IG G F++V A G PVALK + ++ K +E+ +K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ Y ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 242 RKLIARILDPNPMTR 256
R+L+ ++P+P R
Sbjct: 238 RQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 11/263 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +++ + IG G F++V A +PVALK + +++ K + +E+ +K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ + ++ IVLE G+L I + K E +YF QL +AV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L +KI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 242 RKLIARILDPNPMTRITIPEILE 264
R+L++ + P+P R I + +
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 83/278 (29%), Positives = 140/278 (50%), Gaps = 29/278 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
+ E+ IG G + V ++ TG VALKI+ + V I+REVA +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV------SDIQREVALLSQ 55
Query: 68 VKH---PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
++ PN+ + Y +++I++E+ GG + ++ G + E ++++ A+
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y H GV HRD+K N+L+ GN+K+ DFG++AL Q T GTP ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 185 LND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----S 238
+ + + YD + AD+WS G+ ++ + G P+ D + I ++ PP L S
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYS 228
Query: 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
R+ +A LD P R++ E+L+ +W K K PV
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 75/265 (28%), Positives = 135/265 (50%), Gaps = 16/265 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + IG+G+F +V A + T + VA+K++D E+ E I++E+ + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ + Y +K++I++E+ GG D ++ G++ E ++++ ++Y H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL G++K++DFG+S Q+ +T GTP ++APEV+ GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKLI 245
D AD+WS G+ L G P D + M + I PP L S + +
Sbjct: 176 D-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFV 231
Query: 246 ARILDPNPMTRITIPEILEDEWFKK 270
+ L+ +P R + E+L+ ++ KK
Sbjct: 232 SLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-33
Identities = 73/249 (29%), Positives = 123/249 (49%), Gaps = 11/249 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ IG+G+F V A+K +D K + + E+ E + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 130
++R YE K K+ IV+E+ G+L + + ED+ R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+K NL LDAY N+K+ D G++ LS +T GTP Y++PE+ D+
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYLSPELCEDKP 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR--KLIAR 247
Y+ +D+W+ GV+L+ G PFD +N L KI F P ++ + +LI +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQ 235
Query: 248 ILDPNPMTR 256
L + R
Sbjct: 236 CLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-33
Identities = 68/216 (31%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ +GEG++ V A + ETG+ VA+K++ E+ L ++I +E++ +K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPY 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+V+ Y T ++IV+E+ G + D KI N + E+E Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + AD+WS G+ + G P+ D + M I
Sbjct: 177 N-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 5e-33
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K LDK+++ K K + E ++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYHRD 136
+K + +V+ + GG+L I N G EAR F Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LKPEN+LLD +GN+++SD GL+ +++ + GTP Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 197 LWSCGVILFVLLAGYLPFDD 216
++ G L+ ++AG PF
Sbjct: 177 WFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 6e-33
Identities = 71/189 (37%), Positives = 103/189 (54%), Gaps = 10/189 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IGEGT+ V ARN TGE VALK LD E + RE++ +K + HPN+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 64
Query: 77 YEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
+V+ ++ K+++V EF+ + F + + Y QL+ + +CHS V HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DLKP+NLL++ G +K++DFGL+ A VR H T Y APE+L Y +
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTA 181
Query: 195 ADLWSCGVI 203
D+WS G I
Sbjct: 182 VDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-33
Identities = 80/243 (32%), Positives = 113/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V AR +T A+K L K+ VL +K E + + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQ---QVRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q VR D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 96/295 (32%), Positives = 141/295 (47%), Gaps = 49/295 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
KYE IGEGT+ V A+N ET E VALK + D E V + RE+ +K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVD 125
+KH N+VRLY+V+ S K+ +V E+ + FD +G + + + + QL+ +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLA 113
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T Y P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDV 170
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKI-----SAAEFTCP--- 234
L + Y S D+WS G I L P F +++ + K+I + E + P
Sbjct: 171 LFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229
Query: 235 ---------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
P L+ T R L+ +L NP+ RI+ E L+ +F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 84/332 (25%), Positives = 139/332 (41%), Gaps = 69/332 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ + IG G + V A + TG VA+K I + L A++I RE+ ++ ++H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID--AKRILREIKLLRHLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQ-QL 120
N++ L +++ + ++IV E L + K++ + D+ +YF Q+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP N+L+++ +LK+ DFGL A +D T YV
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLT----EYV 167
Query: 181 ------APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------- 226
APE+ L+ Y + D+WS G I LL F + ++ I
Sbjct: 168 VTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226
Query: 227 -----------SAAEF-----TCPPWLSFT---------ARKLIARILDPNPMTRITIPE 261
A + P + A L+ ++L +P RIT E
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPK-KPLSKLFPGASPEAIDLLEKMLVFDPKKRITADE 285
Query: 262 ILEDEWFKKDYKP---PVFEEK-KDTNLDDVE 289
L + + + P PV + DD E
Sbjct: 286 ALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDE 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVAT 64
V KYE IG+GTF +V AR+ +T + VALK +++ EK A RE+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKI 64
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
++L+KH NVV L E+ +K ++V EF G L +K V + E
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEI 121
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT 172
++ + L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S +T
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 173 T-CGTPNYVAPEV-LNDRGYDGSTADLWSCGVIL 204
T Y PE+ L +R Y G D+W G I+
Sbjct: 182 NRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 87/308 (28%), Positives = 130/308 (42%), Gaps = 63/308 (20%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------R 60
R V +YE I EGT+ V AR+ +TGE VALK K KM ++ + R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 61 EVATMKLVKHPNVVRLYE-VMGSK-TKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 117
E+ + ++HPN+V + E V+GS KI++V+E+V +L + + E +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL++ V + H + HRDLK NLLL+ G LK+ DFGL+ T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-------YTQ 165
Query: 178 N-----YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------ 226
Y APE+L + D+WS G I LL F + ++ KI
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT 225
Query: 227 ---------------SAAEFTCPPW-----------LSFTARKLIARILDPNPMTRITIP 260
FT P+ LS L+ R+L +P RI+
Sbjct: 226 PTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE 285
Query: 261 EILEDEWF 268
+ L+ +F
Sbjct: 286 DALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLV 68
YE IGEG + V AR+ TG VALK KV E I RE+A +K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 69 K---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
+ HPN+VRL +V + K+ +V E V K G + + + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP 177
QL+ VD+ HS + HRDLKP+N+L+ + G +K++DFGL+ ++ + T+ T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALTSVVVTL 170
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL 207
Y APEVL Y + D+WS G I L
Sbjct: 171 WYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 87/281 (30%), Positives = 133/281 (47%), Gaps = 34/281 (12%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLV 68
G +E+ IGEGT+ KV AR+ +TG+ VA+KI+D + E+IK E + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 69 KHPNVVRLYEV------MGSKTKIFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQ 118
HPN+ Y G+ ++++V+E GG +L + G R+KE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + + Y H V HRD+K +N+LL +K+ DFG+SA Q G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFT 232
++APEV+ D YD + +D+WS G+ L G P D + M L+K
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP--- 234
Query: 233 CPPWLSFTAR------KLIARILDPNPMTRITIPEILEDEW 267
PP L I+ L N R + E+LE +
Sbjct: 235 -PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 4e-32
Identities = 81/252 (32%), Positives = 138/252 (54%), Gaps = 16/252 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V AR +G VA+K++D + K + E + EV M+ +H NVV +Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
+++LL G +K+SDFG A Q +D + GTP ++APEV++ Y G+ D+W
Sbjct: 145 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDPN 252
S G+++ ++ G P+ + + K++ + PP L S R + R+L
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPKLKNAHKISPVLRDFLERMLTRE 258
Query: 253 PMTRITIPEILE 264
P R T E+L+
Sbjct: 259 PQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-32
Identities = 74/266 (27%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 14 EVGRTIGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
E+G+ +GEG F +V T VA+K L + + + E+ E + MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER--EEFLEEASIMKKLS 59
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+VRL V ++IV E++ GG+L D + HG + + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVL 185
S+ HRDL N L+ +K+SDFG LS+ + +D G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWLSF 239
D + S +D+WS GV+L+ + G P+ + + + + CP L
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL-- 233
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
+L+ + +P R T E++ED
Sbjct: 234 --YELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 9e-32
Identities = 83/258 (32%), Positives = 137/258 (53%), Gaps = 18/258 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A TG+ VA+K +D + K + E + EV M+ H NVV +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL + G +K+SDFG A +S++V L GTP ++APEV++ Y G+ D+
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVDI 201
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDP 251
WS G+++ ++ G P+ + + ++I PP + S R + +L
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVR 258
Query: 252 NPMTRITIPEILEDEWFK 269
P R T E+L+ + K
Sbjct: 259 EPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-31
Identities = 75/243 (30%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V A +T A+K L K+ VL +K E + + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQQ---VRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q+ +R D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL +GY D WS GVILF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 84/272 (30%), Positives = 138/272 (50%), Gaps = 25/272 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K+++ E+ L+ M E + + H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-----IEILATCNH 68
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
P +V+L K++I++EF GG + ++ R + E + + +Q++ A+ Y HS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTPNYVAPEV-- 184
+ HRDLK N+LL G++K++DFG+SA + Q RD + GTP ++APEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVM 183
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLS 238
+ D YD AD+WS G+ L + P + N M + KI+ +E + P S
Sbjct: 184 CETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270
R + LD +P TR + ++LE +
Sbjct: 243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 74/243 (30%), Positives = 126/243 (51%), Gaps = 12/243 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A K + D E K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 74 VRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V+ Y + KT + I +E++ GG + D++ +G + E R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKT-LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRG 189
+ HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT---ARKLIA 246
Y G AD+WS G + +L P+ + M KI A + T P S AR +
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHARDFLG 243
Query: 247 RIL 249
I
Sbjct: 244 CIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 22/201 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLV 68
YE+ + IG GT+ V AR+ TGE VA+K++ + E I++E++ +K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKEC 57
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYC 127
+HPN+V + + K++IV+E+ GG L D V G + E + ++ + + Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDGLLHTTCGTPNYVAPEV 184
H G HRD+K N+LL G++K++DFG+SA + R + GTP ++APEV
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPEV 172
Query: 185 LNDR---GYDGSTADLWSCGV 202
GYDG D+W+ G+
Sbjct: 173 AAVERKGGYDGK-CDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 77/255 (30%), Positives = 128/255 (50%), Gaps = 8/255 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y V R +GEG+F + ++ + + A+K + K E ++E + +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V E + ++IV+E+ GG+L KI + G++ ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ V HRD+K +N+ L G +K+ DFG + L T GTP YV PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ + +D+WS G IL+ L PF ++ NL K+ + P S+ R LI ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 249 LDPNPMTRITIPEIL 263
NP +R + IL
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 94/308 (30%), Positives = 139/308 (45%), Gaps = 53/308 (17%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R V ++E IGEGT+ V AR++ +GE VALK + + + + RE+ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLN 62
Query: 68 VKHPNVVRLYEVMGSK--TKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN+V L EV+ K IF+V+E+ L D + E + + QL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRG 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----- 178
+ Y H + HRDLK NLLL G LK++DFGL+ L TP
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-------LPAKPMTPKVVTLW 173
Query: 179 YVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG--YLP----FDDSNLM---------NL 222
Y APE+L Y + D+W+ G IL LLA LP + +L+ ++
Sbjct: 174 YRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232
Query: 223 YKKIS----AAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
+ S +FT P PWLS +L+ +L +P R T E LE +
Sbjct: 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
Query: 268 FKKDYKPP 275
FK+ KP
Sbjct: 293 FKE--KPL 298
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 72/244 (29%), Positives = 129/244 (52%), Gaps = 8/244 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G+G F +V +++TG +A+K + D E K ++ E+ +K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 71 PNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + + + I +E + GG + D++ ++G + E+ R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLI 245
GY G AD+WS G + +L P+ + M KI+ PP +S R +
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 246 ARIL 249
RI
Sbjct: 243 KRIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-31
Identities = 66/220 (30%), Positives = 120/220 (54%), Gaps = 6/220 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G G F +V +++TG +A+K + D + K ++ E+ +K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 71 PNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + K+ I +E++ GG + D++ +G + E+ RRY +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GY G AD+WS + +L P+ + M KI+
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 73/201 (36%), Positives = 114/201 (56%), Gaps = 11/201 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-RGYDGS 193
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL YD S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 194 TADLWSCGVILFVLLAGYLPF 214
+AD +S G +LF LL G+ PF
Sbjct: 176 SADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 76/221 (34%), Positives = 119/221 (53%), Gaps = 18/221 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKI-LDKEKVLKHKMAEQIK-REVATMKLVK 69
KYE +GEG++ V ++ ETG+ VA+K L+ E KM ++I RE+ +K ++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V L EV K ++++V EFV L D + E R+Y Q++ +++CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
+ HRD+KPEN+L+ G +K+ DFG + A +V D + T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173
Query: 186 NDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYK 224
D Y G D+W+ G ++ +L G P DS++ LY
Sbjct: 174 GDTKY-GRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-30
Identities = 71/200 (35%), Positives = 112/200 (56%), Gaps = 9/200 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL S+
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 195 ADLWSCGVILFVLLAGYLPF 214
AD +S G +LF LL G+ PF
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 81/256 (31%), Positives = 137/256 (53%), Gaps = 29/256 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-----L 67
+E+ + IG G F +V + TG+ A+KIL+K ++LK + E A + L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-------RAETACFREERDVL 55
Query: 68 VKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAV 124
V + L+ + +++V+++ GG+L + R+ ED AR Y +++ A+
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAP 182
D H G HRD+KP+N+LLD G+++++DFG S L ++ DG + + GTP+Y++P
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISP 172
Query: 183 EVL----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
E+L + +G G D WS GV ++ +L G PF +L+ Y KI + F PP
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
Query: 237 ---LSFTARKLIARIL 249
+S A+ LI R++
Sbjct: 233 VTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 25/263 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V + + VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
NVV+L V + ++IV+E++ GG+L + + ++ + + Q+ ++Y S+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 189 GYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTA 241
+ ++ D+WS GV+L+ + G P+ + + + + CPP L
Sbjct: 179 KF--TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPEL---- 232
Query: 242 RKLIARILDPNPMTRITIPEILE 264
L+ + +P R T E++E
Sbjct: 233 YDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +GEG F +V + VA+K L ++ + + + +E MK + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLI-------NAV 124
VRL V + +++VLE++ GG+L D + + + + L+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---A 181
+Y S+ HRDL N L+ +K+SDFG LS+ V DD G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLS 238
PE L D + ++ D+WS GV+L+ + G P+ + + + + P +
Sbjct: 176 PESLKDGIF--TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCP 233
Query: 239 FTARKLIARILDPNPMTRITIPEILE 264
+L+ +P R T E++E
Sbjct: 234 DELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 78/266 (29%), Positives = 137/266 (51%), Gaps = 13/266 (4%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ ++E IG+G V A + TG+ VA+K ++ ++ K E I E+ M+
Sbjct: 18 KKKYTRFE---KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMR 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V + ++++V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 244 LIARILDPNPMTRITIPEILEDEWFK 269
+ R L+ + R + E+L+ + K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 73/212 (34%), Positives = 119/212 (56%), Gaps = 12/212 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEGT+ V RN +TG+ VA+K + E + + I RE++ +K ++HPN+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCLQD 66
Query: 79 VMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ +++++++ EF++ + D + M + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT-TCGTPNYVAPEVLNDRGYDGST 194
LKP+NLL+D G +K++DFGL+ A VR ++T T Y APEVL +
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 195 ADLWSCGVILFVLLAGYLPF--DDSNLMNLYK 224
D+WS G I F +A P DS + L++
Sbjct: 183 VDIWSIGTI-FAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 70/264 (26%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N+V+L V + + IV+E++ GG+L D + + + + + Q+ ++Y S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 188 RGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFT 240
+ ++ D+WS GV+L+ + G P+ + + + + CPP L
Sbjct: 179 GKF--TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPEL--- 233
Query: 241 ARKLIARILDPNPMTRITIPEILE 264
KL+ + +P R T E++E
Sbjct: 234 -YKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-29
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 18/263 (6%)
Query: 31 RNSETGEPVALKILD-KEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82
RN T VA + D KEKV+ + A + E+ + H +V+ ++ S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K+ +++E+ +GG+L +I H +E E F Q++ A+D HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
N+ L G +K+ DFG S S V D + + CGTP Y+APE+ + Y AD+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYS-KKADM 254
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTR 256
WS GVIL+ LL + PF + + +++ ++ P +S + L+ +L NP R
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
Query: 257 ITIPEILEDEWFKKDYKPPVFEE 279
T ++L E+ K Y +F++
Sbjct: 315 PTTQQLLHTEFLK--YVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 18/263 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A +G+ VA+K +D + K + E + EV M+ +H NVV +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL G +K+SDFG A +S++V L GTP ++APE+++ Y G D+
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVDI 199
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKLIARILDP 251
WS G+++ ++ G P+ + + K I PP L S + + + R+L
Sbjct: 200 WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDRLLVR 256
Query: 252 NPMTRITIPEILEDEWFKKDYKP 274
+P R T E+L+ + K P
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-29
Identities = 73/249 (29%), Positives = 132/249 (53%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+L+D G+++++DFG S L ++ +DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSFT 240
+ +G G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 82/262 (31%), Positives = 130/262 (49%), Gaps = 23/262 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR----EVATMKL 67
KY + R +G G V A+ GEP A+K++D E M+E K EV +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-----MSEADKNRAQAEVCCLLN 87
Query: 68 VKHPNVVRLYEVMGSKTK--------IFIVLEFVTGGELFDKIVNHGR----MKEDEARR 115
++V+ +E K I +VL++ G+L +I + + +E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F Q++ AV + HS+ + HRD+K N+LL + G +K+ DFG S + D + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP 234
TP YVAPE+ + Y AD++S GV+L+ LL PFD N+ + K A + P
Sbjct: 208 TPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 235 PWLSFTARKLIARILDPNPMTR 256
P +S ++++ +L +P R
Sbjct: 267 PSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-29
Identities = 75/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + T A+KIL+K ++LK + E +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+LLD G+++++DFG S L ++ DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWL---SFT 240
+ G G D WS GV ++ +L G PF +L+ Y KI E F P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 79/266 (29%), Positives = 139/266 (52%), Gaps = 13/266 (4%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ +YE IG+G V A + TG+ VA+K ++ +K K ++ I E+ MK
Sbjct: 18 KKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMK 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+K+PN+V + ++F+V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H+ V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 244 LIARILDPNPMTRITIPEILEDEWFK 269
+ R L+ + R + E+L+ + K
Sbjct: 248 FLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 1e-28
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA+K ++ ++ K ++ I E+ M+ K+P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 249 LDPNPMTRITIPEILEDEWFK 269
L+ + R + E+L+ + K
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K++D E+ L+ M E + + H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-----IDILASCDH 61
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
PN+V+L + + ++I++EF GG + ++ R + E + R +Q + A++Y H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTPNYVAPEVL-- 185
+ HRDLK N+L G++K++DFG+SA + + R D + GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177
Query: 186 ---NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
DR YD AD+WS G+ L + P + N M + KI+ +E PP L+ +R
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSR 233
Query: 243 ------KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
+ + L+ N R T ++L+ + + P+ E
Sbjct: 234 WSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRE 275
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 81/303 (26%), Positives = 135/303 (44%), Gaps = 68/303 (22%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK-LVK 69
Y++ IGEGTF++V A++ +TG+ A+K + K K EQ+ RE+ ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 70 HPNVVRLYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINA 123
HPN++RL EV+ G +F +++ L++ I R + E + Y QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV--- 180
+D+ H G++HRD+KPEN+L+ LK++DFG S P Y
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC-----------RGIYSKPPYTEYI 159
Query: 181 ------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------- 218
APE L GY G D+W+ G + F +L+ + F +N
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPD 219
Query: 219 --LMNLYKKISAAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILED 265
++ ++K + P P S L+ ++L +P RIT + L
Sbjct: 220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279
Query: 266 EWF 268
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 73/263 (27%), Positives = 126/263 (47%), Gaps = 11/263 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
+Y + + +G+G+F V ++ + LK+L + V L Q +E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVD 125
HP +V+ + + I+ E+ G +L K+ + E++ +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H R + HRDLK +N+ L LK+ DFG+S L D L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244
+GYD S +D+WS G IL+ + F+ N +++ +I + P S +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 245 IARILDPNPMTRITIPEILEDEW 267
+ +L+ +P R + EIL + +
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LDPNPMTRITIPEILEDEWFK 269
LD + R + E+L+ ++ K
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 79/264 (29%), Positives = 134/264 (50%), Gaps = 15/264 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T E VA+KI+D E+ E I++E+ + P + R Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G ++E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
WS G+ L G P D + M + I PP L S ++ + L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPK---NSPPTLEGQYSKPFKEFVEACLNKDP 241
Query: 254 MTRITIPEILEDEWFKKDYKPPVF 277
R T E+L+ ++ + K F
Sbjct: 242 RFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 9/227 (3%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLK-HKMAEQIKREVATMKLVKHPN 72
G +G+G + V + + G+ +A+K LD VL K E+++ EV +K +KH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+ I I +EFV GG + + G + E +Y +Q+++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRD+K N++L G +K+ DFG L+ + +L + GTP ++APEV+N+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
GY G +D+WS G +F + G P + + I A P
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-28
Identities = 80/260 (30%), Positives = 134/260 (51%), Gaps = 15/260 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD S AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
WS G+ L G P D + M + I PP L S ++ I L+ +P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDP 241
Query: 254 MTRITIPEILEDEWFKKDYK 273
R T E+L+ ++ K+ K
Sbjct: 242 SFRPTAKELLKHKFIVKNAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G V + TG+ +A+K + E + + +QI RE+ + P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS-RGVY 133
Y + I I +E++ GG L DKI GR+ E + ++ + Y H +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRD+KP N+L+++ G +K+ DFG+S Q V + L T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 194 TADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAAEFTCPPWL-----SFTARK 243
+D+WS G+ L L G P+ N + L + I PP L S +
Sbjct: 180 -SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---PPRLPSGKFSPDFQD 235
Query: 244 LIARILDPNPMTRITIPEILEDEWFKK 270
+ L +P R + E+LE + KK
Sbjct: 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 93/296 (31%), Positives = 140/296 (47%), Gaps = 48/296 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE IGEGT+ V AR+ T E +ALK + E+ + + I RE++ +K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR------YFQQLINAVD 125
N+VRL +V+ S+ ++++V E+ L + H D A+ Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 126 YCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPE 183
YCHS V HRDLKP+NLL+D N LK++DFGL+ A VR H T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVV-TLWYRAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKI--------------- 226
+L + + D+WS G I F + P DS + L+K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232
Query: 227 SAAEF--TCPPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
S ++ P W L L++++L +P RIT LE E+FK
Sbjct: 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN ETG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQLK 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V L EV K K+ +V E+ L + N + E ++ Q + AV++CH
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVL-ND 187
HRD+KPEN+L+ G +K+ DFG + + DD +T T Y APE+L D
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVGD 175
Query: 188 RGYDGSTADLWSCGVILFVLLAG 210
Y G D+W+ G + LL G
Sbjct: 176 TQY-GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 75/261 (28%), Positives = 133/261 (50%), Gaps = 17/261 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G + E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
N+LL +G +K++DFG++ Q++ + + GTP ++APEV+ YD S AD
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYD-SKAD 183
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPN 252
+WS G+ L G P + + M + I PP L S ++ + L+
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEACLNKE 240
Query: 253 PMTRITIPEILEDEWFKKDYK 273
P R T E+L+ ++ + K
Sbjct: 241 PSFRPTAKELLKHKFIVRFAK 261
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 15/216 (6%)
Query: 34 ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY-EVMGSKTKIFIVLEF 92
TG VA+K+L + + + +RE A + HPN+V L +F V E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---N 149
V G L + + G + E R Q+++A+ H++G+ HRDLKP+N+++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 150 LKVSDFGLSALSQQVRDDGLLHTT-----CGTPNYVAPEVLNDRGYDGSTA--DLWSCGV 202
KV DFG+ L VRD + T GTP Y APE L RG + T DL++ G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RG-EPVTPNSDLYAWGL 177
Query: 203 ILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWL 237
I L G +++ LY+++S + + PPW+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVAT 64
KR V K+++ IGEGT+ +V AR+ +TGE VALK LD EK RE+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKI 59
Query: 65 MKLVKHPNVVRLYEVMGSKTK----------IFIVLEFVTG---GELFDKIVNHGRMKED 111
++ + H N+V L E++ K ++V E++ G L +V+ ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSED 116
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + +QL+ ++YCH + HRD+K N+LL+ G +K++DFGL+ L ++ +
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174
Query: 172 TT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 204
T T Y PE+L G D+WSCG IL
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 23/268 (8%)
Query: 13 YEVGRTIGEGTFAKV-KFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVAT 64
Y V +G G F V K + + +ALK K+K + K I EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIV-NHGRMKEDEARRYFQQ 119
+K ++HPN+VR Y+ +++IV++ + G GE F+ + R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 120 LINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A+ Y H + + HRDL P N++L + ++DFG L++Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVGTIL 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y PE++ + Y G AD+W+ G IL+ + PF +N+++L KI A + P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 239 FT--ARKLIARILDPNPMTRITIPEILE 264
++ +I L P+ R P+I++
Sbjct: 238 YSEDVTDVITSCLTPDAEAR---PDIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-26
Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 14/260 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG GT+ V ARN TGE A+K++ E + +Q E+ MK KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + + K++I +EF GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV--LNDRGY 190
HRD+K N+LL G++K++DFG+SA Q + GTP ++APEV + +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D+W+ G+ L P D + M ++ + F PP L S +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKLKDKMKWSNSFHHF 244
Query: 245 IARILDPNPMTRITIPEILE 264
+ L NP R T ++L+
Sbjct: 245 VKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 78/238 (32%), Positives = 120/238 (50%), Gaps = 27/238 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMK-LVK 69
KYE+ + +G+G + V A + T E VALK I D + A++ RE+ ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTFREIMFLQELGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVD 125
HPN+V+L V+ ++ I L F E + ++ +++ R QL+ A+
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKALK 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT--CGTPNYVAP 182
Y HS V HRDLKP N+LL++ +K++DFGL+ +LS+ + T T Y AP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 183 EVLNDRGYDGSTA-----DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
E+L GST D+WS G IL +L G F ++ +N +KI E PP
Sbjct: 182 EILL-----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI--IEVIGPP 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 87/302 (28%), Positives = 134/302 (44%), Gaps = 54/302 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
YE IGEGT+ KV AR+ TG+ VALK K E I RE++ +++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQM 56
Query: 68 VKH-PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGR-----MKEDEARRY 116
+ +VRL +V + K +++V E++ +L + ++GR + + +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTC 174
QL+ V +CH GV HRDLKP+NLL+D LK++D GL A S V+ H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV 173
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDS---NLMNLYKKI-SAA 229
T Y APEVL + + D+WS G I + F DS L++++K + +
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 230 EFTCP-----------------------PWLSFTARKLIARILDPNPMTRITIPEILEDE 266
E P P LS L+ ++L +P RI+ L
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHP 292
Query: 267 WF 268
+F
Sbjct: 293 YF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-25
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEVLN++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/170 (30%), Positives = 92/170 (54%), Gaps = 2/170 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I G F KV R + A+K++ K ++ M Q++ E + L K P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ S +++V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLK
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
P+N+L+ G++K++DFGLS ++ + + + TP+ P+ R
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT--LNRELNMMDILTTPSMAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-25
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR-EVATMKLVKHPNVVRLY 77
+G+G F +V + TG+ A K LDK++ LK K E++ E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRGVYHR 135
SKT + +V+ + GG+L I N G + R Y Q+ + + HS + +R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
D+KPEN+LLD GN ++SD GL+ +++D + GT Y+APE+L + Y
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV- 175
Query: 196 DLWSCGVILFVLLAGYLPFDD 216
D ++ G ++ ++AG PF D
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K+EV +GEG + V R+ ET E VA+K K+ ++ E RE+ ++ +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V L E + K+++V E+V EL +++ N + ++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRD+KPENLL+ LK+ DFG + LS+ + T Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSPELLLGA 176
Query: 189 GYDGSTADLWSCGVIL 204
Y G D+WS G IL
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 91/325 (28%), Positives = 151/325 (46%), Gaps = 50/325 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKHP 71
Y+ IGEG + V A + TG VA+K K +H+ ++ RE+ ++ KH
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + ++IV E + +L+ K++ + D + + Q++ + Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEV- 184
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D G L T Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF---DDSNLMNLYKKI----SAAEFTC--- 233
LN +GY + A D+WS G IL +L+ F D + +NL + S + C
Sbjct: 182 LNSKGY--TKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239
Query: 234 ----------P-----PWLSF------TARKLIARILDPNPMTRITIPEILEDEWFKKDY 272
P PW A L+ ++L NP RIT+ E L + ++ +
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299
Query: 273 KP---PVFEEKKDTNLDDVEAVFKD 294
P PV EE + + + + K+
Sbjct: 300 DPSDEPVAEEPFPFDFELFDDLPKE 324
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 76/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHP 71
+E+ TIG+GT+ KV N + G A+KILD H + E+I+ E +K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKI---VNHG-RMKEDEARRYFQQLIN 122
NVV+ Y + K ++++VLE GG + D + + G RM+E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + H HRD+K N+LL G +K+ DFG+SA R +T+ GTP ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAP 193
Query: 183 EVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
EV+ D YD + D+WS G+ L G P D + M KI
Sbjct: 194 EVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 4e-24
Identities = 75/242 (30%), Positives = 121/242 (50%), Gaps = 37/242 (15%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R+ +YEV + IG G F +V ++ T E K + + LK + Q+ EV M+ +
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLIN 122
KH N+VR + +K K++I++EF G+L I G+++E +QL++
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 123 AVDYCHS-------RGVYHRDLKPENLLLDA-----------YGNL------KVSDFGLS 158
A+ YCH+ V HRDLKP+N+ L NL K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ + + + H+ GTP Y +PE+L + YD +D+W+ G I++ L +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHK 245
Query: 217 SN 218
+N
Sbjct: 246 AN 247
|
Length = 1021 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-24
Identities = 86/293 (29%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVK 69
K +GEG V R TG ALK I K QI RE+ K K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCK 57
Query: 70 HPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------RYFQQL 120
P +V+ Y + S + I I +E+ GG L D I + ++K+ R + + +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSI--YKKVKKRGGRIGEKVLGKIAESV 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HSR + HRD+KP N+LL G +K+ DFG+S + V + L T GT Y+
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--NSLAGTFTGTSFYM 170
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--------NLMNLYKKISAAEFT 232
APE + + Y T+D+WS G+ L + PF L++ + E
Sbjct: 171 APERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229
Query: 233 CPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
P W S + I + L+ +P R T ++LE W K K V K
Sbjct: 230 DEPGNGIKW-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK 281
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 5e-24
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEG++A V R+ TG+ VALK E L+H+ RE + +K +KH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK----EIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ +K + +V E++ +L + + G + R + QL+ + YCH R V HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL+ G LK++DFGL A ++ V + T Y P+VL GST
Sbjct: 128 DLKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVV-TLWYRPPDVLL-----GSTE 180
Query: 196 -----DLWSCGVILFVLLAG 210
D+W G I + + G
Sbjct: 181 YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 6e-24
Identities = 79/260 (30%), Positives = 126/260 (48%), Gaps = 16/260 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ + +G GT+ V ARN TGE A+KI+ E + I++E+ +K KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + S+ K++I +E+ GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---NDRG 189
HRD+K N+LL G++K++DFG++A + + GTP ++APEV + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARK 243
Y+ D+W+ G+ L P D + M +S + F PP L S T
Sbjct: 186 YN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PPKLKDKTKWSSTFHN 243
Query: 244 LIARILDPNPMTRITIPEIL 263
+ L NP R T +L
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 8e-24
Identities = 78/267 (29%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V AR+ T +A+K D V + + E+A +KH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV------QPLHEEIALHSYLKHRNIVQ 69
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I +E V GG L + + G +K++E Y +Q++ + Y H +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RG 189
HRD+K +N+L++ Y G +K+SDFG S + + T GT Y+APEV++ RG
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---------PPWLSFT 240
Y G+ AD+WS G + + G PF + + AA F P LS
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIE------LGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 241 ARKLIARILDPNPMTRITIPEILEDEW 267
A+ I R +P+P R + ++L+D +
Sbjct: 241 AKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-23
Identities = 75/249 (30%), Positives = 122/249 (48%), Gaps = 15/249 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K L+K+++ K K E E + V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+KT + +V+ + GG+L I N + E A Y Q+I+ +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
RDLKPEN+LLD GN+++SD GL+ Q + G GTP ++APE+L YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYDF 176
Query: 193 STADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
S D ++ GV L+ ++A PF + L ++I T P S ++ +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235
Query: 249 LDPNPMTRI 257
L +P R+
Sbjct: 236 LAKDPEKRL 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-23
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y+ IG G + V A ++ +G+ VA+K K+ +A++ RE+ ++
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV---TGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
KH N++ + +++ F + V +L I + + E+ R + QL+ +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS V HRDLKP NLL++ L++ DFG+ S + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 183 EVLNDRGYDGSTA-DLWSCGVIL 204
E+L + +TA D+WS G I
Sbjct: 181 ELLLSLP-EYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 3e-23
Identities = 80/319 (25%), Positives = 143/319 (44%), Gaps = 51/319 (15%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + +V A +++TG VA+K L + + H A++ RE+ +K + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTYRELRLLKHMDH 73
Query: 71 PNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + +++V + G +L + IV ++ +D + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS G+ HRDLKP N+ ++ LK+ DFGL+ + D + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------------------ 226
+ + + T D+WS G I+ LL G F S+ ++ K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE 246
Query: 227 SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
SA + + P + A L+ ++L +P RIT E L + + +
Sbjct: 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306
Query: 274 P---PVFEEKKDTNLDDVE 289
P PV D + + +
Sbjct: 307 PEDEPV-APPYDQSFESRD 324
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-23
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I + G +E R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD +G++++SD GL+ V + + GT Y+APEV+ + Y S
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W+ G +L+ ++AG PF
Sbjct: 182 PDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-23
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 22/273 (8%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ ++HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 77 YEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++V+E+ G ++ + V+ ++E E + + Y HS H
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG-YD 191
RD+K N+LL G +K++DFG ++L ++ GTP ++APEV+ D G YD
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYD 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA-----RKLIA 246
G D+WS G+ L P + N M+ I+ + P LS R +
Sbjct: 193 GK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLSSNDWSDYFRNFVD 248
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L P R + E+L+ + ++ P V +
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-23
Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK E+ +K
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D + N +KED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H+ V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +D+WS G+ + G P D + M
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-23
Identities = 77/312 (24%), Positives = 127/312 (40%), Gaps = 54/312 (17%)
Query: 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-----------REVA 63
G +GEGT+ KV+ A ++ TG+ VA+K + ++ ++ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLIN 122
M +KH N++ L +V I +V++ + K+V+ R+ E + + Q++N
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILN 130
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPN- 178
++ H HRDL P N+ +++ G K++DFGL+ T
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 179 --------YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKI 226
Y APE+L D+WS G I LL G F N L +++ +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 227 SAAEFT-------CPPWLSFTARK-----------------LIARILDPNPMTRITIPEI 262
P + FT RK L+ +L NP+ RI+ E
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310
Query: 263 LEDEWFKKDYKP 274
L+ E+FK D P
Sbjct: 311 LKHEYFKSDPLP 322
|
Length = 335 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-22
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD G++++SD GL+ Q+ + + GT Y+APEV+N+ Y S
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-22
Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+E+ TIG+GT+ KV N + G A+KILD + E+I+ E ++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 70 HPNVVRLYEVMGSKTK-----IFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQQL 120
HPNVV+ Y + K +++VLE GG EL ++ G R+ E
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPN 178
+ + + H+ + HRD+K N+LL G +K+ DFG+SA S ++R + T+ GTP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPF 193
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYK 224
++APEV+ D YD + D+WS G+ L G P FD + L+K
Sbjct: 194 WMAPEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQ----IKREVATMKLV 68
+ +GEG F KV+ R TGE VA+K L H EQ +RE+ ++ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 69 KHPNVVRL----YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLIN 122
H N+V+ + G ++ ++E++ G L D + H R + + R + Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRL--IMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICK 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+DY S+ HRDL N+L+++ +K+SDFGL+ + + +D + +P + A
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLL 208
PE L + S +D+WS GV L+ L
Sbjct: 181 PECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 84/318 (26%), Positives = 144/318 (45%), Gaps = 53/318 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y + +G G F V AR+ TG+ VA+K K++K +A++ RE+ +K
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++H N++ L ++ S I+ V E + G +++ +++ + + Q++ + Y
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-L 185
HS GV HRDLKP N+L++ +LK+ DFGL+ + Q + G + T Y APE+ L
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIML 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------- 234
+ YD D+WS G I +L G F + +N + I+ T P
Sbjct: 179 TWQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237
Query: 235 --------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
+A L+ ++L +P RI+ E L + + P
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297
Query: 275 ---PVFEEKKDTNLDDVE 289
PV EEK D + +D +
Sbjct: 298 TDEPVAEEKFDWSFNDAD 315
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-22
Identities = 71/253 (28%), Positives = 129/253 (50%), Gaps = 12/253 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVV 74
R +G+G++ +V R+ G+ +K L+ + K AEQ E + +KHPN+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIV 62
Query: 75 RLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRM-KEDEARRYFQQLINAVDYCHSRG 131
E G ++IV+ F GG+L+ K+ G++ E++ +F Q+ A+ Y H +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK +N+ L +KV D G++ + + D + T GTP Y++PE+ +++ Y+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYN 180
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEFTCPPWLSFTARKLIARILD 250
+D+W+ G ++ + F+ ++ +L Y+ I P S +LIA +L
Sbjct: 181 -YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239
Query: 251 PNPMTRITIPEIL 263
P R ++ IL
Sbjct: 240 KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 80/319 (25%), Positives = 132/319 (41%), Gaps = 58/319 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLV 68
+Y R +G G+ V A +S+ + VA+K +L + +KH + RE+ ++ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59
Query: 69 KHPNVVRLYEVMGSKTK--------------IFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
H N+V++YEV+G ++IV E++ ++ G + E+ AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHT 172
+ QL+ + Y HS V HRDLKP N+ ++ LK+ DFGL+ + G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 173 TCGTPNYVAPE-VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNL------ 222
T Y +P +L+ Y D+W+ G I +L G F ++ M L
Sbjct: 178 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 223 ----------------YKKISAAEFTCP-----PWLSFTARKLIARILDPNPMTRITIPE 261
+ + E P P ++ A + +IL NPM R+T E
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296
Query: 262 ILEDEWFKKDYKPPVFEEK 280
L + Y P E
Sbjct: 297 ALMHPYM-SCYSCPFDEPV 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-22
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 19/276 (6%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G+G + V + TG +A+K + E L QI E+ + P +
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V Y + +++ +E++ G +L+ V + ED RR ++ + +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 131 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---- 185
+ HRD+KP N+L++ G +K+ DFG+S V L T G +Y+APE +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKTNIGCQSYMAPERIKSGG 177
Query: 186 -NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFT 240
N +D+WS G+ + + G P+ N++ ++SA PP L S
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
A+ +A+ L+ P R T ++LE W K V
Sbjct: 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 4e-22
Identities = 92/340 (27%), Positives = 162/340 (47%), Gaps = 55/340 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKH 70
+Y++ IG+G++ V A ++ TGE VA+K ++ V +H A +I RE+ ++L++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P++V + +M ++ I++V E + +L I + + + + + QL+ A+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEV 184
Y H+ V+HRDLKP+N+L +A LK+ DFGL+ ++ + T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-------- 235
+ A D+WS G I +L G F N+++ I+ T P
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237
Query: 236 -----WLS---------FT---------ARKLIARILDPNPMTRITIPEILEDEWFK--- 269
+LS F+ A +L+ R+L +P R T E L D +FK
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297
Query: 270 -KDYKP---PV------FEEKKDTNLDDVEAVFKDSEEHH 299
+ +P P+ FE ++ T D E ++++ E+H
Sbjct: 298 KVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYH 337
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVAT 64
++ YE+ +GEGTF +V AR +TG VALK K+L H + RE+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKI 60
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
+K +KHPNVV L ++ + +++V ++ G L + V + E +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173
+ Y QL+ ++Y H + HRD+K N+L+D G LK++DFG L++
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG---LARPYDGPPPNPKG 174
Query: 174 CGTPN------------YVAPE-VLNDRGYDGSTADLWSCGVIL 204
G Y PE +L +R Y + D+W G +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-22
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F +V R PVA+K + L + + +E +K HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V K I+IV+E V GG+ + G R+K E + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLNDRGYDGS 193
N L+ LK+SDFG+S + +DG+ +T G + APE LN Y S
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+D+WS G++L+ + G +P+ +NL N
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPY--ANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 7e-22
Identities = 68/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D I N +KE+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +DLWS G+ + G P D + M
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 71/265 (26%), Positives = 121/265 (45%), Gaps = 14/265 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G+F V FA NS T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ ++V+E+ G V+ ++E E + + Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGSTA 195
N+LL G +K++DFG ++ S ++ GTP ++APEV +++ YDG
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV- 201
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPN 252
D+WS G+ L P + N M+ I+ + W + + R + L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW-TDSFRGFVDYCLQKI 260
Query: 253 PMTRITIPEILEDEWFKKDYKPPVF 277
P R E+L ++ ++D V
Sbjct: 261 PQERPASAELLRHDFVRRDRPARVL 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-21
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 48 KVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG 106
K++K K I+ V MK +PN ++LY + + ++++++ G+LFD + G
Sbjct: 47 KIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL--SQQ 163
++ E E ++ +QL+ A++ H + H D+K EN+L D + + D+GL + +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----- 218
D GT +Y +PE + YD S D W+ GV+ + LL G PF +
Sbjct: 165 CYD--------GTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 219 ---LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258
L+ +K + +S A + +L N R+T
Sbjct: 216 LESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYNINYRLT 254
|
Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ ++ + +V E++ +L + N G M + + QL+ + YCH R + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 128 DLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPI 185
Query: 196 DLWSCGVILFVLLAG 210
D+W G IL+ + G
Sbjct: 186 DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 86/338 (25%), Positives = 140/338 (41%), Gaps = 77/338 (22%)
Query: 13 YEVGRTIGEGTFAKVKFARNSET--GEPVALK----ILDKEKVLKHKMAEQIKREVATMK 66
YE+ + +G+G + V ARN+ET E VA+K + K+ + K + RE+ ++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGG---------ELFD----KIVNHGRMKEDE 112
+ H N+ LY+ ++ V G EL + +I+ G+ D
Sbjct: 57 HFRGHKNITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105
Query: 113 ARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ--QVRDDGL 169
+ F Q++ + Y HS V HRDLKP NLL++A LK+ DFGL+ + G
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 170 LHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAG------------------ 210
+ T Y APE+ L+ + Y + D+WS G IL LL
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQ 224
Query: 211 YLPFDDSNLMNLYKKISAAEFT----CPPWLSFT---------ARKLIARILDPNPMTRI 257
L D ++ A + P F A L+ ++L +P RI
Sbjct: 225 VLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284
Query: 258 TIPEILE----DEWFKKDYKPPVFEEKKDTNLDDVEAV 291
++ E LE W D PV ++ D + + +++
Sbjct: 285 SVEEALEHPYLAIWHDPD-DEPVCQKPFDFSFESEDSM 321
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 3e-21
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 58/308 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
KY + IG G + V A+NSET E VA+K + +++ A++ RE+ ++ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN--AFDNRIDAKRTLREIKLLRHLDH 63
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYF-QQL 120
NV+ + ++M + ++IV E L D +I+ + D+ +YF QL
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP NLLL+A +LK+ DFGL+ + + + T Y
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYR 175
Query: 181 APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPF-------------------DDSNLM 220
APE+ LN Y + D+WS G I LL F + +L
Sbjct: 176 APELLLNCSEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234
Query: 221 NL--------------YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266
+ + S A P + A L+ ++L +P RIT+ E L
Sbjct: 235 FIRNEKARRYIRSLPYTPRQSFARLF--PHANPLAIDLLEKMLVFDPSKRITVEEALAHP 292
Query: 267 WFKKDYKP 274
+ + P
Sbjct: 293 YLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-21
Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+YE IGEG + KV AR+ + G VALK + + + + M REVA ++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 70 --HPNVVRLYEV-----MGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQL 120
HPNVVRL++V +TK+ +V E V DK+ G + + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNY 179
+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + S Q+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 175
Query: 180 VAPEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + DLWS G I
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A ++ + VA+K L + + L H A + RE+ +K +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH--ARRTYRELRLLKHMKH 73
Query: 71 PNVVRLYEVMGSKTKI--FIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
NV+ L +V T I F + VT G + IV ++ ++ + QL+ + Y
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS G+ HRDLKP N+ ++ L++ DFG L++Q D+ + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFG---LARQADDE--MTGYVATRWYRAPEIML 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ LL G F ++ ++ K+I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 6e-21
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 22/285 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K++DFG ++++ ++ GTP ++APEV +++ YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILD 250
D+WS G+ L P + N M+ I+ E W + R + L
Sbjct: 205 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYF-RNFVDSCLQ 262
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS 295
P R T E+L+ + V E+ +T L D+ KD+
Sbjct: 263 KIPQDRPTSEELLKHMF--------VLRERPETVLIDLIQRTKDA 299
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-21
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ YE +GEG++A V ++ G+ VALK++ ++ + RE + +K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGL 60
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KH N+V L++++ +K + +V E+V + DK + G + + + + QL+ + Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---TPNYVAPE 183
H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT T Y P+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPD 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
VL + D+W G I ++ G F
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-21
Identities = 67/244 (27%), Positives = 107/244 (43%), Gaps = 34/244 (13%)
Query: 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81
G KV ++ T + LK L K + I V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCV--------PNMVCLHKYIV 55
Query: 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141
S+ +F+VL+ GG+L+ I + E+ +R+ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 142 LLLDAYGNLKVSDFG-LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA--DLW 198
+LLD G+++++ F S + + + + C APEV G T D W
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV---GGISEETEACDWW 166
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSFTARKLIARILDPNP 253
S G ILF LL G L + + P W+S AR L+ ++L NP
Sbjct: 167 SLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNP 217
Query: 254 MTRI 257
R+
Sbjct: 218 TERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-20
Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 16/237 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TG VA+K L + A++ RE+ +K +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 72 NVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
+ + T D+WS G I+ +L G F + ++ +I + T P F +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI--MKVTGTPSKEFVQK 242
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ + + +V E++ +L + + G M + + Q++ + YCH R V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 129 DLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 196 DLWSCGVILFVLLAGYLPFDDSNL 219
D+W G I F + +G F S +
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-20
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-- 69
+YE IG G + V AR+ +G VALK + + + + + REVA +K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 70 -HPNVVRLYEVMGS-----KTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLI 121
HPN+VRL +V + +TK+ +V E V DK+ G + + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNYV 180
+D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ + S Q+ ++ T Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YR 174
Query: 181 APEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + D+WS G I
Sbjct: 175 APEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 71/265 (26%), Positives = 123/265 (46%), Gaps = 36/265 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++G TIG+G F V G+ VA+K L + A+ E + M ++HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-------NAVDY 126
V+L V+ ++IV E++ G L D + + GR A Q + ++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVL 185
+ HRDL N+L+ KVSDFGL+ + Q +D G L P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEAL 171
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPPWLSF 239
++ + + +D+WS G++L+ + + G +P+ L ++ + A CPP +
Sbjct: 172 REKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEV-- 228
Query: 240 TARKLIARILDPNPMTRITIPEILE 264
K++ + +P R T ++ E
Sbjct: 229 --YKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 57/232 (24%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + R +G G F +V VA+KIL + +LK + ++EV +K ++H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQ-QLINAVDYCHSR 130
++ L+ V ++I+ E + G L + + G++ + Q+ + Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KV+DFGL+ L +++D L + P + APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+ + +D+WS G++L+ + G +P+ N +Y +I+A CP
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++++ ++ + +V E++ + D N M + + QL+ ++YCH R V H
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLH 127
Query: 135 RDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
RDLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P++L
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDY 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNL 219
+ D+W G I + + G F S +
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+G+F V+ ++ G+ PVA+K L +K+ + + +E A M + H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQQLINAVDYC 127
LY V+ + + +V E G L D R+++D Y Q+ N + Y
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
S+ HRDL N+LL + +K+ DFGL Q D ++ P + APE L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 187 DRGYDGSTADLWSCGVIL 204
R + +D+W GV L
Sbjct: 174 TRTFS-HASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG++A V + G+ VALK++ + + + RE + +K +KH N+V L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
++ +K + V E++ +L ++ H G + R + QL+ + Y H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 138 KPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
KP+NLL+ G LK++DFGL+ ++ Q ++ T Y P+VL S
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATDYSSA 184
Query: 195 ADLWSCGVILFVLLAG 210
D+W G I +L G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 71/308 (23%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +Y++ R IG+G +V A + VALK + ++ + ++ RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR------------RYF 117
HP +V +Y + ++ + ++ G L ++ KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------G 168
++ ++Y HS+GV HRDLKP+N+LL +G + + D+G + + +D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 169 LLHTT-------CGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLPF---DDS 217
+ +++ GTP+Y+APE L G S + D+++ GVIL+ +L P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 218 NLMNLYKKISAAEFT----CPPWLSFTARKLIARILDPNPMTRI-TIPEILED------- 265
+ +S E PP+LS ++ + L +P R ++ E+ +D
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAERYSSVQELKQDLEPHLQG 293
Query: 266 --EWFKKD 271
EW K
Sbjct: 294 SPEWTVKA 301
|
Length = 932 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 16/233 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + H A++ RE+ +K +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMKH 75
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G + IV ++ +D + Q++ +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237
+ + + T D+WS G I+ LL G F ++ ++ K I T L
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 241
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TGE VA+K L + A++ RE+ +K ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V S ++V+ ++ KI+ H + ED+ + Q++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGLK 131
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y HS G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVI 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ +L G F + ++ +I
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-18
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K+ DFG +++ + GTP ++APEV +++ YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
D+WS G+ L P + N M+ I+ E
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-18
Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 51/273 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKIL-------DKEKVLKHKMAEQIKREVATMKLVK 69
IG+G F V E VA+K K K L+ E +K
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQ---------EAEILKQYD 50
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE--ARRYFQQLINA---V 124
HPN+V+L V K I+IV+E V GG L + R K++ ++ Q ++A +
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLLQMSLDAAAGM 106
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YV 180
+Y S+ HRDL N L+ LK+SDFG+S + + G+ + G +
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWT 162
Query: 181 APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYK--------KISAAEF 231
APE LN Y S +D+WS G++L+ G P+ + N ++ A +
Sbjct: 163 APEALNYGRYT-SESDVWSYGILLWETFSLGDTPY--PGMSNQQTRERIESGYRMPAPQL 219
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CP + +L+ + +P R + EI
Sbjct: 220 -CPEEI----YRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-18
Identities = 72/260 (27%), Positives = 122/260 (46%), Gaps = 28/260 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V F + PVA+K ++ L ++ + E +K HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD------YCHSRG 131
V + I+IV+E V GG+ + R K+DE + +QL+ A+D Y S+
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLND 187
HRDL N L+ LK+SDFG+S ++D ++++ G + APE LN
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245
Y S +D+WS G++L+ + G P+ +++ +CP K++
Sbjct: 169 GRYS-SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVM 227
Query: 246 ARILDPNPMTRITIPEILED 265
R D P R E+ ++
Sbjct: 228 QRCWDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 17 RTIGEGTFAKVK---FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V + S VA+K L +E + K ++ RE + M + HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
VRL V + + +V+E G L + + + + Q+ + Y S+
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDRGY 190
HRDL N+LL K+SDFG+S AL D TT G P + APE +N +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 191 DGSTADLWSCGVIL 204
S +D+WS GV L
Sbjct: 176 S-SKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 87/355 (24%), Positives = 147/355 (41%), Gaps = 83/355 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDK--EKVLKHKMAEQIKREVATMKLVK 69
+Y+ + IG G V A ++ TG+ VA+K L + + V K A RE+ MKLV
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA---YRELVLMKLVN 73
Query: 70 HPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF-QQL 120
H N++ L V + +++V+E + ++ ++H RM Y Q+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQM 127
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYR 184
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----- 235
APEV+ GY D+WS G I+ ++ G + F ++ ++ + KI T
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243
Query: 236 ----------------WLSFT----------------------ARKLIARILDPNPMTRI 257
SF AR L++++L +P RI
Sbjct: 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI 303
Query: 258 TIPEILEDE----WFKKD--YKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEE 306
++ + L+ W+ PP D ++D+ EH V E KE
Sbjct: 304 SVDDALQHPYINVWYDPSEVEAPP--PAPYDHSIDER--------EHTVEEWKEL 348
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPNVVR 75
R IG G F V + G+ VALK + V ++ ++ +++ RE+ + KH NV+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 76 LYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+++ +I++V E + +L IV+ + D + + Q++ + Y HS
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLNDR 188
G+ HRD+KP NLL+++ LK+ DFGL+ + + D H T T Y APE+L
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP---DESKHMTQEVVTQYYRAPEILMGS 179
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ S D+WS G I LL + F +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-17
Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 16/254 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F V + + VA+K +++ + + E+ K MKL HP +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAK---VMMKL-SHPKLVQL 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
Y V + ++IV EF+ G L + + G++ +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDG 192
DL N L+ + G +KVSDFG +++ V DD ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFG---MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 193 STADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTARKLIARILD 250
S +D+WS GV+++ V G +PF+ + + + IS P L S T +++
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWH 239
Query: 251 PNPMTRITIPEILE 264
P R T E+L
Sbjct: 240 EKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-17
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K +G IGEG F V + TG+ VA+K + + A+ E A M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHK 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHS 129
N+VRL V+ ++IV+E ++ G L + + GR + ++ + ++Y S
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDL N+L+ G KVSDFGL+ + D+ L + APE L +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173
Query: 190 YDGSTADLWSCGVILF 205
+ S +D+WS GV+L+
Sbjct: 174 FS-SKSDVWSYGVLLW 188
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 83/344 (24%), Positives = 146/344 (42%), Gaps = 64/344 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ G VA+K L + A++ RE+ +K V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHK 80
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQMLCG 135
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ + ++ T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRAPE 192
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP--- 234
V+ GY D+WS G I+ L+ G + F ++ ++ + K+ +AEF
Sbjct: 193 VILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251
Query: 235 ------------PWLSFT---------------------ARKLIARILDPNPMTRITIPE 261
P +SF AR L++++L +P RI++ E
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311
Query: 262 ILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKE 305
L + Y P E + D + + EH + E KE
Sbjct: 312 ALRHPYITVWYDPAE-AEAPPPQIYDAQL---EEREHAIEEWKE 351
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE+ IG GT+ +V A+ N + G+ A+K +K +++ RE+A ++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 70 HPNVVRLYEVMGSKT--KIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ------- 118
H NVV L EV ++++ ++ D +I+ R R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQA---KRVSIPPSMVKSL 113
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGL-----SALSQQVRDD 167
Q++N V Y HS V HRDLKP N+L+ G +K+ D GL + L D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 168 GLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLA 209
++ T Y APE+ L R Y D+W+ G I LL
Sbjct: 174 PVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 16 GRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V R VA+K++ +E + + E M + HPN+
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID---VAIKMI-REGAMSE---DDFIEEAKVMMKLSHPNL 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
V+LY V + IFIV E++ G L + + G++ + + A++Y S G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N L+ +KVSDFG L++ V DD + GT + PEV D
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFG---LARYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYS 176
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFD 215
S +D+WS GV+++ V G +P++
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-17
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 13 YEVGRT-------IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+E+ RT +G G + +V + VA+K L KE ++ E+ +E A M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAVM 56
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--QLINA 123
K +KHPN+V+L V + +I+ EF+T G L D + R + + + Q+ +A
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAP 182
++Y + HRDL N L+ +KV+DFGLS L D H P + AP
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAP 174
Query: 183 EVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
E L + +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 175 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-17
Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 73 VVRLYEVM--GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+V+ + I +++EF+ G E + N +K+ +Y Q+ +DY
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ--QLKYAVQICKGMDYL 125
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVL- 185
SR HRDL N+L+++ +K+ DFGL+ + ++ + +P + APE L
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230
+ Y S D+WS GV L+ LL Y + S + K I
Sbjct: 186 QSKFYIAS--DVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242
Query: 231 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
PP +L+ + + P R T ++E
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y V +T+ G+ +V A +PV LKI K L M ++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V+R+ + + S +VL + +L+ + + D+A +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+K EN+ ++ + + D G + GL GT APEVL Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 191 DGSTADLWSCGVILFVLLA 209
+ S AD+WS G++LF +LA
Sbjct: 234 N-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-16
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV N TGE VA+K L +E ++ K+E+ +K + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 73 VVRLY---EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+V+ G K + +++E+V G L D + H ++ + + QQ+ + Y HS
Sbjct: 68 IVKYKGCCSEQGGKG-LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTTCGTPNY-VAP 182
+ HRDL N+LLD +K+ DFGL+ +VR+DG +P + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLL 208
E L + + ++ D+WS GV L+ LL
Sbjct: 180 ECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-16
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE-QIKREVATMKLVKHPNVVR 75
+ +G G F VK+ + VA+K++ KE M+E + E M + H +V+
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG----SMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 134
LY V + I+IV E+++ G L + + HG R + + + + + Y S+ H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYD 191
RDL N L+D G +KVSDFG LS+ V DD ++ G+ + PEVL +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFG---LSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS 179
Query: 192 GSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
S +D+W+ GV+++ V G +P++ N +K+S
Sbjct: 180 -SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E +G G V ++ TG +A K++ K + +QI RE+ M + P +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-G 131
V Y ++ I + +EF+ G L D+I G + + + ++ + Y ++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + D T GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN 218
+D+WS G+ + L G PF SN
Sbjct: 180 T-VKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KH--PNVV 74
IG GT +V R +TG +A+K ++ + E+ KR + + +V H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSR-G 131
+ Y + + +FI +E + DK++ G + ED + ++ A+ Y + G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN---- 186
V HRD+KP N+LLDA GN+K+ DFG+S + V D T + G Y+APE ++
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ YD AD+WS G+ L L G P+ +
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-16
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMK 66
+ E + +G G F V GE PVA+K+L +E K ++I E M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
V HP+VVRL + S + ++ + + G L D + NH + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPE 183
Y + + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
+ R Y +D+WS GV ++ L+ G P++
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 19 IGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHP 71
+G+G F V+ R TGE VA+K L+H AE + +RE+ +K ++H
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK------KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 72 NVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYC 127
N+V+ V S + + +V+E++ G L D + H R + D + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVLN 186
S+ HRDL N+L+++ +K+ DFGL+ + Q ++ + +P + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 187 DRGYDGSTADLWSCGVILFVL 207
+ + +D+WS GV+L+ L
Sbjct: 185 ESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 17 RTIGEGTFAKVKFARNSETGEP---VALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V R G+ VA+K L DK+++ E + M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIMGQF 62
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN------ 122
HPN++RL V+ + I+ E++ G L DK ++E++ + QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 123 -AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--TP-N 178
+ Y HRDL N+L+++ KVSDFG LS+++ D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKGGKIPIR 173
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ APE + R + S +D+WS G++++ V+ G P+ D
Sbjct: 174 WTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-16
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V ++ +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ EA+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 178
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y +D+WS G+ L L G P
Sbjct: 179 YS-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 35/204 (17%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
R +G G F +V N T VA+K L K + E +E MK ++H +V
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTT--KVAVKTL-KPGTMS---PEAFLQEAQIMKKLRHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR-YFQQLI-------NAVDY 126
+LY V + I+IV E+++ G L D +K E ++ QL+ + Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP---NYVAP 182
SR HRDL N+L+ K++DFGL+ L + DD +T G + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 183 EVLNDRGYDGST--ADLWSCGVIL 204
E N Y T +D+WS G++L
Sbjct: 174 EAAN---YGRFTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 14 EVGRTIGEGTFAKV-KFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+GR IGEG F V + S E VA+K + E+ +E M+ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++IV+E GEL + VN + Y QL A+ Y S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFGLS + D+ + G P ++APE +N
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINF 182
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPF 214
R + S +D+W GV ++ +L+ G PF
Sbjct: 183 RRFT-SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ GE VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQ 118
+VVRL V+ + +V+E + G+L + + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123
Query: 119 ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDG--LL 170
++ + + Y ++ HRDL N ++ +K+ DFG++ + R G LL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
P ++APE L D G + +D+WS GV+L+
Sbjct: 184 ------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+TIG+G F V G VA+K + + A+ E + M ++H N+V+L
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQL 64
Query: 77 YEVM-GSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVY 133
V+ K ++IV E++ G L D + + GR + D ++ + A++Y +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRDL N+L+ KVSDFGL+ + +D G L + APE L ++ + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-T 178
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+D+WS G++L+ + + G +P+ L ++ ++ A CPP
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 47/300 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-----KREV----AT 64
EV +G G + V R+ TG +A+K ++ + KR + +
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVK----------RIRATVNSQEQKRLLMDLDIS 53
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHG-RMKEDEARRYFQQLI 121
M+ V P V Y + + ++I +E + + + K+ + G + ED + ++
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 122 NAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
A++Y HS+ V HRD+KP N+L++ G +K+ DFG+S + D G Y+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYM 170
Query: 181 APE----VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
APE LN +GYD +D+WS G+ + L G P+D + ++++ P
Sbjct: 171 APERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYD--SWKTPFQQLKQVVEEPSPQ 227
Query: 237 L---SFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAV 291
L F+ + + + L N R PE+L+ P FE N D V
Sbjct: 228 LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH---------PFFELHLSKNTDVASFV 278
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 19/269 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 131
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 188
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTAR 242
V+ GY D+WS G I+ ++ + F + ++ + K+ T CP ++
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271
+ + + +T P++ D F D
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPAD 276
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 83
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + ++IV+E + ++ ++H RM Q++
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 138
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
V+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-15
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77
+G G V A + T +A+K++ + ++ + +QI E+ + P ++ Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +I I EF+ GG L D + ++ E R ++ + Y S + HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DV---YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KP N+L++ G +K+ DFG+S +Q V + + T GT Y+APE ++ Y G +D+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 198 WSCGVILFVLLAGYLPF 214
WS G+ L G P+
Sbjct: 177 WSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 63/266 (23%), Positives = 124/266 (46%), Gaps = 33/266 (12%)
Query: 1 MSQPKIKRR---VGKYEVGRTIGEGTFAKV---------------KFARNSETGEPVALK 42
++Q K+K + + V + G F K+ + ++ G+P +
Sbjct: 135 LAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCER 194
Query: 43 ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV---LEFVTGGELF 99
++ K + A Q++ E+ + + H N++++ E++ S+ +++ +F ++
Sbjct: 195 LIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMY 254
Query: 100 DKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
D+ + R + R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG +
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217
++ R + + GT +PE+L GY T D+WSCG+IL +L+ + P D
Sbjct: 315 MPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGDG 372
Query: 218 ------NLMNLYKKISAA--EFTCPP 235
L+ + +S EF PP
Sbjct: 373 GGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 50/223 (22%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+ + V A++ T VA+K ++ + + + +++E+ T + ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS 129
++ +++++V + G D + H G + E + ++NA+DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-------NYVAP 182
+G HR +K ++LL G + +S GL ++ P +++P
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 183 EVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223
EVL N +GY+ +D++S G+ L G++PF D +
Sbjct: 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-14
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-G 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS 180
Query: 192 GSTADLWSCGVILFVLLAGYLP 213
+D+WS G+ L + G P
Sbjct: 181 -VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 19 IGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IG G V AR TGE V ++ ++ E ++M ++ E+ KL HPN+V
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++++V F+ G D I H M E Q ++ A+DY H G H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPEVL-- 185
R +K ++L+ G + +S GL + + L P Y ++PEVL
Sbjct: 125 RSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
N +GYD + +D++S G+ L G++PF D
Sbjct: 183 NLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G F +V R G+ PVA+K L K + E + M HPN+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNI 67
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
+ L V+ + IV E++ G L + H G+ + + + + + Y G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N+L+++ KVSDFGLS + + D +TT G + APE + R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
+ S +D+WS G++++ V+ G P+ + + ++ K I A CP
Sbjct: 186 FT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-14
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 19 IGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKR----EVATMKLVKHP 71
IG G F +V R G+ VA+K LK E+ +R E + M HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++ L V+ + I+ EF+ G L D + N G+ + + + + Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + D ++ G + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--FTCPP 235
R + S +D+WS G++++ V+ G P+ D M+ I+A E + PP
Sbjct: 185 YRKFT-SASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIEQDYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 26/222 (11%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +GR +G+G F V+ A+ + + VA+K+L K + E+ RE A MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 70 HPNVVRLYEV-MGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-- 121
HPNV++L V + S+ K ++L F+ G+L ++ R+ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRF 118
Query: 122 -----NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++Y S+ HRDL N +L+ + V+DFG LS+++ C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG---LSKKIYSGDYYRQGCAS 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L D Y + +D+W+ GV ++ ++ G P+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK----ILDKEKVLKHKMAEQIKREV-ATMKLVKHPNV 73
IG G F V + +G +A+K +D+ K +++ ++ M+ P +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------KEQKRLLMDLDVVMRSSDCPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
V+ Y + + +I +E + + F K V + +K ++++ + +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYV-YEVLK----SVIPEEILGKIAVATVKAL 120
Query: 132 --------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----QVRDDGLLHTTCGTPNY 179
+ HRD+KP N+LLD GN+K+ DFG+S + RD G C P Y
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG-----C-RP-Y 173
Query: 180 VAPEVLNDRGYDGS--TADLWSCGVILFVLLAGYLPFDDSN 218
+APE ++ DG +D+WS G+ L+ + G P+ N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F V E + VA+K + +E + E E M + HP +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V ++ I +V EF+ G L D + G+ ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDGST 194
N L+ +KVSDFG++ V DD +T GT + +PEV + Y S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF---VLDDQYTSST-GTKFPVKWSSPEVFSFSKYS-SK 181
Query: 195 ADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
+D+WS GV+++ V G P+++ + + + I+A P L+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V + +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ +A R + ++ + RG
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLTYLREK 118
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 174
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y + D+WS G+ L + G P
Sbjct: 175 YTVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMK 66
+ +G+ +GEG F +V A P VA+K+L K+ + +++ + E+ MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 67 LV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ------- 118
++ KH N++ L V + +++V+E+ G L D + R + A
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129
Query: 119 ----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-- 166
Q+ +++ S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIH 183
Query: 167 --DGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
D TT G P ++APE L DR Y + D+WS GV+L+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+G+ +GEG F V + + + G VA+K + K + + E+ E A MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 72 NVVRLYEV---MGSKTKI---FIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLIN- 122
NV++L V S KI ++L F+ G+L ++ + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKF 118
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
VD Y +R HRDL N +L + V+DFG LS+++
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG---LSKKIYSGDYYRQGRIA 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L DR Y S +D+W+ GV ++ + G P+
Sbjct: 176 KMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
+QL++A+DY H G+ HRD+K EN+L++ ++ + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 1 MSQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
M I R K Y++G IG G+F V A +T E VA+K KVL+ +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKN-- 107
Query: 60 REVATMKLVKHPNVVRLYE------VMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKED 111
RE+ MK + H N++ L + ++ IF +V+EF+ + K + H
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNH 165
Query: 112 E-----ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVR 165
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG + +
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLA 223
Query: 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ C + Y APE++ + DLWS G I+ ++ GY F
Sbjct: 224 GQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + NS VA+K L + E E MK ++H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK---VAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ + I+I+ E++ G L D K G++ + + Q+ + Y +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL+ N+L+ K++DFGL+ +V +D G + APE +N G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAIN-FG 179
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPF 214
+D+WS G++L+ ++ G +P+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 7e-12
Identities = 54/246 (21%), Positives = 102/246 (41%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GEG F KV + VA+K L + + K+ ++ ++E M ++HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--------------- 118
V L V + ++ E++ G+L + +V + + A +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ ++Y S HRDL N L+ +K+SDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--ISAAEF 231
++ PE + G + +D+WS GV+L+ + L Y F + ++ + + +
Sbjct: 191 RWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE 249
Query: 232 TCPPWL 237
CP +
Sbjct: 250 DCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 40/248 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSE-TGEP----VALKILDKEKVLKHKMAEQIKREVATMK 66
+G+T+GEG F KV A G VA+K+L + + E +K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLK 58
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKE 110
V HP+V++LY + +++E+ G L D N +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 111 DEAR--------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ R + Q+ + Y + HRDL N+L+ +K+SDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 163 QVRDDGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF--VLLAG--YLPFDD 216
+D + + G P ++A E L D Y + +D+WS GV+L+ V L G Y
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 217 SNLMNLYK 224
L NL K
Sbjct: 236 ERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-12
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
R +G G F +V N+ T PVA+K L K + + E MK ++HP +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMD---PKDFLAEAQIMKKLRHPKLIQ 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVY 133
LY V + I+IV E + G L + + +K + Q+ + + Y ++
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGY 190
HRDL N+L+ KV+DFGL+ +V + + G + APE Y
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAKFPIKWTAPEAAL---Y 178
Query: 191 DGST--ADLWSCGVILFVLLA-GYLPF 214
+ + +D+WS G++L ++ G +P+
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + +KE LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S + K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 15 VGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + VA+K+L K+ +A+ I E+ MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI---------VNHGRMKEDEARRYF 117
+ KH N++ L V + +++++E+ G L + + K E + F
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 118 QQLINAV-------DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170
+ L++ +Y SR HRDL N+L+ +K++DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 171 HTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
T+ G ++APE L DR Y +D+WS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + D++ LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEP--VALKILDKEKVLKHKM 54
+ PK + + +G+ +GEG F +V A + +P VA+K+L + K
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKD 60
Query: 55 AEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKI 102
+ E+ MK++ KH N++ L +++++E+ + G L D
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 103 VNHGRMKEDEARRYFQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155
+ ++ E++ F+ L++ ++Y S+ HRDL N+L+ +K++DF
Sbjct: 121 FDTCKLPEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 156 GLSALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYL 212
GL+ + D TT G ++APE L DR Y +D+WS GV+L+ + G
Sbjct: 179 GLARDVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGS 235
Query: 213 PFDDSNLMNLYK 224
P+ + L+K
Sbjct: 236 PYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 66/267 (24%), Positives = 107/267 (40%), Gaps = 29/267 (10%)
Query: 18 TIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
T+G G F +V A+ E V +K L K K + +RE+ + + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHKN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
VVRL + +++LE+ G+L F + K +Q + A+ +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIAL 128
Query: 131 GV--------YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
G+ HRDL N L+ + +KVS LS + P ++A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLA 186
Query: 182 PEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF----DDSNLMNLYKKISAAEFTCPPW 236
PE + + + + D+WS GV+++ V G LPF D+ L L + E P
Sbjct: 187 PEAVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL--QAGKLELPVPEG 243
Query: 237 LSFTARKLIARILDPNPMTRITIPEIL 263
KL+ R NP R + E++
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 2/155 (1%)
Query: 60 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
RE+ +K + H ++ L K+ + +V+ +LF + G + ++A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
L+ A+ Y H RG+ HRD+K EN+ LD N + DFG + D + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+PE+L Y T D+WS G++LF + +
Sbjct: 254 NSPELLALDPYCAKT-DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K L + K ++I E M V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ----QLINAVDYCH 128
V RL + + T + ++ + + G L D + H K++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLN 186
R + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESIL 184
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFD 215
R Y +D+WS GV ++ L+ G P+D
Sbjct: 185 HRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L + +++ +E+ G L D + ++ D A +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ +DY + HRDL N+L+ K++DFGLS + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 68/281 (24%), Positives = 111/281 (39%), Gaps = 48/281 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLVKHPN 72
R +GEG F KV F EP K L K LK + + RE + +H N
Sbjct: 11 RELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-------MKEDEAR-------RYFQ 118
+V+ Y V +V E++ G+L + +HG +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT----- 173
Q+ + + Y S+ HRDL N L+ +K+ DFG+S RD ++TT
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTDYYRV 180
Query: 174 CGTP----NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
G ++ PE + R + + +D+WS GV+L+ + G P+ + + + I+
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 229 AEF-----TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
TCP ++ +P RI I +I E
Sbjct: 240 GRLLQRPRTCPS----EVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-11
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+ +G G F +V A N T VA+K + + E E MK ++H +V+
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR--------YFQQLINAVDYC 127
L+ V+ +K I+I+ EF+ G L D +K DE + + Q+ + +
Sbjct: 66 LHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
R HRDL+ N+L+ A K++DFGL+ + + ++ P + APE +N
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAIN 176
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPF 214
G +D+WS G++L ++ G +P+
Sbjct: 177 -FGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IG G F +V K E VA+K L K + + E + M H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEV--AVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHH 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ I+ E++ G L DK + + G + + + + Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
R + S +D+WS G++++ V+ G P+ D + + K I+ A CP
Sbjct: 184 YRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E+GR G V AR++ TG V ++I D E + + + ++ EV +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+ + V + + ++++ F+ G L G M E + ++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPE 183
G HR++K ++L+ G + +S GLS L VR+ P + ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 184 VLND--RGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+L GY+ +D++S G+ L G +PF D
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 6/190 (3%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + ++ + VA+KIL K + +++ RE M+ + +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ +++ +V+E G L + + + E Q+ + Y HRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L N+LL K+SDFGLS + T P + APE +N + S +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 196 DLWSCGVILF 205
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+T+GEG F V + ++ VA+K + + +M E E MK HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPN 61
Query: 73 VVRLYEV--MGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI----- 121
V+RL V +++ + ++L F+ G+L ++ + R+ + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTD 120
Query: 122 --NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTT 173
+ ++Y S+ HRDL N +L+ N+ V+DFGLS +Q R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---- 176
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
++A E L DR Y + +D+WS GV ++
Sbjct: 177 --PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 40/241 (16%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + +P VA+K+L K + +++ I E+ MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 79
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------- 116
+ KH N++ L +++++E+ + G L + + R + Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQVPEE 135
Query: 117 ---FQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
F+ L++ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 193
Query: 167 DGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLY 223
D TT G ++APE L DR Y +D+WS GV+L+ + G P+ + L+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 224 K 224
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 60/248 (24%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAE 56
P+ + K +G+ +GEG F +V A + VA+K+L K+ + +++
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSD 66
Query: 57 QIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------- 102
+ E+ MK++ KH N++ L +++++E+ + G L + +
Sbjct: 67 LVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 103 ---VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
V +M + Q+ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 160 LSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ D TT G ++APE L DR Y +D+WS GV+++ + G P+
Sbjct: 186 DVNNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPG 242
Query: 217 SNLMNLYK 224
+ L+K
Sbjct: 243 IPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-10
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V A + G + I K+LK +E R+ A KL HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L ++ ++I +E+ G L D + ++ D A ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ + Y + HRDL N+L+ K++DFGLS ++ + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRL 180
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 9e-10
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 27/221 (12%)
Query: 14 EVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ R +G G F +V VA+K L + + E M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-FQQLIN-AVD- 125
H N+VRL V + FI+LE + GG+L + R + + + L+ A D
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 126 -----YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA---LSQQVRDDGLLHTTC 174
Y HRD+ N LL G K++DFG++ + R G
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAM 182
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++ PE D G S D+WS GV+L+ + GY+P+
Sbjct: 183 LPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-09
Identities = 51/193 (26%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + VA+K L K+ + E E MK ++HP +V
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTK---VAIKSL-KQGSMS---PEAFLAEANLMKQLQHPRLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ ++ I+I+ E++ G L D K ++ ++ Q+ + + +
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYD 191
HRDL+ N+L+ K++DFGL+ L + ++ P + APE +N G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAIN-YGTF 180
Query: 192 GSTADLWSCGVIL 204
+D+WS G++L
Sbjct: 181 TIKSDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREV 62
IKRR + R +GEG F KV F P K+L K LK + +RE
Sbjct: 2 IKRR--DIVLKRELGEGAFGKV-FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 58
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------------- 106
+ ++H ++V+ Y V G + +V E++ G+L + HG
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQ 163
+ + Q+ + + Y S+ HRDL N L+ A +K+ DFG+S +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G HT ++ PE + R + + +D+WS GVIL+
Sbjct: 179 YRVGG--HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 15 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA---------RRYFQQLIN-- 122
+ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 123 -----AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+DY + HRDL N+L+ K++DFGLS Q+V + T G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGRL 185
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 186 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 44/242 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++++ +GEGTF KV A + + E A+KI+ V K+ +I E+ M+ V+
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKI--EIQFMEKVRQ 184
Query: 71 PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-- 121
+ + +M + IV+ G L D I+ HG R+ Q+I
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSH----RHLAQIIFQ 239
Query: 122 --NAVDYCHSR-GVYHRDLKPENLLLDAYGN----------------LKVSDFGLSALSQ 162
A+DY H+ + H DLKPEN+L++ +++ D G +
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMN 221
R T +Y +PEV+ G+ ST D+WS G I++ L G L +D NL +
Sbjct: 300 HSRT-----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 222 LY 223
L+
Sbjct: 354 LH 355
|
Length = 467 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 18/213 (8%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
IG G F KV + G A +++ KE EQ+ +EV + + HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQL----INAVDYCHSRG 131
+VLEF G+L + + N G + + + Q++ + + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGY 190
H DL N L A ++K+ D+GL AL Q D + P ++APE++ RG
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 191 DGSTAD------LWSCGVILFVLL-AGYLPFDD 216
D D +WS GV ++ L A P+ D
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+KIL++ K + + E M + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+VRL V S T I +V + + G L D + H + + Q+ + Y R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP--NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L + D+ + G ++A E ++ R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKWMALECIHYRK 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 49/175 (28%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE--TGEP---VALKILDKEKVLKHKMAEQIKREVATM 65
E R IG+G F +V AR EP VA+K+L +E M +RE A M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 62
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ 118
HPN+V+L V + ++ E++ G+L + + AR+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 119 ---------QLINAVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
QL A Y R HRDL N L+ +K++DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +G G F ++ K E PVA+ L K + E T+ H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRG--FLAEALTLGQFDHS 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N+VRL V+ + IV E+++ G L + H G++ + L + + Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN--YVAPEVLNDR 188
G H+ L +L+++ K+S F Q+ + + + T G + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ-Y 182
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWL 237
+ S +D+WS G++++ +++ G P+ D + ++ K + A CP L
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNV 73
R +GEG F KV A P KIL K LK + RE + ++H ++
Sbjct: 11 RELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQL 120
V+ Y V + +V E++ G+L + HG + + + QQ+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTP 177
+ Y S+ HRDL N L+ +K+ DFG+S + R G HT
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI- 186
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
++ PE + R + + +D+WS GV+L+
Sbjct: 187 RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K+L + K ++I E M V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPY 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V RL + + T + +V + + G L D + + R+ + + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L D+ H G P ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRR 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 67/261 (25%), Positives = 117/261 (44%), Gaps = 17/261 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F +V + + VA+K L + E E MK ++H +V+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN-HGR-MKEDEARRYFQQLINAVDYCHSRGVYH 134
Y V+ S+ I+IV E+++ G L D + + GR +K Q+ + Y H
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGS 193
RDL+ N+L+ K++DFGL+ L + ++ P + APE G
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTI 182
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251
+D+WS G++L L+ G +P+ N + +++ CP + +L+ +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKK 242
Query: 252 NPMTRITIPEILEDEWFKKDY 272
+P R T E L+ F +DY
Sbjct: 243 DPEERPTF-EYLQS--FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 83/315 (26%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V AR+ GE VA+K +++ L+ ++ + E + MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELF--------DKIVNHGRMKE--DEARRY 116
+VVRL V+ +V+E + G+L + N GR E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y +++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVIL--------------------- 204
GLL ++APE L D G +++D+WS GV+L
Sbjct: 179 GKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 232
Query: 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
FV+ GYL D+ CP ++ L+ NP R T EI+
Sbjct: 233 FVMDGGYLDQPDN---------------CPERVT----DLMRMCWQFNPKMRPTFLEIV- 272
Query: 265 DEWFKKDYKPPVFEE 279
K D P F E
Sbjct: 273 -NLLKDDLHPS-FPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + T + VA+K L + M E +E MK ++H +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 79 VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ S+ I+IV EF+ G L D K + +K + Q+ + + Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L+ N+L+ K++DFGL+ L + ++ P + APE G +
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKS 184
Query: 196 DLWSCGVILFVLLA-GYLPF 214
D+WS G++L L+ G +P+
Sbjct: 185 DVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-08
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + + VA+K+L E + + +++ RE M + +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-----RYFQQLINAVDYCHSRG 131
V ++ + +V+E +GG L + K+DE Q+ + Y +
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP---NYVAPEVLND 187
HRDL N+LL K+SDFGLS AL DD + APE +N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINF 172
Query: 188 RGYDGSTADLWSCGVILF 205
R + S +D+WS G+ ++
Sbjct: 173 RKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 40/249 (16%)
Query: 19 IGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+GE F K+ + + + VA+K L + + ++E + M + HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIV-------------NHGRMKEDEARRYFQ--- 118
L V+ + + ++ E++ G+L + ++ G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-----SALSQQVRDDGLLHT 172
Q+ ++Y S H+DL N+L+ ++K+SD GL SA +V+ LL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--I 226
++ PE + G S +D+WS GV+L+ + L Y F + ++ + +K +
Sbjct: 191 -----RWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 227 SAAEFTCPP 235
CPP
Sbjct: 245 LPCSEDCPP 253
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+I R + EV +G+G F +V + T VA+K L + E +E
Sbjct: 2 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQV 54
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
MK ++H +V+LY V+ S+ I+IV E+++ G L D K ++ + Q+ +
Sbjct: 55 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+ Y HRDL+ N+L+ KV+DFGL+ L + ++ P + A
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTA 171
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
PE G +D+WS G++L L G +P+
Sbjct: 172 PEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 61 EVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 116
E ++ + HP++++L G+ K I+ + T +L+ + + +
Sbjct: 133 EAHILRAINHPSIIQL---KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAI 187
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++ A+ Y H + HRD+K EN+ ++ G++ + DFG + + + + GT
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGT 246
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
APE+L Y G D+WS G++LF + +
Sbjct: 247 IATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 6e-08
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 17 RTIGEGTFAKV------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G G F +V VA+K L K + K E +K E M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLK-EAHLMSNFNH 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVDYCHS 129
PN+V+L V +I++E + GG+L + + + ++L++ +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 130 RGVY-------HRDLKPENLLLDAYGN-----LKVSDFGL-----SALSQQVRDDGLLHT 172
VY HRDL N L+ G +K+ DFGL + + +GLL
Sbjct: 119 -CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++APE L D G + +D+WS GV+++ +L G P+
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 28/266 (10%)
Query: 17 RTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
R IG+G F V + A+K L++ L+ EQ +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58
Query: 74 VRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDYCHSRG 131
+ L + S+ +VL ++ G+L + I + + F Q+ ++Y S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL----HTTCGTP-NYVAPEVLN 186
HRDL N +LD +KV+DFG L++ + D HT P ++A E L
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY------KKISAAEFTCPPWLSF 239
+ + + +D+WS GV+L+ L+ G P+ D + ++ +++ E+ CP L
Sbjct: 176 TQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPDPLY- 232
Query: 240 TARKLIARILDPNPMTRITIPEILED 265
+++ P P R T E++
Sbjct: 233 ---EVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 2e-07
Identities = 14/23 (60%), Positives = 19/23 (82%)
Query: 311 MNAFELISLSKGLNLGNLFDAEQ 333
+NAF+LISLS GL+L LF+ E+
Sbjct: 1 LNAFDLISLSSGLDLSGLFEEEK 23
|
Length = 58 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 21 EGTFAKVKFAR-NSETG---EPVALKILDKEKVLKHKMAEQIKR---EVATMKLVKHPNV 73
EGTF ++ + E E V +K V H Q+ E + + H N+
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-----TVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 74 VRLYEVMGSKT-KIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQ------QLINAV 124
+ + V F++ ++ G L F + G +A Q Q+ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN------ 178
Y H RGV H+D+ N ++D +K++D +ALS RD + C N
Sbjct: 131 SYLHKRGVIHKDIAARNCVIDEELQVKITD---NALS---RDLFPMDYHCLGDNENRPVK 184
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
++A E L ++ Y S +D+WS GV+L+ L+ G P+ +
Sbjct: 185 WMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 6 IKRR--VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKR 60
IKRR V K+E +GEG F KV A P K+L K LK + +R
Sbjct: 2 IKRRDIVLKWE----LGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQR 56
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E + +++H ++VR Y V + +V E++ G+L + +HG + E
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 117 FQ-----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQ 162
Q Q+ + + Y S HRDL N L+ +K+ DFG+S +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G T ++ PE + R + + +D+WS GV+L+
Sbjct: 177 YYRVGG---RTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 19 IGEGTFAKVKFAR------------NSETGEP--VALKIL--DKEKVLKHKMAEQIKREV 62
+GEG F +V G+P VA+K+L D K ++ ++IK
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK--- 69
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL------------FDKIVNHGRMKE 110
M +K+PN++RL V S + ++ E++ G+L F N +
Sbjct: 70 -IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ + +K++DFG+S
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 56/246 (22%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR--NSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GE F KV + GE VA+K L K+K + + E+ K E ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKED-------EARRYFQ-- 118
V L V+ + + ++ + + +L + +V + G +D E +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ +++ S V H+DL N+L+ N+K+SD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLY--KKISAAEF 231
+++PE + G +D+WS GV+L+ + L Y + + +++ + +++
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 232 TCPPWL 237
CP W+
Sbjct: 250 DCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 54/243 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KL 67
G+T+G G F KV A S+ VA+K+L + E + E+ M L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHL 95
Query: 68 VKHPNVVRLYEVMGSKTK---IFIVLEFVTGGELFDKIVNHGRMKE------DEARRYFQ 118
H N+V L +G+ T I ++ E+ G+L +N R K ++ +
Sbjct: 96 GNHENIVNL---LGACTIGGPILVITEYCCYGDL----LNFLRRKRESFLTLEDLLSFSY 148
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ + + S+ HRDL N+LL +K+ DFGL+ RD +++ + N
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----N 196
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + + Y +D+WS G++L+ + + G P+ DS
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
Query: 222 LYK 224
L K
Sbjct: 256 LIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ EP VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ- 118
+VVRL V+ +++E +T G+L ++ N+ ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
GLL +++PE L D G + +D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGE----------PVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+GTF + + V LK+L H+ + + M
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF----QQLIN 122
+ H ++V+LY V I +V E+V G L D ++ R K + + + +QL +
Sbjct: 57 QLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLH--REKNNVSLHWKLDVAKQLAS 112
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG--LSALSQQVRDDGLLHTT 173
A+ Y + + H ++ +N+L+ YG +K+SD G ++ LS++ R + +
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---- 168
Query: 174 CGTPNYVAPEVL-NDRGYDGSTADLWSCGVILF 205
P ++APE + N + AD WS G L
Sbjct: 169 ---P-WIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 16/124 (12%)
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234
GTP+Y+APE+L + + G D W+ GV LF L G PF+D +++ I +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 235 PW------LSFTARKLIARILDPNPMTRITIPEILED------EWFKKDYKPPVFEEKKD 282
PW LS A+ I +L +P R + E+ + +W + F + D
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 283 TNLD 286
D
Sbjct: 658 DETD 661
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKM 54
+GEG F +V FA N P VA+K+L + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL---------FDKIVNH 105
+ +K EV + + PN+ RL V + +++E++ G+L +
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 106 G-RMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ Y Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 44/201 (21%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA----TMKLVKHP 71
+ +G G F V G+ ++KI K ++ + Q +E+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 72 NVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
+VRL + G+ ++ V + G L D + H + + Q+ + Y
Sbjct: 70 YIVRLLGICPGASLQL--VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDR 188
+ HR+L N+LL + ++++DFG++ L D ++ TP ++A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFG 186
Query: 189 GYDGSTADLWSCGVILFVLLA 209
Y +D+WS GV ++ +++
Sbjct: 187 RYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 25/102 (24%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYK 225
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + D+ Y + +D+WS GV+L+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR---RYFQQLINAVDYCHSRGV 132
L ++M SK + V + L K+ + + E E + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 133 YHRDLKPENLLLD-AYGNLKVSDFGLSA 159
HRD+KP+N++ G+ K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 41/163 (25%), Positives = 72/163 (44%), Gaps = 26/163 (15%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLL 170
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD D +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVR 232
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMNLYK 224
+ P ++APE + D+ Y + +D+WS GV+L+ + + G P+ + K
Sbjct: 233 KGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
Query: 225 ---KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
++ A E P +++ +P R T ++E
Sbjct: 292 DGTRMRAPENATP-----EIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 19 IGEGTFAKV---------KFARNSETGEP-------VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V KF + + VA+K+L +E K+ + +K E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQ 118
M +K PN++RL V + + ++ E++ G+L + H K D +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 119 QLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
LI + Y S HRDL N L+ +K++DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 19 IGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V +F N G P VA+KIL + K+ + +K EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------- 114
+ +K PN++RL V + + ++ E++ G+L ++ ++ + + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 115 ------------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 26/112 (23%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFG L++ + D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG---LARDIYKD-------- 232
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
P+YV APE + DR Y +D+WS GV+L+ + + G P+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 20/66 (30%), Positives = 35/66 (53%)
Query: 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
EF+ G+ + + + + +Q++ + H G+ HRD+KPENLL+ G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 151 KVSDFG 156
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 14/21 (66%), Positives = 17/21 (80%)
Query: 312 NAFELISLSKGLNLGNLFDAE 332
NAF+LISLS GL+L LF+ E
Sbjct: 1 NAFDLISLSSGLDLSGLFEEE 21
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 63/243 (25%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98
V LK+LD +A + M V H ++ ++ V ++ +V EFV G L
Sbjct: 47 VVLKVLDPSH---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 99 FDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------N 149
D + GR+ QQL +A+ Y + + H ++ +N+LL G
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 150 LKVSDFGLS--ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-V 206
+K+SD G+S ALS++ R + + ++APE + + AD WS G L +
Sbjct: 163 IKLSDPGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
Query: 207 LLAGYLPFDD---SNLMNLY-KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEI 262
G +P + S Y KK E +C + LI++ L P R + I
Sbjct: 215 CFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELAT-----LISQCLTYEPTQRPSFRTI 269
Query: 263 LED 265
L D
Sbjct: 270 LRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 23/136 (16%)
Query: 33 SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-----PNVVRLYEVMGSKTKIF 87
E LKI + +REVA ++L+ P V+ E S +
Sbjct: 18 GTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGE---SDGWSY 69
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY---HRDLKPENLLL 144
+++E++ G L + ++ +L H + H DL P N+L+
Sbjct: 70 LLMEWIEGETLDEVSEEEKEDIAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILV 122
Query: 145 DAYGNLKVSDFGLSAL 160
D L + D+ +
Sbjct: 123 DDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE 97
V LK+LD H+ E A+M + V H ++V LY V + +V EFV G
Sbjct: 35 VILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 98 LFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYG------ 148
L + H + F+ QL +A+ Y + + H ++ +N+LL G
Sbjct: 91 L--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148
Query: 149 -NLKVSDFG--LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
+K+SD G ++ LS+Q + + ++APE + D AD WS G L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 206 -VLLAGYLPFDDSNL 219
+ G +P D L
Sbjct: 201 EICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 9e-04
Identities = 63/288 (21%), Positives = 121/288 (42%), Gaps = 52/288 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVV 74
+ IG G F KV +G A +++ KE + + EQ+K E + ++H N++
Sbjct: 1 KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA------RRYFQQLINAVDYCH 128
+ T +V+EF G+L + R E +R ++ + + H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDL-KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------YVA 181
H DL N LL A +K+ D+GLS + ++D + TP+ ++A
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIA 170
Query: 182 PEVLNDRGYDGSTAD------LWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCP 234
PE++++ + D +WS GV ++ L G P Y+ +S +
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP---------YRHLSDEQV--- 218
Query: 235 PWLSFTARKLIARILDPNPMTRITIP----EILEDEWFKKDYKPPVFE 278
L++T R+ ++ P P ++ + E+++ W + + +P E
Sbjct: 219 --LTYTVREQQLKL--PKPRLKLPLSDRWYEVMQFCWLQPEQRPSAEE 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NV +Y V I V+E++ G L D ++N M+E E R +L+ + HS G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKD-LINSNGMEELELSREIGRLVGKL---HSAG 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
+ H DL N++L G + + DFGL+ S+ + D
Sbjct: 116 IIHGDLTTSNMILSG-GKIYLIDFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 30/123 (24%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ S+ HRDL N+LL +K+ DFGL+ RD ++H + N
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA------RD--IMHDS----N 292
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + D Y + +D+WS G++L+ + + G P+ DS N
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
Query: 222 LYK 224
K
Sbjct: 352 KIK 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+A M ++HPN+V+L + S+ +++ E++ G L + + N + + R+ +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGI 789
Query: 121 INAVDYCH---SRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDGLLHTTCG 175
A+ + H S V +L PE +++D +L++S GL T C
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD----------TKCF 839
Query: 176 TPN-YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
+ YVAPE + +D++ G+IL LL G P D
Sbjct: 840 ISSAYVAPET-RETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGT 176
Q+ N +++ S+ HRDL N+L+ +K+ DFGL+ +RD + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRDSNYISKGSTFLP 304
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
++APE + + Y + +D+WS G++L+ + G P+ +
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.94 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.79 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.73 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.63 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.62 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.47 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.44 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.26 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.17 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.02 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.92 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.84 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.82 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.72 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.68 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.44 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.29 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.18 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.11 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.08 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.99 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.97 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.97 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.73 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.71 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.42 | |
| PLN02236 | 344 | choline kinase | 97.3 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.15 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.02 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.91 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 96.91 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.73 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.31 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.27 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.27 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.83 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.56 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.4 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.36 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-63 Score=453.26 Aligned_cols=261 Identities=38% Similarity=0.708 Sum_probs=246.7
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|...+.||+|||+.||.+++..+|+.||+|++.+....+....+.+.+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|+|..++|..++++.++++|.+++.+++||+.||.|||+++|+|||||..|++++.+-+|||+|||+|+.... +....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999986553 23445
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
.+.||||.|.|||++...++. ..+||||+||++|.|+.|++||...+..+.+.+|....+.+|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 788999999999999987774 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHhHHhcCccccCCCCC
Q 019904 251 PNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 251 ~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+||.+|||++++|.|+||...+-+
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999999999999999765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-64 Score=437.55 Aligned_cols=261 Identities=39% Similarity=0.693 Sum_probs=232.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh----HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+..... ......+.+|+++|++|+|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5578999999999999999999999999999999998765433 122445789999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEeeccchhcc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALS 161 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~a~~~ 161 (334)
..|+||||+.||+|.+++..++.+.+...+.+++|++.|+.|||++||+||||||+|||++.+ ..+||+|||+|...
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 56999999999876
Q ss_pred ccccCCCcccccccCCcccChHhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCccCCC----
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCP---- 234 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~-~~~~~~~~~~~~~---- 234 (334)
+ ......+.||||.|.|||++...+ ++..++|+|||||++|.+++|.+||.+..... +.+.|..+.+.+-
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 5 345667889999999999998654 44468899999999999999999998865444 7888888877553
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..+|+++++||.+||..||++|||++|+|+||||+...
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 34899999999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=429.57 Aligned_cols=262 Identities=61% Similarity=1.070 Sum_probs=244.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-h-HHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-K-HKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 83 (334)
....++|.+++.||.|+||+|+.|.+..+|..||+|++.+.... . ....+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35688999999999999999999999999999999988765222 1 234567889999999999 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 162 (334)
..+|+|||||.||+|.+++...+++.|.+++.+++|++.|++|+|++||+||||||+|||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999998654
Q ss_pred cccCCCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCC-CHH
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFT 240 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (334)
.......+.+||+.|+|||++.+.. |.+.++||||+|+++|.|++|+.||...+...++.++....+.+|.++ |.+
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3445677889999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+++|+.+||..||.+|+|+.+++.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-59 Score=408.39 Aligned_cols=258 Identities=28% Similarity=0.489 Sum_probs=232.5
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe-EEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IFI 88 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~ 88 (334)
.+..+.++.||+|..|+||+++++.+++.+|+|++.. ..++...+++.+|+++++..+|||||.+|+.|..+.. +++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 3467788999999999999999999999999999953 2355667889999999999999999999999999995 999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||++|||.+.++..++++|..+..++.++++||.|||+ .+|+||||||+|||++..|.|||||||.|.....
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn---- 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN---- 231 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh----
Confidence 99999999999999999999999999999999999999995 9999999999999999999999999999875433
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhcC-ccCCCCC-CCHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAA-EFTCPPW-LSFT 240 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-----~~~~~~~~~~~~-~~~~~~~-~~~~ 240 (334)
....+.+||..|||||.+.+..|. .++||||||+.++||.+|+.||... +..+++..|... .+..|.. +|++
T Consensus 232 S~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e 310 (364)
T KOG0581|consen 232 SIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE 310 (364)
T ss_pred hhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence 255788999999999999998774 8899999999999999999999874 677888888774 4566775 9999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+++||..||++||.+|||+.|+++|||+.+...+
T Consensus 311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 9999999999999999999999999999876543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-59 Score=404.88 Aligned_cols=260 Identities=38% Similarity=0.708 Sum_probs=242.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...+.|++++.||+|+||+||.++.+.+++.||+|++++..+......+....|..+|..++||+||+++..|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 45788999999999999999999999999999999999988888777899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+|+||+.||.|...|.+.+.++|..++.++..|+.||.|||++||+||||||+|||++.+|+++|+|||+++..-. .+
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999875332 33
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 246 (334)
....+.|||+.|||||++.+.+++ .++|-||||+++|+|++|..||.+.+....++++..... ..|..++.+++++|+
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 445668999999999999999886 999999999999999999999999999999999998884 445559999999999
Q ss_pred HhcCCCCCCCC----CHhHHhcCccccC
Q 019904 247 RILDPNPMTRI----TIPEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rp----t~~e~l~h~~~~~ 270 (334)
++|+.||.+|. +++++-+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999995 7899999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-59 Score=419.18 Aligned_cols=263 Identities=35% Similarity=0.671 Sum_probs=245.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 85 (334)
.+....|.+++.||.|+|++|++|++..+++.||||++.+..+.++...+.+.+|-.+|..| .||+|++++..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45678899999999999999999999999999999999999888888889999999999999 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+|+||+++|+|.++|++.+.|++..++.++.+|+.||+|||++|||||||||+|||++++++++|+|||.|.......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987654322
Q ss_pred CC---------Cc--ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC
Q 019904 166 DD---------GL--LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234 (334)
Q Consensus 166 ~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 234 (334)
.. .. ..+.+||-.|.+||++.+... ++.+|+|+||||+|+|+.|.+||.+.+...++++|....+.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 11 11 245799999999999998766 5999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+.+++.+++||+++|..||++|+|+++|.+||||..
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 999999999999999999999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-58 Score=423.82 Aligned_cols=264 Identities=45% Similarity=0.852 Sum_probs=248.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
...+|-|++++.||.|+-|.|-+|++..+|+.+|||++.+.....+.....+.+|+.+|+.+.||||+++|++|+....+
T Consensus 8 ~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 8 KNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred cccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 35678999999999999999999999999999999999887544555567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+|.||++||.|++++.+.+++++.++..+++||+.|+.|+|..+|+||||||+|+|++..+++||+|||+|.+-. .
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~ 164 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P 164 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988633 3
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
+....+.||+|.|.|||++.+.+|++.++||||.|+|||.+++|++||++.+...++.++..+.+..|..+|.++++||.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR 244 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence 45677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+||..||.+|+|.+|+++|||+.....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999999999986443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-57 Score=397.75 Aligned_cols=261 Identities=38% Similarity=0.675 Sum_probs=236.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|.+.+.||+|+||+||+|+++.++..||||.+.+.+. .....+.+..|+.+|+.++|||||.++++.+.++.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 4578999999999999999999999999999999999988764 344567888999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC------CCeEEeeccchhc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY------GNLKVSDFGLSAL 160 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~------~~~kl~Dfg~a~~ 160 (334)
|+|||||.||+|.+++++.+.+++..++.++.||+.||++||+++|+||||||.|||++.. -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999999999999999999999999999999999999999999999999765 3589999999986
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---CCCCCC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWL 237 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~ 237 (334)
.. ......+.||++.|||||++....|+ .|+|+||+|+|+|+|++|+.||...+..+++..+..... .++..+
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 54 34556778999999999999988886 889999999999999999999999999999887766543 345668
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+....+++...|..+|..|.++.+-+.|++.....
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88999999999999999999999999999987643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=382.13 Aligned_cols=257 Identities=38% Similarity=0.742 Sum_probs=244.7
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
-.++.|++++.||.|+||.|.+++++.+|..||+|++.+....+....+...+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56789999999999999999999999999999999999999888888899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||.+||.|..++++.+++++..++.++.||+.||+|||+++|++|||||+|||++++|.+||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987532
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
+...+.||||.|+|||++...++. .++|-|+||+++|||+.|..||...+...++++|..+...+|+.++.++++||.+
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 235678999999999999998885 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCC-----CCHhHHhcCccccC
Q 019904 248 ILDPNPMTR-----ITIPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~R-----pt~~e~l~h~~~~~ 270 (334)
+|+.|-.+| ...+++..||||+.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccc
Confidence 999999999 46789999999985
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-58 Score=385.81 Aligned_cols=257 Identities=27% Similarity=0.465 Sum_probs=224.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|+.+..+|.|+||+||+|+++.+|+.||||.|-.+. .++...+...+|+++|+.++|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 478999999999999999999999999999999996543 3344556778999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
+|||+. ++.+-+.+ ...++++.++.++.|++.|+.|+|+++++||||||+|||++.+|.+||||||+|+.... .+.
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 999988 45555554 45699999999999999999999999999999999999999999999999999997654 455
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---------------- 232 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---------------- 232 (334)
.+..++.|++|+|||.+.+...+++.+|||++||++.||++|.+.|++.++.+++..|......
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 6777899999999999999777789999999999999999999999999888776665322111
Q ss_pred ---CC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 233 ---CP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 233 ---~~------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+| +.++.-+.+|+..||+.||++|++.+++|.|+||..
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11 235677899999999999999999999999999953
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-56 Score=399.71 Aligned_cols=265 Identities=37% Similarity=0.659 Sum_probs=238.5
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..+...+.|++++.||+|+||.||+|+.+.+|..||+|++.++........+.++.|-.+|....+|+||++|..|++.+
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 44567889999999999999999999999999999999999999888888999999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc-
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ- 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 163 (334)
++|+||||.+||++..+|.+.+.|+++.++.++.+++.|+..||+.|++||||||+|+||+..|++||+|||++.....
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999843111
Q ss_pred ------------------ccCC--C------------------------cccccccCCcccChHhhhcCCCCCCccchhh
Q 019904 164 ------------------VRDD--G------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWS 199 (334)
Q Consensus 164 ------------------~~~~--~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 199 (334)
.... . ...+.+|||.|+|||++.+.+| +..+|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHH
Confidence 0000 0 0123579999999999999997 49999999
Q ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccCC
Q 019904 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKKD 271 (334)
Q Consensus 200 lG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~~ 271 (334)
||||+|||+.|.+||.+.++.+.+.+|..-. ..+|. .++.++++||.+||. ||++|. +++||.+||||+..
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999999999999999987654 44554 478999999999999 999997 59999999999863
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=402.51 Aligned_cols=261 Identities=32% Similarity=0.526 Sum_probs=228.5
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 84 (334)
....++||+++++||.|.||.||+|+...+|..||||.+.+.-. ..+....+ ||++.|++++ ||||+++.+++.+.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nL-REvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNL-REVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHH-HHHHHHHhcCCCCcchhhHHHhhccC
Confidence 34567899999999999999999999999999999999976443 33334444 7999999999 999999999998887
Q ss_pred -eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 -KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 -~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
.+|+|||||+. +|+++++.. +.+++..++.|+.||++||+|+|.+|++|||+||+|||++....+||+|||+|+-
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe-- 159 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE-- 159 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc--
Confidence 99999999986 899999765 4699999999999999999999999999999999999999889999999999984
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------- 229 (334)
......+..++.|++|+|||++....+++.+.|||++|||++|+.+-+..|+|.+..+++.+|...
T Consensus 160 -v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 160 -VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred -cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 334556777899999999999999899999999999999999999999999999888887776321
Q ss_pred ------ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 ------EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 ------~~~~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.+.+| +.++.++.++|.+||..||++||||+|+|+||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 12222 23788999999999999999999999999999998644
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-56 Score=390.43 Aligned_cols=261 Identities=31% Similarity=0.553 Sum_probs=223.5
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC--eEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--KIF 87 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~ 87 (334)
..+|..++.||+|+||+||++.+..+|..+|||.+....... .+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456899999999999999999999999999999997653222 677899999999999999999999855544 699
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhcccc-c
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQ-V 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~-~ 164 (334)
+.|||+++|+|.+++.+.+ ++++..++.+.+||++||+|||++||+|+||||+|||++. ++.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999887 7999999999999999999999999999999999999999 79999999999876543 1
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC--ccCCCCCCCHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA--EFTCPPWLSFTA 241 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~ 241 (334)
..........||+.|||||++........++|||||||++.||+||+.||.. .......-.+... .+.+|..+|.++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1222344678999999999999643334589999999999999999999987 4444444444332 357788999999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
++||.+|+..||.+||||+++|+|||......
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-57 Score=378.23 Aligned_cols=248 Identities=32% Similarity=0.562 Sum_probs=221.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEE-EEe-eCCe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-VMG-SKTK 85 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~-~~~~ 85 (334)
..+..|++.+.||+|+||+||++++..+|+.||.|.+.-... +....+++..|+.+|+.|+|||||++++ .|. +...
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev 94 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV 94 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence 345679999999999999999999999999999999985433 4445688889999999999999999998 443 4445
Q ss_pred EEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEEeecCCCCEEEecCCCeEEeeccc
Q 019904 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS--RG--VYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~--~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
+++|||||.+|+|...++. .+.++|..++.++.|++.||.++|+ .. |+||||||.||+++.+|.|||+|||+
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 8999999999999998865 3469999999999999999999999 45 99999999999999999999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-CC-C
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-P 235 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-~~-~ 235 (334)
++.... ......+.+|||+||+||.+.+.+|+ .+|||||+||++|||+.-+.||.+.+...+..+|..+.++ +| .
T Consensus 175 ~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~ 251 (375)
T KOG0591|consen 175 GRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE 251 (375)
T ss_pred HhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH
Confidence 987553 33456778999999999999999996 9999999999999999999999999999999999999875 56 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCH
Q 019904 236 WLSFTARKLIARILDPNPMTRITI 259 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~ 259 (334)
.+|.+++.+|..|+..||..||+.
T Consensus 252 ~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 252 HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HhhhHHHHHHHHHccCCcccCCCc
Confidence 799999999999999999999985
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-55 Score=380.05 Aligned_cols=263 Identities=29% Similarity=0.466 Sum_probs=226.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-----CC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 84 (334)
-.+|..++.||+|+||.|+.|.++.+|+.||||.+.. .+......++..+|+++|+.++|+||+.+++++.. -.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3566668999999999999999999999999999864 34555667889999999999999999999999866 34
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+|+|+|.. +|...++.+..++++.+..+++|++.||+|+|+.|++||||||+|++++.++.+||||||+|+.....
T Consensus 100 DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 68999999955 89998888888999999999999999999999999999999999999999999999999999976543
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC------------
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------ 232 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~------------ 232 (334)
......+.++.|.+|+|||++.....++.+.||||+|||+.||++|+..|+|.+..++++.|......
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 33444567788999999999987777789999999999999999999999998877766655321111
Q ss_pred -----------CC--------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 233 -----------CP--------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 233 -----------~~--------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.| +..++.+.+|+++||..||.+|+|++|+|.|||+.....+
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 11 3478899999999999999999999999999999875543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-56 Score=401.08 Aligned_cols=257 Identities=33% Similarity=0.599 Sum_probs=239.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... .+.....+.+|+++++.++||||+.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 4689999999999999999999999999999999987653 344468899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
.|||.| +|..++..++.++|+.++.++.+++.||.|||+++|+|||+||.|||+.+.|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 9999999999999999999999999999999999999999999999999999999999999986543 3344
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 249 (334)
..+..|||.|||||++.+.+|+ ..+|+||||||+|||++|++||...+..++...|.......|...|..+++|++.+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 5667899999999999998886 889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHhHHhcCccccCC
Q 019904 250 DPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+||.+|.|+.+++.|||+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hcChhhcccHHHHhcChHHhhh
Confidence 9999999999999999999853
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-55 Score=361.11 Aligned_cols=258 Identities=32% Similarity=0.487 Sum_probs=225.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|...+.||+|.||.||+|++..+|+.||||.+...+.. +.......+|++.|+.++|+||+.++++|...+.+-+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5899999999999999999999999999999999876432 222345679999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||++. +|...++.. ..++...++.|+.++++||+|+|++.|+||||||+|+|++.+|.+||+|||+|+....... .
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--I 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--c
Confidence 99987 888888664 3689999999999999999999999999999999999999999999999999998765433 2
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC-----------C----
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-----------P---- 234 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~---- 234 (334)
....+-|.+|+|||.+.+...++..+||||+|||+.||+.|.+-|+|.++.+++..|.+...++ |
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3344789999999999998888899999999999999999999999999988888775432111 1
Q ss_pred -------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 235 -------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 235 -------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+..+.++.+|+.+||..||.+|+|+.|+|+|+||....
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 12467889999999999999999999999999999743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=383.08 Aligned_cols=266 Identities=41% Similarity=0.755 Sum_probs=249.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
-.||++.+.||+|.||.|-+|.+...|+.||||.++++.+.+++..-.+++|++||+.|+||||+.+|++|+..+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 35799999999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||..+|.|++++.+.+.+++.+++.+++||++|+.|+|.++++|||||.+|||+++++++||+|||++.... ....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccH
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987654 4556
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 249 (334)
.++.||+|.|.+||++++.+|.++.+|.||||+++|.++.|..||++.+...+..+|..+.+.-|+. +.++.-||+.||
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmL 287 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIRWML 287 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHH
Confidence 7899999999999999999999999999999999999999999999999999999999998877654 557899999999
Q ss_pred CCCCCCCCCHhHHhcCccccCCCCCCcccc
Q 019904 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEE 279 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~h~~~~~~~~~~~~~~ 279 (334)
..||++|.|++++-.|-|.+=.+.-++.++
T Consensus 288 mVNP~RRATieDiAsHWWvNwgy~~~V~~~ 317 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVNWGYNMPVIQE 317 (668)
T ss_pred hcCcccchhHHHHhhhheeecccccccccc
Confidence 999999999999999999987666655443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=388.34 Aligned_cols=259 Identities=36% Similarity=0.715 Sum_probs=235.8
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
-.-.++.|++.+.||+|+||.||+|++..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987655555556788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.|+||||+.+++|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......+|.+++..+++||
T Consensus 171 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 171 ---RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV 246 (329)
T ss_pred ---CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHH
Confidence 1234578999999999987776 489999999999999999999999988888888888888888999999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
.+||+.||.+||+ ++++++||||..
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999997 799999999986
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=388.72 Aligned_cols=261 Identities=33% Similarity=0.528 Sum_probs=229.0
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--C
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--T 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 84 (334)
....+.|+.+++||+|.||.||+|++..+|+.||+|.++.+.. ++.......+|+.||++|.||||+++.++..+. +
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 4567789999999999999999999999999999999987653 344556677999999999999999999998877 7
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
.+|+|+|||+. +|.-++...+ .|++.+++.++.||+.||+|+|++||+|||||.+||||+.+|.+||+|||+|++...
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999998 7887776643 799999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------cCC
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------FTC 233 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~----------~~~ 233 (334)
. ........+-|++|+|||.+.+...++.++|+||+|||+.||++|++.|.+.+..+++.+|...- ..+
T Consensus 271 ~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 271 S-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred C-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence 3 23346677889999999999998888999999999999999999999999999999888874310 111
Q ss_pred C-------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 234 P-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 234 ~-------------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
| ..++..+.+|+..||..||.+|.||.++|+++||..
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1 126788999999999999999999999999999954
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=381.52 Aligned_cols=254 Identities=33% Similarity=0.663 Sum_probs=231.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998655444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999874322 12
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++..+++||.+||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 34578999999999987766 48899999999999999999999999888888888888888888899999999999999
Q ss_pred CCCCCCCC-----HhHHhcCccccC
Q 019904 251 PNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 251 ~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
.||.+||+ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-56 Score=363.48 Aligned_cols=260 Identities=38% Similarity=0.704 Sum_probs=235.0
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....+.|.+.+.||+|.|+.|+++.+..+|+.+|+|++....+... ..+.+.+|++|.+.|+||||+++.+.+.++...
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 4567889999999999999999999999999999999987665544 468899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEeeccchhcccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQ 163 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~ 163 (334)
|+|+|++.|++|..-+.....++|..+-.+++||+++|.|.|.+||+|||+||.|+++... .-+||+|||+|....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 9999999999998877776778999999999999999999999999999999999999543 359999999987443
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~ 239 (334)
.........|||.|+|||++...++. ..+|||+.|+|+|-++.|++||.+.+...+++.|.++.+.+|+ .+++
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~ 241 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP 241 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence 44556678999999999999988885 8899999999999999999999999999999999998876654 4899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
++++||++||..||.+|+|+.|+|+|||+...
T Consensus 242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 242 EAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999999999999853
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-53 Score=373.00 Aligned_cols=264 Identities=33% Similarity=0.510 Sum_probs=227.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...+.|++...||.|..++||+|++...+..||||++..+++... .+.+++|+..|+.++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 456789999999999999999999999999999999999887665 788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||+||.+||+.+.++.. ..++|..+..+++++++||.|||.+|.||||||+.|||++.+|.|||+|||.+.......
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999999875 359999999999999999999999999999999999999999999999999875433321
Q ss_pred C-CCcc-cccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC-------
Q 019904 166 D-DGLL-HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------- 234 (334)
Q Consensus 166 ~-~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 234 (334)
. .... .+.+||++|||||++.. .+| +.|+||||||++..|+.+|..||..-.++..+..-....++.+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 1 1111 56689999999999543 345 5999999999999999999999998777765544333333322
Q ss_pred ---CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 235 ---PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 235 ---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
..++..++.+|..||++||.+|||++++|+|+||++....
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 2367789999999999999999999999999999875543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=380.27 Aligned_cols=268 Identities=37% Similarity=0.679 Sum_probs=232.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH-----------HHHHHHHHHHHHHHhCCCCCeee
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----------KMAEQIKREVATMKLVKHPNVVR 75 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~ 75 (334)
.+.+++|++.+.||+|.||.|-+|++..+++.||||++.+...... ...+.+++|+.+|+++.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 4568899999999999999999999999999999999976443221 12468899999999999999999
Q ss_pred EEEEEeeC--CeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEE
Q 019904 76 LYEVMGSK--TKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (334)
Q Consensus 76 ~~~~~~~~--~~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl 152 (334)
++++..+. +.+|+|+|||..|.+.+ ....++ +++.+++.++++++.||+|||.+||+||||||+|+|++.+|+|||
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 99999765 57999999999987753 334455 999999999999999999999999999999999999999999999
Q ss_pred eeccchhcccccc---CCCcccccccCCcccChHhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHh
Q 019904 153 SDFGLSALSQQVR---DDGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 153 ~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~ 226 (334)
+|||.+....... ........+|||.|+|||.+.+ ..+.+.+.||||+|++||.|+.|++||.+....+++.+|
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI 331 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI 331 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence 9999876542221 1123345789999999999987 456778899999999999999999999999999999999
Q ss_pred hcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 227 SAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 227 ~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
......+|.. +.+.+++||.+||.+||.+|+++.++..|||.......+
T Consensus 332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 9988877765 799999999999999999999999999999998764443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-53 Score=382.53 Aligned_cols=252 Identities=36% Similarity=0.628 Sum_probs=227.0
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765545555667889999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccC
Q 019904 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (334)
Q Consensus 97 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 176 (334)
+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999999888999999999999999999999999999999999999999999999999998764221 12223446799
Q ss_pred CcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++.++.+||.+||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999987766 48999999999999999999999998888888888888888889999999999999999999999
Q ss_pred C-----CHhHHhcCccccCC
Q 019904 257 I-----TIPEILEDEWFKKD 271 (334)
Q Consensus 257 p-----t~~e~l~h~~~~~~ 271 (334)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=382.36 Aligned_cols=259 Identities=32% Similarity=0.612 Sum_probs=233.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCC-CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
....++|++.+.||+|+||.||+|.+..++ ..||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 446788999999999999999999876554 6899999987665555556778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.|+||||+.+|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++..++++|
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 1234578999999999987666 488999999999999999999999998888888888888888899999999999
Q ss_pred HHhcCCCCCCCC-----CHhHHhcCccccCC
Q 019904 246 ARILDPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 246 ~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
.+||+.||.+|+ |++++++||||...
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999995 89999999999853
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=375.43 Aligned_cols=250 Identities=36% Similarity=0.619 Sum_probs=225.1
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876544555567788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCc
Q 019904 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (334)
Q Consensus 99 ~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 178 (334)
.+++...+++++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99998888899999999999999999999999999999999999999999999999999874321 1122334579999
Q ss_pred ccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCC-
Q 019904 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRI- 257 (334)
Q Consensus 179 y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp- 257 (334)
|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..++.++++||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988766 488999999999999999999999988888888888888888899999999999999999999997
Q ss_pred --CHhHHhcCccccCC
Q 019904 258 --TIPEILEDEWFKKD 271 (334)
Q Consensus 258 --t~~e~l~h~~~~~~ 271 (334)
++.++++||||...
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=349.82 Aligned_cols=257 Identities=37% Similarity=0.721 Sum_probs=242.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.++.|++++.||+|.||.||.|+.+.++.-||+|++.++.........++++|+++-+.|+||||+++|++|-+...+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 57889999999999999999999999999999999999888888888899999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
++||...|+++..|. ...++++.....++.|++.||.|+|.++++||||||+|+|++.+|.+|++|||.+-...
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 999999999999999 56789999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.....+.|||..|.|||...+..++ ..+|+|++|++.||++.|..||...+..+.+++|....+.+|+.++.+++++|.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLIS 254 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHH
Confidence 3445678999999999999998886 889999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+||.++|.+|.+..|++.|||+..
T Consensus 255 ~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-53 Score=361.52 Aligned_cols=261 Identities=31% Similarity=0.392 Sum_probs=224.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--CCe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTK 85 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 85 (334)
+.++.|+.+..|+.|+||.||+|+++.+++.||+|.++.+. ..+..--.-.+|+.+|.+.+|||||.+.++... -+.
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 35678999999999999999999999999999999997654 222222334589999999999999999998754 457
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+|+|||||.. +|...+..-+ ++...+++.++.|++.|++|||++.|+||||||+|+|++..|.+||+|||+|+..+.+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999999987 8998888765 8999999999999999999999999999999999999999999999999999976643
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------------
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------- 231 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------- 231 (334)
-......+-|.+|+|||.+.+...++++.||||+|||+.||+++++.|+|.+..+++.+|.....
T Consensus 231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 23345667899999999999998888999999999999999999999999998888887743210
Q ss_pred ------CCC------------CC-CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 232 ------TCP------------PW-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 232 ------~~~------------~~-~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.++ .. +++...+|++.+|..||.+|.||+|+|+|.||....
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 111 11 568889999999999999999999999999998743
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=387.06 Aligned_cols=260 Identities=32% Similarity=0.598 Sum_probs=240.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (334)
...++.|++++.||+|+||+|++|..+.+++.||||++.+..+...+..+....|.+++.... ||.+++++..|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 346789999999999999999999999999999999999998888888899999999999886 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+.||++. .+...+.+++..++.|+..|+.||.|||++|||+||||.+|||++.+|++||+|||+++- ...
T Consensus 444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMG 520 (694)
T ss_pred EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCC
Confidence 99999999999944 344456899999999999999999999999999999999999999999999999999763 333
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
......+.||||.|+|||++.+..|. .++|-|||||++|||+.|..||.+.+..+++..|....+.+|.++|.++.+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 44556788999999999999998884 99999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
+++|.+||.+|.. ++++..||||+.
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999985 588999999985
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-53 Score=384.77 Aligned_cols=254 Identities=30% Similarity=0.527 Sum_probs=226.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+|+..++||+|+.|.||.|+...+++.||||.+....... .+-+.+|+.+|+..+|+|||++++.|.-.+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 467889999999999999999999999999999998654333 46688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||++||+|.+.+... .++|.++..+++.++.||+|||.+||+|||||.+|||++.+|.+||+|||++...... ...
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~~K 425 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--QSK 425 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc--cCc
Confidence 9999999999888664 4999999999999999999999999999999999999999999999999998754432 234
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---CccCCCCCCCHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~ 246 (334)
..+.+|||+|||||++....| ++++||||||++++||+.|.+||-..++...+..|.. .....|..+|..+++|+.
T Consensus 426 R~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~ 504 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD 504 (550)
T ss_pred cccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence 567899999999999998777 5999999999999999999999987776665555543 345678889999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+||+.|+.+|+++.|+|+||||+.
T Consensus 505 ~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 505 RCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHhhcchhcCCCHHHHhcChhhhh
Confidence 999999999999999999999954
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=374.67 Aligned_cols=255 Identities=32% Similarity=0.562 Sum_probs=225.3
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874332 23
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCCC------CCCHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP------WLSFTAR 242 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~------~~~~~~~ 242 (334)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.... ...|. .++.++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 44578999999999988766 489999999999999999999999888777666554321 11221 4589999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+||.+||..+|.+||+++++++||||...
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=374.99 Aligned_cols=251 Identities=35% Similarity=0.635 Sum_probs=225.6
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||+|+||.||++.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555555677889999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccC
Q 019904 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (334)
Q Consensus 97 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 176 (334)
+|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999998764221 11222345799
Q ss_pred CcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++.++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987666 58999999999999999999999988888888888777888889999999999999999999999
Q ss_pred C-----CHhHHhcCccccC
Q 019904 257 I-----TIPEILEDEWFKK 270 (334)
Q Consensus 257 p-----t~~e~l~h~~~~~ 270 (334)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=376.27 Aligned_cols=260 Identities=40% Similarity=0.702 Sum_probs=235.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 87 (334)
.-..|++.+.||+|.||.||.+.+..+|+.+|+|++.+.........+.+.+|+.+|+.+. |||||.++++|++...++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4457999999999999999999999999999999999877655555678999999999999 999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC----CCeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~----~~~kl~Dfg~a~~~~~ 163 (334)
+|||+|.||.|.+.+.+. .+++..+..++.|++.+++|||+.|++||||||+|+|+... +.++++|||+|.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999887 49999999999999999999999999999999999999543 4799999999886543
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (334)
.......+||+.|+|||++...++. ..+||||+|+++|.|++|..||.+.+......++....+.++ +.+|.
T Consensus 192 ---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 192 ---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 4456778999999999999987775 899999999999999999999999998888888888876543 34799
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+++||.+||..||.+|+|+.++|+|||+.....
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 9999999999999999999999999999987533
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=373.58 Aligned_cols=251 Identities=35% Similarity=0.654 Sum_probs=224.1
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876554445556777888888876 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|.+.+...+.+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++..... .........|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999998888999999999999999999999999999999999999999999999999998764221 1122334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......|..++.++++||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987666 4889999999999999999999999998888888888888888899999999999999999999
Q ss_pred CCCH------hHHhcCccccC
Q 019904 256 RITI------PEILEDEWFKK 270 (334)
Q Consensus 256 Rpt~------~e~l~h~~~~~ 270 (334)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=374.25 Aligned_cols=252 Identities=35% Similarity=0.632 Sum_probs=225.8
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||+|+||.||++++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455667788999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccC
Q 019904 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (334)
Q Consensus 97 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 176 (334)
+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .........||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9999998888899999999999999999999999999999999999999999999999998764211 11222345789
Q ss_pred CcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+......+|..+++++++||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999987766 48899999999999999999999998888888888777888888999999999999999999999
Q ss_pred C-----CHhHHhcCccccCC
Q 019904 257 I-----TIPEILEDEWFKKD 271 (334)
Q Consensus 257 p-----t~~e~l~h~~~~~~ 271 (334)
| ++.++++|+||...
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-51 Score=376.53 Aligned_cols=259 Identities=32% Similarity=0.585 Sum_probs=223.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555555678889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC----
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---- 166 (334)
|||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 019904 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (334)
Q Consensus 167 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~ 217 (334)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0011245799999999999887764 8999999999999999999999998
Q ss_pred cHHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCC---CCCCHhHHhcCccccCC
Q 019904 218 NLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPM---TRITIPEILEDEWFKKD 271 (334)
Q Consensus 218 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~li~~~L~~dp~---~Rpt~~e~l~h~~~~~~ 271 (334)
+....+.++... ...+|+ .+++++++||.+|+. +|. .||+++|+++||||...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 888877776542 233443 478999999999875 444 46899999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=370.11 Aligned_cols=257 Identities=31% Similarity=0.565 Sum_probs=228.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEeeCCeEEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~v~ 90 (334)
.|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..++..+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 489999999999999999999999999999999876554445567788899999999865 5888999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++|+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999998888899999999999999999999999999999999999999999999999998763211 11223
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 34578999999999988776 48899999999999999999999999888888888888888888999999999999999
Q ss_pred CCCCCCCCH-----hHHhcCccccCC
Q 019904 251 PNPMTRITI-----PEILEDEWFKKD 271 (334)
Q Consensus 251 ~dp~~Rpt~-----~e~l~h~~~~~~ 271 (334)
+||.+|++. +++++||||...
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999986 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=362.93 Aligned_cols=264 Identities=28% Similarity=0.484 Sum_probs=236.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.--+..|++++.||+|.-|+||+|....++..+|+|++.+..........+++.|..||+.++||.++.+|..|+++...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~ 152 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYS 152 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecccee
Confidence 34567899999999999999999999999999999999998888778889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc-
Q 019904 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ- 163 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~- 163 (334)
|+|||||+||+|..+.+++ +.+++..++.++..++.||+|||..|||+|||||+|||+.++|++.|+||.++.....
T Consensus 153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999999999888775 4699999999999999999999999999999999999999999999999998632100
Q ss_pred --------------------------------c-c--------------------CCCcccccccCCcccChHhhhcCCC
Q 019904 164 --------------------------------V-R--------------------DDGLLHTTCGTPNYVAPEVLNDRGY 190 (334)
Q Consensus 164 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 190 (334)
. . ......+.+||-.|.|||++.+.+.
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0011234579999999999999888
Q ss_pred CCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC--CCCHHHHHHHHHhcCCCCCCCCC----HhHHhc
Q 019904 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--WLSFTARKLIARILDPNPMTRIT----IPEILE 264 (334)
Q Consensus 191 ~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~ 264 (334)
. .++|-|+||+.+|||+.|..||.|.+..+.+.++......+|. .++..+++||+++|.+||.+|.. +.||-+
T Consensus 313 g-sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 313 G-SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred C-chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 5 9999999999999999999999999999999999888777764 57899999999999999999998 999999
Q ss_pred CccccCC
Q 019904 265 DEWFKKD 271 (334)
Q Consensus 265 h~~~~~~ 271 (334)
||||..-
T Consensus 392 HpFF~gV 398 (459)
T KOG0610|consen 392 HPFFEGV 398 (459)
T ss_pred CccccCC
Confidence 9999853
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-51 Score=376.47 Aligned_cols=259 Identities=34% Similarity=0.619 Sum_probs=223.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||.|+||+||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555555677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC---
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--- 167 (334)
|||.+|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999987643211000
Q ss_pred ---------------------------------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 019904 168 ---------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (334)
Q Consensus 168 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf 214 (334)
......+||+.|+|||++....+ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 01113469999999999987776 48999999999999999999999
Q ss_pred CCCcHHHHHHHhhcCc--cCCCC--CCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCccccCC
Q 019904 215 DDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (334)
Q Consensus 215 ~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 271 (334)
.+.+.......+.... ...|. .+++++++||.+||. +|.+|++ ++++++||||...
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9888777766664432 23333 478999999999996 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=363.54 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=219.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999986554444444567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+++|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998877543 3689999999999999999999999999999999999999999999999999865321 122
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ......+.......+..++.++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 234578999999999987766 4889999999999999999999987543 22333334444566777999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccCC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKKD 271 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~~ 271 (334)
.+||+.||.+||+ ++++++||||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-51 Score=365.00 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=213.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
++++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..+...|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL 80 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 57889999999999999999999999999999999875432 1223456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+.+ +|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--~ 157 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--T 157 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC--C
Confidence 9999986 8888887654 5789999999999999999999999999999999999999999999999988643221 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------------- 230 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~----------------- 230 (334)
.......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 122345679999999999765545689999999999999999999998877655544332110
Q ss_pred --cCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 --FTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 --~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..+ .+.++.++++||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001 12468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-51 Score=372.54 Aligned_cols=252 Identities=35% Similarity=0.630 Sum_probs=225.3
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544455667788999999999999999999999999999999999999
Q ss_pred chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 97 ~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
+|...+...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++..... .........|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999999888889999999999999999999997 7999999999999999999999999998763221 1222334579
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999987766 4899999999999999999999999888888888887888888899999999999999999999
Q ss_pred CC-----CHhHHhcCccccCC
Q 019904 256 RI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 256 Rp-----t~~e~l~h~~~~~~ 271 (334)
|+ ++.++++||||...
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 99999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=376.49 Aligned_cols=258 Identities=32% Similarity=0.535 Sum_probs=220.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++++.||+|+||+||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987665555667789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC-----
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----- 166 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~----- 166 (334)
|+++|+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999998753210000
Q ss_pred ----------------------------------------CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHH
Q 019904 167 ----------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFV 206 (334)
Q Consensus 167 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 206 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~e 240 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFE 240 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHHH
Confidence 001123579999999999987776 488999999999999
Q ss_pred HHhCCCCCCCCcHHHHHHHhhc--CccCCCC--CCCHHHHHHHHHhc--CCCCCCCCCHhHHhcCccccC
Q 019904 207 LLAGYLPFDDSNLMNLYKKISA--AEFTCPP--WLSFTARKLIARIL--DPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 207 ~~~g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L--~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
|++|..||...+.......+.. .....|. .++.++++||.+|+ ..+|..|++++++++||||..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 9999999988776665555442 2233333 58999999999965 455556999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=370.03 Aligned_cols=251 Identities=33% Similarity=0.603 Sum_probs=224.5
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554455556677888988866 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
++|...+...+.+++..+..++.||+.||+|||++||+||||||+||+++.+|.++|+|||++..... .........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99999998888899999999999999999999999999999999999999999999999998764221 1122334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......|..++.++.++|.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999987766 4889999999999999999999999998888888888888888899999999999999999999
Q ss_pred CC-------CHhHHhcCccccC
Q 019904 256 RI-------TIPEILEDEWFKK 270 (334)
Q Consensus 256 Rp-------t~~e~l~h~~~~~ 270 (334)
|| +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=374.32 Aligned_cols=265 Identities=32% Similarity=0.554 Sum_probs=227.2
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
......++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++....
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34556789999999999999999999999999999999998655444444566789999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999999988654 5899999999999999999999999999999999999999999999999998643221
Q ss_pred cCCCcccccccCCcccChHhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCCC--CC
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP--WL 237 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~--~~ 237 (334)
. .......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.+.+....+.++.... ..+|. .+
T Consensus 196 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (370)
T cd05596 196 G-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI 274 (370)
T ss_pred C-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence 1 11123457999999999987543 34688999999999999999999999988877777775432 33444 57
Q ss_pred CHHHHHHHHHhcCCCCCC--CCCHhHHhcCccccCC
Q 019904 238 SFTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 271 (334)
|.++++||.+||+.+|.+ |+|++++++||||+..
T Consensus 275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999999999998 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=375.68 Aligned_cols=259 Identities=35% Similarity=0.645 Sum_probs=227.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||+||+|++..+|+.||||++.............+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765555455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc-----
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----- 165 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----- 165 (334)
||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999986543221
Q ss_pred ----------------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 019904 166 ----------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (334)
Q Consensus 166 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~ 223 (334)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0012234568999999999988766 48999999999999999999999988877777
Q ss_pred HHhhc--CccCCCC--CCCHHHHHHHHHhcCCCCCCCCC-HhHHhcCccccCC
Q 019904 224 KKISA--AEFTCPP--WLSFTARKLIARILDPNPMTRIT-IPEILEDEWFKKD 271 (334)
Q Consensus 224 ~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt-~~e~l~h~~~~~~ 271 (334)
.++.. .....|. .+++++.+||.+||. ||.+||+ ++++++||||...
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 76665 3334443 369999999999997 9999999 9999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-51 Score=376.83 Aligned_cols=258 Identities=33% Similarity=0.604 Sum_probs=221.3
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++++.||.|+||.||+|.+..+++.||||++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555556678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC---
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--- 167 (334)
||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998532110000
Q ss_pred -------C-----------------------------------cccccccCCcccChHhhhcCCCCCCccchhhHHHHHH
Q 019904 168 -------G-----------------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (334)
Q Consensus 168 -------~-----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 205 (334)
. .....+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0 0012469999999999987766 48899999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCCCC---CCHhHHhcCccccC
Q 019904 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (334)
Q Consensus 206 e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~li~~~L~~dp~~R---pt~~e~l~h~~~~~ 270 (334)
+|++|..||.+.+....+..+... ...+|. .++.++++||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877766666532 233343 478999999999998 66665 59999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=375.92 Aligned_cols=259 Identities=34% Similarity=0.550 Sum_probs=222.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765555556678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc-----
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----- 165 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~----- 165 (334)
|||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999874221000
Q ss_pred ----------------------------------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHH
Q 019904 166 ----------------------------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (334)
Q Consensus 166 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 205 (334)
........+||+.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00011234689999999999887775 8999999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHhhcC--ccCC--CCCCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCccccCC
Q 019904 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTC--PPWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (334)
Q Consensus 206 e~~~g~~pf~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 271 (334)
+|++|+.||.+.+......++... .... ...+++++.++|.+|+ .+|.+|++ ++++++||||...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999988776666555432 2223 3458999999999987 59999997 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=367.93 Aligned_cols=255 Identities=30% Similarity=0.538 Sum_probs=223.7
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHH---HhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
|++.+.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999876544444456677776665 566799999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||+++++|...+.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999887754 5699999999999999999999999999999999999999999999999998764221 1122
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 249 (334)
.....|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..++..+.++|.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 334678999999999987666 4889999999999999999999999988888888888778888889999999999999
Q ss_pred CCCCCCCC-----CHhHHhcCccccCC
Q 019904 250 DPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 250 ~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
+.||.+|| ++.++++||||...
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 99999999 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=366.73 Aligned_cols=252 Identities=31% Similarity=0.603 Sum_probs=221.1
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+|+.||+|++...........+....|..++..+ +||||+++++++...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999875443333455667788888754 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|...+...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... .........|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999998888899999999999999999999999999999999999999999999999998763211 1222345678
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|.+++.++++||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 4889999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCH-hHHhcCccccCC
Q 019904 256 RITI-PEILEDEWFKKD 271 (334)
Q Consensus 256 Rpt~-~e~l~h~~~~~~ 271 (334)
||++ +++++||||...
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9998 588899999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=366.19 Aligned_cols=252 Identities=33% Similarity=0.632 Sum_probs=220.6
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++...........+....|..++.. .+||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987654444445556667777765 4799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|...+...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... .......+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccccccC
Confidence 999999988888999999999999999999999999999999999999999999999999998643221 122344578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987766 4889999999999999999999999988888888877777788889999999999999999999
Q ss_pred CCCHh-HHhcCccccCC
Q 019904 256 RITIP-EILEDEWFKKD 271 (334)
Q Consensus 256 Rpt~~-e~l~h~~~~~~ 271 (334)
||++. +++.||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99864 88899999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=361.96 Aligned_cols=255 Identities=29% Similarity=0.426 Sum_probs=212.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976432 2233567789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||++++.+..+......+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 999997776555555679999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------------------
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------- 231 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------------- 231 (334)
....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34568999999999987776 5899999999999999999999987665443322211100
Q ss_pred CC-------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 TC-------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 ~~-------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.. ...+|.++.+||.+||+.||.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 11367889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=365.70 Aligned_cols=256 Identities=31% Similarity=0.562 Sum_probs=227.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++..+. |++|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444444556677888888774 899999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++|+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998764221 11223
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 34578999999999988776 48999999999999999999999999988888888888888888999999999999999
Q ss_pred CCCCCCCCH-----hHHhcCccccC
Q 019904 251 PNPMTRITI-----PEILEDEWFKK 270 (334)
Q Consensus 251 ~dp~~Rpt~-----~e~l~h~~~~~ 270 (334)
.||.+|+++ .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=367.21 Aligned_cols=251 Identities=32% Similarity=0.600 Sum_probs=218.5
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|..+++.+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555567788999999988 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|.+++.+.+++++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999998763211 1222344679
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------cHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
|+.|+|||++.+..+ +.++|+|||||++|+|++|+.||... ......+.+.......|..++.++.++|.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 48899999999999999999999631 12234455566667788889999999999
Q ss_pred HhcCCCCCCCCC------HhHHhcCccccC
Q 019904 247 RILDPNPMTRIT------IPEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt------~~e~l~h~~~~~ 270 (334)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999987 789999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=365.76 Aligned_cols=252 Identities=34% Similarity=0.634 Sum_probs=225.0
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|..+++.+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555566778899999888 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|...+...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99999998888899999999999999999999999999999999999999999999999998763211 1122234578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
++.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+.......|..++.++.+||.+||+.||++
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999887764 889999999999999999999999888888888887777888889999999999999999999
Q ss_pred CCCH-----hHHhcCccccCC
Q 019904 256 RITI-----PEILEDEWFKKD 271 (334)
Q Consensus 256 Rpt~-----~e~l~h~~~~~~ 271 (334)
|||+ .+++.||||...
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=353.96 Aligned_cols=259 Identities=29% Similarity=0.431 Sum_probs=221.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeeCC----
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKT---- 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~---- 84 (334)
+..|..+++||+|.||+||+|+...+|+.||+|+++.+... +..-....+|+.+|+.++|+| |+++++++.+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688889999999999999999999999999999865432 223355679999999999999 999999998877
Q ss_pred --eEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
..++|+||++. +|..++.... .++...++.+++||+.||+|||++||+||||||.|||++..|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999987 8999998765 4777899999999999999999999999999999999999999999999999
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------- 231 (334)
+.... ........++|.+|+|||++.+...++...||||+|||++||++++..|.+.+..++...|.....
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85442 223356678899999999999987778999999999999999999999999988877776642211
Q ss_pred -----------CCC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 232 -----------TCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 232 -----------~~~------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.++ +..+++..+++.+||+.+|.+|.|++.+|.||||....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 111 11345899999999999999999999999999998754
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=375.00 Aligned_cols=258 Identities=34% Similarity=0.556 Sum_probs=221.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC----
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---- 166 (334)
|||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999998742210000
Q ss_pred -------------------------------------CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh
Q 019904 167 -------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 209 (334)
Q Consensus 167 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~ 209 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 000123479999999999987776 489999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhhcC--ccCCC--CCCCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccC
Q 019904 210 GYLPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (334)
Q Consensus 210 g~~pf~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~ 270 (334)
|+.||.+.+..+....+... ....| ..++.++.++|.+|+ .+|.+|+ |++++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99999988876665555432 22222 358999999999987 5999999 9999999999985
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=366.65 Aligned_cols=251 Identities=35% Similarity=0.613 Sum_probs=219.8
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||+||+|.+..+|+.||+|++.............+..|.. +++.++||||+++++.+...+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765443333444555544 56889999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999998764221 1222334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......++.++..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999987766 4889999999999999999999999888888888877777778889999999999999999999
Q ss_pred CCCH----hHHhcCccccC
Q 019904 256 RITI----PEILEDEWFKK 270 (334)
Q Consensus 256 Rpt~----~e~l~h~~~~~ 270 (334)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-53 Score=372.60 Aligned_cols=258 Identities=29% Similarity=0.473 Sum_probs=227.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
-..|+..+.||+|+||.||+|.+..+++.||||++..+.. +...+++++|+.+|..++++||.++|+.|.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 4568888999999999999999999999999999987654 33478899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||||.||++.+.++....+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+...... ...
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKR 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hhc
Confidence 999999999999999888899999999999999999999999999999999999999999999999998654432 222
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 248 (334)
..+.+|||+|||||++....|+ .++||||||++.|||.+|.+||....++..+..|....+ .....+|+.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 3678999999999999977776 889999999999999999999988777655444443332 22335899999999999
Q ss_pred cCCCCCCCCCHhHHhcCccccCCC
Q 019904 249 LDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|++||+.||+|.++|+|+|++...
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhcC
Confidence 999999999999999999998744
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=363.32 Aligned_cols=258 Identities=27% Similarity=0.449 Sum_probs=210.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||.|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 357899999999999999999999999999999998754321 123456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+.+ +|.+.+... +.+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++...... .
T Consensus 81 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 157 (303)
T cd07869 81 VFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S 157 (303)
T ss_pred EEECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence 9999975 777777654 56899999999999999999999999999999999999999999999999987643221 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCc----------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAE---------------- 230 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~~~~~~~~~---------------- 230 (334)
.......||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 2223456899999999997665556889999999999999999999987532 22222221000
Q ss_pred -----c--CCC---------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 -----F--TCP---------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 -----~--~~~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
. ..+ ..++..+++||.+||+.||.+|||++|+|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0 000 0145688999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=365.45 Aligned_cols=259 Identities=31% Similarity=0.577 Sum_probs=221.0
Q ss_pred ceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (334)
.|++++.||+|+||.||++++. .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999998864 47889999999865432 2334567888999999995 99999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.+|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987432211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC----cHHHHHHHhhcCccCCCCCCCHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLSFTAR 242 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (334)
........||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+......+|..++..++
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 112234579999999999987654568899999999999999999999643 3334445555566677788999999
Q ss_pred HHHHHhcCCCCCCCC-----CHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
+||.+||+.||++|| +++++++||||...
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88899999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=363.68 Aligned_cols=252 Identities=31% Similarity=0.596 Sum_probs=220.6
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++................|..+++. ++||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987644333344556677788875 4899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|.+.+.....+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++..... .........|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999998888899999999999999999999999999999999999999999999999998763211 1122334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|.+++.++++||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999987766 4899999999999999999999999888888887777777778889999999999999999999
Q ss_pred CCCHh-HHhcCccccCC
Q 019904 256 RITIP-EILEDEWFKKD 271 (334)
Q Consensus 256 Rpt~~-e~l~h~~~~~~ 271 (334)
||++. ++++||||...
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 89999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=368.43 Aligned_cols=259 Identities=29% Similarity=0.516 Sum_probs=222.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766545555677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999875432111 12
Q ss_pred ccccccCCcccChHhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----cCCCCCCCHH
Q 019904 170 LHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFT 240 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~ 240 (334)
.....||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ++..+.++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 233468999999999873 2333588999999999999999999999887776666654322 2233458999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+.+||.+||. +|.+|||++++++||||...
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=365.38 Aligned_cols=253 Identities=35% Similarity=0.639 Sum_probs=223.0
Q ss_pred eeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 16 GRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
++.||+|+||.||++++. .+++.||+|++...... .......+.+|+.+|+.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 46889999999865432 22334567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
|+++++|.+.+...+.+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 999999999999888899999999999999999999999999999999999999999999999998763221 122233
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 251 (334)
...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......|+.++..+.+||.+||+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 4578999999999987666 488999999999999999999999988888888888888888899999999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccCC
Q 019904 252 NPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 252 dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
||.+|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=356.19 Aligned_cols=252 Identities=32% Similarity=0.477 Sum_probs=214.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----eE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 86 (334)
.|.-.+.+|+|+||.||.|....+++.||||.+-.+.-. --+|+.+|+.++|||||++..+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 588899999999999999999999999999988654322 237999999999999999998885432 34
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccchhcc
Q 019904 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALS 161 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a~~~ 161 (334)
.+||||++. +|.+.++. +.+++.-.++-+..||++||+|||+.||+||||||.|+|++.+ |.+||||||.|...
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 699999997 89888874 5679999999999999999999999999999999999999876 89999999999865
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~----------- 230 (334)
.. +....++..|++|+|||.+.+...++.+.||||.||++.||+-|++.|+|.+..+++..|....
T Consensus 177 ~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred cc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 43 3334667789999999999998888899999999999999999999999988777766553211
Q ss_pred ------cC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 231 ------FT------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 231 ------~~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.. +....++++.+|+.++|..+|++|.++.|+|.||||..-..+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11 112368899999999999999999999999999999865443
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-50 Score=370.02 Aligned_cols=264 Identities=33% Similarity=0.583 Sum_probs=224.8
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44556899999999999999999999999999999999986554444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999999999988654 58999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCCcccChHhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCC--CCC
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--WLS 238 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~--~~~ 238 (334)
.......+||+.|+|||++.+.. ..+.++|+|||||++|+|++|..||.+.+....+..+... ...+|. .++
T Consensus 197 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred -ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 11123557999999999997643 3458899999999999999999999988877777776543 234444 479
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHhHHhcCccccCC
Q 019904 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 271 (334)
..+++++.+||..++.+ |+|++|+++||||...
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 99999999999866654 8999999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=364.48 Aligned_cols=252 Identities=27% Similarity=0.471 Sum_probs=217.5
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCe-EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEP-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 84 (334)
........+.+.||.|+||+||+|.+. |.. ||+|++......... .+.+.+|+.+|++++|||||++++++....
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344556677778999999999999985 455 999999876555444 789999999999999999999999999887
Q ss_pred eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-cEEeecCCCCEEEecCC-CeEEeeccchhc
Q 019904 85 KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDAYG-NLKVSDFGLSAL 160 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~-i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~ 160 (334)
..++||||+++|+|.+++.. .+.++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999988 578999999999999999999999999 99999999999999998 999999999986
Q ss_pred cccccCCCcccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCccCCCCC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCPPW 236 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~ 236 (334)
..... .......||+.|||||++.+ ..+ +.++||||||+++|||+||..||.+.........+. ...+.+|..
T Consensus 194 ~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 194 KVISK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE 270 (362)
T ss_pred ecccc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence 44321 22333689999999999994 455 599999999999999999999999988766555553 334566777
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+++.+..++.+||+.||.+||++.+++.
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999999874
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-50 Score=370.79 Aligned_cols=259 Identities=32% Similarity=0.612 Sum_probs=223.7
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765555555678889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC----
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---- 166 (334)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999998764321100
Q ss_pred -----------------------------CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 019904 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (334)
Q Consensus 167 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~ 217 (334)
.......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 0011235799999999999887764 8999999999999999999999998
Q ss_pred cHHHHHHHhhcC--ccCCCC--CCCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccCC
Q 019904 218 NLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKKD 271 (334)
Q Consensus 218 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~~ 271 (334)
+......++... ...+|+ .++.++++||.+|+. ||.+|+ +++++++||||...
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 887777766542 233343 378999999999874 999998 58999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=361.81 Aligned_cols=257 Identities=31% Similarity=0.565 Sum_probs=227.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.|++.+.||+|+||.||+|.+..+|+.||+|++.+.........+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765544455667788899998886 577888999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++|+|.+++...+.+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998764221 11122
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..++.++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 34568999999999987766 48899999999999999999999998888888888888888888899999999999999
Q ss_pred CCCCCCCC-----HhHHhcCccccCC
Q 019904 251 PNPMTRIT-----IPEILEDEWFKKD 271 (334)
Q Consensus 251 ~dp~~Rpt-----~~e~l~h~~~~~~ 271 (334)
+||.+|++ .+++++||||...
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 4789999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-50 Score=363.72 Aligned_cols=252 Identities=32% Similarity=0.601 Sum_probs=217.5
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876554555566788899888776 799999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|...+...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++..... .........|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99999998888999999999999999999999999999999999999999999999999998764221 1122334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---------CcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .........+......+|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999987766 4889999999999999999999952 112234455566667788889999999999
Q ss_pred HhcCCCCCCCCC------HhHHhcCccccCC
Q 019904 247 RILDPNPMTRIT------IPEILEDEWFKKD 271 (334)
Q Consensus 247 ~~L~~dp~~Rpt------~~e~l~h~~~~~~ 271 (334)
+||+.||.+||| ++++++||||...
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5799999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=364.86 Aligned_cols=264 Identities=41% Similarity=0.745 Sum_probs=242.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
+.-|-|.+.+.||+|-|+.|-+|++.-+|++||||++.+.+.. ......+..|++.|+.++|||||++|++...+..+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 4456799999999999999999999999999999999886654 334567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE-ecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~-~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+|+-++|+|+++|.++. .+.|+.+++++.||+.|+.|+|+..+|||||||+||++ .+-|-|||.|||++....
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--- 170 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--- 170 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC---
Confidence 9999999999999998874 69999999999999999999999999999999999876 567999999999987543
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
......+.||++.|-|||++.+..|+.+++||||||+|+|-+++|+.||...++.+.+..|..+.+..|..+|.++++||
T Consensus 171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI 250 (864)
T KOG4717|consen 171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLI 250 (864)
T ss_pred CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHH
Confidence 34456778999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
.+||..||.+|.+.+||..++|++....++
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 999999999999999999999999766543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=362.76 Aligned_cols=260 Identities=29% Similarity=0.465 Sum_probs=210.4
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----CeE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----TKI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 86 (334)
+|++.+.||+|+||.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864321 222345678999999999999999999987543 358
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+|||||. ++|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999996 58999998888899999999999999999999999999999999999999999999999999875322111
Q ss_pred -CCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----------------
Q 019904 167 -DGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (334)
Q Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~---------------- 228 (334)
........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1122345789999999998752 3345889999999999999999999987654333221110
Q ss_pred -----------Ccc-C---CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 229 -----------AEF-T---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 229 -----------~~~-~---~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
... . ..+.+++.+.++|.+||+.||++|||++|+++||||.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 0 01246788999999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-51 Score=367.61 Aligned_cols=258 Identities=30% Similarity=0.505 Sum_probs=235.8
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe-EE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~ 87 (334)
.+++|..++.+|+|+||.+++++++.+++.|++|.+......... .+...+|+.++++++|||||.+++.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 468899999999999999999999999999999999876655444 3467899999999999999999999988888 99
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+||+||++.+.+.+.+ -++++.+..|+.|++.|+.|||+++|+|||||+.||++++++.|+|+|||+|+.....
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~- 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE- 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc-
Confidence 9999999999999998765 5899999999999999999999999999999999999999999999999999876542
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 244 (334)
.....+.+||+.|+.||++.+.+|. .++|||||||++|||++-+.+|.+.+...+..++.... .+.|..++.+++.+
T Consensus 160 -~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 -DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred -hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 2355678999999999999999986 99999999999999999999999999999999998877 57788899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
|..||.++|..||++.++|.+|....
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhh
Confidence 99999999999999999999987763
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=362.33 Aligned_cols=251 Identities=36% Similarity=0.608 Sum_probs=219.2
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||+||+|.+..+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999998754433333445555554 57789999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|...+...+++++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99999998888999999999999999999999999999999999999999999999999998764221 1222334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+. .++|||||||++|+|++|..||...+.......+.......++..+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999887764 889999999999999999999999888888888877777777789999999999999999999
Q ss_pred CCCH----hHHhcCccccC
Q 019904 256 RITI----PEILEDEWFKK 270 (334)
Q Consensus 256 Rpt~----~e~l~h~~~~~ 270 (334)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 58999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=364.87 Aligned_cols=264 Identities=34% Similarity=0.582 Sum_probs=224.2
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
+....++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44556899999999999999999999999999999999986554444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~- 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE- 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-
Confidence 99999999999999988654 5899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccccCCcccChHhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCC--CCCC
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLS 238 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~--~~~~ 238 (334)
........+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+....+.++.... ..+| ..++
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 111223457999999999997543 34688999999999999999999999988877777765432 3333 4689
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHhHHhcCccccCC
Q 019904 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 271 (334)
..++++|.+||..++.+ |++++++++|+||...
T Consensus 276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999999999855544 7899999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=360.38 Aligned_cols=251 Identities=36% Similarity=0.621 Sum_probs=218.1
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|++..+++.||+|++.............+..|. .+++.++||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999865443333333444444 457889999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
++|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999864221 1222345579
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.......++.++..+.++|.+||++||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999877664 889999999999999999999999888888888777777777889999999999999999999
Q ss_pred CCCHh----HHhcCccccC
Q 019904 256 RITIP----EILEDEWFKK 270 (334)
Q Consensus 256 Rpt~~----e~l~h~~~~~ 270 (334)
||++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=359.52 Aligned_cols=251 Identities=35% Similarity=0.592 Sum_probs=219.2
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876544433344555555 467889999999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
++|...+.....+++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||++..... .........|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999998764221 1222334578
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
|+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+.......+.......|+..+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999877664 889999999999999999999999888888888877777888889999999999999999999
Q ss_pred CCCH----hHHhcCccccC
Q 019904 256 RITI----PEILEDEWFKK 270 (334)
Q Consensus 256 Rpt~----~e~l~h~~~~~ 270 (334)
||++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-49 Score=357.19 Aligned_cols=252 Identities=31% Similarity=0.593 Sum_probs=218.8
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++..+ .||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876655555667788999999888 599999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|...+...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99999998888899999999999999999999999999999999999999999999999998763221 1222345679
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-------cHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-------NLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (334)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||... ........+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987766 48999999999999999999999532 2234455555566677888999999999999
Q ss_pred cCCCCCCCCC------HhHHhcCccccCC
Q 019904 249 LDPNPMTRIT------IPEILEDEWFKKD 271 (334)
Q Consensus 249 L~~dp~~Rpt------~~e~l~h~~~~~~ 271 (334)
|+.||.+|++ ++++++||||...
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999998 5799999999863
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=364.38 Aligned_cols=250 Identities=33% Similarity=0.586 Sum_probs=217.0
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
||+|+||+||+|++..+|+.||+|++.+..............|..++... .||||+++++++.....+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999865544444444555666776655 699999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
|+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999998888999999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC-CCCHHHHHHHHHhcCCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNPM 254 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~ 254 (334)
|+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+......+|. .++.++++||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999986654568999999999999999999999998888888887776666664 4799999999999999999
Q ss_pred CCC----CHhHHhcCccccC
Q 019904 255 TRI----TIPEILEDEWFKK 270 (334)
Q Consensus 255 ~Rp----t~~e~l~h~~~~~ 270 (334)
+|| +++++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=358.43 Aligned_cols=257 Identities=23% Similarity=0.399 Sum_probs=218.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||++.+..++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999987542 23345678999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----
Confidence 999999999999998888899999999999999999999986 699999999999999999999999998764322
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------------ 229 (334)
.......|++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..++...+...
T Consensus 157 ~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 12234578999999999987766 48999999999999999999999876654433221110
Q ss_pred ----------------------------c-cC-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 ----------------------------E-FT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 ----------------------------~-~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
. .. ....++.++++||.+||+.||++|||++++++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 00 1123678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=351.85 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=218.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58999999999999999999998999999999976554444444567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+.+|+|.+.+... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999999887653 3689999999999999999999999999999999999999999999999998765321 122
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCccCCCCCCCHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li 245 (334)
.....|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+...... ...+.......+..++..+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 234578999999999987665 4889999999999999999999987654332 23333444456677999999999
Q ss_pred HHhcCCCCCCCC-----CHhHHhcCccccC
Q 019904 246 ARILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
.+||+.||.+|| +++++++||||..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=361.71 Aligned_cols=251 Identities=35% Similarity=0.620 Sum_probs=221.4
Q ss_pred eeeeccCceEEEEEEE---CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
+.||+|+||.||++++ ..+|+.||+|++....... .....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999886 3578999999998654322 22456678999999999999999999999999999999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccc
Q 019904 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (334)
Q Consensus 94 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 173 (334)
.+++|.+++.+...+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceecc
Confidence 99999999988888999999999999999999999999999999999999999999999999987643221 1223345
Q ss_pred ccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCC
Q 019904 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253 (334)
Q Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 253 (334)
.|++.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......|..++.++.+||.+||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 78999999999987666 48899999999999999999999998888888888887888888999999999999999999
Q ss_pred CCCCC-----HhHHhcCccccCC
Q 019904 254 MTRIT-----IPEILEDEWFKKD 271 (334)
Q Consensus 254 ~~Rpt-----~~e~l~h~~~~~~ 271 (334)
.+||+ ++++++||||...
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 7779999999753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=351.23 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=212.4
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||+|+||+||++.+..+++.||+|++...........+.+..|+.+++.++||||+++.+++..+...|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876544444456778899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 99 FDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 99 ~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
...+.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887743 346899999999999999999999999999999999999999999999999988643321 11223457
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
||+.|+|||++.+..+. .++|||||||++|+|++|+.||...+. ......+.......+..++..+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 89999999999887664 889999999999999999999976432 2333344444455667799999999999999
Q ss_pred CCCCCCC-----CHhHHhcCccccC
Q 019904 251 PNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 251 ~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
.||.+|| +++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=369.31 Aligned_cols=248 Identities=31% Similarity=0.486 Sum_probs=213.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-C-----CCeeeEEEEEeeCCe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-H-----PNVVRLYEVMGSKTK 85 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~ 85 (334)
+|.+.+.||+|+||+|.+|.+..+++.||||+++... ....+...|+.+|..++ | -|+|+++++|..+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 8999999999999999999999999999999997543 34566778999999998 4 479999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC--CeEEeeccchhcc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALS 161 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~a~~~ 161 (334)
.|+|+|.+.. +|+++++.++ .++...++.++.||+.||.+||+.||||+||||+|||+.+.+ .+|++|||.|...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999976 9999999875 588999999999999999999999999999999999997655 5999999998854
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC---------
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--------- 232 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~--------- 232 (334)
.. ...+++.+++|+|||++.+.+|. .+.||||||||++||++|.+.|+|.+..+++..|......
T Consensus 342 ~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 32 23477889999999999999996 8999999999999999999999998877776655311110
Q ss_pred -------------------------------------------CCC-----------CCCHHHHHHHHHhcCCCCCCCCC
Q 019904 233 -------------------------------------------CPP-----------WLSFTARKLIARILDPNPMTRIT 258 (334)
Q Consensus 233 -------------------------------------------~~~-----------~~~~~~~~li~~~L~~dp~~Rpt 258 (334)
.|+ .-...+.+||.+||..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 110 01235789999999999999999
Q ss_pred HhHHhcCccccC
Q 019904 259 IPEILEDEWFKK 270 (334)
Q Consensus 259 ~~e~l~h~~~~~ 270 (334)
+.++|+||||..
T Consensus 496 p~qal~Hpfl~~ 507 (586)
T KOG0667|consen 496 PAQALNHPFLTG 507 (586)
T ss_pred HHHHhcCccccc
Confidence 999999999984
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=356.32 Aligned_cols=259 Identities=29% Similarity=0.534 Sum_probs=219.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||++++..+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755545555677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999976 45799999999999999999999999999999999999999999999999998764322111 11
Q ss_pred ccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCC---CCCCHH
Q 019904 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 240 (334)
.....||+.|+|||++.. ....+.++|||||||++|+|++|+.||.+.+..+.+..+.... ...+ ..++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223468999999999974 2334578999999999999999999999887777666654322 2222 347999
Q ss_pred HHHHHHHhcCCCCCC--CCCHhHHhcCccccC
Q 019904 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (334)
Q Consensus 241 ~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~ 270 (334)
+++||.+||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999765544 889999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-51 Score=339.85 Aligned_cols=260 Identities=36% Similarity=0.645 Sum_probs=230.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehh-----hhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-----KVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 81 (334)
....+|.-.+.||+|..++|.++.++.+|+.+|+|++... ........+.-.+|+.||+++. ||+|+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4567888999999999999999999999999999998632 1123455677889999999987 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
++...++|+|.|+.|.|+++|...-.+++...+.+++|+++|+.|||.++|+||||||+|||++++-+++|+|||+|...
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999998854
Q ss_pred ccccCCCcccccccCCcccChHhhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC--C
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--P 234 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~--~ 234 (334)
. ........||||.|.|||.+... +-++..+|+|++|+|+|.++.|..||-....+-++..|..+.+.+ |
T Consensus 174 ~---~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 174 E---PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred C---CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 4 33445667999999999998642 334578999999999999999999999988888888888887654 4
Q ss_pred CC--CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 ~~--~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.| +|.++++||.+||+.||.+|.|++|+|.||||..
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 44 7889999999999999999999999999999953
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=364.17 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=207.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|.+++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 345789999999999999999999999999999997532 34568999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+|||++. ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....... .
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-A 237 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-c
Confidence 9999996 5898898888889999999999999999999999999999999999999999999999999986432211 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-------HHHHHHHhh-------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKIS------------- 227 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-------~~~~~~~~~------------- 227 (334)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ....+..+.
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 22334679999999999987766 589999999999999999998874321 111111110
Q ss_pred -------------cCccC----CC-----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 228 -------------AAEFT----CP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 228 -------------~~~~~----~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..... .| ..++.++.+||.+||+.||.+|||++|+|+||||....
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 00000 01 12466899999999999999999999999999998643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=372.92 Aligned_cols=266 Identities=31% Similarity=0.504 Sum_probs=227.7
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
++......++|++.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..++|+||+++++.+..
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 345566778999999999999999999999999999999999765432 3345678899999999999999999887654
Q ss_pred CC--------eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCe
Q 019904 83 KT--------KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (334)
Q Consensus 83 ~~--------~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~ 150 (334)
.. .+++||||+++|+|.+.+... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence 32 378999999999999988653 468999999999999999999999999999999999999999999
Q ss_pred EEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Q 019904 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (334)
Q Consensus 151 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~ 230 (334)
||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR 261 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999875443222233345679999999999988766 489999999999999999999999988877777665544
Q ss_pred c-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 231 F-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 231 ~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
. +.|+.+++++.+++.+||+.||.+||++.++++|||+..
T Consensus 262 ~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 3 467789999999999999999999999999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=370.67 Aligned_cols=251 Identities=28% Similarity=0.387 Sum_probs=205.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 83 (334)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 457999999999999999999999999999999886432 2234799999999999999999887432
Q ss_pred --CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeecc
Q 019904 84 --TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFG 156 (334)
Q Consensus 84 --~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg 156 (334)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999986 6666654 345799999999999999999999999999999999999998665 69999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------- 229 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------- 229 (334)
+|..... ........||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9875432 122234578999999999887655568999999999999999999999987665544433211
Q ss_pred ----------c------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 230 ----------E------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 230 ----------~------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
. ..+|...+.++++||.+||+.||.+|||+.|+|+||||...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 0 01234578899999999999999999999999999999754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=347.05 Aligned_cols=254 Identities=37% Similarity=0.724 Sum_probs=229.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|++|.||++.+..+++.||+|++.............+.+|+.+++.+.||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555555678889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+++...+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999998889999999999999999999999999999999999999999999999999987754321 2
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
....|++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.......+.......|..++..++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 33468899999999977655 48899999999999999999999988877777777777778888899999999999999
Q ss_pred CCCCCCC-----CHhHHhcCccccC
Q 019904 251 PNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 251 ~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 9999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=352.49 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=214.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..++..|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 467899999999999999999999999999999998754321 223456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+.+ +|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 158 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--T 158 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--c
Confidence 9999986 7888776544 5889999999999999999999999999999999999999999999999998643221 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------------- 230 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~----------------- 230 (334)
.......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 122334678999999999765555689999999999999999999998876554433332100
Q ss_pred --cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 --FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 --~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.. ..+.++.++++||.+||+.||.+|||++|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00 1124788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=364.27 Aligned_cols=264 Identities=43% Similarity=0.796 Sum_probs=246.5
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
-...++.|.+.+.||+|.|+.|.+|++..++..||||.+.+....... .+.+.+|+++|..++|||||+++.+.+.+..
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 356789999999999999999999999999999999999886554443 4558899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+.+|.+++++.+++++.+..++.++.|++.|++|+|+++|+|||||++|||++.+-++||+|||++....
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988654
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
......+.+|++.|.|||++.+..++++.+|+||+|+++|.++.|.+||.+.+...+......+.+.+|-.++.++.++|
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lL 286 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLL 286 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHH
Confidence 34567889999999999999999999999999999999999999999999999999888888899999999999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.++|-.+|.+|++.++++.|+|......
T Consensus 287 rk~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 287 RKFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HHhhccCccccCCHHHhhhhcccchhhh
Confidence 9999999999999999999999986543
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=352.68 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=219.8
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997655444555566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999987 457999999999999999999999999999999999999999999999999987643211 1111
Q ss_pred ccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCC---CCCCHH
Q 019904 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 240 (334)
.....||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+.++.... ..+| ..++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 223579999999999863 2334688999999999999999999999988877777765432 2233 357999
Q ss_pred HHHHHHHhcCCCCCC--CCCHhHHhcCccccC
Q 019904 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (334)
Q Consensus 241 ~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~ 270 (334)
+++||.+||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765555 689999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=362.67 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=215.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----eE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 86 (334)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999999999999999986432 22233567889999999999999999999998776 78
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.+ +|.+.+.....+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 999999975 78888888888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----------------
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------------- 229 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~----------------- 229 (334)
........+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 122233467899999999987665568899999999999999999999887765554433210
Q ss_pred ------c---------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 230 ------E---------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 230 ------~---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
. +......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0 01223468899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=369.54 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=221.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCC-CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
....|.+.+.||+|++|.||+|.+..+ +..||+|.+.... ......+++|+.+|+.++||||+++++++...+.+|
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 345699999999999999999998877 7889999775432 233456788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
+||||+++|+|.+.+.. ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999887753 34689999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTAR 242 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (334)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..... +.|..++.+++
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 222222345579999999999987666 5889999999999999999999998888777777655544 45667899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+||.+||+.||++||++++++.|+|+.
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~ 327 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLK 327 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHH
Confidence 999999999999999999999999986
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=351.55 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=219.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654444445567888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999987 4679999999999999999999999999999999999999999999999999986432211 111
Q ss_pred ccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCCC---CCCHH
Q 019904 170 LHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP---WLSFT 240 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~---~~~~~ 240 (334)
.....||+.|+|||++.+. ...+.++|||||||++|+|++|+.||...+....+..+.... .++|. .++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2235689999999998752 233578999999999999999999999888777776665432 33333 36899
Q ss_pred HHHHHHHhcCCCCCC--CCCHhHHhcCccccC
Q 019904 241 ARKLIARILDPNPMT--RITIPEILEDEWFKK 270 (334)
Q Consensus 241 ~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~ 270 (334)
++++|.+||..++++ |++++++++|+||..
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=343.94 Aligned_cols=253 Identities=35% Similarity=0.654 Sum_probs=213.3
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
|++++.||+|+||+||++.+..+++.||+|++......... .....+|+.+++.++||||+++++++......++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999876544333 33445699999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 172 (334)
+.+++|.+++...+.+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999997888999999999999999999999999999999999999999999999999987643 112233345
Q ss_pred cccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccCCC----CCCCHHHHHHH
Q 019904 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCP----PWLSFTARKLI 245 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~~~~~~----~~~~~~~~~li 245 (334)
..++..|+|||++......+.++|+||||+++|+|++|..||.... ......+........+ ...+..+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 6789999999999833444699999999999999999999999873 3333333322222111 12248999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 019904 246 ARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=346.73 Aligned_cols=252 Identities=32% Similarity=0.458 Sum_probs=204.3
Q ss_pred cceEEeeeeeccCceEEEEEEECC-CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEe-----
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMG----- 81 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~----- 81 (334)
.+|++.+.||+|+||.||+|.+.. +++.||+|.+....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46889999987543221 2223455677766655 6999999999875
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
....+++||||+.+ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34568999999975 888888654 358999999999999999999999999999999999999999999999999986
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------- 231 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-------- 231 (334)
.... ........||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 4332 122334568999999999987666 4889999999999999999999998877666555432110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 -------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+.++..+++||.+||+.||++|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=357.93 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=209.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 5689999999999999999999999999999999986543 22333566779999999999999999999986543
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+.+ +|...+. ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999986 5666653 358899999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------- 229 (334)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 1 2223345789999999999887764 8899999999999999999999877654332221100
Q ss_pred ---------ccC--------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 230 ---------EFT--------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 230 ---------~~~--------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
... .+...+..+++||.+||..||++|||+.|+|+||||.....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 000 01124578999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=358.01 Aligned_cols=260 Identities=28% Similarity=0.466 Sum_probs=214.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
....++.|+.++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 3445788999999999999999999999999999999986432 23335678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+.+++|... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~- 221 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT- 221 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence 9999999999988543 34677888899999999999999999999999999999999999999999998754321
Q ss_pred CCCcccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhh-cCccCCCCCC
Q 019904 166 DDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKIS-AAEFTCPPWL 237 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~-~~~~~~~~~~ 237 (334)
........||..|+|||.+.. ..+.+.++|||||||++|+|++|+.||.... .......+. ......+..+
T Consensus 222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 112234578999999999753 2344568999999999999999999997432 222222222 2233445678
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.++++||.+||+.||++|||+.|+|+||||.....
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence 999999999999999999999999999999987543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=339.17 Aligned_cols=257 Identities=28% Similarity=0.528 Sum_probs=220.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+.|.+.+.||.|++|.||.|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|+||+++++|.+.+...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999986543221111
Q ss_pred -cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHH
Q 019904 169 -LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLI 245 (334)
Q Consensus 169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 245 (334)
......|+..|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1123457889999999987665 58999999999999999999999876665554444332 3456677899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 019904 246 ARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+||..+|.+|||+.++++|+||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-48 Score=351.25 Aligned_cols=257 Identities=24% Similarity=0.414 Sum_probs=215.8
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||.|+||.||+|.+..++..+|+|.+.... .......+.+|+++++.++||||+++++++...+..|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3578999999999999999999999999999999987542 22335678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+++++|.+++...+.+++..+..++.|++.||.|||+. +++||||||+|||++.+|.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 999999999999999888899999999999999999999975 799999999999999999999999998864322
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhh--------------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-------------------- 227 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~-------------------- 227 (334)
.......|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||...........+.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 11233468999999999987665 488999999999999999999998655433321110
Q ss_pred ------------------------cC-ccCCC-CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 228 ------------------------AA-EFTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 228 ------------------------~~-~~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.. ....+ ..++.++++||.+||+.||++|||++|++.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00 00111 13678899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=354.01 Aligned_cols=241 Identities=27% Similarity=0.457 Sum_probs=211.7
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
+++++.||+|.||.||.|.+.. ...||+|.+...... .+.+.+|+++|++|+|+|||++++++..++.+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4567899999999999999965 347999998764332 35677999999999999999999999999999999999
Q ss_pred cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 93 VTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 93 ~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
++.|+|.++|+. ...+.......++.|||+|++||+++++|||||-..||||+.++.+||+|||+|+... ++.+
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~----d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG----DDEY 358 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC----CCce
Confidence 999999999997 4578999999999999999999999999999999999999999999999999999322 2222
Q ss_pred ccccc---CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 171 HTTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 171 ~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
....| ...|.|||.+....++ .+|||||||++||||+| |+.||++.+..+.+..+..+ ..+.|+.+|+++.+++
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 22222 4469999999988775 99999999999999998 99999999999999888776 4688999999999999
Q ss_pred HHhcCCCCCCCCCHhHHh
Q 019904 246 ARILDPNPMTRITIPEIL 263 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l 263 (334)
..||..+|++|||++.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 999999999999999764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-48 Score=366.73 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=203.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC------CCeeeEEEEEee
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMGS 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~ 82 (334)
..++|++.+.||+|+||+||+|.+..+++.||||+++.... .......|+.+++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 35789999999999999999999999999999999964221 12344567777766654 458889998876
Q ss_pred C-CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCC------------
Q 019904 83 K-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYG------------ 148 (334)
Q Consensus 83 ~-~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~------------ 148 (334)
. ..+|+|||++ |++|.+++.+.+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5789999988 56899999888889999999999999999999998 5999999999999998765
Q ss_pred ----CeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 019904 149 ----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224 (334)
Q Consensus 149 ----~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~ 224 (334)
.+||+|||.+.... ......+||+.|+|||++.+..+. .++|||||||++|||++|+.||.+.+..+...
T Consensus 282 ~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred CCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999865321 122356799999999999887764 88999999999999999999998877655443
Q ss_pred HhhcCccCCCC------------------------------------------CCCHHHHHHHHHhcCCCCCCCCCHhHH
Q 019904 225 KISAAEFTCPP------------------------------------------WLSFTARKLIARILDPNPMTRITIPEI 262 (334)
Q Consensus 225 ~~~~~~~~~~~------------------------------------------~~~~~~~~li~~~L~~dp~~Rpt~~e~ 262 (334)
.+......+|. ..+..+.+||.+||..||.+|||++|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 33211110000 013457799999999999999999999
Q ss_pred hcCccccCCC
Q 019904 263 LEDEWFKKDY 272 (334)
Q Consensus 263 l~h~~~~~~~ 272 (334)
|+||||...+
T Consensus 436 L~Hp~~~~~~ 445 (467)
T PTZ00284 436 TTHPYVLKYY 445 (467)
T ss_pred hcCccccccC
Confidence 9999998754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=355.46 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=210.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46899999999999999999999999999999999875432 223346677899999999999999999987543
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999986 67776643 58889999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---------- 232 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---------- 232 (334)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+.++......
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 122234578999999999988766 48899999999999999999999887765554443211000
Q ss_pred --------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 233 --------------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 233 --------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.+...+..+++||.+||+.||.+|||++++|+||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0011346789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=345.16 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=214.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
++++|++.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++..+...|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 578899999999999999999999999999999998754321 123456789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+.+ +|.+.+... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--T 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--C
Confidence 9999985 888888654 46899999999999999999999999999999999999999999999999988643221 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------------ 229 (334)
.......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 12233457889999999887655568899999999999999999999887765544332211
Q ss_pred -ccCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 230 -EFTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 230 -~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.... .+.++..+++||.+||+.||.+|||++|+|+||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0011 12468899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=341.85 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=214.4
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|++|+++++.+...+..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876544444444567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+.+++|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 999999998886543 589999999999999999999999999999999999999999999999998764321 112
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH---HHHHHh-hcCccCCCCCCCHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKI-SAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~li 245 (334)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...... ...... .......+..++.++++|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234578999999999987665 48899999999999999999999864321 111111 1222345567899999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
.+||+.||.+||| ++|+++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=353.22 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=209.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 57899999999999999999999999999999999875432 233356777899999999999999999988644
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
...|+||||+.+ ++.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999986 66666643 58899999999999999999999999999999999999999999999999987432
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------ 230 (334)
. ........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2223345789999999999877664 88999999999999999999998876544333221100
Q ss_pred ---------------c---------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 ---------------F---------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 ---------------~---------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
. ..+...+..+++||.+||+.||.+|||++|+|+||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 0 01112456789999999999999999999999999998554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=339.51 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=218.5
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|+..+.||.|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+.+++.+..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999976554444445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+.+++|.+.+... .++++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 99999998888653 3699999999999999999999999999999999999999999999999998864321 112
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCccCCCCCCCHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li 245 (334)
.....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+...... ...+.......+..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 234578999999999987665 4889999999999999999999987654332 22333334455677899999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccCC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKKD 271 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~~ 271 (334)
.+||+.||.+||| +++++.|+||...
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=339.05 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=206.6
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||+|+||.||++.+..+|+.||+|.+.............+..|+.+++.++||||+++++++......|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344556799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccC
Q 019904 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (334)
Q Consensus 99 ~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 176 (334)
.+.+.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 88886543 588889999999999999999999999999999999999999999999998764332 1122345689
Q ss_pred CcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCccCC-CCCCCHHHHHHHHHhcCC
Q 019904 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTC-PPWLSFTARKLIARILDP 251 (334)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~ 251 (334)
+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .............. ...++.++++||.+||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 5899999999999999999999976422 23333333333322 245899999999999999
Q ss_pred CCCCCCCH----hHHhcCccccC
Q 019904 252 NPMTRITI----PEILEDEWFKK 270 (334)
Q Consensus 252 dp~~Rpt~----~e~l~h~~~~~ 270 (334)
||.+||++ ++++.|+||..
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=351.28 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=210.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++++.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45789999999999999999999999999999999875432 222345677899999999999999999987543
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..+|++|+++ +++|.+.+. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 4579999988 568877664 4569999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------ 230 (334)
. ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 12345789999999999875555689999999999999999999998766554443322110
Q ss_pred -----------cCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 231 -----------FTC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 231 -----------~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
... ....++.+.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~ 306 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD 306 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence 000 1135667899999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=341.39 Aligned_cols=251 Identities=30% Similarity=0.462 Sum_probs=203.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEee-----C
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-----K 83 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~-----~ 83 (334)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... ........+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 699999999999999999999999999999998753221 11123345666666655 69999999998764 3
Q ss_pred CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
...++||||+.+ +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999986 888888664 34899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----------
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~----------- 230 (334)
... .......||..|+|||++.+..+ +.++|||||||++|+|++|..||.+........++....
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 321 12233567899999999987665 589999999999999999999998776655444432110
Q ss_pred -------c---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 -------F---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 -------~---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+ ...+.++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=336.15 Aligned_cols=253 Identities=28% Similarity=0.557 Sum_probs=223.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999987655554557889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
|+.+++|.+.+....++++..+..++.|+++||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 9999999999988878999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (334)
...|+..|+|||.+..... +.++|+||||+++|+|++|..||...+ ...+...........|..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 4567889999999987664 588999999999999999999998766 444444444355667788999999999999
Q ss_pred cCCCCCCCCCH--hHHhcCccc
Q 019904 249 LDPNPMTRITI--PEILEDEWF 268 (334)
Q Consensus 249 L~~dp~~Rpt~--~e~l~h~~~ 268 (334)
|+.||.+||++ +|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=336.40 Aligned_cols=260 Identities=33% Similarity=0.621 Sum_probs=243.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..++.|..++.||+|.||.|.+++.+.+++.||+|+++++-....+..+.-..|-++|+..+||.+..+...|+..+.+|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 35788999999999999999999999999999999999887777777788889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||..||.|+-.|.+.+.++++..+.+...|+.||.|||+++||.||||.+|.|++++|++||+|||++.- .....
T Consensus 245 FVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~g 322 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKYG 322 (516)
T ss_pred EEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--ccccc
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999753 33445
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
....+.||||.|.|||++.+..| +.++|-|.+|+++|||++|++||...+...++.-|......+|..++++++.|+..
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred ceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence 55678899999999999998877 59999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccC
Q 019904 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
+|.+||.+|. .+.|++.|+||..
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999996 5889999999975
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=349.36 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=203.0
Q ss_pred ccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
-++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 368999999999999999999752 345689999986432 222346788999999999 899999999988654
Q ss_pred -CeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNH--------------------------------------------------------- 105 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~--------------------------------------------------------- 105 (334)
..+++||||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999998753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCccc
Q 019904 106 -----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180 (334)
Q Consensus 106 -----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 180 (334)
.++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 236778889999999999999999999999999999999999999999999987532211111112234567899
Q ss_pred ChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCC
Q 019904 181 APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRI 257 (334)
Q Consensus 181 aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 257 (334)
|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+.. .....|..+++++.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999987666 489999999999999997 999998755333 2333322 23445667899999999999999999999
Q ss_pred CHhHHhc
Q 019904 258 TIPEILE 264 (334)
Q Consensus 258 t~~e~l~ 264 (334)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=329.63 Aligned_cols=253 Identities=25% Similarity=0.505 Sum_probs=216.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-CCeEEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL 90 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~~v~ 90 (334)
+|++.+.||.|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999999999999998754332 2335668899999999999999999998764 44689999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 91 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||+++++|.+.+... ..+++..+..++.|++.|+++||++|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 999999999988763 45899999999999999999999999999999999999999999999999988654321 12
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 247 (334)
......+++.|+|||++.+..+. .++|+|||||++|+|++|..||...+.......+..... ..+..++..+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 23345688999999999876664 789999999999999999999988776666555544433 4556789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 019904 248 ILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
||+.||.+|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=333.76 Aligned_cols=256 Identities=30% Similarity=0.523 Sum_probs=218.5
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh------hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
+|++.+.||.|++|.||+|.+..+++.||+|.+...... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999888999999988653221 23345778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999886543211
Q ss_pred C----CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 019904 166 D----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (334)
Q Consensus 166 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (334)
. ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111123457889999999987665 47899999999999999999999876655544443332 34556678999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=357.42 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=225.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|.-++.||.|+||-||.|++..+.+.||||.+.-+.....+..+++..|+..|+.++|||++.+.++|..+.+.|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 36667899999999999999999999999999987666666667899999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 92 FVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 92 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||-| |-.|++.-+ +++.+.++..|..+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.+..+ .
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------A 179 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------A 179 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------h
Confidence 9976 777877654 5799999999999999999999999999999999999999999999999999876443 4
Q ss_pred cccccCCcccChHhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCC-CCCCHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCP-PWLSFTARKLIA 246 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~li~ 246 (334)
++++|||+|||||++. +.+.++-++||||||++..|+...++|+...+.+..+..|.... +.++ +.||..+++||.
T Consensus 180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd 259 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 259 (948)
T ss_pred hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHH
Confidence 6789999999999986 33444588999999999999999999988777666655554443 3333 458999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCCCCcc
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVF 277 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~~~ 277 (334)
.||++-|..|||.+++|.|+|......+.+.
T Consensus 260 ~CLqKipqeRptse~ll~H~fv~R~Rp~tvi 290 (948)
T KOG0577|consen 260 SCLQKIPQERPTSEELLKHRFVLRERPPTVI 290 (948)
T ss_pred HHHhhCcccCCcHHHHhhcchhccCCCchHH
Confidence 9999999999999999999999887665443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=340.79 Aligned_cols=260 Identities=32% Similarity=0.552 Sum_probs=224.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|++.+.||.|++|.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765554445677899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC-
Q 019904 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (334)
Q Consensus 91 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 167 (334)
||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998764 46899999999999999999999999999999999999999999999999987643221100
Q ss_pred --------------------------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH
Q 019904 168 --------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (334)
Q Consensus 168 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~ 221 (334)
.......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01112367889999999987665 588999999999999999999999888777
Q ss_pred HHHHhhcCccCCCCC--CCHHHHHHHHHhcCCCCCCCCC----HhHHhcCccccCC
Q 019904 222 LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRIT----IPEILEDEWFKKD 271 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~Rpt----~~e~l~h~~~~~~ 271 (334)
.+..+.......+.. ++..++++|.+||..||++||| ++++|.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 776666555444443 6899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=337.77 Aligned_cols=259 Identities=32% Similarity=0.619 Sum_probs=222.1
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++.+.||+|+||.||++.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC----
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---- 166 (334)
||++|++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998763211000
Q ss_pred ---------CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC---
Q 019904 167 ---------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (334)
Q Consensus 167 ---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 234 (334)
........++..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+..+....+.......|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001112357888999999887665 5889999999999999999999998887777776655543332
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCC---HhHHhcCccccC
Q 019904 235 PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKK 270 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~ 270 (334)
..++.++.++|.+||+.||.+||+ +.++|+||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 257899999999999999999998 789999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=334.34 Aligned_cols=255 Identities=30% Similarity=0.461 Sum_probs=212.1
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|++|.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999999865432 1222355778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||++++.|...+.....+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 9999988887777767899999999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------------------
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--------------------- 229 (334)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 23457889999999876555568899999999999999999999876654433222110
Q ss_pred ccCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 230 EFTC----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 230 ~~~~----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..+. .+.++..+.+||.+||+.||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 12467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=352.32 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=206.3
Q ss_pred cceEEeeeeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+|.+++.||.|+||.||+|... ..++.||+|.+... ....+|+.+|+.++||||+++++++......|+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 47999999999999999999754 35678999988643 234579999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 999997 4888888777889999999999999999999999999999999999999999999999999986543322222
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH---HHHHHHhhc-----------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISA----------------- 228 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~---~~~~~~~~~----------------- 228 (334)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ...+..+..
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 2334579999999999987766 4889999999999999999999976431 111111100
Q ss_pred ------------CccCCC-----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 229 ------------AEFTCP-----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 229 ------------~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..+..| ..++.++++||.+||..||.+|||+.|+|.||||.+..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 001111 12467889999999999999999999999999998643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=335.24 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=208.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++.+.||.|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999875432 22234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 92 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|+.+ +|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.+|.++|+|||++...... ..
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 9984 788877543 46899999999999999999999999999999999999999999999999987643221 11
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------------ 230 (334)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 22334568899999998765555688999999999999999999998765433222111000
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 -----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
......+++++.+||.+||+.||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 01123478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=326.56 Aligned_cols=253 Identities=29% Similarity=0.478 Sum_probs=219.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++.+...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999998764433 3345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 99999999999774 56899999999999999999999999999999999999999999999999987654321 112
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 248 (334)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|+.||...+.......+..... ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 233467889999999987765 4889999999999999999999998887776666655443 34446889999999999
Q ss_pred cCCCCCCCCCHhHHhcCccc
Q 019904 249 LDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~ 268 (334)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=337.37 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=214.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+.+++.++||||+++++++..++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999986432 2334566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++++|.+++...+++++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 999999999999888889999999999999999999997 5999999999999999999999999998764321 12
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------------- 230 (334)
.....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 234578899999999876655 588999999999999999999997655443332221110
Q ss_pred ------------------cCCC-CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 ------------------FTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 ------------------~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...| ..++.++++|+.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0111 1267889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=346.26 Aligned_cols=264 Identities=27% Similarity=0.407 Sum_probs=214.7
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 83 (334)
.+...-..|++++.||+||.+.||++...+.+ .||+|.+... ..+...+.-+.+|+.+|.+|+ |.+|++++++-..+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 34556678999999999999999999986544 4566655432 345566788999999999998 99999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
+.+|+||||-+ .+|...|.+.+. ++.-.++.++.|+|.|+.++|.+||||.||||.|+|+-+ |.+||+|||+|....
T Consensus 433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99999999765 499999988764 344689999999999999999999999999999999987 999999999998766
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCC----------CCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcC--
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA-- 229 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~-- 229 (334)
....+-...+.+||+.|||||.+...... +.++||||||||+|+|+.|+.||..-. ...-+..|...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 65555566788999999999999754432 567999999999999999999997422 22223333333
Q ss_pred ccCCCCCCCHH-HHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 EFTCPPWLSFT-ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 ~~~~~~~~~~~-~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.+.+|..-+.. +.++++.||..||++|||+.++|+|||+....
T Consensus 591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~ 634 (677)
T KOG0596|consen 591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP 634 (677)
T ss_pred cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence 23455444433 99999999999999999999999999998643
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=329.81 Aligned_cols=255 Identities=27% Similarity=0.481 Sum_probs=215.5
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh---hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+..... ........+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999987 4688999999875322 223335678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc---
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--- 165 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--- 165 (334)
||||+++++|.+++.+..++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999886532211
Q ss_pred -CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---CccCCCCCCCHHH
Q 019904 166 -DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTA 241 (334)
Q Consensus 166 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 241 (334)
.........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+.. .....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1112234568899999999987665 4889999999999999999999987654443333322 2234566789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.++|.+||+.+|.+|||+.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=330.20 Aligned_cols=248 Identities=35% Similarity=0.682 Sum_probs=218.5
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||.|++|.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876555445567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCc
Q 019904 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (334)
Q Consensus 99 ~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 178 (334)
.+++.+...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ......+++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 9999888889999999999999999999999999999999999999999999999999887543221 1233467889
Q ss_pred ccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc--HHHHHHHhh--cCccCCCCCCCHHHHHHHHHhcCCCCC
Q 019904 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPM 254 (334)
Q Consensus 179 y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~--~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dp~ 254 (334)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+. ......|...+.++.++|.+||+.||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877665 488999999999999999999998776 556666555 445567777899999999999999999
Q ss_pred CCCC-----HhHHhcCccccC
Q 019904 255 TRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 255 ~Rpt-----~~e~l~h~~~~~ 270 (334)
+||+ ++|+++||||..
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=334.79 Aligned_cols=257 Identities=32% Similarity=0.467 Sum_probs=219.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||.|++|.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++.+..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 367999999999999999999998889999999986432 23356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 9999999999988764 46999999999999999999999999999999999999999999999999987643321 11
Q ss_pred cccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 241 (334)
......+++.|+|||.+... ...+.++|+|||||++|+|++|..||...+.......+.... ...+..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345688999999998632 223468999999999999999999998877666555555432 23456689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.++|.+||+.+|.+||+++++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=338.25 Aligned_cols=253 Identities=33% Similarity=0.530 Sum_probs=207.9
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 68999999999999999999999999999999875432 22233567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 92 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|+.+ +|.+.+.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCc
Confidence 9985 78777765 4679999999999999999999999999999999999999999999999999887433211 112
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCC-CCCcHHHHHHHhhcC----------------c---
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA----------------E--- 230 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf-~~~~~~~~~~~~~~~----------------~--- 230 (334)
....+++.|+|||.+.+....+.++|||||||++|+|++|..|| .+.+....+..+... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 33467889999999987665568899999999999999998885 444443333322110 0
Q ss_pred c----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 F----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ~----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
. ...+.++.++++||.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=341.75 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=192.9
Q ss_pred eeeeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--CCeEEEEEe
Q 019904 16 GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLE 91 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e 91 (334)
++.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999965 4678899999865432 2346789999999999999999999854 457899999
Q ss_pred ccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE----ecCCCeEEeeccch
Q 019904 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (334)
Q Consensus 92 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~----~~~~~~kl~Dfg~a 158 (334)
|+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9875 787777532 258999999999999999999999999999999999999 45578999999998
Q ss_pred hcccccc-CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH---------HHHHHHhhc
Q 019904 159 ALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---------MNLYKKISA 228 (334)
Q Consensus 159 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~---------~~~~~~~~~ 228 (334)
....... .........||+.|+|||++.+....+.++||||+||++|+|++|+.||.+... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7543221 111223457899999999998766556899999999999999999999964321 011111100
Q ss_pred C----------------------------ccC----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 229 A----------------------------EFT----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 229 ~----------------------------~~~----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
. ... .....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 000 001235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=328.53 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=217.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++|+||+++++.+......|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998889999999987544322 4577899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 91 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|++++++|.+.+... ..+++..+..++.|++.||++||+.|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 35899999999999999999999999999999999999999999999999998654432222
Q ss_pred --CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-CC-----CCCCH
Q 019904 168 --GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-----PWLSF 239 (334)
Q Consensus 168 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-~~-----~~~~~ 239 (334)
.......|+..|+|||.+......+.++|+|||||++|+|++|+.||...+......+....... .+ ..++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12234468899999999987644568999999999999999999999877665555444333221 11 25678
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+.+++.+||..||++|||++++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=333.64 Aligned_cols=241 Identities=16% Similarity=0.224 Sum_probs=208.1
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----CCeEEEEEec
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEF 92 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~ 92 (334)
..||.|++|.||+|.. +|+.||+|.+...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999998 688999999986554444556788899999999999999999999876 4578999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
+++|+|.+++...+.++......++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 99999999999888899999999999999999999984 9999999999999999999999999998753221 12
Q ss_pred ccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHHh
Q 019904 172 TTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 248 (334)
...|+..|+|||++.+. ...+.++|||||||++|+|++|..||.+.+..++...+... ....|...+..+++|+.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 34688999999999762 23458999999999999999999999988877777766433 3455557899999999999
Q ss_pred cCCCCCCCCCHhHHhc
Q 019904 249 LDPNPMTRITIPEILE 264 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~ 264 (334)
|+.||++|||++++++
T Consensus 259 l~~dp~~Rps~~ell~ 274 (283)
T PHA02988 259 TSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCcccCcCHHHHHH
Confidence 9999999999999985
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=329.57 Aligned_cols=257 Identities=31% Similarity=0.507 Sum_probs=214.9
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-------hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999889999999988643221 1223457888999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..++||||+++++|.+++...+++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCC----CCC
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP----PWL 237 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~----~~~ 237 (334)
..........|+..|+|||.+.... ..+.++|+||||+++|++++|..||...........+... ....+ +.+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222223346788999999987654 2458899999999999999999999766555444333221 22222 235
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+.++.++|.+||..+|++|||++++++|||+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=340.94 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=205.5
Q ss_pred Eeeeeecc--CceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 15 VGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 15 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
+++.||+| +|++||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 7899999999999999999999765432 33456788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC----
Q 019904 93 VTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (334)
Q Consensus 93 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~---- 166 (334)
+++++|.+++..+ ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998753 4589999999999999999999999999999999999999999999999986432211000
Q ss_pred -CCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------------
Q 019904 167 -DGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------- 231 (334)
Q Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------- 231 (334)
........++..|+|||++.+. ...+.++|||||||++|+|++|+.||.................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 0111223567789999999763 2345889999999999999999999986543332222111100
Q ss_pred ---------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 232 ---------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 232 ---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+....+++.+.+||.+||+.||++|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112356789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=333.92 Aligned_cols=257 Identities=34% Similarity=0.657 Sum_probs=227.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v 89 (334)
++|.+.+.||+|++|.||+|.+..+|+.||+|++..+..........+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555555677889999999999 99999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC--
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-- 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-- 167 (334)
||++.+++|.+.+.+.+.+++..+..++.|++.||.+||++|++|+||+|+||+++.+|.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999988654332210
Q ss_pred ----------------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Q 019904 168 ----------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (334)
Q Consensus 168 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~ 231 (334)
.......++..|+|||.+..... +.++|+||||++++++++|..||...+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11223457889999999887654 5889999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCH----hHHhcCccc
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITI----PEILEDEWF 268 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~----~e~l~h~~~ 268 (334)
..|..++..+.+||.+||+.+|.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7888899999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=331.94 Aligned_cols=253 Identities=29% Similarity=0.428 Sum_probs=211.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+...+..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3589999999999999999999999999999999875432 2235677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||+++++|.+++...+.+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987643221 112
Q ss_pred ccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC-----CCCCCHHHH
Q 019904 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-----PPWLSFTAR 242 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 242 (334)
.....|++.|+|||.+.. ....+.++|+|||||++|+|++|..||................... ...++..+.
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 234578999999999852 2223578999999999999999999997654433333322222211 124678999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 243 KLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
++|.+||+.+|++|||++++++|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=331.70 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=216.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
-|++.+.||.|+||.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4788999999999999999999999999999986432 2335678889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 92 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|+++++|...+.. ..++++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 9999999887765 457999999999999999999999999999999999999999999999999987643221 1122
Q ss_pred cccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHH
Q 019904 171 HTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARK 243 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 243 (334)
....+++.|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+... ....|..++.++++
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34568899999999852 122347899999999999999999999887766555554332 22345568899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
||.+||+.||.+|||++++++||||.....
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 999999999999999999999999986544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=325.22 Aligned_cols=253 Identities=30% Similarity=0.594 Sum_probs=218.9
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999998764332 2334678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+.+++|.+.+.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 999999999887643 57899999999999999999999999999999999999999999999999886433211 11
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 248 (334)
.....|++.|+|||.+.+... +.++|+|||||++|+|++|..||...+..+....+..... ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 123457889999999987665 4789999999999999999999988877777666554443 45667899999999999
Q ss_pred cCCCCCCCCCHhHHhcCccc
Q 019904 249 LDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~ 268 (334)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=335.67 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=213.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999988999999998654322 233566788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.........+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 999998888877766679999999999999999999999999999999999999999999999999876533211 222
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------------------
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------- 231 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------------- 231 (334)
....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+.....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 3346788999999998655556889999999999999999999987665443333221000
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 ------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+.++..+.+|+.+||+.+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=325.84 Aligned_cols=255 Identities=37% Similarity=0.646 Sum_probs=216.0
Q ss_pred cccceEEe-eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee----
Q 019904 9 RVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS---- 82 (334)
Q Consensus 9 ~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---- 82 (334)
..+.|.+. +.||-|-.|.|..+.++.+|+++|+|++..+ ...++|+++.-.. .|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 34566664 5689999999999999999999999987532 3456777765544 49999999999854
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEeeccc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGL 157 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~ 157 (334)
...+.+|||.++||.|+..+..++ .++|.++..|++||+.|+.|||+.+|.||||||+|+|++.. ..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 467889999999999999998876 49999999999999999999999999999999999999654 4699999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCccCC
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTC 233 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~----~~~~~~~~~~~~~~~ 233 (334)
|..... .....+.+-||+|.|||++....|+ ..+|+||+|+++|-|++|.+||.... ......+|..+.+.+
T Consensus 211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred ccccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 885432 3445677899999999999877775 88999999999999999999997543 345667788888877
Q ss_pred CCC----CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 234 PPW----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 234 ~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
|.. +|+.++++|+.+|..+|.+|.|+++++.|||+.....-|
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 743 899999999999999999999999999999998765433
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=330.25 Aligned_cols=254 Identities=30% Similarity=0.411 Sum_probs=211.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
-.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 34679999999999999999999999999999999865322 123467789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||+++++|.+.+....++++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT--IA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--cc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998744221 11
Q ss_pred cccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-----CCCCCCHHH
Q 019904 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFTA 241 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 241 (334)
......|++.|+|||.+.. ....+.++|+||+||++|+|++|..||...........+....+. .+..++..+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence 1233468889999999853 222347899999999999999999999765444333222222222 123468899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
.+||.+||+.+|.+|||++++++|+|
T Consensus 242 ~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=351.78 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=203.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|+||+++++++...+..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2345899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||++. ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++..........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99996 5888887664 469999999999999999999999999999999999999999999999999987543222222
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-C-------cHHHHHHHhhcCcc---------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-S-------NLMNLYKKISAAEF--------- 231 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~-~-------~~~~~~~~~~~~~~--------- 231 (334)
......||+.|+|||++.+..+ +.++|||||||++|||++|..|+.. . ....+...+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234579999999999988766 4899999999999999998765422 1 12222222221110
Q ss_pred --------------------CCCC-----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 232 --------------------TCPP-----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 232 --------------------~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..+. .++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0010 24568999999999999999999999999999974
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=332.54 Aligned_cols=259 Identities=29% Similarity=0.487 Sum_probs=219.1
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
++....+|++.+.||.|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.+.||||+++++.+.....
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~ 91 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDE 91 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence 455667999999999999999999999999999999998754322 24668899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.|+||||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~- 169 (296)
T cd06654 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 169 (296)
T ss_pred EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc-
Confidence 9999999999999998865 45899999999999999999999999999999999999999999999999987643221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 242 (334)
........|++.|+|||.+.+... +.++|||||||++|+|++|+.||...........+... ....+..++..+.
T Consensus 170 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 170 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred -ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 111233468899999999987665 48999999999999999999999877654433322222 2234556889999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
++|.+||..||.+|||+.++++||||...
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=356.48 Aligned_cols=255 Identities=29% Similarity=0.472 Sum_probs=223.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|.|+..||.|+||.||+|..+.++-..|.|++.. ..++.++++.-|+.||...+||+||++++.|..++.+|++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 458899999999999999999998888888998853 34555788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||.||.....+.. ...+++..+..+++|+|.||.|||+++|+|||||..|||++.+|.++|+|||.+...... -..
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk 186 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK 186 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence 99999988766654 457999999999999999999999999999999999999999999999999987643221 223
Q ss_pred ccccccCCcccChHhhh-----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC---CCCCCCHHH
Q 019904 170 LHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSFTA 241 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 241 (334)
..++.|||+|||||+.. +.+|+ .++||||||+++.||..+.+|...-+++..+-++....++ -|..|+..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 45679999999999975 45665 8999999999999999999999998888888777665443 367799999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+|+.+||.+||..||++.++|+||||.+.
T Consensus 266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 999999999999999999999999999853
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=334.45 Aligned_cols=261 Identities=33% Similarity=0.476 Sum_probs=217.0
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+|++.+.||.|++|.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++|+||+++++++......|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999989999999999765432 122345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+ +++|.+++.... .+++..+..++.||++||+|||++|++|+||+|+||+++.+|.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 889999998766 79999999999999999999999999999999999999999999999999987543221 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------------- 231 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------------- 231 (334)
......+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+......++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 222335678899999987655556889999999999999999988887766554444321100
Q ss_pred -----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 232 -----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 232 -----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
......+..+.+||.+||+.||++|||+.|++.|+||.+...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 00123577899999999999999999999999999999866554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=336.45 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=223.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+-|.++.+||.|+||.||+|+++.+|+.+|||.+..+.. ++.+..|+.+|++.+.|+||++|+.|.....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 347889999999999999999999999999999876442 677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||..|++.+.++. +++++++++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..... ....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAK 185 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAK 185 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHh
Confidence 99999999998875 46899999999999999999999999999999999999999999999999998864332 1223
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIA 246 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~ 246 (334)
..+..|||.|||||++..-+|+ .++||||||++..||..|++||.+--++..+..|... .+..|..+|.++.+||+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 4567899999999999998987 7789999999999999999999876655544444332 23456679999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+||-++|++|-|+-++++|+|+++..
T Consensus 265 ~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 265 SCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999998754
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=330.44 Aligned_cols=257 Identities=27% Similarity=0.486 Sum_probs=220.2
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+......|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999875432 223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+++... ++++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999998765 79999999999999999999999999999999999999999999999999987544321 122
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCC-CCHHHHHHHHHh
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW-LSFTARKLIARI 248 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~li~~~ 248 (334)
....++..|+|||.+.+..+ +.++|||||||++|+|++|..||...+.......+..... ..+.. ++.++.+++.+|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 34467889999999987765 5899999999999999999999987766555554444322 33334 788999999999
Q ss_pred cCCCCCCCCCHhHHhcCccccCCCC
Q 019904 249 LDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
|..+|++|||++++++||||....+
T Consensus 235 l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 235 LNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hhCChhhCcCHHHHhhChhhcCCCc
Confidence 9999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=367.33 Aligned_cols=262 Identities=29% Similarity=0.461 Sum_probs=215.3
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--C
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 83 (334)
-...+++|++++.||.|+||+||+|++..+++.||+|++...... ......+..|+.+++.++||||++++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 456778999999999999999999999999999999998764432 2335678899999999999999999998854 4
Q ss_pred CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CcEEeecCCCCEEEec------
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR-------GVYHRDLKPENLLLDA------ 146 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~-------~i~H~dlkp~NIl~~~------ 146 (334)
..+|+||||+++++|.++|... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5799999999999999988753 5699999999999999999999984 4999999999999964
Q ss_pred -----------CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCC
Q 019904 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPF 214 (334)
Q Consensus 147 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf 214 (334)
.+.+||+|||++..... ........||+.|+|||++.+. ...+.++|||||||++|+|++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999875322 1222345789999999998653 33458899999999999999999999
Q ss_pred CCCcHH-HHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 215 DDSNLM-NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...... .+...+...........+.++.+||..||+.+|.+||++.++|.|+|+...
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 765443 334443333322234578999999999999999999999999999999744
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=331.97 Aligned_cols=256 Identities=29% Similarity=0.466 Sum_probs=216.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++++.||.|+||.||+|.+..+++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 67999999999999999999999999999999986532 334577888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++++|...+.+ ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ...
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~ 166 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR 166 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence 99999999887754 456899999999999999999999999999999999999999999999999987643221 112
Q ss_pred ccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTAR 242 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 242 (334)
.....+++.|+|||.+.+. ...+.++|+|||||++|+|++|..||...+......++.... ...+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 2345678899999998532 223478999999999999999999998766655554443332 233556889999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
++|.+||+.||++||+++++++||||...
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 99999999999999999999999999753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=331.59 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=213.8
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 689999999999999999999989999999998764322 2335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 92 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|+ +++|.+.+.. ..++++..++.++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 8999998865 35689999999999999999999999999999999999999999999999998875432211 123
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------c
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------F 231 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-------------------~ 231 (334)
....|+..|+|||.+.+....+.++||||+||++|+|++|..||.+.+....+..+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 345688999999998766555689999999999999999999998776555444332110 0
Q ss_pred -----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 232 -----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 232 -----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
...+..+..+.+||.+||+.||.+|||++++|+||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 01124578899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=330.18 Aligned_cols=248 Identities=31% Similarity=0.479 Sum_probs=212.0
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||.|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765444444455667899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccC
Q 019904 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (334)
Q Consensus 99 ~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 176 (334)
.+++...+ .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 99997765 799999999999999999999999999999999999999999999999998865332 1222334678
Q ss_pred CcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCC
Q 019904 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (334)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 252 (334)
..|+|||.+.+..+ +.++|||||||++|+|++|+.||..... ..+...+.......++.+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999987664 5889999999999999999999976543 233333334445566778999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccC
Q 019904 253 PMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 253 p~~Rp-----t~~e~l~h~~~~~ 270 (334)
|.+|| ++.++++||||..
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=326.17 Aligned_cols=256 Identities=27% Similarity=0.503 Sum_probs=213.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--CCeEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIF 87 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 87 (334)
.|++.+.||.|+||.||+|.+..++..||+|.+..... ........+.+|+.+++.++||||+++++++.. ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68999999999999999999999999999999865422 122345678899999999999999999998865 46789
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc-C
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR-D 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~ 166 (334)
++|||+++++|.+.+...+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 999999999999999888889999999999999999999999999999999999999999999999999886433211 1
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l 244 (334)
........++..|+|||.+.+..+ +.++|+||+||++|+|++|+.||...........+... ....|..++..++++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 111223457889999999987655 48899999999999999999999876655544443322 234456688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 245 IARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+ +||..+|++|||++|+++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=328.40 Aligned_cols=257 Identities=27% Similarity=0.492 Sum_probs=215.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh---hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+|+..+.||+|++|.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58889999999999999999999999999999874321 223346788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhccccccC-
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD- 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~- 166 (334)
||||+++++|.+.+...+++++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998776 599999998765432211
Q ss_pred -CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH---HHHHhh--cCccCCCCCCCHH
Q 019904 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKIS--AAEFTCPPWLSFT 240 (334)
Q Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~---~~~~~~--~~~~~~~~~~~~~ 240 (334)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||....... ....+. ......|+.++.+
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223467889999999977665 488999999999999999999997544322 222221 2233456678899
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+.+++.+||..+|++|||+.++++||||.
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=322.25 Aligned_cols=253 Identities=29% Similarity=0.536 Sum_probs=220.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.+++.++|+||+++++++......++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987644332 335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+++++|.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 99999999999775 468999999999999999999999999999999999999999999999999876543222 12
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 248 (334)
.....|++.|+|||.+.+... +.++|+|||||++|+|++|..||......+....+..... ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 234568999999999987665 4889999999999999999999998887777766655443 33456789999999999
Q ss_pred cCCCCCCCCCHhHHhcCccc
Q 019904 249 LDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~ 268 (334)
|..+|.+||++.++|+|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=332.40 Aligned_cols=259 Identities=30% Similarity=0.497 Sum_probs=220.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
++....+|++.+.||.|++|.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 44455679999999999999999999999999999999865432 224667899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+|+||+++++|..++... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 99999999999999888654 58999999999999999999999999999999999999999999999999876433211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 242 (334)
.......++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+.+.......+... ....+..++..+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06655 170 --SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246 (296)
T ss_pred --ccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence 11233468889999999987665 48899999999999999999999887765544433322 2334566889999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+||.+||..||.+|||+.+++.||||+..
T Consensus 247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 247 DFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 99999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=324.69 Aligned_cols=253 Identities=32% Similarity=0.599 Sum_probs=220.5
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
.+.||.|+++.|-.+....+|.+||||++.+.. .....++.+|+.++...+ |+||+.++++|+++..+|+|||.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 357899999999999999999999999998753 334678889999999997 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEeeccchhccccccC-----
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD----- 166 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~a~~~~~~~~----- 166 (334)
||+|...|.+++.+++.++..+.++|+.||.+||.+||.||||||+|||..+.+. ||||||.+........+
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999999999999999999999999999999999999999999999977654 89999998654322111
Q ss_pred CCcccccccCCcccChHhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---------------HHHHHHHhh
Q 019904 167 DGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------LMNLYKKIS 227 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---------------~~~~~~~~~ 227 (334)
.....+.+|+..|||||+.. ...++..++|.||||+|+|-|+.|++||.|.. ...++..|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22234568899999999964 23345689999999999999999999997522 566788889
Q ss_pred cCccCCCCC----CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 228 AAEFTCPPW----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 228 ~~~~~~~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+.+.+|.. +|.+++++|..+|..|+.+|.++.++++|||++.-
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 999999864 89999999999999999999999999999999864
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=329.42 Aligned_cols=250 Identities=30% Similarity=0.454 Sum_probs=204.5
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHH---HHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT---MKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
.||+|+||.||++.+..+++.||+|.+.+.............+|..+ +....||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999976543322222233344433 344579999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
+++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999987643221 122346
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 251 (334)
|+..|+|||.+......+.++|+||+||++|+|++|..||.... ...............|+.++.+++++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 89999999998754434588999999999999999999997532 222222222334456777899999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccCC
Q 019904 252 NPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 252 dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
||.+|| |+.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999 69999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=323.54 Aligned_cols=254 Identities=28% Similarity=0.494 Sum_probs=217.9
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+|+..+.||+|++|.||+|.+..+++.|++|.+..... ......+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 68889999999999999999988899999999865432 1233457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999999999888889999999999999999999999999999999999999999999999999876533211 2
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CccCCCCCCCHHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~ 247 (334)
.....|+..|+|||.+......+.++|+|||||++|+|++|..||...........+.. .....++.++..+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 23456888999999987655245889999999999999999999987665444444333 2334566789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 019904 248 ILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
||+.+|++||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=323.90 Aligned_cols=251 Identities=31% Similarity=0.473 Sum_probs=214.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||.|+||.||+|.+..+++.+++|++..... ...+.+.+|+.+++.++||||+++++.+......|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 689999999999999999999998899999999975432 23577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+.+++|.+++... .++++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~ 157 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AK 157 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--hc
Confidence 999999999988776 689999999999999999999999999999999999999999999999999876543211 11
Q ss_pred ccccccCCcccChHhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-----CCCCCCHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFTA 241 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 241 (334)
.....++..|+|||.+... .+ +.++|+|||||++|+|++|..||...+.......+....+. .+..++.++
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 2334678899999998765 44 47899999999999999999999877655544444333222 233467889
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
.+|+.+||..+|..|||+.+++.|+|
T Consensus 237 ~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=330.43 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=214.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCC-----CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
.++.|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999876554 679999886432 233456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
...|++|||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 357888999999999999999999999999999999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~ 226 (334)
+.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999864322211112233456788999999887665 588999999999999998 99999988877777776
Q ss_pred hcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 227 ~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.... ...|..++.++.+|+.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 5443 34567789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=323.94 Aligned_cols=257 Identities=28% Similarity=0.525 Sum_probs=214.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--CeE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 86 (334)
..|++.+.||+|+||.||.|.+..+|..||+|.+..... ......+.+.+|+.+++.+.||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864321 1223457888999999999999999999988663 568
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
++||||+++++|.+++...+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999998888899999999999999999999999999999999999999999999999998875432111
Q ss_pred -CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHH
Q 019904 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (334)
Q Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 243 (334)
........|+..|+|||.+.+... +.++|+|||||++|+|++|+.||...........+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 111233468889999999987665 58899999999999999999999876555544443322 23345668889999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+|.+|+. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=332.01 Aligned_cols=260 Identities=29% Similarity=0.475 Sum_probs=218.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+....+|++++.||.|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+......
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 45568999999999999999999999999999999998754322 235678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~-- 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 168 (297)
T ss_pred EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC--
Confidence 999999999999998865 45899999999999999999999999999999999999999999999999987643221
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc---CccCCCCCCCHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTARK 243 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 243 (334)
........+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+.......+.. .....|..++..+++
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 111233468889999999987665 4889999999999999999999987654433222221 122345568899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
|+.+||..||++||+++++++||||.....
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=327.96 Aligned_cols=251 Identities=30% Similarity=0.452 Sum_probs=208.4
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHH---HHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
.||+|+||.||+|.+..+++.||+|.+.+..............| ..+++...||+|+++++.+...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999876433222111222233 344555679999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
|++|.+++...+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++...... ......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999999988888999999999999999999999999999999999999999999999999987643221 123457
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 251 (334)
|+..|+|||.+.+....+.++||||+||++|+|++|+.||... ................|..+|.++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 8999999999975544458899999999999999999999875 3344444444445566777899999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccCCC
Q 019904 252 NPMTRI-----TIPEILEDEWFKKDY 272 (334)
Q Consensus 252 dp~~Rp-----t~~e~l~h~~~~~~~ 272 (334)
+|.+|| ++.++++||||....
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=326.03 Aligned_cols=251 Identities=34% Similarity=0.649 Sum_probs=220.1
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||.|+||.||++.+..+|+.|++|++...........+.+.+|+.+++.++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999989999999999766554455567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC------CCcccc
Q 019904 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------DGLLHT 172 (334)
Q Consensus 99 ~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~ 172 (334)
.+++...+.+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998878899999999999999999999999999999999999999999999999998765332211 012223
Q ss_pred cccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCC--CHHHHHHHHHhcC
Q 019904 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL--SFTARKLIARILD 250 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~ 250 (334)
..++..|+|||.+..... +.++|+||||+++|++++|..||...........+.......|... +..+.+|+.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 457889999999987664 5889999999999999999999998888888777776666666555 8999999999999
Q ss_pred CCCCCCCCH---hHHhcCccccC
Q 019904 251 PNPMTRITI---PEILEDEWFKK 270 (334)
Q Consensus 251 ~dp~~Rpt~---~e~l~h~~~~~ 270 (334)
.+|++|||+ .++|+||||..
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.74 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=203.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECC----------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 73 (334)
-++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998532 34479999987542 22335678899999999999999
Q ss_pred eeEEEEEeeCCeEEEEEeccCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEE
Q 019904 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------------RMKEDEARRYFQQLINAVDYCHSRGVYH 134 (334)
Q Consensus 74 v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H 134 (334)
+++++++...+..++||||+.+++|.+++.... .++...+..++.||+.||+|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886532 3567788999999999999999999999
Q ss_pred eecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh--CCC
Q 019904 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYL 212 (334)
Q Consensus 135 ~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~--g~~ 212 (334)
|||||+|||++.++.+||+|||++................++..|+|||++....+ +.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999864322111111122345778999999987665 589999999999999986 678
Q ss_pred CCCCCcHHHHHHHhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 213 PFDDSNLMNLYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 213 pf~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
||.+.+..+....... .....|+.++..+.+|+.+||+.||.+|||++++..
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8877665554433211 112345668899999999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=332.13 Aligned_cols=256 Identities=32% Similarity=0.420 Sum_probs=213.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--CeE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 86 (334)
.+++|++.+.||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence 467899999999999999999999989999999999754332 22334567899999999999999999998877 899
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999999985 8988887644 58999999999999999999999999999999999999999999999999877543321
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------------
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------------- 230 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--------------- 230 (334)
.......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 122334578899999999876555688999999999999999999998877665544432110
Q ss_pred ----------------cCCCCC-CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 ----------------FTCPPW-LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ----------------~~~~~~-~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..++.. ++..+.++|.+||+.||++|||+.|+|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 012222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=326.49 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=211.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC---
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK--- 83 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--- 83 (334)
.-.+.|++.+.||.|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.+ +||||+++++.+...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 346789999999999999999999999999999999865321 134677899999988 699999999998653
Q ss_pred ---CeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 84 ---TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 84 ---~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
..+|+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999998864 36899999999999999999999999999999999999999999999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--C
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--T 232 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~--~ 232 (334)
...... ........|+..|+|||++... ...+.++||||+||++|+|++|..||................. .
T Consensus 159 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 159 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred eecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 643321 1223345688999999998632 2235789999999999999999999977655544443333221 2
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 233 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 233 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=321.71 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=217.4
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999765433 2335778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhccccccCCC
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 99999999999764 3589999999999999999999999999999999999998654 5799999988754321 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 247 (334)
......|+..|+|||.+.+... +.++||||||+++|+|++|..||...+.......+... ....+..++.++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2223467889999999987665 48899999999999999999999987776666555443 335566789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 019904 248 ILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
||+.||++|||++++++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=329.76 Aligned_cols=256 Identities=32% Similarity=0.497 Sum_probs=214.3
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 579999999999999999999999999999998865432 2334577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||++++.+.........+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9999877766666666799999999999999999999999999999999999999999999999999875433221 122
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------------------
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--------------------- 229 (334)
....++..|+|||++.+....+.++|+||||+++|+|++|..||.+....+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 34567889999999987744568999999999999999999999876554433322110
Q ss_pred c-----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 230 E-----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 230 ~-----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
. ...+..++.++.+||.+||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01233458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=325.59 Aligned_cols=256 Identities=31% Similarity=0.473 Sum_probs=212.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCC-
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT- 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~- 84 (334)
+...++|++.+.||.|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++.+ .||||+++++++....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 4567899999999999999999999998899999999875432 235688999999998 6999999999986644
Q ss_pred -----eEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeec
Q 019904 85 -----KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (334)
Q Consensus 85 -----~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Df 155 (334)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCC
Confidence 48999999999999988865 347899999999999999999999999999999999999999999999999
Q ss_pred cchhccccccCCCcccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-
Q 019904 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 230 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~- 230 (334)
|++...... ........|+..|+|||.+... ...+.++|||||||++|+|++|+.||...........+....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 235 (275)
T cd06608 158 GVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP 235 (275)
T ss_pred ccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence 987643321 1222345688899999998642 223578999999999999999999998765555444443332
Q ss_pred --cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 --~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+..++..+++||.+||..||.+|||++++++|||+
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 22233478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=332.96 Aligned_cols=262 Identities=33% Similarity=0.461 Sum_probs=214.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--Ce
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TK 85 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 85 (334)
...++|++.+.||.|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.++|+||+++++++... +.
T Consensus 4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence 35789999999999999999999999999999999987543221 2223456799999999999999999998755 56
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+|+||||+.+ +|.+.+... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 83 IFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 8999999976 788877653 57899999999999999999999999999999999999999999999999988754322
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------------
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--------------- 229 (334)
. .......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 162 A--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred c--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 1 11223345788999999976555568999999999999999999999988777665544321
Q ss_pred ----ccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 230 ----EFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 230 ----~~~~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+..+ ...++++.+||.+||+.||.+|||+++++.||||.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 00111 225788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=330.60 Aligned_cols=257 Identities=25% Similarity=0.434 Sum_probs=215.7
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999886532 2233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 91 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||+++++|..++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999998888763 378999999999999999999997 5999999999999999999999999998764321
Q ss_pred CCcccccccCCcccChHhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHH---hh-cCccCCCCCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---IS-AAEFTCPPWL 237 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~---~~-~~~~~~~~~~ 237 (334)
.......+++.|+|||.+.+... .+.++|+|||||++|+|++|..||........... +. ......|+.+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 12233467889999999865432 35789999999999999999999976554443332 22 2234556678
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.++.+||.+||+.+|++||++++++.||||.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=326.96 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=208.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999987542 2233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ...
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence 99999988644 3578899999999999999999999999999999999999999999999998864322 122
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCc-cC-CCCCCCHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-------MNLYKKISAAE-FT-CPPWLSFTA 241 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-------~~~~~~~~~~~-~~-~~~~~~~~~ 241 (334)
....|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||..... ......+.... .. .....+.++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 34578999999999987665 5899999999999999999999964221 12222222111 11 123478899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+++|.+||+.||.+||++++++.||||....
T Consensus 230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 230 VHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 9999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=326.48 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=214.7
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 82 (334)
..+....++|.+.+.||.|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4566778999999999999999999999999999999999864321 134567889999988 79999999999865
Q ss_pred C-----CeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 83 K-----TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 83 ~-----~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
. ...|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 368999999999999988753 3568999999999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~ 229 (334)
|||++........ ......|+..|+|||.+.... ..+.++|||||||++|+|++|+.||...........+...
T Consensus 171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 9998775432211 122346788999999986432 1358899999999999999999999877655544444332
Q ss_pred c---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 230 E---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 230 ~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
. ...+..++..+.+||.+||+.+|++||++.++++||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 2 223455778899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=321.24 Aligned_cols=249 Identities=31% Similarity=0.556 Sum_probs=215.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2235678889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 99999999988653 45899999999999999999999999999999999999999999999999988654321 112
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHHHh
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 248 (334)
.....|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..... +.+..++..+++||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234568889999999987665 5889999999999999999999998887776666655443 45667899999999999
Q ss_pred cCCCCCCCCCHhHHhcC
Q 019904 249 LDPNPMTRITIPEILED 265 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h 265 (334)
|+.||++|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=322.05 Aligned_cols=251 Identities=27% Similarity=0.479 Sum_probs=215.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||.|+||.||+|.+..+++.|++|.+..... .+.+.+|+.+++.++||||+++++.+......|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999998899999999875432 56788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999875 45789999999999999999999999999999999999999999999999999875433211
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLI 245 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li 245 (334)
......++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+... ....+..++..+.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 2233457889999999987765 48899999999999999999999876655443333221 2233455788999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 019904 246 ARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+||+.||++|||+.++|.||||
T Consensus 234 ~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 234 KKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=343.03 Aligned_cols=247 Identities=28% Similarity=0.407 Sum_probs=199.0
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+|++++.||.|+||.||+|.+..+++.||+|+.... ....|+.+++.++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 35799999999999999999999999999999986432 234689999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||++.+ +|.+++.. ..++++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999975 78877765 45799999999999999999999999999999999999999999999999998864221 11
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCCcH----------HHHHHHhhcC---ccCCC
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNL----------MNLYKKISAA---EFTCP 234 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~p-f~~~~~----------~~~~~~~~~~---~~~~~ 234 (334)
......||+.|+|||++.+..+ +.++|||||||++|+|+++..| |..... ..+...+... ...++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2234568999999999987766 4899999999999999985444 433211 1111111100 00011
Q ss_pred ------------------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 ------------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 ------------------------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134667888999999999999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=342.94 Aligned_cols=253 Identities=22% Similarity=0.353 Sum_probs=204.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 82 (334)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ......+.+|+.+++.+ +||||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 34579999999999999999998643 335799999975432 22356788999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc---------------------------------------------------------
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNH--------------------------------------------------------- 105 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~--------------------------------------------------------- 105 (334)
....|+|||||++|+|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccc
Q 019904 106 -------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (334)
Q Consensus 106 -------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 172 (334)
.++++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++..............
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 2467888999999999999999999999999999999999999999999999864322111111112
Q ss_pred cccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHHhc
Q 019904 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L 249 (334)
..++..|+|||++.+..+ +.++|||||||++|+|++ |+.||............... ....|..++.++.+++.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 234567999999987665 589999999999999997 99999875543333332222 34456678999999999999
Q ss_pred CCCCCCCCCHhHHhc
Q 019904 250 DPNPMTRITIPEILE 264 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~ 264 (334)
+.||.+|||++++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=327.96 Aligned_cols=255 Identities=29% Similarity=0.488 Sum_probs=206.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++.+.||.|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++......|+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence 4689999999999999999999999899999999987543211 12345689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+.+ +|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.+|.++|+|||++.......
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 9999986 898888764 468999999999999999999999999999999999999999999999999876432211
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcC-----------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA----------------- 229 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~----------------- 229 (334)
.......++..|+|||.+.+....+.++||||+||++|+|++|+.||.+.. ..+....+...
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 111223467889999998765545688999999999999999999997654 22222211100
Q ss_pred ----cc---------CCCCCCC--HHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 230 ----EF---------TCPPWLS--FTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 230 ----~~---------~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.. ...+.++ .++.+++.+||+.+|.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0001234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=331.73 Aligned_cols=261 Identities=29% Similarity=0.410 Sum_probs=208.8
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 84 (334)
+...+++|++.+.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 45678899999999999999999999999999999999865332 1222344568999999999999999999886543
Q ss_pred -------eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 85 -------KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 85 -------~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
..|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence 45999999975 7877776543 68999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCC--CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---
Q 019904 157 LSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--- 231 (334)
Q Consensus 157 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~--- 231 (334)
++......... .......++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98754322111 1122345788899999987655446889999999999999999999987765543332221100
Q ss_pred ----------------CCC-------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 ----------------TCP-------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 ----------------~~~-------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..+ ...+..+.+||.+||..||.+|||++++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 001 1135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.00 Aligned_cols=252 Identities=22% Similarity=0.387 Sum_probs=203.8
Q ss_pred ccceEEeeeeeccCceEEEEEEE-----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
.++|++.+.||+|+||.||+|.+ ..++..||+|++..... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 34799999999999999999974 34567899999864332 22346788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---------------------------------------------------------
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG--------------------------------------------------------- 106 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~--------------------------------------------------------- 106 (334)
+..|+|||||++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886532
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 107 ------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 107 ------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
.+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36778899999999999999999999999999999999999999999999987443221111
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHH-HHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...... .....+... ....|...+.++++|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 1112234567999999987766 489999999999999998 99999875433 333333322 2334556788999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||+.||++|||+.++++
T Consensus 351 ~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHccCChhHCcCHHHHHH
Confidence 9999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=336.56 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=210.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4688999999999999999999999999999999986532 2223345677899999999999999999988644
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999975 888877653 8999999999999999999999999999999999999999999999999987533
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---------- 232 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---------- 232 (334)
. ........+++.|+|||.+.+..+. .++|||||||++|+|++|+.||...+....+.++......
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 1122334678899999999887764 8899999999999999999999876654433332110000
Q ss_pred --------------------------C-------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 233 --------------------------C-------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 233 --------------------------~-------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
. +...+..+++||.+||+.||.+|||+.|+|.||||...+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 11245678999999999999999999999999999865554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=326.10 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=212.0
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEe-
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG- 81 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~- 81 (334)
+.+....++|++.+.||+|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4456678899999999999999999999999999999998764221 134577899999999 6999999999873
Q ss_pred ----eCCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 82 ----SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 82 ----~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
.....|+||||+++++|.+.+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 44678999999999999987753 3468899999999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~ 229 (334)
|||++...... ........|++.|+|||++... ...+.++||||+||++|+|++|..||...............
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 167 DFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred cCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99987643321 1122344689999999998532 22357899999999999999999999876654444333222
Q ss_pred ---ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 230 ---EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 230 ---~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
....|..++..+.++|.+||+.||++|||+.|+++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 122345578899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=325.81 Aligned_cols=249 Identities=30% Similarity=0.515 Sum_probs=204.3
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeC--CeEEEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TKIFIV 89 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~~~~v 89 (334)
|++.+.||.|+||.||+|.+..+++.||+|.+....... . .....+|+..++++. ||||+++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999986532211 1 223447888888885 99999999999887 889999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+ +|.+.+... ..+++..+..++.|++.||+|||+.|++||||+|+||+++. +.++|+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999985 787777653 57899999999999999999999999999999999999999 99999999988754321 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------------c
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------E 230 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------------~ 230 (334)
......+++.|+|||.+......+.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 1223457889999998866555568999999999999999999999887665544433211 1
Q ss_pred cCC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 FTC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ~~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
... .+.++..+.++|.+||+++|++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111 12467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=322.77 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=210.3
Q ss_pred cccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
...+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+..++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3467999999999999999999764 3457899999875422 2334678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999998774 47899999999999999999999999999999999999999999999999976532211
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
. ........++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.......+... ..+.|..++..+.
T Consensus 161 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 A-IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred c-hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 0 001112234578999999987666 489999999999999775 99999988777776666544 3355677899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+++.+||+.+|.+|||++++++
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=325.34 Aligned_cols=258 Identities=29% Similarity=0.529 Sum_probs=216.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEeeCCeEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 88 (334)
.|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+. |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999986532 2223467788999999987 9999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 9999999999998866 479999999999999999999999999999999999999999999999999886543321 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCC-CCCHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPP-WLSFTARKLIA 246 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~li~ 246 (334)
......|+..|+|||.+.+....+.++|+|||||++|+|++|..||.+.........+..... .++. .++.++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 123346888999999987655456889999999999999999999988766555444333222 2222 27889999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+||+.||++||++.+++.|+||+.....
T Consensus 237 ~~l~~~p~~R~~~~~il~~~~~~~~~~~ 264 (277)
T cd06917 237 ACLDEEPKERLSAEELLKSKWIKAHSKT 264 (277)
T ss_pred HHcCCCcccCcCHHHHhhChHhhccccC
Confidence 9999999999999999999999876544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=334.59 Aligned_cols=261 Identities=28% Similarity=0.482 Sum_probs=210.0
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----C
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 84 (334)
.++|++.+.||.|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 47899999999999999999999999999999998642 2223356677899999999999999999886544 3
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..|+|+||+.+ +|.+.+.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 78777644 56999999999999999999999999999999999999999999999999998654322
Q ss_pred cC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--------------
Q 019904 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------- 229 (334)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-------------- 229 (334)
.. ........|++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 112233568899999999876554568899999999999999999999876543322221100
Q ss_pred ----------cc-------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 230 ----------EF-------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 230 ----------~~-------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.. ...+..+.++.+||.+||+.||.+|||+.++++||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00 0113467889999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=321.16 Aligned_cols=248 Identities=34% Similarity=0.590 Sum_probs=209.4
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
+.||.|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+|||++++++++...+.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765433333333444555444 455899999999999999999999999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998888899999999999999999999999999999999999999999999999998764322 223457
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----CCCCCCHHHHHHHHHhcCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSFTARKLIARILDP 251 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~ 251 (334)
+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+...... .+..++..+.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 889999999987664 58999999999999999999999988877776666544332 2335789999999999999
Q ss_pred CCCCCC---CHhHHhcCccccCC
Q 019904 252 NPMTRI---TIPEILEDEWFKKD 271 (334)
Q Consensus 252 dp~~Rp---t~~e~l~h~~~~~~ 271 (334)
||++|| +++|++.||||...
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhcC
Confidence 999999 45799999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=328.53 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=208.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++.+.||.|++|.||+|.+..+|+.||||.+..... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999865432 22233568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+. ++|..++... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 996 4888887653 468999999999999999999999999999999999999999999999999876433211 11
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------------- 230 (334)
.....+++.|+|||.+.+....+.++|||||||++|+|+||+.||.+.+......++....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 2233568899999998766555688999999999999999999998766544332221100
Q ss_pred ----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 ----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
....+.++.+++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=331.17 Aligned_cols=261 Identities=30% Similarity=0.467 Sum_probs=230.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..-..+.|+.-+.||+||||.||.++.+.+|+-||.|.+.+..........-..+|-.+|++++.+.||.+-..|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34456778889999999999999999999999999999987666555555567789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
+++||..|.||+|.-.|...+ .+++..+..++.+|+.||.+||+.+||.|||||+|||+++.|+++|+|+|+|.-.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei-- 337 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI-- 337 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec--
Confidence 999999999999988887766 7999999999999999999999999999999999999999999999999998743
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCccCCCCCCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~ 239 (334)
.........+||..|||||++.+..| +...|-|||||++|+|+.|+.||.... ..++-+.+......++..+|+
T Consensus 338 -~~g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 338 -PEGKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred -CCCCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 33445566799999999999998876 588999999999999999999997543 234555556666778899999
Q ss_pred HHHHHHHHhcCCCCCCCC-----CHhHHhcCccccC
Q 019904 240 TARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
+++++.+.+|++||.+|. +++++.+||||+.
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 999999999999999997 5779999999985
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=326.24 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=204.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++|+||+++++++..+...|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999865432 1223356789999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+. +++.+.+.. ...+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 999997 467666654 3568888999999999999999999999999999999999999999999999886432211
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCc----------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAE---------------- 230 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~---------------- 230 (334)
.......+++.|+|||.+.+....+.++|||||||++|+|++|..||.+.+.. +.+.++....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 11233457889999999876554457899999999999999999999764432 2222211000
Q ss_pred -------cCCCC---------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 -------FTCPP---------WLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 -------~~~~~---------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+. ..+..+.+++.+||..||.+|||+++++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000 125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=319.37 Aligned_cols=256 Identities=32% Similarity=0.560 Sum_probs=215.8
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
||++.+.||.|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999765433 3456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC-c-
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-L- 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~-~- 169 (334)
|+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999887543321111 1
Q ss_pred ccccccCCcccChHhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhc-CccCCCCC--CCHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA-AEFTCPPW--LSFTARK 243 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~-~~~~~~~~--~~~~~~~ 243 (334)
.....++..|+|||.+.+.. ..+.++||||||+++|++++|+.||...+ .......+.. .....|.. ++..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 12346788999999998654 23588999999999999999999997653 2233222222 22334444 4899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 244 LIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
||.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=326.49 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=207.8
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCe----
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK---- 85 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~---- 85 (334)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 579999999999999999999999999999999865432 2223456778999999996 6999999999887665
Q ss_pred -EEEEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccch
Q 019904 86 -IFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLS 158 (334)
Q Consensus 86 -~~~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a 158 (334)
.|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++|++||||+|+||+++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 788877643 35799999999999999999999999999999999999998 889999999987
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--------
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------- 230 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-------- 230 (334)
...... ........+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+......++....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 643221 1112233568889999998765555689999999999999999999998876655443332110
Q ss_pred -----------c---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 231 -----------F---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 231 -----------~---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+ ...+.++.++.+||.+||..||.+|||++|++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00134788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=323.77 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=215.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.+.||||+++++.+.....+++|+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876432 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||+.+++|.+++... .++++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999876443211
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhcC-ccCCCCC-CCHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAA-EFTCPPW-LSFTA 241 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-----~~~~~~~~~~~~-~~~~~~~-~~~~~ 241 (334)
.....++..|+|||.+.+..+ +.++|||||||++|+|++|..||... ...+....+... ....+.. ++.++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 112567889999999987765 48899999999999999999999754 233333333322 2233333 78899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+++|.+||..||.+|||+.+++.||||+..
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=325.13 Aligned_cols=258 Identities=29% Similarity=0.470 Sum_probs=218.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.+.|+..+.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.+.||||+++++++......|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568899999999999999999998999999999875432 23357788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||+++++|.+++.. +++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cc
Confidence 999999999998865 568999999999999999999999999999999999999999999999999986433211 11
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHh
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 248 (334)
.....++..|+|||.+.+... +.++|+|||||++|+|++|..||...........+... ....+..++.++.+++.+|
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred cccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence 223457889999999987665 58899999999999999999999877666555444332 2233445788999999999
Q ss_pred cCCCCCCCCCHhHHhcCccccCCCC
Q 019904 249 LDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
|+.+|++||+++++++|+||.....
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcch
Confidence 9999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=319.12 Aligned_cols=253 Identities=34% Similarity=0.576 Sum_probs=217.2
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--CCeEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIV 89 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v 89 (334)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999875433 23335678899999999999999999997753 4568999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH-----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH-----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
|||+++++|.+++.. ..++++..++.++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998876 357899999999999999999999 99999999999999999999999999998875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCH
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSF 239 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (334)
..... .......+++.|+|||.+.+... +.++|+||||+++|+|++|+.||...+.......+..... ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 43321 11234468999999999987665 4889999999999999999999998877666666655544 45667889
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+.+++.+||+.+|++|||++++++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=324.44 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=210.7
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEe---
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG--- 81 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~--- 81 (334)
+....+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++.+ .||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 4456689999999999999999999999999999999986532 1235677899999988 6999999999984
Q ss_pred ---eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 82 ---SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 82 ---~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
....+|++|||+.+|+|.+++... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 346789999999999999988764 358888899999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~- 231 (334)
++...... ........|++.|+|||.+.. ....+.++|+|||||++|+|++|..||...........+.....
T Consensus 167 ~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 244 (282)
T cd06636 167 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 244 (282)
T ss_pred chhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCC
Confidence 87643321 112234568899999999863 12234789999999999999999999977655444433332221
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 -~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..+..++.++.+||.+||+.||.+|||+.|+|+||||
T Consensus 245 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 245 KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 1223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=364.43 Aligned_cols=263 Identities=31% Similarity=0.535 Sum_probs=233.1
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+-.-+.|.+++.||+|+||.|..++++.+++.||.|++.+-...+.....-|..|-.+|..-+.+.|+.++..|.++.++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 44557899999999999999999999999999999999875555555567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||++||+|..++.+..++|++-++.|+..|+.||..||+.|+|||||||+|||++..|++||+|||.+-.... .+
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-CC
Confidence 99999999999999999988999999999999999999999999999999999999999999999999998654332 12
Q ss_pred CCcccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCC--CCCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLS 238 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~--~~~~ 238 (334)
.-.....+|||-|++||++.. .+.++..+|-||+||++|||+.|..||...+..+.+.+|..- .+.+| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 223456689999999999973 245679999999999999999999999999999999988654 66777 5699
Q ss_pred HHHHHHHHHhcCCCCCCCCC---HhHHhcCccccCC
Q 019904 239 FTARKLIARILDPNPMTRIT---IPEILEDEWFKKD 271 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~ 271 (334)
.++++||++++ -+|..|.. ++++..||||...
T Consensus 310 eeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 310 EEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence 99999999998 57888887 9999999999863
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=332.65 Aligned_cols=247 Identities=26% Similarity=0.424 Sum_probs=191.7
Q ss_pred eeeeeccCceEEEEEEECC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe--eCCeEEEEEe
Q 019904 16 GRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLE 91 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~~v~e 91 (334)
+..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++. .+..+|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 4689999999999999653 568899998865332 235678999999999999999999884 3567899999
Q ss_pred ccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE----ecCCCeEEeeccch
Q 019904 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (334)
Q Consensus 92 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~----~~~~~~kl~Dfg~a 158 (334)
|+.+ +|.+.+... ..+++..++.++.||+.||+|||+.||+||||||+||++ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9876 777776532 248889999999999999999999999999999999999 45678999999998
Q ss_pred hccccccC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH---------HHHHHhhc
Q 019904 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKKISA 228 (334)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~---------~~~~~~~~ 228 (334)
+....... ........||+.|+|||++.+....+.++|||||||++|+|++|..||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 75432211 112234568999999999987665568999999999999999999999653211 00000000
Q ss_pred ----------------------------Ccc----------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 229 ----------------------------AEF----------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 229 ----------------------------~~~----------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
... ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=320.69 Aligned_cols=252 Identities=30% Similarity=0.526 Sum_probs=211.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 47899999999999999999999999999999988754444445566788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+++++|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999888753 3458899999999999999999999999999999999999999999999999876533211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCccC-C-CCCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFT-C-PPWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~--~~~~~~~~~~~~~~-~-~~~~~~~~ 241 (334)
.......|++.|+|||.+.+... +.++|+||+|+++|+|++|..||.... .......+.....+ . +..++..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11223467889999999987666 488999999999999999999996543 33444444443322 1 23577899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++|.+||+.+|++||++.++++
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHH
Confidence 99999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.04 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=213.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----CCeE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKI 86 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 86 (334)
++|++.+.||.|++|.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 789999999999999999999999999999999875322 22335667789999999999999999988753 3578
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+. ++|.+.+...+.+++..+..++.||+.||+|||++|++||||||+||+++.+|.++|+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 58999988777899999999999999999999999999999999999999999999999999865432211
Q ss_pred --CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------------
Q 019904 167 --DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (334)
Q Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--------------- 229 (334)
........|+..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 112234478899999999876554568999999999999999999999876544332221110
Q ss_pred -----------ccC-----CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 230 -----------EFT-----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 230 -----------~~~-----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
... ..+..+.++.++|.+||+.+|.+|||+++++.||||.....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 000 113468899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=339.26 Aligned_cols=248 Identities=32% Similarity=0.619 Sum_probs=213.7
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
.+.||+|.||+||-|+++.+|+.||||++.+..+...+ ...+++|+.||+.+.||+||.+--.|++.+.+|+|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 36799999999999999999999999999987665444 37799999999999999999999999999999999999987
Q ss_pred CchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEeeccchhccccccCCCccc
Q 019904 96 GELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 96 ~~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
..|.-.|. +.+++++...+.++.||+.||+|||-+||+|.||||+|||+.... .+||||||+|++.++ .....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFRr 724 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFRR 724 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhhh
Confidence 54443333 346899999999999999999999999999999999999997654 599999999998664 34556
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHHHHHHHHH
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIAR 247 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~ 247 (334)
+.+|||.|.|||++...+|+ ...||||+|+|+|.-+.|..||+... ++-.+|....+.+|+ .++.++.+||+.
T Consensus 725 sVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~ 801 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINN 801 (888)
T ss_pred hhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHH
Confidence 78999999999999999986 77899999999999999999997543 333344444444332 489999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+|+..-.+|.|++..|.|||++.
T Consensus 802 LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 802 LLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHhcchHhhccchhhhc
Confidence 99999999999999999999985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=323.15 Aligned_cols=250 Identities=24% Similarity=0.442 Sum_probs=207.1
Q ss_pred ccccccceEEeeee--eccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee
Q 019904 6 IKRRVGKYEVGRTI--GEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (334)
Q Consensus 6 ~~~~~~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 82 (334)
+....++|++.+.+ |.|+||.||++.+..++..+|+|.+....... .|......+ +||||+++++.+..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 44556788888887 99999999999999999999999987543221 122222222 69999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~ 161 (334)
.+.+|+||||+++++|.+++....++++..+..++.|++.||.|||+.|++||||+|+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 999999999999999999998888899999999999999999999999999999999999999988 9999999987643
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCccCCCCCC
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPWL 237 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~ 237 (334)
.. .....++..|+|||++.+..+ +.++|+||+|+++|+|++|..||....... ............++.+
T Consensus 161 ~~------~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T PHA03390 161 GT------PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233 (267)
T ss_pred CC------CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccccc
Confidence 21 123457889999999987776 488999999999999999999997543322 1222223344556679
Q ss_pred CHHHHHHHHHhcCCCCCCCCC-HhHHhcCccccC
Q 019904 238 SFTARKLIARILDPNPMTRIT-IPEILEDEWFKK 270 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt-~~e~l~h~~~~~ 270 (334)
|+.+.+||.+||+.||.+||+ ++++|+||||.+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999999996 699999999963
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=324.92 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=216.8
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..+.|++.+.||+|+||+||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 3568999999999999999999999999999999986532 23345778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+++++|.+++...+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---- 156 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----
Confidence 99999999999999888889999999999999999999997 6999999999999999999999999998764321
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-----------HHHHHhhcCc-cCCCC
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-----------NLYKKISAAE-FTCPP 235 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-----------~~~~~~~~~~-~~~~~ 235 (334)
.......|+..|+|||++.+... +.++|+|||||++|++++|..||...... .....+.... ..++.
T Consensus 157 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd06620 157 SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235 (284)
T ss_pred hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc
Confidence 11223568999999999877655 48899999999999999999999864431 2223332221 22222
Q ss_pred C-CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 236 W-LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 236 ~-~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
. ++.++.+|+.+||+.||++|||++|+++|+||.....
T Consensus 236 ~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 2 7789999999999999999999999999999976544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=315.64 Aligned_cols=255 Identities=30% Similarity=0.551 Sum_probs=219.2
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--CeEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIV 89 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v 89 (334)
+|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+... ..+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998765432 34467888999999999999999999999888 899999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
+||+++++|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998887899999999999999999999999999999999999999999999999998775543322112
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhh--cCccCCCCCCCHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKIS--AAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~li~ 246 (334)
.....++..|+|||.+..... +.++||||||+++|+|++|..||.... .......+. ......|..++..+++||.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 334568889999999987664 588999999999999999999998765 333333333 2334556678999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 019904 247 RILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+||+.||++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=328.42 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=217.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45666788999999999999999899999999986432 233566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cccC
Confidence 99999999987754 46899999999999999999999999999999999999999999999999987643221 1122
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 247 (334)
....|+..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+.... ......++..+.+++.+
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 34568899999999977665 488999999999999999999998877666555443321 22233578899999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
||..||.+|||++++++||||.....+.
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccCCcc
Confidence 9999999999999999999998665543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=324.73 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=212.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998743 357899999865432 22356888999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG--------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
...++||||+++++|.+++...+ .+++..+..++.|++.|+++||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 3788899999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~ 228 (334)
++|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999998864322111111223345678999999987766 488999999999999998 9999988777777776665
Q ss_pred Ccc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 229 AEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 229 ~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
... ..+..++..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 544 345568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.50 Aligned_cols=258 Identities=31% Similarity=0.471 Sum_probs=210.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++......|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865432 222345678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhccccccC
Q 019904 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|||+++ +|.+.+.... .+++..+..++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999975 7877776544 3578888999999999999999999999999999999985 456999999988643221
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------------
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---------------- 230 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---------------- 230 (334)
........+++.|+|||.+.+....+.++|||||||++|+|++|..||...+..+...++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1112334578899999998775555688999999999999999999998776655444332100
Q ss_pred -------c------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 -------F------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 -------~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
. ...+.+++.+.++|.+||+.+|.+||+++++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123478899999999999999999999999999999754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=340.20 Aligned_cols=239 Identities=23% Similarity=0.396 Sum_probs=212.4
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
..-++-||.|+.|-||+|+. .++.||||+++. .-..+++.|++|+||||+.+.++|...-.|||||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl--~netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL--HNETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeec--cCceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 34466789999999999986 478999998742 223578889999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 172 (334)
|..|-|...|+...+++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.+.-... .....+
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~---~STkMS 270 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD---KSTKMS 270 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh---hhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999998774332 234557
Q ss_pred cccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHHhcC
Q 019904 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~ 250 (334)
++||+.|||||++...+.. .++|||||||+||||+||..||.+-+...++..+... ..+.|..++..++-||++||+
T Consensus 271 FaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~ 349 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN 349 (904)
T ss_pred hhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence 8999999999999998886 9999999999999999999999988877777665544 356788899999999999999
Q ss_pred CCCCCCCCHhHHhcCcc
Q 019904 251 PNPMTRITIPEILEDEW 267 (334)
Q Consensus 251 ~dp~~Rpt~~e~l~h~~ 267 (334)
-.|..||++.++|.|-=
T Consensus 350 sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 350 SKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCCCCCccHHHHHHHHh
Confidence 99999999999999843
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=329.58 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=205.3
Q ss_pred ceEEeeeeeccCceEEEEEEECC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--CeEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIF 87 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~ 87 (334)
+|++.+.||+|++|.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 68999999999999999999988 7899999999764322233346677899999999999999999999888 8899
Q ss_pred EEEeccCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec----CCCeEEeeccch
Q 019904 88 IVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA----YGNLKVSDFGLS 158 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~----~~~~kl~Dfg~a 158 (334)
+||||+.+ ++.+.+... ..+++..++.++.|++.||+|||+.|++||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999986 676666432 26899999999999999999999999999999999999999 899999999998
Q ss_pred hccccccC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH---------HHHHh--
Q 019904 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------LYKKI-- 226 (334)
Q Consensus 159 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~---------~~~~~-- 226 (334)
........ ........++..|+|||.+.+....+.++|||||||++|+|++|+.||.+..... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 75433221 1112334678899999998876555688999999999999999999997543221 00000
Q ss_pred ------------------------hcCccCCC-----------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 227 ------------------------SAAEFTCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 227 ------------------------~~~~~~~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.......+ ...+..+.+++.+||+.||.+|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 1466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=326.82 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=214.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++......|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45699999999999999999999989999999998754444444456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+ ++.+.+.. ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 999985 67666654 45789999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCC-CCCCCHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTC-PPWLSFTARKL 244 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~l 244 (334)
.....+++.|+|||++.+ ....+.++||||||+++|+|++|..||.+.+.......+.... ... +..++..+.++
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred -CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 123467889999998752 2334588999999999999999999998877665544443322 222 23478899999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|.+||+.||++||++.+++.||||....
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=321.35 Aligned_cols=255 Identities=30% Similarity=0.501 Sum_probs=216.6
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|...+.||.|++|.||++.+..+++.+++|++.... ....+.+.+|+.+++.+.||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4566689999999999999998899999999886432 2224567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
|+++++|.+.+.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+...... .....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Ccccc
Confidence 9999999998877 67999999999999999999999999999999999999999999999999987643221 11223
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC---CCCCCCHHHHHHHHHh
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSFTARKLIARI 248 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~ 248 (334)
...|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+...... .+..++..+.+|+.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 3468899999999987665 48899999999999999999999887776666655544322 2333788999999999
Q ss_pred cCCCCCCCCCHhHHhcCccccCCCC
Q 019904 249 LDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
|+.+|++|||+.++++||||.+...
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred cccChhhCcCHHHHccCcccccCCC
Confidence 9999999999999999999987544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.75 Aligned_cols=255 Identities=30% Similarity=0.513 Sum_probs=219.7
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++.+.||.|++|.||+|.+..+++.|++|++...... .....+.+|+..++.++||||+++++++......|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765322 34577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++++|.+++....++++..+..++.|++.|++|||+ .|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 999999999999888889999999999999999999999 999999999999999999999999999877543221 11
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcC-ccCCCCC-CCHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAA-EFTCPPW-LSFTARKL 244 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---~~~~~~~~~~~~-~~~~~~~-~~~~~~~l 244 (334)
.....++..|+|||.+....+ +.++|+||||+++|+|++|..||... ...+....+... ....+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 124467889999999887654 58899999999999999999999776 444555544432 2334445 78999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
|.+||+.+|++|||+.++++|||++.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=318.46 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=210.5
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....+.......||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 3445555566789999999999999998999999998865432 2346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQ 162 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l--~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~~ 162 (334)
++|+||+++++|.+.+... ..+ ++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999998764 445 78889999999999999999999999999999999976 6789999999876433
Q ss_pred cccCCCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCcHHH--HHHH-hhcCccCCCCCCC
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--LYKK-ISAAEFTCPPWLS 238 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~~~~ 238 (334)
.. ........|++.|+|||.+.... ..+.++|+||+|+++|+|++|..||....... .... ........|..++
T Consensus 161 ~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 161 GI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 21 11223345788999999986543 24588999999999999999999997543221 1111 1223345567789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+++++|+.+||+.+|.+|||+.+++.||||
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=316.87 Aligned_cols=247 Identities=40% Similarity=0.721 Sum_probs=221.0
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||.|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+..+...|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999876655555567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCc
Q 019904 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (334)
Q Consensus 99 ~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 178 (334)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999888889999999999999999999999999999999999999999999999999876543221 12234567889
Q ss_pred ccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCC
Q 019904 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRIT 258 (334)
Q Consensus 179 y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt 258 (334)
|+|||.+.+... +.++|+||||+++|++++|..||...+.......+.......|..++..+.++|.+||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999987665 4889999999999999999999988887777777777777888889999999999999999999999
Q ss_pred H---hHHhcCccc
Q 019904 259 I---PEILEDEWF 268 (334)
Q Consensus 259 ~---~e~l~h~~~ 268 (334)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.51 Aligned_cols=252 Identities=32% Similarity=0.512 Sum_probs=209.4
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|++|.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 1223556789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 92 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|+.+ +|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 888887654 35899999999999999999999999999999999999999999999999988643221 11
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------------ 230 (334)
......++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+..+....+....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12334578899999998776555688999999999999999999998876555444322110
Q ss_pred cC-----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 FT-----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ~~-----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.. ..+.++..++++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=322.67 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=209.7
Q ss_pred cceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..|.+.+.||.|+||.||++.+. .++..+|+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57999999999999999999852 345668999886432 2335678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEE
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl 152 (334)
.++||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 999999999999999997543 3899999999999999999999999999999999999999999999
Q ss_pred eeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCcc
Q 019904 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF 231 (334)
Q Consensus 153 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~~ 231 (334)
+|||++................++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+.....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999874332111111122345678999999987655 488999999999999998 9999988877777777665543
Q ss_pred -CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 232 -TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 232 -~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 445568899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=314.88 Aligned_cols=253 Identities=35% Similarity=0.616 Sum_probs=220.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||+|++|.||++.+..+++.||+|++...... ......+.+|+.+++.++|||++++.+.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999989999999999764332 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 92 FVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 92 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
++++++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999998774 679999999999999999999999999999999999999999999999999887543321
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 246 (334)
.......|++.|+|||.+.+... +.++|+||+|+++++|++|..||...+............ ...|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 12234568889999999887665 488999999999999999999998887776666655443 3455678999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 019904 247 RILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+||..+|++|||+.++|+||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.81 Aligned_cols=253 Identities=32% Similarity=0.573 Sum_probs=215.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||+|+||.||++.+..+|..||+|.+....... ...+.+.+|+.+++.++|+||+++++.+......|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6899999999999999999999999999999997653322 234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC-eEEeeccchhccccccCCC
Q 019904 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~-~kl~Dfg~a~~~~~~~~~~ 168 (334)
|+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++. ++|+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 999999999987654 4789999999999999999999999999999999999988865 699999988754321 11
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 247 (334)
......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... ...++.++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2223458889999999887665 488999999999999999999998777666555544333 23456688999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccc
Q 019904 248 ILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
||..+|++|||++++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=331.36 Aligned_cols=259 Identities=30% Similarity=0.439 Sum_probs=211.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----C
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 84 (334)
..+|.+.+.||.|+||+||+|.+..+++.||||.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4689999999999999999999999999999999875322 222245667899999999999999999987644 3
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..|+|+||+. ++|.+.+...+++++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999997 589999988888999999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---------------
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--------------- 229 (334)
. .......++..|+|||.+......+.++|+|||||++|+|++|+.||.+.+.......+...
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 1 22234467889999999876444568999999999999999999999876543322211100
Q ss_pred -------------c---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 -------------E---FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 -------------~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
. ....+.++.++.+||.+||+.||.+|||++++++||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 011235788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=313.52 Aligned_cols=253 Identities=30% Similarity=0.530 Sum_probs=220.5
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|++|.||++.+..+++.|++|.+...... ......+.+|+.+++.++|||++++++++......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999989999999999765432 2345788999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
|+++++|.+.+.....+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999875443221 123
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhh-cCccCCCCCCCHHHHHHHHHhcC
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-AAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
...++..|+|||.+.+... +.++|+||||+++|+|++|..||...+......... ......++.++..+++++.+||+
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 3467889999999987664 588999999999999999999998766544444333 34445677789999999999999
Q ss_pred CCCCCCCCHhHHhcCccc
Q 019904 251 PNPMTRITIPEILEDEWF 268 (334)
Q Consensus 251 ~dp~~Rpt~~e~l~h~~~ 268 (334)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.78 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=203.0
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999899999999876432 2334567889999999999999999999999999999999999999
Q ss_pred chHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 97 ELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 97 ~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
+|.+++...+ .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.................
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999987644 589999999999999999999999999999999999999999999999998764321110000011122
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc-CccCCCCCCCHHHHHHHHHhcCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTARKLIARILDPNP 253 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp 253 (334)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+.. .....+..++..+.+|+.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999987665 588999999999999997 9999987666555554433 2345566789999999999999999
Q ss_pred CCCCCHhHHhc
Q 019904 254 MTRITIPEILE 264 (334)
Q Consensus 254 ~~Rpt~~e~l~ 264 (334)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999974
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=320.92 Aligned_cols=254 Identities=19% Similarity=0.276 Sum_probs=207.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34689999999999999999998642 356799998864322 12245678999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
...++||||+++++|.+++...+ .++...+..++.|++.||+|||+.|++|+||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999987532 25677889999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-c
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-F 231 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~ 231 (334)
|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9998764322111111112345678999999987665 588999999999999998 799998887776665544433 3
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
..+...+..+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5566788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=321.05 Aligned_cols=254 Identities=19% Similarity=0.333 Sum_probs=210.6
Q ss_pred cccceEEeeeeeccCceEEEEEEEC----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.+..|++.+.||+|+||.||+|... ..+..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 356789999986432 2233467889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985332 37788899999999999999999999999999999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~ 226 (334)
+.++|+|||++................++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.....+...+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999865432211111223345677999999987665 589999999999999998 99999887766666655
Q ss_pred hcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 227 ~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.... .+.+..++..+.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4433 45566789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.40 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=208.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCe--EEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
...++.|++.+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|+.++..+ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 34678999999999999999999998877764 46666543 22233456788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
+.+|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 47888999999999999999999999999999999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~ 226 (334)
+.++|+|||++........ .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred CcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 9999999998753221110 111223567999999977665 588999999999999998 99999887777766665
Q ss_pred hcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 227 ~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.... ...+..++.++.+|+.+||+.+|++||++++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4432 23455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=321.29 Aligned_cols=259 Identities=21% Similarity=0.296 Sum_probs=211.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999987542 3457999988644322 2234577899999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
...|+||||+++|+|.+++...+ .++...+..++.|++.||+|||++|++||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 24567788999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cc
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~ 231 (334)
|||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+..+....+... ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9998874332111111112234677999999987665 488999999999999998 89999988777766655443 33
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc------CccccC
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE------DEWFKK 270 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~------h~~~~~ 270 (334)
..+...+..+.+++.+||+.||++|||+.++++ ||||..
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 456667899999999999999999999999986 888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=320.21 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=217.7
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+-|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+......|+||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 457889999999999999999988999999999865432 223467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhh
Confidence 99999999988865 468999999999999999999999999999999999999999999999999876432211 112
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhc
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L 249 (334)
....++..|+|||.+.+... +.++|+|||||++|+|++|..||...........+... ....+..++.++.+++.+||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence 23467889999999976655 47899999999999999999999877666555554433 23345568899999999999
Q ss_pred CCCCCCCCCHhHHhcCccccCCCC
Q 019904 250 DPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.+|.+||++.++++||||.....
T Consensus 238 ~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 238 NKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred cCChhhCcCHHHHHhCHHHhhhhh
Confidence 999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=316.74 Aligned_cols=249 Identities=25% Similarity=0.378 Sum_probs=211.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
...|.+.+.||.|++|.||+|.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++..+..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 4569999999999999999999998999999999865322 245678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999998764 35889999999999999999999999999999999999999999999999998654321111
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|..++.++.++|
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 1111223567999999987666 488999999999999998 99999988877776666543 3456677899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||+.||++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=350.31 Aligned_cols=247 Identities=31% Similarity=0.507 Sum_probs=206.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEE-EEee------
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYE-VMGS------ 82 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-~~~~------ 82 (334)
.+++|.+.|.+|||+.||+|++...|.+||+|.+-. .++...+.+++|+.+|++|+ |+|||.+++ ....
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 468899999999999999999998889999998854 36677899999999999998 999999999 3321
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCCeEEeeccch
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
.-.+++.||||.||.|.+++... ..|++.++++|+.|+++|+++||... |||||||-+|||++.+|..||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 13578999999999999999753 46999999999999999999999998 999999999999999999999999988
Q ss_pred hccccccCCCc-------ccccccCCcccChHhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Q 019904 159 ALSQQVRDDGL-------LHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 228 (334)
Q Consensus 159 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~ 228 (334)
.-......... .-...-|+.|+|||++. +.+. +.|+|||+|||+||-++...+||+......+ ..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~laI----ln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKLAI----LN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcceeE----Ee
Confidence 64322211110 01123589999999975 4445 5999999999999999999999998754443 44
Q ss_pred CccCCCC--CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 229 AEFTCPP--WLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 229 ~~~~~~~--~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+.+.+|+ .++..+++||..||+.||++||++-+++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 5565554 699999999999999999999999998864
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=344.85 Aligned_cols=252 Identities=28% Similarity=0.494 Sum_probs=215.5
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
-.||+|.||+||.|+|..+....|||.+.... ....+-+..|+.+.+.|+|.|||++++.+..++.+-+.||..+||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 36899999999999999999999999986543 233566889999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhccccccCCCcccc
Q 019904 97 ELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHT 172 (334)
Q Consensus 97 ~L~~~l~~~-~~l--~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 172 (334)
||.++++.. +++ +|..+..+.+||++||.|||++.|||||||-+|||++. .|.+||+|||.+...... +....+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC--Cccccc
Confidence 999999876 466 88999999999999999999999999999999999965 588999999988754432 334567
Q ss_pred cccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCC--cHHHHHH-HhhcCccCCCCCCCHHHHHHHHHh
Q 019904 173 TCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYK-KISAAEFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~ 248 (334)
..||+.|||||++... .-++.++|||||||++.||.||++||-.- ....+++ .+....+++|..+|.+++.||.+|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 7899999999999743 34478999999999999999999999643 2222222 234456678888999999999999
Q ss_pred cCCCCCCCCCHhHHhcCccccCCCC
Q 019904 249 LDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.+||.+||++.++|.+||++...+
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred cCCCcccCccHHHhccCcccccCCC
Confidence 9999999999999999999987643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=319.82 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=205.2
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+.|++.+.||+|+||.||+|.+..+|+.||+|.+........ ...+..|+. .++.+.||||+++++++...+..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 469999999999999999999999999999999876432222 223444555 46777899999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
|||+++ +|.+.+.. ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999975 77776654 24689999999999999999999997 9999999999999999999999999998753221
Q ss_pred cCCCcccccccCCcccChHhhhcC---CCCCCccchhhHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCccCCC-CCCC
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKKISAAEFTCP-PWLS 238 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~e~~~g~~pf~~~--~~~~~~~~~~~~~~~~~-~~~~ 238 (334)
.......|+..|+|||.+.+. ...+.++|+|||||++|+|++|+.||... ....+...+.......| ..+|
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 112234678899999998642 22357899999999999999999999742 22233332222223333 3578
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.++.+||.+||..+|++|||++++++||||.....
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 99999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=324.97 Aligned_cols=260 Identities=29% Similarity=0.489 Sum_probs=217.9
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
++...++|.+.+.||.|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.+.....
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 4566789999999999999999999998889999999986432 2224667899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.|+|+||+++++|.+++.+. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999999999988654 58899999999999999999999999999999999999999999999999876433211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 242 (334)
.......|++.|+|||.+....+ +.++|+|||||++|++++|+.||...+.......+... ....+..++..++
T Consensus 170 --~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 246 (293)
T cd06647 170 --SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246 (293)
T ss_pred --cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence 12233468889999999987665 58899999999999999999999876654443322211 2223445788999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
++|.+||..+|.+||++++++.|+||....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=319.76 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=209.8
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|.+.+.||+|++|.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34789999999999999999999876 67889999886432 222245688899999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~ 153 (334)
...++||||+.+++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997654 488899999999999999999999999999999999998765 58999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cc
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~ 231 (334)
|||++.................+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999875421111111111223467999999987666 589999999999999997 99999988777666555433 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
..|..++..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=330.12 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=213.6
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 84 (334)
+....++|++++.||.|+||.||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3446788999999999999999999999999999999986432 22333456889999999999999999999987654
Q ss_pred -----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 85 -----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 85 -----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.+++||||+ +++|.+.+.. ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 468999998 6688877654 579999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------- 231 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-------- 231 (334)
.... ......+++.|+|||.+.+....+.++|+|||||++|++++|..||.+.+.......+.....
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 4321 122346788999999997644456889999999999999999999987765544433221110
Q ss_pred -----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 -----------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 -----------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
...+.++..+.++|.+||+.||.+|||+.+++.||||+....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 112357888999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=324.46 Aligned_cols=258 Identities=23% Similarity=0.405 Sum_probs=212.2
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeee
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 75 (334)
|+.....++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... .......+.+|+.+++.+ +||||++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3444556899999999999999999998643 23569999987542 222346688899999999 7999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCC
Q 019904 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (334)
Q Consensus 76 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp 139 (334)
+++++...+..|+||||+++++|.+++...+ .++...+..++.|++.||+|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999999999999997642 378889999999999999999999999999999
Q ss_pred CCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCc
Q 019904 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (334)
Q Consensus 140 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~ 218 (334)
+||+++.++.++|+|||++................+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999998764432111111111234568999999987665 588999999999999998 999999888
Q ss_pred HHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+....+.... ...|..++.++.+|+.+||..+|.+|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 777666665543 3556678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=335.94 Aligned_cols=257 Identities=21% Similarity=0.352 Sum_probs=207.0
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEE
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYE 78 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~ 78 (334)
.....-++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+++.+. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4445567889999999999999999986432 3469999986532 2233467889999999996 999999999
Q ss_pred EEeeCCeEEEEEeccCCCchHHHHHhc-----------------------------------------------------
Q 019904 79 VMGSKTKIFIVLEFVTGGELFDKIVNH----------------------------------------------------- 105 (334)
Q Consensus 79 ~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------------------------------------------- 105 (334)
++......|+|||||++|+|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999888642
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCE
Q 019904 106 -------------------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (334)
Q Consensus 106 -------------------------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NI 142 (334)
..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367778889999999999999999999999999999
Q ss_pred EEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH
Q 019904 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (334)
Q Consensus 143 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~ 221 (334)
+++.++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999999875432211111223346778999999987666 589999999999999997 999998754333
Q ss_pred -HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 222 -LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 222 -~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+... ....+..++..+.+++.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 33333322 23455678999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=323.27 Aligned_cols=252 Identities=32% Similarity=0.475 Sum_probs=209.1
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.+++.++|||++++++++...+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999999999999998754322 22235677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 93 VTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 93 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
+. ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 96 58999887765 6899999999999999999999999999999999999999999999999998643221 1112
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--------------------
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------- 230 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-------------------- 230 (334)
....++..|+|||++.+....+.++|+||||+++|+|++|+.||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 233568899999988765544588999999999999999999998776544333321100
Q ss_pred ---------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 ---------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ---------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
....+.++..+.++|.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01124577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=315.29 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=213.1
Q ss_pred eeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 17 RTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
+.||+|+||.||+|.+... +..||+|.+....... ..+.+.+|+.+++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8899999997643322 4678889999999999999999999999999999999999
Q ss_pred CCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 94 TGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 94 ~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999885 67999999999999999999999999999999999999999999999999998755432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
..........++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ....|..+|.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122334457889999999987655 588999999999999999 69999998887777777643 3456777899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcC
Q 019904 243 KLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+++.+||+.+|.+|||+++++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=354.33 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=207.4
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+++.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765434444567788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 90 LEFVTGGELFDKIVNH-----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
|||++|++|.+++... .+++...+..++.||+.||+|||++||+||||||+||+++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999988642 23455678889999999999999999999999999999999999999999998
Q ss_pred hccccccC----------------CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH
Q 019904 159 ALSQQVRD----------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222 (334)
Q Consensus 159 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~ 222 (334)
........ .......+||+.|+|||.+.+..+ +.++|||||||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 75411100 001122468999999999987766 5899999999999999999999987655443
Q ss_pred HHHhhcCc---cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 223 YKKISAAE---FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 223 ~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
........ ......+++.+.+++.+||+.||++||+..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 32211111 1112357889999999999999999987665553
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=292.25 Aligned_cols=257 Identities=33% Similarity=0.505 Sum_probs=218.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|...++||.|.||+||+|+...+++.||+|.++.+.. .+..-....+|+-+|+.++|.|||+++++..++..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 467778999999999999999999999999999987543 2222345668999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||.. +|..+... ++.+..+.++.++.|++.||.+.|++++.|||+||.|.|++.+|.+||+|||+++..+.+. .-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 99986 77777654 5678999999999999999999999999999999999999999999999999998654321 22
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCcc-----------CCC---
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----------TCP--- 234 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~~-----------~~~--- 234 (334)
....+-|.+|+||.++.+...+++..|+||-|||+.|+.. |++.|++.+..+++.+|..... ..|
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 3445679999999999998888889999999999999986 8999999998888877743211 011
Q ss_pred ---------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 235 ---------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 235 ---------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+.++...+++++++|.-+|.+|++++++|+||||...
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1244567899999999999999999999999999754
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=314.19 Aligned_cols=256 Identities=28% Similarity=0.501 Sum_probs=215.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--CeE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK--VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~ 86 (334)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875421 12234457888999999999999999999998664 568
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999998877899999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHH
Q 019904 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (334)
Q Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 243 (334)
........++..|+|||.+.+... +.++|+|||||++|++++|+.||...........+... ....|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 111223468889999999987665 48899999999999999999999877655555444332 23457789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 244 LIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+|.+||+ +|.+|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=325.55 Aligned_cols=255 Identities=28% Similarity=0.470 Sum_probs=214.7
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|+..+.||.|+||.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999988899999999874432 223567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|.+.+.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999988864 56899999999999999999999999999999999999999999999999987643321 1112
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhc
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L 249 (334)
....|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...........+.... ...+..++.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 23457889999999987665 488999999999999999999998665554444333222 2334457889999999999
Q ss_pred CCCCCCCCCHhHHhcCccccCC
Q 019904 250 DPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+.+|++|||+.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=316.00 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=211.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998654 4579999886532 233356788899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
++||||+++++|.+++... +.++...+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999998764 468999999999999999999999999999999999999999999999999987653211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
.........++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111112234568999999987665 488999999999999998 99999887777766666544 33455668999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 019904 244 LIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h 265 (334)
++.+||+.+|++||++++++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=318.10 Aligned_cols=252 Identities=31% Similarity=0.543 Sum_probs=211.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++.+.||+|++|.||+|.+..+++.||+|.+.............+.+|+.+++.+.||||+++++++...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 46899999999999999999999989999999988765444444557888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998864 346899999999999999999999999999999999999999999999999987654321
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH--HHHHHHhhcCccC--CCCCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKISAAEFT--CPPWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~--~~~~~~~~~~~~~--~~~~~~~~~ 241 (334)
........|+..|+|||.+.+... +.++|+||||+++|+|++|..||.+... ......+.....+ .+..++..+
T Consensus 160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 112234468889999999987665 4889999999999999999999976432 3333343333222 223578899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++++.+||+.||.+|||+.++++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 99999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=329.47 Aligned_cols=265 Identities=29% Similarity=0.390 Sum_probs=215.2
Q ss_pred cccceEE-eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHH-----------HHHHHHHHHHHHHhCCCCCeeeE
Q 019904 9 RVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------MAEQIKREVATMKLVKHPNVVRL 76 (334)
Q Consensus 9 ~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~iv~~ 76 (334)
..+||.. .+.||.|+||.||+|.+..+++.||+|++......... ....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4577875 57799999999999999999999999998654322100 11246789999999999999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 77 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
++++...+..|+||||+.+ +|.+++.....+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999999975 899999887889999999999999999999999999999999999999999999999999
Q ss_pred chhcccccc------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH
Q 019904 157 LSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224 (334)
Q Consensus 157 ~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~ 224 (334)
.+....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 886543100 01112233567889999999876555689999999999999999999999877665544
Q ss_pred HhhcCcc----------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 225 KISAAEF----------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 225 ~~~~~~~----------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.+..... ...+..+..+.++|.+||+.+|.+|||++++|.||||+....+
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 3321000 0012357889999999999999999999999999999876443
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=321.27 Aligned_cols=260 Identities=24% Similarity=0.420 Sum_probs=214.7
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeE
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRL 76 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 76 (334)
.+.+...-++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+.+++.+ +||||+++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 345666778999999999999999999987643 36799999875322 22345688999999999 79999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCC
Q 019904 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (334)
Q Consensus 77 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~ 140 (334)
++++...+..+++|||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 99999999999999999999999998642 35888999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcH
Q 019904 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (334)
Q Consensus 141 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~ 219 (334)
||+++.++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+...
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 99999999999999999875432211111112234567999999877666 488999999999999997 9999998877
Q ss_pred HHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 220 MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+....+.... ...+...+.++.+|+.+||..||++|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 77666655443 34566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=325.68 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=208.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCe----EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
...+|++.+.||+|+||.||+|.+..++.. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 346799999999999999999997665554 8999986432 233356788999999999999999999998764
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..++|+||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 5679999999999999998754 688999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....++...+... ..+.++.++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 240 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 211111122234567999999987666 489999999999999997 99999887766655444332 334566788999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 242 RKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+++.+||..||.+|||+.+++.+
T Consensus 241 ~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 241 YMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=317.23 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=211.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||.|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 456899999999999999999987643 3789999986432 222245678899999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
...|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999986532 36778899999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cc
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~ 231 (334)
|||+++...............++..|+|||.+.+... +.++|||||||++|++++ |..||.+.+.......+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 9999875432221112223346778999999976665 588999999999999998 99999888777766666543 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..|..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=328.89 Aligned_cols=257 Identities=28% Similarity=0.435 Sum_probs=207.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 83 (334)
.++|++.+.||.|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4799999999999999999999999999999999865432 2346678899999999999999999876543
Q ss_pred --------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEee
Q 019904 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSD 154 (334)
Q Consensus 84 --------~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~D 154 (334)
...|+||||+.+ +|.+.+.. ..+++..++.++.||+.||.|||+.|++||||||+||+++. ++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 358999999975 88877754 46999999999999999999999999999999999999974 45789999
Q ss_pred ccchhccccccC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---
Q 019904 155 FGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--- 230 (334)
Q Consensus 155 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--- 230 (334)
||.+........ ........++..|+|||.+......+.++|||||||++|+|++|..||.+.........+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 998865432211 1112234578899999988765555688999999999999999999998765544433321110
Q ss_pred ----------------------c-----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 ----------------------F-----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 ----------------------~-----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
. ...+.++.++++||.+||+.||.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123478899999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=330.98 Aligned_cols=261 Identities=29% Similarity=0.441 Sum_probs=218.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----eE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 86 (334)
+|++.+.||.|++|.||+|.+..+++.||||.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999889999999987532 22334567889999999999999999999987775 78
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.+ +|.+.+....++++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999985 8999988877899999999999999999999999999999999999999999999999999875433211
Q ss_pred -CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-------------
Q 019904 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------- 232 (334)
Q Consensus 167 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~------------- 232 (334)
........+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..+....+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 012234467889999999987744568999999999999999999999888766655544321110
Q ss_pred ------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 233 ------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 233 ------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
..+.++..+.+||.+||+.+|.+|||+++++.||||.....+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 113367889999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.97 Aligned_cols=255 Identities=30% Similarity=0.443 Sum_probs=209.1
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--CCeEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFI 88 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~ 88 (334)
++|...+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999875432 2335678899999999999999999998855 347899
Q ss_pred EEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887653 345899999999999999999999999999999999999999999999999987643221
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-----cHHHHHHHhhcCc-cCCC----
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAAE-FTCP---- 234 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-----~~~~~~~~~~~~~-~~~~---- 234 (334)
......++..|+|||.+.+..+ +.++|||||||++|+|++|..||... ...+....+.... ...+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 1123456888999999987666 48899999999999999999999865 2233333333211 1111
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 235 --PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 235 --~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..++..+.+||.+||+.+|.+|||+.|++.||||.+..
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 12467899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=329.40 Aligned_cols=260 Identities=27% Similarity=0.417 Sum_probs=214.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe-
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK- 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 85 (334)
....++|++.+.||.|++|.||+|.+..+++.||+|++..... .......+.+|+.+++.+.||||+++++++...+.
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3456789999999999999999999999999999999865322 22334667789999999999999999988766554
Q ss_pred -----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 86 -----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 86 -----~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.|+|+||+ +++|.+++.. .++++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 89999998 5589888765 5699999999999999999999999999999999999999999999999999874
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------- 231 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~--------- 231 (334)
.... .....++..|+|||.+.+....+.++|||||||++|+|++|+.||.+......+..+.....
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 168 TDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred cccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 3221 23346788999999987654556889999999999999999999988776555444322110
Q ss_pred ----------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 232 ----------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 232 ----------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.....++..+.+||.+||+.||.+|||+.++++||||.....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0012358899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=323.36 Aligned_cols=257 Identities=30% Similarity=0.516 Sum_probs=216.3
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
..|.....||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.+.||||+++++.+......|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 345566789999999999999998999999999865332 22456788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
||+++++|...+.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~ 174 (297)
T cd06659 98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKR 174 (297)
T ss_pred ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--cccc
Confidence 99999999887654 56899999999999999999999999999999999999999999999999987643221 1112
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 247 (334)
....|+..|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+.... ...+..++..+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 34568899999999987665 588999999999999999999998777666555554332 22334578899999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
||+.+|.+||+++++++||||.+...+
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~~~~ 280 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQTGLP 280 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccCCCc
Confidence 999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.71 Aligned_cols=252 Identities=31% Similarity=0.552 Sum_probs=211.4
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||.|++|.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++|+||+++++.+...+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999989999999998754444444467888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+++++|..++.. ...+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999998864 245899999999999999999999999999999999999999999999999987643221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCcc-CCCC-CCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEF-TCPP-WLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~--~~~~~~~~~~~~~-~~~~-~~~~~~ 241 (334)
........++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.... .......+..... +.|. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 112233468889999999987666 488999999999999999999996543 2333444333322 2333 678899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++|.+||..+|++|||+.++++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=329.44 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=202.0
Q ss_pred cceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee-C
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS-K 83 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~ 83 (334)
++|++.+.||.|+||.||+|.+. .+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++.. +
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 58999999999999999999743 3457899999864322 22345677899999999 79999999998764 4
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------------------------------------------------
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH---------------------------------------------------------- 105 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~---------------------------------------------------------- 105 (334)
..++++|||+++++|.+++...
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 6789999999999999988642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccCh
Q 019904 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (334)
Q Consensus 106 ---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 182 (334)
.+++...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788899999999999999999999999999999999999999999999998754321111111223456789999
Q ss_pred HhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHH-HHHhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 019904 183 EVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL-YKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITI 259 (334)
Q Consensus 183 E~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 259 (334)
|++.+..+. .++|||||||++|+|++ |..||.+....+. ...+.. .....|...++++.+++.+||+.+|++||++
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999887764 88999999999999998 9999987543332 222222 2234456688999999999999999999999
Q ss_pred hHHhcC
Q 019904 260 PEILED 265 (334)
Q Consensus 260 ~e~l~h 265 (334)
+|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=320.32 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=211.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
.+..|++.+.||.|+||.||+|.+.. .++.||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 35678899999999999999998754 35789999987432 223456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
...++++||+.+++|.+++... ..++...+..++.|++.||+|||++|++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999988532 247888899999999999999999999999999999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~ 226 (334)
+.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999998775432211111223345778999999987665 588999999999999998 99999988877777776
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 227 ~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..... ..+..++..+.+|+.+||+.+|.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 65543 456779999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=319.57 Aligned_cols=253 Identities=33% Similarity=0.504 Sum_probs=210.4
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--CeEEEEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVL 90 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~~~~v~ 90 (334)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998653 2333346678899999999999999999999888 8999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++ +|.+.+... ..+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99986 888888765 5799999999999999999999999999999999999999999999999998875433221 11
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------ 231 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------------ 231 (334)
.....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 23345678899999887655556899999999999999999999988776555444322100
Q ss_pred -----C--------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 -----T--------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 -----~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
. +...++..+.+++.+||+.+|.+||+++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 001137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=327.04 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=211.7
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK- 83 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 83 (334)
++....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 344556899999999999999999999999999999999875322 222345677899999999999999999988543
Q ss_pred -----CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 84 -----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 84 -----~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
...|++++++ +++|.+.+.. ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~ 167 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccc
Confidence 3478888887 6688877654 46999999999999999999999999999999999999999999999999987
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-------
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------- 231 (334)
..... ......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 168 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 168 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred ccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 74321 123446788999999987644446889999999999999999999987665443332211000
Q ss_pred ----------------CC--------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 232 ----------------TC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 232 ----------------~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
.. ....+..+.+||.+||+.||.+|||+.+++.||||.+...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 00 113578899999999999999999999999999999755443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=318.18 Aligned_cols=259 Identities=30% Similarity=0.555 Sum_probs=216.5
Q ss_pred ceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
.|++.+.||.|+||.||.|.+. .+|+.||+|++...... .....+.+.+|+.+++.+ .|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 47899999999764332 223346678899999999 499999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+++++|.+++....++++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999886532211
Q ss_pred CCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCC----cHHHHHHHhhcCccCCCCCCCHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLSFTA 241 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 241 (334)
........|+..|+|||.+.... ..+.++||||||+++|+|++|..||... ........+.....+.|..++..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 11223456889999999987532 3357899999999999999999999743 233444444445556677789999
Q ss_pred HHHHHHhcCCCCCCCC-----CHhHHhcCccccCC
Q 019904 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
.+++.+||+.||++|| ++++++.||||...
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=320.72 Aligned_cols=259 Identities=23% Similarity=0.413 Sum_probs=215.2
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEEC-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCee
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVV 74 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 74 (334)
.|......++|++.+.||.|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCch
Confidence 3566777889999999999999999999753 234579999886432 223356788999999999 799999
Q ss_pred eEEEEEeeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecC
Q 019904 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (334)
Q Consensus 75 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlk 138 (334)
++++++......|+||||+++++|.+++.... .++...+..++.||+.||+|||++|++|||||
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 99999999999999999999999999997642 36777889999999999999999999999999
Q ss_pred CCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 019904 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217 (334)
Q Consensus 139 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~ 217 (334)
|+||+++.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999875433222211222345678999999987665 488999999999999998 89999988
Q ss_pred cHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 218 NLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 218 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+..+....+.... ...+..++..+.+|+.+||+.+|.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 8888777765443 3445678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=319.51 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=209.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCC----------------CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----------------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 72 (334)
..++|++++.||+|+||.||+|.+...+ ..||+|.+..... ....+.+.+|+.+++.++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3578999999999999999998876533 4589999875432 234567889999999999999
Q ss_pred eeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCC
Q 019904 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (334)
Q Consensus 73 iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~N 141 (334)
|+++++++..+...++|||++.+++|.+++.... .+++..++.++.|++.||+|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred EEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCcH
Q 019904 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNL 219 (334)
Q Consensus 142 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~--g~~pf~~~~~ 219 (334)
|+++.++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999998865332221122223345778999999887555 589999999999999998 7889987666
Q ss_pred HHHHHHhhcC--------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 220 MNLYKKISAA--------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 220 ~~~~~~~~~~--------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...+...... ....++.++.++.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6655544322 12345567899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=323.90 Aligned_cols=257 Identities=26% Similarity=0.425 Sum_probs=206.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 83 (334)
+++|++.+.||.|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 78999999999999999999999999999999998654322 11234567899999999999999999887443
Q ss_pred --CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 84 --TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 84 --~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..+|+||||+.+ ++...+.. ...+++..+..++.|+++||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999976 67666654 34799999999999999999999999999999999999999999999999999875
Q ss_pred cccccCC---------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Q 019904 161 SQQVRDD---------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (334)
Q Consensus 161 ~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~ 231 (334)
....... .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 4322111 0112235678899999987655456889999999999999999999988776655444322100
Q ss_pred -----------------------CCC-------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 -----------------------TCP-------PWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 -----------------------~~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..+ ..++..+.+||.+||+.||.+|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=318.52 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=209.8
Q ss_pred cccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|.+.+.||+|+||.||+|.+. .++..+++|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999853 3456689998864332 2235688999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
...++||||+++++|.+++..+. .+++..++.++.||+.||+|||++|++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997643 37889999999999999999999999999999999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~ 226 (334)
+.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999864332211111223446788999999987665 488999999999999998 99999887777766666
Q ss_pred hcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 227 ~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 55443 345567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=318.05 Aligned_cols=248 Identities=31% Similarity=0.518 Sum_probs=203.3
Q ss_pred EEeeeeeccCceEEEEEEEC----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 14 EVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.+.+.||.|.||.||+|... ..+..|+||.+... ......+.+.+|+..+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 34577999999542 2333467889999999999999999999999988889999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+|||++|+|.+++... ..++...+..++.||+.||+|||+++++|++|+++||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999987 67999999999999999999999999999999999999999999999999998754221111
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li 245 (334)
.......+...|+|||.+....+ +.++||||||+++||+++ |+.||...+..+....+.... ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 11223345678999999987765 589999999999999999 789999888877777765443 345667899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||+.||.+|||++++++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.14 Aligned_cols=251 Identities=29% Similarity=0.483 Sum_probs=218.4
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++.+.||.|++|.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 92 FVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 92 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998866 356899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 246 (334)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+....+ ..+..++.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 2233567889999999987665 4789999999999999999999998887776666555443 345568899999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccc
Q 019904 247 RILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+||+.+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=322.08 Aligned_cols=258 Identities=30% Similarity=0.502 Sum_probs=209.7
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC---
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 84 (334)
...++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 457899999999999999999999999999999999875432 1222356778999999999999999999887654
Q ss_pred -------eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 85 -------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 85 -------~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
.+|+|+||+++ ++...+... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999987 676766654 468999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----- 231 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----- 231 (334)
++........ .......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+.....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 8875432211 1112234577899999987655456889999999999999999999987665544433322100
Q ss_pred -------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 -------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 -------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.....++..+.++|.+||+.||.+|||+++++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012368899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=307.62 Aligned_cols=249 Identities=33% Similarity=0.566 Sum_probs=213.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|++.+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 38899999999999999999998899999999976433 335678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 92 FVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 92 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|+++++|.+.+... ..+++..+..++.|++.||++||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998776 5799999999999999999999999999999999999999999999999998775433211 2
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-cc--CCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EF--TCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~ 247 (334)
....++..|+|||.+.+... +.++|+||||+++|+|++|..||...+........... .. ..+..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 34567889999999987664 58899999999999999999999877544443333322 22 2223348999999999
Q ss_pred hcCCCCCCCCCHhHHhcCcc
Q 019904 248 ILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~ 267 (334)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=335.67 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=217.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
.-.+...+...||+|.||+||+|++-. .||||++.......+ ..+.|++|+..+++-+|.||+-+.+++..+.. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 345667889999999999999999854 599999987665444 68999999999999999999999999988877 8
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||.-+|.|.+|+.+|+-.. +|.....+.|++||++|+.|||.++|||||||..||++..++.|||+|||++........
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 9999999999999997654 688889999999999999999999999999999999999999999999999987666555
Q ss_pred CCcccccccCCcccChHhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-----CCCCCCH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSF 239 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~ 239 (334)
........|...|||||+++.. ..+++.+|||||||++|||++|.+||......+++..+.++... .....+.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 5556666788999999999742 23468999999999999999999999977777777666665332 2234677
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 240 TARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++++|+..||..++++||.+.++|.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 9999999999999999999999986
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=311.77 Aligned_cols=248 Identities=25% Similarity=0.433 Sum_probs=208.4
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
...|++.+.||+|+||.||++.... +..+|+|.+...... ...+.+|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 3579999999999999999998754 567999987644322 34678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-e
Confidence 9999999999998753 4689999999999999999999999999999999999999999999999998764321111 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 246 (334)
......++..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...+..+....+.... ...|...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1112234567999999987665 488999999999999999 999999888777777766543 3345667889999999
Q ss_pred HhcCCCCCCCCCHhHHhc
Q 019904 247 RILDPNPMTRITIPEILE 264 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~ 264 (334)
+||+.+|++|||++++++
T Consensus 236 ~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 SCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHccCCcccCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=312.93 Aligned_cols=265 Identities=29% Similarity=0.419 Sum_probs=212.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-C
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-K 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 83 (334)
.+..|+++..||+|.||.||+|....++ +.+|||.+..++. .........+|+.+++.++||||+.+..+|.+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 4568999999999999999999655443 3789999875532 12234556799999999999999999999877 8
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC----CCeEEee
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSD 154 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~----~~~kl~D 154 (334)
...++++||.+. +|...|+.+. .++...+++++.||+.|+.|||++=|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999987 8988887543 58999999999999999999999999999999999999988 8999999
Q ss_pred ccchhccccccCCC-cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH---------HHHHH
Q 019904 155 FGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---------MNLYK 224 (334)
Q Consensus 155 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~---------~~~~~ 224 (334)
||++++...+-..- .....+-|.+|+|||.+.+...++++.|||+.|||+.||+|-.+.|.+... .++..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999865442221 233456688999999999999999999999999999999999888865321 12222
Q ss_pred HhhcCcc-----------CCCC--------------------------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 225 KISAAEF-----------TCPP--------------------------WLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 225 ~~~~~~~-----------~~~~--------------------------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
+|..... ..|. .-++.+.+|+.+||+.||.+|.|++++|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 2211100 0111 02445889999999999999999999999999
Q ss_pred ccCCCCCC
Q 019904 268 FKKDYKPP 275 (334)
Q Consensus 268 ~~~~~~~~ 275 (334)
|.....+|
T Consensus 340 F~~d~lpp 347 (438)
T KOG0666|consen 340 FTEDPLPP 347 (438)
T ss_pred cccCCCCC
Confidence 99886664
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.32 Aligned_cols=252 Identities=22% Similarity=0.363 Sum_probs=207.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
...+|++.+.||.|+||+||+|.+..++. .||+|++.... .......+.+|+.+++.+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 45689999999999999999999877666 48999986432 22335678899999999999999999998865 4
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..+++++|+++|+|.+.+... +.+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++.....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 567899999999999999774 4689999999999999999999999999999999999999999999999998875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...........+++.|+|||.+.+..+ +.++|||||||++|||++ |..||...........+... ..+.+..++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHH
Confidence 211111122234678999999987666 488999999999999998 99999887766665555443 234456789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+++.+||+.||++||++.+++.
T Consensus 241 ~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 241 YMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=304.14 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=206.6
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 82 (334)
++...-.||++.+.||.|||+-||+++...+++.||+|.+.... .+..+...+|+...++++||||++++++...
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 45566789999999999999999999999999999999996543 3446788899999999999999999876432
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCCeEEe
Q 019904 83 ---KTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 83 ---~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
....|++++|+..|+|.+.+... ..+++.++..|+.+|++||++||+.. ++||||||.|||+++.+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 34599999999999999988653 26999999999999999999999999 9999999999999999999999
Q ss_pred eccchhccccccCCCc-------ccccccCCcccChHhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCcHH--HH
Q 019904 154 DFGLSALSQQVRDDGL-------LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NL 222 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~e~~~g~~pf~~~~~~--~~ 222 (334)
|||.++.....-.+.. ......|..|+|||.+.-.. ..+.++|||||||++|.|+.|.-||+..-.. .+
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 9998765432111110 11224688999999987433 3358899999999999999999999632100 00
Q ss_pred HHHhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 223 YKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 223 ~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.-.+....+.+| ..+|+.+.++|+.||+.||.+||++.+++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 001122233333 4599999999999999999999999999863
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=314.67 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=206.1
Q ss_pred eEEeeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe----
Q 019904 13 YEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 85 (334)
|++.+.||+|+||.||.|....+ +..||+|.+..... .......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67889999999999999987643 47899999875432 23335678899999999999999999998765544
Q ss_pred --EEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 86 --IFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 86 --~~~v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
.++||||+++++|..++... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999888542 2588999999999999999999999999999999999999999999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCC
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~ 235 (334)
++...............++..|+|||.+....+ +.++|||||||++|||++ |..||.+.........+... ....|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875432211111122234668999999876655 589999999999999999 99999887777766665543 345677
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.91 Aligned_cols=255 Identities=26% Similarity=0.391 Sum_probs=213.2
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|...+.||.|+||.||+|.+..+|+.|++|++.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34777788999999999999999999999999997654444444567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+.+ ++.+.+.. ..++++..+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.... .
T Consensus 101 e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~ 173 (313)
T cd06633 101 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P 173 (313)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence 99975 77777755 4578999999999999999999999999999999999999999999999999875322 1
Q ss_pred ccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC--CCCCCCHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLI 245 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 245 (334)
.....|+..|+|||.+.. ....+.++|||||||++|+|++|..||...+.......+.....+ ....++..+++|+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 223568889999999852 233457899999999999999999999887665555544333221 2234778899999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.+||+.+|.+||++.+++.||||....
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.59 Aligned_cols=258 Identities=29% Similarity=0.497 Sum_probs=219.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...+.|++.+.||.|++|.||+|.+..++..|++|++..... ..+.+.+|+.+++.++|+||+++++.+......|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 91 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence 456679999999999999999999998899999999975432 3466788999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|+||+++++|.+++.... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 9999999999999998876 89999999999999999999999999999999999999999999999999876433211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARK 243 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 243 (334)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..... ..+..++..+.+
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 11223457889999999887665 4889999999999999999999988766554444433221 223337899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+|.+||+.+|.+|||+.++++|+||...-
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 99999999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=319.85 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=210.3
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEE
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 77 (334)
....-++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.+ .||||++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 34456799999999999999999998632 345699998874322 23356788999999999 599999999
Q ss_pred EEEeeCCeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCC
Q 019904 78 EVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (334)
Q Consensus 78 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~N 141 (334)
+++.....+|+||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|
T Consensus 85 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 164 (314)
T cd05099 85 GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARN 164 (314)
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccccee
Confidence 9999999999999999999999999763 247888899999999999999999999999999999
Q ss_pred EEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHH
Q 019904 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (334)
Q Consensus 142 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~ 220 (334)
|+++.++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999875432211111112234467999999987665 588999999999999999 99999988877
Q ss_pred HHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 221 NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 221 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.....+.... ...+..++.++++++.+||+.||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7776665543 3456678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.96 Aligned_cols=248 Identities=22% Similarity=0.368 Sum_probs=208.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||+|++|.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999975 4578999998754321 35678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|||+++++|.+++.... .++...+..++.|++.||.+||++|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999999997654 6899999999999999999999999999999999999999999999999988754321111
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
.......+..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||.+.........+... ..+.+..++..+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 0111122357999999887665 488999999999999999 99999988777766666443 2345667899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||+.+|.+||+++++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=326.56 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=208.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC------
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------ 83 (334)
.++|.+.+.||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 479999999999999999999999899999999987532 2223345678899999999999999999998654
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..+|+||||+.. +|.... ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 357999999975 676654 34689999999999999999999999999999999999999999999999998764321
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------- 230 (334)
......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 12234678899999998765445688999999999999999999999876555443322110
Q ss_pred ----------cCC--------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 231 ----------FTC--------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 231 ----------~~~--------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
... .+..+..+.+||.+||+.||.+||++++++.||||.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 000 1246778999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=311.10 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=207.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||+|+||.||.|.+.. +..+|+|.+...... ...+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 456999988654322 34578899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||.+........ .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 9999999999998764 3689999999999999999999999999999999999999999999999998764322111 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~ 246 (334)
......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+.... ...+...+..+++++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1112234567999999987665 488999999999999998 999998877666666555433 3345567899999999
Q ss_pred HhcCCCCCCCCCHhHHhcC
Q 019904 247 RILDPNPMTRITIPEILED 265 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h 265 (334)
+||+.||.+|||+.+++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=314.66 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=203.9
Q ss_pred eEEeeeeeccCceEEEEEEECCCCC--eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC------C
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------T 84 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~ 84 (334)
|.+.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+.+|+.+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3577899999999999999877665 689998865432 233457788999999999999999999976432 2
Q ss_pred eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 85 KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
..+++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 468999999999998877432 34789999999999999999999999999999999999999999999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCC
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 236 (334)
................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... ...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 75432111111122245678999999987665 588999999999999999 899998877777766665543 345667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++..+.++|.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=311.26 Aligned_cols=249 Identities=20% Similarity=0.352 Sum_probs=208.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 4578999999999999999999975 467799998765332 24678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+++++|.+++... ..++...+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999998763 4688889999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
.......++..|+|||.+....+ +.++|||||||++|+|++ |..||...........+... ..+.+..++.++.++
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI 236 (261)
T ss_pred -eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11122335667999999987665 478999999999999998 99999887777666665543 233445688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||+.+|++|||++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 237 MKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=318.37 Aligned_cols=249 Identities=22% Similarity=0.358 Sum_probs=206.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCC--eEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (334)
++|++.+.||.|+||.||+|.+..++. .+++|.+... ......+.+.+|+.+++++ +||||+++++++...+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999877664 4688877532 1223346788999999999 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 88 IVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997642 478889999999999999999999999999999999999999999
Q ss_pred EeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc
Q 019904 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~ 230 (334)
|+|||++........ ......+..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+....
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999998763221100 111122456999999987665 488999999999999997 999999888777776665442
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 231 -~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
...+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34556789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=313.82 Aligned_cols=249 Identities=22% Similarity=0.401 Sum_probs=211.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.-..|++.+.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999977 88899999875432 224568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+++++|.+++... ..++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 99999999999999763 468999999999999999999999999999999999999999999999999886542211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
.......++..|+|||.+....+ +.++||||||+++|+|++ |+.||.+.+..+....+... ..+.+..++..+.++
T Consensus 159 -~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05148 159 -YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI 236 (261)
T ss_pred -ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence 11123345668999999987665 488999999999999998 89999888777766665543 345567789999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||+.||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 237 MLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=318.73 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=215.9
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|...+.||+|+||.||+|.+..++..||+|.+.............+.+|+.+++.++|||++++++++......|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 48889999999999999999998999999999876544444556778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 92 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|+.| ++.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... .
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------A 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------c
Confidence 9986 77776654 45689999999999999999999999999999999999999999999999998764322 2
Q ss_pred cccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--CCCCCCCHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIA 246 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 246 (334)
....|++.|+|||.+.. ....+.++|||||||++|+|++|..||...+.......+..... ..+..++..++++|.
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 258 (317)
T cd06635 179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVD 258 (317)
T ss_pred ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHH
Confidence 23467889999999852 23345889999999999999999999987766665555544332 223457889999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
+||+.+|.+||++.++++|+|+.......
T Consensus 259 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 259 SCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred HHccCCcccCcCHHHHHhChhhhccCccc
Confidence 99999999999999999999997654433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=311.17 Aligned_cols=247 Identities=24% Similarity=0.421 Sum_probs=206.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|++.+.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999885 4667999998653322 245678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+++++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 999999999998764 4689999999999999999999999999999999999999999999999998764322111 01
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 247 (334)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+... ....|..++..+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111223457999999987666 488999999999999998 89999887777766665544 345566789999999999
Q ss_pred hcCCCCCCCCCHhHHhc
Q 019904 248 ILDPNPMTRITIPEILE 264 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~ 264 (334)
||..+|++|||+.++++
T Consensus 237 cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 237 CWHEKPEDRPAFKKLLS 253 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=326.54 Aligned_cols=261 Identities=31% Similarity=0.433 Sum_probs=212.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC--Ce
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK--TK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~ 85 (334)
..++|++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.+ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4678999999999999999999999889999999885432 1222345677899999999 999999999988654 46
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.|+||||+.+ +|..++... .+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 8999999985 898888765 78888999999999999999999999999999999999999999999999987543322
Q ss_pred CC---CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Q 019904 166 DD---GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (334)
Q Consensus 166 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------ 230 (334)
.. .......|+..|+|||.+.+....+.++|+|||||++|+|++|+.||.+....+...++....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 11 122345688999999998765555688999999999999999999998766554433321110
Q ss_pred -------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 -------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 -------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
....+.++.++.++|.+||+.||++|||+.++++|||++...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 011123688999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=316.58 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=206.6
Q ss_pred ceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ......+.+|+.+++.+.||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235689998865332 22346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCE
Q 019904 87 FIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NI 142 (334)
|+||||+.+++|.+++... .+++...+..++.|++.||+|||+.|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988642 2477888999999999999999999999999999999
Q ss_pred EEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH
Q 019904 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (334)
Q Consensus 143 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~ 221 (334)
++++++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999864332211111122345678999999876665 488999999999999998 999999887777
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 222 ~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+....... ....|..++.++.+|+.+||+.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66655433 33456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=310.66 Aligned_cols=244 Identities=23% Similarity=0.346 Sum_probs=203.3
Q ss_pred eeeccCceEEEEEEE--CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 18 TIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
.||+|+||.||+|.+ ..+++.+|+|++.... ......+.+.+|+.+++.+.||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4567889999986543 23344677889999999999999999999875 4567899999999
Q ss_pred CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC-Ccccccc
Q 019904 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTC 174 (334)
Q Consensus 96 ~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~ 174 (334)
++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988888999999999999999999999999999999999999999999999999998754321110 0111223
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~d 252 (334)
++..|+|||.+....+ +.++|+|||||++|+|++ |..||...........+.... .+.|..++.++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4578999999876555 478999999999999998 999999877777776666543 4567779999999999999999
Q ss_pred CCCCCCHhHHhc
Q 019904 253 PMTRITIPEILE 264 (334)
Q Consensus 253 p~~Rpt~~e~l~ 264 (334)
|.+||+++++..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=318.12 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=206.8
Q ss_pred cccceEEeeeeeccCceEEEEEEE-----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEee
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 82 (334)
..++|.+.+.||.|+||.||+|.+ ..++..||+|.+.... .....+.+.+|+.+++++ +||||+++++.+..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 345799999999999999999975 2345689999886532 223356788999999999 79999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.+..|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999999987643 389999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC--ccCCCCCC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWL 237 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~--~~~~~~~~ 237 (334)
..............++..|+|||.+.+..+ +.++||||+||++|+|++ |..||..........+.... ....+...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA 269 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCC
Confidence 332111111122345678999999987766 488999999999999998 99999876655444333222 22345567
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+..+.+++.+||+.+|++|||+.++++
T Consensus 270 ~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 270 PAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.81 Aligned_cols=261 Identities=33% Similarity=0.526 Sum_probs=225.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
-.-||.-+..||.|.||.||.|.+..+|.-.|+|.+...... ......+.+|+.++..++|||+|++|++-.+++..||
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 344788899999999999999999999999999988754433 3445778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc--C
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--D 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~ 166 (334)
.||||++|+|.+.+...+-.++...+.+..|++.|++|||++|||||||||+||+++.+|.+|++|||.|....... -
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 99999999999999888888999999999999999999999999999999999999999999999999987543321 1
Q ss_pred CCcccccccCCcccChHhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~e~~~g~~pf~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
.+..+...||+.|||||++.+.. -.+-+.|||||||++.||+||+.||..- ...++..++..+ .+++|..+|.+.+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~ 1471 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGR 1471 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHH
Confidence 23456778999999999998644 2246789999999999999999999754 334555555554 4578888999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+||++||..||++|+++.|+|+|.|-..
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999999988653
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.74 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=208.0
Q ss_pred ccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..+|.+.+.||+|+||.||++... .++..+|+|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457889999999999999999743 346679999876432 233567899999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG---------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
..++||||+++++|.+++...+ .+++..+..++.|++.|++|||++|++||||||+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997653 3788999999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~ 228 (334)
++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999998764322111111122334678999999987766 488999999999999998 9999987766666555544
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 229 A-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 229 ~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
. ....+..++..+.++|.+||+.||.+||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 34556678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.14 Aligned_cols=151 Identities=31% Similarity=0.629 Sum_probs=141.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++++.||.|+||.||+|.+..+++.||||++.............+..|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 46899999999999999999999999999999999987655555556788899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
||||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=317.24 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=205.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v 89 (334)
+.|...+.||.|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4667788999999999999999999999999998754322 33566788999999996 99999999999999999999
Q ss_pred EeccCCCchHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 90 LEFVTGGELFDKI---V--NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 90 ~e~~~~~~L~~~l---~--~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
|||+.+ ++.++. . ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 544432 2 235799999999999999999999975 999999999999999999999999999864322
Q ss_pred ccCCCcccccccCCcccChHhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCc-cC----CCC
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAE-FT----CPP 235 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~~~~~~~~~-~~----~~~ 235 (334)
. .......|+..|+|||.+.+. ...+.++||||+||++|+|++|+.||..... ......+.... .. .+.
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 S---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred C---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1 112334678899999999865 2445889999999999999999999976432 22222222211 11 122
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.++.++.+||.+||+.||++|||++++++||||+..
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 478899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=323.51 Aligned_cols=256 Identities=20% Similarity=0.318 Sum_probs=203.1
Q ss_pred eeeecc--CceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
..||+| +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 99999999999999999999987543322 345788999999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC----
Q 019904 95 GGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---- 168 (334)
Q Consensus 95 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~---- 168 (334)
+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 999999887643 58999999999999999999999999999999999999999999999998654321111100
Q ss_pred -cccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------------
Q 019904 169 -LLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------------- 231 (334)
Q Consensus 169 -~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~--------------- 231 (334)
......++..|+|||++.+.. ..+.++|||||||++|+|++|+.||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011123456799999997642 235889999999999999999999987654333322211100
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 --------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 --------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.+..++..+.+||.+||+.||.+|||++++|+||||....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 011235678999999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.98 Aligned_cols=254 Identities=29% Similarity=0.486 Sum_probs=213.0
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
....||+|+||.||++....+|+.||+|++.... ......+.+|+.+++.++|+||+++++.+...+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3467999999999999999999999999885432 2335668899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
+++|.+.+.. .++++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++...... ........
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 177 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLV 177 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--cccccccc
Confidence 9999887644 56899999999999999999999999999999999999999999999999987643221 11123356
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHHHHhcCC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~ 251 (334)
|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.........+... .......++..+.+++.+||+.
T Consensus 178 ~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (292)
T cd06657 178 GTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256 (292)
T ss_pred cCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence 8899999999876555 58899999999999999999999887666554444322 2223345789999999999999
Q ss_pred CCCCCCCHhHHhcCccccCCCCCC
Q 019904 252 NPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 252 dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
||.+||++.+++.||||.....++
T Consensus 257 ~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 257 DPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred CcccCcCHHHHhcChHHhccCCCc
Confidence 999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=308.26 Aligned_cols=244 Identities=24% Similarity=0.349 Sum_probs=203.0
Q ss_pred eeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 17 RTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
+.||+|+||.||+|.+...+ ..||+|.+...... ...+.+.+|+.+++.+.||||+++++++. ....++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 78999998765432 33467889999999999999999999876 45679999999
Q ss_pred CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC-cccc
Q 019904 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHT 172 (334)
Q Consensus 94 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~ 172 (334)
.+++|.+++.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999888889999999999999999999999999999999999999999999999999987543211110 0111
Q ss_pred cccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcC
Q 019904 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~ 250 (334)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.... ...|..++..++++|.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123457999999977665 589999999999999998 999998877766666554443 35567789999999999999
Q ss_pred CCCCCCCCHhHHhc
Q 019904 251 PNPMTRITIPEILE 264 (334)
Q Consensus 251 ~dp~~Rpt~~e~l~ 264 (334)
.+|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=318.27 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=212.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+|...+.||.|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|+|++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 44588889999999999999999999999999998754333344456788899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+ ++.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 999975 77776654 45689999999999999999999999999999999999999999999999998764322
Q ss_pred cccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-C-CCCCCCHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-T-CPPWLSFTARKL 244 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~l 244 (334)
.....+++.|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..... . .+..++..+.+|
T Consensus 168 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (308)
T cd06634 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (308)
T ss_pred -cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHH
Confidence 123467889999999853 22335789999999999999999999987655544443333222 1 234588899999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
|.+||+.+|.+||+++++++|||+...
T Consensus 247 i~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhCCcccCCCHHHHhhCcccccc
Confidence 999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=310.01 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=205.4
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||.|+||.||+|.+..+ ..||+|.+...... .+.+.+|+.+++.++||||+++++.+. ....|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 46899999999999999999998665 46999998753321 246788999999999999999999874 4568999
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||.+....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-~ 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-c
Confidence 9999999999999764 357889999999999999999999999999999999999999999999999886543211 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
.......++..|+|||...+..+ +.++|+|||||++|+|++ |..||.+.........+... ..+.+..++..+.+++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 11123345678999999877665 588999999999999999 89999887776666665443 2344566899999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||++||++|||+.++++
T Consensus 237 ~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.93 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=203.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCC--------------CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeee
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSET--------------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 75 (334)
.++|++.+.||+|+||.||+|.+... ...||+|.+.... .....+.+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 35899999999999999999987543 2358999987532 2334567889999999999999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEE
Q 019904 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (334)
Q Consensus 76 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl 143 (334)
+++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 3678889999999999999999999999999999999
Q ss_pred EecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCcHHH
Q 019904 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (334)
Q Consensus 144 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~--g~~pf~~~~~~~ 221 (334)
++.++.+||+|||++................++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999998864322111111122234678999999887665 589999999999999988 678888766555
Q ss_pred HHHHhhc--------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 222 LYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 222 ~~~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+.. .....++..+..+.+|+.+||+.||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 4443311 112335567899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=312.53 Aligned_cols=252 Identities=19% Similarity=0.326 Sum_probs=205.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..++|++.+.||.|+||+||+|.+..++. .+++|.+.... .......+..|+..++.+.||||+++++++. ..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 34789999999999999999999877776 47777775321 1223456778888999999999999999875 45
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..++++||+++|+|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 578899999999999999764 5689999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 241 (334)
...........++..|+|||.+.+..+ +.++|||||||++||+++ |..||.+.........+.... ...+...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV 240 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence 211111223346678999999987665 589999999999999998 999998877666555444333 34455678899
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+++.+||..||++|||+.|+++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=331.48 Aligned_cols=249 Identities=27% Similarity=0.507 Sum_probs=217.9
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe--EEEEEec
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK--IFIVLEF 92 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~v~e~ 92 (334)
...||+|+|-+||+|.|..+|..||.-.++.+... .+...++++.|+.+|+.|+||||+++|+.|.+..+ +.+|.|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 56799999999999999999999998887765544 35557999999999999999999999999987765 8899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecC-CCeEEeeccchhccccccCCCc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
+..|+|..+++++++++...++.|++||++||.|||++. |+|||||=+||+|+.+ |.|||+|+|+|+.... ..
T Consensus 125 ~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~----s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK----SH 200 (632)
T ss_pred ccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc----cc
Confidence 999999999999999999999999999999999999985 9999999999999865 8899999999987543 22
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccC--CCCCCCHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFT--CPPWLSFTARKLIA 246 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~ 246 (334)
..+.+|||.|||||++. ..| ...+||||||+.+.||+|+..||.. ....++++++..+..+ +..--++++++||.
T Consensus 201 aksvIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIe 278 (632)
T KOG0584|consen 201 AKSVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIE 278 (632)
T ss_pred cceeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHH
Confidence 34578999999999998 345 4899999999999999999999974 6778888888766532 12223789999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+||.. ...|+|+.|+|+||||...
T Consensus 279 kCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHhcC-chhccCHHHHhhChhhccc
Confidence 99999 9999999999999999874
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=321.25 Aligned_cols=259 Identities=24% Similarity=0.416 Sum_probs=212.0
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCC-------CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeee
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 75 (334)
|+......+|++++.||+|+||.||+|.+... +..||+|.+.... .....+.+.+|+.+++.+ +||||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 44445566899999999999999999986432 2368999886432 223356788999999999 7999999
Q ss_pred EEEEEeeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCC
Q 019904 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (334)
Q Consensus 76 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp 139 (334)
+++++......|++|||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999987532 367788889999999999999999999999999
Q ss_pred CCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCc
Q 019904 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (334)
Q Consensus 140 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~ 218 (334)
+||+++.++.++|+|||+++...............++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998754322111111222345679999999876664 88999999999999998 899999888
Q ss_pred HHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.......+.... ...+...+.++.+++.+||+.+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777777665543 34566788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=316.24 Aligned_cols=252 Identities=33% Similarity=0.502 Sum_probs=210.6
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
|++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+.+++.++||||+++++++......|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999989999999998764332 23356788899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 93 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
+.+ +|.+.+... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 986 787777663 579999999999999999999999999999999999999999999999999876543321 1222
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------cC
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------------FT 232 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-------------------~~ 232 (334)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+...++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 34578889999999876445689999999999999999999998877655544432110 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 233 -----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 233 -----------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
..+.++.++.+||.+||+.||.+||++.++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 112367899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=308.39 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=210.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||.|+||.||+|.+. +++.||+|.+...... .+.+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4578999999999999999999975 4678999998754322 3568899999999999999999999999899999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+++++|.+++.... .++...+..++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE- 157 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh-
Confidence 999999999999997653 68999999999999999999999999999999999999999999999999876543211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
........++..|+|||.+.+... +.++|+||+||++|++++ |+.||.+.+.......+... ..+.+...+.++.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112234568999999987665 588999999999999998 99999988777777766544 334566678999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||+.+|.+||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=313.65 Aligned_cols=260 Identities=32% Similarity=0.554 Sum_probs=215.9
Q ss_pred ceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
.|++.+.||+|++|.||++.+. .+++.||+|++...... .......+.+|+.+++.+ .||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 45788999999764432 233456788999999999 499999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.+++|.+.+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999876533221
Q ss_pred CCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCccCCCCCCCHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 241 (334)
........|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .......+.......|..++..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11122346788999999987543 23578999999999999999999996432 23444444455566777789999
Q ss_pred HHHHHHhcCCCCCCCCC---HhHHhcCccccCCC
Q 019904 242 RKLIARILDPNPMTRIT---IPEILEDEWFKKDY 272 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt---~~e~l~h~~~~~~~ 272 (334)
.++|.+||+.||++||| +.++|+||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999998 56779999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=320.73 Aligned_cols=260 Identities=28% Similarity=0.422 Sum_probs=208.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCC--CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEee----CC
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS----KT 84 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~----~~ 84 (334)
+|++.+.||.|+||.||++.+..+ +..||+|.+.... ......+.+.+|+.+++.+. ||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8899999986432 22233456778999999994 9999999986432 24
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..|++++++. ++|.+.+.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6789999986 589999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cC--CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-------------
Q 019904 165 RD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (334)
Q Consensus 165 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------- 229 (334)
.. ........|++.|+|||.+.+....+.++|+||+||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 111233468999999999876444468899999999999999999999876544333221110
Q ss_pred ---------------cc---CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 230 ---------------EF---TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 230 ---------------~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.. ...+..+..+.+|+.+||+.||.+|||+.+++.|||+.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 00 011235789999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=319.47 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=210.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-CCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 85 (334)
-...++|++.+.||.|+||.||+|.+..+++.||+|.+.+.. ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 345789999999999999999999999999999999886532 222334667889999999999999999999865 567
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.|+||||+. ++|.+.+.. .++++..+..++.|+++||+|||+.|++||||+|+||+++.++.++|+|||.+.....
T Consensus 85 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 899999985 588877754 4688889999999999999999999999999999999999999999999998764321
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-----------------
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA----------------- 228 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~----------------- 228 (334)
......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||...........+..
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd07856 161 ---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN 237 (328)
T ss_pred ---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence 123346788999999986644446899999999999999999999987654322211110
Q ss_pred ----------Cc-cC---CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 229 ----------AE-FT---CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 229 ----------~~-~~---~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.. .+ ..+.++..++++|.+||+.+|.+|||+++++.||||.....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00 00 113467899999999999999999999999999999866544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=314.18 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=209.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.+.||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 34679999999999999999998743 57889999986532 223346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~N 141 (334)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997532 36788889999999999999999999999999999
Q ss_pred EEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHH
Q 019904 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (334)
Q Consensus 142 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~ 220 (334)
|+++.++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998764322211111122234567999999987665 488999999999999997 88999887777
Q ss_pred HHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 221 NLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 221 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+....+..... ..+..++.++.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77666654433 446678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=309.43 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=209.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.+.|++.+.||+|+||.||+|.+..+++ .||+|.+.... .......+..|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 5679999999999999999999877665 59999986532 233457789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
++||||+++++|.+++... +.++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999988764 468999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccc---cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 019904 166 DDGLLHTTC---GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (334)
Q Consensus 166 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (334)
......... .+..|+|||.+.+..+ +.++|||||||++|||++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 1347999999987666 488999999999999886 99999887777666665433 23445668899
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 241 ARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+++.+||+.+|++||++++++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=340.47 Aligned_cols=260 Identities=24% Similarity=0.399 Sum_probs=194.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCC-CeEEEE--------------EeehhhhhhHHHHHHHHHHHHHHHhCCCCCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALK--------------ILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 73 (334)
..++|++++.||+|+||+||+|..+... ..+++| .+.+...........+.+|+.+|+.++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3578999999999999999998764322 222222 1111111122335668899999999999999
Q ss_pred eeEEEEEeeCCeEEEEEeccCCCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC
Q 019904 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (334)
Q Consensus 74 v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~ 148 (334)
+++++++...+..|+|++++.+ +|.+++.... ......++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 9999999999999999999965 6777665422 234567888999999999999999999999999999999999
Q ss_pred CeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCC-CCCCC--cH-HHHHH
Q 019904 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDS--NL-MNLYK 224 (334)
Q Consensus 149 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~-pf~~~--~~-~~~~~ 224 (334)
.+||+|||++....... ........||+.|+|||++.+..+ +.++|||||||++|||++|.. ||... .. ..+..
T Consensus 305 ~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 305 KIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999987543211 112234579999999999988776 488999999999999999875 44322 11 22222
Q ss_pred HhhcCc---cCCC----------------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 225 KISAAE---FTCP----------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 225 ~~~~~~---~~~~----------------------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+.... ..+| ..++.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 111000 0000 1245678889999999999999999999999999764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=308.53 Aligned_cols=247 Identities=23% Similarity=0.380 Sum_probs=205.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+...... .+.+.+|+.+++.++|||++++++++. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 468999999999999999999875 4667999998754332 245789999999999999999999875 4568899
Q ss_pred EeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 9999999999998763 3589999999999999999999999999999999999999999999999999865332111
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
.......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.+..+....+... ..+.+...+..+.+|+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11112234567999999876655 488999999999999999 99999888777776666543 3445667889999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||.++|++|||++++.+
T Consensus 237 ~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 237 LQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHcccCcccCcCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=306.80 Aligned_cols=243 Identities=24% Similarity=0.452 Sum_probs=205.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-eeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~ 87 (334)
...+|++.+.||+|+||.||++... |..||+|.+.... ..+.+.+|+.+++.++|+|++++++++ ......|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4568999999999999999999764 7789999886432 245688999999999999999999875 4556789
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999999987654 4788999999999999999999999999999999999999999999999987643221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
.....++..|+|||++.+..+ +.++|||||||++|+|++ |+.||...+.......+... ....++.++..+.+
T Consensus 156 ----~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05082 156 ----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYD 230 (256)
T ss_pred ----CCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 112234567999999987665 488999999999999997 99999887777766655443 23455678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.+||+.+|++|||+.++++
T Consensus 231 li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 231 VMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=306.54 Aligned_cols=244 Identities=25% Similarity=0.462 Sum_probs=209.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..+.|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 3568999999999999999999874 78899999875432 35678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999999998765 68999999999999999999999999999999999999999999999999887542211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
....++..|+|||.+....+ +.++|+||||+++|+|++ |..||...+.......+... ....+..+++.+.++
T Consensus 157 ----~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05039 157 ----DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKV 231 (256)
T ss_pred ----ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHH
Confidence 12234567999999976655 488999999999999997 99999888777766655443 234456688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
|.+||..+|++|||++++++
T Consensus 232 i~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 232 MKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHhccChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=309.69 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=210.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..++|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45789999999999999999999876654 589998765432 3345678899999999999999999999887 7
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 889999999999999999875 4689999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 241 (334)
...........++..|+|||.+....+ +.++|+|||||++|++++ |..||.+....+....+.... .+.|...+.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV 240 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence 211111112223567999999876665 488999999999999998 999999888777766665443 45566688999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 241 YMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=311.62 Aligned_cols=250 Identities=31% Similarity=0.466 Sum_probs=204.1
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEeeCCe----
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTK---- 85 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~---- 85 (334)
|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999988899999999975432 222234455677776655 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 86 -IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 86 -~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
.+++|||+.+ +|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999986 7888887643 58999999999999999999999999999999999999999999999999886543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------- 231 (334)
.. .......++..|+|||.+.+... +.++|+|||||++|+|++|..||.+....+...++.....
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 11223357888999999987665 4889999999999999999999988776665554422100
Q ss_pred ----------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 ----------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 ----------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+.++..+.++|.+||+.||++||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0011346788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=313.38 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=202.1
Q ss_pred cceEEeeeeeccCceEEEEEEECC----------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCee
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 74 (334)
++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 479999999999999999986432 34468999986532 233356788999999999999999
Q ss_pred eEEEEEeeCCeEEEEEeccCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEE
Q 019904 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (334)
Q Consensus 75 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl 143 (334)
++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987643 3566789999999999999999999999999999999
Q ss_pred EecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCcHHH
Q 019904 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (334)
Q Consensus 144 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~--g~~pf~~~~~~~ 221 (334)
++.++.++|+|||++................++..|+|||......+ +.++|+|||||++|+|++ |..||...+..+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999864322111111112234568999999877665 589999999999999998 789998766555
Q ss_pred HHHHhh--------cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 222 LYKKIS--------AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 222 ~~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...... ....+.+..++..+.+|+.+||+.||++|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 443321 1123445668899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=305.06 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=204.3
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999977 999999998754332 33567889999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 97 ~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
+|.+++... ..++...+..++.+++.||+|||++|++||||+|+||+++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999998663 4688999999999999999999999999999999999999999999999998864331111111111233
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp 253 (334)
+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...........+... ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 557999999877665 589999999999999998 89999887766665555443 344566789999999999999999
Q ss_pred CCCCCHhHHhc
Q 019904 254 MTRITIPEILE 264 (334)
Q Consensus 254 ~~Rpt~~e~l~ 264 (334)
++|||++|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=306.69 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=206.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.-+.|++++.||+|+||.||+|... +++.||+|.+...... ...+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 3467999999999999999999864 5788999998754332 356788999999999999999999874 567899
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+.+++|.+.+... ..++...+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 99999999999988754 368899999999999999999999999999999999999999999999999876433111
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
........++..|+|||.+....+ +.++||||||+++|+|++ |+.||.+.+.......+... ..+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112345668999999987665 488999999999999998 99999988777766665443 234556688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||+.+|++|||++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=330.80 Aligned_cols=244 Identities=34% Similarity=0.596 Sum_probs=211.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (334)
..+.|.+...+|.|+|+.|-.+.+..+++.+++|++.++.. +..+|+.++... +||||+++++++.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 46789999999999999999999999999999999987622 233566555544 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE-ecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~-~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||.+.|+-+.+.+...+.+. ..+..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999998888766555 7888899999999999999999999999999999 68899999999988743321
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
..+.+-|..|.|||++...+++ .++|+||||+++|+|++|+.||...... ++...+..+.+. .++|..+++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 3345678899999999977775 9999999999999999999999865544 666666554444 78999999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccc
Q 019904 246 ARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
++||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=313.73 Aligned_cols=252 Identities=31% Similarity=0.506 Sum_probs=210.4
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++|+|++++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999997643 2233346677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 93 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
+.+ +|.+++... ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence 985 899999876 579999999999999999999999999999999999999999999999999876543211 1222
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC------------------cc--
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------EF-- 231 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~------------------~~-- 231 (334)
...++..|+|||.+.+....+.++|||||||++|+|++|..||.+.+....+.++... ..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3345778999999987645568899999999999999999999887655544433210 00
Q ss_pred ---------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 ---------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 ---------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+.++..+.++|.+||..||.+||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0012347789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=327.05 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=214.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCC---e-EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGE---P-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
.-.+.++||+|+||.||+|.....+. . ||+|....+..........+.+|+++|+.++|||||++||+...+..+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34556899999999999998765432 3 8999987655455666788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||+++++||||-..|||++.++.+||+|||+++.......
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 9999999999999999987 499999999999999999999999999999999999999999999999999875431111
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc--cCCCCCCCHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARK 243 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 243 (334)
.. ....-...|+|||.+....+ +.++||||+||++||+++ |..||.+....+...++.... .+.|...+..+..
T Consensus 318 ~~--~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 318 KK--FLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred cc--ccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 11 01123568999999998755 699999999999999998 899999999999999885543 3566778899999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.+|+..||++|||+.++.+
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHhccCChhhccCHHHHHH
Confidence 999999999999999999864
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=305.67 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=204.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||.|++|.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999988654 4699998765332 2356788999999999999999999875 4568899
Q ss_pred EeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|||+.+++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence 99999999999997643 47889999999999999999999999999999999999999999999999986543211 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 245 (334)
.......++..|+|||...+... +.++||||||+++|+|++ |..||.+.........+... ....+...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 11122345678999999876665 588999999999999999 99999987777766665543 2345567889999999
Q ss_pred HHhcCCCCCCCCCHhHHhc
Q 019904 246 ARILDPNPMTRITIPEILE 264 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||.+||++||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=312.81 Aligned_cols=250 Identities=32% Similarity=0.466 Sum_probs=206.3
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEEe
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e 91 (334)
|++.+.||.|++|.||+|....+++.||||.+........ .....+|+..++.++ ||||+++++++...+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 7889999999999999999998899999999865432111 223456889999999 9999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+ +++|.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence 99 679998887765 789999999999999999999999999999999999999999999999998864332 112
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------------ 231 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------------ 231 (334)
.....++..|+|||.+......+.++|+||||+++++|++|+.||..........++.....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23356788999999986555456889999999999999999999987765554433221100
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 232 ------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
...+..+..+.+||.+||+.||.+|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=325.57 Aligned_cols=254 Identities=21% Similarity=0.341 Sum_probs=205.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 81 (334)
...++|.+.+.||+|+||.||+|++. ..++.||+|++..... ....+.+.+|+.+|..+. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34567889999999999999999864 3456899999975422 222456889999999998 999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC-------------------------------------------------------
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHG------------------------------------------------------- 106 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~------------------------------------------------------- 106 (334)
..+..|+|||||++|+|.+++.+.+
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999986532
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEE
Q 019904 107 -------------------------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (334)
Q Consensus 107 -------------------------------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl 143 (334)
.++...+..++.|++.||+|||+.|++||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 2456678889999999999999999999999999999
Q ss_pred EecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 019904 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 222 (334)
Q Consensus 144 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~ 222 (334)
++.++.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 99999999999999875322111111123356788999999987665 588999999999999998 8999987554444
Q ss_pred HHH-hhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 223 YKK-ISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 223 ~~~-~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
... +... ....|..++.++.+++.+||..+|.+||+++++++
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 333 2222 23456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=309.39 Aligned_cols=254 Identities=19% Similarity=0.280 Sum_probs=209.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEECC----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS- 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 82 (334)
..-++|++.+.||+|+||.||+|.+.. ++..|++|.+... ......+.+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999865 3578999987632 233445778899999999999999999998655
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEee
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~D 154 (334)
....+++++|+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57789999999999999998764 3588999999999999999999999999999999999999999999999
Q ss_pred ccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cC
Q 019904 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FT 232 (334)
Q Consensus 155 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~ 232 (334)
||+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |+.||...+...+...+.... ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 999874322111111122345677999999987665 588999999999999998 999999887777666555432 23
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 233 CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 233 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+..++.++.+++.+||..||++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 44567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.29 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=208.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.++|++.+.||+|+||.||+|.+..++ ..+|+|.+..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999886444 3699998865322 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+||||+++++|.+++... ..++...+..++.|++.||++||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999887543221
Q ss_pred CCCc-ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 166 DDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
.... .....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||...+..+....+... ..+.+..++..+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1110 011123457999999987665 589999999999999886 99999887766666655543 2344456789999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=305.17 Aligned_cols=244 Identities=27% Similarity=0.446 Sum_probs=204.1
Q ss_pred eeeeccCceEEEEEEECC-CCC--eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 17 RTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
+.||+|++|.||+|.+.. .++ .||||.+...... ...+.+.+|+.+++.++||||+++++.+.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999765543 456788999999999999999999999988 8899999999
Q ss_pred CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC-Ccc
Q 019904 94 TGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLL 170 (334)
Q Consensus 94 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~ 170 (334)
++++|.+.+.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999997764 6899999999999999999999999999999999999999999999999998754331111 111
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC--ccCCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~ 247 (334)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+... ....+...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 12346778999999887666 488999999999999998 99999877776666555432 233455678999999999
Q ss_pred hcCCCCCCCCCHhHHhc
Q 019904 248 ILDPNPMTRITIPEILE 264 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~ 264 (334)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=299.45 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=212.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (334)
..++..+++..||.|+.|+||+++.+.+|...|||.++... +.+..+++.+.+.++.... +|+||+.+++|..+...
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 34555667788999999999999999999999999998643 3444677888888877665 89999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
++.||.|.. .+..++++ .++++|..+-.+...++.||.||.. +||+|||+||+|||++..|++||||||++...-
T Consensus 167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv-- 243 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV-- 243 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee--
Confidence 999999865 33444443 3579999999999999999999985 599999999999999999999999999876433
Q ss_pred cCCCcccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccCCC---CCCC
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEFTCP---PWLS 238 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~-~~~~~~~~~~~~~~~~~---~~~~ 238 (334)
++.......|.+.|||||.+.- .+.+..++||||||++++|+.||+.||.+. ...+.+.++...+++.. ..+|
T Consensus 244 -dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFS 322 (391)
T KOG0983|consen 244 -DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFS 322 (391)
T ss_pred -cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcC
Confidence 2333344578999999999863 233348899999999999999999999973 45566666665554332 2389
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+.+++|+..||.+|+.+||...++|+|||+....
T Consensus 323 p~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 323 PDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 9999999999999999999999999999997643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=309.06 Aligned_cols=253 Identities=28% Similarity=0.499 Sum_probs=210.5
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
||.+.+.||+|+||.||++.+...+..+++|++...... .......+.+|+.+++.++||||+++++.+......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999887777777776542221 122234566789999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+++++|.+.+.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999888764 346899999999999999999999999999999999999975 67999999987654221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 244 (334)
........|++.|+|||.+.+..+. .++|+||||+++|+|++|..||...........+.... ...+..++.++.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1222344678899999998776654 78999999999999999999998877666666554433 34456688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccc
Q 019904 245 IARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=304.25 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=209.9
Q ss_pred eEEeeeeeccCceEEEEEEECCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+++.+.||.|+||.||++.+...+ ..||+|++..... ....+.+.+|+.+++.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357889999999999999998766 8899999865432 2245678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||+++++|.+.+..... +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999977554 99999999999999999999999999999999999999999999999999875443211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 244 (334)
... ....+++.|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+.... ...+...+..+.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11236788999999965555 589999999999999998 899998877777776665443 34456689999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=321.24 Aligned_cols=253 Identities=23% Similarity=0.398 Sum_probs=200.9
Q ss_pred ccceEEeeeeeccCceEEEEEEE-----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
-++|++.+.||+|+||.||+|.+ ..+++.||||.+..... ......+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 36899999999999999999984 34678899999975332 22346788999999999 589999999987654
Q ss_pred -CeEEEEEeccCCCchHHHHHhcC--------------------------------------------------------
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHG-------------------------------------------------------- 106 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~-------------------------------------------------------- 106 (334)
...++|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 56899999999999999886421
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 107 -----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 107 -----------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
.++...+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 356777888999999999999999999999999999999999999999998865322111111112234
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHhhc-CccCCCCCCCHHHHHHHHHhcCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISA-AEFTCPPWLSFTARKLIARILDPN 252 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~d 252 (334)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||....... ....+.. .....|...++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 667999999987665 488999999999999997 999998654322 2222222 234456668899999999999999
Q ss_pred CCCCCCHhHHhcC
Q 019904 253 PMTRITIPEILED 265 (334)
Q Consensus 253 p~~Rpt~~e~l~h 265 (334)
|.+|||+.++++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=307.18 Aligned_cols=242 Identities=23% Similarity=0.384 Sum_probs=199.8
Q ss_pred eeeeccCceEEEEEEECCCCC--eEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 17 RTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
+.||+|+||.||+|.+..++. .+++|.+... ......+.+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999987775 4688877532 2223346788999999999 7999999999999999999999999
Q ss_pred CCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 94 TGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 94 ~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999997643 378899999999999999999999999999999999999999999999998
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCC
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~ 235 (334)
+....... .......+..|+|||.+....+ +.++|||||||++|+|++ |..||.+.+.......+... ....+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 75322111 0111223567999999977665 589999999999999997 99999887777766665443 234556
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++.++.+++.+||..||.+|||+++++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 68899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=303.63 Aligned_cols=243 Identities=23% Similarity=0.359 Sum_probs=199.9
Q ss_pred eeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 18 TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
.||.|+||.||+|.+. ..+..||+|++.... .....+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999765 345579999986542 2334567889999999999999999999885 4578999999999
Q ss_pred CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC-Cccccc
Q 019904 96 GELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTT 173 (334)
Q Consensus 96 ~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~ 173 (334)
++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......... ......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998875 457899999999999999999999999999999999999999999999999988643221111 011112
Q ss_pred ccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 019904 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 251 (334)
.++..|+|||.+....+ +.++|||||||++|++++ |..||.+.........+... ....|+..++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23568999999887665 488999999999999996 99999887777766655443 3456777899999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019904 252 NPMTRITIPEILE 264 (334)
Q Consensus 252 dp~~Rpt~~e~l~ 264 (334)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=304.30 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=208.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
...|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .....+.+.+|+.+++.++||||+++.+++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999876554 69999886532 222356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+||||+++++|.+++... +.+++..+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999999999998764 578999999999999999999999999999999999999999999999999876443211
Q ss_pred CCCcc-cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 166 DDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
..... .....+..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11110 11123457999999987665 588999999999999997 99999887777776666543 2233445788999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.16 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=210.1
Q ss_pred cceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
.+|++.+.||.|+||.||+|+... ..+.|++|.+.... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999653 34679999876432 22345778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
.|+||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999998765 68999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCcc--CC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF--TC 233 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~~--~~ 233 (334)
++...... .........++..|+|||.+.+... +.++||||||+++|+|++ |..||...........+..... ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 87633211 1111223345678999999887665 488999999999999998 8999987766666666654433 34
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 234 PPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 234 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+..++..+.+++.+||+.+|.+|||+.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 56688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=308.20 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=198.1
Q ss_pred cce-EEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--
Q 019904 11 GKY-EVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (334)
Q Consensus 11 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 83 (334)
+|| ++.+.||+|+||+||++. ...++..||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 566 999999999999998764 335678899999875421 22346678899999999999999999987653
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
...|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4689999999999999988764 599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH--HHH-------------HHhh
Q 019904 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM--NLY-------------KKIS 227 (334)
Q Consensus 164 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~--~~~-------------~~~~ 227 (334)
.... .......++..|+|||.+.+..+ +.++|||||||++|+|++|..||...... +.. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 11122245667999999987665 48999999999999999999998643211 110 0010
Q ss_pred -cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 228 -AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 228 -~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+.+..++..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1122345668899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=308.97 Aligned_cols=238 Identities=23% Similarity=0.311 Sum_probs=196.0
Q ss_pred eeeeccCceEEEEEEECCCCC-------eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 17 RTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+.||.|+||.||+|.+...+. .||+|.+.... ....+.+.+|+.+++.+.||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999998865443 48888875432 23356788899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC--------eEEeeccchhc
Q 019904 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LKVSDFGLSAL 160 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~--------~kl~Dfg~a~~ 160 (334)
|||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987765 69999998753
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcCccCCCCCCCH
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTCPPWLSF 239 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (334)
... .....++..|+|||.+.+....+.++|||||||++|+|++| ..||...+...... ........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence 321 12346788999999998755456889999999999999998 56776655544333 22334556666788
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 240 TARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.++|.+||+.||++|||++++++
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=315.77 Aligned_cols=261 Identities=31% Similarity=0.562 Sum_probs=235.4
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (334)
..+...|.++..||+|+||.|.+|..+.+.+.||||+++++...+.+..+--..|-++|.... -|.+++++.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 445678999999999999999999999999999999998876655554555556777777664 7899999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+.||+|.-.+..-+++.|..+..++..|+-||-+||++||+.||||.+||+++.+|++||+|||++.- ...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998752 334
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
......+.+|||.|+|||++..++| +..+|-||+|+++|||+.|+.||.+.+..++++.|......+|..+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 4455678899999999999999888 489999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
...|.+.|.+|.. -.++-.||||+.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhh
Confidence 9999999999974 367889999985
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=301.58 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=208.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+|++.+.||.|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++|||++++++++......++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999999999885 4678999988654332 24577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+++|.+++... ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-c
Confidence 9999999999998764 4689999999999999999999999999999999999999999999999998764322111 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 246 (334)
......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1112234568999999987665 488999999999999998 99999988877777766544 23345567899999999
Q ss_pred HhcCCCCCCCCCHhHHhc
Q 019904 247 RILDPNPMTRITIPEILE 264 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~ 264 (334)
+||+.+|++|||+.++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 236 HCWKERPEDRPSFSLLLH 253 (256)
T ss_pred HHcccChhhCCCHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=335.83 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=213.5
Q ss_pred cceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..-...+.||.|.||.||+|+... ....||||.++... ..+..++|++|+.++..++|||||++++++..++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 345668899999999999998542 34569999987543 34457899999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 86 IFIVLEFVTGGELFDKIVNHG--------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
+|+|+|||..|||.++|+.+. +++..+.+.|+.||+.|+.||-++.+|||||-..|+||+++-.||
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEE
Confidence 999999999999999997643 278889999999999999999999999999999999999999999
Q ss_pred EeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc
Q 019904 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~ 230 (334)
|+|||+++.......-.......-...|||||.+....+. ++|||||+||++||+++ |+.||.+-+..+.++.+..+.
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999854332111111011123579999999988885 89999999999999998 999999999999988887765
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHH
Q 019904 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEI 262 (334)
Q Consensus 231 -~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 262 (334)
.+.|..+|.++.+|+..||+.+|.+||++.||
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 57889999999999999999999999999998
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=304.24 Aligned_cols=239 Identities=22% Similarity=0.292 Sum_probs=193.6
Q ss_pred eeeeccCceEEEEEEECC------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 17 RTIGEGTFAKVKFARNSE------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
+.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22358899876432 233567888999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC-------eEEeecc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG 156 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~-------~kl~Dfg 156 (334)
..++||||+++++|..++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998888754 56899999999999999999999999999999999999987664 8999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHH-hCCCCCCCCcHHHHHHHhhcCccCCCC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISAAEFTCPP 235 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~-~g~~pf~~~~~~~~~~~~~~~~~~~~~ 235 (334)
++..... .....++..|+|||.+......+.++|||||||++|+|+ +|..||......+... ..........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCC
Confidence 8754321 123457888999999875454568899999999999997 5899998765444322 2233333344
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
..+.++.+||.+||+.||.+||++.+++++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=309.38 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=207.3
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 84 (334)
.....+.|++.+.||.|++|.||+|.+..+++.||||.+...... .....+.+|+.++.... ||||+++++++....
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 455778999999999999999999999988999999999754321 22345556776666665 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+.+ ++.+.+.. ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999999865 66666654 4578999999999999999999997 599999999999999999999999999876432
Q ss_pred cccCCCcccccccCCcccChHhhhcCC---CCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCc-cCCC--C
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAE-FTCP--P 235 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~~~~~~~~~-~~~~--~ 235 (334)
.. .......++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.||..... .+....+.... ...+ .
T Consensus 167 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06618 167 DS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243 (296)
T ss_pred CC---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence 21 1122335778999999987543 235789999999999999999999976322 23333332222 2222 2
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.++.++.+|+.+||+.||.+||++++++.||||...
T Consensus 244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 378899999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=300.82 Aligned_cols=248 Identities=22% Similarity=0.367 Sum_probs=205.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||++.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++++.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4678999999999999999999865 456699998865322 24568889999999999999999999877 77899
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 156 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 156 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-
Confidence 99999999999999764 357888899999999999999999999999999999999999999999999876432211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
........++..|+|||.+....+ +.++|+|||||++|++++ |..||.+.+.......+... ..+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 111112234567999999976555 588999999999999998 99999988777666655443 234456788999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||+.+|++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=303.97 Aligned_cols=265 Identities=29% Similarity=0.434 Sum_probs=217.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-----
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 82 (334)
...++|....+||+|.||.||+|+...+|+.||+|++--++ .++..-....+|+++|+.++|+|++.+++++.+
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 35678999999999999999999999999999998764322 123334556789999999999999999887643
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 83 ---KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 83 ---~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
...+|+||.+|.. +|.-.+... .+++..++..++.+++.||.|+|++.|+|||+||.|+||+.+|.++|+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3569999999987 888888665 47999999999999999999999999999999999999999999999999999
Q ss_pred hccccccCC--CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cc---
Q 019904 159 ALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF--- 231 (334)
Q Consensus 159 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~--- 231 (334)
+........ ..+...+-|++|++||.+.+...++++.|||.-|||+.+|+||.+.+.+.+....+..|... .+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 754332221 12334566999999999999888889999999999999999999999998877766655321 00
Q ss_pred -----------------CCCC-------------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 232 -----------------TCPP-------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 232 -----------------~~~~-------------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+.|. .-++++-+|+.+||..||.+|++++++|+|.||.+..-+
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0111 024578899999999999999999999999999976554
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-45 Score=325.89 Aligned_cols=259 Identities=32% Similarity=0.595 Sum_probs=238.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
-.+...+++..||.|+||.|=++........+|+|++++.-..+....+.+..|-.+|...+.|+||++|..|.+..+.|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 45667788899999999999999877666669999999887777777899999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+.||-|-||.|+..++..+.+.+...+.++..+++|++|||++||+.|||||+|++++.+|-+||.|||+|..... .
T Consensus 497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---g 573 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---G 573 (732)
T ss_pred hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999986543 4
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCCCCCCHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLI 245 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li 245 (334)
....+.||||.|.|||++.+.+.+ .++|.||||+++||+++|.+||.+.+++..++.|..+- ..+|..++..+.+||
T Consensus 574 ~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred CceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 445678999999999999999987 88999999999999999999999999999999887653 577899999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
.++...+|.+|.. +.++-+|.||..
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 9999999999985 889999999975
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=298.87 Aligned_cols=243 Identities=25% Similarity=0.430 Sum_probs=201.2
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
+.||.|+||.||+|... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999864 68889999986532 2223456889999999999999999999999999999999999999
Q ss_pred chHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccccc
Q 019904 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (334)
Q Consensus 97 ~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 175 (334)
+|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 999988754 4578999999999999999999999999999999999999999999999998764221110 01111233
Q ss_pred CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCC
Q 019904 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (334)
Q Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp 253 (334)
+..|+|||.+....+ +.++||||||+++|++++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 567999999976655 588999999999999998 99999887766665555443 234566789999999999999999
Q ss_pred CCCCCHhHHhc
Q 019904 254 MTRITIPEILE 264 (334)
Q Consensus 254 ~~Rpt~~e~l~ 264 (334)
++|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=304.01 Aligned_cols=245 Identities=22% Similarity=0.270 Sum_probs=192.1
Q ss_pred eeeeccCceEEEEEEECC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996432 34568888775432 22334567889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 95 ~~~L~~~l~~~~-----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
+|+|.+++.... ..++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997653 245778889999999999999999999999999999999999999999998764221111111
Q ss_pred ccccccCCcccChHhhhcC------CCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cc-----CCCCC
Q 019904 170 LHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF-----TCPPW 236 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~-----~~~~~ 236 (334)
.....++..|+|||++... ...+.++|||||||++|+|++ |..||......+........ .. ..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1223456779999998532 233578999999999999998 88999877665554443222 21 22345
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++....+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999999 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=302.75 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=206.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
.-.+|++.+.||.|+||.||+|.+... ...||||...... .....+.+.+|+.+++.+.||||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987543 3468999886432 12335678899999999999999999998875 45
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.|+||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997754 5899999999999999999999999999999999999999999999999987643321
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
... ......++..|+|||.+....+ +.++|||||||++|++++ |..||.+.+..+....+... ....++.++..+.
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (270)
T cd05056 161 SYY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 238 (270)
T ss_pred cce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHH
Confidence 110 1112233467999999876665 488999999999999986 99999887776666555443 3456677899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++|.+||..+|++|||+.+++.
T Consensus 239 ~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 239 SLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=306.04 Aligned_cols=238 Identities=24% Similarity=0.292 Sum_probs=192.4
Q ss_pred eeeccCceEEEEEEECC------------------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe
Q 019904 18 TIGEGTFAKVKFARNSE------------------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 73 (334)
.||+|+||.||+|.... ....|++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999987422 12358899886432 2334667889999999999999
Q ss_pred eeEEEEEeeCCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC----
Q 019904 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---- 148 (334)
Q Consensus 74 v~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---- 148 (334)
+++++++......++||||+++++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988865 45789999999999999999999999999999999999998654
Q ss_pred ---CeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHH-hCCCCCCCCcHHHHHH
Q 019904 149 ---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYK 224 (334)
Q Consensus 149 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~-~g~~pf~~~~~~~~~~ 224 (334)
.++++|||.+..... .....++..|+|||.+.+....+.++|||||||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 379999998653211 122356788999999876554568999999999999984 7999998766544333
Q ss_pred HhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 225 KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.. ......|...+..+.++|.+||+.+|++|||+.+++++
T Consensus 233 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22 22334455567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=311.87 Aligned_cols=249 Identities=20% Similarity=0.358 Sum_probs=197.5
Q ss_pred CceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHHH
Q 019904 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (334)
Q Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l 102 (334)
++|.||.+++..+++.||+|++..... .......+.+|+.+++.++||||+++++++......|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 556667777777899999999976432 2334678999999999999999999999999999999999999999999998
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC-----CCccccccc
Q 019904 103 VNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCG 175 (334)
Q Consensus 103 ~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~~~~~g 175 (334)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.+|.++|+|||.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 764 4689999999999999999999999999999999999999999999999998753321111 111233456
Q ss_pred CCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHH-HHhhcCc-----------------------
Q 019904 176 TPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISAAE----------------------- 230 (334)
Q Consensus 176 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~-~~~~~~~----------------------- 230 (334)
+..|+|||++... ...+.++|+||+||++|+|++|..||......... .++....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 7789999999753 22357899999999999999999999865433322 2221100
Q ss_pred ----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 ----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
...+..++.++.+|+.+||+.||++|||++++|+||||....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112356788999999999999999999999999998554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=308.99 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=205.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..+.|+..+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 35678999999999999999999877775 468888764322 22234678899999999999999999998654
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..++++||+++|+|.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 4678999999999999987754 689999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+... ..+.++..+..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV 240 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 211111122345678999999987665 488999999999999997 99999876655544444332 234456678999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 242 RKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+++.+||..+|++||+++++++.
T Consensus 241 ~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 241 YMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=300.25 Aligned_cols=242 Identities=26% Similarity=0.456 Sum_probs=203.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++.+.||+|+||.||.+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 357899999999999999999864 67889999986532 135678899999999999999999998654 4789
Q ss_pred EEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997654 5789999999999999999999999999999999999999999999999987643221
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
......+..|+|||.+.+..+ +.++|+|||||++|+|++ |+.||...+.......+... ....+..++..+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 112234567999999876665 488999999999999997 99999888776666655443 234456688999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||+.+|++||++++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 230 MTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=301.75 Aligned_cols=229 Identities=29% Similarity=0.431 Sum_probs=192.4
Q ss_pred cCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHH
Q 019904 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK 101 (334)
Q Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~ 101 (334)
|.+|.||++++..+++.||+|.+..... ..+|...+....||||+++++++......|+||||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976432 22344445556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccC
Q 019904 102 IVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181 (334)
Q Consensus 102 l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 181 (334)
+.+..++++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 988888999999999999999999999999999999999999999999999999976543221 123345778999
Q ss_pred hHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCH--
Q 019904 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI-- 259 (334)
Q Consensus 182 PE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~-- 259 (334)
||.+....+ +.++|+||+||++|+|++|..|+....... ........|+.++..++++|.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876665 488999999999999999999876432211 0112234677899999999999999999999985
Q ss_pred ---hHHhcCccc
Q 019904 260 ---PEILEDEWF 268 (334)
Q Consensus 260 ---~e~l~h~~~ 268 (334)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=305.35 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=199.4
Q ss_pred ceEEeeeeeccCceEEEEEEE----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--Ce
Q 019904 12 KYEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TK 85 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~~ 85 (334)
-|++++.||+|+||.||+|.. ..++..||+|.+.... .......+.+|+.+++.+.||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 468999999999999999974 4567889999986442 233356789999999999999999999998775 57
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999999999999987653 5899999999999999999999999999999999999999999999999998754321
Q ss_pred cCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---------------HHHHHHHhh-
Q 019904 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---------------LMNLYKKIS- 227 (334)
Q Consensus 165 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---------------~~~~~~~~~- 227 (334)
... .......++..|+|||.+.+..+ +.++|||||||++|+|+++..|+.... .......+.
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 11123446678999999887665 488999999999999999877653211 011111111
Q ss_pred cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 228 AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 228 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+.+..++..+.+|+.+||+.||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1223445668999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=304.11 Aligned_cols=245 Identities=24% Similarity=0.356 Sum_probs=201.3
Q ss_pred eeeeccCceEEEEEEECCCC------CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 17 RTIGEGTFAKVKFARNSETG------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.||+|+||.||+|.+...+ +.+|+|.+.... .......+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876433 679999875432 1223457888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-----CeEEeeccch
Q 019904 91 EFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLS 158 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-----~~kl~Dfg~a 158 (334)
||+++++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998653 2377889999999999999999999999999999999999887 8999999988
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCC
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 236 (334)
................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+... .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 64322111111122345678999999987665 589999999999999998 99999887766666655433 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+|..+.++|.+||..+|.+||+++++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=302.27 Aligned_cols=245 Identities=20% Similarity=0.230 Sum_probs=191.6
Q ss_pred eeeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
+.||+|+||.||+|... .++..+|+|.+...... .....+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999754 34567999988654322 223568889999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 95 ~~~L~~~l~~~~-----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
+|+|.+++.... ..+...+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999987532 356677888999999999999999999999999999999999999999998864322111111
Q ss_pred ccccccCCcccChHhhhcCC------CCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc-Ccc--C---CCCC
Q 019904 170 LHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEF--T---CPPW 236 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~-~~~--~---~~~~ 236 (334)
.....++..|+|||++.+.. ..+.++|+|||||++|+|++ |..||......+....... ... . ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22345678899999986432 23578999999999999996 9999987665554332221 111 1 1224
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+..+.+++++|+ .+|++|||+++++.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.73 Aligned_cols=251 Identities=31% Similarity=0.467 Sum_probs=204.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC--CC----eeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PN----VVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~----iv~~~~~~~~~ 83 (334)
.+||.+++.+|.|.||.|..+.+..++..||||+++.-. ...+...-|+.+|+++.+ |+ +|.+.++|.-.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 679999999999999999999999999999999986422 234556679999999952 32 78888999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---------------
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--------------- 146 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~--------------- 146 (334)
++.|+|+|.+ |-|+++++..+. +++...++.+..|+++++++||+.+++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999988 449999998865 7999999999999999999999999999999999999832
Q ss_pred -----CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH
Q 019904 147 -----YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (334)
Q Consensus 147 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~ 221 (334)
+..++++|||.|+...+. -.+.+.|..|+|||++.+.++. ..+||||+||||+|+++|...|...+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHH
Confidence 224899999998864432 2455789999999999999996 88999999999999999999998766444
Q ss_pred HHHHhhcCccCCCCC----------------------------------------------CCHHHHHHHHHhcCCCCCC
Q 019904 222 LYKKISAAEFTCPPW----------------------------------------------LSFTARKLIARILDPNPMT 255 (334)
Q Consensus 222 ~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~li~~~L~~dp~~ 255 (334)
.+..+.....++|.. --.++-+||++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 222221111111100 0124679999999999999
Q ss_pred CCCHhHHhcCccccCC
Q 019904 256 RITIPEILEDEWFKKD 271 (334)
Q Consensus 256 Rpt~~e~l~h~~~~~~ 271 (334)
|+|+.|+|.||||...
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 9999999999999753
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.69 Aligned_cols=251 Identities=24% Similarity=0.400 Sum_probs=198.7
Q ss_pred ccceEEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--C
Q 019904 10 VGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 83 (334)
..+|++.+.||+|+||.||.|. +..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 3589999999999999999987 44578899999986533 2335678899999999999999999998643 3
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..+++||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5689999999999999999764 468999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCC-cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH----------------HHHH
Q 019904 163 QVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----------------LYKK 225 (334)
Q Consensus 163 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~----------------~~~~ 225 (334)
...... ......++..|+|||.+.+..+ +.++|||||||++|+|++|..|+....... +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 211110 0111123446999999987665 488999999999999999887764332110 1111
Q ss_pred hhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 226 ISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 226 ~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.. ...+.+..++.++.+|+.+||+.+|++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 123445568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=335.32 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=213.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCC-----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..-++.+.||+|.||.||.|....... .||||.+.+ ..+.+....+.+|..+|+.++|||||++++++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 456788999999999999998654333 388888764 3456667889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
.++++|||.||+|..+|++.+ .++..+...++.||++|+.||+++++|||||..+|+|++....|||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999999999862 4888999999999999999999999999999999999999999999999999
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHH-HhhcCccCCCCC
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK-KISAAEFTCPPW 236 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~-~~~~~~~~~~~~ 236 (334)
+...............-...|||||.+....+ +.++|||||||++||+++ |..||.+.+..+... -...+....|..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 83321111000000011357999999998555 699999999999999998 999999988888776 555668888999
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++..+.++|..||+.+|++||++..+++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=300.24 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=202.1
Q ss_pred eEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 019904 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 84 (334)
|++.+.||+|+||.||+|.+. .+++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678899999999999999864 357889999986543 22333567889999999999999999999875532
Q ss_pred -eEEEEEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 85 -KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 85 -~~~~v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
..+++++|+.+|+|.+++... ..++...+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999998877532 2478899999999999999999999999999999999999999999999998
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCC
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~ 235 (334)
+................+++.|++||.+....+ +.++|||||||++|+|++ |..||.+.+..+....+... ....++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 875322111111122334568999999987666 478999999999999999 99999887776666655443 334456
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+..+.+++.+||+.+|++|||+.+++.
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 68899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.82 Aligned_cols=258 Identities=32% Similarity=0.524 Sum_probs=208.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-------
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM------- 80 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~------- 80 (334)
+....|+.++.||+||||.||+++++-+|+.||||.+.... .......+.+|+..|.+|+|||||+++..|
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 56778899999999999999999999999999999998754 344467788999999999999999997321
Q ss_pred -----------------------------------------------------e------------------e-------
Q 019904 81 -----------------------------------------------------G------------------S------- 82 (334)
Q Consensus 81 -----------------------------------------------------~------------------~------- 82 (334)
. +
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0 0
Q ss_pred --------------------------C--------CeEEEEEeccCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHH
Q 019904 83 --------------------------K--------TKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYC 127 (334)
Q Consensus 83 --------------------------~--------~~~~~v~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~qil~~l~~L 127 (334)
+ ..+||-||||+...+.+++.++... ..+.++.++++|++||+|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 1378999999997778777776644 4778999999999999999
Q ss_pred HhCCcEEeecCCCCEEEecCCCeEEeeccchhccc----c--c----------cCCCcccccccCCcccChHhhhcCC--
Q 019904 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----Q--V----------RDDGLLHTTCGTPNYVAPEVLNDRG-- 189 (334)
Q Consensus 128 H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~----~--~----------~~~~~~~~~~gt~~y~aPE~~~~~~-- 189 (334)
|+.|||||||||.||+++.++.|||+|||+|.... . . .......+.+||-.|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999987611 0 0 0111335568999999999998766
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccCCCCCC----CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 190 YDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 190 ~~~~~~DiwslG~il~e~~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++.|+||||||+|++||+. ||... .....+..+..+.++.|+.+ -+....+|+.||+.||++||||.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 45699999999999999985 56532 33455666666666655222 235678999999999999999999999
Q ss_pred CccccC
Q 019904 265 DEWFKK 270 (334)
Q Consensus 265 h~~~~~ 270 (334)
+.||..
T Consensus 871 s~llpp 876 (1351)
T KOG1035|consen 871 SELLPP 876 (1351)
T ss_pred ccCCCc
Confidence 999974
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=297.56 Aligned_cols=245 Identities=24% Similarity=0.348 Sum_probs=195.8
Q ss_pred eeeeccCceEEEEEEECC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe-eCCeEEEEEec
Q 019904 17 RTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEF 92 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e~ 92 (334)
+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998643 34579999875322 2233567888999999999999999999765 45668999999
Q ss_pred cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC--CCc
Q 019904 93 VTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGL 169 (334)
Q Consensus 93 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~ 169 (334)
+.+++|.+++.... .++...+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 99999999987643 467778889999999999999999999999999999999999999999998864322110 011
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 247 (334)
.....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+.... ...+..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 112345678999999987665 488999999999999999 577787777666665554433 33455678999999999
Q ss_pred hcCCCCCCCCCHhHHhc
Q 019904 248 ILDPNPMTRITIPEILE 264 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~ 264 (334)
||+.+|++||++.++++
T Consensus 238 cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 238 CWHPKPEMRPTFSELVS 254 (262)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=316.09 Aligned_cols=257 Identities=33% Similarity=0.545 Sum_probs=221.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
-|..++.||-|+||.|.++...++...||.|.+++...........++.|-.||.....+.||++|..|.+.+++|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 48889999999999999999999999999999999888888888999999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC---
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG--- 168 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~--- 168 (334)
|++||++..+|.+-+-|+|+.++.++..+..|+++.|..|+|||||||+||||+.+|++||+|||+++...-.....
T Consensus 710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999975421111000
Q ss_pred -------------------------------------cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCC
Q 019904 169 -------------------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211 (334)
Q Consensus 169 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~ 211 (334)
.....+||+.|+|||++...++. ..+|-||.|+|||||+.|+
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhhCC
Confidence 01224699999999999988885 8899999999999999999
Q ss_pred CCCCCCcHHHHHHHhhc----CccCCCCCCCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccC
Q 019904 212 LPFDDSNLMNLYKKISA----AEFTCPPWLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (334)
Q Consensus 212 ~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~ 270 (334)
.||-..+..+...++.. ..++.-..+|.++.++|.++. -+++.|. .++++-.||||+.
T Consensus 869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 99987665554444322 223344569999999999876 5677776 4678999999985
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.27 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=203.3
Q ss_pred ccceEEeeeeeccCceEEEEEEEC----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--C
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 83 (334)
...|++.+.||+|+||.||+|... .+++.||+|++...... ...+.+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357888999999999999999864 34788999999754432 345778999999999999999999999877 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
...++||||+++++|.+++.... .++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997755 68999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH---------------HHHHh
Q 019904 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------------LYKKI 226 (334)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~---------------~~~~~ 226 (334)
..... .......++..|+|||.+.+... +.++|||||||++|+|++|..|+....... ....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 21111 11112234567999999987665 488999999999999999999986532211 11111
Q ss_pred hc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 227 SA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 227 ~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.. ...+.+..++.++.+++.+||+.+|.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 223445567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.07 Aligned_cols=236 Identities=21% Similarity=0.268 Sum_probs=192.2
Q ss_pred eeeeccCceEEEEEEECCCC----------CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 17 RTIGEGTFAKVKFARNSETG----------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 34788876543211 4678899999999999999999999887 778
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-------CeEEeeccch
Q 019904 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------NLKVSDFGLS 158 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-------~~kl~Dfg~a 158 (334)
++||||+++++|.+++.... .++...+..++.||+.||+|||++|++||||||+||+++.++ .++|+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 789999999999999999999999999999999999999887 7999999988
Q ss_pred hccccccCCCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCccCCCCC
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPW 236 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 236 (334)
..... .....++..|+|||.+.+. ...+.++|||||||++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 74332 2234567789999999876 344688999999999999999 688887664333222222 12222222
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.08 Aligned_cols=249 Identities=29% Similarity=0.518 Sum_probs=207.1
Q ss_pred ceEEeeeeeccCceEEEEEEECC-CCCeEEEEEeehhhh-------hhHHHHHHHHHHHHHHHh-CCCCCeeeEEEEEee
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV-------LKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS 82 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~ 82 (334)
.|++.+.||.|+||.||+|.+.. +++.+|+|.+..... .......++.+|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 678899998864221 223345667788888865 789999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
.+..++||||+++++|.+.+.. ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC-CC-
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PP- 235 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~- 235 (334)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+....... +.
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87543221 2344568889999999987665 589999999999999999999998877666665555444322 22
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++..+.++|.+||+.||++||++.|+..
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 57899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=301.12 Aligned_cols=255 Identities=16% Similarity=0.188 Sum_probs=192.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhh--hHH------HHHHHHHHHHHHHhCCCCCeee
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVL--KHK------MAEQIKREVATMKLVKHPNVVR 75 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~------~~~~~~~e~~~l~~l~h~~iv~ 75 (334)
...-++|++.+.||+|+||.||+|.+..+ +..+|+|+....... .+. .......+...++.+.|+|+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34447999999999999999999998877 677888865432211 000 0111223444566778999999
Q ss_pred EEEEEeeCC----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 76 LYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 76 ~~~~~~~~~----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
++++..... ..+++++++.. ++.+.+......++..+..++.|++.||+|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765443 45788888754 6777776666678899999999999999999999999999999999999999999
Q ss_pred EeeccchhccccccC-----CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HH----
Q 019904 152 VSDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MN---- 221 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~---- 221 (334)
|+|||+|+....... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999875432111 111223469999999999987766 5899999999999999999999987632 11
Q ss_pred ----HHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 222 ----LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 222 ----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+...... ++..+..+.+++..|++.+|.+||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22333333322 3346889999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=300.72 Aligned_cols=253 Identities=28% Similarity=0.461 Sum_probs=213.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
...||.-++.+|.|.- .|..|.|...++.||+|.+..+ ........+..+|..++..++|+||++++.+|....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 4568999999999999 8889999999999999998776 444555688899999999999999999999996654
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+|||++.. +|...+. -.+....+..++.|++.|++|||+.||+||||||+||++..++.+|++|||+|+...
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 47999999986 7877775 347788999999999999999999999999999999999999999999999988543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---------- 232 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---------- 232 (334)
.. -.....+.|+.|+|||++.+.++ ...+||||+||++.||++|+..|+|.+..+++.++......
T Consensus 170 ~~---~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 TD---FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cc---cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 32 23455688999999999999886 48899999999999999999999998877776665321110
Q ss_pred ---------------------CCC-----------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 233 ---------------------CPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 233 ---------------------~~~-----------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+|+ .-+..+++++.+||-.||++|.+++++|+|||++-
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 111 11345899999999999999999999999999973
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=296.49 Aligned_cols=245 Identities=18% Similarity=0.248 Sum_probs=191.2
Q ss_pred eeeeccCceEEEEEEECCC--CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
+.||+|+||.||+|..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975432 34566777654322 2235678899999999999999999999999999999999999
Q ss_pred CCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 95 GGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 95 ~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
+|+|.+++.... .+++..+..++.||+.||+|||+.+++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999999997642 3567778899999999999999999999999999999999999999999987532111111112
Q ss_pred cccccCCcccChHhhhcCC------CCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc------cCCCCCC
Q 019904 171 HTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE------FTCPPWL 237 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~------~~~~~~~ 237 (334)
....++..|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3346788999999985321 22478999999999999996 678998766665555432221 2233457
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.+.+++..|| .+|++||+++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=308.63 Aligned_cols=264 Identities=29% Similarity=0.447 Sum_probs=220.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH----HHHHHHHHHHHHHHhCCCCCeeeEEEEEee-CC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH----KMAEQIKREVATMKLVKHPNVVRLYEVMGS-KT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 84 (334)
-+||.++..||+|||+.||+|.|...+++||+|+-...+.+.+ ...+..-+|..|.+.|.||.||++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 4689999999999999999999999999999999877665543 445677899999999999999999999964 56
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcEEeecCCCCEEEec---CCCeEEeeccchh
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--GVYHRDLKPENLLLDA---YGNLKVSDFGLSA 159 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--~i~H~dlkp~NIl~~~---~~~~kl~Dfg~a~ 159 (334)
.+|-|+|||+|.+|.-+|+.++.+++.+++.|+.||+.||.||... -|+|-||||.|||+.. .|.+||+|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999999999999999999999999999999999999976 5999999999999954 4679999999998
Q ss_pred ccccccCC-----CcccccccCCcccChHhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHH---hh
Q 019904 160 LSQQVRDD-----GLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKK---IS 227 (334)
Q Consensus 160 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~---~~ 227 (334)
+......+ .......||.+|+|||.+.- .+..+.++||||+|+|+|.++.|+.||.... ..++++. +.
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 76543222 22334578999999999852 4455689999999999999999999998643 3334332 22
Q ss_pred cCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 228 AAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 228 ~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.+ ++..+-++.++++||++||+..-..|..+.++-.||||.....
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r 749 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR 749 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence 333 4444569999999999999999999999999999999986443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=307.88 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=201.8
Q ss_pred CcccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 2 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
+...+....+.|.-...||+|+||.||+|.-.. |..||||.+....... ..++.+|+.++.+++|||+|+++++|.
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 455677788899999999999999999999854 4889999776533221 345999999999999999999999999
Q ss_pred eCC-eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cEEeecCCCCEEEecCCCeEEeec
Q 019904 82 SKT-KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDAYGNLKVSDF 155 (334)
Q Consensus 82 ~~~-~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~Df 155 (334)
+.+ ..++|+||++.|+|.+.|.... ++++....+|+.+++.||+|||... |+||||||+|||++.+...||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 888 5999999999999999998765 8999999999999999999999854 999999999999999999999999
Q ss_pred cchhccccccCCCccccc-ccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHH----Hhh
Q 019904 156 GLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYK----KIS 227 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~----~~~ 227 (334)
|+|...... ....... .||..|+|||.+..... +.++||||||+++.|++||+.|..... ...+.. .+.
T Consensus 222 GLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 222 GLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCcccCCcc--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999643321 1111222 79999999999986444 689999999999999999998876432 111111 111
Q ss_pred cCc------cCCC-CCCC--HH---HHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 228 AAE------FTCP-PWLS--FT---ARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 228 ~~~------~~~~-~~~~--~~---~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
... ..+. ...+ .. +..+..+|++.+|..||++.++++
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 110 1111 1223 22 456778999999999999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=290.30 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=202.4
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
+-+..||+|+||+|++..++.+|+..|||.++..... ...+++..|... ++.-+.||||++|+....++..|+.||+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 3456799999999999999999999999999876543 335666677665 4555699999999999999999999999
Q ss_pred cCCCchHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 93 VTGGELFDKIV-----NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 93 ~~~~~L~~~l~-----~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+- ||..+.+ ....++|+.+-.+....+.||.||-.. .|+|||+||+|||++..|.+||||||++.... .
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~ 220 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---D 220 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH---H
Confidence 975 5533222 235799999999999999999999864 89999999999999999999999999876432 2
Q ss_pred CCcccccccCCcccChHhhhcCCC-CCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCccCC---CC---CCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGY-DGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEFTC---PP---WLS 238 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~~~~~---~~---~~~ 238 (334)
+-....-.|...|||||.+..... +..+||+||||+++||+.||+.|+.+-+ ..+++..+..+.++. +. .++
T Consensus 221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 222334578999999999974332 3489999999999999999999998643 344444444444322 22 278
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..+..||.-||.+|.+.||.+.+++++||++...
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 8999999999999999999999999999998543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=288.53 Aligned_cols=259 Identities=31% Similarity=0.590 Sum_probs=231.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (334)
-+..|++++.||+|+|+.|..++...+.+.||+|++.++-.+..+.+...+.|-.+.... +||.+|-++.+|.+++.++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 467899999999999999999999999999999999988877777778888888877766 5999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+|.||.+||+|.-.+.+.+++|++.++.+...|+.||.|||+.||+.||||..|||++..|++||+|+|...- .....
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCCCC
Confidence 9999999999988888889999999999999999999999999999999999999999999999999998753 33345
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC--------CcHHHHHHHhhcCccCCCCCCCH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD--------SNLMNLYKKISAAEFTCPPWLSF 239 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~--------~~~~~~~~~~~~~~~~~~~~~~~ 239 (334)
....+.+|||.|.|||++.+..| +..+|-|+||++++||+.|+.||.- .+..-+++-|......+|..+|-
T Consensus 406 d~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 55678899999999999999887 5999999999999999999999952 23344566777778889999999
Q ss_pred HHHHHHHHhcCCCCCCCC------CHhHHhcCccccC
Q 019904 240 TARKLIARILDPNPMTRI------TIPEILEDEWFKK 270 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rp------t~~e~l~h~~~~~ 270 (334)
.+..+++..|++||.+|. .+.++-.|+||+.
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999995 4788999999984
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=314.68 Aligned_cols=201 Identities=33% Similarity=0.555 Sum_probs=174.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 84 (334)
-+-|...+.||+|+||.||+++++.+|+.||||.++.... ....++.-+|+++|++++|||||++.++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~--~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS--LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcc--cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 3567888999999999999999999999999999986442 223567789999999999999999999876554
Q ss_pred -eEEEEEeccCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--CC--CeEEeecc
Q 019904 85 -KIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YG--NLKVSDFG 156 (334)
Q Consensus 85 -~~~~v~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~--~~--~~kl~Dfg 156 (334)
.-.+|||||.||||...+.+. ..+++.+++.++.++..||.|||.+||+||||||.||++-. +| ..||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 357999999999999999764 36999999999999999999999999999999999999843 34 37999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~ 215 (334)
.|+-. .++....+.+||+.|.+||.+..+.+++..+|.||+||++|+++||..||.
T Consensus 170 ~Arel---~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 170 AAREL---DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccccC---CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 98843 345567888999999999999876666789999999999999999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=313.68 Aligned_cols=259 Identities=29% Similarity=0.428 Sum_probs=220.8
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEee-
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS- 82 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~- 82 (334)
......+.|++.+.||.|.+|.||++++..+++..|+|+...... .-+.++.|+.+|+.++ |||++.+|++|.-
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 345667899999999999999999999999999999999865432 2356778999999886 9999999999853
Q ss_pred ----CCeEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 83 ----KTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 83 ----~~~~~~v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
.+.+|+|||||.|||..|+++. ..++.|..+..|++.++.|+.+||.+.++|||+|-.|||++.+|.|||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 4679999999999999999876 3579999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~- 231 (334)
.+....... ....+.+|||+|||||++.... .+..++|+||||++..||..|.+|+-+.-++..+-.|.....
T Consensus 169 vSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP 246 (953)
T KOG0587|consen 169 VSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 246 (953)
T ss_pred eeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence 987554332 2345678999999999997432 234789999999999999999999988766666655544332
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 232 --TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 232 --~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
.-|..++.++.+||..||.+|..+||+..++|+|||+.
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 22556899999999999999999999999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=305.01 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=212.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC------CCeeeEEEEEee
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMGS 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~~ 82 (334)
-.++|.+....|+|-||+|..|.+...|+.||||+++.. +-+.+.=..|+.+|++|+. -|+++++..|..
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 357899999999999999999999999999999999754 3345566789999999973 378999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccch
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS 158 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a 158 (334)
.+++|+|+|-... +|.+.|++-+ .|....++.|+.|++.||..|-.+||+|.||||.|||++.. ..+||||||.|
T Consensus 506 knHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 506 KNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred cceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 9999999998865 8999998865 48889999999999999999999999999999999999875 45899999988
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC---
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--- 235 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 235 (334)
...... ....+.-+.+|+|||++.+.+|+ ...|+||+||+|||+.||+..|+|.+..+++.-......++|.
T Consensus 585 ~~~~en----eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml 659 (752)
T KOG0670|consen 585 SFASEN----EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML 659 (752)
T ss_pred cccccc----cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence 754432 23345567899999999999997 8899999999999999999999998877766544322222221
Q ss_pred --------------------------------------------------CCC-------HHHHHHHHHhcCCCCCCCCC
Q 019904 236 --------------------------------------------------WLS-------FTARKLIARILDPNPMTRIT 258 (334)
Q Consensus 236 --------------------------------------------------~~~-------~~~~~li~~~L~~dp~~Rpt 258 (334)
.++ ..+++|+.+||..||.+|.|
T Consensus 660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit 739 (752)
T KOG0670|consen 660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT 739 (752)
T ss_pred hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence 011 35789999999999999999
Q ss_pred HhHHhcCccccC
Q 019904 259 IPEILEDEWFKK 270 (334)
Q Consensus 259 ~~e~l~h~~~~~ 270 (334)
+.++|.||||..
T Consensus 740 ~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 740 VNQALKHPFITE 751 (752)
T ss_pred HHHHhcCCcccC
Confidence 999999999974
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=307.89 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=214.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
++.++.+.||.|+||.|++|.+...+ -.||||.++...... ...+|.+|+.+|.+|+|||++++|++..+ ..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 34566789999999999999886543 358999998765543 57899999999999999999999999987 7788
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|||++++|+|.+.|.+. ..|.-...-.++.||+.|+.||.++++|||||-..|+|+-....|||||||+.+..+...
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999999883 357788888999999999999999999999999999999998999999999988655432
Q ss_pred CCCccc-ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 166 DDGLLH-TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
+.-... ...-...|+|||.++...+. .++|||++|+++|||++ |..||.|.....+++++... ..+-|+.+|+++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 211011 11123469999999988875 89999999999999998 89999999999999988754 4577888999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+++..||..+|.+|||+..+.+.-+.
T Consensus 346 ~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999998644333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=313.25 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=177.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCC----CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEE-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSET----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV----- 79 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~----- 79 (334)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... +...++ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 678999999999999999999999888 899999987542211 111111 1111222222222111
Q ss_pred -EeeCCeEEEEEeccCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEEeecC
Q 019904 80 -MGSKTKIFIVLEFVTGGELFDKIVNHGR--------------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (334)
Q Consensus 80 -~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dlk 138 (334)
......+++||||+.+++|.+++..... .....+..++.||+.||+|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456679999999999999998865421 1234467899999999999999999999999
Q ss_pred CCCEEEec-CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCC---------------------CCCccc
Q 019904 139 PENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY---------------------DGSTAD 196 (334)
Q Consensus 139 p~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------~~~~~D 196 (334)
|+|||++. ++.+||+|||+|...... .........+++.|+|||.+..... .+.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 578999999998743221 1122345678999999997643221 124569
Q ss_pred hhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---------------------CCCCCCCHHHHHHHHHhcCCCCCC
Q 019904 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------------------TCPPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 197 iwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~li~~~L~~dp~~ 255 (334)
||||||++|||+++..|+... .......+..... ......+....+||.+||++||.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999987775432 1111111111100 011112334568999999999999
Q ss_pred CCCHhHHhcCccccCCC
Q 019904 256 RITIPEILEDEWFKKDY 272 (334)
Q Consensus 256 Rpt~~e~l~h~~~~~~~ 272 (334)
|||+.++|+||||....
T Consensus 441 R~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 441 RISAKAALAHPYFDREG 457 (566)
T ss_pred CCCHHHHhCCcCcCCCC
Confidence 99999999999998643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=279.03 Aligned_cols=240 Identities=46% Similarity=0.822 Sum_probs=206.7
Q ss_pred CceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHHH
Q 019904 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (334)
Q Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l 102 (334)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..++.++|+||+++++.+......++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999998899999999976443221 578889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccCh
Q 019904 103 VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (334)
Q Consensus 103 ~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 182 (334)
.....++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 877678999999999999999999999999999999999999999999999999887544321 23345678899999
Q ss_pred HhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccCCCCC---CCHHHHHHHHHhcCCCCCCCCC
Q 019904 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW---LSFTARKLIARILDPNPMTRIT 258 (334)
Q Consensus 183 E~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dp~~Rpt 258 (334)
|.+.+.... .++|+||||++++++++|..||.. .+.......+.......... ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999866664 799999999999999999999987 55555555555444433332 8899999999999999999999
Q ss_pred HhHHhcCccc
Q 019904 259 IPEILEDEWF 268 (334)
Q Consensus 259 ~~e~l~h~~~ 268 (334)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=285.13 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=211.3
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----eEEE
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KIFI 88 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~~ 88 (334)
+-.+.||.|+||.||.+.|..+|+.||+|.+.. ...+-...+++.+|+++|...+|.||+..+++..... .+|+
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 446789999999999999999999999998853 2334445688899999999999999999999876543 4788
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
+.|.+.. +|...+.....++.+.++-+++||+.||+|||+.||.||||||.|.|++.+..+||||||+++..... ...
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~~~ 212 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-DRL 212 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-hhh
Confidence 9999976 88888888888999999999999999999999999999999999999999999999999999865432 222
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--------------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------------- 228 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~-------------------- 228 (334)
.....+-|.+|+|||++.+...++.+.||||+|||+.|++..+..|...++.+.++.|..
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 233446688999999999988888999999999999999999999988777666554421
Q ss_pred ---CccCCCC-----------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 229 ---AEFTCPP-----------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 229 ---~~~~~~~-----------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.....|. .-..+...++..||..||++|.+.++++.|++...
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1111111 12346788999999999999999999999999864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=270.43 Aligned_cols=251 Identities=25% Similarity=0.457 Sum_probs=207.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC--e
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT--K 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 85 (334)
..+.|++.+++|+|.++.||.|++..++++++||++.+-+ .+.+++|+.+|+.|. ||||++++++..+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 5678999999999999999999999999999999987543 467899999999998 999999999987764 4
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 164 (334)
..+|+||....+...+. ..++...++.++.+++.||.|+|+.||.|||+||.|++++... .++|+|+|+|....+.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999887655443 4588899999999999999999999999999999999998755 5999999999875532
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcC-------------c
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAA-------------E 230 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~-~~~~~~~~~~~~~~-------------~ 230 (334)
......+.+.+|--||.+.+-..+....|+|||||++..|+..+.||- |.+..+++-+|... .
T Consensus 187 ---~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 187 ---KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred ---ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 234556778999999999887777788999999999999999999984 44433333332110 0
Q ss_pred cCCC------------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 FTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 ~~~~------------------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...+ ..+++++.+|+.++|..|-.+|+|+.|++.||||...
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0111 1257899999999999999999999999999999743
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.37 Aligned_cols=245 Identities=27% Similarity=0.466 Sum_probs=206.4
Q ss_pred ceEEeeeeeccCceEEEEEEECC--CCC--eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSE--TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+..+.||.|.||.||.|.... .|+ -||||....+. ..+..+.|..|+.+|+.++||||+++++++. +...|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeee-cccee
Confidence 34566789999999999998643 233 48888876532 3334788999999999999999999999995 55789
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||+++.|.|..+|..++ .++......++.||+.||+|||+.++|||||-..|||+.....|||+|||+++... +
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e---d 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE---D 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc---c
Confidence 9999999999999998875 68888999999999999999999999999999999999999999999999998543 3
Q ss_pred CCcccccccCC--cccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc-CccCCCCCCCHHHH
Q 019904 167 DGLLHTTCGTP--NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTAR 242 (334)
Q Consensus 167 ~~~~~~~~gt~--~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 242 (334)
...+....|.+ .|||||.++-..+ +.+||||.||+.+||++. |..||.+-...+.+-.+.. ...++|+.+|+.+.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY 622 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY 622 (974)
T ss_pred cchhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence 33444444543 5999999988777 489999999999999986 9999998776666655544 45789999999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHh
Q 019904 243 KLIARILDPNPMTRITIPEIL 263 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l 263 (334)
.|+.+||..+|.+||.+.++.
T Consensus 623 slmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 623 SLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHHHHhccCcccCCcHHHHH
Confidence 999999999999999988753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=294.31 Aligned_cols=263 Identities=19% Similarity=0.247 Sum_probs=188.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEEC----------------CCCCeEEEEEeehhhhhhH-----------HHHHHHHH
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNS----------------ETGEPVALKILDKEKVLKH-----------KMAEQIKR 60 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~-----------~~~~~~~~ 60 (334)
...++|.+.+.||+|+||.||+|.+. ..++.||||.+........ ...+....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35678999999999999999999752 3456799999864321110 01122334
Q ss_pred HHHHHHhCCCCCe-----eeEEEEEee--------CCeEEEEEeccCCCchHHHHHhcC---------------------
Q 019904 61 EVATMKLVKHPNV-----VRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNHG--------------------- 106 (334)
Q Consensus 61 e~~~l~~l~h~~i-----v~~~~~~~~--------~~~~~~v~e~~~~~~L~~~l~~~~--------------------- 106 (334)
|+.++.+++|.++ +++++++.. .+..++||||+.+++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6667777776554 566666542 356899999999999999886421
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChH
Q 019904 107 ---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183 (334)
Q Consensus 107 ---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 183 (334)
.++...++.++.|++.||.|||+.+|+||||||+||+++.++.++|+|||++........ .......+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChh
Confidence 234567888999999999999999999999999999999999999999999864322111 1111223478999999
Q ss_pred hhhcCCC--------------------C-CCccchhhHHHHHHHHHhCCC-CCCCCc-----------HHHHHHHhhcCc
Q 019904 184 VLNDRGY--------------------D-GSTADLWSCGVILFVLLAGYL-PFDDSN-----------LMNLYKKISAAE 230 (334)
Q Consensus 184 ~~~~~~~--------------------~-~~~~DiwslG~il~e~~~g~~-pf~~~~-----------~~~~~~~~~~~~ 230 (334)
.+..... . ..+.||||+||++|+|++|.. ||.+.. ....+.......
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9864221 1 124699999999999999876 775321 111122222222
Q ss_pred c--CCCCCCCHHHHHHHHHhcCCCC---CCCCCHhHHhcCccccCC
Q 019904 231 F--TCPPWLSFTARKLIARILDPNP---MTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 ~--~~~~~~~~~~~~li~~~L~~dp---~~Rpt~~e~l~h~~~~~~ 271 (334)
+ ...+..+..+++|+.+||.++| .+|+|++|+|+||||...
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 2 3335578999999999999866 689999999999999753
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=301.06 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=216.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.....|.+.||.|.||.||+|+.+..| ..||||.++... .+....+|..|+.||-+.+||||+++-++.......
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv 705 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV 705 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence 345678899999999999999987766 459999997533 344467899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
.||.|||++|+|..+|+.+ ++++..++..+++.|+.|++||-+.|+|||||-..|||++.+-.+|++|||+++......
T Consensus 706 MIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999999999875 578888999999999999999999999999999999999999999999999999765433
Q ss_pred CCCccccccc--CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 166 DDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...+.+..| ...|.|||.+....+ +.+|||||+|+++||.++ |..||-+.+..+.++.+..+ ..+.|..+|..+
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL 863 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL 863 (996)
T ss_pred -CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence 222222223 357999999998888 489999999999998765 99999988888888877665 456677899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+|+..||++|-.+||.+.+++.
T Consensus 864 ~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 864 YQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHHHhhcCCCHHHHHH
Confidence 99999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=289.05 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=207.2
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+..++++||+|.||.|.++.-.. +.+||+|.++.... .....++.+|+++|.+++||||++++++|..++.+++|+|
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 46789999999999999998643 68999999986543 3336889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+..|+|.+++.++. .+......+++.||+.|++||.+.++|||||.+.|||++.++++||+|||.++..........
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 999999999999884 334556677999999999999999999999999999999999999999999884322111111
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh--CCCCCCCCcHHHHHHHhhc--------CccCCCCCCCH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMNLYKKISA--------AEFTCPPWLSF 239 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~--g~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~~ 239 (334)
-...+-...|||||.+....+ +.+||+|+||+++||+++ ...||...+..+...+... .....|+-++.
T Consensus 696 qgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~ 774 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ 774 (807)
T ss_pred ecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence 111122468999999998777 589999999999999864 8899988777766655422 12345677899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
.+.+++-+||..+-.+|||++++ |.+|+
T Consensus 775 ~lyelml~Cw~~es~~RPsFe~l--h~~lq 802 (807)
T KOG1094|consen 775 GLYELMLRCWRRESEQRPSFEQL--HLFLQ 802 (807)
T ss_pred HHHHHHHHHhchhhhcCCCHHHH--HHHHH
Confidence 99999999999999999999998 44443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.68 Aligned_cols=129 Identities=29% Similarity=0.511 Sum_probs=113.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-----C---CCeeeEEEEEee
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----H---PNVVRLYEVMGS 82 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~iv~~~~~~~~ 82 (334)
+||.+.++||.|-|++||+|.|..+.+.||+|+++.. +...+....|+++|+.++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 6999999999999999999999999999999998753 345677789999999885 2 369999999965
Q ss_pred ----CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEE
Q 019904 83 ----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLL 144 (334)
Q Consensus 83 ----~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~ 144 (334)
..++|+|+|+. |.+|..+|... +.++...+++|++|||.||.|||. .||+|.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 45899999988 56888888765 469999999999999999999996 599999999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.10 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=194.5
Q ss_pred eeeeeccCceE-EEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEEecc
Q 019904 16 GRTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 16 ~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
.+.+|.|+.|+ ||+|.. .|+.||||.+-.+. ...+.+|+..|+.-+ |||||++++.-.++...|+..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 45679999987 788886 57899999764332 356779999999886 999999999999999999999999
Q ss_pred CCCchHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CC--CeEEeeccchhccccc
Q 019904 94 TGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALSQQV 164 (334)
Q Consensus 94 ~~~~L~~~l~~~~~----l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~--~~kl~Dfg~a~~~~~~ 164 (334)
.. +|.+++..+.. ......+.++.|+++||++||+.+|+||||||.||||+. ++ +++|+|||++......
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 86 99999987421 121456788999999999999999999999999999976 34 5899999998754432
Q ss_pred cC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcCccCC---CCCCCH
Q 019904 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTC---PPWLSF 239 (334)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~ 239 (334)
.. ........||-+|+|||++...... .++|||||||++|+.++| .+||...-..+ .+|....+.. .+....
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccCchH
Confidence 21 1123445789999999999976664 789999999999988885 99998643322 2233333221 222223
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
++.+||.+||+++|..||+|.++|.||+|+...+.-
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL 777 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL 777 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence 899999999999999999999999999999866543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=287.49 Aligned_cols=242 Identities=26% Similarity=0.418 Sum_probs=210.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
..+...+||-|.||.||.|.++.-.-.||||.+..+.. ..+.|..|+.+|+.++|||+|+++++|..+..+|||.|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 34567899999999999999988888899999865443 25778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||..|+|.++|++.. -++--.+..++.||..|+.||..+++|||||-..|+|+..+..||++|||++++... ..
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DT 419 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DT 419 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Cc
Confidence 999999999998864 367777888999999999999999999999999999999999999999999987543 22
Q ss_pred cccccc---CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 170 LHTTCG---TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 170 ~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
+....| ...|.|||.+..+.+. .++|||+||+++||+.| |-.||++-+..+.+.-+..+ ...-|..+++.+.+|
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred eecccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHH
Confidence 333334 3469999999877764 89999999999999988 99999998888777665544 345688899999999
Q ss_pred HHHhcCCCCCCCCCHhHH
Q 019904 245 IARILDPNPMTRITIPEI 262 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~ 262 (334)
+..||+.+|..||++.|+
T Consensus 499 MraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHhcCCcccCccHHHH
Confidence 999999999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=315.32 Aligned_cols=236 Identities=19% Similarity=0.315 Sum_probs=184.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
..|...+.||+|+||.||+|.+..++..||+|.+..... ....|+..+++++||||+++++++......|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 456667889999999999999988999999998864321 1124688899999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH---SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||+++|+|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.++..+++ ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999853 888999999999999999999 6799999999999999998887775 665432111
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-----HHHHHHHhh---------cCcc--
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKIS---------AAEF-- 231 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-----~~~~~~~~~---------~~~~-- 231 (334)
.....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ......... ....
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 122367899999999987666 589999999999999999999985321 111111000 0000
Q ss_pred --CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 232 --TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 232 --~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 001111235678999999999999999999986
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.27 Aligned_cols=206 Identities=30% Similarity=0.558 Sum_probs=184.7
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHH-----HHHHHHHHHHHHhCC---CCCeeeEE
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-----AEQIKREVATMKLVK---HPNVVRLY 77 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~---h~~iv~~~ 77 (334)
....+..|+.++.+|.|+||.|++|.++.++..|+||.+.++....... .-.+-.|++||..++ |+||++++
T Consensus 556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 3456778999999999999999999999999999999998876543222 334568999999998 99999999
Q ss_pred EEEeeCCeEEEEEeccC-CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 78 EVMGSKTKIFIVLEFVT-GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 78 ~~~~~~~~~~~v~e~~~-~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
++|++++++|++||-.. |-+|++++..+..++|.++..|++|++.|+++||+.||+|||||-+||.++.+|.+||+|||
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence 99999999999999754 55999999999999999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~ 215 (334)
.|... .+++....+||..|.|||++.+.+|.+..-|||+||+++|.++...-||.
T Consensus 716 saa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 88753 34556778999999999999999999999999999999999998888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=289.92 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=223.5
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
-+.|..+..+|.|.+|.||+|++..+++..|+|++....... ...++.|+-+++..+||||+.+++.|...+..+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 357999999999999999999999999999999997654322 45677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||||.||+|++.-.--+++++.++....+..++||+|||+.|-+|||||-.||++++.|.+|+.|||.+...... -..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--hhh
Confidence 999999999998887889999999999999999999999999999999999999999999999999987644321 223
Q ss_pred ccccccCCcccChHhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC-----CCCCHHH
Q 019904 170 LHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-----PWLSFTA 241 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 241 (334)
..+..||++|||||+-. ..+| ...+|+|++|+...|+---+.|....-++....-+....+..| ..+++.+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 46778999999999864 3344 4889999999999999888888777767776666666666555 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+|++.+|.++|++|||++.+|.|||....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999999753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=283.00 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=209.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+..+.||+|+||+||+|.+-..|+ +||||++.... .......+.+|+-.|.++.|||++++++++.... .-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 45567899999999999999876664 58999887543 2334577889999999999999999999997665 77
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|.+|+++|.|.++++.++ ++.....+.|..||++||.|||.++++||||-..|||+..-..+|+.|||+++.......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 8999999999999998865 688999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccc--CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 167 DGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 167 ~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
. +....| ...|||-|.+....+ +.++||||+||++||++| |..|+.+....++..-+..+ ..+.|+..+.++.
T Consensus 854 e--y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 854 E--YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred c--ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 2 222222 456999999987777 599999999999999988 99999998888877666544 4677899999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHh
Q 019904 243 KLIARILDPNPMTRITIPEIL 263 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l 263 (334)
-++.+||..|++.||+++++.
T Consensus 931 ~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 931 MVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHHHHhccCcccCccHHHHH
Confidence 999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=265.30 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=202.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEee
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 82 (334)
......|.++++||.|.|++||+|.+.. .+++||+|.+..-.. ..++.+|+++|..+. +.||+++.+++..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3455679999999999999999999877 788999998864322 456889999999997 8999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~ 161 (334)
++...+||||++.....++... ++...++.+++.++.||+++|.+||+||||||+|+|.+. .+.-.|+|||+|...
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 9999999999999888777754 678899999999999999999999999999999999975 467899999998621
Q ss_pred ccc---------------c----------------CCC-----------cccccccCCcccChHhhhcCCCCCCccchhh
Q 019904 162 QQV---------------R----------------DDG-----------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWS 199 (334)
Q Consensus 162 ~~~---------------~----------------~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 199 (334)
... . ..+ ......||++|+|||++...+..++++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 000 0 000 0012359999999999999888889999999
Q ss_pred HHHHHHHHHhCCCCCCCCc-HHHHHHHh---------------------hc----------------C---c-cC-----
Q 019904 200 CGVILFVLLAGYLPFDDSN-LMNLYKKI---------------------SA----------------A---E-FT----- 232 (334)
Q Consensus 200 lG~il~e~~~g~~pf~~~~-~~~~~~~~---------------------~~----------------~---~-~~----- 232 (334)
.|+|+..+++++.||-... +...+..+ .. . . .+
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 9999999999999994321 00000000 00 0 0 00
Q ss_pred -----CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 233 -----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 233 -----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..+..+..+.+|+.+||+.||.+|.|++++|+||||..
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00124557899999999999999999999999999984
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=282.90 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=204.8
Q ss_pred EEeeeeeccCceEEEEEEEC---C----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCe
Q 019904 14 EVGRTIGEGTFAKVKFARNS---E----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~---~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (334)
.+.+.||.|.||.|++|.-. . ....||||........ ...+.+..|+.+|+.+- ||||+.+++++...+.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 56669999999999998632 1 1456999988754332 44688999999999986 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 86 IFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
.++|+||+..|+|.++++..+ .++......++.||+.|++||++.+++||||-..|||++.+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998866 3888999999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCccccccc--CCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCc-HHHHHHH
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN-LMNLYKK 225 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~-~~~~~~~ 225 (334)
+||+|||+|+......... .....| ...|||||.+....+ +.++||||+|+++||+++ |..||++-. ..+++..
T Consensus 457 ~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 9999999998432211110 011122 234999999998555 599999999999999998 999999854 5566665
Q ss_pred hhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 226 ISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 226 ~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+..+. ...|..++.++.+++..||+.+|.+||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 55543 4678889999999999999999999999999865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=265.36 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=191.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHH--hCCCCCeeeEEEEEeeCC---
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK--LVKHPNVVRLYEVMGSKT--- 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~~--- 84 (334)
+...++.+.+|+|.||.||+|+. .++.||||++.... .+.+.+|-.|.+ .++|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45567788999999999999986 46999999997543 355666666665 457999999998865544
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCcEEeecCCCCEEEecCCCeEEee
Q 019904 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------RGVYHRDLKPENLLLDAYGNLKVSD 154 (334)
Q Consensus 85 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~---------~~i~H~dlkp~NIl~~~~~~~kl~D 154 (334)
.+++|++|.+.|+|.++|+.+ .++......++..+++||+|||+ ..|+|||||..|||+..++++-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 799999999999999999876 48899999999999999999995 3599999999999999999999999
Q ss_pred ccchhccccccCCCcccccccCCcccChHhhhcCCCCC-----CccchhhHHHHHHHHHhCC------------CCCC--
Q 019904 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG-----STADLWSCGVILFVLLAGY------------LPFD-- 215 (334)
Q Consensus 155 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~e~~~g~------------~pf~-- 215 (334)
||+|.........+.....+||..|||||++.+.-... .+.||||+|.++|||++.. .||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998776655555556689999999999997643322 4689999999999999853 3332
Q ss_pred ---CCcHHHHHHHh--hcCccCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHh
Q 019904 216 ---DSNLMNLYKKI--SAAEFTCPPW-----LSFTARKLIARILDPNPMTRITIPEIL 263 (334)
Q Consensus 216 ---~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~li~~~L~~dp~~Rpt~~e~l 263 (334)
..+..++.... ....+.+|.. --.-+++.++.||..||+.|.|+.=+.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 11222222222 2233344432 234678999999999999999987553
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=237.30 Aligned_cols=211 Identities=22% Similarity=0.404 Sum_probs=169.8
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
...+..||+|++|.|-+.++..+|...|+|.+...-. .+..+++.+|+.+.. ...+|++|.+|+.+..+...++.||
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3446789999999999999999999999999875432 333566777887755 4469999999999999999999999
Q ss_pred ccCCCchHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 92 FVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 92 ~~~~~~L~~----~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
.|+. ||.. .+++.+..+|..+-+++..+..||.|||++ .++|||+||+|||++.+|+||+||||.+.....
T Consensus 126 ~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d--- 201 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD--- 201 (282)
T ss_pred Hhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh---
Confidence 9976 6643 344567899999999999999999999986 899999999999999999999999998764332
Q ss_pred CCcccccccCCcccChHhhhc---CCCCCCccchhhHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC
Q 019904 167 DGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA 229 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~e~~~g~~pf~~-~~~~~~~~~~~~~ 229 (334)
+-......|...|||||.+.. +..++-++||||||+++.||.+++.||.. .++.+++..+...
T Consensus 202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 222223568889999999863 22335899999999999999999999974 4556666555443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=237.31 Aligned_cols=213 Identities=43% Similarity=0.786 Sum_probs=185.5
Q ss_pred eeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCch
Q 019904 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (334)
Q Consensus 19 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L 98 (334)
||.|++|.||++.+..+++.+++|++....... ....+.+|+..++.++|++|+++++++......+++||++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 346788999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhccccccCCCcccccccC
Q 019904 99 FDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (334)
Q Consensus 99 ~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 176 (334)
.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9998776 47899999999999999999999999999999999999999 89999999998765432211 12334578
Q ss_pred CcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
..|++||.+......+.++|+|++|++++++ ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8899999998753445889999999999998 578899999999999999
Q ss_pred CCHhHHhcCc
Q 019904 257 ITIPEILEDE 266 (334)
Q Consensus 257 pt~~e~l~h~ 266 (334)
|+++++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=252.26 Aligned_cols=244 Identities=24% Similarity=0.397 Sum_probs=185.2
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHH--hCCCCCeeeEEEEEeeC----C
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK--LVKHPNVVRLYEVMGSK----T 84 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~~~~~~~~~----~ 84 (334)
.+.++.+.||+|-||.||+|+++ |+.||||+|..... ....+|.+|.+ .|+|+||+.+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 45788999999999999999995 78899999975432 33456777666 46899999998764332 2
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~--------~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
.+|+|.+|.+.|||+|+|.+ ..++.+...+++..++.||+|||. -.|.|||||..|||+.++|.+-|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 48999999999999999988 569999999999999999999994 249999999999999999999999999
Q ss_pred chhccccccC--CCcccccccCCcccChHhhhcCCC----CC-CccchhhHHHHHHHHHhC----------CCCCCCC--
Q 019904 157 LSALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY----DG-STADLWSCGVILFVLLAG----------YLPFDDS-- 217 (334)
Q Consensus 157 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~----~~-~~~DiwslG~il~e~~~g----------~~pf~~~-- 217 (334)
+|-.-..... .......+||..|||||++...-. .+ ..+||||||.++||+... ++||.+-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 9864333211 223456799999999999864321 11 457999999999998752 5787542
Q ss_pred --cHHHHHHHh---hcCccCCCCCCC-H----HHHHHHHHhcCCCCCCCCCHhHHh
Q 019904 218 --NLMNLYKKI---SAAEFTCPPWLS-F----TARKLIARILDPNPMTRITIPEIL 263 (334)
Q Consensus 218 --~~~~~~~~~---~~~~~~~~~~~~-~----~~~~li~~~L~~dp~~Rpt~~e~l 263 (334)
...+...++ ....+.+|..+. . .+-.+++.||..||.-|.|+--+-
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 222223322 223344444432 2 345789999999999999986553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=245.28 Aligned_cols=252 Identities=25% Similarity=0.451 Sum_probs=199.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEE-EeeCCeE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEV-MGSKTKI 86 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~-~~~~~~~ 86 (334)
..+.|++.+.||.|.||.+-+|.++.++..+++|.+..+.. ..+++.+|...--.|. |.||+.-|++ |++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 45789999999999999999999999999999999976543 2577889988776665 8999988875 7888899
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--CCCeEEeeccchhccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~a~~~~~~ 164 (334)
+++|||++.|+|..-+... .+.|...+.++.|+++|+.|+|++++||||||.+|||+-. ..+|||||||.++..+.
T Consensus 98 vF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred EEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 9999999999999888664 4889999999999999999999999999999999999943 34799999998764332
Q ss_pred cCCCcccccccCCcccChHhhhcCC----CCCCccchhhHHHHHHHHHhCCCCCCCCcHH-----HHHHHhhcCccCCC-
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLM-----NLYKKISAAEFTCP- 234 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-----~~~~~~~~~~~~~~- 234 (334)
.......+..|.|||...... ...+.+|+|.||+++|.++||+.||.....+ +..+-........|
T Consensus 176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~ 251 (378)
T KOG1345|consen 176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK 251 (378)
T ss_pred ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence 122233466899999875322 1236689999999999999999999743221 22222222223333
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCC---CCHhHHhcCccccC
Q 019904 235 --PWLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKK 270 (334)
Q Consensus 235 --~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~h~~~~~ 270 (334)
..+|+.+..+.++-|..+|++| .++.......|...
T Consensus 252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 3478999999999999999999 67777777777653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=236.16 Aligned_cols=216 Identities=45% Similarity=0.768 Sum_probs=182.5
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
|.+.+.||.|++|.||++.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999999765432 2457888999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 93 VTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
+.+++|.+.+..... +++..+..++.+++.++.+||++|++|+|++|.||+++.++.++|+|||.+........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 999999999988766 89999999999999999999999999999999999999999999999998875443220 1223
Q ss_pred ccccCCcccChHhh-hcCCCCCCccchhhHHHHHHHHHhCCCCCCC--CcHHHHHHHhhcCccC
Q 019904 172 TTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISAAEFT 232 (334)
Q Consensus 172 ~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~e~~~g~~pf~~--~~~~~~~~~~~~~~~~ 232 (334)
...++..|++||.+ ....+ +.++|+||||+++++|++|+.||.. .+...+.+.+..+...
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 45678889999998 44444 4689999999999999999999987 3444566666555433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=273.91 Aligned_cols=197 Identities=18% Similarity=0.245 Sum_probs=143.1
Q ss_pred CCeeeEEEEE-------eeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCE
Q 019904 71 PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (334)
Q Consensus 71 ~~iv~~~~~~-------~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NI 142 (334)
+||+++++.+ .....++.+||++. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4677777766 22345778889874 5999999753 4699999999999999999999999999999999999
Q ss_pred EEecCC-------------------CeEEeeccchhccccccC--------------CCcccccccCCcccChHhhhcCC
Q 019904 143 LLDAYG-------------------NLKVSDFGLSALSQQVRD--------------DGLLHTTCGTPNYVAPEVLNDRG 189 (334)
Q Consensus 143 l~~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~ 189 (334)
|++..| .+|++|||+++....... ........||+.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 996544 455666666543111000 00001235789999999998877
Q ss_pred CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 190 ~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+ +.++|||||||++|||++|..|+.... .....+.....+ .+..-.....+++.+||+++|.+|||+.|+++||||
T Consensus 192 ~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 192 S-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred C-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 7 589999999999999999999876432 111111111111 111124567789999999999999999999999999
Q ss_pred cCC
Q 019904 269 KKD 271 (334)
Q Consensus 269 ~~~ 271 (334)
...
T Consensus 269 ~~~ 271 (793)
T PLN00181 269 NEP 271 (793)
T ss_pred hhh
Confidence 753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-33 Score=267.84 Aligned_cols=264 Identities=29% Similarity=0.499 Sum_probs=212.9
Q ss_pred cce-EEeeeeeccCceEEEEEEECCCCCeEEEEEeeh---hhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDK---EKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 11 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.+| .....+|.|++|.|+.+......+.++.|.+.. ...........+..|+.+-..+.|||++.....+.....+
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 456788999999888888877777677776542 2222333334477888889999999998877777776666
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+-+||||++ +|+.++.....+...++-.++.|++.|++|+|+.|+.|||+||+|++++.+|.+||+|||.+........
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 667999999 9999999888899999999999999999999999999999999999999999999999999877655544
Q ss_pred C--CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH--HHHh-------hcCccCCCC
Q 019904 167 D--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL--YKKI-------SAAEFTCPP 235 (334)
Q Consensus 167 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~--~~~~-------~~~~~~~~~ 235 (334)
. ......+|+..|+|||++.+..|+....||||.|++++.|++|+.||......+. .... ..+...+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 4 4456678999999999999999998899999999999999999999975433221 1111 111222334
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
.++...+.+|.+||+.||.+|.|+++|++.+||+......
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~ 595 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCH 595 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEE
Confidence 5788999999999999999999999999999999765443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=228.38 Aligned_cols=255 Identities=19% Similarity=0.239 Sum_probs=206.4
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCC-----CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETG-----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
...-.|++....+-+|.||.||.|++.+.. +.|-+|.+... -++-....+..|..++..+.|||+..+.++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 334467888888999999999999776432 34556655422 22334567788999999999999999999875
Q ss_pred e-CCeEEEEEeccCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEE
Q 019904 82 S-KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (334)
Q Consensus 82 ~-~~~~~~v~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl 152 (334)
. ...-++++.+..-|+|..++... +.++..++..++.|++.|++|||+.|++|.||-..|++|++.-.|||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 4 45667888888889999998732 24677788889999999999999999999999999999999999999
Q ss_pred eeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-c
Q 019904 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-E 230 (334)
Q Consensus 153 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~ 230 (334)
+|=.+++...+......-........||+||.+.+..+. .++|+||||+++|||+| |+.|+..-++.+...-+..+ .
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccce
Confidence 999998866554433333333446689999999987775 89999999999999998 99999999998888777655 3
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 231 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..-|-.+|+++-.++.-||..+|++||+++++..
T Consensus 517 laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 4557779999999999999999999999999753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=213.33 Aligned_cols=158 Identities=22% Similarity=0.254 Sum_probs=126.8
Q ss_pred CchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 96 GELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 96 ~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
|+|.+++... .++++..++.++.|++.||+|||+++ ||+||+++.++.+++ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 6899999874 46999999999999999999999999 999999999999999 9987754321 126
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCccC-------CCCCCCH--HHHHH
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT-------CPPWLSF--TARKL 244 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~~~-------~~~~~~~--~~~~l 244 (334)
||+.|+|||++.+..+. .++|||||||++|+|++|..||...... .....+...... .+..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999887764 8999999999999999999999764332 222222211111 1122333 69999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 245 IARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
|.+||+.||.+|||+.++++|+|+.
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=214.89 Aligned_cols=256 Identities=36% Similarity=0.621 Sum_probs=211.0
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEeeCCeEEEEEe
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~v~e 91 (334)
|.+.+.||.|+||.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +++++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 78999999876554444577889999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhccccccCC
Q 019904 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~ 167 (334)
++.++++.+.+.... .++......++.|++.++.++|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997777765 799999999999999999999999999999999999999988 6999999998743332211
Q ss_pred C----cccccccCCcccChHhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCcH----HHHHHHhhcCccC-CCCC
Q 019904 168 G----LLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFT-CPPW 236 (334)
Q Consensus 168 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~e~~~g~~pf~~~~~----~~~~~~~~~~~~~-~~~~ 236 (334)
. ......|+..|+|||.+.+. .......|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 24567899999999999874 4556889999999999999999999887653 4444444443332 2222
Q ss_pred CC--------HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 237 LS--------FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 237 ~~--------~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.. ..+.+++.+++..+|..|.+..+...+++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 21 478999999999999999999999888666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=220.44 Aligned_cols=170 Identities=22% Similarity=0.230 Sum_probs=132.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECC-CCCeEEEEEeehhhh--hhHHHHHHHHHHHHHHHhCCCCCeee-EEEEEe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVR-LYEVMG 81 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~ 81 (334)
++...++|++.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+.+|+.++|+|++. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 35567899999999999999999999876 677789998753211 12334567899999999999999985 4432
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeec-CCCCEEEecCCCeEEeeccchhc
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dl-kp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+..|+||||++|++|.. +. +.. ...++.|+++||.|||++||+|||| ||+|||++.++.++|+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 45799999999999863 21 111 1468899999999999999999999 99999999999999999999886
Q ss_pred cccccCCCc------ccccccCCcccChHhhh
Q 019904 161 SQQVRDDGL------LHTTCGTPNYVAPEVLN 186 (334)
Q Consensus 161 ~~~~~~~~~------~~~~~gt~~y~aPE~~~ 186 (334)
......... .....+++.|+|||.+.
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 543221111 13456788899999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-27 Score=213.30 Aligned_cols=249 Identities=26% Similarity=0.315 Sum_probs=193.0
Q ss_pred ceEEeeeeeccCceEEEEEEECCCC-CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC----CCCeeeEEEEE-eeCCe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK----HPNVVRLYEVM-GSKTK 85 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~-~~~~~ 85 (334)
+|++.+.||.|+||.||.+.+..++ ..+|+|+......... ..+..|..++..+. .+++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 5789998765432211 15678888888887 36899999999 57888
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-----CeEEeeccch
Q 019904 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLS 158 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-----~~kl~Dfg~a 158 (334)
-|+||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||+|+++...+ .+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999987 56999877554 5799999999999999999999999999999999999998653 5899999999
Q ss_pred hccccccCC-------Cc-ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH---HHHHHhh
Q 019904 159 ALSQQVRDD-------GL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKIS 227 (334)
Q Consensus 159 ~~~~~~~~~-------~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~---~~~~~~~ 227 (334)
+........ .. .....||..|+++.++.+... +.+.|+||++.++.+++.|.+||.+.... .......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 832211111 01 233569999999999998777 48899999999999999999999765432 2222222
Q ss_pred cCc-cC-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 228 AAE-FT-CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 228 ~~~-~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
... .. .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 111 11 234456788888888888999999998887653
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-29 Score=239.91 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=188.5
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhh--hhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK--VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.|...+.||++-|=.|.+|++.+ |. |+||++-+.. ..-....+++ .|++ ...+++||++++.-+...+...|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 78899999999999999999864 54 9999986543 2222223333 4555 6678899999999998888999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
.+|... +|+|++....-+..-+.+.|+.|++.||.-+|..||+|||||.+|||++..+.+.|+||...+....+.++..
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 999987 9999999988889999999999999999999999999999999999999999999999987543222222211
Q ss_pred -----ccccccCCcccChHhhhcCC----------CCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh-hcCccC
Q 019904 170 -----LHTTCGTPNYVAPEVLNDRG----------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFT 232 (334)
Q Consensus 170 -----~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~-~~~~~~ 232 (334)
..+.....+|.|||.+.... ..+++.||||+||+++|+++ |++||.......+...- ...+..
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 12223445899999986421 13578899999999999987 79999643332222110 000000
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 233 CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 233 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
...--+..++.+|..|++.||++|.++++.|+.
T Consensus 259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 001124478999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=226.62 Aligned_cols=239 Identities=35% Similarity=0.600 Sum_probs=206.8
Q ss_pred eeccCceEEEEEE---ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 19 IGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 19 lG~G~~g~V~~~~---~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
+|.|+||.|++++ ..+.|.-+|.|+..+......... ....|..++...+ ||.++++...++.+...++++++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 7999999998754 345678899998876544333322 5567888888887 9999999999999999999999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
||+|...+.....+.+.....+...++-++.++|+.|++|||+|++||+++.+|++++.|||+++..-.. ...|
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIAC 154 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhcc
Confidence 9999999988888889999999999999999999999999999999999999999999999998753321 1128
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 254 (334)
||..|||||+++ +. ..++|-||+|++.++|++|..||.+ +....|....+..|..++..+++++..++..+|.
T Consensus 155 gt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred cchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 999999999998 34 3778999999999999999999988 6777788888899999999999999999999999
Q ss_pred CCCC-----HhHHhcCccccCC
Q 019904 255 TRIT-----IPEILEDEWFKKD 271 (334)
Q Consensus 255 ~Rpt-----~~e~l~h~~~~~~ 271 (334)
+|.- +.|+++|+||+..
T Consensus 228 nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 228 NRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHhccCcchhHHHhccchheee
Confidence 9974 5799999999853
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=185.65 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=192.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (334)
...++|.++++||+|+||.+|.|....+|..||||+-+... . ..++..|.++.+.|+ ..+|..+..+..+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 35789999999999999999999999999999999865432 2 234667888888888 46788888888888888
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEeeccchhccc
Q 019904 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQ 162 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~a~~~~ 162 (334)
.+||+.. |-||.++..- .+.++..+++-++-|++.-++|+|.++++||||||+|.|+.-+ ..+.|+|||+|....
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999987 5688877754 3569999999999999999999999999999999999999643 458999999997654
Q ss_pred cccCCC-----cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcCccCCC
Q 019904 163 QVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKISAAEFTCP 234 (334)
Q Consensus 163 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~---~~~~~~~~~~~~~~ 234 (334)
...... ......||..|.+-..+.+... +.+-|+-|+|.++.++--|.+||.+-... +-+.+|.......|
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 432221 1234468999999888876655 37789999999999999999999875433 33444443333322
Q ss_pred -----CCCCHHHHHHHHHhcCCCCCCCCCHhH
Q 019904 235 -----PWLSFTARKLIARILDPNPMTRITIPE 261 (334)
Q Consensus 235 -----~~~~~~~~~li~~~L~~dp~~Rpt~~e 261 (334)
..+|.++--.+.-|=..--.+-|...-
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 457888888888887766666666543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-26 Score=197.57 Aligned_cols=240 Identities=25% Similarity=0.315 Sum_probs=155.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC----------CCeeeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH----------PNVVRL 76 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~~iv~~ 76 (334)
....-....++.||.|+++.||.+.+..+|+.+|+|++...........+.+++|.-....+.+ -.++..
T Consensus 8 ~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 8 GQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp S--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred CCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 3344467889999999999999999999999999999976554444456777777765555433 122222
Q ss_pred EEEE---------eeC---C-----eEEEEEeccCCCchHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHhCCc
Q 019904 77 YEVM---------GSK---T-----KIFIVLEFVTGGELFDKIVN---HGRM----KEDEARRYFQQLINAVDYCHSRGV 132 (334)
Q Consensus 77 ~~~~---------~~~---~-----~~~~v~e~~~~~~L~~~l~~---~~~l----~~~~~~~i~~qil~~l~~LH~~~i 132 (334)
++.. ... . +.+++|+-+.+ +|.+.+.. .... .......+..|+++.+++||+.|+
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~Gl 166 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGL 166 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcce
Confidence 2322 111 1 34778888765 88776542 2222 222334556899999999999999
Q ss_pred EEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCC-------CCCCccchhhHHHHHH
Q 019904 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-------YDGSTADLWSCGVILF 205 (334)
Q Consensus 133 ~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~~DiwslG~il~ 205 (334)
+|+||+|+|++++.+|.++|+||+.....+.. ......+..|.|||...... ..+.+.|.|+||+++|
T Consensus 167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred EecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999875533221 11133457899999875431 2357789999999999
Q ss_pred HHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 206 VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 206 e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
.|++|..||........... .--.+. .+|+.++.||..+|+.||.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999986543322110 111333 789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=193.62 Aligned_cols=173 Identities=14% Similarity=0.200 Sum_probs=134.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHH------HHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ------IKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
-++|++.+.||.|+||.||++.+ ++..+|+|++.......+...+. +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999755 46689999998665545544444 57999999999999999998886543
Q ss_pred --------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeec
Q 019904 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (334)
Q Consensus 84 --------~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Df 155 (334)
...++||||++|.+|.+.. .+++ ....+++.++..+|+.|++|||++|+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3578999999999997763 2333 2466999999999999999999999999999988 999999
Q ss_pred cchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHH
Q 019904 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~ 208 (334)
|.+......... ........+. .++|+||||+++....
T Consensus 179 g~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 976533211000 1133444555 7899999999877543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=188.21 Aligned_cols=141 Identities=22% Similarity=0.287 Sum_probs=111.6
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHH-----------------------HHHHHHHHHHHHHhCCCCC
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------------------MAEQIKREVATMKLVKHPN 72 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~~ 72 (334)
...||+|++|.||+|.+. +|+.||||+++........ ......+|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999986 8999999999764221110 0123345999999998887
Q ss_pred eeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEeecCCCCEEEecCCCeE
Q 019904 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 73 iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~L-H~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
+........ .. .++||||+.|+++........+++...+..++.|++.+|.++ |+.||+||||||+||+++ ++.++
T Consensus 81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 754433322 22 389999999987765545557899999999999999999999 799999999999999998 48899
Q ss_pred Eeeccchhc
Q 019904 152 VSDFGLSAL 160 (334)
Q Consensus 152 l~Dfg~a~~ 160 (334)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=216.09 Aligned_cols=222 Identities=32% Similarity=0.612 Sum_probs=177.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..-..|..++.+..|++|-||.++|+.+.+.+|+| +++.+.. +++ ++.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee-------------
Confidence 45678999999999999999999999999999994 4443321 111 44444455555
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|+-...++..++++.+. +.+++|||+.||+|||+||+|.+|+.-|++|+.|||++....-....
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 46666777767777654 77899999999999999999999999999999999998643211110
Q ss_pred -------------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC
Q 019904 168 -------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234 (334)
Q Consensus 168 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 234 (334)
-.....+||+.|+|||++...+| +..+|-|++|+|+|+++-|..||.+.+..+++..........|
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence 01234589999999999998888 5899999999999999999999999999999988877766555
Q ss_pred C---CCCHHHHHHHHHhcCCCCCCCC---CHhHHhcCccccC
Q 019904 235 P---WLSFTARKLIARILDPNPMTRI---TIPEILEDEWFKK 270 (334)
Q Consensus 235 ~---~~~~~~~~li~~~L~~dp~~Rp---t~~e~l~h~~~~~ 270 (334)
. .+++++++++.++|..+|..|. .+-++.+|+||+.
T Consensus 279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 4 3788999999999999999995 5778889999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=180.97 Aligned_cols=142 Identities=21% Similarity=0.273 Sum_probs=113.6
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-----------------------hHHHHHHHHHHHHHHHhCCCCC
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----------------------KHKMAEQIKREVATMKLVKHPN 72 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~h~~ 72 (334)
.+.||+|++|+||+|.+. +|+.||||+++..... .......+.+|...+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999999864211 0111234568999999999998
Q ss_pred eeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeE
Q 019904 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 73 iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~k 151 (334)
+.....+.... .|+||||++|+++........+++......++.|++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 85544443332 48999999988654443344568888999999999999999999 9999999999999999 79999
Q ss_pred Eeeccchhcc
Q 019904 152 VSDFGLSALS 161 (334)
Q Consensus 152 l~Dfg~a~~~ 161 (334)
|+|||++...
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999988743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=183.32 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=185.5
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 88 (334)
--.|+++++||+|+||..+.|...-+++.||||.-.... ..-+++.|++..+.|. .++|...|.+-.+..+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 347999999999999999999999999999999754322 1456778888888776 7999999988888888889
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-----CeEEeeccchhccc
Q 019904 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLSALSQ 162 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-----~~kl~Dfg~a~~~~ 162 (334)
|||+. |-||.|+..- .++++...+.-++.|++.-++++|++.+|.|||||+|+||...+ .+-++|||+|....
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99987 5588777754 35799999999999999999999999999999999999996543 48999999997654
Q ss_pred cccCCC-----cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcCccCC-
Q 019904 163 QVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTC- 233 (334)
Q Consensus 163 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---~~~~~~~~~~~~~~~~- 233 (334)
.+.... ...+..||..||+-..+.+.... .+-|+-|||.++++++-|.+||.+- +..+-+++|....-.-
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 332211 12345799999999999988774 8889999999999999999999874 3344455553322111
Q ss_pred ----CCCCCHHHHHHHHHhcCCCCCCCCCHh
Q 019904 234 ----PPWLSFTARKLIARILDPNPMTRITIP 260 (334)
Q Consensus 234 ----~~~~~~~~~~li~~~L~~dp~~Rpt~~ 260 (334)
...+|.++-.-+.-.=..+-.+-|..+
T Consensus 260 i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 260 IEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred HHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 123555554444444444444445443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-25 Score=192.01 Aligned_cols=192 Identities=25% Similarity=0.370 Sum_probs=144.0
Q ss_pred CCCCCeeeEEEEEe---------------------------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHH
Q 019904 68 VKHPNVVRLYEVMG---------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120 (334)
Q Consensus 68 l~h~~iv~~~~~~~---------------------------~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi 120 (334)
-+|||||++..+|. ...+.|+||..+.. +|..++..+. .+.-...-++.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHH
Confidence 35999999987652 23468999999876 8999997765 4445666788999
Q ss_pred HHHHHHHHhCCcEEeecCCCCEEEe--cCC--CeEEeeccchhcccc----ccCCCcccccccCCcccChHhhhcCC---
Q 019904 121 INAVDYCHSRGVYHRDLKPENLLLD--AYG--NLKVSDFGLSALSQQ----VRDDGLLHTTCGTPNYVAPEVLNDRG--- 189 (334)
Q Consensus 121 l~~l~~LH~~~i~H~dlkp~NIl~~--~~~--~~kl~Dfg~a~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~--- 189 (334)
++|+.|||.+|+.|||+|.+|||+. +++ .+.++|||++-.-.. ....+-.....|.-.-||||+....+
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999984 444 378999998532111 01111122345777899999987543
Q ss_pred --CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH--HhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhH
Q 019904 190 --YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK--KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPE 261 (334)
Q Consensus 190 --~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 261 (334)
.+-.++|.|+.|.+.||+++..-||.+...+.+-. -.....+..|+.+++.+++++..+|+.||++|++..-
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i 506 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI 506 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence 12257899999999999999999998754433221 1123345677889999999999999999999998653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=171.70 Aligned_cols=190 Identities=17% Similarity=0.212 Sum_probs=141.3
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHH-HHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEEe
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.+...|++|+||+|+.+.. .+.+++.+.+.......... ...+.+|+.+|+++. ++++++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999997765 57788888776554432221 235789999999996 5889999886 44699999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeec-CCCCEEEecCCCeEEeeccchhccccccCC---
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dl-kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--- 167 (334)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 9999888654321 1 2357889999999999999999999 799999999999999999998743321110
Q ss_pred -C-------cccccccCCcccChHhhhcCCCCC-CccchhhHHHHHHHHHhCCCCCCC
Q 019904 168 -G-------LLHTTCGTPNYVAPEVLNDRGYDG-STADLWSCGVILFVLLAGYLPFDD 216 (334)
Q Consensus 168 -~-------~~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~e~~~g~~pf~~ 216 (334)
. ...-...++.|++|+...-....+ .+.+-++.|+-+|.++|+..++-+
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 011123688899998765332211 455788999999999999998754
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=180.13 Aligned_cols=243 Identities=21% Similarity=0.363 Sum_probs=195.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.++...+..+|.....|..|+|++. |..+++|++..... ......++..|.-.|+...||||+.+++.+.+..+..+
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred chhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 4455567778889999999999995 45577788765443 23345778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCCeEEe--eccchhccc
Q 019904 89 VLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVS--DFGLSALSQ 162 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~--Dfg~a~~~~ 162 (334)
+..|++.|||+..+..... ....++.+++.+++.|++|||+.. |----|+...++++++-+.+|+ |--++.
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--- 341 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--- 341 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---
Confidence 9999999999999987643 566788999999999999999874 4445688899999998776664 322211
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCC--CccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhc--CccCCCCCCC
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDG--STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLS 238 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 238 (334)
. .....-+|.|++||.+...+.+. .++|+|||.+++||+.|...||..-++++.-.++.- ....+|+.++
T Consensus 342 q------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 342 Q------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred e------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 1 11233478999999998765432 568999999999999999999999888887666543 3567899999
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHh
Q 019904 239 FTARKLIARILDPNPMTRITIPEIL 263 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l 263 (334)
.....|+.-|++.||.+||.++.+.
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999998764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=201.96 Aligned_cols=240 Identities=22% Similarity=0.300 Sum_probs=181.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.....+|.|.+.||.|+||+||.|.+.. |+.||+|+-.....+.-....++...++ ++ --+.|..+...+.-.+..
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcc
Confidence 3445689999999999999999999977 9999999988777665433333333222 11 134556666666666777
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-------CCCeEEeeccchh
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLSA 159 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-------~~~~kl~Dfg~a~ 159 (334)
++|+||.+.|+|.+++...+.+++..+..+..|++..+.+||..+||||||||+|+|+.. .-.++|+|||.|.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999998889999999999999999999999999999999999999943 2348999999987
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-----cCCC
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-----FTCP 234 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-----~~~~ 234 (334)
......+.......++|-.+-.+|...++++. ...|.|.|+.+++.|+.|+.-- ...+. ..++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccch
Confidence 65555555566777889999999999999995 9999999999999999986531 11111 1122
Q ss_pred CCCCH-HHHHHHHHhcCCCCCCCCCHhHH
Q 019904 235 PWLSF-TARKLIARILDPNPMTRITIPEI 262 (334)
Q Consensus 235 ~~~~~-~~~~li~~~L~~dp~~Rpt~~e~ 262 (334)
..+-. -..+|+..+|+.|-..=|...++
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 22222 23578888888555444555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=168.07 Aligned_cols=133 Identities=20% Similarity=0.239 Sum_probs=106.7
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEeeCC---e-
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-----KHPNVVRLYEVMGSKT---K- 85 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~---~- 85 (334)
-.+.||+|+||.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||++++++++++. .
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 6666655 79998764321 245689999999999 5799999999998874 4
Q ss_pred EEEEEec--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEEeecCCCCEEEecC----CCeEEeecc
Q 019904 86 IFIVLEF--VTGGELFDKIVNHGRMKEDEARRYFQQLINAV-DYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFG 156 (334)
Q Consensus 86 ~~~v~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l-~~LH~~~i~H~dlkp~NIl~~~~----~~~kl~Dfg 156 (334)
+.+|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 3378999 5579999999764 46665 35678888887 89999999999999999999743 379999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-22 Score=170.98 Aligned_cols=144 Identities=19% Similarity=0.250 Sum_probs=114.6
Q ss_pred ceEEeeeeeccCceEEEEEE-ECCCCCeEEEEEeehhhhhh---------------------HHHHHHHHHHHHHHHhCC
Q 019904 12 KYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLK---------------------HKMAEQIKREVATMKLVK 69 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~ 69 (334)
-|.+.+.||.|++|.||+|. +..+|+.||+|++....... ......+.+|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 66789999999997542100 011234678999999997
Q ss_pred CCC--eeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cEEeecCCCCEEEec
Q 019904 70 HPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDA 146 (334)
Q Consensus 70 h~~--iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~-i~H~dlkp~NIl~~~ 146 (334)
+.+ ++++++. ...++||||+.|++|.........+....+..++.|++.++++||+.| ++||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 4444442 235899999999888765544455667778899999999999999999 99999999999999
Q ss_pred CCCeEEeeccchhc
Q 019904 147 YGNLKVSDFGLSAL 160 (334)
Q Consensus 147 ~~~~kl~Dfg~a~~ 160 (334)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 78999999998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-23 Score=201.77 Aligned_cols=260 Identities=33% Similarity=0.546 Sum_probs=212.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCC-CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 87 (334)
...|.+.+.||.|+|+.|-.+....+ ...+|.|.+.... .......++..|..+-..+. |+|++.+++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 56799999999999999988776433 3446666554432 23344566677888888887 999999999999999999
Q ss_pred EEEeccCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEEeecCCCCEEEecCC-CeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKI-VNHG-RMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~ 163 (334)
+.++|..|+++.+.+ ..+. ..+......++.|+..++.|+| ..++.|+|+||+|.+++..+ .+++.|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 5554 6778888999999999999999 99999999999999999999 999999999986655
Q ss_pred -ccCCCccccccc-CCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHH--HHhhc-C--ccCCCCC
Q 019904 164 -VRDDGLLHTTCG-TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY--KKISA-A--EFTCPPW 236 (334)
Q Consensus 164 -~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~--~~~~~-~--~~~~~~~ 236 (334)
..........+| ++.|.|||...+..+.++..|+||.|+++..+++|..||......... ..+.. . .......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 344445566788 999999999998778788999999999999999999999764433211 11111 1 2344456
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++....+++.+++..+|..|.+.+++-.++|+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 8899999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=159.40 Aligned_cols=137 Identities=24% Similarity=0.327 Sum_probs=114.7
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+.||+|++|.||+|.+ .|..+++|+...... ........+.+|+.++..+.|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 577899998654322 112223567889999999999998877777777788899999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865432 7888999999999999999999999999999999 78999999998764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=173.57 Aligned_cols=200 Identities=23% Similarity=0.356 Sum_probs=157.4
Q ss_pred HHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-EEeecCCCCE
Q 019904 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV-YHRDLKPENL 142 (334)
Q Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i-~H~dlkp~NI 142 (334)
|+.+.|.|+.++++...+....++|.+||..|+|.+.+... ..++......++++|+.||+|||+..| .|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45688999999999999999999999999999999999873 467888888899999999999998865 9999999999
Q ss_pred EEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCC------CCCccchhhHHHHHHHHHhCCCCCCC
Q 019904 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY------DGSTADLWSCGVILFVLLAGYLPFDD 216 (334)
Q Consensus 143 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~e~~~g~~pf~~ 216 (334)
+++..-.+||+|||+..+..............-...|.|||.+..... -+.+.|+||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999776543111111122223457999999986421 24668999999999999999999975
Q ss_pred C----cHHHHHHHhhc-CccCCCC------CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 217 S----NLMNLYKKISA-AEFTCPP------WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 217 ~----~~~~~~~~~~~-~~~~~~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
. +..++...+.. ....+-| ...+++..++++||..+|..||+++.+-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 2 23445555544 2221211 24457899999999999999999999854
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=9e-20 Score=153.96 Aligned_cols=133 Identities=20% Similarity=0.249 Sum_probs=107.6
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
.||+|++|.||+|.. .|..+++|+....... ......++.+|+.+++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 5678999986542211 122246778999999999988765555455566677899999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
++|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988755321 7899999999999999999999999999999 79999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.3e-21 Score=174.89 Aligned_cols=178 Identities=24% Similarity=0.384 Sum_probs=134.6
Q ss_pred CeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.+.|+.|++|...+|.+++.+.. ..+....+.++.|+..|+.| +|.+|+|+||.||+...++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 45899999999999999997654 35667889999999999999 9999999999999999999999999998754
Q ss_pred ccccc----CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCccCCCC
Q 019904 161 SQQVR----DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPP 235 (334)
Q Consensus 161 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 235 (334)
..... .........||+.||+||.+.+..|. .++||||||++++|++. =..+|.. ......+..+.++...
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHH
Confidence 33222 11123456899999999999998885 99999999999999987 3333322 1122222233322111
Q ss_pred CC-CHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 236 WL-SFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 236 ~~-~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+. .+.-..|+.+||.+.|.+||++.+.-.|+|.
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 11 2345689999999999999988777666664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.2e-20 Score=154.47 Aligned_cols=137 Identities=22% Similarity=0.329 Sum_probs=108.3
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh-------------------HHHHHHHHHHHHHHHhCCCCC
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------HKMAEQIKREVATMKLVKHPN 72 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~h~~ 72 (334)
.|.+.+.||.|+||.||++... +|+.||||+++.+.... ........+|+.++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888999999999999999875 79999999976532100 011224678899999998774
Q ss_pred --eeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCe
Q 019904 73 --VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (334)
Q Consensus 73 --iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~ 150 (334)
++..++ ....++||||++|++|...... .....++.+++.++.++|+.|++||||+|+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 444443 2445899999999988765321 3456788999999999999999999999999999999999
Q ss_pred EEeeccchh
Q 019904 151 KVSDFGLSA 159 (334)
Q Consensus 151 kl~Dfg~a~ 159 (334)
+|+|||.+.
T Consensus 165 ~liDfg~~~ 173 (198)
T cd05144 165 YIIDWPQMV 173 (198)
T ss_pred EEEECCccc
Confidence 999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=172.39 Aligned_cols=139 Identities=19% Similarity=0.230 Sum_probs=112.1
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhh-----hhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK-----VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..|...+.||+|+||+||++.... ..+++|+..... .......+++.+|+.+++.++|++++....+......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345668899999999999998754 334555432211 1122234678899999999999999887777777777
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.++||||++|++|.+.+. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998875 356789999999999999999999999999999 678999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=146.70 Aligned_cols=137 Identities=23% Similarity=0.391 Sum_probs=99.1
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHH---------------------HHHHHHHHHHhCCCCC--
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---------------------QIKREVATMKLVKHPN-- 72 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~h~~-- 72 (334)
.+.||+|+||+||+|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 7899999998754322111111 1135666666665443
Q ss_pred eeeEEEEEeeCCeEEEEEeccCCCchHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCe
Q 019904 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNL 150 (334)
Q Consensus 73 iv~~~~~~~~~~~~~~v~e~~~~~~L~~-~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~ 150 (334)
+.+.+++ ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|+ .|++|+||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4455543 23589999999854321 121111 11 5678899999999999999 9999999999999999 8999
Q ss_pred EEeeccchhc
Q 019904 151 KVSDFGLSAL 160 (334)
Q Consensus 151 kl~Dfg~a~~ 160 (334)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999998763
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-18 Score=145.29 Aligned_cols=137 Identities=20% Similarity=0.296 Sum_probs=104.9
Q ss_pred eeee-ccCceEEEEEEECCCCCeEEEEEeehhhh----------hhHHHHHHHHHHHHHHHhCCCCCe--eeEEEEEeeC
Q 019904 17 RTIG-EGTFAKVKFARNSETGEPVALKILDKEKV----------LKHKMAEQIKREVATMKLVKHPNV--VRLYEVMGSK 83 (334)
Q Consensus 17 ~~lG-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~ 83 (334)
..|| .||.|+||.+... +..+++|.+..... ........+.+|+.++..+.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888889888764 67899998854221 111234567899999999998875 6677664332
Q ss_pred -Ce---EEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 84 -TK---IFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 84 -~~---~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
.. .++|||+++| .+|.+.+.. .++++. .+.+++.+|.+||++||+||||||.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999997 688887755 345554 3578999999999999999999999999999899999999987
Q ss_pred hc
Q 019904 159 AL 160 (334)
Q Consensus 159 ~~ 160 (334)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=131.41 Aligned_cols=132 Identities=23% Similarity=0.305 Sum_probs=111.3
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEeeCCeEEEEEec
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+.+++.+.+ .++++++......+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 46789999999999999844 6799999865432 3567789999999986 5899999988888889999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+.++.+... +......++.+++.+++++|.. +++|+|++|+||+++..+.++++|||.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998766543 4556677899999999999984 799999999999999989999999998663
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-18 Score=158.09 Aligned_cols=256 Identities=19% Similarity=0.208 Sum_probs=193.7
Q ss_pred ccceEEeeeeec--cCceEEEEEEE--CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGE--GTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 84 (334)
...+.+.+.+|. |++|.||.+.. ..++..+|+|.-... ........+-.+|+...+.++ |+|.++.+..++..+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p-~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP-FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCC-CCCccccccccchhhcccccCccccccccCcccccCC
Confidence 345778889999 99999999998 888999999973221 111111233346666666665 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccch
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLIN----AVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS 158 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~----~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a 158 (334)
..|+-.|+|. .+|..+...... +++..++..+.+..+ ||.++|+.+++|-|+||.||++..+ ..++++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999997 588888877654 899999999999999 9999999999999999999999998 78999999987
Q ss_pred hccccccCCCcc---cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCccCC
Q 019904 159 ALSQQVRDDGLL---HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKKISAAEFTC 233 (334)
Q Consensus 159 ~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~--~~~~~~~~~~~~~~~~ 233 (334)
............ ....|...|++||...+. .+...|+|++|.++.+..+|..++... +......... ....+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~ 347 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEF 347 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhh
Confidence 654433222111 122567789999999753 357889999999999999987766433 2111111111 11122
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 234 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
-...+.++...+..|++.+|..|++++.++.|+++..
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2334666777999999999999999999999998863
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.4e-18 Score=163.61 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=209.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....+.+.+.+.+-+|+++.++.+.-..+|...++|+............+.+..+-.++-...+|-++...-.+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 34677888999999999999999998888877777776543322222223333333333334456677655556678889
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc-
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR- 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 165 (334)
++||+|..+++|...++..+..+.+.++.++..+..++++||+..+.|+|++|.|++...+|..++.|||.........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 9999999999999999998888888999999999999999999999999999999999999999999998432211110
Q ss_pred ----------------------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 019904 166 ----------------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (334)
Q Consensus 166 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~ 217 (334)
.........||+.|.+||...+... +..+|.|++|+++++.++|..||+..
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0011233468999999999998777 48889999999999999999999999
Q ss_pred cHHHHHHHhhcCccCCC---CCCCHHHHHHHHHhcCCCCCCCCCHh---HHhcCccccCC
Q 019904 218 NLMNLYKKISAAEFTCP---PWLSFTARKLIARILDPNPMTRITIP---EILEDEWFKKD 271 (334)
Q Consensus 218 ~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dp~~Rpt~~---e~l~h~~~~~~ 271 (334)
.....+..+.....+.| ...+.++++++...|..+|.+|..+. ++-.|+||+..
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 99999988877665544 45789999999999999999999887 88889999854
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3e-15 Score=140.71 Aligned_cols=218 Identities=17% Similarity=0.307 Sum_probs=152.7
Q ss_pred EEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCC
Q 019904 29 FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM 108 (334)
Q Consensus 29 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l 108 (334)
.|..+.++.+|.|.+...++. ...+.+.+.++-|+.++||||+++++.++.++..|+|.|.+. .|..++++ +
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---L 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---h
Confidence 355567788999998876543 334667788999999999999999999999999999999884 56667766 3
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhc
Q 019904 109 KEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187 (334)
Q Consensus 109 ~~~~~~~i~~qil~~l~~LH-~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 187 (334)
....+..-+.||+.||.+|| +.+++|++|.-+.|+++..|..||++|.++........ ......---.|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence 36677778899999999997 67899999999999999999999999998754332221 1111112224667776543
Q ss_pred CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHh----H-H
Q 019904 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIP----E-I 262 (334)
Q Consensus 188 ~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~----e-~ 262 (334)
.. -..|.|.|||++++++.|..+=. .....+..++.....+-.+-+--.+..||... + .
T Consensus 180 s~---~s~D~~~Lg~li~el~ng~~~~~-------------~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~ 243 (690)
T KOG1243|consen 180 SE---WSIDSWGLGCLIEELFNGSLLTK-------------TDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECR 243 (690)
T ss_pred cc---cchhhhhHHHHHHHHhCcccCcc-------------hhhhccCccchhHHHHHHHHhccccccccchhhHHHHHH
Confidence 32 23599999999999999943311 11112222333444444444445555555422 2 2
Q ss_pred hcCccccCCC
Q 019904 263 LEDEWFKKDY 272 (334)
Q Consensus 263 l~h~~~~~~~ 272 (334)
+-|.||++.+
T Consensus 244 ~~~gff~n~f 253 (690)
T KOG1243|consen 244 LLGGFFRNDF 253 (690)
T ss_pred hccccccchH
Confidence 3488888755
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=5e-16 Score=147.55 Aligned_cols=146 Identities=19% Similarity=0.380 Sum_probs=97.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-------------------------------hHHHHH
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-------------------------------KHKMAE 56 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------------~~~~~~ 56 (334)
..+..|.. +.||+|++|+||+|+...+|+.||||+.++.-.. -.+..+
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34556777 8999999999999999888999999999753110 012223
Q ss_pred HHHHHHHH------HHhCC----CCCeeeEEEEEee-CCeEEEEEeccCCCchHHH--HHhcC----CCCHHHHHHHHHH
Q 019904 57 QIKREVAT------MKLVK----HPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDK--IVNHG----RMKEDEARRYFQQ 119 (334)
Q Consensus 57 ~~~~e~~~------l~~l~----h~~iv~~~~~~~~-~~~~~~v~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~q 119 (334)
.+.+|+.+ +.++. +...+.+-.++.+ ....++||||+.|+.+.+. +...+ .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 33333333 33332 3333333333322 3456799999999999764 33333 2444444555555
Q ss_pred HHHHHHHHHhCCcEEeecCCCCEEEecCC----CeEEeeccchhcc
Q 019904 120 LINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALS 161 (334)
Q Consensus 120 il~~l~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~a~~~ 161 (334)
++ ..|++|+|++|.||+++.+| .++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 54 59999999999999999888 8999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.3e-15 Score=137.49 Aligned_cols=141 Identities=22% Similarity=0.362 Sum_probs=95.9
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh-------------------------------HHHHH------HH
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE------QI 58 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~~~------~~ 58 (334)
.+.||.|++|+||+|... +|+.||||+.++..... .+... ++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 368999999999999874 68999999986531100 00001 23
Q ss_pred HHHHHHHHhCC-----CCCeeeEEEEE-eeCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHH-HHHHHHhC
Q 019904 59 KREVATMKLVK-----HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLIN-AVDYCHSR 130 (334)
Q Consensus 59 ~~e~~~l~~l~-----h~~iv~~~~~~-~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~-~l~~LH~~ 130 (334)
.+|+..+..+. +++| .+-.++ ......++||||++|++|.+...... .. ....++.+++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC
Confidence 44555554442 3333 222222 22344689999999999987764321 12 23345556655 47889999
Q ss_pred CcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 131 ~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
|++|+|++|.||+++.+|.++++|||++...
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-14 Score=118.34 Aligned_cols=139 Identities=15% Similarity=0.242 Sum_probs=102.2
Q ss_pred eeeeeccCceEEEEEEECC------CCCeEEEEEeehhhh-----------------------hhHHHHHHHHHHHHHHH
Q 019904 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKV-----------------------LKHKMAEQIKREVATMK 66 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~ 66 (334)
...||.|.-+.||.|.... .+..+|||+.+.+.. .........++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 357899999853110 01111223448999999
Q ss_pred hCCC--CCeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEeecCCCCEE
Q 019904 67 LVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLL 143 (334)
Q Consensus 67 ~l~h--~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~L-H~~~i~H~dlkp~NIl 143 (334)
++.. -+++.++++ ..-++||||+.++.+.....+...+++.....++.+++.+|..| |+.|++|+||+|.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9974 456677764 45678999998754432222333466667778889999999998 8999999999999999
Q ss_pred EecCCCeEEeeccchh
Q 019904 144 LDAYGNLKVSDFGLSA 159 (334)
Q Consensus 144 ~~~~~~~kl~Dfg~a~ 159 (334)
+.+ +.+.|+|||.+-
T Consensus 158 ~~~-~~v~iIDF~qav 172 (197)
T cd05146 158 WHD-GKVWFIDVSQSV 172 (197)
T ss_pred EEC-CcEEEEECCCce
Confidence 974 789999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-15 Score=141.36 Aligned_cols=254 Identities=20% Similarity=0.180 Sum_probs=190.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEEC-CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 84 (334)
....++|..+..||.|.|+.|+....+ .++..|++|..........+....+ .|+.+...+. |.+++.++..|....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl-~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSL-GEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcch-hhhhHhhHhhcccccCCCCCCccccc
Confidence 346788999999999999999987655 6778899998765443333322222 4555555554 899999998888888
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~ 163 (334)
..|+--|||.++++...+.....+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..++.|||.+....-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 888999999999887776555568889999999999999999999999999999999999886 7789999998753110
Q ss_pred ccCCCcccccccCCccc-ChHhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCCcHHHHHHHhhcCccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYV-APEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (334)
. .....+.-.+. .+|++........+.|++|||..+.+.++|... +.+. ....+..+..+..+.....+
T Consensus 420 --~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 --S---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred --e---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhh
Confidence 0 01112233344 356665555556899999999999999987543 3332 23344555555566666889
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..+...++..++..||.+.++..|.-|..
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhhh
Confidence 99999999999999999999988776643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.6e-14 Score=115.80 Aligned_cols=127 Identities=20% Similarity=0.299 Sum_probs=95.7
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEEEEeccC
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~ 94 (334)
++.|+.|.++.||++... ++.|++|+...... ......+|+.+++.+.+.++ .+++.... ...++|||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 577899999999999864 77899998754321 12245688888888875554 45555433 33579999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EEeecCCCCEEEecCCCeEEeeccchh
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV-----YHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i-----~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
|.++... .. ....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9877543 11 123457899999999999985 9999999999999 6789999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.5e-14 Score=125.21 Aligned_cols=203 Identities=15% Similarity=0.257 Sum_probs=141.1
Q ss_pred HHHHhCCCCCeeeEEEEEeeC-----CeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 019904 63 ATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG-- 131 (334)
Q Consensus 63 ~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~-- 131 (334)
.-|-.+-|.|||+++.++.+. ....++.||+..|++..+|++- ..+......+|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 334455699999999887554 3477899999999999999764 35888899999999999999999884
Q ss_pred cEEeecCCCCEEEecCCCeEEeeccchhccccccCC--CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh
Q 019904 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 209 (334)
Q Consensus 132 i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~ 209 (334)
|+|+++.-+.|++..+|-+|+.--.-...-...... .......+-++|.+||.=..... +.++|||++|....+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHH
Confidence 999999999999999888887532211110000000 01112345678999997654444 367899999999999988
Q ss_pred CCCCCCC-CcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 210 GYLPFDD-SNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 210 g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
|..--.. .+....-..+...-+... ...-++++.+||+..|..||++.+++.||..-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred heeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 7655322 221111111111111111 11235789999999999999999999998764
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.47 E-value=9e-13 Score=106.21 Aligned_cols=136 Identities=21% Similarity=0.267 Sum_probs=103.0
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeeh-----hhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDK-----EKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
..+++|+-+.+|.+... |..+++|.=-+ +.....-...+..+|+.++..++--+|.-..=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988652 44566765332 222333334667889999999986666555555556777789999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
|..|..|.+.+... ...++..+-.-+.-||..||+|+||.++||+++.. .+.++|||++....
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~ 142 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD 142 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence 99998888888765 24577778888899999999999999999999884 49999999987543
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=3e-12 Score=102.80 Aligned_cols=151 Identities=20% Similarity=0.221 Sum_probs=111.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeeh-----hhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDK-----EKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..+.. ....+-+|+-+.|+++.. .|+.++||.-.. +.....-...+.++|+++|.++.--+|.-..-++.+.
T Consensus 6 ~~~~~-~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~ 82 (229)
T KOG3087|consen 6 YLTPD-SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT 82 (229)
T ss_pred ccCCC-cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence 34444 678889999999999887 577777875432 2233333456778999999988765665544455566
Q ss_pred CeEEEEEeccCC-CchHHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEeeccc
Q 019904 84 TKIFIVLEFVTG-GELFDKIVNHG-R-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGL 157 (334)
Q Consensus 84 ~~~~~v~e~~~~-~~L~~~l~~~~-~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~ 157 (334)
..-.++|||.+| .++.+++...- . ....-...++.+|-+.+.-||.++|+|+||..+||++..+|. +.++|||+
T Consensus 83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecc
Confidence 667799999987 46677776532 2 222333688999999999999999999999999999977664 58999999
Q ss_pred hhccc
Q 019904 158 SALSQ 162 (334)
Q Consensus 158 a~~~~ 162 (334)
+..+.
T Consensus 163 s~~s~ 167 (229)
T KOG3087|consen 163 SSVSR 167 (229)
T ss_pred hhccc
Confidence 87543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.2e-12 Score=106.82 Aligned_cols=141 Identities=21% Similarity=0.309 Sum_probs=105.0
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEeeC---CeEEEEE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVMGSK---TKIFIVL 90 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~---~~~~~v~ 90 (334)
.+.||.|..+.||++.... |+.+++|........ .....+.+|+.+++.+.+. .+.+++.+.... +..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3678999999999998743 678999987653321 1245678899999999764 456777776553 3678999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----------------------------------------- 129 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~----------------------------------------- 129 (334)
||++|.++.+.+.. ..++......++.+++.+|+.||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999877664432 346666666777777777777773
Q ss_pred ---------------CCcEEeecCCCCEEEec--CCCeEEeeccchhc
Q 019904 130 ---------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSAL 160 (334)
Q Consensus 130 ---------------~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~a~~ 160 (334)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34699999999999988 56789999997664
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.4e-10 Score=106.63 Aligned_cols=212 Identities=20% Similarity=0.247 Sum_probs=154.5
Q ss_pred CceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----CCeEEEEEeccCC-Cc
Q 019904 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTG-GE 97 (334)
Q Consensus 23 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~v~e~~~~-~~ 97 (334)
--.+.|++....+|..|++|.+........ ...-.-+++++++.|+|||++.++|.+ +..+++|++|+++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 446789999999999999999843222211 122245778899999999999999863 4578999999986 46
Q ss_pred hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 98 LFDKIVN---------------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 98 L~~~l~~---------------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
|.++--. +...+|..+|.++.|+..||.++|+.|+.-+-|.|.+|+++.+-+++|+..|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6654422 1247889999999999999999999999999999999999998899998777655433
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHH-HHHhhcCccCCCCCCCHH
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNL-YKKISAAEFTCPPWLSFT 240 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 240 (334)
... . +.+.. ..+-|.--||.++..+.||..--...+ .... ...+ -+.+|.+
T Consensus 445 ~d~--------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D 497 (655)
T KOG3741|consen 445 EDP--------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTD 497 (655)
T ss_pred CCC--------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHH
Confidence 211 0 11111 134588899999999999976532222 1222 2222 2347889
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 241 ARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
++++|.-+...+++. -++++++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999999887 478877754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.7e-11 Score=98.92 Aligned_cols=126 Identities=25% Similarity=0.406 Sum_probs=83.7
Q ss_pred EEEEEEECCCCCeEEEEEeehhh-----------------------hhhHHHHHHHHHHHHHHHhCCCC--CeeeEEEEE
Q 019904 26 KVKFARNSETGEPVALKILDKEK-----------------------VLKHKMAEQIKREVATMKLVKHP--NVVRLYEVM 80 (334)
Q Consensus 26 ~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~ 80 (334)
.||.|... +|..+|+|+.+... .+........++|++.|+.+..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48888874 57799999985311 11223346778999999999866 466777553
Q ss_pred eeCCeEEEEEeccC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 81 GSKTKIFIVLEFVT--GGELFDKIVNHGRMKEDEARRYFQQLINAVDY-CHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 81 ~~~~~~~~v~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~-LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
.-++||||+. |..+.. +.... ++......++.+++..+.. +|..|++|+||++.||+++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDVD-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHCG-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhh-HHhcc-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2359999998 655543 33221 2244566788888885555 689999999999999999886 999999997
Q ss_pred hh
Q 019904 158 SA 159 (334)
Q Consensus 158 a~ 159 (334)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 65
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.7e-12 Score=119.87 Aligned_cols=153 Identities=20% Similarity=0.352 Sum_probs=114.2
Q ss_pred HHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccC-------CCcccccccCCcccChHhhhcCC
Q 019904 118 QQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------DGLLHTTCGTPNYVAPEVLNDRG 189 (334)
Q Consensus 118 ~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~ 189 (334)
.++..|+.++|.. ++||++|.|++|.++..|..||+.|+++........ ............|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~- 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT- 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-
Confidence 3555999999965 899999999999999999999999998654333111 1111112345679999999884
Q ss_pred CCCCccchhhHHHHHHHHH-hCCCCCCCCcHHHHHHH----hhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 190 YDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 190 ~~~~~~DiwslG~il~e~~-~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+.++|+||+||++|.+. .|+..+........+.. ...........++.++++=+.++|..++.-||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 4468999999999999998 56666654432222111 112233455779999999999999999999999999999
Q ss_pred CccccCC
Q 019904 265 DEWFKKD 271 (334)
Q Consensus 265 h~~~~~~ 271 (334)
-|||...
T Consensus 265 ~~ff~D~ 271 (700)
T KOG2137|consen 265 IPFFSDP 271 (700)
T ss_pred ccccCCc
Confidence 9999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.9e-10 Score=101.41 Aligned_cols=236 Identities=18% Similarity=0.190 Sum_probs=149.9
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEE-----E-eeCC-eE
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV-----M-GSKT-KI 86 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-----~-~~~~-~~ 86 (334)
..++.||+|+-+.+|..-... ..+.|++.....-. ..+.-..+...-.||-+-.-+.+ + .+++ .+
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 356789999999999654322 23568876543211 11111222233346543321111 1 1222 37
Q ss_pred EEEEeccCCCchHHHHHh----c---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 87 FIVLEFVTGGELFDKIVN----H---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~----~---~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
-+.|+...|..--..+.. . .-...+.+....+.++.+.+.||..|.+-+|++++|+|+++++.|.|+|=+...
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788998887532222211 1 125667888999999999999999999999999999999999999999866433
Q ss_pred ccccccCCCcccccccCCcccChHhhhc-----CCCCCCccchhhHHHHHHHHHhC-CCCCCCCcH-----HHHHHHhhc
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAG-YLPFDDSNL-----MNLYKKISA 228 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~-----~~~~~~~~~ 228 (334)
+- .........+|...|.+||.-.- -.. +...|.|.||+++++++.| ++||.+-.. .-.-..|..
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 21 11222344578999999998652 222 3568999999999999886 999976210 001111111
Q ss_pred C----------cc-CCC-----CCCCHHHHHHHHHhcCC--CCCCCCCHhH
Q 019904 229 A----------EF-TCP-----PWLSFTARKLIARILDP--NPMTRITIPE 261 (334)
Q Consensus 229 ~----------~~-~~~-----~~~~~~~~~li~~~L~~--dp~~Rpt~~e 261 (334)
+ .. +.| .-++++++.|..+|+.. ++.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1 11 111 12678999999999975 4678999764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.17 E-value=9.3e-10 Score=96.54 Aligned_cols=133 Identities=17% Similarity=0.097 Sum_probs=93.3
Q ss_pred eEEEEEEECCCCCeEEEEEeehhhhhh---H-----HHHHHHHHHHHHHHhCCCCCe--eeEEEEEee-----CCeEEEE
Q 019904 25 AKVKFARNSETGEPVALKILDKEKVLK---H-----KMAEQIKREVATMKLVKHPNV--VRLYEVMGS-----KTKIFIV 89 (334)
Q Consensus 25 g~V~~~~~~~~~~~vaiK~~~~~~~~~---~-----~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~-----~~~~~~v 89 (334)
..|+++.. .|+.|.||......... . .....+.+|...+..+..-+| +.++.+.+. ....++|
T Consensus 36 rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 34555543 56789999764322110 0 001136788888888854443 334444432 2357899
Q ss_pred EeccCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-------CCCeEEeeccchh
Q 019904 90 LEFVTGG-ELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLSA 159 (334)
Q Consensus 90 ~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-------~~~~kl~Dfg~a~ 159 (334)
+|++++. +|.+++.. ..+.+......++.+++..++.||+.||+|+|++++|||++. ++.+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999986 78888753 234566778899999999999999999999999999999975 3579999999765
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.8e-10 Score=96.46 Aligned_cols=137 Identities=22% Similarity=0.331 Sum_probs=104.9
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehh-------------------hhhhHHHHHHHHHHHHHHHhCCCC--
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-------------------KVLKHKMAEQIKREVATMKLVKHP-- 71 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------------~~~~~~~~~~~~~e~~~l~~l~h~-- 71 (334)
+.++..||-|.-|.||.|.+. .|.++|||.-+.. ..+..-.....++|..+|+.|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999986 6889999975321 011123345678999999999865
Q ss_pred CeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 72 ~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
.|.+.+++ +...+|||+.+|-.|... ++.......++..|++-+..+-..|++|+|+++-||+++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67777764 455799999999666432 123455666777888888877799999999999999999999999
Q ss_pred Eeeccchh
Q 019904 152 VSDFGLSA 159 (334)
Q Consensus 152 l~Dfg~a~ 159 (334)
++||-.+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=5e-09 Score=88.80 Aligned_cols=106 Identities=19% Similarity=0.365 Sum_probs=84.0
Q ss_pred HHHHHHHHHHHHhCCCCC--eeeEEEEEeeC----CeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 019904 55 AEQIKREVATMKLVKHPN--VVRLYEVMGSK----TKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127 (334)
Q Consensus 55 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~----~~~~~v~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~L 127 (334)
..+..+|...+..+..-+ +++.+.+.+.. ...++|+|++++. +|.+.+......+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 345778888887776433 34555555442 2468999999884 7888887755577778889999999999999
Q ss_pred HhCCcEEeecCCCCEEEecCC---CeEEeeccchhc
Q 019904 128 HSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 160 (334)
Q Consensus 128 H~~~i~H~dlkp~NIl~~~~~---~~kl~Dfg~a~~ 160 (334)
|..||+|+|++|.|||++.++ .+.++||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.6e-09 Score=86.76 Aligned_cols=139 Identities=17% Similarity=0.284 Sum_probs=91.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHH------HHHHHHHHhCCCC---CeeeEEEE-
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI------KREVATMKLVKHP---NVVRLYEV- 79 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------~~e~~~l~~l~h~---~iv~~~~~- 79 (334)
.++|.+.+.+-......|.+..- +|+.+++|..+......+.....+ .+.+..+..+... ....++-+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 46788888888888887776553 578899999876543333222222 2333333333322 22222222
Q ss_pred ----EeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeec
Q 019904 80 ----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (334)
Q Consensus 80 ----~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Df 155 (334)
+.-....+++|||++|..|.+... +++ .+...+.+++.-||+.|++|+|.+|.|+++++ +.++++||
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEEC
Confidence 222345678999999987765431 232 24466778899999999999999999999986 55999999
Q ss_pred cchh
Q 019904 156 GLSA 159 (334)
Q Consensus 156 g~a~ 159 (334)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=7e-11 Score=111.04 Aligned_cols=247 Identities=19% Similarity=0.186 Sum_probs=175.7
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEe
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMG 81 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~ 81 (334)
-|+++.+...|...+.+++|+.+++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~ 304 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYD 304 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCC
Confidence 4677778888999999999999999999876654443 6666432 34556889999999999 888888888
Q ss_pred eCCeEEEEEeccCCC-chHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 82 SKTKIFIVLEFVTGG-ELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~-~L~~-~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.+...+++|+++.++ +... .....-.+.+.....+.+.-+++++++|+.-=+|+| ||+.+. +..+..||+...
T Consensus 305 ~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 305 GEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPP 379 (829)
T ss_pred cccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCc
Confidence 899999999999987 2211 111112344455666777788999999999888998 776655 789999999765
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCC---
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--- 236 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 236 (334)
...... ...+..+++.++|||+.....+. .+.|.|++|.-..+|.-|..|-... ......+.. ....|..
T Consensus 380 ~L~~~~---~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~-~p~s~~L~~~ 452 (829)
T KOG0576|consen 380 QLTRTM---KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGN-GPNSPMLTDK 452 (829)
T ss_pred ccCccc---ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCC-CCCccccchh
Confidence 433221 34556789999999999887776 7789999998878888887775431 000000000 0001111
Q ss_pred --CCHHHH-HHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 237 --LSFTAR-KLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 237 --~~~~~~-~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++.... ++...|+..-|..|+..-.++.|.+|..
T Consensus 453 ~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 453 SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 112222 4788999999999999999999988874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.9e-08 Score=81.60 Aligned_cols=138 Identities=16% Similarity=0.141 Sum_probs=98.1
Q ss_pred eccCceEEEEEEECCCCCeEEEEEeehhhh---hhHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEe--e--CCeEEEEE
Q 019904 20 GEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPN--VVRLYEVMG--S--KTKIFIVL 90 (334)
Q Consensus 20 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~--~--~~~~~~v~ 90 (334)
|+||-|-|+..... |+.+-+|.-..... ..+.-...+.+|+..++.+..-+ +.++...-. . .-..++|+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56899999987653 44677786541111 10223467889999999887433 444442111 1 12367899
Q ss_pred eccCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC--eEEeeccchh
Q 019904 91 EFVTG-GELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 159 (334)
Q Consensus 91 e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~a~ 159 (334)
|-+.| .+|.+.+... .+.+......++.+++.+++-||+.|+.|+|+.+.||+++.+|. +.++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97664 4787777553 24577777899999999999999999999999999999987777 9999999655
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.82 E-value=7.6e-08 Score=82.64 Aligned_cols=134 Identities=15% Similarity=0.161 Sum_probs=84.6
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
..||.|..+.||+. .|..+++|...... ....+.+|.++++.+..-+ +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999974 24568899876422 1345688999999887443 4677888877888899999999
Q ss_pred CCc-hH--------------HHH-------Hhc--CCCCHHH-HHHHHHH----------HHHH-HHHHH----hCCcEE
Q 019904 95 GGE-LF--------------DKI-------VNH--GRMKEDE-ARRYFQQ----------LINA-VDYCH----SRGVYH 134 (334)
Q Consensus 95 ~~~-L~--------------~~l-------~~~--~~l~~~~-~~~i~~q----------il~~-l~~LH----~~~i~H 134 (334)
|.. +. ..+ +.. ...+... ...+..+ +... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 111 110 0011000 0001000 1111 11221 235789
Q ss_pred eecCCCCEEEecCCCeEEeeccchhc
Q 019904 135 RDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 135 ~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+|+.|.||++++++ +.++||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2e-07 Score=79.19 Aligned_cols=136 Identities=20% Similarity=0.260 Sum_probs=93.7
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhhhhh---------------------HHHHHHHHHHHHHHHhCCCC--Cee
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---------------------HKMAEQIKREVATMKLVKHP--NVV 74 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~l~h~--~iv 74 (334)
.|+.|.-+.||+|.. .++..+|+|++......- .........|+.-|+++... .+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 455677788999886 457899999986433211 11123345788888877644 345
Q ss_pred eEEEEEeeCCeEEEEEeccCCCch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEE
Q 019904 75 RLYEVMGSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKV 152 (334)
Q Consensus 75 ~~~~~~~~~~~~~~v~e~~~~~~L-~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl 152 (334)
+.+.+.. -.+||||+..... .=.|+.. ++...++..+..++++.+.-|-. .|+||+||+.-|||+. +|.+.+
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 5555542 3489999865411 1112111 23333688889999999998877 8999999999999999 799999
Q ss_pred eeccchhc
Q 019904 153 SDFGLSAL 160 (334)
Q Consensus 153 ~Dfg~a~~ 160 (334)
+|||.|..
T Consensus 208 ID~~QaV~ 215 (268)
T COG1718 208 IDVSQAVT 215 (268)
T ss_pred EECccccc
Confidence 99997653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.68 E-value=2.8e-07 Score=92.62 Aligned_cols=205 Identities=19% Similarity=0.211 Sum_probs=146.1
Q ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe----EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019904 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130 (334)
Q Consensus 55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~ 130 (334)
+....-|+..+.++.|+|++.++.+-..+.. ..+..++|+..++...+...+..+....+.+..++++|++++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 4455567777888899999999887644433 234557898889999998888999999999999999999999999
Q ss_pred CcEEeecCCC---CEEEecCCCeEEe--eccchhccccccCCCcccccccCCcccChHhhhcCCCCC-CccchhhHHHHH
Q 019904 131 GVYHRDLKPE---NLLLDAYGNLKVS--DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG-STADLWSCGVIL 204 (334)
Q Consensus 131 ~i~H~dlkp~---NIl~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il 204 (334)
...|.-+..+ +--++..+.+..+ ||+.+...... .......-+..+.+||......... ...|+|++|...
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~---~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN---EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCc---ccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 7777766666 4444556666666 88876543322 2222334456788888877655431 236999999999
Q ss_pred HHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCC-HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS-FTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 205 ~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..+..|..+-..... ...+.+..+ ....+++.+|+.-++++|+++.+++.|+|.+...
T Consensus 383 ~~~~~~~~i~~~~~~----------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV----------PVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhhcCcccccccc----------hhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 999887655322110 011111111 1678899999999999999999999999987543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.5e-07 Score=78.61 Aligned_cols=138 Identities=20% Similarity=0.310 Sum_probs=81.3
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC--CeeeEEEEE---eeCCeEEEEE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVM---GSKTKIFIVL 90 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~---~~~~~~~~v~ 90 (334)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999855 48999997654 2245667888888877633 245666543 2334579999
Q ss_pred eccCCCchHH----------------HHH---hc----CCCCHHH---------HHHH------------HHHHHH-HHH
Q 019904 91 EFVTGGELFD----------------KIV---NH----GRMKEDE---------ARRY------------FQQLIN-AVD 125 (334)
Q Consensus 91 e~~~~~~L~~----------------~l~---~~----~~l~~~~---------~~~i------------~~qil~-~l~ 125 (334)
++++|..+.. .+. .. .++.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999977665 111 11 0001000 0000 011112 233
Q ss_pred HHH-------hCCcEEeecCCCCEEEe-cCCCeEEeeccchhc
Q 019904 126 YCH-------SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSAL 160 (334)
Q Consensus 126 ~LH-------~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~a~~ 160 (334)
.++ ...++|+|+.|.||+++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24699999999999999 556668999997653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.3e-07 Score=88.29 Aligned_cols=140 Identities=21% Similarity=0.324 Sum_probs=88.5
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-------------------------------hHHHHHH------HH
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-------------------------------KHKMAEQ------IK 59 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------------~~~~~~~------~~ 59 (334)
+.|+.++-|+||+|.... |+.||||+.++.-.. -.+..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 789999999999999854 999999998642110 0111122 23
Q ss_pred HHHHHHHhCC-----CCCeeeEEEEEeeCCeEEEEEeccCCCchHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019904 60 REVATMKLVK-----HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK--IVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132 (334)
Q Consensus 60 ~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~--l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i 132 (334)
+|+..+..+. .|+|.-..=+++-.+.-.++|||+.|-.+.+. ++. ...+...+...+.++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 3444444332 23332222222334556799999999888776 444 3344333322222111 233335899
Q ss_pred EEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 133 YHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 133 ~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+|.|.+|.||+++.+|.+.+.|||+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceec
Confidence 9999999999999999999999998654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.46 E-value=2e-06 Score=74.79 Aligned_cols=135 Identities=14% Similarity=0.078 Sum_probs=82.5
Q ss_pred eeeccCc-eEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeEEEEEeccCC
Q 019904 18 TIGEGTF-AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVTG 95 (334)
Q Consensus 18 ~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~ 95 (334)
.|..|.. +.||++... +..+++|...... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4555555 788988653 3678889875432 234567888888775 33456778877766778999999999
Q ss_pred CchHHHH-------------------HhcC----CCCHH--HHHHHHH--------------------HHHHHHHHHH--
Q 019904 96 GELFDKI-------------------VNHG----RMKED--EARRYFQ--------------------QLINAVDYCH-- 128 (334)
Q Consensus 96 ~~L~~~l-------------------~~~~----~l~~~--~~~~i~~--------------------qil~~l~~LH-- 128 (334)
.++.... +... ++... ....... .+...+..|-
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7665321 0000 01100 0000000 0111112221
Q ss_pred -----hCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 129 -----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 129 -----~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
...++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999977788999997653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2e-06 Score=69.38 Aligned_cols=129 Identities=19% Similarity=0.317 Sum_probs=93.5
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeee-EEEEEeeCCeEEEEEec
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR-LYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~~v~e~ 92 (334)
++.+.||+|.+|.||++.+. |..+|+|+-+.+.. ...+..|+++|..+...++.+ +|.+- ..++.|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~-----r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP-----RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCcc-----hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence 45678999999999999984 56899998765432 567889999999999877754 44432 23455999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecC-CCCEEEecCCCeEEeeccchhc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK-PENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlk-p~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..|-.|.+.-... . +.-+..+++.---|-..||-|+.|+ |...++..++.+.|+||..|+.
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9997776554321 1 2234456666566778899999997 5555665667999999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.5e-06 Score=84.44 Aligned_cols=81 Identities=19% Similarity=0.325 Sum_probs=57.1
Q ss_pred EeeeeeccCceEEEEEEECCCC--CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCe--eeEEEEEeeC---CeE
Q 019904 15 VGRTIGEGTFAKVKFARNSETG--EPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNV--VRLYEVMGSK---TKI 86 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~---~~~ 86 (334)
.++.++.|.++.+|+......+ ..+++|......... ....+.+|+.+|+.+. |++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998765432 467888764422111 1346779999999996 6665 7777777654 457
Q ss_pred EEEEeccCCCc
Q 019904 87 FIVLEFVTGGE 97 (334)
Q Consensus 87 ~~v~e~~~~~~ 97 (334)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.5e-05 Score=66.77 Aligned_cols=134 Identities=19% Similarity=0.270 Sum_probs=92.6
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhh-------------hhHHHHHHHHHHHHHHHhCC------CCCeeeE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-------------LKHKMAEQIKREVATMKLVK------HPNVVRL 76 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~ 76 (334)
...||+|+.-.||.-- .+...+||++..... ..........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3579999999999532 345579999976550 00111344455555555544 7889999
Q ss_pred EEEEeeCCeEEEEEeccCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC--
Q 019904 77 YEVMGSKTKIFIVLEFVTG------GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-- 148 (334)
Q Consensus 77 ~~~~~~~~~~~~v~e~~~~------~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-- 148 (334)
+++.+++....+|+|.... -+|.+++... .++. . +...+-+-..+|-+++|+.+|++|.||++...+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999997543 3577777443 4555 3 333444556788899999999999999996543
Q ss_pred --CeEEee-ccc
Q 019904 149 --NLKVSD-FGL 157 (334)
Q Consensus 149 --~~kl~D-fg~ 157 (334)
.+.|+| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 477887 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.7e-06 Score=72.10 Aligned_cols=73 Identities=11% Similarity=0.100 Sum_probs=45.9
Q ss_pred eeeeeccCceE-EEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC---CeeeEEEEEeeC---CeEEE
Q 019904 16 GRTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMGSK---TKIFI 88 (334)
Q Consensus 16 ~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~---~~~~~ 88 (334)
++.++.|+... ||.. +..+++|...... ....+.+|..+++.+... -+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 35678777764 8875 2357888754321 134688899999887632 244445443332 23488
Q ss_pred EEeccCCCch
Q 019904 89 VLEFVTGGEL 98 (334)
Q Consensus 89 v~e~~~~~~L 98 (334)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=8e-06 Score=77.69 Aligned_cols=137 Identities=26% Similarity=0.382 Sum_probs=85.0
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhh----------------------------hHHHHHHHHHHHH-----
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL----------------------------KHKMAEQIKREVA----- 63 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~~~~~~~~e~~----- 63 (334)
+.||..+.|+|++|+-.. |+.||||+-++.-.. -.+..+.+..|+.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 689999999999999865 999999986531100 0111222222222
Q ss_pred -----HHHhCCCCC------eeeEEEEEeeCCeEEEEEeccCCCchH--HHHHhcCCCCHHHHHHHHHHHHHHHH-HHHh
Q 019904 64 -----TMKLVKHPN------VVRLYEVMGSKTKIFIVLEFVTGGELF--DKIVNHGRMKEDEARRYFQQLINAVD-YCHS 129 (334)
Q Consensus 64 -----~l~~l~h~~------iv~~~~~~~~~~~~~~v~e~~~~~~L~--~~l~~~~~l~~~~~~~i~~qil~~l~-~LH~ 129 (334)
+.+.+.|-+ |.++|--+ ...-.++||||+|..+. +.+.+.+ ++... ++..+.++.. -+=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHh
Confidence 233333444 33333322 34567999999997664 3555544 33332 3333333322 2335
Q ss_pred CCcEEeecCCCCEEEec----CCCeEEeeccchhc
Q 019904 130 RGVYHRDLKPENLLLDA----YGNLKVSDFGLSAL 160 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~----~~~~kl~Dfg~a~~ 160 (334)
.|++|.|=+|.||++.. ++.+.+-|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 78999999999999984 56799999998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.18 E-value=5.8e-06 Score=74.05 Aligned_cols=137 Identities=20% Similarity=0.186 Sum_probs=81.9
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEE------EEeeCCeE
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYE------VMGSKTKI 86 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~------~~~~~~~~ 86 (334)
-.+.+..|....+|+... .+..+++|+..... ...+..|+.+++.+.+.+ +.+++. +....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKVS------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCCC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 356777788889998864 23468999876411 245667777777775332 444443 22334567
Q ss_pred EEEEeccCCCchHH-----------HH---Hhc-CCCCH--------HHH------------HHHHHHHHHHHHHHHh--
Q 019904 87 FIVLEFVTGGELFD-----------KI---VNH-GRMKE--------DEA------------RRYFQQLINAVDYCHS-- 129 (334)
Q Consensus 87 ~~v~e~~~~~~L~~-----------~l---~~~-~~l~~--------~~~------------~~i~~qil~~l~~LH~-- 129 (334)
++|+++++|..+.. .+ +.. ..+.. .-. ......+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999865421 11 100 00000 000 0011112233444442
Q ss_pred -----CCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 130 -----RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 130 -----~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999997778899999765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.4e-05 Score=63.54 Aligned_cols=128 Identities=22% Similarity=0.263 Sum_probs=88.6
Q ss_pred cceEEeeeeeccCc-eEEEEEEECCCCCeEEEEEeeh---h-------hhh-h-------HHHHHHHHHHHHHHHhCC--
Q 019904 11 GKYEVGRTIGEGTF-AKVKFARNSETGEPVALKILDK---E-------KVL-K-------HKMAEQIKREVATMKLVK-- 69 (334)
Q Consensus 11 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~---~-------~~~-~-------~~~~~~~~~e~~~l~~l~-- 69 (334)
..++.++.||.|.- |.||+++- .|+.||+|++.. . ... . .....-+..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57899999999999 99999986 577999999431 0 000 0 022334556666655554
Q ss_pred -CCCe--eeEEEEEeeC------------------CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019904 70 -HPNV--VRLYEVMGSK------------------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128 (334)
Q Consensus 70 -h~~i--v~~~~~~~~~------------------~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH 128 (334)
+.++ |+.+++..-. ....||.||.+... .+... =+.++++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence 5566 8888886221 12467888776643 12222 3467788889999
Q ss_pred hCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 129 ~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
..||+-+|+++.|.. .-+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999974 4589999853
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.4e-05 Score=62.56 Aligned_cols=98 Identities=20% Similarity=0.304 Sum_probs=78.2
Q ss_pred HHHHHHHHhCCC-CCeeeEEEEEeeCCeEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 019904 59 KREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHS---RG 131 (334)
Q Consensus 59 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~qil~~l~~LH~---~~ 131 (334)
..|.-+|+.+++ +++++++|++. .++|.||...+++... +..-...+......++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 368889999986 69999999883 2568899887655321 1122246788999999999999999997 45
Q ss_pred cEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 132 VYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 132 i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+.-.|++|+|+-++++|++|++|.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77799999999999999999999997654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.11 E-value=9.5e-05 Score=68.50 Aligned_cols=79 Identities=19% Similarity=0.214 Sum_probs=54.7
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhh--hh--HHHHHHHHHHHHHHHhCC---CCCeeeEEEEEeeCCeEEE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LK--HKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~ 88 (334)
.+.||.|.+..||++.....++.|+||.-..... .. ....++...|...|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999865446899998532100 00 122456677888888763 3467778777 4466789
Q ss_pred EEeccCCC
Q 019904 89 VLEFVTGG 96 (334)
Q Consensus 89 v~e~~~~~ 96 (334)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.08 E-value=5e-05 Score=65.57 Aligned_cols=75 Identities=21% Similarity=0.340 Sum_probs=48.4
Q ss_pred eeeeeccCceEEEEEEECC-CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEEEEecc
Q 019904 16 GRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~ 93 (334)
++.|..|-...+|++.... .++.|++|+....... .-...+|+.+++.+...++ ++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4678888888999987543 3567999987543211 1233478888888864333 44544432 2 3799999
Q ss_pred CCCch
Q 019904 94 TGGEL 98 (334)
Q Consensus 94 ~~~~L 98 (334)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.9e-06 Score=74.04 Aligned_cols=141 Identities=20% Similarity=0.267 Sum_probs=97.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh-------------------hhHHHHHHHHHHHHHHHh
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-------------------LKHKMAEQIKREVATMKL 67 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~~~~~e~~~l~~ 67 (334)
..+-.-+.++..||-|.-+.||.+-+. .|+..|+|.-+.... |-.-..-...+|+..|+.
T Consensus 88 ~~R~~v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 88 SNRGSVESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred HhcchhhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 344445778899999999999999884 488889986532111 111112334578888888
Q ss_pred CCCC--CeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe
Q 019904 68 VKHP--NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (334)
Q Consensus 68 l~h~--~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~ 145 (334)
|... -|++.+++ +..++|||+..|-.|...-.- ..+..+...+..-+.-|..+|+||+|++--||++.
T Consensus 167 L~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 167 LYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred HHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 8632 24444443 456899999998766432211 12333555566667788999999999999999999
Q ss_pred cCCCeEEeeccch
Q 019904 146 AYGNLKVSDFGLS 158 (334)
Q Consensus 146 ~~~~~kl~Dfg~a 158 (334)
+++.++++||-..
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999753
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=3.6e-05 Score=71.85 Aligned_cols=162 Identities=20% Similarity=0.253 Sum_probs=106.1
Q ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeeC-CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEE
Q 019904 56 EQIKREVATMKLVKHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134 (334)
Q Consensus 56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H 134 (334)
..+.-...+++.+.|+|...++++-... ....+|||++.. ||.+.+..+. +..... + .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~-l~~~s~-------~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN-LKDESL-------L-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc-cchhhh-------c-------ccccce
Confidence 3455678899999999999999886543 347899999965 8999887754 322111 1 233333
Q ss_pred eecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 019904 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (334)
Q Consensus 135 ~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf 214 (334)
- | ..+.+| -++... | ...++++||||+|.++.++.-|...|
T Consensus 91 ~-----~-------~~~~td-~~~t~~--------------------~------~~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L-----N-------IIYITD-HFLTKY--------------------P------SPIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e-----h-------hhhccc-cccccC--------------------C------CCCCcchhhhhHHHHHHHHHHhhHHH
Confidence 2 2 222333 111100 0 01125899999999999999998888
Q ss_pred CCCcHHHHHHHhhcCccCCC------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 215 DDSNLMNLYKKISAAEFTCP------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
......+....+..-..... -.++.....+..+|+...|..||...++++++-|....
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~ 201 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY 201 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence 76555554444432221111 12566778899999999999999999999999887543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.97 E-value=3e-05 Score=67.97 Aligned_cols=133 Identities=14% Similarity=0.185 Sum_probs=76.6
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEEEEeccCCC
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~~~~ 96 (334)
.+..|-.+.+|+... +++.+++|....... ...-+..+|..+++.+...++ .+++.... -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 355677788998873 466788997643211 100134678888888874433 34444332 26899999986
Q ss_pred chHH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCcEEeec
Q 019904 97 ELFD--------------KIVN---HG----RMKE-DEARRYFQQL---------INAVDYCHS--------RGVYHRDL 137 (334)
Q Consensus 97 ~L~~--------------~l~~---~~----~l~~-~~~~~i~~qi---------l~~l~~LH~--------~~i~H~dl 137 (334)
.+.. .+.+ .. +++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 1111 11 1111 1222222222 111222211 25899999
Q ss_pred CCCCEEEecCCCeEEeeccchhc
Q 019904 138 KPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 138 kp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.|.||++++++ +.++||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0002 Score=64.21 Aligned_cols=79 Identities=15% Similarity=0.150 Sum_probs=55.3
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEee---CCeE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGS---KTKI 86 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~---~~~~ 86 (334)
-.-.+.||.|..+.||...... + .+++|.... .. . ...+..|+..|+.+.. -.|.++++++.. .+..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-FS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecc-cc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 3446789999999999986533 3 477787532 10 1 2467788888888863 357788877654 3668
Q ss_pred EEEEeccCCCch
Q 019904 87 FIVLEFVTGGEL 98 (334)
Q Consensus 87 ~~v~e~~~~~~L 98 (334)
++|||+++|+++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998654
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.89 E-value=1.5e-06 Score=89.71 Aligned_cols=208 Identities=16% Similarity=0.058 Sum_probs=146.1
Q ss_pred HHHHHHHHhCCCCCeeeEEEEEee--CCeEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--
Q 019904 59 KREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSR-- 130 (334)
Q Consensus 59 ~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~-- 130 (334)
..|...++...|+++.....-... ....|.+++|+.+|.+.+.+.+. ..+.+..+.....+.+.+..-.|+.
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 345555666789988776654433 33568999999999999988764 2344555555555546666666643
Q ss_pred ---CcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHH
Q 019904 131 ---GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 207 (334)
Q Consensus 131 ---~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~ 207 (334)
--+|+++|+-|.++..+-.+++.++|+.++..+ .........+++.|++|++.+...+. .++|+|..|+.+|..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHH
Confidence 278999999999999999999999999884332 22334456788899999999887774 669999999999999
Q ss_pred HhCCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 208 LAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 208 ~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
..|..+|-.-....+...+... ....+...|.++......+|-..-..||.-...+.-+.|.
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9888887432222222222222 2234444566677777777777888899988888777665
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00021 Score=64.36 Aligned_cols=139 Identities=21% Similarity=0.220 Sum_probs=79.3
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEEE------EeeCCe
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTK 85 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~ 85 (334)
..++.++.|....+|++.. . +..+++|+...... ...+..|..++..|...+ +++++.. ....+.
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~-----~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~ 97 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVK-----AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK 97 (307)
T ss_pred eeccccCCccccceEEEEe-C-CCcEEEEEecCCCC-----HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence 3356677787789998864 3 33688898754211 123445666666664222 3444331 122456
Q ss_pred EEEEEeccCCCchH-----------HH---HHhc-CCC--------CHHH-----HH----------HHHHHHHHHHHHH
Q 019904 86 IFIVLEFVTGGELF-----------DK---IVNH-GRM--------KEDE-----AR----------RYFQQLINAVDYC 127 (334)
Q Consensus 86 ~~~v~e~~~~~~L~-----------~~---l~~~-~~l--------~~~~-----~~----------~i~~qil~~l~~L 127 (334)
.++++++++|..+. .. ++.. ..+ .... .. .....+...++++
T Consensus 98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l 177 (307)
T TIGR00938 98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL 177 (307)
T ss_pred EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence 78999999885431 11 1110 001 0000 00 0011123344444
Q ss_pred H-------hCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 128 H-------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 128 H-------~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
. ..+++|+|+++.||+++.++.+.++||+.+.
T Consensus 178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3 2689999999999999998877899999754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00058 Score=61.86 Aligned_cols=30 Identities=33% Similarity=0.457 Sum_probs=26.0
Q ss_pred CCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.|+||+|+.|.||+++.+...-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999976666899999765
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00029 Score=63.27 Aligned_cols=75 Identities=17% Similarity=0.221 Sum_probs=47.8
Q ss_pred eeeeeccCceEEEEEEECC------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEE
Q 019904 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFI 88 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~ 88 (334)
++.+..|-...+|++.... .++.+++|+...... ...+..+|..+++.+...++ .+++..+. + ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 4566667777899887543 257899999764321 12345678888888864433 34555543 2 35
Q ss_pred EEeccCCCch
Q 019904 89 VLEFVTGGEL 98 (334)
Q Consensus 89 v~e~~~~~~L 98 (334)
|++|++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8899888655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00027 Score=63.32 Aligned_cols=142 Identities=22% Similarity=0.286 Sum_probs=84.7
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEeeCC--eEEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSKT--KIFI 88 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~--~~~~ 88 (334)
..+++.+..|-...+|...+. +++++++ ... ............+|+.+++.+.--- +...++.+..+. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 344555544444445655543 7888888 332 1222233566778888888776423 344555555554 5699
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHS-------------------------------------- 129 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~-~qil~~l~~LH~-------------------------------------- 129 (334)
||++++|..+.+.+. +.....+.+ ..+...|+.||+
T Consensus 103 v~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 103 VMEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 999999843221110 000001111 134444444442
Q ss_pred --------------------CCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 130 --------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 130 --------------------~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..++|+|+.+.|++++..+.+-+.||+.+....+
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 3589999999999999998999999999876443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00082 Score=61.17 Aligned_cols=76 Identities=14% Similarity=0.128 Sum_probs=50.0
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhhh----hhHHHHHHHHHHHHHHHhCC--CC-CeeeEEEEEeeCCeEEEEE
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKV----LKHKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|.|....||++.+...++.|+||.-..--. .-+-...+..-|...|+... .| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57999999999999854446899997542111 11223456667888887664 34 45556554 556667899
Q ss_pred eccCC
Q 019904 91 EFVTG 95 (334)
Q Consensus 91 e~~~~ 95 (334)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0011 Score=59.94 Aligned_cols=140 Identities=21% Similarity=0.277 Sum_probs=93.1
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhh----------------------hhHHH-HHHHHHHHHHHHhCCCCC
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV----------------------LKHKM-AEQIKREVATMKLVKHPN 72 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~-~~~~~~e~~~l~~l~h~~ 72 (334)
...|..|.-+.||-|... +|..+|||++.-+-. +...+ .-....|++-|.++...+
T Consensus 149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 345667888999999874 578899998742100 01111 123456788888877655
Q ss_pred eeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEEeecCCCCEEEecCCCeE
Q 019904 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 73 iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
|.-.--+.. ....+||+++....-..-..++..++...+..+-.|++.-+.-|- .+++||.||+--|+|+-+ |.+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ly 304 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLY 304 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEE
Confidence 432211111 123589999865432222223345777788888888888887764 679999999999999976 8999
Q ss_pred Eeeccchh
Q 019904 152 VSDFGLSA 159 (334)
Q Consensus 152 l~Dfg~a~ 159 (334)
++|.+.|-
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99988653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0021 Score=59.53 Aligned_cols=77 Identities=14% Similarity=0.109 Sum_probs=51.8
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh----HHHHHHHHHHHHHHHhCC---CCCeeeEEEEEeeCCeEE
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 87 (334)
..+.||.|....||+..+. ++.|+||.-....... +....+...|+..|+.+. ...+++++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678899999999998873 4569999765211100 112445556677776664 247888888766 5567
Q ss_pred EEEeccCC
Q 019904 88 IVLEFVTG 95 (334)
Q Consensus 88 ~v~e~~~~ 95 (334)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0022 Score=58.79 Aligned_cols=137 Identities=16% Similarity=0.224 Sum_probs=79.3
Q ss_pred eeeeeccCceEEEEEEECC----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCee-eEEEEEeeCCeEEEEE
Q 019904 16 GRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVL 90 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~~v~ 90 (334)
++.|..|-...+|++.... .++.|++|+..... ..... ..+|..+++.+..-++. ++++.+.. + .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 3455557788899986432 24679999876532 12222 25788888888754443 55665532 2 478
Q ss_pred eccCCCchHH--------------HHH---hcC-C-----CCHHHHHHHHHHH-----------------HHHHHHH---
Q 019904 91 EFVTGGELFD--------------KIV---NHG-R-----MKEDEARRYFQQL-----------------INAVDYC--- 127 (334)
Q Consensus 91 e~~~~~~L~~--------------~l~---~~~-~-----l~~~~~~~i~~qi-----------------l~~l~~L--- 127 (334)
+|+.+.++.. .+. ... + .....+..++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 8887755421 111 101 0 1112233333222 1111111
Q ss_pred -H----hCCcEEeecCCCCEEEec-CCCeEEeeccchhc
Q 019904 128 -H----SRGVYHRDLKPENLLLDA-YGNLKVSDFGLSAL 160 (334)
Q Consensus 128 -H----~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~ 160 (334)
. ...++|+|+++.||++++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 236899999999999986 46799999997763
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0015 Score=57.84 Aligned_cols=31 Identities=23% Similarity=0.398 Sum_probs=25.8
Q ss_pred CcEEeecCCCCEEEecCCC-eEEeeccchhcc
Q 019904 131 GVYHRDLKPENLLLDAYGN-LKVSDFGLSALS 161 (334)
Q Consensus 131 ~i~H~dlkp~NIl~~~~~~-~kl~Dfg~a~~~ 161 (334)
.++|+|++|.||++++++. +-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997555 569999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0033 Score=58.04 Aligned_cols=78 Identities=18% Similarity=0.204 Sum_probs=52.6
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhh---hhHHHHHHHHHHHHHHHhCC--CC-CeeeEEEEEeeCCeEEEE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~e~~~l~~l~--h~-~iv~~~~~~~~~~~~~~v 89 (334)
.+.||.|.-.-||++.+...++.|+||.-..--. .-+-...+..-|...|+... .| .++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 5789999999999999854456799996432110 11223566777888888764 34 45666654 55666789
Q ss_pred EeccCC
Q 019904 90 LEFVTG 95 (334)
Q Consensus 90 ~e~~~~ 95 (334)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.013 Score=52.67 Aligned_cols=29 Identities=34% Similarity=0.574 Sum_probs=25.4
Q ss_pred CCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999988 678999999644
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0089 Score=54.47 Aligned_cols=137 Identities=17% Similarity=0.239 Sum_probs=76.6
Q ss_pred eeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEEEEe
Q 019904 16 GRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e 91 (334)
++.|..|=-..+|++..... +..|++|+...... . .-+-.+|..+++.+..-++ +++++++. .+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence 34454477778898864432 34799998754321 1 1223478888888875555 35565553 22 4788
Q ss_pred ccCCCchHH--------------HH---HhcC-C----C-CHHHHHHHHHHH----------------------HHHHHH
Q 019904 92 FVTGGELFD--------------KI---VNHG-R----M-KEDEARRYFQQL----------------------INAVDY 126 (334)
Q Consensus 92 ~~~~~~L~~--------------~l---~~~~-~----l-~~~~~~~i~~qi----------------------l~~l~~ 126 (334)
|++|..+.. .+ +... + . ....+..++.++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 887654411 11 1111 0 1 112222222221 111221
Q ss_pred HH----hC----CcEEeecCCCCEEEec-CCCeEEeeccchhc
Q 019904 127 CH----SR----GVYHRDLKPENLLLDA-YGNLKVSDFGLSAL 160 (334)
Q Consensus 127 LH----~~----~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~ 160 (334)
+. +. -++|+|+.+.||++++ ++.++++||+.|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12 2799999999999975 47899999998764
|
|
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0004 Score=46.06 Aligned_cols=27 Identities=44% Similarity=0.912 Sum_probs=20.6
Q ss_pred CCCcchhHHHhhcCCCCCCcCCCCcCC
Q 019904 307 QPVAMNAFELISLSKGLNLGNLFDAEQ 333 (334)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (334)
.|..+|+||+||+|.|+||..||+.++
T Consensus 1 ~p~~lNAFdiIS~S~G~DLSgLFe~~~ 27 (63)
T PF03822_consen 1 KPKSLNAFDIISLSSGFDLSGLFEEKD 27 (63)
T ss_dssp --EE--HHHHHCTSTTTSCGGGGGCG-
T ss_pred CCccccHHHHHHhccCCChHHhcCccc
Confidence 377899999999999999999997653
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.021 Score=51.53 Aligned_cols=30 Identities=17% Similarity=0.186 Sum_probs=27.4
Q ss_pred CcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 131 ~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+++|+|+.+.||++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999997653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.023 Score=50.53 Aligned_cols=76 Identities=14% Similarity=0.190 Sum_probs=46.1
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEeeCCeEEEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~v 89 (334)
-+-.+.++.|....+|+.. .+++.+.+|+-.... ...+..|+.-|+.|. .-.+++++.+....+..|+|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3456778889999999887 567889999876321 234556666666663 45678888888777778999
Q ss_pred EeccCCC
Q 019904 90 LEFVTGG 96 (334)
Q Consensus 90 ~e~~~~~ 96 (334)
|||.+.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998875
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.0038 Score=52.94 Aligned_cols=31 Identities=32% Similarity=0.582 Sum_probs=22.0
Q ss_pred CCcEEeecCCCCEEE-ecCCCeEEeeccchhc
Q 019904 130 RGVYHRDLKPENLLL-DAYGNLKVSDFGLSAL 160 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~-~~~~~~kl~Dfg~a~~ 160 (334)
..++|+|+.|.||++ +.++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 369999999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.019 Score=48.56 Aligned_cols=115 Identities=18% Similarity=0.217 Sum_probs=71.4
Q ss_pred cCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHH
Q 019904 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK 101 (334)
Q Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~ 101 (334)
++.++.-.++... | ...+|+++...+.-. ...++++++++.++. +|+++..- ..-.+-++.|+|-.-..
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---
Confidence 4445544444433 3 345666654444311 234577888887654 67777742 44457799999853211
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 102 IVNHGRMKEDEARRYFQQLINAVDYCHS--RGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 102 l~~~~~l~~~~~~~i~~qil~~l~~LH~--~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
.+. .++.-=+.+|.-.|+ .+.+|||-.|+||+.++.|.+||.|=+.
T Consensus 142 ------~~~----N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ------NFS----NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ------chh----HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 111 111222456777784 4799999999999999999999999663
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.027 Score=52.30 Aligned_cols=76 Identities=17% Similarity=0.245 Sum_probs=44.5
Q ss_pred EeeeeeccCceEEEEEEECCC-CCe-----EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEE
Q 019904 15 VGRTIGEGTFAKVKFARNSET-GEP-----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIF 87 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~ 87 (334)
.++.|..|-...+|++..... +.. |.+++... .. ...-+-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345665688889999864332 122 44443211 11 111223578889998875555 456666642 5
Q ss_pred EEEeccCCCch
Q 019904 88 IVLEFVTGGEL 98 (334)
Q Consensus 88 ~v~e~~~~~~L 98 (334)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 88899988654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.12 Score=46.99 Aligned_cols=71 Identities=20% Similarity=0.103 Sum_probs=41.1
Q ss_pred cCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEE---E--EEeeCCeEEEEEeccC
Q 019904 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLY---E--VMGSKTKIFIVLEFVT 94 (334)
Q Consensus 22 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~---~--~~~~~~~~~~v~e~~~ 94 (334)
+.-..||.... .++..+++|+.+..... ...+..|...+..|.... |+... + +...++..+.++++.+
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 44566888875 34667999988643211 344556777766664221 22211 1 2233567888999988
Q ss_pred CCc
Q 019904 95 GGE 97 (334)
Q Consensus 95 ~~~ 97 (334)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.18 Score=52.99 Aligned_cols=31 Identities=32% Similarity=0.452 Sum_probs=26.0
Q ss_pred CCcEEeecCCCCEEEecCC--CeE-Eeeccchhc
Q 019904 130 RGVYHRDLKPENLLLDAYG--NLK-VSDFGLSAL 160 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~~~--~~k-l~Dfg~a~~ 160 (334)
.++||+|+++.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 454 999997653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.055 Score=49.91 Aligned_cols=60 Identities=18% Similarity=0.221 Sum_probs=41.2
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEEeecCCCCEEEecC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV-DYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l-~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
.++-+|..|-++..+++.. ..++.....++.--..|+ +.|---+++|.|+.|.||++.-+
T Consensus 321 vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4555677777777777553 356656666665555554 34556799999999999999543
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.2 Score=42.77 Aligned_cols=74 Identities=20% Similarity=0.348 Sum_probs=49.4
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
+.+.-|.--..|...+ ...+|-+|+=..+ ....+..|+.-|..+ +.-.|.+++.+-.+..+.|+||||.
T Consensus 22 ~~v~gG~inea~~v~d--g~~~~FvK~n~~~------~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L 93 (286)
T COG3001 22 EEVSGGDINEAWRLRD--GTDPFFVKCNQRE------QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYL 93 (286)
T ss_pred cccCCccccceeEeec--CCcceEEEecchh------hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeec
Confidence 3445565566666655 3466888864432 234455565555555 4456888999999999999999999
Q ss_pred CCCch
Q 019904 94 TGGEL 98 (334)
Q Consensus 94 ~~~~L 98 (334)
+.+.+
T Consensus 94 ~~~~~ 98 (286)
T COG3001 94 PTGPL 98 (286)
T ss_pred cCCCC
Confidence 87554
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.11 Score=46.39 Aligned_cols=30 Identities=27% Similarity=0.439 Sum_probs=24.6
Q ss_pred CcEEeecCCCCEEEecC--C---CeEEeeccchhc
Q 019904 131 GVYHRDLKPENLLLDAY--G---NLKVSDFGLSAL 160 (334)
Q Consensus 131 ~i~H~dlkp~NIl~~~~--~---~~kl~Dfg~a~~ 160 (334)
-++|||++++|||+..+ | .++++||-.++.
T Consensus 216 vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 216 VLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 39999999999999654 3 589999987653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 334 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-77 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-76 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-75 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-75 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-75 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-75 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-74 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-73 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-65 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-65 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-65 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-64 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-64 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-64 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-63 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-63 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-63 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-61 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-60 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-57 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-57 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-56 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-56 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-56 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-53 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-52 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-51 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-51 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-51 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-51 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-51 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-51 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-51 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-51 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-51 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-51 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-51 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-51 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-51 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-51 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-51 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-51 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-51 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-51 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-51 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-51 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-50 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-50 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-50 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-50 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-50 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-50 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-50 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-50 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-50 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-50 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-50 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-50 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-50 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-50 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-50 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-50 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-50 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-50 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-50 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-50 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-50 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-50 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-50 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-50 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-50 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-50 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-50 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-50 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-49 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-49 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-49 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-49 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-49 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-49 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-49 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-47 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-47 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-47 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-47 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-47 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-47 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-46 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-46 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-46 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-46 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-46 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-46 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-45 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-45 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-45 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-45 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-45 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-45 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-45 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-45 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-45 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-44 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-44 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-44 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-44 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-43 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-43 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-43 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-42 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-42 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-42 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-42 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-42 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-42 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-42 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-41 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-41 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-41 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-41 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-41 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-41 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-41 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-41 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-41 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-41 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-41 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-41 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-41 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-41 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-41 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-41 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-41 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-41 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-41 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-41 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-41 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-41 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-41 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-41 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-41 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-41 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-41 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-41 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-41 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-41 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-41 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-41 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-41 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-41 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-41 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-41 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-41 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-41 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-40 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-40 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-40 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-40 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-40 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-40 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-40 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-40 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-40 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-40 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-40 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-40 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-40 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-40 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-40 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-40 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-40 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-40 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-40 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-40 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-40 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-40 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-40 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-40 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-40 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-40 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-40 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-40 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-40 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-40 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-40 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-40 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-40 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-40 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-40 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-39 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-39 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-39 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-39 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-39 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-39 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-39 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-39 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-39 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-39 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-39 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-39 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-39 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-38 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-38 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-38 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-38 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-38 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-38 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-38 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-38 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-38 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-38 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-38 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-38 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-38 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-37 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-37 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-37 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-37 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-37 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-37 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-37 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-37 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-37 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-37 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-37 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-37 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-37 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-37 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-37 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-37 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-37 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-37 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-36 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-36 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-36 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-36 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-35 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-34 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-34 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-34 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-34 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-34 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-33 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-33 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-33 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-33 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-32 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-32 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-32 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-31 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-31 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-31 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-31 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-31 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 4e-31 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 4e-31 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-31 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 4e-31 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-31 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-31 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-31 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-30 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-30 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-30 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-29 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-29 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-29 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-29 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-29 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-28 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-28 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-28 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-28 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-28 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-28 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-28 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-28 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-27 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-27 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-27 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-27 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-27 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-27 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-27 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-27 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-27 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-26 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-26 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-26 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-26 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-26 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-25 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-25 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-25 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-25 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-25 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-24 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-24 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-24 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-24 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-24 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-24 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-24 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-24 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-24 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-24 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-24 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-24 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-24 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-24 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-24 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-24 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-24 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-24 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-24 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-24 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-24 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-24 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-24 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-24 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-24 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-24 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-24 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-24 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-24 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-24 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-24 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-24 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-23 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-23 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-19 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-18 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-18 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-18 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-18 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-18 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-18 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-18 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-18 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-18 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-18 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-18 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-18 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-18 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-18 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-18 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-18 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-18 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-18 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-18 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-18 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-18 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-18 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-18 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-18 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-18 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-18 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-18 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-18 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-18 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-18 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-18 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-18 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-18 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-18 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-18 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-18 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-18 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-18 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-18 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-18 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-18 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-18 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-18 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-18 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-18 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-18 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-18 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-18 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-18 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-17 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-17 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-16 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-16 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-16 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-16 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-16 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-15 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-15 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-15 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-12 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-11 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-11 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 6e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 7e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 5e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 515 bits (1329), Expect = 0.0
Identities = 133/278 (47%), Positives = 191/278 (68%), Gaps = 3/278 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S+ + ++G Y +G T+G GTF KVK + TG VA+KIL+++K+ + +IKRE
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + T F+V+E+V+GGELFD I HGR++E EARR FQQ++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AVDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 178
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WSCGVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L+ +L +P+ R TI +I E EWFK+D +F E
Sbjct: 239 ATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 135/326 (41%), Positives = 204/326 (62%), Gaps = 12/326 (3%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
KR +G Y + T+GEG+F KVK A + +T + VALK + ++ + K M +++RE++
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+KL++HP++++LY+V+ + T I +V+E+ GGELFD IV RM EDE RR+FQQ+I A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++YCH + HRDLKPENLLLD N+K++DFGLS + + D L T+CG+PNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+N + Y G D+WSCG++L+V+L G LPFDD + NL+KK+++ + P +LS A+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVF-EEKKDTNLDDVEAVFKDSEEHHVTE 302
LI R++ +PM RITI EI D WF + + E+ + D V K E +E
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSE 297
Query: 303 Q-------KEEQPVAMNAFELISLSK 321
+E A+ L+ ++
Sbjct: 298 DYIVEALRSDENNEVKEAYNLLHENQ 323
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 515 bits (1327), Expect = 0.0
Identities = 137/326 (42%), Positives = 206/326 (63%), Gaps = 13/326 (3%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++G Y +G T+G GTF KVK ++ TG VA+KIL+++K+ + +I+RE
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + + IF+V+E+V+GGELFD I +GR+ E E+RR FQQ++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ VDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 183
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WS GVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD--DVEAVFKDSEEHH 299
L+ +L +PM R TI +I E EWFK+D +F E + D EA+ + E+
Sbjct: 244 ISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFE 303
Query: 300 VTEQK--------EEQPVAMNAFELI 317
+E++ Q A+ LI
Sbjct: 304 CSEEEVLSCLYNRNHQDPLAVAYHLI 329
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 508 bits (1309), Expect = 0.0
Identities = 108/308 (35%), Positives = 163/308 (52%), Gaps = 9/308 (2%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEE 297
L+ +IL NP RITIP+I +D W+ K K + +
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHI 294
Query: 298 HHVTEQKE 305
+
Sbjct: 295 QSNLDFSP 302
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 505 bits (1303), Expect = 0.0
Identities = 108/276 (39%), Positives = 160/276 (57%), Gaps = 9/276 (3%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
L+ +IL NP RITIP+I +D W+ K K
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = 0.0
Identities = 118/341 (34%), Positives = 176/341 (51%), Gaps = 16/341 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I +Y+ + IG G F + R+ T E VA+K +++ + E ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ + ++HPN+VR EV+ + T + I++E+ +GGEL+++I N GR EDEAR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ V YCHS + HRDLK EN LLD LK+ DFG S S +T GTP Y
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAY 183
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK----ISAAEFTCPP 235
+APEVL + YDG AD+WSCGV L+V+L G PF+D Y+K I + +++ P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 236 --WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT-NLDDVEAVF 292
+S LI+RI +P TRI+IPEI WF K+ + E + E
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPM 303
Query: 293 KDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
+ + + P N ++ L+L + D
Sbjct: 304 QSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFD 344
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 497 bits (1282), Expect = e-179
Identities = 91/303 (30%), Positives = 156/303 (51%), Gaps = 12/303 (3%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-MAEQIKREVATMK 66
+ +GKY +G +GEG++ KVK +SET A+KIL K+K+ + +K+E+ ++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67 LVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLIN 122
++H NV++L +V+ K K+++V+E+ G E+ D + R +A YF QLI+
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLID 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++Y HS+G+ H+D+KP NLLL G LK+S G++ D T+ G+P + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 183 EVLND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
E+ N + G D+WS GV L+ + G PF+ N+ L++ I + P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS-----E 296
L+ +L+ P R +I +I + WF+K + P + D + + E
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLE 300
Query: 297 EHH 299
+ H
Sbjct: 301 DLH 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 480 bits (1239), Expect = e-173
Identities = 93/271 (34%), Positives = 139/271 (51%), Gaps = 3/271 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 189 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
++L +P R TI E+L DE+F Y P
Sbjct: 248 KMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 479 bits (1236), Expect = e-172
Identities = 93/269 (34%), Positives = 139/269 (51%), Gaps = 3/269 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 214
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 215 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPP 275
++L +P R TI E+L DE+F Y P
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPA 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-172
Identities = 90/277 (32%), Positives = 152/277 (54%), Gaps = 4/277 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
I ++ ++VG +G+G+FA V A + TG VA+K++DK+ + K M ++++ EV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN 122
+KHP+++ LY +++VLE GE+ + N E+EAR + Q+I
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRDL NLLL N+K++DFGL+ + +T CGTPNY++P
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+ + G +D+WS G + + LL G PFD + N K+ A++ P +LS A+
Sbjct: 182 EIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
LI ++L NP R+++ +L+ + ++ +E
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 469 bits (1209), Expect = e-168
Identities = 119/298 (39%), Positives = 182/298 (61%), Gaps = 4/298 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + +G Y + +TIG+G FAKVK AR+ TG VA+KI+DK + L +++ RE
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
V MK++ HPN+V+L+EV+ ++ +++++E+ +GGE+FD +V HGRMKE EAR F+Q++
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AV YCH + + HRDLK ENLLLDA N+K++DFG S + G L CG P Y A
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAA 181
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+ + YDG D+WS GVIL+ L++G LPFD NL L +++ ++ P ++S
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHH 299
L+ R L NP+ R T+ +I++D W ++ + + LD + D
Sbjct: 242 ENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGM 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 462 bits (1192), Expect = e-166
Identities = 94/283 (33%), Positives = 163/283 (57%), Gaps = 8/283 (2%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
PK K + +++GR +G+G F V AR + +ALK+L K ++ K + Q++RE
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ ++HPN++R+Y + +I+++LEF GEL+ ++ HGR E + + ++L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A+ YCH R V HRD+KPENLL+ G LK++DFG S + +R T CGT +Y+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLP 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ + +D DLW GV+ + L G PFD + +++I + PP+LS +
Sbjct: 181 PEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK---PPVFEEKK 281
+ LI+++L +P R+ + ++E W K + + PPV++ +
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQ 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 461 bits (1188), Expect = e-165
Identities = 95/298 (31%), Positives = 157/298 (52%), Gaps = 32/298 (10%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
++ +Y + IG+G++ VK A N A+K+L K+K+++
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 54 ---------------MAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG 96
EQ+ +E+A +K + HPNVV+L EV+ ++ +++V E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
+ + + + ED+AR YFQ LI ++Y H + + HRD+KP NLL+ G++K++DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPF 214
+S + D LL T GTP ++APE L++ + + G D+W+ GV L+ + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 215 DDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
D +M L+ KI + P P ++ + LI R+LD NP +RI +PEI W +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 454 bits (1171), Expect = e-163
Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 5/280 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
K + + +E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN++RLY T+++++LE+ G ++ ++ + E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ YCHS+ V HRD+KPENLLL + G LK++DFG S + R CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
++ R +D DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR
Sbjct: 178 MIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
LI+R+L NP R + E+LE W + P + K++
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 445 bits (1146), Expect = e-158
Identities = 81/319 (25%), Positives = 144/319 (45%), Gaps = 15/319 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----- 56
KY +G G F V A + E + V +K + KEKVL+ E
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 57 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARR 115
++ E+A + V+H N++++ ++ ++ +V+E +G +LF I H R+ E A
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCG 191
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
T Y APEVL Y G ++WS GV L+ L+ PF + ++ A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDS 295
+S L++ +L P P R T+ +++ D W + + ++ ++ E+ +
Sbjct: 246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSA 305
Query: 296 EEHHVTEQKEEQPVAMNAF 314
+ +
Sbjct: 306 ASLEMGNRSLSDVAQAQEL 324
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-154
Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 17/297 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQ 57
+ + +Y+VG +G G F V PVA+K ++K+++ +
Sbjct: 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR 92
Query: 58 IKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEAR 114
+ EV +K V V+RL + ++LE +LFD I G ++E+ AR
Sbjct: 93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTT 173
+F Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL + D +
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF 208
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT Y PE + Y G +A +WS G++L+ ++ G +PF+ ++I +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF 262
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEA 290
+S + LI L P R T EI W + P E +L +
Sbjct: 263 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPS 319
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-154
Identities = 86/287 (29%), Positives = 133/287 (46%), Gaps = 19/287 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ--- 57
+ +Y +G +G+G F V VA+K++ + +VL
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 58 IKREVATMKLV----KHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDE 112
EVA + V HP V+RL + ++ +VLE + +LFD I G + E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLH 171
+R +F Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231
GT Y PE ++ Y A +WS G++L+ ++ G +PF+ ++I AE
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL 250
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
P +S LI R L P P +R ++ EIL D W + +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 410 bits (1055), Expect = e-144
Identities = 66/325 (20%), Positives = 130/325 (40%), Gaps = 50/325 (15%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
+ + + Y + RT+ +G F K+ + + ALK +K + K +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 54 ------MAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR 107
+ K E+ + +K+ + ++ + +++I+ E++ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 108 MK--------EDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ + + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD- 216
D + + GT ++ PE ++ Y+G+ D+WS G+ L+V+ +PF
Sbjct: 200 EYMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 217 SNLMNLYKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRI 257
+L+ L+ I P +LS + L NP RI
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315
Query: 258 TIPEILEDEWFKKDYKPPVFEEKKD 282
T + L+ EW + E K+
Sbjct: 316 TSEDALKHEWLADTNIEDLREFSKE 340
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 345 bits (886), Expect = e-119
Identities = 81/303 (26%), Positives = 133/303 (43%), Gaps = 36/303 (11%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R +E +G+G F +V ARN+ A+K + + + I EV +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLAS 58
Query: 68 VKHPNVVRLYEV-------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK-EDEA 113
+ H VVR Y + K+ +FI +E+ G L+D I + + DE
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ---------- 163
R F+Q++ A+ Y HS+G+ HRDLKP N+ +D N+K+ DFGL+ +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 164 --VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
L + GT YVA EVL+ G+ D++S G+I F ++ Y +N
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 222 LYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
+ KK+ + PP +K+I ++D +P R +L W ++ V
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296
Query: 278 EEK 280
+E
Sbjct: 297 KEA 299
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-115
Identities = 100/311 (32%), Positives = 162/311 (52%), Gaps = 21/311 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA+KI+ K K + A ++ E+ +K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 CHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 184 VLNDRGYD--GSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW-- 236
VL G D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSE 296
+S A L+ ++L +P R T E L W + + F++ + ++
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLL--SEENESTALPQVL 304
Query: 297 EHHVTEQKEEQ 307
T +K +
Sbjct: 305 AQPSTSRKRPR 315
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 323 bits (831), Expect = e-111
Identities = 103/271 (38%), Positives = 145/271 (53%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + TIG G++ +VK A T A K + K V + ++ K+E+ MK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLYE T I++V+E TGGELF+++V+ +E +A R + +++AV YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HRDLKPEN L LK+ DFGL+A + ++ T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G D WS GV+++VLL GY PF + KI F W +S A L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I R+L +P RIT + LE EWF+K
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-111
Identities = 100/279 (35%), Positives = 159/279 (56%), Gaps = 12/279 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFG L+ +V D H GTP Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
I +L NP RIT + L+ W + ++DT
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-110
Identities = 97/276 (35%), Positives = 153/276 (55%), Gaps = 21/276 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA++I+ K K + A ++ E+ +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 127 CHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
Query: 184 VLND---RGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW- 236
VL GY D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 312 VLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+S A L+ ++L +P R T E L W + +
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = e-110
Identities = 92/275 (33%), Positives = 143/275 (52%), Gaps = 20/275 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMK 66
KY+ IG G + V+ + TG A+KI++ ++ E +RE ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
V HP+++ L + S + +F+V + + GELFD + + E E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ H+ + HRDLKPEN+LLD +++SDFG S + L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 186 ------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
GY G DLW+CGVILF LLAG PF + + + I +F+ P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S T + LI+R+L +P R+T + L+ +F++
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-110
Identities = 69/289 (23%), Positives = 128/289 (44%), Gaps = 19/289 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + Y + + IG G +KV N E + A+K ++ E+ ++ + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRN 75
Query: 61 EVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK 134
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + GT N
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 179 YVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI 226
Y+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
E P + ++ L +P RI+IPE+L + + P
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-109
Identities = 91/282 (32%), Positives = 140/282 (49%), Gaps = 21/282 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK------HKMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 66 KLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
+ V HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 185 L------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW 236
+ N GY G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S T + L++R L P R T E L +F++ V
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 317 bits (815), Expect = e-107
Identities = 98/271 (36%), Positives = 155/271 (57%), Gaps = 12/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 88
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFGL+ +V D H GTP Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +L NP RIT + L+ W +
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = e-107
Identities = 96/270 (35%), Positives = 147/270 (54%), Gaps = 15/270 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F++V + TG+ ALK + K + ++ E+A +K +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHE 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S T ++V++ V+GGELFD+I+ G E +A QQ+++AV Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL + + ++DFGLS ++ +G++ T CGTP YVAPEVL +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D WS GVI ++LL GY PF + L++KI EF P W +S +A+
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKP 274
I +L+ +P R T + L W +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTAL 271
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-106
Identities = 83/269 (30%), Positives = 138/269 (51%), Gaps = 17/269 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R +G G F V +G +K ++K++ EQI+ E+ +K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYC 127
N+++++EV ++IV+E GGEL ++IV + E +Q++NA+ Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
HS+ V H+DLKPEN+L + +K+ DFGL+ L + D GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW-LSFTA 241
R D+WS GV+++ LL G LPF ++L + +K + E + L+ A
Sbjct: 198 FK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270
L+ ++L +P R + ++L EWFK+
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-106
Identities = 59/307 (19%), Positives = 114/307 (37%), Gaps = 50/307 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 C-------------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
L ++A IL+ + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 268 FKKDYKP 274
Sbjct: 306 DILHRGN 312
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = e-106
Identities = 72/347 (20%), Positives = 142/347 (40%), Gaps = 21/347 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ I + Y + + IG G +KV N E + A+K ++ E+ ++ + + E
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNE 104
Query: 62 VATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + G NY
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 180 VAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI- 226
+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 227 SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
E P + ++ L +P RI+IPE+L + + P + +
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP--VNQMAKGTTE 340
Query: 287 DVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
+++ V + + + S + F+ ++
Sbjct: 341 EMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKR 387
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-106
Identities = 94/267 (35%), Positives = 150/267 (56%), Gaps = 13/267 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFGLS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNPMTRITIPEILEDEWFKKD 271
I ++L +P RIT + LE W +K
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-106
Identities = 71/288 (24%), Positives = 127/288 (44%), Gaps = 19/288 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + + IG G +KV N E + A+K ++ E+ ++ + + E+A + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 72 N--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ ++RLY+ + I++V+E +L + + E + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ H DLKP N L+ G LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 190 YD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISA-AEFTCPPW 236
+D+WS G IL+ + G PF + + L+ I E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
+ ++ L +P RI+IPE+L + + P K T
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 293
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-106
Identities = 78/362 (21%), Positives = 129/362 (35%), Gaps = 51/362 (14%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + G +E+ +G G F V + +TGE VA+K +E K++ E+ E
Sbjct: 5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLE 62
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGR---MKEDE 112
+ MK + HPNVV EV K+ + +E+ GG+L + +KE
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGL 169
R + +A+ Y H + HRDLKPEN++L K+ D G ++++ L
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGEL 179
Query: 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISA 228
GT Y+APE+L + Y T D WS G + F + G+ PF + + + K+
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 229 AEFTCPPWLSFT-----------------------ARKLIARILDPNPMTRITIPEILED 265
+ + +L + R T P+
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298
Query: 266 EWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNL 325
F+ + +V T E N + G+
Sbjct: 299 GCFQ---------ALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPE 349
Query: 326 GN 327
Sbjct: 350 EE 351
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-104
Identities = 64/358 (17%), Positives = 128/358 (35%), Gaps = 50/358 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 -------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267
L ++A IL+ + + +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 268 FKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFELISLSKGLNL 325
+ + ++ ++ + + ELI + L L
Sbjct: 306 DILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVL 363
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-102
Identities = 97/271 (35%), Positives = 151/271 (55%), Gaps = 11/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ +G+G F+ V+ G+ A I++ +K+ ++++RE +L+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + + +++ + VTGGELF+ IV E +A QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HR+LKPENLLL +K++DFGL+ + + GTP Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G DLW+CGVIL++LL GY PF D + LY++I A +F P W ++ A+ L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I ++L NP RIT E L+ W
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVA 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-101
Identities = 93/278 (33%), Positives = 147/278 (52%), Gaps = 19/278 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK 69
YE+ IG+G F+ V+ N ETG+ A+KI+D K E +KRE + ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HP++V L E S +++V EF+ G +L +IV E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVA 181
YCH + HRD+KP +LL + +K+ FG++ Q+ + G + GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--L 237
PEV+ Y G D+W CGVILF+LL+G LPF + L++ I + W +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
S +A+ L+ R+L +P RIT+ E L W K+ +
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYA 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-101
Identities = 96/268 (35%), Positives = 146/268 (54%), Gaps = 17/268 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+EV +G G + V + T +P ALK+L K + ++ E+ + + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L E+ + T+I +VLE VTGGELFD+IV G E +A +Q++ AV Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL LK++DFG LS+ V L+ T CGTP Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFG---LSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW--LSFTARK 243
Y G D+WS G+I ++LL G+ PF D+ ++++I F P W +S A+
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKD 271
L+ +++ +P R+T + L+ W
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = e-100
Identities = 88/276 (31%), Positives = 141/276 (51%), Gaps = 22/276 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKH 70
YEV IG G+++ K + T A+KI+DK K E+ + + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN++ L +V +++V E + GGEL DKI+ E EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 131 GVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
GV HRDLKP N+L ++++ DFG + + ++GLL T C T N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAA--EFTCPPW--LSF 239
+GYD + D+WS GV+L+ +L GY PF + + +I + + W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
TA+ L++++L +P R+T +L W + P
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = e-100
Identities = 94/312 (30%), Positives = 142/312 (45%), Gaps = 53/312 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
KY + IG+G++ V+ A ++T A+KI++K K+ + K E+IK EV MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------------------- 109
HPN+ RLYEV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 --------------------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAY 147
E +Q+ +A+ Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 148 GNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVI 203
+K+ DFGLS + + T GTP +VAPEVLN + Y G D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 204 LFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIARILDPNPMTRITI 259
L +LL G +PF N + ++ + F P + LS AR L++ +L+ N R
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 260 PEILEDEWFKKD 271
L+ W +
Sbjct: 326 MRALQHPWISQF 337
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 1e-99
Identities = 94/276 (34%), Positives = 151/276 (54%), Gaps = 15/276 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
YE+G +G G FA V+ R TG+ A K + K ++ + E+I+REV ++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPN++ L+++ +KT + ++LE V+GGELFD + + EDEA ++ +Q+++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S+ + H DLKPEN++L +K+ DFG ++ ++ GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF ISA +F + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
A+ I R+L +P R+TI + LE W K + V
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 3e-99
Identities = 97/289 (33%), Positives = 158/289 (54%), Gaps = 17/289 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFG LS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ + F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
I ++L +P RIT + LE W +K E ++L +E+
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSS----ETPTISDLPSLESAMT 301
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = 4e-99
Identities = 98/283 (34%), Positives = 144/283 (50%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF +SA EF + S
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I R+L +P R+TI + L+ W K K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASA 290
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 2e-98
Identities = 97/272 (35%), Positives = 155/272 (56%), Gaps = 12/272 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ R +G+G+F +V ++ TG+ A+K++ K +V + E + REV +K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LYE K ++V E TGGELFD+I++ R E +A R +Q+++ + Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL N+++ DFG LS + GT Y+APEVL+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF+ +N ++ KK+ + F P W +S +A+ L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
I ++L P RI+ + L+ EW + K +
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 3e-98
Identities = 89/283 (31%), Positives = 146/283 (51%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H NV+ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I++ +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I ++L R+TI E L W ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 5e-98
Identities = 97/327 (29%), Positives = 158/327 (48%), Gaps = 35/327 (10%)
Query: 12 KYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
Y++ + +GEG+F+ + + ++ + A+KI+ K ++E+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 69 K-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ HPN+V+L+EV + F+V+E + GGELF++I E EA ++L++AV +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H GV HRDLKPENLL + +K+ DFG + L D+ L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAA--EFTCPP 235
LN GYD S DLWS GVIL+ +L+G +PF + + + KKI F
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 236 W--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
W +S A+ LI +L +P R+ + + +EW + + L + +
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS------SNPLMTPDILGS 293
Query: 294 DSEEHHVTEQKEEQPVAMNAFELISLS 320
V + A N ++
Sbjct: 294 SG--AAVHTCVKATFHAFNKYKREGFC 318
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 1e-97
Identities = 90/283 (31%), Positives = 147/283 (51%), Gaps = 15/283 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPN++ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I+A +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
A+ I ++L R+TI E L W ++
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 1e-96
Identities = 93/271 (34%), Positives = 145/271 (53%), Gaps = 13/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ + +G G + +V R+ T A+KI+ K + ++ EVA +KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LY+ K ++V+E GGELFD+I++ + E +A +Q+++ V Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL + +K+ DFGLSA+ + + GT Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVILF+LLAGY PF + +K+ + F P W +S A+ L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I ++L + RI+ + LE W K+
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 1e-96
Identities = 92/287 (32%), Positives = 148/287 (51%), Gaps = 22/287 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA----------EQIKRE 61
Y R +G G + +V + A+K++ K + K + + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +K + HPN+++L++V K ++V EF GGELF++I+N + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 122 NAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + Y H + HRD+KPEN+LL ++ N+K+ DFG LS D L GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG---LSSFFSKDYKLRDRLGTAY 213
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
Y+APEVL + Y D+WSCGVI+++LL GY PF N ++ KK+ + F W
Sbjct: 214 YIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKK 281
+S A++LI +L + R T E L W KK ++K
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 9e-95
Identities = 64/271 (23%), Positives = 126/271 (46%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + + + +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ + +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
+ D+WS G +++VLL+G PF + + I A F + +S A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ R+L +R+T E L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 282 bits (725), Expect = 2e-94
Identities = 81/286 (28%), Positives = 140/286 (48%), Gaps = 16/286 (5%)
Query: 12 KYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y + + +G G FA V+ + TG+ A K L K + +I E+A ++L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYC 127
P V+ L+EV + ++I ++LE+ GGE+F + + E++ R +Q++ V Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + H DLKP+N+LL G++K+ DFG +S+++ L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG---MSRKIGHACELREIMGTPEYLAPEI 204
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
LN + D+W+ G+I ++LL PF + Y IS +++ + +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
A I +L NP R T L W ++ +F ++ ++
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 4e-94
Identities = 49/311 (15%), Positives = 102/311 (32%), Gaps = 53/311 (17%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ ++ R G +G+ A + ETGE + + + +Q+K EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 63 ATMKL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFV------- 93
++L VK P ++ V + ++++ F
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 94 ----TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149
G L H + + Q+I + H G+ H L+P +++LD G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWS 199
+ ++ F DG + + + PE+ R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITI 259
G++++ + LP + + I F + R L+ L R+
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 260 PEILEDEWFKK 270
+ +E +++
Sbjct: 355 LQAMETPEYEQ 365
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 1e-93
Identities = 106/346 (30%), Positives = 157/346 (45%), Gaps = 39/346 (11%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 104
Query: 62 VATMK-LVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEAR 114
V + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + A+ Y HS + HRD+KPENLL LK++DFG +++ L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLT 221
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKIS 227
T C TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +I
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 228 AA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDT 283
EF P W +S + LI +L P R+TI E + W + K P T
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QT 334
Query: 284 NLDDVEAVFKDSEEHHVTEQKEEQPVAMNAF--ELISLSKGLNLGN 327
L + +D E +++ +A E I + K + N
Sbjct: 335 PLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 380
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 6e-93
Identities = 96/324 (29%), Positives = 150/324 (46%), Gaps = 40/324 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
Y++ + +G G KV + TG+ ALK+L + ++EV +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 70 HPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINA 123
P++V + +V K + I++E + GGELF +I G E EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 124 VDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + HS + HRD+KPENLL + LK++DFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYV 196
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAA--EFTCP 234
APEVL YD S D+WS GVI+++LL G+ PF + + ++I F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 235 PW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVF 292
W +S A++LI +L +P R+TI + + W + P T L +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP------QTPLHTARVLQ 309
Query: 293 KDSEEHHVTEQKEEQPVAMNAFEL 316
+D + H E KEE A+ +
Sbjct: 310 EDKD--HWDEVKEEMTSALATMRV 331
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-92
Identities = 84/294 (28%), Positives = 139/294 (47%), Gaps = 38/294 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
Y++ +GEG A+V+ N T + A+KI++K+ + ++ REV + +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NV+ L E + + ++V E + GG + I E EA Q + +A+D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 130 RGVYHRDLKPENLLL---DAYGNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNYVA 181
+G+ HRDLKPEN+L + +K+ DF L + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--------------- 221
PEV+ YD DLWS GVIL++LL+GY PF +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 222 LYKKISAA--EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271
L++ I EF W +S A+ LI+++L + R++ ++L+ W +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 8e-92
Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 14/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG K ++ L +K E++ M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q + + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D+KPEN++ + +K+ DFG L+ ++ D ++ T T + APE+++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+W+ GV+ +VLL+G PF + + + + EF + +S A+
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +L P R+T+ + LE W K D+
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 4e-90
Identities = 84/282 (29%), Positives = 140/282 (49%), Gaps = 16/282 (5%)
Query: 12 KYEVGRT--IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
Y V +T +G G F +V + TG +A KI+ + K E++K E++ M +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD 144
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCH 128
H N+++LY+ SK I +V+E+V GGELFD+I++ + E + + +Q+ + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 129 SRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ H DLKPEN+L +K+ DFG L+++ + L GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFG---LARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTAR 242
+ D+WS GVI ++LL+G PF N I A + + +S A+
Sbjct: 262 -YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
+ I+++L RI+ E L+ W +K N
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKN 362
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 5e-90
Identities = 79/289 (27%), Positives = 134/289 (46%), Gaps = 14/289 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG A K + E +++E+ TM +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHP 214
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR 130
+V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+ + + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 131 GVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
H DLKPEN++ LK+ DFG L+ + + T GT + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFG---LTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+WS GV+ ++LL+G PF N + + + + +S +
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFK 293
I ++L +P TR+TI + LE W P + + + K
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 439
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-89
Identities = 79/291 (27%), Positives = 126/291 (43%), Gaps = 34/291 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
+ V R + EG FA V A++ +G ALK L + + I +EV MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 71 PNVVRLY-------EVMGSKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQL 120
PN+V+ E + F++L + G+L + + G + D + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 121 INAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA-------LSQQVRDDGLLH 171
AV + H + + HRDLK ENLLL G +K+ DFG + S + L+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 172 ---TTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
T TP Y PE+++ G D+W+ G IL++L PF+D + +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 227 SAAEFTCPPWLSFTA--RKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+++ PP + LI +L NP R++I E++ +
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 2e-88
Identities = 65/284 (22%), Positives = 116/284 (40%), Gaps = 23/284 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +GEG F+ V G ALK + + + E+ +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHP 86
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINA 123
N++RL G+K + +++L F G L+++I + ED+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGT 176
++ H++G HRDLKP N+LL G + D G S+Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 177 PNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC 233
+Y APE+ + + + D+WS G +L+ ++ G P+D + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 234 PPWLSFT--ARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
P + +L+ ++ +P R IP +L + P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 2e-88
Identities = 82/289 (28%), Positives = 140/289 (48%), Gaps = 14/289 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 21 PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
M + HP V+LY K++ L + GEL I G E R Y +++
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P A
Sbjct: 201 PELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 242 RKLIARILDPNPMTRITIP------EILEDEWFKK-------DYKPPVF 277
R L+ ++L + R+ + +F+ PP
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 308
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-86
Identities = 87/274 (31%), Positives = 135/274 (49%), Gaps = 16/274 (5%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + EV ++ +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLREL 62
Query: 69 KHPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLIN 122
KHPN+VR Y+ + + T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D T GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S ++I R+L+ R ++ EILE+ +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-84
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 44/312 (14%)
Query: 2 SQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ P ++ + + +G G+ V F S G PVA+K + + +
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALM 57
Query: 61 EVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDE 112
E+ + + HPNV+R Y + ++I LE L D + + KE
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-------------AYGNLKVSDFGLSA 159
+Q+ + V + HS + HRDLKP+N+L+ + +SDFGL
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 L--SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD------GSTADLWSCGVILFVLL-AG 210
S Q L+ GT + APE+L + + D++S G + + +L G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 211 YLPFDDSNLMN---LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILED 265
PF D + S E C L A LI++++D +P+ R T ++L
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296
Query: 266 EWFKKDYKPPVF 277
F K F
Sbjct: 297 PLFWPKSKKLEF 308
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 3e-83
Identities = 76/262 (29%), Positives = 139/262 (53%), Gaps = 7/262 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K +++E G +K ++ + + K E+ +REVA + +KHP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V+ E ++IV+++ GG+LF +I +ED+ +F Q+ A+ + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+K +N+ L G +++ DFG++ + L GTP Y++PE+ ++
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARI 248
Y+ + +D+W+ G +L+ L F+ ++ NL KI + F S+ R L++++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 249 LDPNPMTRITIPEILEDEWFKK 270
NP R ++ ILE + K
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 3e-82
Identities = 67/282 (23%), Positives = 114/282 (40%), Gaps = 33/282 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
KR ++ IG G F +V A++ G+ +K + E+ +REV +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59
Query: 67 LVKHPNVVRLYE----------------VMGSKTKIFIVLEFVTGGELFDKIV--NHGRM 108
+ H N+V +FI +EF G L I ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ A F+Q+ VDY HS+ + +RDLKP N+ L +K+ DFGL +++DG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDG 176
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 228
+ GT Y++PE ++ + Y DL++ G+IL LL +++ + +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233
Query: 229 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
+ L+ ++L P R EIL K
Sbjct: 234 GII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 7e-81
Identities = 45/310 (14%), Positives = 87/310 (28%), Gaps = 47/310 (15%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ + K ++ + G + V R+ E E ALK+ E++
Sbjct: 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEAT 113
Query: 63 ATMKLVKHPNVVRLYEVMG--------------------------SKTKIFIVLEFVTG- 95
+ + + + +++ +
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 96 ----GELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
D + + A QLI S+G+ H P+NL + G L
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233
Query: 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVILFVLLA 209
+ D + + Y E LN + W G+ ++ +
Sbjct: 234 MLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 210 GYLPFDDSN--LMNLYKKISAAE-------FTCPPWLSFTARKLIARILDPNPMTRITIP 260
+LPF + +K+ S F L + LI R L+ + R+
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348
Query: 261 EILEDEWFKK 270
E +E F +
Sbjct: 349 EAMETPEFLQ 358
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-80
Identities = 85/295 (28%), Positives = 124/295 (42%), Gaps = 57/295 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ +G G KV N T E ALK+L + +REV + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVD 125
++VR+ +V + + IV+E + GGELF +I + G E EA + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS + HRD+KPENLL LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAA--EFTCPPW 236
E YD S D+WS GVI+++LL GY PF ++ + + +I EF P W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 237 --LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
+S + LI +L P R+TI E + W + K P T L
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP------QTPLHTSR 275
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 5e-80
Identities = 66/287 (22%), Positives = 113/287 (39%), Gaps = 24/287 (8%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
VGK + +G G + + R VA+K + E REV
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQL 70
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLIN 122
++ +HPNV+R + + +I +E L + + E QQ +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 123 AVDYCHSRGVYHRDLKPENLLL-----DAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGT 176
+ + HS + HRDLKP N+L+ +SDFGL L+ GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 177 PNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC 233
++APE+L++ + T D++S G + + +++ G PF S + A C
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 234 PPW---LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVF 277
AR+LI +++ +P R + +L+ +F K F
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 1e-79
Identities = 88/288 (30%), Positives = 150/288 (52%), Gaps = 20/288 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
+ L+ +L + R + +I +WF + + P
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP 313
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 2e-79
Identities = 96/303 (31%), Positives = 167/303 (55%), Gaps = 27/303 (8%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK + +++ RT+G G+F +V R+ G A+K+L KE V++ K E E
Sbjct: 1 PKYS--LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+ +V HP ++R++ +IF++++++ GGELF + R A+ Y ++ A
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++Y HS+ + +RDLKPEN+LLD G++K++DFG + + +T CGTP+Y+APE
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V++ + Y + D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + +
Sbjct: 174 VVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 232
Query: 244 LIARILDPNPMTRI-----TIPEILEDEWFK---------KD----YKPPVFEEKKDT-N 284
L++R++ + R+ ++ WFK ++ Y+PP+ + + DT
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQ 292
Query: 285 LDD 287
D
Sbjct: 293 FDK 295
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 4e-79
Identities = 48/302 (15%), Positives = 98/302 (32%), Gaps = 42/302 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R G +G+ A + ETGE + + + +Q+K EV +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 66 KL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFVT--------- 94
+L VK P ++ V + ++++ F
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 95 --GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152
G L H + + Q+I + H G+ H L+P +++LD G + +
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
Query: 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLL 208
+ F + + P A +L + + D W+ G+ ++ +
Sbjct: 253 TGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 209 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268
LP D + + I + P R L+ L R+ + +E +
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQP----VRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 269 KK 270
++
Sbjct: 368 EQ 369
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-78
Identities = 82/289 (28%), Positives = 137/289 (47%), Gaps = 15/289 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + + + IG G F++V A G PVALK + ++ K +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E+ +K + HPNV++ Y ++ IVLE G+L I + + + E +Y
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
F QL +A+++ HSR V HRD+KP N+ + A G +K+ D GL H+ GT
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 199
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCP 234
P Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P
Sbjct: 200 PYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--P 256
Query: 235 PW----LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
P S R+L+ ++P+P R + + + E
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEH 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-78
Identities = 64/261 (24%), Positives = 111/261 (42%), Gaps = 10/261 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G++ +V R+ E G A+K A ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
VRL + +++ E G L G + E + Y + + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ H D+KP N+ L G K+ DFGL ++ G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 191 DGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
+ AD++S G+ + + LP L + EF LS R ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 250 DPNPMTRITIPEILEDEWFKK 270
+P+P R T +L ++
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-75
Identities = 67/294 (22%), Positives = 114/294 (38%), Gaps = 31/294 (10%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R + +E + +G G F V A+N A+K + + E++ REV +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAK 59
Query: 68 VKHPNVVRLYEV------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK---EDE 112
++HP +VR + K ++I ++ L D + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL----------SQ 162
F Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222
+ GT Y++PE ++ Y D++S G+ILF LL Y +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 223 YKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ +F ++ +L P+PM R I+E+ F+ P
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-74
Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 21/289 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG+G+F KV + ++T + A+K ++K+K ++ + +E+ M+ ++HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ + +F+V++ + GG+L + + KE+ + + +L+ A+DY ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR---GYDGS 193
+KP+N+LLD +G++ ++DF ++A + + + T GT Y+APE+ + R GY
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SF 196
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
D WS GV + LL G P+ ++ + T P S L+ ++L+
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 251 PNPMTRI-TIPEILEDEWFK---------KDYKPPVFEEKKDTNLDDVE 289
PNP R + ++ + K P F K D
Sbjct: 257 PNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPG-FIPNKGRLNCDPT 304
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 229 bits (584), Expect = 5e-73
Identities = 47/298 (15%), Positives = 106/298 (35%), Gaps = 36/298 (12%)
Query: 3 QPKIKRRVG--KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMA 55
+PK + ++G V +GEG FA+V A +++ + LK+ + +
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKE 110
Q+ +K ++ Y + +V E + G L + I M +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-----------DAYGNLKVSDFGLSA 159
+ +++ ++ H + H D+KP+N +L D L + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSN 218
+ + C T + E+L+++ ++ D + ++ +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 219 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE---DEWFKKDYK 273
+ + W + +L+ + ++L + F++ Y
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 2e-69
Identities = 91/273 (33%), Positives = 140/273 (51%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV AR+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + + T CGTP Y+APEVL+ + Y T
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTV 220
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 256 RITIP----EILEDEWFK---------KDYKPP 275
R+ EI +F K PP
Sbjct: 281 RLGAKDDFMEIKSHVFFSLINWDDLINKKITPP 313
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-69
Identities = 91/273 (33%), Positives = 142/273 (52%), Gaps = 17/273 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTR 256
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 257 I-----TIPEILEDEWFK---------KDYKPP 275
+ E++E +F K PP
Sbjct: 248 LGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 4e-69
Identities = 82/287 (28%), Positives = 146/287 (50%), Gaps = 16/287 (5%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
+P ++ ++ + + + +G+G+F KV A +T + A+K L K+ VL E
Sbjct: 6 ERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + L +HP + ++ +K +F V+E++ GG+L I + + A Y
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++I + + HS+G+ +RDLK +N+LLD G++K++DFG+ + + D +T CGTP+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPD 183
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + Y + D WS GV+L+ +L G PF + L+ I P WL
Sbjct: 184 YIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242
Query: 239 FTARKLIARILDPNPMTRI-TIPEILEDEWFK---------KDYKPP 275
A+ L+ ++ P R+ +I + F+ K+ PP
Sbjct: 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPP 289
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 2e-68
Identities = 88/277 (31%), Positives = 146/277 (52%), Gaps = 21/277 (7%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPN 72
R +G+G + KV R + TG+ A+K+L K ++ K K E ++ VKHP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF ++ G ED A Y ++ A+ + H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN++L+ G++K++DFGL S + D + HT CGT Y+APE+L G+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIEYMAPEILMRSGH-N 199
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 253 PMTRI-----TIPEILEDEWFK---------KDYKPP 275
+R+ E+ +F+ + +PP
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPP 296
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 3e-68
Identities = 88/276 (31%), Positives = 148/276 (53%), Gaps = 21/276 (7%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV + S+ + A+K+L K + K E + V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS S + + ++ CGT Y+APEV+N RG+
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGH-TQ 205
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+AD WS GV++F +L G LPF + I A+ P +LS A+ L+ + NP
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 254 MTRI-----TIPEILEDEWFK---------KDYKPP 275
R+ + EI +F ++ PP
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPP 301
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-67
Identities = 97/302 (32%), Positives = 154/302 (50%), Gaps = 30/302 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YEV + IG G F +V+ R+ T + A+K+L K +++K + E M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+L+ +++V+E++ GG+L ++++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI + F +S A+
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 244 LIARILDPNPMTRIT---IPEILEDEWFK---------KDYKPPV---FEEKKDT-NLDD 287
LI L + R+ + EI +FK +D PV DT N DD
Sbjct: 307 LICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365
Query: 288 VE 289
+E
Sbjct: 366 LE 367
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-67
Identities = 91/275 (33%), Positives = 146/275 (53%), Gaps = 19/275 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R +G+G+F KV AR ETG+ A+K+L K+ +L+ E E + L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + ++F V+EFV GG+L I R E AR Y ++I+A+ + H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAV 205
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +L G+ PF+ N +L++ I E P WL A ++ + NP
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 256 RI------TIPEILEDEWFK---------KDYKPP 275
R+ IL +FK + +PP
Sbjct: 266 RLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPP 300
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-66
Identities = 93/289 (32%), Positives = 151/289 (52%), Gaps = 18/289 (6%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++PK + + ++E + +G+GTF KV + TG A+KIL KE ++ E
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +HP + L + ++ V+E+ GGELF + ED AR Y +++
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 122 NAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+A+DY HS + V +RDLK ENL+LD G++K++DFGL + ++D + T CGTP Y+
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYL 316
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D Y G D W GV+++ ++ G LPF + + L++ I E P L
Sbjct: 317 APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375
Query: 241 ARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
A+ L++ +L +P R+ EI++ +F K PP
Sbjct: 376 AKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPP 424
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-66
Identities = 81/274 (29%), Positives = 143/274 (52%), Gaps = 18/274 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 202
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262
Query: 256 RI-----TIPEILEDEWFK---------KDYKPP 275
R+ +I E +F+ K+ +PP
Sbjct: 263 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-65
Identities = 85/284 (29%), Positives = 147/284 (51%), Gaps = 28/284 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 191
Query: 196 DLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PF D + L++ I + P LS A ++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 247 RILDPNPMTRI------TIPEILEDEWFK---------KDYKPP 275
L+ +P R+ +I +F+ K PP
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPP 295
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-65
Identities = 78/304 (25%), Positives = 140/304 (46%), Gaps = 32/304 (10%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ +++V+++ GG+L + R+ E+ AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLND-- 187
HRD+KP+N+L+D G+++++DFG ++ +DG + GTP+Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 188 ---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSF 239
Y G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 240 TARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---FEEKKDT-NL 285
A+ LI R++ R+ I + + +F ++ + P DT N
Sbjct: 312 NAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNF 370
Query: 286 DDVE 289
D +
Sbjct: 371 DVDD 374
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-65
Identities = 90/337 (26%), Positives = 151/337 (44%), Gaps = 38/337 (11%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+ R+ + +E+ + IG G F++V + +TG+ A+KI++K +LK + E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINA 123
+ + +L+ + +++V+E+ GG+L + G R+ + AR Y +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVA 181
+D H G HRD+KP+N+LLD G+++++DFG ++R DG + GTP+Y++
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLS 231
Query: 182 PEVLNDRGYD------GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTC 233
PE+L G G D W+ GV + + G PF + Y KI +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 234 P---PWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFK-------KDYKPPV---F 277
P + AR I R+L P TR+ + +F +D PP F
Sbjct: 292 PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350
Query: 278 EEKKDT-NLDDVEAVFKDSEEHHVTEQKEEQPVAMNA 313
E DT N D VE D V+ E
Sbjct: 351 EGATDTCNFDLVE----DGLTAMVSGGGETLSDIREG 383
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-64
Identities = 86/301 (28%), Positives = 153/301 (50%), Gaps = 30/301 (9%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
K +G +++ R IG G++AKV R +T A++++ KE V + + ++
Sbjct: 41 ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ 100
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A++Y H RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPN
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPN 218
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAA 229
Y+APE+L Y G + D W+ GV++F ++AG PF D + L++ I
Sbjct: 219 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 230 EFTCPPWLSFTARKLIARILDPNPMTRI------TIPEILEDEWFK---------KDYKP 274
+ P LS A ++ L+ +P R+ +I +F+ K P
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337
Query: 275 P 275
P
Sbjct: 338 P 338
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 5e-64
Identities = 81/274 (29%), Positives = 143/274 (52%), Gaps = 18/274 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 523
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 256 RI-----TIPEILEDEWFK---------KDYKPP 275
R+ +I E +F+ K+ +PP
Sbjct: 584 RLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 617
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 9e-64
Identities = 81/314 (25%), Positives = 141/314 (44%), Gaps = 33/314 (10%)
Query: 3 QPKIKRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMA 55
++ + + V R IG G F +V R ++TG+ A+K LDK+++ +
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 115
E + ++ + P +V + + K+ +L+ + GG+L + HG E + R
Sbjct: 239 E--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y ++I +++ H+R V +RDLKP N+LLD +G++++SD GL+ H + G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVG 352
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAAEFT 232
T Y+APEVL S+AD +S G +LF LL G+ PF + + +
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 233 CPPWLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKP---P 275
P S R L+ +L + R+ E+ E +F+ + Y P P
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472
Query: 276 VFEEKKDTNLDDVE 289
E + D+
Sbjct: 473 PRGEVNAADAFDIG 486
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 1e-63
Identities = 76/316 (24%), Positives = 133/316 (42%), Gaps = 29/316 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G G F +V + TG+ A K L+K+++ K K + E + V +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGV 132
+KT + +V+ + GG++ I N + +E A Y Q+++ +++ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD GN+++SD GL+ + GTP ++APE+L Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFMAPELLLGEEY-D 367
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
+ D ++ GV L+ ++A PF L +++ T P S ++ +
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 249 LDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVF---EEKKDTNLDDVEAV 291
L +P R+ + + F+ PP N+ DV
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVG-A 486
Query: 292 FKDSEEHHVTEQKEEQ 307
F + + E
Sbjct: 487 FSTVKGVAFEKADTEF 502
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-63
Identities = 83/284 (29%), Positives = 149/284 (52%), Gaps = 27/284 (9%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-P 71
+ +G G + KV R +TG+ A+K+L K ++ K K E + E ++ ++ P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ ++TK+ ++L+++ GGELF + R E E + Y +++ A+++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ +RD+K EN+LLD+ G++ ++DFGLS + + CGT Y+AP+++ D G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSG 238
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+D + D WS GV+++ LL G PF + ++ + ++I +E P +S A+ LI
Sbjct: 239 HDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297
Query: 246 ARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPP 275
R+L +P R+ EI E +F+ K P
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 341
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 1e-62
Identities = 79/304 (25%), Positives = 137/304 (45%), Gaps = 26/304 (8%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++ V K + R +G+G F +V + TG+ A K L+K+++ K K E
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM--KEDEARRYFQQLIN 122
++ V VV L +K + +VL + GG+L I + G+ E A Y ++
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++ H + +RDLKPEN+LLD +G++++SD G L+ V + + GT Y+AP
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 354
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLS 238
EV+ + Y + D W+ G +L+ ++AG PF + + + S
Sbjct: 355 EVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
Query: 239 FTARKLIARILDPNPMTRI-----TIPEILEDEWFK---------KDYKPPVFEEKKDTN 284
AR L +++L +P R+ + E+ E FK +PP + +
Sbjct: 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIY 473
Query: 285 LDDV 288
DV
Sbjct: 474 CKDV 477
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-61
Identities = 54/284 (19%), Positives = 94/284 (33%), Gaps = 35/284 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IG G F V G A+K K ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
+VVR + + I E+ GG L D I + R KE E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 128 HSRGVYHRDLKPENLLLDAYGNL-------------------KVSDFGLSALSQQVRDDG 168
HS + H D+KP N+ + K+ D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185
Query: 169 LLHTTCGTPNYVAPEVLN-DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
G ++A EVL + + AD+++ + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241
Query: 228 AAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
P LS +L+ ++ P+P R + +++
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 5e-57
Identities = 64/328 (19%), Positives = 114/328 (34%), Gaps = 72/328 (21%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILD-------KEKVLK------------- 51
+E + +G G F V A+N A+K + +EKV++
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 52 -----------------------------------HKMAEQIKREVATMKLVKHPNVVRL 76
+ ++ M N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE---ARRYFQQLINAVDYCHSRGVY 133
+ K ++I ++ L D + +++ E F Q+ AV++ HS+G+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPE 183
HRDLKP N+ +KV DFGL Q ++ GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF-TAR 242
++ Y D++S G+ILF LL Y + + + +F +
Sbjct: 247 QIHGNNYSHK-VDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKK 270
++ +L P+P R +I+E+ F+
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-57
Identities = 75/274 (27%), Positives = 128/274 (46%), Gaps = 15/274 (5%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V R+ +A+K + + + ++ + E+A K +KH N+V+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I I +E V GG L + G +K++E Y +Q++ + Y H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DRG 189
HRD+K +N+L++ Y G LK+SDFG S + T GT Y+APE+++ RG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRG 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEF--TCPPWLSFTARKLIA 246
Y + AD+WS G + + G PF + K+ + P +S A+ I
Sbjct: 202 YGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
+ +P+P R ++L DE+ K K + K
Sbjct: 261 KCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-55
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 22/267 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G G+F +V ++ +TG A+K + E E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLSSPR 111
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + + I +E + GG L I G + ED A Y Q + ++Y H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 133 YHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC------GTPNYVAPEVL 185
H D+K +N+LL + G+ + DFG + ++ DGL + GT ++APEV+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTAR 242
+ D D+WS ++ +L G P+ L KI++ PP +
Sbjct: 229 MGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 243 KLIARILDPNPMTRITIPEILEDEWFK 269
+ I L P+ R + E+
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-53
Identities = 78/315 (24%), Positives = 136/315 (43%), Gaps = 60/315 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN +TG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---REIRMLKQLK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V L EV K ++ +V E+ + ++ + R + E + Q + AV++CH
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYV------A 181
HRD+KPEN+L+ + +K+ DFG + L+ + + V +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRWYRS 170
Query: 182 PEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISA--------- 228
PE+L D Y D+W+ G + LL+G P S++ LY
Sbjct: 171 PELLVGDTQY--GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGDLIPRHQ 227
Query: 229 ---------AEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEW 267
+ P +S+ A L+ L +P R+T ++L +
Sbjct: 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287
Query: 268 FKKDYKPPVFEEKKD 282
F+ + ++ D
Sbjct: 288 FENIREIEDLAKEHD 302
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-53
Identities = 67/272 (24%), Positives = 129/272 (47%), Gaps = 18/272 (6%)
Query: 11 GKYE-VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ IG G+F V ++ET VA L K+ K ++ K E +K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 70 HPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y + K I +V E +T G L + MK R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 126 YCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAE--FTCPPWLSF 239
E+ + YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271
+++I + N R +I ++L +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 80/321 (24%), Positives = 132/321 (41%), Gaps = 70/321 (21%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
+ + KYE +GEG++ V RN +TG VA+K + + + +K RE
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMRE 74
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQ 119
+ +K ++H N+V L EV K + ++V EFV + + + ++Y Q
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQ 132
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN 178
+IN + +CHS + HRD+KPEN+L+ G +K+ DFG + L+ + +
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----D 183
Query: 179 YV------APEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK--KI 226
V APE+L D Y A D+W+ G ++ + G P DS++ LY
Sbjct: 184 EVATRWYRAPELLVGDVKY--GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMC 240
Query: 227 ----------------SAAEFTCPPW------------LSFTARKLIARILDPNPMTRIT 258
A P LS L + L +P R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300
Query: 259 IPEILEDEWFKKDYKPPVFEE 279
E+L ++F+ D F +
Sbjct: 301 CAELLHHDFFQMDGFAERFSQ 321
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-51
Identities = 86/312 (27%), Positives = 127/312 (40%), Gaps = 58/312 (18%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVA 63
+K R +YE +GEG FA V AR+ T + VA+K L K + RE+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLI 121
++ + HPN++ L + G K+ I +V +F+ + N + + Y +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTT 173
++Y H + HRDLKP NLLLD G LK++DFGL+ A + QV
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------- 174
Query: 174 CGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK----- 224
T Y APE+L R Y D+W+ G IL LL +LP DS+L L +
Sbjct: 175 --TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTRIFETL 229
Query: 225 ---------KIS----AAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEI 262
+ F LI + NP RIT +
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 289
Query: 263 LEDEWFKKDYKP 274
L+ ++F P
Sbjct: 290 LKMKYFSNRPGP 301
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 9e-51
Identities = 79/326 (24%), Positives = 131/326 (40%), Gaps = 71/326 (21%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQI 58
+S + +Y +GEGT+ +V A ++ T E VA+K L+ E+ E +
Sbjct: 24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-------EGV 76
Query: 59 K----REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
REV+ +K ++H N++ L V+ ++ ++ E+ +L + + + +
Sbjct: 77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS--------ALS 161
+ QLIN V++CHSR HRDLKP+NLLL LK+ DFGL+ +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 162 QQVRDDGLLHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD- 216
++ T Y PE+L R Y ST+ D+WS I +L P D
Sbjct: 196 HEII----------TLWYRPPEILLGSRHY--STSVDIWSIACIWAEMLMKTPLFPGDSE 243
Query: 217 ----------------------SNL---MNLYKKISAAEF--TCPPWLSFTARKLIARIL 249
+ L + K L L+ +L
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPP 275
+ +P+ RI+ LE +F + P
Sbjct: 304 EMDPVKRISAKNALEHPYFSHNDFDP 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 98/313 (31%), Positives = 142/313 (45%), Gaps = 72/313 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KYE IGEGT+ V A+N ET E VALK LD + E + RE+ +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLL 55
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+VRL++V+ S K+ +V EF + FD +G + + + + QL+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ +CHSR V HRDLKP+NLL++ G LK+++FGL+ S +V
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------- 163
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAA-- 229
T Y P+VL + Y ST+ D+WS G I L P + L +I
Sbjct: 164 TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220
Query: 230 ---EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEI 262
E P P L+ T R L+ +L NP+ RI+ E
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 263 LEDEWFKKDYKPP 275
L+ +F D+ PP
Sbjct: 281 LQHPYF-SDFCPP 292
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-50
Identities = 83/323 (25%), Positives = 131/323 (40%), Gaps = 77/323 (23%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REV 62
+++ +G GT+A V N TG VALK LD E E RE+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--------EGTPSTAIREI 54
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-----ELFDKIVNHGRMKEDEARRYF 117
+ MK +KH N+VRLY+V+ ++ K+ +V EF+ + ++ + + +
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--------TFS 166
Query: 177 PN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD----------- 216
Y AP+VL R Y ST+ D+WSCG IL ++ G P +
Sbjct: 167 SEVVTLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224
Query: 217 ------------SNL------------MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
+ L +L + + L + +L N
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT---KEPLDGNLMDFLHGLLQLN 281
Query: 253 PMTRITIPEILEDEWFKKDYKPP 275
P R++ + L WF + Y
Sbjct: 282 PDMRLSAKQALHHPWFAEYYHHA 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-49
Identities = 88/317 (27%), Positives = 142/317 (44%), Gaps = 69/317 (21%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----R 60
+ + KY+ +GEGT+ V A++S G VALK LD E E I R
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-------EGIPSTAIR 68
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
E++ +K + HPN+V L +V+ S+ + +V EF+ ++ D+ N +++ + + Y
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLY 126
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP 177
QL+ V +CH + HRDLKP+NLL+++ G LK++DFGL+ A VR T
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--------SYTH 178
Query: 178 N-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDD------------ 216
Y AP+VL + Y ST+ D+WS G I ++ G P
Sbjct: 179 EVVTLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 217 -----------SNLMNLYKKISAAEFTCP------PWLSFTARKLIARILDPNPMTRITI 259
L +K+ + F P L++ +L +P RI+
Sbjct: 237 GTPNPREWPQVQELPL-WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295
Query: 260 PEILEDEWFKKDYKPPV 276
+ + +F KD P +
Sbjct: 296 RDAMNHPYF-KDLDPQI 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-49
Identities = 82/320 (25%), Positives = 126/320 (39%), Gaps = 62/320 (19%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKRE 61
P +YE IG G + V AR+ +G VALK + + RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 62 VATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKED 111
VA ++ ++ HPNVVRL +V + K+ +V E V DK + +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAE 120
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQV 164
+ +Q + +D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ AL+ V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMN 221
T Y APEVL Y +T D+WS G I + +S
Sbjct: 181 V----------TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRRKPLFC-GNSEADQ 227
Query: 222 LYK-----------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMT 255
L K + F P + + +L+ +L NP
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 256 RITIPEILEDEWFKKDYKPP 275
RI+ L+ + KD P
Sbjct: 288 RISAFRALQHSYLHKDEGNP 307
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-48
Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 15/268 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
V + Y TK++I++E++ GG D ++ G + E + ++++ +DY HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYD 191
HRD+K N+LL +G +K++DFG++ Q+ D + T GTP ++APEV+ YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIAR 247
AD+WS G+ L G P + + M + I PP L S ++ +
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEA 253
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275
L+ P R T E+L+ ++ ++ K
Sbjct: 254 CLNKEPSFRPTAKELLKHKFILRNAKKT 281
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-48
Identities = 95/307 (30%), Positives = 140/307 (45%), Gaps = 69/307 (22%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KY IGEGT+ V A+N GE ALK L+KE E I RE++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-------EGIPSTTIREISIL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V+LY+V+ +K ++ +V E + +L D G ++ A+ + QL+N
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
+ YCH R V HRDLKP+NLL++ G LK++DFGL+ A VR T
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVTL 164
Query: 179 -YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYKKISAA---- 229
Y AP+VL + Y ST D+WS G I ++ G P S L +I
Sbjct: 165 WYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLM-RIFRILGTP 220
Query: 230 -EFTCP------------------------PWLSFTARKLIARILDPNPMTRITIPEILE 264
P L + L++++L +P RIT + LE
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 265 DEWFKKD 271
+FK++
Sbjct: 281 HAYFKEN 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-48
Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 28/277 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G+F V A G VA+KIL ++ + + REVA MK ++HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNI 96
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSR 130
V + + IV E+++ G L+ + G ++ + RR + ++Y H+R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 131 G--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LK NLL+D +KV DFGLS L + + GTP ++APEVL D
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWLSF 239
+ +D++S GVIL+ L P+ + +N + ++A F P +
Sbjct: 215 PSN-EKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268
Query: 240 TARKLIARILDPNPMTRITIPEILED-EWFKKDYKPP 275
+I P R + I++ K PP
Sbjct: 269 --AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 5e-48
Identities = 85/322 (26%), Positives = 128/322 (39%), Gaps = 69/322 (21%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
V KYE IG+GTF +V AR+ +TG+ VALK +++ EK E RE
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALRE 66
Query: 62 VATMKLVKHPNVVRLYEVM--------GSKTKIFIVLEFV----TGGELFDKIVNHGRMK 109
+ ++L+KH NVV L E+ K I++V +F G L + +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFT 122
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDG 168
E +R Q L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 169 LLHTTC-GTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--------------- 210
+T T Y PE+L +R Y DLW G I+ +
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 240
Query: 211 -----------------YLP-FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
++ L+ K+ A LI ++L +
Sbjct: 241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLD 299
Query: 253 PMTRITIPEILEDEWFKKDYKP 274
P RI + L ++F D P
Sbjct: 300 PAQRIDSDDALNHDFFWSDPMP 321
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-47
Identities = 71/313 (22%), Positives = 122/313 (38%), Gaps = 72/313 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
Y +GEGT+A V ++ T VALK L+ E E REV+ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V L++++ ++ + +V E++ + D + + + QL+
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ YCH + V HRDLKP+NLL++ G LK++DFGL+ +V
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------- 162
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG--YLPFDDSNLMNLYK------- 224
T Y P++L Y ST D+W G I + + G P + L+
Sbjct: 163 TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRILGT 219
Query: 225 -------------KISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEI 262
+ + P L L+ ++L RI+ +
Sbjct: 220 PTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA 279
Query: 263 LEDEWFKKDYKPP 275
++ +F +
Sbjct: 280 MKHPFFLSLGERI 292
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-47
Identities = 71/267 (26%), Positives = 113/267 (42%), Gaps = 37/267 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G G F V A+ + VA+K ++ E K E+ + V HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI---NAVDYCHSR 130
V+LY + +V+E+ GG L++ + + A + V Y HS
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 131 ---GVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ HRDLKP NLLL A G LK+ DFG + Q + G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWL 237
Y D++S G+IL+ ++ PFD+ + +I A P +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 238 SFTARKLIARILDPNPMTRITIPEILE 264
L+ R +P R ++ EI++
Sbjct: 234 ----ESLMTRCWSKDPSQRPSMEEIVK 256
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-46
Identities = 60/265 (22%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
VG+ IG G+F V + + + VA+K+L + + K EV ++ +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
++ + ++ IV ++ G L+ + + + + + +Q +DY H++
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK N+ L +K+ DFGL+ + G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 192 GST--ADLWSCGVILFVLLAGYLPFDDSNLM----------NLYKKISAAEFTCPPWLSF 239
+ +D+++ G++L+ L+ G LP+ + N +L +S CP +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM-- 258
Query: 240 TARKLIARILDPNPMTRITIPEILE 264
++L+A L R + P IL
Sbjct: 259 --KRLMAECLKKKRDERPSFPRILA 281
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-46
Identities = 87/328 (26%), Positives = 133/328 (40%), Gaps = 74/328 (22%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALK--ILDKEKVLKHKMAEQ 57
M + + R +YE IGEG + KV AR+ G VALK + + E
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------EG 53
Query: 58 IK----REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIV 103
+ REVA ++ ++ HPNVVRL++V +TK+ +V E V DK+
Sbjct: 54 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV- 112
Query: 104 NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS----- 158
+ + + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 159 --ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG--YLP 213
AL+ V T Y APEVL Y +T DLWS G I +
Sbjct: 173 QMALTSVVV----------TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRRKPLFR 220
Query: 214 FDDSNLMNLYK-----------------KISAAEFTCP---------PWLSFTARKLIAR 247
S++ L K + F + + L+ +
Sbjct: 221 -GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK 279
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275
L NP RI+ L +F+ +
Sbjct: 280 CLTFNPAKRISAYSALSHPYFQDLERCK 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 58/270 (21%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E+G IG+G F +V R + E VA++++D E+ + KREV + +H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
VV S + I+ G L+ + + ++ R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H+DLK +N+ D G + ++DFGL + Q R + L G ++APE++
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 189 GYDGST--------ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP 234
D +D+++ G I + L A PF + ++ + ++
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILE 264
+ ++ R T ++++
Sbjct: 270 KEI----SDILLFCWAFEQEERPTFTKLMD 295
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-45
Identities = 77/271 (28%), Positives = 139/271 (51%), Gaps = 10/271 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IGEG+ V AR +G VA+K++D K + E + EV M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHF 102
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV +Y+ ++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +++LL G +K+SDFG A Q +D + GTP ++APEV++ Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248
D+WS G+++ ++ G P+ + + K++ + + +S R + R+
Sbjct: 220 TE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L +P R T E+L+ + + P
Sbjct: 279 LVRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-45
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 44/279 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G +G+G F + + ETGE + +K L + + +EV M+ ++HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAV 124
++ V+ ++ + E++ GG L I + +D A +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS--------GM 121
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL------------SQQVRDDGLLHT 172
Y HS + HRDL N L+ N+ V+DFGL+ L S + D +T
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231
G P ++APE++N R YD D++S G++L ++ D + ++ F
Sbjct: 182 VVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 232 ------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CPP + R D +P R + ++
Sbjct: 241 DRYCPPNCPPSF----FPITVRCCDLDPEKRPSFVKLEH 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-45
Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 10/271 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIARI 248
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 195 PK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
L+ + R + E+L+ ++ K
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 34/273 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVK 69
E + IG+G F V R + VA+K L + + + ++ +REV M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V+LY + +V+EFV G+L+ ++++ +K R + ++Y
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 129 SRGVY--HRDLKPENLLLDAYG-----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
++ HRDL+ N+ L + KV+DFGLS S + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 182 PEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------F 231
PE + Y AD +S +IL+ +L G PFD+ + + E
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CPP L R +I +P R I++
Sbjct: 254 DCPPRL----RNVIELCWSGDPKKRPHFSYIVK 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-45
Identities = 45/269 (16%), Positives = 98/269 (36%), Gaps = 36/269 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ E ++ R G + +K+L + + E +++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNV 69
Query: 74 VRLYEVM--GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------ 125
+ + ++ ++ G L++ + D+++ + A+D
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGMA 125
Query: 126 YCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ H+ + L ++++D ++S + Q P +VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE 178
Query: 184 VLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------TCPP 235
L + D + AD+WS V+L+ L+ +PF D + M + K++ P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILE 264
+ KL+ ++ +P R I+
Sbjct: 239 HV----SKLMKICMNEDPAKRPKFDMIVP 263
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 69/264 (26%), Positives = 129/264 (48%), Gaps = 14/264 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y++ +G G + V A ++ VA+K + K + ++ +REV + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V + +V ++V+E++ G L + I +HG + D A + Q+++ + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC--GTPNYVAPEVLND 187
+ HRD+KP+N+L+D+ LK+ DFG++ ALS+ L T GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSPEQAKG 186
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFTAR 242
D T D++S G++L+ +L G PF+ ++ + K I + + +
Sbjct: 187 EATDECT-DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 243 KLIARILDPNPMTR-ITIPEILED 265
+I R + + R TI E+ +D
Sbjct: 246 NVILRATEKDKANRYKTIQEMKDD 269
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 25/290 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V+ A + E VA+K ++ EK +++ +E+ M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHHPN 74
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--------KIVNHGRMKEDEARRYFQQLINAV 124
+V Y K ++++V++ ++GG + D G + E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLL--HTTCGTPNYVA 181
+Y H G HRD+K N+LL G+++++DFG+SA L+ T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 182 PEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK---------KISAAE 230
PEV+ RGYD AD+WS G+ L G P+ M L + +
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEK 280
+ RK+I+ L +P R T E+L ++F+K +EK
Sbjct: 254 KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-44
Identities = 66/265 (24%), Positives = 120/265 (45%), Gaps = 19/265 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++ + + G Y + R +G G V A ++ VALK++ + +++RE
Sbjct: 25 AESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE 84
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
T ++ P+VV +++ ++++ + + G +L + G + A +Q+
Sbjct: 85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHT--TCGTPN 178
+A+D H+ G HRD+KPEN+L+ A + DFG+ SA + D+ L T GT
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLY 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE ++ AD+++ +L+ L G P+ L + I+ A P S
Sbjct: 201 YMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA----IPRPS 255
Query: 239 FTARKL-------IARILDPNPMTR 256
+ IAR + NP R
Sbjct: 256 TVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-44
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 21/277 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
E +G GT +V R +TG +A+K + + + ++I ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-R 130
+V+ + + T +FI +E + K G + E + ++ A+ Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV HRD+KP N+LLD G +K+ DFG+S ++ DD + G Y+APE ++
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 191 DGST----ADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL------SF 239
AD+WS G+ L L G P+ + + K+ E PP L S
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPLLPGHMGFSG 258
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
+ + L + R ++LE + K+ V
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 77/299 (25%), Positives = 141/299 (47%), Gaps = 19/299 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++V +GEG++ V A + ETG+ VA+K + E L ++I +E++ M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
+VV+ Y T ++IV+E+ G + D I + + + EDE Q + ++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G+ K++DFG++ Q +T GTP ++APEV+ + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTCPPWLSFTARKLIAR 247
+ AD+WS G+ + G P+ D + M ++ F P S + +
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ 261
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEE 306
L +P R T ++L+ + + + + + + ++Q+EE
Sbjct: 262 CLVKSPEQRATATQLLQHPFVRSAKGVSILRDL-------INEAMDVKLKRQESQQREE 313
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-43
Identities = 77/277 (27%), Positives = 133/277 (48%), Gaps = 15/277 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ +G+G F KV A+N ETG A K+++ + + E E+ + HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+L K++I++EF GG + ++ + E + + +Q++ A+++ HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-----L 185
+ HRDLK N+L+ G+++++DFG+SA + ++ + GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYK--KISAAEFTCPPWLSFTAR 242
D YD AD+WS G+ L + P + N M L K K P S R
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
+ LD NP TR + ++LE + E
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 7e-43
Identities = 69/272 (25%), Positives = 115/272 (42%), Gaps = 36/272 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPN 72
+ IG G F KV A G+ VA+K + E +++E ++KHPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++ L V + + +V+EF GG L + R+ D + Q+ ++Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 133 Y---HRDLKPENLLLDAYG--------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
HRDLK N+L+ LK++DFGL+ + + G ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------T 232
PEV+ + +D+WS GV+L+ LL G +PF ++ T
Sbjct: 183 PEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGVAMNKLALPIPST 238
Query: 233 CPPWLSFTARKLIARILDPNPMTRITIPEILE 264
CP KL+ +P+P +R + IL+
Sbjct: 239 CPEPF----AKLMEDCWNPDPHSRPSFTNILD 266
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-42
Identities = 69/256 (26%), Positives = 116/256 (45%), Gaps = 12/256 (4%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 71 PNVVRLY---EVMGSKTKI-FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y E + +IV+E+V G L D + G M A A+++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ A++ GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFT 240
D + D++S G +L+ +L G PF DS + Y+ + + P LS
Sbjct: 192 RGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSAD 249
Query: 241 ARKLIARILDPNPMTR 256
++ + L NP R
Sbjct: 250 LDAVVLKALAKNPENR 265
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-42
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 11 GKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
G YE+ IG+G V AR TGE V ++ ++ E +M ++ E+ KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDY 126
HPN+V + ++++V F+ G D I H M E Q ++ A+DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--------GTPN 178
H G HR +K ++L+ G + +S + + G
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200
Query: 179 YVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+++PEVL N +GYD +D++S G+ L G++PF D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPAT 243
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 7e-42
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 11/271 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + + + GT +Y++PE L Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFVGTRSYMSPERLQGTHY 207
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
+D+WS G+ L + G P + L + + R L+
Sbjct: 208 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG-DAAETPPRPRTPGRPLN 265
Query: 251 PNPMTRITIPEILEDEWFKKDYKPPVFEEKK 281
M I E + + PP
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 7e-42
Identities = 85/314 (27%), Positives = 130/314 (41%), Gaps = 73/314 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ ++GE VA+K KVL+ K + RE+ M+ + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN--RELQIMRKLDHC 107
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLI 121
N+VRL S + +VL++V ++ ++ R K + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN- 178
++ Y HS G+ HRD+KP+NLLLD LK+ DFG + L + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------------GEPNV 214
Query: 179 -YV------APEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF--------------- 214
Y+ APE+ Y +++ D+WS G +L LL G F
Sbjct: 215 SYICSRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
Query: 215 ------DDSNLMN-LYKKISAAEFTCPPWLSF-------TARKLIARILDPNPMTRITIP 260
+ MN Y + + PW A L +R+L+ P R+T
Sbjct: 273 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332
Query: 261 EILEDEWFKKDYKP 274
E +F + P
Sbjct: 333 EACAHSFFDELRDP 346
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 29/279 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 70 HPNVVRLYE------VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D K +KE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236
PEV+ D YD +DLWS G+ + G P D + M I P
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP---APR 253
Query: 237 L-----SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
L S + I L N R ++++ + +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRD 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-41
Identities = 73/294 (24%), Positives = 128/294 (43%), Gaps = 26/294 (8%)
Query: 1 MSQPKIKRRVGK------YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM 54
+ P + K + R IG G+F V FAR+ E VA+K + ++
Sbjct: 38 LKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
+ I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTT 173
+ + Y HS + HRD+K N+LL G +K+ DFG ++ ++ ++
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSF 210
Query: 174 CGTPNYVAPEV---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
GTP ++APEV +++ YDG D+WS G+ L P + N M+ I+ E
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 231 FTCPPWL-----SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEE 279
P L S R + L P R T +L+ + ++ P V +
Sbjct: 270 ---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 95/359 (26%), Positives = 148/359 (41%), Gaps = 72/359 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ E+ E VA+K KVL+ K RE+ M++VKHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-----KVLQDK--RFKNRELQIMRIVKHP 92
Query: 72 NVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQL 120
NVV L S + + +VLE+V E + H M + Y QL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ ++ Y HS G+ HRD+KP+NLLLD G LK+ DFG + + + + C + Y
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA--KILIAGEPNVSYIC-SRYY 207
Query: 180 VAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPFD-DSNLMNLYKKI---------- 226
APE+ Y +T D+WS G ++ L+ G F +S + L + I
Sbjct: 208 RAPELIFGATNY--TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265
Query: 227 ------SAAEFTCPPW------------LSFTARKLIARILDPNPMTRITIPEILEDEWF 268
+ E P A LI+R+L+ P R+T E L +F
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325
Query: 269 KKDYK------------PPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPVAMNAFE 315
+ + PP+F K+ L + H + + + ++ F+
Sbjct: 326 -DELRTGEARMPNGRELPPLFNWTKE-ELSVRPDLISRLVPQHAEAELLSRGIDVHNFQ 382
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 1e-40
Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 35/257 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKIL----DKEKVLKHKMAEQIKREVATM 65
G+YEV I G + A + G PV LK L D E E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMAMAERQFL 133
Query: 66 KLVKHPNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
V HP++V+++ +IV+E+V G L ++ EA Y ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHTTCGTPNY 179
+ A+ Y HS G+ + DLKPEN++L LK+ D G S ++ G L GTP +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS----FGYL---YGTPGF 243
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF 239
APE++ R D+++ G L L + + L + +
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT--YDSY-- 297
Query: 240 TARKLIARILDPNPMTR 256
+L+ R +DP+P R
Sbjct: 298 --GRLLRRAIDPDPRQR 312
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-40
Identities = 64/285 (22%), Positives = 121/285 (42%), Gaps = 32/285 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
+ IG G + V + +G+ +A+K + + K +Q+ ++ M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKEDEARRYFQQLINAVD 125
+V+ Y + + +I +E ++ FDK + E+ + + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 126 YCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ + HRD+KP N+LLD GN+K+ DFG+S Q+ D G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 185 L----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWL-- 237
+ + +GYD +D+WS G+ L+ L G P+ N + + ++ + PP L
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD---PPQLSN 252
Query: 238 ------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S + + L + R E+L+ + + V
Sbjct: 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 66/281 (23%), Positives = 120/281 (42%), Gaps = 28/281 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHP 71
E +G G + V+ R+ +G+ +A+K + + + +++ ++ +M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKEDEARRYFQQLINAVDY 126
V Y + + ++I +E + DK + ED + ++ A+++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 127 CHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV- 184
HS V HRD+KP N+L++A G +K+ DFG+S + DD G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL--- 237
LN +GY +D+WS G+ + L P+D K++ P L
Sbjct: 182 NPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---SPQLPAD 237
Query: 238 --SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPV 276
S ++ L N R T PE+++ +F
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 70/302 (23%), Positives = 133/302 (44%), Gaps = 58/302 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 90
Query: 71 PNVVRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
PN++ L +++ S+T + E V + ++ + + + R Y +++ A+DYC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDF-KQLYQ--TLTDYDIRFYMYEILKALDYC 146
Query: 128 HSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
HS G+ HRD+KP N+++D + L++ D+GL+ ++ + + + PE+L
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--------------------DDSNLMNLYKK 225
+ + YD S D+WS G +L ++ PF D + ++ Y
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 226 ISAAEF-------TCPPWLSF-----------TARKLIARILDPNPMTRITIPEILEDEW 267
F + W F A + ++L + +R+T E +E +
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 268 FK 269
F
Sbjct: 323 FY 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 70/346 (20%), Positives = 124/346 (35%), Gaps = 78/346 (22%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIK 59
+ +R +E G +G GT+ V A+ + + ALK ++ +
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----- 66
Query: 60 REVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFV--------TGGELFDKIVNHGRMK 109
RE+A ++ +KHPNV+ L +V S K++++ ++ ++
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN----LKVSDFGLSALSQQVR 165
+ Q+++ + Y H+ V HRDLKP N+L+ G +K++D G A
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSP 185
Query: 166 DDGLLHTTCG--TPNYVAPEVL-NDRGYDGSTA-DLWSCGVIL----------------- 204
L T Y APE+L R Y + A D+W+ G I
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTSEPIFHCRQEDI 243
Query: 205 ----------------------------FVLLAGYLPFDDSNLMNLYKKISAAEF--TCP 234
+ + N Y S ++
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP--PVFE 278
A L+ ++L +P+ RIT + ++D +F +D P VF
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFA 349
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 79/358 (22%), Positives = 148/358 (41%), Gaps = 65/358 (18%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + ++ + +++V R G+GTF V+ + TG VA+K KV++ R
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NR 65
Query: 61 EVATMKL---VKHPNVVRLYEVMGSKTK-------IFIVLEFVTGGELFDKIVNHGRMK- 109
E+ M+ + HPN+V+L + + + +V+E+V L N+ R +
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 110 ---EDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQ 163
+ + QLI ++ H S V HRD+KP N+L++ A G LK+ DFG + +
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA--KKL 182
Query: 164 VRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAGYLPF------- 214
+ + C + Y APE+ ++ Y +TA D+WS G I ++ G F
Sbjct: 183 SPSEPNVAYIC-SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239
Query: 215 --------------DDSNLMN-LYKKISAAEFTCPPW----------LSFTARKLIARIL 249
+ +N + + PW + A L++ +L
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299
Query: 250 DPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQ 307
P R+ E L +F + P + + +L + F +E ++E ++ +
Sbjct: 300 QYLPEERMKPYEALCHPYF-DELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAK 356
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 54/296 (18%), Positives = 107/296 (36%), Gaps = 56/296 (18%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G + +V GE VA+KI + + + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI 64
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ S T+++++ + G L+D + + R + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + + D + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY----------LPFDDSNLMN--- 221
+APEVL++ D+W+ G++L+ + PF D +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 222 -------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ L+ KL+ NP R+T I +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKK 295
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 42/253 (16%), Positives = 80/253 (31%), Gaps = 39/253 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+Y + G + A ++ VAL +D + VL + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P V R+ +V+ ++ +V E++ GG L + V A R Q L A D H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV P + + G++ ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------PWLSFTARK 243
D+ G L+ LL P ++ + + P + F
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 244 LIARILDPNPMTR 256
+ AR + + R
Sbjct: 239 VAARSVQGDGGIR 251
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-36
Identities = 84/351 (23%), Positives = 150/351 (42%), Gaps = 71/351 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + A++ RE+ +K +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G +L + IV ++ +D + Q++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS + HRDLKP NL ++ LK+ DFGL+ + D + YV
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM-------TGYVATRW 194
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APE+ LN Y+ T D+WS G I+ LL G F ++ ++ K I
Sbjct: 195 YRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253
Query: 227 -------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILEDE 266
SA + + ++F A L+ ++L + RIT + L
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313
Query: 267 WFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEEHHVTEQKEEQ 307
+F + + P PV + E +D +D+ + + +E+
Sbjct: 314 YFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQEE 364
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 59/296 (19%), Positives = 121/296 (40%), Gaps = 56/296 (18%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + IG+G + +V + GE VA+K+ + + + E+ L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + GS T+++++ ++ G L+D + + + + ++ + + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + D +T GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVIL---------FVLLAGY-LPFDDSNLMN--- 221
+ PEVL++ AD++S G+IL ++ Y LP+ D +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 222 -------LYKKI------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
KK+ + C + KL+ NP +R+T + +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMG----KLMTECWAHNPASRLTALRVKK 324
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 85/352 (24%), Positives = 144/352 (40%), Gaps = 71/352 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + +G G + V A + TG VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V ++V+ F+ G +L K++ H ++ ED + Q++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTRW 190
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APEV LN Y T D+WS G I+ ++ G F S+ ++ K+I
Sbjct: 191 YRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 227 -------SAAEF--TCP-----------PWLSFTARKLIARILDPNPMTRITIPEILEDE 266
A + P S A L+ ++L + R+T E L
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 267 WFKKDYKP---PVFE------EKKDTNLDDV-EAVFKDSEEHHVTEQKEEQP 308
+F+ + P + + D LD+ +K+ Q +
Sbjct: 310 YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARV 361
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 81/343 (23%), Positives = 145/343 (42%), Gaps = 66/343 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K K +H+ ++ RE+ + +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRH 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ + +++ + T ++IV + + +L K++ + D + Q++ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV----- 180
Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 181 -APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SAAEF 231
APE+ LN +GY + D+WS G IL +L+ F + ++ I S +
Sbjct: 198 RAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 232 TC---------------PPWLSFT---------ARKLIARILDPNPMTRITIPEILEDEW 267
C + + A L+ ++L NP RI + + L +
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 268 FKKDYKP---PVFE-------EKKDTNLDDV-EAVFKDSEEHH 299
++ Y P P+ E E D + + E +F+++
Sbjct: 317 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQ 359
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-35
Identities = 76/340 (22%), Positives = 126/340 (37%), Gaps = 86/340 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY +G+T+G G+F V + E+G+ ALK KVL+ RE+ MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHV 60
Query: 72 NVVRLYEVMGSKTK--------------------------------------IFIVLEFV 93
N+++L + + + +++E+V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 94 TGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G 148
L + + R + Y QL AV + HS G+ HRD+KP+NLL+++
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVL 207
LK+ DFG + + + + + C + Y APE+ L Y + DLWS G + L
Sbjct: 180 TLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGEL 235
Query: 208 LAGYLPF---------------------DDSNLMN-LYKKISAAEFTCPPWLSF------ 239
+ G F + MN Y ++ W
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 240 -TARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
A L+ +IL P RI E + +F +
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFF-DHLRNSYES 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-35
Identities = 59/294 (20%), Positives = 114/294 (38%), Gaps = 52/294 (17%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +IG+G F +V + GE VA+KI + + + E+ +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + G+ T++++V ++ G LFD +N + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ D D + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVILFVLLAGY----------LPFDDSNLMN--- 221
+APEVL+D AD+++ G++ + + LP+ D +
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277
Query: 222 -------LYKK----ISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+K I +C K++ N R+T I +
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVM--AKIMRECWYANGAARLTALRIKK 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-35
Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 23/235 (9%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + ++ G F V + E VA+KI + K + Q +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPIQ----DKQSWQNEY 67
Query: 61 EVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMK 109
EV ++ +KH N+++ ++++ F G L D + + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 110 EDEAR--RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
E AR Y + I + H + HRD+K +N+LL ++DFGL+ + +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFDDSN 218
G H GT Y+APEVL D+++ G++L+ L + D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-34
Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 54/314 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y + +G G V A +++ + VA+K + VL + RE+ ++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDH 67
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGG--------ELFD----KIVNHGRMKEDEARRYFQ 118
N+V+++E++G E + ++ G + E+ AR +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + Y HS V HRDLKP NL ++ LK+ DFGL+ + G L T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--------- 226
Y +P + L+ Y D+W+ G I +L G F ++ + + I
Sbjct: 188 KWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 227 --------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILED 265
+ T A + +IL +PM R+T E L
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306
Query: 266 EWFKKDYKP---PV 276
+ P P+
Sbjct: 307 PYMSIYSFPMDEPI 320
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 5e-34
Identities = 82/346 (23%), Positives = 139/346 (40%), Gaps = 68/346 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+++ +GEG + V A + TGE VA+K K + + A + RE+ +K KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ ++ + + ++I+ E + +L ++++ + +D + + Q + AV
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYV--- 180
H V HRDLKP NLL+++ +LKV DFGL + G +V
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 ---APEV-LNDRGYDGSTADLWSCGVILFVLLAG--------YL------------PFDD 216
APEV L Y D+WSCG IL L Y P D
Sbjct: 187 WYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 217 SNL--------------MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPE 261
++L + +Y + F P ++ L+ R+L +P RIT E
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMF---PRVNPKGIDLLQRMLVFDPAKRITAKE 302
Query: 262 ILEDEWFKKDYKP---PVFEEKKDTNLDDVEAVFKDSEEHHVTEQK 304
LE + + + P P E + + D + +T +
Sbjct: 303 ALEHPYLQTYHDPNDEPEGEPIPPSFFEF------DHYKEALTTKD 342
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 78/326 (23%), Positives = 139/326 (42%), Gaps = 65/326 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y +G G + V A + +GE VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + ++V+ F+ +L + + E++ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS GV HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----------- 226
APEV L+ Y+ T D+WS G I+ +L G F + ++ +I
Sbjct: 189 YRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 227 -------SAAEF--TCPPW--LSFT---------ARKLIARILDPNPMTRITIPEILEDE 266
+A + + P FT A L+ ++L+ + R+T + L
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 267 WFKKDYKP---PVFEEKKDTNLDDVE 289
+F+ P ++ D +L+ +
Sbjct: 308 FFEPFRDPEEETEAQQPFDDSLEHEK 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 73/356 (20%), Positives = 146/356 (41%), Gaps = 74/356 (20%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + +++ A++ RE+ MK V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYFQ-QLIN 122
N++ L V + ++IV+E + L I +M+ + E Y Q++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----QMELDHERMSYLLYQMLC 138
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAP 195
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---------------- 226
EV+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 EVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 227 --------------------------SAAEFTCPPWLSFTARKLIARILDPNPMTRITIP 260
A+ + AR L++++L + RI++
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314
Query: 261 EILEDEWFKK--------DYKPPVFE---EKKDTNLDDV-EAVFKDSEEHHVTEQK 304
E L+ + P + + ++++ +++ E ++K+ +
Sbjct: 315 EALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHH 370
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 76/383 (19%), Positives = 145/383 (37%), Gaps = 85/383 (22%)
Query: 1 MSQPKIKRRVGKYEVGRT-------------IGEGTFAKVKFARNSETGEPVALKILDKE 47
MS+ K+ + EVG + IG G V A ++ VA+K L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--S 96
Query: 48 KVLKHKM-AEQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFD 100
+ +++ A++ RE+ MK V H N++ L V + +++V+E + L
Sbjct: 97 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-C 154
Query: 101 KIVNHGRMKEDEARRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+++ + E Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG
Sbjct: 155 QVIQMEL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--- 209
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L++ ++ T Y APEV+ GY D+WS G I+ ++ + F +
Sbjct: 210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 220 MNLYKKI------------------------------------------SAAEFTCPPWL 237
++ + K+ A+
Sbjct: 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK 328
Query: 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKDTNLDDV----- 288
+ AR L++++L +P RI++ + L+ + + D LD+
Sbjct: 329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 388
Query: 289 ---EAVFKDSEEHHVTEQKEEQP 308
E ++K+ +
Sbjct: 389 EWKELIYKEVMNSEEKTKNGVVK 411
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKM-AEQIKREVATMKLVK 69
+YE+ IG G++ V A + VA+K IL V + + ++I RE+A + +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN 110
Query: 70 HPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINA 123
H +VV++ +++ K ++++VLE + K+ + + L+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
V Y HS G+ HRDLKP N L++ ++KV DFGL+ + + L + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 179 --------------YV------APEV-LNDRGYDGSTA-DLWSCGVIL 204
+V APE+ L Y + A D+WS G I
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 79/372 (21%), Positives = 139/372 (37%), Gaps = 90/372 (24%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMK-LVK 69
KYE+ + +G+G + V + + TGE VA+K + ++ A++ RE+ + L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSG 67
Query: 70 HPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDY 126
H N+V L V+ + +++V +++ +L ++ + E ++Y QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANIL-EPVHKQYVVYQLIKVIKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS G+ HRD+KP N+LL+A ++KV+DFGLS +R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 179 -----YV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG---------------- 210
YV APE+ L Y D+WS G IL +L G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 211 ----------------------YL---------PFDDSNLMNLYKKISAAEFTCPPWLSF 239
+ + + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYKP---PV--------FEEKKDTNLDDV 288
A L+ ++L NP RI+ + L+ + + P P + ++DD
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363
Query: 289 -EAVFKDSEEHH 299
V+ +
Sbjct: 364 RNLVYSEISRRK 375
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 3e-31
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + IG G++ V A + T + VA+K + ++ + + ++I RE+ + +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAV 124
++RLY+++ ++IVLE +L K+ +E + L+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP------- 177
++ H G+ HRDLKP N LL+ ++KV DFGL+ +D +++
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 178 -------NYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
++V APE+ L Y + D+WS G I LL
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 71/347 (20%), Positives = 134/347 (38%), Gaps = 67/347 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM--------AEQIKREVA 63
Y V R I G++ V +S G PVA+K + + +++ RE+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 64 TMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYF 117
+ HPN++ L ++ + +++V E + +L ++++ R+ + +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 118 Q-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + H GV HRDL P N+LL ++ + DF L+++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTH 196
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SA 228
Y APE+ + +G+ D+WS G ++ + F S N KI
Sbjct: 197 RWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 229 AEFTC----------------PPWLSFT---------ARKLIARILDPNPMTRITIPEIL 263
+ P ++T A LIA++L+ NP RI+ + L
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315
Query: 264 EDEWFKKDYKP---PV-------FEEKKDTNLDDV-EAVFKDSEEHH 299
+F+ + P F+E + D+ + + E +
Sbjct: 316 RHPYFESLFDPLDLTEGLSERFHFDESVTD-VYDMHKIFTAEVERFN 361
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 33/217 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ IG G + V + S PVA+K+ ++ ++ + + L++H N+
Sbjct: 16 KLLELIGRGRYGAVY--KGSLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69
Query: 74 VRLY-----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
R + + +V+E+ G L + H + R + + Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128
Query: 129 S---------RGVYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT 173
+ + HRDL N+L+ G +SDFGLS L + +D +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 174 CGTPNYVAPEVLNDR------GYDGSTADLWSCGVIL 204
GT Y+APEVL D+++ G+I
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-30
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+Y + R +G G F+ V A++ VA+KI+ +K E + E+ ++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 70 ----------HPNVVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEA 113
++++L G + +V E V G L K H +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 114 RRYFQQLINAVDYCHSR-GVYHRDLKPENLLLD------AYGNLKVSDFGLSALSQQVRD 166
++ +QL+ +DY H R G+ H D+KPEN+L++ +K++D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
D + T Y +PEVL + AD+WS ++F L+ G F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 236
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
+YEV + IG+G+F +V A + + + VALK++ EK + Q E+ + L K
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRK 152
Query: 70 HP-----NVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
NV+ + E + I + E + L++ K R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+D H + H DLKPEN+LL G +KV DFG S Q ++T + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV+ Y D+WS G IL LL GY + + +
Sbjct: 267 APEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 25/273 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+G IG G F +V R VA+K +E + A+ +E +K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAK-FLQEARILKQYSHPNI 174
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGV 132
VRL V K I+IV+E V GG+ + G ++ + ++Y S+
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY----VAPEVLNDR 188
HRDL N L+ LK+SDFG+S + DG+ + G APE LN
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 189 GYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPPWLSFTA 241
Y S+ D+WS G++L+ G P+ + + + + CP +
Sbjct: 291 RY--SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV---- 344
Query: 242 RKLIARILDPNPMTRITIPEILED-EWFKKDYK 273
+L+ + P R + I ++ + +K ++
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 18/235 (7%)
Query: 15 VGRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK + + + VA+KIL K + + +++ E M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VR+ + +V+E G L + + +K+ Q+ + Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRG 189
HRDL N+LL K+SDFGLS + D+ P + APE +N
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
+ S+ D+WS GV+++ G P+ + + E CP +
Sbjct: 197 F--SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+G+F V+ ++ +G+ VA+K L + + + + + REV M + H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
++RLY V+ + +V E G L D++ H G RY Q+ + Y S+
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDR 188
HRDL NLLL +K+ DFGL Q +D APE L R
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 189 GYDGSTA-DLWSCGVIL 204
+ S A D W GV L
Sbjct: 200 TF--SHASDTWMFGVTL 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G + +V + VA+K L KE E+ +E A MK +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED---TMEVEEFLKEAAVMKEIKHPNL 278
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L V + +I+ EF+T G L D + R + Q+ +A++Y +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY--VAPEVLNDRG 189
HR+L N L+ +KV+DFG LS+ + D APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ IG+G+F +V A + E VA+KI+ +K Q + EV ++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNK 109
Query: 71 P------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLIN 122
+V L + + +V E + L+D + N + + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 123 AVDYCHSR--GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
A+ + + + H DLKPEN+LL +K+ DFG S Q ++ +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRF 223
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
Y +PEVL YD + D+WS G IL + G F +N ++ KI
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-24
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQ 57
G E+ + +G G F VK + + VA+K++ +++ +
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFFQ------ 52
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRY 116
E TM + HP +V+ Y V + I+IV E+++ G L + + +HG+ ++ +
Sbjct: 53 ---EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG- 175
+ + + S HRDL N L+D +KVSDFG +++ V DD + +
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDDQYVSSVGTK 166
Query: 176 -----TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
+ APEV + Y S+ D+W+ G++++ V G +P+D + K+S
Sbjct: 167 FPVKWS----APEVFHYFKY--SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
Query: 229 AE-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDY 272
+ +++ P R T ++L + +KD
Sbjct: 221 GHRLYRPHLASDTI----YQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-24
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDA----TAQAFLAEASVMTQLRHSNL 76
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLND 187
HRDL N+L+ KVSDFGL+ + +D G L P V APE L +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALRE 188
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ + + +D+WS G++L+ + G +P+ L ++ ++
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-24
Identities = 64/337 (18%), Positives = 121/337 (35%), Gaps = 89/337 (26%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ V R +G+GTF +V ++ + + A+K++ K K K E +K +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQN 90
Query: 71 -----PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINA 123
N+V+ + + ++ E G L++ I + ++ + Y +++ A
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYG-------------------------NLKVSDFGLS 158
++Y + H DLKPEN+LLD +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY------- 211
A + T Y APEV+ + G+D S +D+WS G +L L G
Sbjct: 209 A----TFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263
Query: 212 --------------LP--------------FDDSNLMNLY-------KKISAAEFTCPPW 236
+P + + + + L C P
Sbjct: 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323
Query: 237 LSFTARK----LIARILDPNPMTRITIPEILEDEWFK 269
+ + IL +P R + E+L+ ++ +
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ +G G + +V + VA+K L + E+ LK E A MK +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V+L V + +I+ EF+T G L D + N + Q+ +A++Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYV 180
+ HRDL N L+ +KV+DFG LS+ + D T
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWT---- 179
Query: 181 APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
APE L + S D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 180 APESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 75/342 (21%), Positives = 119/342 (34%), Gaps = 95/342 (27%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ T+GEG F KV + + G VA+KI+ + E + E+ ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V++ E I IV E + G +D I +G + D R+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+V++ HS + H DLKPEN+L +KV DFG +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 189 EH------HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPT 236
Query: 217 SNLMNLYKKISAAEFTCPPWLSFTARK--------------------------------- 243
+ + P + RK
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 244 -----------LIARILDPNPMTRITIPEILEDEWFKKDYKP 274
LI ++L+ +P RIT+ E L+ +F K
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 71
Query: 72 NVVRLYEV--MGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--------TPNYV 180
++ HRDL N+L++ +K+ DFG L++ + D
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFG---LTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + S A D+WS GV+L
Sbjct: 185 APESLTESKF--SVASDVWSFGVVL 207
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L + + E MK ++H
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEK 323
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 440 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-23
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L K + E +E MK ++H
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KPGTMSP---EAFLQEAQVMKKLRHEK 240
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 357 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-23
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KN----DATAQAFLAEASVMTQLRHSNL 248
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KVSDFGL+ + +D G L P + APE L ++
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKK 362
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ ST D+WS G++L+ + G +P+ L ++ ++
Sbjct: 363 F--STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 102
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
++ HRDL N+L++ +K+ DFGL+ + Q V++ G P + A
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIFWYA 216
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + + S A D+WS GV+L
Sbjct: 217 PESLTESKF--SVASDVWSFGVVL 238
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-23
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ + IG G +V + + PVA+K L K + + E + M H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTE-RQRRDFLSEASIMGQFDH 109
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
PN++RL V+ IV E++ G L + H G+ + + + + Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
G HRDL N+L+D+ KVSDFGLS + + D +TT G + APE +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
R + S+A D+WS GV+++ VL G P+ + ++ +
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-23
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV N TGE VA+K L + +H+ K+E+ ++ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
++++ + + +V+E+V G L D + H + + + QQ+ + Y H+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQ-----QVRDDGLLHTTCGTPNYV--- 180
+ HRDL N+LLD +K+ DFGL+ A+ + +VR+DG P V
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VFWY 204
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + A D+WS GV L
Sbjct: 205 APECLKEYKF--YYASDVWSFGVTL 227
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-23
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHE 83
Query: 72 NVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ + I +++EF+ G L + + + ++ + +Y Q+ +DY
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
SR HRDL N+L+++ +K+ DFGL+ + V+DD P + A
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFWYA 197
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + A D+WS GV L
Sbjct: 198 PECLMQSKF--YIASDVWSFGVTL 219
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 6e-23
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKRE 61
GK+ + + IG G F V ++ VA+K + +E M+E+ E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI-RE----GAMSEEDFIEE 53
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQL 120
M + HP +V+LY V + I +V EF+ G L D + G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ Y V HRDL N L+ +KVSDFG +++ V DD Y
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG---MTRFVLDD----------QYT 160
Query: 181 ------------APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
+PEV + Y S+ D+WS GV+++ V G +P+++ + + + I
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-23
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRGYDG 192
DL N+LL K+SDFGLS DD P + APE +N R +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 190
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-23
Identities = 70/343 (20%), Positives = 115/343 (33%), Gaps = 95/343 (27%)
Query: 11 GKYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ +GEGTF KV ++ VALKI+ K E + E+ +K +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIK 74
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V + + + I E + G F+ + + R QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+A+ + H + H DLKPEN+L ++V+DFG +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD- 215
+ HTT V PEV+ + G+ D+WS G ILF G+ F
Sbjct: 194 EH------HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQT 241
Query: 216 DSNL--------------MNLYKKISAAEF---TCPPWLSFTARK--------------- 243
N ++ + ++ W ++
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 244 -----------LIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
L+ R+L+ +P RIT+ E L +F
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-23
Identities = 48/237 (20%), Positives = 101/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E+ + PV +K++ ++K + + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQA-VTDHMLAIGSLDHA 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
++VRL + + + +V +++ G L D + H G + + Q+ + Y
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
G+ HR+L N+LL + ++V+DFG++ L + D P ++A E ++
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
Y + D+WS GV ++ ++ G P+ L + + E C +
Sbjct: 192 GKY--THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIK---REVATMKLV 68
+G+G F V+ R TG VA+K L+H +Q + RE+ +K +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILKAL 81
Query: 69 KHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+V+ V G + + +V+E++ G L D + H R+ Y Q+ ++
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-N 178
Y SR HRDL N+L+++ ++K++DFGL+ L VR+ G P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIF 195
Query: 179 YVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+ APE L+D + S D+WS GV+L
Sbjct: 196 WYAPESLSDNIF--SRQSDVWSFGVVL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E+GR IGEG F V N VA+K K + + +E TM+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTC-KNCTSDSVREKFL-QEALTMRQF 73
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVA 181
S+ HRD+ N+L+ + +K+ DFG LS+ + D + G A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWM----A 185
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PE +N R + ++A D+W GV ++ +L+ G PF ++ +I
Sbjct: 186 PESINFRRF--TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-22
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 15 VGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + +G G F +V + S+ VA+K L K + E + M HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N++RL V+ + IV E++ G L + H + + + + + + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYV---APEVLN 186
G HRDL N+L+++ KVSDFG L + + DD +TT G + +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R + ++A D+WS G++L+ V+ G P+ + + ++ K + CP L
Sbjct: 224 YRKF--TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 5e-22
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDRGYDG 192
+L N+LL K+SDFGLS DD + APE +N R +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 516
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-22
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ IG G F +V + +G+ PVA+K L K + + + E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSH 105
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ + I+ E++ G L + G + + + + Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE ++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAIS 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDD-SN 218
R + ++A D+WS G++++ V+ G P+ + SN
Sbjct: 224 YRKF--TSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-22
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 4 PKIKRRVGKYEV-------GRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHK 53
++K ++ + GR +G+G F V + + + VA+K+L K ++
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASS 67
Query: 54 MAEQIKREVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGR 107
E+ RE A MK HP+V +L V G ++L F+ G+L ++ R
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-R 126
Query: 108 MKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160
+ E+ Q L+ VD Y SR HRDL N +L + V+DFGLS
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-- 184
Query: 161 SQQVRDDGLLHTTCGTPNY-------------VAPEVLNDRGYDGSTADLWSCGVIL 204
R +++ +Y +A E L D Y +D+W+ GV +
Sbjct: 185 ----RK---IYSG----DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTM 229
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-22
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKL 67
++ +G G F +V N T VA+K L + L E MK
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA---------EANLMKQ 64
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVD 125
++H +VRLY V+ ++ I+I+ E++ G L D + +K + Q+ +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNY 179
+ R HRDL+ N+L+ + K++DFG L++ + D+ T
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG---LARLIEDNEYTAREGAKFPIKWT--- 177
Query: 180 VAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
APE +N + + D+WS G++L ++ G +P+ + + +
Sbjct: 178 -APEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-22
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 11 GKYEVGRT-------IGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+Y + R +GEG F +V + + VA+K K+ L +K E+
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMS 62
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 119
E MK + HP++V+L ++ + +I++E GEL + + +K Y Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---- 175
+ A+ Y S HRD+ N+L+ + +K+ DFG LS+ + D+ +
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDEDYYKASVTRLPI 178
Query: 176 --TPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+PE +N R + +TA D+W V +
Sbjct: 179 KWM----SPESINFRRF--TTASDVWMFAVCM 204
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 16 GRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
GR IGEG F V N VA+K K + +E TM+ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTC-KNCTSDSVREK-FLQEALTMRQFDH 450
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFG LS+ + D + G P ++APE +N
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 567 RRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + +G G F +V A ++ VA+K + + E MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L+ V+ +K I+I+ EF+ G L D + + K+ + + Q+ + + R
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVAPEVL 185
HRDL+ N+L+ A K++DFG L++ + D+ T APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFG---LARVIEDNEYTAREGAKFPIKWT----APEAI 357
Query: 186 NDRGYDGSTA-DLWSCGVIL 204
N + + D+WS G++L
Sbjct: 358 NFGSF--TIKSDVWSFGILL 375
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-21
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKREVATMKLVKHP 71
+ +G G F VK+ + + VA+K++ KE M+E E M + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY--DVAIKMI-KE----GSMSEDEFIEEAKVMMNLSHE 79
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---------- 180
HRDL N L++ G +KVSDFG LS+ V DD Y
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD----------EYTSSVGSKFPVR 186
Query: 181 --APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PEVL + S+ D+W+ GV+++ + G +P++ + I
Sbjct: 187 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 73/372 (19%), Positives = 118/372 (31%), Gaps = 125/372 (33%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
G+Y V R +G G F+ V + + + + VA+K++ E E+ +K V+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRN 92
Query: 70 ----HPN---VVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEARRY 116
PN VV+L ++ G I +V E V G L N+ + ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 117 FQQLINAVDYCHSR-GVYHRDLKPENLLL------------------------------- 144
QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 145 ------------------DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-YVAPEVL 185
+K++D G + + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK--------------------- 224
GY+ + AD+WS + F L G F+ + +
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 225 --KISAAEFT----------CPPWLSF---------------TARKLIARILDPNPMTRI 257
K S FT PW F + +L+ P R
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384
Query: 258 TIPEILEDEWFK 269
T E L W
Sbjct: 385 TAAECLRHPWLN 396
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I IG G F V N A+K L Q E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRI-TDIGEVSQFLTE 76
Query: 62 VATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 119
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHT 172
+ + Y S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-- 194
Query: 173 TCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 195 ----P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G+ +GEG F V + T VA+K + K + E+ E A MK H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 71 PNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AV 124
PNV+RL V K ++L F+ G+L ++ R++ Q L+ V
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 D------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----------D 167
D Y +R HRDL N +L + V+DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 168 GLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+ P V A E L DR Y S +D+W+ GV +
Sbjct: 209 AKM------P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 9e-20
Identities = 66/300 (22%), Positives = 110/300 (36%), Gaps = 38/300 (12%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L + Q E
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR-ITDIGEVSQFLTEG 141
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q+
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQVRDDGLLHTT 173
+ + S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--- 258
Query: 174 CGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAA 229
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 259 ---P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312
Query: 230 E-----FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTN 284
CP L +++ + P R + E++ + + E N
Sbjct: 313 RRLLQPEYCPDPL----YEVMLKCWHPKAEMRPSFSELVSR--ISAIFSTFIGEHYVHVN 366
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 16 GRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPN 72
IGEG F +V AR A+K + KE K + E+ + L HPN
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPN 87
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQLIN- 122
++ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
A D Y + HRDL N+L+ K++DFGLS R +
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 201
Query: 177 --PNYV---APEVLNDRGYDGSTA-DLWSCGVILF 205
P V A E LN Y +T D+WS GV+L+
Sbjct: 202 RLP--VRWMAIESLNYSVY--TTNSDVWSYGVLLW 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 52/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 88
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI++E + GG+L + + L++ A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKG 202
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + T D WS GV+L
Sbjct: 203 GCAML------P--VKWMPPEAFMEGIFTSKT-DTWSFGVLL 235
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-19
Identities = 53/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 129
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI+LE + GG+L + + L++ A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKG 243
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + S D WS GV+L
Sbjct: 244 GCAML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G+G+F V K E VA+K + E M E+I+ E + MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEA---ASMRERIEFLNEASVMK 83
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---FQQLIN- 122
+VVRL V+ +++E +T G+L + + + ++I
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
A + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 197
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
GLL P V +PE L D + + +D+WS GV+L
Sbjct: 198 GKGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-19
Identities = 44/214 (20%), Positives = 73/214 (34%), Gaps = 39/214 (18%)
Query: 14 EVGRTIGEGTFAKV-------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
++G+GTF K+ V LK+LDK +E + M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+ H ++V Y V + +V EFV G L + + + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNL--------KVSDFGLSALSQQVRDDGLLHTTCGTP 177
+ + H ++ +N+LL + K+SD G +S V
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---ISITVLPK---------- 174
Query: 178 NY-------VAPEVLNDRGYDGSTADLWSCGVIL 204
+ V PE + + D WS G L
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-19
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R IG+G F V + A+K L + + E RE M+ +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRI--QCAIKSL-SRIT-EMQQVEAFLREGLLMRGL 79
Query: 69 KHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDY 126
HPNV+ L + + + ++L ++ G+L I + R + + Q+ ++Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGTPNY 179
+ HRDL N +LD +KV+DFGL+ S Q L P
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P-- 191
Query: 180 V---APEVLNDRGYDGSTADLWSCGVIL 204
V A E L + + +D+WS GV+L
Sbjct: 192 VKWTALESLQTYRFT-TKSDVWSFGVLL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+ VG+ IG G F +++ +N T E VA+K+ E + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--QLHLEYRFYKQLGS 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ ++Y +VLE G +LFD QLI+ ++Y
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVS-----DFGLSALSQQVRD-DGLLH-------TT 173
HS+ + +RD+KPEN L+ GN DF L+++ D + H +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA---LAKEYIDPETKKHIPYREHKSL 177
Query: 174 CGTPNYVAPEVLND-RGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
GT Y++ +N G + S DL + G + L G LP L Y+KI
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+T+G G F KV A S+ VA+K+L L + A + E+ + L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYL 83
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKIVNHGRMKEDEARRY 116
H N+V L ++ E+ G+L + M++DE
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 117 FQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169
+ L+ + + S+ HRDL N+LL K+ DFG L++ +++D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG---LARDIKNDS- 199
Query: 170 LHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NYV APE + + Y +D+WS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
K+ +GR IG G+F ++ N +T E VA+K+ E V Q+ E + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP--QLLYESKIYRILQG 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
+ + +V++ + G L D R + Q+IN V++ H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 129 SRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD-DGLLHTT-------CGTP 177
S+ HRD+KP+N L+ + + DFG L+++ RD H GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG---LAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 178 NYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLP 213
Y + V G + S DL S G +L L G LP
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 47/222 (21%)
Query: 16 GRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+T+G G F KV A + VA+K+L K + + E+ M L +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHLGQ 108
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-------FQQLIN 122
H N+V L + ++ E+ G+L + + R+ E + + L++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 123 -AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + S+ HRD+ N+LL K+ DFGL+ RD
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD------IMN 216
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NY+ APE + D Y +D+WS G++L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 54/226 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ +GEG F KV + VA+K L KE + +RE + ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL--------FDKIVNHGRMKEDEARRYFQQL 120
+H ++VR + V + +V E++ G+L D + G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 121 IN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------- 166
+ A Y HRDL N L+ +K+ DFG+S RD
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYY 214
Query: 167 ----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+L P + PE + R + +T D+WS GV+L
Sbjct: 215 RVGGRTML------P--IRWMPPESILYRKF--TTESDVWSFGVVL 250
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 32/236 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+Y +GR IG G+F + + GE VA+K+ E V Q+ E K +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHP--QLHIESKIYKMMQG 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ + +V+E + G +LF+ + Q+I+ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDD-GLLHTT-------CG 175
HS+ HRD+KP+N L+ + + DFG L+++ RD H G
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG---LAKKYRDARTHQHIPYRENKNLTG 177
Query: 176 TPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
T Y + + G + S DL S G +L G LP + Y++IS
Sbjct: 178 TARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 54/227 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+GE F KV E + VA+K L K+K E + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLRARL 69
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQ 119
+HPNVV L V+ + ++ + + G+L + +V + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------ 166
++ Y S V H+DL N+L+ N+K+SD GL R+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183
Query: 167 -----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+ LL P + APE + + S D+WS GV+L
Sbjct: 184 YKLLGNSLL------P--IRWMAPEAIMYGKF--SIDSDIWSYGVVL 220
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 55/228 (24%)
Query: 16 GRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+ +GEG F +V A VA+K+L K + +++ I E+ MK +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMKMI 131
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQ 118
KH N++ L +++++E+ + G L + ++ E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 119 QLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----- 166
L++ A Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------RDIHHID 245
Query: 167 ------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+L+
Sbjct: 246 YYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 61/240 (25%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQ 57
IKRR + R +GEG F KV ++ VA+K L K+ +A +
Sbjct: 9 VQHIKRR--DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPT----LAAR 61
Query: 58 IK--REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHG 106
RE + ++H ++V+ Y V G + +V E++ G+L I+ G
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 107 RMKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+ ++ + Q+++ A Y S+ HRDL N L+ A +K+ DFG+S
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS- 180
Query: 160 LSQQVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
RD +L P + PE + R + +T D+WS GVIL
Sbjct: 181 -----RDVYSTDYYRVGGHTML------P--IRWMPPESIMYRKF--TTESDVWSFGVIL 225
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 16 GRTIGEGTF-----AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+T+GEG F A + VA+K+L KE ++ + + E +K V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLKQVNH 85
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKEDEA 113
P+V++LY + +++E+ G L + DE
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 114 RRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
LI+ A Y + HRDL N+L+ +K+SDFGLS RD
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------RD 199
Query: 167 DGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
++ +YV A E L D Y + +D+WS GV+L+
Sbjct: 200 ---VYE---EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-17
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 209
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 210 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 8e-17
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 34/246 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
Y+VGR IGEG+F + N + VA+K E Q++ E T K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP--QLRDEYRTYKLLAG 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ +Y +V++ G +L D + +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQS 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLK-----VSDFGLSALSQQVRD-DGLLH-------TT 173
H + + +RD+KP+N L+ + V DFG + + RD H
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG---MVKFYRDPVTKQHIPYREKKNL 178
Query: 174 CGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKISAA 229
GT Y++ + G + S DL + G + L G LP + Y++I
Sbjct: 179 SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236
Query: 230 EFTCPP 235
+ + P
Sbjct: 237 KQSTPL 242
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-16
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F KV R G VA+K L +E+ ++ Q + EV + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR- 93
Query: 79 VMG---SKTKIFIVLEFVTGG----ELFDKIVNHG------RMK--EDEAR--RYFQQLI 121
G + T+ +V ++ G L ++ + R + AR Y
Sbjct: 94 --GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--- 148
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPN 178
D+C + + HRD+K N+LLD V DFGL+ L D H T GT
Sbjct: 149 ---DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIG 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
++APE L+ G D++ GV+L L+ G FD + L N
Sbjct: 201 HIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 61/237 (25%), Positives = 88/237 (37%), Gaps = 54/237 (22%)
Query: 8 RRVGKYEVGRTIGEGTFAKV-KFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATM 65
G +GEG F V K N VA+K L + ++ +Q +E+ M
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 66 KLVKHPNVVRL-------------YEVM--GSKTKIFIVLEFVTGGELFDKIVNHG---- 106
+H N+V L Y M GS L L
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGS-------LLDR----LSCLDGTPPLSWH 133
Query: 107 -RMK--EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163
R K + A +++ H HRD+K N+LLD K+SDFGL+ S+
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE- 184
Query: 164 VRDDGLLHTT---CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
T GT Y+APE L RG +D++S GV+L ++ G D+
Sbjct: 185 --KFAQTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 255
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 256 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 55/235 (23%), Positives = 85/235 (36%), Gaps = 62/235 (26%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E R IGEG F +V E VA+K+L KE+ A+ +RE A M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALMAEF 107
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKED 111
+PN+V+L V + ++ E++ G+L D
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
+ + A Y R HRDL N L+ +K++DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 165 RD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
R+ + + P + PE + Y +T D+W+ GV+L
Sbjct: 222 RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRY--TTESDVWAYGVVL 266
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 50/225 (22%)
Query: 16 GRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+ +G G F +V A + T VA+K+L KE + + E+ + +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKILIHIGH 89
Query: 70 HPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQQ 119
H NVV L + +++EF G L + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172
LI + + SR HRDL N+LL +K+ DFGL+ RD ++
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD---IYK 200
Query: 173 TCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + DR Y +D+WS GV+L+
Sbjct: 201 ---DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 3e-16
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F KV + G VALK E + + + E+ T+ +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------YCHSRGV 132
+ ++ ++ +++ G L + +G + + Q+L + Y H+R +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPE-----V 184
HRD+K N+LLD K++DFG+S + H + GT Y+ PE
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGT---ELDQTHLSTVVKGTLGYIDPEYFIKGR 217
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
L ++ +D++S GV+LF +L S
Sbjct: 218 LTEK------SDVYSFGVVLFEVLCARSAIVQS 244
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.5 bits (187), Expect = 7e-16
Identities = 39/192 (20%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMK 66
K + IGEG F +V PVA+KI+ D K E+I E+ K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 67 LV---------KHPNVVRLYEV------------------------------MGSKTKIF 87
+ + + L V ++F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDA 146
IVLEF GG +++ A+ QL ++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 147 YGNLKVSDFGLS 158
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 56/233 (24%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
E G+ +G G F KV A + VA+K+L KEK + + E+ M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMMTQL 105
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKED 111
H N+V L I+++ E+ G+L + +ED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
F+ L+ A + + HRDL N+L+ +K+ DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 165 RDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
RD + + NYV APE L + Y +D+WS G++L+
Sbjct: 220 RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++ +G+ IG G F + A + E A + KV + + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV---VKVEYQE-NGPLFSELKFYQRVAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTGGELFDKIVNHGRMKED 111
+ ++ + + F+V+E + G +L +G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDGL 169
+ ++++ ++Y H H D+K NLLL +V +D+G LS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG---LSYRYCPNGN 208
Query: 170 L----------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
H GT + + L+ +G S +D+ G + L G LP
Sbjct: 209 HKQYQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 41/237 (17%), Positives = 84/237 (35%), Gaps = 45/237 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++VG IG+G F + + + + E V KV + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTG---GELFDKIVNHGRM 108
P ++ + + F++++ G ++++ N R
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRF 149
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRD 166
+ ++++ ++Y H H D+K NLLL+ +V D+G L+ +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG---LAYRYCP 206
Query: 167 DGLL--------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
+G+ GT + + ++ G S DL G + L G+LP
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 36/244 (14%), Positives = 78/244 (31%), Gaps = 59/244 (24%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG--------EPVALKI------LDKEKVLKHKMA- 55
++++ + A + T + +LK+ L E+ + A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 56 -EQIKREVATMKLVKHPNVVRLYEVMGSKTKI--FIVLEFVTGGELFDKIVNHGRMKEDE 112
Q+ + + G F+VL + G L + +
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMG-FGVHQDKYRFLVLPSL-GRSLQSALDVSPK----- 153
Query: 113 ARRYF---------QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALS 161
+L++A+++ H H ++ EN+ +D +V + +G +
Sbjct: 154 --HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG---FA 208
Query: 162 QQVRDDG----------LLHTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLA 209
+ G H G +++ ++ +G S +DL S G + L
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLY 263
Query: 210 GYLP 213
G+LP
Sbjct: 264 GFLP 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-08
Identities = 60/338 (17%), Positives = 103/338 (30%), Gaps = 105/338 (31%)
Query: 42 KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL------EFVT 94
++ K V + + ++++ A ++L NV+ + V+GS KT + +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQ--ALLELRPAKNVL-IDGVLGSGKT----WVALDVCLSYKV 176
Query: 95 GGELFDKI--VNHGRMKEDEAR-RYFQQLINAVD--YC----HSRGVYHR--DLK----- 138
++ KI +N E Q+L+ +D + HS + R ++
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 139 -------PENLL-LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
LL L N K +A + + +L TT R
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKA----WNAFNLSCK---ILLTT--------------R-- 273
Query: 191 DGSTAD-LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D L + L + + +L K +L + L +L
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK----------YLDCRPQDLPREVL 323
Query: 250 DPNPMTRITIPEILEDE---WFKKDYKPPVFEEKKDT-------NLDDVE--------AV 291
NP I E + D W D V +K T L+ E +V
Sbjct: 324 TTNPRRLSIIAESIRDGLATW---DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
Query: 292 FKDSEEHHVTEQ----------KEEQPVAMNAFELISL 319
F S H+ K + V +N SL
Sbjct: 381 FPPSA--HIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 25/99 (25%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ SR HRDL N+LL +K+ DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILF 205
YV APE + DR Y + D+WS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQS-DVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
++G+ +G G F +V A + T VA+K+L + A E+ + +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--SELKILIHI 82
Query: 68 VKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH 105
H NVV L + +++EF G L + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 4e-07
Identities = 18/29 (62%), Positives = 23/29 (79%)
Query: 305 EEQPVAMNAFELISLSKGLNLGNLFDAEQ 333
+E P+ MNAFE+I+LS+GLNL LFD Q
Sbjct: 1 DEGPLMMNAFEMITLSQGLNLSALFDRRQ 29
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 25/159 (15%), Positives = 58/159 (36%), Gaps = 28/159 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-------------- 58
+G+ +GEG + V + + +K K+ E+
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 59 -KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + EL+ ++ +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYR-------VRVENPDEVL 199
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
++ V + RG+ H DL N+L+ + + DF
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 1e-05
Identities = 12/23 (52%), Positives = 14/23 (60%)
Query: 308 PVAMNAFELISLSKGLNLGNLFD 330
MNAF++IS S G NL LF
Sbjct: 3 ARRMNAFDIISGSPGFNLSGLFG 25
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.4 bits (94), Expect = 3e-04
Identities = 31/168 (18%), Positives = 56/168 (33%), Gaps = 26/168 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARN--SETGEPVALKI-------LDKEKVLKHKMAEQIKREVA 63
+G I G A V +A +A+KI DK + R ++
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 64 TMKLVK------HPNVVRLYEVMGSKTKIF------IVLEFVTGGELFDKIVNH--GRMK 109
+ V N+ R E S + + +++EF+ EL + +K
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 110 EDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFG 156
E + F ++ V + + H DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.81 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.55 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.28 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.05 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.84 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.7 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.38 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.11 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.03 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.32 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.67 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.24 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.81 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.09 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-70 Score=489.78 Aligned_cols=263 Identities=30% Similarity=0.574 Sum_probs=243.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|++++.+|
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 45678999999999999999999999999999999999877666666788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999865443333
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+++.++....+.+|..+|+++++||.+
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 44566799999999999998887 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCHhH------HhcCccccCC
Q 019904 248 ILDPNPMTRITIPE------ILEDEWFKKD 271 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e------~l~h~~~~~~ 271 (334)
||++||.+|||++| +++||||+..
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 99999999999998 4789999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-70 Score=482.87 Aligned_cols=261 Identities=49% Similarity=0.920 Sum_probs=223.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+..+++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 46789999999999999999999999999999999999877666666677899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||| +|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 579999999999999999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+...+...+....+.+|..+|+++++||.
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 22345678999999999999988877899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+||++||++|||++|+|+||||+..
T Consensus 245 ~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 245 RMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHccCChhHCcCHHHHHcCcccccC
Confidence 9999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-68 Score=480.96 Aligned_cols=261 Identities=29% Similarity=0.573 Sum_probs=228.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+++|++++.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 35689999999999999999999999999999999998765433 34678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|||||+||+|.+++...+ .+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST- 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence 9999999999999997653 5789999999999999999999999999999999999999999999999999754321
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCCCCHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 244 (334)
.......+||+.|+|||++.+..+. .++|||||||++|||++|+.||.+.+..+++.++....+ +.+..+|.++++|
T Consensus 179 -~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 179 -VELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp -HHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred -cccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 1123456899999999999988774 899999999999999999999999999998888877665 4567899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|.+||++||++|||++|+|+||||.+..
T Consensus 257 i~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-67 Score=473.67 Aligned_cols=256 Identities=29% Similarity=0.464 Sum_probs=228.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
..|++++.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999997654322 356789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|||+||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 99999999998876 5699999999999999999999999999999999999999999999999999875432 22334
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~ 247 (334)
.+.+||+.|+|||++.+..| +.++|||||||++|||++|+.||.+.+..+.+..+..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 56789999999999988777 5999999999999999999999999998888887765432 3345689999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
||++||++|||++|+|+||||++...
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-67 Score=469.35 Aligned_cols=257 Identities=33% Similarity=0.607 Sum_probs=226.1
Q ss_pred ccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.++|++++.||+|+||+||+|++. .+++.||||++.+....... ...+.+|+.+|+.++|||||++++++.+++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 367999999999999999999874 46789999999765433222 34577899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+|||||+||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~ 179 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--H 179 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--C
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999875332 1
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.....+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..++...+....+.+|..+|+++++||.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 258 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 2234567899999999999988875 899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 247 RILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
+||++||++||| ++|+++||||+.
T Consensus 259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 259 MLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999999998 589999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-65 Score=474.58 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=228.9
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++++.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999997654322 356789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 99999999998865 5699999999999999999999999999999999999999999999999999875432 22334
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~ 247 (334)
.+.+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.+..+.+..+.... ...+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 56789999999999988777 599999999999999999999999999888888776543 34456789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
||++||++|||++|+|+||||++...
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~~ 409 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAGP 409 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCCC
Confidence 99999999999999999999987543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-65 Score=453.40 Aligned_cols=254 Identities=26% Similarity=0.501 Sum_probs=219.9
Q ss_pred ccce-EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----CC
Q 019904 10 VGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KT 84 (334)
Q Consensus 10 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 84 (334)
.++| ++.+.||+|+||+||+|.+..++..||+|++....... ...+.+.+|+.+|+.++|||||++++++.+ +.
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 3566 77888999999999999999999999999998654433 345789999999999999999999999865 35
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEec-CCCeEEeeccchhcc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALS 161 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~ 161 (334)
.+|+|||||+||+|.+++.+.+++++..++.|+.||+.||+|||++| |+||||||+|||++. +|.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 68999999999999999999999999999999999999999999999 999999999999974 799999999999753
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCcc--CCCCCCC
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLS 238 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~~~--~~~~~~~ 238 (334)
. .....+.+||+.|||||++.+ .+ +.++|||||||++|||+||+.||.+.. ...+...+..... .++..++
T Consensus 183 ~----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 256 (290)
T 3fpq_A 183 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred C----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence 2 233456789999999999875 45 589999999999999999999997654 4555555554432 3456688
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+++++||.+||++||++|||++|+|+||||++
T Consensus 257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 99999999999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-65 Score=459.85 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=223.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....+.|++.+.||+|+||+||+|++..+|+.||||+++.+.. ..+|+.+|+.++|||||++++++.+++.+
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3456789999999999999999999999999999999986532 23699999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 165 (334)
|+|||||+||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+......
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999999989999999999999999999999999999999999999999988 59999999997644321
Q ss_pred CCC---cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCH
Q 019904 166 DDG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSF 239 (334)
Q Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~ 239 (334)
... .....+||+.|||||++.+..+. .++|||||||++|||++|+.||.+.+...+..++..... ..|+.+|+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 284 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAP 284 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCH
T ss_pred cccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCH
Confidence 111 12345799999999999988775 899999999999999999999998776666666655443 46788999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHH-------------hcCccccCCCC
Q 019904 240 TARKLIARILDPNPMTRITIPEI-------------LEDEWFKKDYK 273 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~-------------l~h~~~~~~~~ 273 (334)
++++||.+||++||.+|||+.|+ |+|||+.....
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 99999999999999999999997 57999876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-63 Score=459.67 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=225.2
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee------CC
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 84 (334)
++|++++.||+|+||+||+|++..+|+.||||++..... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976432 23345678899999999999999999999764 36
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+|||||. |+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7899999996 589999999899999999999999999999999999999999999999999999999999999754322
Q ss_pred --cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC---------
Q 019904 165 --RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (334)
Q Consensus 165 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 233 (334)
.......+.+||+.|+|||++.+..+++.++||||+||++|||++|+.||.+.+..+++..+......+
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 122334567999999999999987777799999999999999999999999999888877764322111
Q ss_pred ----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 234 ----------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 234 ----------------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+.+|+++++||.+||..||.+|||++|+|+||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 1246899999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=465.76 Aligned_cols=260 Identities=29% Similarity=0.457 Sum_probs=229.5
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHH---HHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---QIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
...++.|++++.||+|+||.||+|++..+|+.||||++.+.......... ..+.++.+++.++|||||+++++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 45678999999999999999999999999999999999876544333223 334456777888999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
+.+|+|||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcCccCCCCCCCHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSFT 240 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~ 240 (334)
....+.+||+.|+|||++.....++.++|+|||||++|||++|..||.+. +...+...+....+.+|..+|++
T Consensus 345 ----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~ 420 (689)
T 3v5w_A 345 ----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420 (689)
T ss_dssp ----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHH
Confidence 22356799999999999975444469999999999999999999999763 44566777777888899999999
Q ss_pred HHHHHHHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 241 ARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
+++||.+||++||.+|++ ++|+++||||+.
T Consensus 421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 999999999999999998 799999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=431.36 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=219.8
Q ss_pred ccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
-++|.+.+.||+|+||+||+|++. .++..||||++.... ....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 357999999999999999999864 357889999997532 334578999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
.+|+|||||++|+|.++|...+ .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999999997643 699999999999999999999999999999999999999999999
Q ss_pred EeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc
Q 019904 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~ 230 (334)
|+|||+|+...............||+.|+|||++.+..+. .++|||||||++|||+| |+.||.+.+..++...+....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999864433222223345689999999999988774 99999999999999998 999999999888888877654
Q ss_pred -cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 231 -FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 231 -~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
.+.|+.+|+++.+||.+||+.||++|||++++ ++|++
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 46788899999999999999999999999999 44654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-62 Score=435.25 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=203.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC---
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 84 (334)
+.++.|++++.||+|+||+||+|++..+|+.||||++.... .+...+.+.+|+.+|+.++|||||++++++...+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 45678999999999999999999999999999999997543 3334577899999999999999999999986544
Q ss_pred ---------eEEEEEeccCCCchHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEE
Q 019904 85 ---------KIFIVLEFVTGGELFDKIVNHGRM---KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (334)
Q Consensus 85 ---------~~~~v~e~~~~~~L~~~l~~~~~l---~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl 152 (334)
.+|+|||||+||+|.+++.....+ +...++.++.||+.||+|||++||+||||||+|||++.+|.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 379999999999999999876654 45668899999999999999999999999999999999999999
Q ss_pred eeccchhccccccCC----------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HH
Q 019904 153 SDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MN 221 (334)
Q Consensus 153 ~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~ 221 (334)
+|||+|+........ ....+.+||+.|||||++.+..+ +.++|||||||++|||++ ||.+... ..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 999998764332111 11234579999999999998777 489999999999999996 8865432 22
Q ss_pred HHHHhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 222 LYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 222 ~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
....+....++ .++..++.+.+||.+||++||.+|||+.|+|+||||+..
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 33333332221 112356778999999999999999999999999999753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-61 Score=439.69 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=210.7
Q ss_pred ccccccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 81 (334)
+....++|++.+.||+|+||+||+|++. .+++.||+|.+..... ..++.+|+.+|+.+ .||||++++++|.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 3445678999999999999999999875 4578899999865432 34577899999988 5999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccchhc
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL 160 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a~~ 160 (334)
+.+++|+|||||+||+|.+++ +.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 999999999999999999988 359999999999999999999999999999999999999876 7999999999864
Q ss_pred ccccc--------------------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCC
Q 019904 161 SQQVR--------------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (334)
Q Consensus 161 ~~~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf 214 (334)
..... ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 32211 0112234579999999999988776679999999999999999999999
Q ss_pred CC-CcHHHHHHHhhc--------------------------------------Cc----------------cCCCCCCCH
Q 019904 215 DD-SNLMNLYKKISA--------------------------------------AE----------------FTCPPWLSF 239 (334)
Q Consensus 215 ~~-~~~~~~~~~~~~--------------------------------------~~----------------~~~~~~~~~ 239 (334)
.. .+..+.+..+.. .. ......+|+
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 54 444443333211 00 011234789
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++++||.+||+.||++|||++|+|+||||+.
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999975
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-60 Score=429.39 Aligned_cols=252 Identities=21% Similarity=0.328 Sum_probs=213.0
Q ss_pred ccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
...|.+.+.||+|+||+||+|++. .+++.||||++... .....+.+.+|+.+|++++|||||++++++.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357899999999999999999864 36788999999753 2334578999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 85 KIFIVLEFVTGGELFDKIVNH---------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
.+|+|||||++|+|.+++... .++++..+..++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 999999999999999999764 35899999999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~ 228 (334)
+||+|||+|+...............||+.|||||++.+..+ +.++|||||||++|||+| |+.||.+.+..+....+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999986543333333345679999999999998777 499999999999999999 9999999888888877765
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 229 A-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 229 ~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
. ..+.|..+|+++.+|+.+||+.||++|||++|++++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4 467788899999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=426.23 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=221.1
Q ss_pred cccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..+.+++.+.||+|+||+||+|... .+++.||||++.... .....+.+.+|+.+|++++|||||++++++..+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 4578999999999999999999853 467889999997532 223357799999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
+.+|+|||||++|+|.++|... ..+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 9999999999999999999653 358999999999999999999999999999999999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHh
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~ 226 (334)
+.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i 260 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999986544333333445689999999999998777 499999999999999998 89999999988888887
Q ss_pred hcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 227 ~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.... .+.|+.+|.++.+|+.+||+.||.+|||+.|++++
T Consensus 261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6654 46778899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-60 Score=422.84 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=205.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..+++++.+.||+|+||+||+|++. ..||||+++.... .....+.+.+|+.+|++++|||||++++++. ++.+|+
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEE
Confidence 3567889999999999999999864 3599999875432 3344678999999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
|||||++|+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999999765 57999999999999999999999999999999999999999999999999999865443333
Q ss_pred CcccccccCCcccChHhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHh-hcCc-----cCCCCCCCH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAE-----FTCPPWLSF 239 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~-~~~~-----~~~~~~~~~ 239 (334)
......+||+.|||||++.+.. .++.++|||||||++|||+||+.||.+.+.......+ .... ...++.+|+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 3445678999999999997532 3458999999999999999999999886554443333 2221 123456899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 240 TARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
++.+||.+||+.||++|||+.|++++
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999988653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-60 Score=455.60 Aligned_cols=259 Identities=31% Similarity=0.589 Sum_probs=232.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++++.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999999764422 24678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC--CCeEEeeccchhcccccc
Q 019904 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~--~~~kl~Dfg~a~~~~~~~ 165 (334)
|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+ |.+||+|||+|+...
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--- 308 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--- 308 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC---
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc---
Confidence 9999999999999964 4579999999999999999999999999999999999999854 889999999987543
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 241 (334)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+....+.++ +.+|+++
T Consensus 309 ~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 387 (573)
T 3uto_A 309 PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387 (573)
T ss_dssp TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHH
T ss_pred CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2334456789999999999998877 5899999999999999999999999999999998887766554 4689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
++||.+||+.||.+|||++|+|+||||+....+
T Consensus 388 ~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 999999999999999999999999999875543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=417.90 Aligned_cols=264 Identities=43% Similarity=0.817 Sum_probs=241.3
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++...+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345678999999999999999999999999999999999986543 3344677889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+||||+++++|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 166 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence 9999999999999999999988999999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (334)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+....+..|..+|.++.+|
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 233456689999999999998888778999999999999999999999999999999999999899999999999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|.+||+.||.+|||++|+++||||....
T Consensus 245 i~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-58 Score=421.52 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=213.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~ 83 (334)
-++|++++.||+|+||+||+|.+... ++.||||.+..... ....+.+.+|+.+|+++.| ||||++++++...
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999987653 36799999975432 2335678999999999975 8999999998664
Q ss_pred -CeEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~ 146 (334)
+.+|+|||||++|+|.++|+.. ..+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 5789999999999999999763 24889999999999999999999999999999999999999
Q ss_pred CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcH-HHHHH
Q 019904 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL-MNLYK 224 (334)
Q Consensus 147 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~-~~~~~ 224 (334)
++.+||+|||+|+..............+||+.|||||++.+..+ +.++|||||||++|||+| |..||.+... ..+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999985443222222344578999999999998877 499999999999999998 9999988653 34444
Q ss_pred Hhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 225 KISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 225 ~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+.. .....|+.+++++.+||.+||+.||++|||+.|+++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4443 3467788899999999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=407.53 Aligned_cols=259 Identities=34% Similarity=0.626 Sum_probs=237.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 56899999999999999999999999999999999987655445556778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ...
T Consensus 83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~ 160 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGA 160 (337)
T ss_dssp EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCC
Confidence 999999999999999888999999999999999999999999999999999999999999999999999874221 222
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (334)
.....+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+...+...+......+|..+|+++++||.+|
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l 239 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGL 239 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 3455689999999999987776 589999999999999999999999999988888888888888999999999999999
Q ss_pred cCCCCCCCC-----CHhHHhcCccccC
Q 019904 249 LDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 249 L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
|+.||.+|| +++|+++||||..
T Consensus 240 L~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 240 LKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999 9999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-57 Score=412.66 Aligned_cols=260 Identities=35% Similarity=0.637 Sum_probs=233.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
..+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4578999999999999999999999999999999999887655556677888999999988 699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--N 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--C
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999874221 1
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..++...+......+|..++.++.+||.
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp --------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 223345689999999999988776 4899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCH------hHHhcCccccC
Q 019904 247 RILDPNPMTRITI------PEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt~------~e~l~h~~~~~ 270 (334)
+||++||.+||++ +++++||||..
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 9999999999998 89999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-58 Score=415.10 Aligned_cols=262 Identities=48% Similarity=0.908 Sum_probs=236.0
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+..+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 56789999999999999999999999999999999999876555444456789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+ +|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 679999998888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.........+.......|..+|+++++||.
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 22334568999999999998877767899999999999999999999998776666666666677788899999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+||+.||.+|||++|+++||||+...
T Consensus 241 ~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 241 RMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp TTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHcCCChhHCcCHHHHHhChhhccCC
Confidence 99999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-56 Score=401.34 Aligned_cols=257 Identities=34% Similarity=0.715 Sum_probs=236.7
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
-.+++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 35789999999999999999999999999999999998765544445677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999875332
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
.....+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+....+..+......+|+.++.++++||.+
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred -ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2345689999999999988776 48999999999999999999999999999989888888888999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccC
Q 019904 248 ILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
||+.||.+|| +++++++||||+.
T Consensus 237 lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9999999999 9999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=406.60 Aligned_cols=263 Identities=30% Similarity=0.582 Sum_probs=235.8
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 84 (334)
.....++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999876554444566788899999876 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999864321
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (334)
........+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+...+...+......+|..++.++++|
T Consensus 171 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (345)
T 1xjd_A 171 -GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL 248 (345)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred -CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 1223455689999999999988776 58999999999999999999999999999999999888888899999999999
Q ss_pred HHHhcCCCCCCCCCHh-HHhcCccccCC
Q 019904 245 IARILDPNPMTRITIP-EILEDEWFKKD 271 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~-e~l~h~~~~~~ 271 (334)
|.+||+.||.+||++. ++++||||...
T Consensus 249 i~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 249 LVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999999999998 99999999853
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=403.53 Aligned_cols=258 Identities=33% Similarity=0.646 Sum_probs=238.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
...+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45679999999999999999999999999999999999876655555567888999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999875332
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..++.++++||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2245689999999999988776 4899999999999999999999999999999999988888899999999999999
Q ss_pred HhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 247 RILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
+||+.||.+||+ ++++++||||..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 999999999998 999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-56 Score=419.67 Aligned_cols=265 Identities=47% Similarity=0.891 Sum_probs=242.1
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
...+++|.+++.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+.+
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 34689999999999999999999999999999999999876555445567899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+......++....+..|..+++++.+||.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 22344568999999999999877767899999999999999999999999988888888888888888999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+||+.||.+|||++++++||||......
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 276 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQDLPK 276 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTTCCT
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhcCcc
Confidence 9999999999999999999999875443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=403.59 Aligned_cols=260 Identities=34% Similarity=0.600 Sum_probs=231.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
....++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 4556789999999999999999999999999999999986543211 1246788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC----CeEEeeccchh
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~a~ 159 (334)
..+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999998888999999999999999999999999999999999999998877 79999999987
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----C
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~ 235 (334)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++ +
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred EcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 5432 222345679999999999987766 5899999999999999999999999999888888887766655 5
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.+|..+++||.+||..||.+|||++|+|+||||..
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 68999999999999999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-55 Score=401.87 Aligned_cols=261 Identities=30% Similarity=0.548 Sum_probs=235.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 85 (334)
...+++|++++.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 44678999999999999999999999999999999999876655555567788999999988 79999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999874221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
........+||+.|+|||++.+..+ +.++|+|||||++|+|++|+.||.+.+...+...+......+|..+|.++++||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1223445689999999999988776 589999999999999999999999999999999998888889999999999999
Q ss_pred HHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 246 ARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
.+||+.||.+||+ ++++++||||+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999995 699999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=399.81 Aligned_cols=260 Identities=31% Similarity=0.589 Sum_probs=232.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
..+++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..+++.+ +||||+++++++.+...+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4578999999999999999999999999999999999877655566677888999999987 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--T
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--C
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999874222 1
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---------CcHHHHHHHhhcCccCCCCCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPWL 237 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~---------~~~~~~~~~~~~~~~~~~~~~ 237 (334)
.......+||+.|+|||++.+..+ +.++|+|||||++|+|++|+.||.. .....+...+......+|..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 223445689999999999988776 5899999999999999999999975 234456666777778888999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCH------hHHhcCccccC
Q 019904 238 SFTARKLIARILDPNPMTRITI------PEILEDEWFKK 270 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~------~e~l~h~~~~~ 270 (334)
+.++++||.+||+.||.+||++ +++++||||..
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 9999999999999999999995 89999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-55 Score=407.93 Aligned_cols=260 Identities=31% Similarity=0.586 Sum_probs=229.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
..+++|++++.||+|+||.||+|++..+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4578999999999999999999999999999999999876655555556788899999876 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--T
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc--C
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999874222 2
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------cHHHHHHHhhcCccCCCCCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPWL 237 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---------~~~~~~~~~~~~~~~~~~~~ 237 (334)
.......+||+.|+|||++.+..+ +.++|+|||||++|+|++|+.||... ....+...+......+|..+
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred CCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 233456789999999999998777 58999999999999999999999642 23446667777788899999
Q ss_pred CHHHHHHHHHhcCCCCCCCCCH------hHHhcCccccC
Q 019904 238 SFTARKLIARILDPNPMTRITI------PEILEDEWFKK 270 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~------~e~l~h~~~~~ 270 (334)
|.++++||.+||+.||.+||++ +|+++||||+.
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999985 79999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-55 Score=411.20 Aligned_cols=266 Identities=36% Similarity=0.662 Sum_probs=230.7
Q ss_pred CCcccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 019904 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (334)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (334)
|+.-......++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 1 M~~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp ------CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred CCccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 445556667789999999999999999999999999999999998654332 3356788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe---cCCCeEEeeccc
Q 019904 81 GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGL 157 (334)
Q Consensus 81 ~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~ 157 (334)
.+.+..|+|||||.||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999999999999989999999999999999999999999999999999999998 457899999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC---
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 234 (334)
+...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.++
T Consensus 160 a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 160 AIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eEEecCC--CceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 8654321 222345679999999999987766 5899999999999999999999999999888888887766554
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 -PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 -~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+.+|+++++||.+||+.||.+|||+.|+|+||||..
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 358999999999999999999999999999999974
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=402.08 Aligned_cols=260 Identities=27% Similarity=0.534 Sum_probs=233.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+....|
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45789999999999999999999999999999999998776555556678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||+.||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~---~ 168 (384)
T 4fr4_A 92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---E 168 (384)
T ss_dssp EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---T
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC---C
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999875432 2
Q ss_pred CcccccccCCcccChHhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCC---CcHHHHHHHhhcCccCCCCCCCHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTCPPWLSFTAR 242 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~e~~~g~~pf~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (334)
......+||+.|+|||++... ..++.++|||||||++|+|++|..||.. .........+.......|..++..+.
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 248 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV 248 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHH
Confidence 334567899999999999742 2235899999999999999999999974 34556667777777888999999999
Q ss_pred HHHHHhcCCCCCCCCC-HhHHhcCccccC
Q 019904 243 KLIARILDPNPMTRIT-IPEILEDEWFKK 270 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt-~~e~l~h~~~~~ 270 (334)
+||.+||+.||.+||+ ++++++||||..
T Consensus 249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp HHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred HHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999999999999998 999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-54 Score=387.80 Aligned_cols=261 Identities=28% Similarity=0.485 Sum_probs=227.8
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.++...++|++.+.||+|+||+||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 34566789999999999999999999999999999999997644322 456789999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+||||+.+++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999999999998775 5999999999999999999999999999999999999999999999999998654322
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTA 241 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 241 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+... ....|..++..+
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred --ccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 222345679999999999998776 58999999999999999999999988776655544332 344566789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
++||.+||+.||.+|||++|+++||||+...
T Consensus 247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 9999999999999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=384.27 Aligned_cols=263 Identities=36% Similarity=0.687 Sum_probs=236.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.-.+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45789999999999999999999999999999999999876555555567789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+++++|.+.+....++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 99999999999999999888999999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......|..++..+++||.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred -ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 12234578999999999987666 4899999999999999999999999999998888888888889999999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+||+.||.+|||++|+++||||......
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHhccChhhCCCHHHHhhCccccCCccC
Confidence 9999999999999999999999865443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-55 Score=396.29 Aligned_cols=263 Identities=40% Similarity=0.696 Sum_probs=223.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 678999999999999999999999999999999999754322 224568899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987544332233
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCc--cCCCCCCCHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAE--FTCPPWLSFTARKLI 245 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~li 245 (334)
......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...... .......... ......++..+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 3445689999999999998777667899999999999999999999865442 2222222222 222345899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+||+.||.+|||++|+++||||.....
T Consensus 243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHccCChhhCcCHHHHhhChhhccccc
Confidence 9999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=385.57 Aligned_cols=259 Identities=33% Similarity=0.502 Sum_probs=217.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4789999999999999999999999999999999976543 233356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+ ++.+.+.. .+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--cc
Confidence 999987 55555544 678999999999999999999999999999999999999999999999999998754321 22
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCCcHHHHHHHhhcCc-----------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAE----------------- 230 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~p-f~~~~~~~~~~~~~~~~----------------- 230 (334)
......||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 234557899999999998777567999999999999999988777 56666666555543210
Q ss_pred ------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 ------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 ------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
....+.++.++++||.+||+.||.+|||++|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011234789999999999999999999999999999998643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=410.89 Aligned_cols=261 Identities=34% Similarity=0.611 Sum_probs=226.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 45688999999999999999999999999999999998765555555677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+||||+++|+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||++..... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 999999999999999988899999999999999999999998 9999999999999999999999999999874322 1
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 223345689999999999988776 5899999999999999999999999999999998888888899999999999999
Q ss_pred HhcCCCCCCCC-----CHhHHhcCccccCC
Q 019904 247 RILDPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 247 ~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
+||+.||.+|| |++|+++||||...
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999 99999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=383.27 Aligned_cols=265 Identities=49% Similarity=0.909 Sum_probs=231.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45678999999999999999999999999999999999876554445567889999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.+++|.+++...+++++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~--- 163 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 163 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
........|++.|+|||.+.+..+.+.++||||||+++|+|++|..||...........+.......|..++..+.++|.
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM 243 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence 12233457899999999998877656889999999999999999999999888888888888878888889999999999
Q ss_pred HhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 247 RILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+||+.||.+|||++++++||||+.....
T Consensus 244 ~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HHccCChhhCCCHHHHHhChhhccCchh
Confidence 9999999999999999999999876543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=399.48 Aligned_cols=261 Identities=34% Similarity=0.581 Sum_probs=226.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHH-HHhCCCCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~ 85 (334)
....++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 4567899999999999999999999999999999999987665544445666677776 577899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875322
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (334)
........+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+...++..+......+++.++.++++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 2223456689999999999988776 489999999999999999999999999999999988888888899999999999
Q ss_pred HHhcCCCCCCCCCH----hHHhcCccccC
Q 019904 246 ARILDPNPMTRITI----PEILEDEWFKK 270 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~----~e~l~h~~~~~ 270 (334)
.+||+.||.+||++ +++++||||..
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999999987 69999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=397.02 Aligned_cols=260 Identities=42% Similarity=0.757 Sum_probs=217.4
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++++.||+|+||.||+|++..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.....+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 34578999999999999999999999999999999999764332 24577999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC--eEEeeccchhccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQV 164 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~ 164 (334)
|+||||+.+|+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 999999999999999988889999999999999999999999999999999999999987765 99999999874222
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCccCCCC--CCC
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPP--WLS 238 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~----~~~~~~~~~~~~~~~~~--~~~ 238 (334)
........||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.. .......+.......|. .++
T Consensus 171 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 171 --HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred --cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 2223456799999999999988877566999999999999999999998643 34555555555555554 589
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+++.+||.+||+.||.+|||++|+++||||.+...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99999999999999999999999999999976543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=391.34 Aligned_cols=256 Identities=25% Similarity=0.493 Sum_probs=228.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 35689999999999999999999999999999999987543 22456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--CCCeEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~a~~~~~~ 164 (334)
+|||||+|++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~- 156 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC-
Confidence 9999999999999997754 7999999999999999999999999999999999999987 78999999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ +.+|.+
T Consensus 157 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 157 --GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp --TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred --CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 223345679999999999987655 5899999999999999999999999998888888877766655 468999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+++||.+||..||.+|||+.|+|+||||...
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=390.14 Aligned_cols=260 Identities=37% Similarity=0.612 Sum_probs=228.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
...++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 445789999999999999999999999999999999976432211 12467889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC----CeEEeeccchhc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSAL 160 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~a~~ 160 (334)
..|+||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999999998888899999999999999999999999999999999999998887 799999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PW 236 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~ 236 (334)
... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ +.
T Consensus 168 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 168 IDF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp CCT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred CCC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 432 122345679999999999987766 5899999999999999999999999888888777766655544 46
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
++..+++||.+||+.||.+|||++++|+||||...
T Consensus 244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 89999999999999999999999999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=395.98 Aligned_cols=257 Identities=37% Similarity=0.689 Sum_probs=228.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999999865433 2335678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEeeccchhcccccc
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVR 165 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~Dfg~a~~~~~~~ 165 (334)
||||+.+|+|.+.+.....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~-- 183 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND-- 183 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT--
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC--
Confidence 999999999999998888899999999999999999999999999999999999997654 599999999875432
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 241 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+.+|. .++.++
T Consensus 184 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 261 (362)
T 2bdw_A 184 -SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 261 (362)
T ss_dssp -CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred -CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 222345679999999999987766 48999999999999999999999999888888888777665543 479999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++||.+||+.||.+|||+.++|+||||..
T Consensus 262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 262 KSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 99999999999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=389.50 Aligned_cols=262 Identities=34% Similarity=0.590 Sum_probs=223.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
....++|++.+.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 345689999999999999999999985 67899999999765332 22334667899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
.+.+|+||||+++++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999986432
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHH
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (334)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|+.++.+++
T Consensus 173 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 HD--GTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred cC--CccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 21 122345679999999999987766 589999999999999999999999999888888888888888999999999
Q ss_pred HHHHHhcCCCCCCCC-----CHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
+||.+||+.||.+|| +++++++||||...
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 999999999999999 88999999999753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=402.92 Aligned_cols=264 Identities=34% Similarity=0.563 Sum_probs=229.6
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
+....++|++++.||+|+||+||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 45667899999999999999999999999999999999987554444344567899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999998876 469999999999999999999999999999999999999999999999999986533211
Q ss_pred CCCcccccccCCcccChHhhhcCCC---CCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCC--CCCC
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGY---DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLS 238 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~--~~~~ 238 (334)
.......+||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+....+.++.... ..+| ..+|
T Consensus 223 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp -EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred -cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 112235689999999999986552 3588999999999999999999999999888888876532 3333 4699
Q ss_pred HHHHHHHHHhcCCCCCC--CCCHhHHhcCccccCC
Q 019904 239 FTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 271 (334)
.++++||.+||+.+|.+ ||+++|+++||||+..
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999999 9999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-54 Score=380.55 Aligned_cols=264 Identities=34% Similarity=0.705 Sum_probs=236.7
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
|...-.+++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 86 (284)
T 2vgo_A 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR 86 (284)
T ss_dssp ---CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred CccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence 34456789999999999999999999999999999999999876554444457789999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
+..|+||||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 87 KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999998764332
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (334)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......+|+.++..+++
T Consensus 167 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T 2vgo_A 167 ----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKD 241 (284)
T ss_dssp ----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred ----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHH
Confidence 12234578999999999987766 4899999999999999999999999888888888887788888999999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
||.+||+.||.+|||++++++||||+...
T Consensus 242 li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 242 LISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 99999999999999999999999998644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=386.14 Aligned_cols=263 Identities=28% Similarity=0.421 Sum_probs=216.9
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
.......++|++++.||+|+||+||+|.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 91 (311)
T 3niz_A 14 LYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSE 91 (311)
T ss_dssp -CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred eeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence 345667899999999999999999999995 589999999976432 233356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
...|+||||+.+ +|.+.+.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 92 RCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 999999999986 7888777654 59999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------- 231 (334)
.. ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 171 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 IP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp SC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred CC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 21 12234457899999999998766557899999999999999999999987665554444322100
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 232 -------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...+.+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123467899999999999999999999999999999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=404.45 Aligned_cols=265 Identities=26% Similarity=0.489 Sum_probs=229.3
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
+....++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|..++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 44567899999999999999999999999999999999987554444444558899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999999987 468999999999999999999999999999999999999999999999999998643321
Q ss_pred cCCCcccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCC---
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--- 235 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~--- 235 (334)
........+||+.|+|||++.. ...++.++|||||||++|||++|+.||.+.+..+.+.++... .+.+|.
T Consensus 229 -~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 229 -GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp -SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred -CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 1112234589999999999972 333468999999999999999999999999988888777543 234443
Q ss_pred CCCHHHHHHHHHhcCCCCCC--CCCHhHHhcCccccCC
Q 019904 236 WLSFTARKLIARILDPNPMT--RITIPEILEDEWFKKD 271 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~--Rpt~~e~l~h~~~~~~ 271 (334)
.+|+++++||.+||..+|++ ||+++|+++||||+..
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 48999999999999999988 9999999999999853
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=380.84 Aligned_cols=265 Identities=34% Similarity=0.638 Sum_probs=211.3
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.++..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp HHCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred ccccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 45778899999999999999999999999999999999998765555555678899999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..|+||||+++++|.+++... .++++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999999875 5799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (334)
.. .......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+.......|..++.++.+
T Consensus 165 ~~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 3cok_A 165 PH--EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD 241 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred CC--CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence 21 12234578999999999987665 5899999999999999999999998776666666666666778889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
||.+||+.||.+|||++++++||||....
T Consensus 242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999999998643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=394.73 Aligned_cols=267 Identities=23% Similarity=0.355 Sum_probs=221.7
Q ss_pred cccccccceEEeeeeecc--CceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 5 KIKRRVGKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
.+....++|++++.||+| +||.||+|++..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 345678999999999999 999999999999999999999987543 33456788899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.+.+|+|||||.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999999876 6799999999999999999999999999999999999999999999999998753
Q ss_pred ccccc-----CCCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----
Q 019904 161 SQQVR-----DDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---- 230 (334)
Q Consensus 161 ~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---- 230 (334)
..... .........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 32111 11222345789999999999873 234589999999999999999999998755443333222111
Q ss_pred ------------------------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 231 ------------------------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 231 ------------------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
.+.+..+++.+.+||.+||+.||.+|||++|+|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f 337 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHH
Confidence 12345578999999999999999999999999999999
Q ss_pred cCCC
Q 019904 269 KKDY 272 (334)
Q Consensus 269 ~~~~ 272 (334)
+...
T Consensus 338 ~~~~ 341 (389)
T 3gni_B 338 KQIK 341 (389)
T ss_dssp GGC-
T ss_pred HHHh
Confidence 8654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=387.29 Aligned_cols=247 Identities=21% Similarity=0.309 Sum_probs=192.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----eE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 86 (334)
.+|.+.+.||+|+||+||+|++ +|+.||||++...... ......|+..+..++|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999997 5889999999754321 223345677777899999999999987653 68
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
|+|||||++|+|.+++... +++++.+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999999764 589999999999999999999987 9999999999999999999999999998
Q ss_pred hccccccC--CCcccccccCCcccChHhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCC--------------
Q 019904 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDS-------------- 217 (334)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~e~~~g~~pf~~~-------------- 217 (334)
+....... .......+||+.|+|||++.+... ++.++|||||||++|||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 76443221 112234589999999999976431 246899999999999999997765321
Q ss_pred -cHHHHHHHhhcCc--cCCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 218 -NLMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 218 -~~~~~~~~~~~~~--~~~~~~-----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
........+.... +.+|.. .+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1223333332222 222322 2346889999999999999999999976
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=381.67 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=217.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 579999999999999999999999999999999986543 2334456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||+.+++|.+++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc--ccc
Confidence 999999999999888888999999999999999999999999999999999999999999999999998754321 122
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------------- 230 (334)
.....||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 3445789999999999875555799999999999999999999999887666554432210
Q ss_pred --cCC----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 231 --FTC----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 231 --~~~----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+. .+.++.++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 000 1357889999999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=379.72 Aligned_cols=256 Identities=32% Similarity=0.485 Sum_probs=214.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||+||+|.+ .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 67899999999754322 22245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+ +|.+.+... +.+++..++.++.|++.||+|||++||+||||||+||+++.+|.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999986 898888764 57999999999999999999999999999999999999999999999999998754321 11
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------------- 231 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------------- 231 (334)
......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 233457899999999998766557899999999999999999999998877665554432100
Q ss_pred ------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 232 ------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 232 ------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.....++.++.+||.+||+.||++|||++|+|+||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 112347899999999999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-54 Score=399.33 Aligned_cols=265 Identities=27% Similarity=0.486 Sum_probs=227.9
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.+....++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 34556789999999999999999999999999999999998755444444566889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
.+|+||||++||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999999999998754 799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhc------CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCC-
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP- 234 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~- 234 (334)
.. .......+||+.|+|||++.. ...++.++|+|||||++|||++|+.||.+.+..+.+.++... ...+|
T Consensus 215 ~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 215 DG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 11 111234589999999999973 223468999999999999999999999999888887777542 23333
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCC---CCHhHHhcCccccCC
Q 019904 235 --PWLSFTARKLIARILDPNPMTR---ITIPEILEDEWFKKD 271 (334)
Q Consensus 235 --~~~~~~~~~li~~~L~~dp~~R---pt~~e~l~h~~~~~~ 271 (334)
..+|.++++||.+||. +|.+| |+++|+++||||...
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 5799999999999999 99998 599999999999753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=376.62 Aligned_cols=264 Identities=35% Similarity=0.579 Sum_probs=238.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 45678999999999999999999999999999999998765555556778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||+.+++|.+++...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... .
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--c
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
.......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......+....+.......|..++..+.++|.+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHH
Confidence 22344578999999999987666 58999999999999999999999998888888888888888888999999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
||+.||.+|||++++++||||.....+
T Consensus 249 ~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 249 MLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HcccChhhCcCHHHHhhChheecCCcC
Confidence 999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=383.98 Aligned_cols=260 Identities=37% Similarity=0.680 Sum_probs=218.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh-----------------------HHHHHHHHHHHHH
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVAT 64 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~~e~~~ 64 (334)
..+++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45789999999999999999999999999999999997643221 1224568899999
Q ss_pred HHhCCCCCeeeEEEEEee--CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCE
Q 019904 65 MKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (334)
Q Consensus 65 l~~l~h~~iv~~~~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NI 142 (334)
++.++||||+++++++.. ...+|+||||+++++|.+.+ ...++++..++.++.||+.||+|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 67899999999999998754 345799999999999999999999999999999999999
Q ss_pred EEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCCcHH
Q 019904 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (334)
Q Consensus 143 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~e~~~g~~pf~~~~~~ 220 (334)
+++.++.+||+|||++...... ........||+.|+|||++.+... .+.++|||||||++|+|++|..||.+....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 9999999999999998754321 122344579999999999976543 357889999999999999999999998887
Q ss_pred HHHHHhhcCccCCC--CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 221 NLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 221 ~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.....+.......| +.++.++.+||.+||+.||.+|||+.|+++||||.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 77777666554443 468999999999999999999999999999999963
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=389.55 Aligned_cols=257 Identities=35% Similarity=0.656 Sum_probs=220.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
.++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4689999999999999999999999999999999976543221 12467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEeeccchhc
Q 019904 88 IVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSAL 160 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~a~~ 160 (334)
+|||||++++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998877643 35899999999999999999999999999999999999987654 99999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PW 236 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~ 236 (334)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ......+.......+ ..
T Consensus 183 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 183 LGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred ecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence 4321 112345679999999999987766 589999999999999999999998854 445555555544443 46
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++.++++||.+||+.||.+|||+.++|+||||..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 8999999999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=387.54 Aligned_cols=263 Identities=27% Similarity=0.392 Sum_probs=214.2
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
....+++|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 45678899999999999999999999999999999999976432 23334667799999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe-----cCCCeEEeeccchhc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-----AYGNLKVSDFGLSAL 160 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~-----~~~~~kl~Dfg~a~~ 160 (334)
+|+||||+.+ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+|||++..
T Consensus 108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999999986 9999999988999999999999999999999999999999999999995 444599999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC-------
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC------- 233 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~------- 233 (334)
.... ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 187 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 187 FGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence 4322 1223445789999999999876655799999999999999999999999988777666553221100
Q ss_pred -----------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 234 -----------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 234 -----------------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+..++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 011678999999999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=384.41 Aligned_cols=265 Identities=35% Similarity=0.577 Sum_probs=239.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 35678999999999999999999999999999999998765555566778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 99999999999999988888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......+....+.......|..++..+.+||.+
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 22344578999999999987766 58999999999999999999999998888888888888888888999999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
||+.||.+|||++++++||||.....+.
T Consensus 275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 275 MLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HccCChhHCcCHHHHhcCccccCCCccc
Confidence 9999999999999999999999766543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=373.63 Aligned_cols=261 Identities=36% Similarity=0.681 Sum_probs=230.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
+..++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++......|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 3568999999999999999999999999999999999865433 333577889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~a~~~~~~ 164 (334)
+||||+.+++|.+.+.....+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 99999999999999998889999999999999999999999999999999999999976655 99999999864432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......| ..++++
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred --CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 222344678999999999988766 5899999999999999999999999988888887776655444 368999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 999999999999999999999999999986543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=395.98 Aligned_cols=261 Identities=29% Similarity=0.416 Sum_probs=210.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC--e
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT--K 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~--~ 85 (334)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.+. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4689999999999999999999999999999999986532 23344567889999999998 999999999997554 7
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+|||||.+ +|...+.. ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 9999999985 89888876 479999999999999999999999999999999999999999999999999987532210
Q ss_pred -------------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHh
Q 019904 166 -------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226 (334)
Q Consensus 166 -------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~ 226 (334)
........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1112344579999999999987555579999999999999999999999998887776665
Q ss_pred hcCcc-----------------------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 019904 227 SAAEF-----------------------------------------------TCPPWLSFTARKLIARILDPNPMTRITI 259 (334)
Q Consensus 227 ~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 259 (334)
..... ..+..+++++.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 32110 1122578999999999999999999999
Q ss_pred hHHhcCccccCCC
Q 019904 260 PEILEDEWFKKDY 272 (334)
Q Consensus 260 ~e~l~h~~~~~~~ 272 (334)
+|+|+||||+...
T Consensus 324 ~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 324 NDALKHPFVSIFH 336 (388)
T ss_dssp HHHTTSTTTTTTC
T ss_pred HHHhCCHHHHHhc
Confidence 9999999997643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=385.03 Aligned_cols=260 Identities=29% Similarity=0.460 Sum_probs=206.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++++.||+|+||.||+|.+..+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 35799999999999999999999999999999999975432 2223567799999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 89 VLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 999888754 358999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------ 230 (334)
.. ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 21 1223445789999999999875555689999999999999999999999988776665543210
Q ss_pred ----------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 231 ----------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 231 ----------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
...+..++.++.+||.+||+.||.+|||++|+|+||||...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 0112357889999999999999999999999999999987554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=416.73 Aligned_cols=260 Identities=30% Similarity=0.549 Sum_probs=237.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
..+++|++++.||+|+||.||+|++..+++.||||++.+.........+.+..|..++..+ +||+|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3578899999999999999999999999999999999876555555567788999999987 699999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999874222 2
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|||++|..||.+.+..+++..+......+|..++.++++||.
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 223456789999999999988777 5899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCH-----hHHhcCccccC
Q 019904 247 RILDPNPMTRITI-----PEILEDEWFKK 270 (334)
Q Consensus 247 ~~L~~dp~~Rpt~-----~e~l~h~~~~~ 270 (334)
+||++||.+||++ +|+++||||+.
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 9999999999998 99999999985
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=381.52 Aligned_cols=262 Identities=33% Similarity=0.578 Sum_probs=230.5
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
.....++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34556789999999999999999999999999999999976432211 124678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC----CeEEeeccch
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLS 158 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~a 158 (334)
....|+||||+++++|.+++.....+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999999999888899999999999999999999999999999999999999888 7999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 234 (334)
..... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 75432 222344578999999999987766 5899999999999999999999999888888887776665544
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
..++..+.+||.+||+.||.+|||++|+++||||...
T Consensus 243 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 5689999999999999999999999999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-53 Score=389.73 Aligned_cols=260 Identities=27% Similarity=0.542 Sum_probs=227.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.....+
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3456889999999999999999999999999999999975432 2235688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--CCCeEEeeccchhcccc
Q 019904 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~a~~~~~ 163 (334)
|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. .+.+||+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999987654 7999999999999999999999999999999999999974 46799999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ ..++.
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 223345679999999999987666 5899999999999999999999999888888777766554333 45899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
++++||.+||+.||.+|||++++|+||||.....
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 9999999999999999999999999999986543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=406.91 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=230.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998766555555677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||||++||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-- 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence 9999999999999998754 499999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCccCCCCCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 241 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ...+...+......+|..+|.++
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 223345689999999999987666 489999999999999999999998753 45566666666777888899999
Q ss_pred HHHHHHhcCCCCCCCC-----CHhHHhcCccccC
Q 019904 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
++||.+||+.||.+|| +++|+++||||+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999 8999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=406.28 Aligned_cols=259 Identities=36% Similarity=0.665 Sum_probs=231.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999976654444446788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE---ecCCCeEEeeccchhcccccc
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||||.+++|.+.+...+++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-- 181 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-- 181 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC--
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc--
Confidence 99999999999999998899999999999999999999999999999999999999 5678999999999875432
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 241 (334)
........||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+....+.++ ..+|+++
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 182 -SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp -CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred -ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 223455679999999999976 34 5899999999999999999999999999888888877665443 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
++||.+||+.||.+|||++|+|+||||+...
T Consensus 259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999999999999999999999998644
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-53 Score=403.24 Aligned_cols=262 Identities=34% Similarity=0.635 Sum_probs=228.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH----------HHHHHHHHHHHHHHhCCCCCeeeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH----------KMAEQIKREVATMKLVKHPNVVRL 76 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~ 76 (334)
+...++|++++.||+|+||+||+|.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3456789999999999999999999999999999999976543221 335678899999999999999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEe
Q 019904 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (334)
Q Consensus 77 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~ 153 (334)
++++.....+|+|||||++|+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999999888999999999999999999999999999999999999998876 69999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~ 233 (334)
|||++..... ........||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+...+...+....+.+
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999875432 223345679999999999874 34 589999999999999999999999999999988888777655
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 234 ~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+ ..+|.++++||.+||+.||.+|||++|+|+||||+....
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 4 568999999999999999999999999999999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=371.52 Aligned_cols=257 Identities=40% Similarity=0.675 Sum_probs=229.1
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+...++|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 34567899999999999999999999999999999999764322 246788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE---ecCCCeEEeeccchhcccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~ 163 (334)
|+||||+++++|.+.+...+.+++..+..++.|++.||+|||++|++||||||+||++ +.++.++|+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 9999999999999999988899999999999999999999999999999999999999 7788999999998865332
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~ 239 (334)
........||+.|+|||++.+. .+.++|||||||++|+|++|..||...+.......+.......|. .+++
T Consensus 162 ---~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (277)
T 3f3z_A 162 ---GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP 236 (277)
T ss_dssp ---TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred ---ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence 2233456799999999998754 468999999999999999999999999888888888777766664 6899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-53 Score=403.07 Aligned_cols=261 Identities=26% Similarity=0.394 Sum_probs=231.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++.+.||+|+||.||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.....+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 35678999999999999999999999999999999999876655545567888999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
|+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC----cHHHHHHHhhcCccCCCCCCC
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLS 238 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~ 238 (334)
.. .......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+. ....+...+......+|..+|
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC--CcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 21 122334589999999999998766 48999999999999999999999875 346677777777788889999
Q ss_pred HHHHHHHHHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 239 FTARKLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
..+++||.+||++||.+||+ ++++++||||+.
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 99999999999999999996 589999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-53 Score=373.81 Aligned_cols=263 Identities=40% Similarity=0.696 Sum_probs=224.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++.+.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 578999999999999999999999999999999999754322 235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||+++++|.+++.....+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999999887789999999999999999999999999999999999999999999999999987543322222
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCc--cCCCCCCCHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAE--FTCPPWLSFTARKLI 245 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~li 245 (334)
......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...... .......... ...+..++..+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3345678999999999988776667899999999999999999999875432 2222222222 222346899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+||+.||.+|||++++++||||+....
T Consensus 243 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 243 HKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHCCCCchhCCCHHHHhcCccccChhh
Confidence 9999999999999999999999987644
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=382.22 Aligned_cols=256 Identities=35% Similarity=0.665 Sum_probs=204.5
Q ss_pred cccceEEe---eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 84 (334)
..++|.+. +.||+|+||.||+|.+..+|+.||||++.... ...+.+|+.+++.+. ||||+++++++.+..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~ 79 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQL 79 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 45678886 78999999999999999999999999997542 356778999999997 999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEeeccchhcc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALS 161 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~Dfg~a~~~ 161 (334)
..|+||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 80 HTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999999998999999999999999999999999999999999999998766 7999999998753
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-------HHHHHHHhhcCccCCC
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAAEFTCP 234 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-------~~~~~~~~~~~~~~~~ 234 (334)
... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ..+....+....+.++
T Consensus 160 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 160 PPD--NQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp CC------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred CCC--CCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 321 222345678999999999988776 489999999999999999999998643 3566667766666554
Q ss_pred C----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 235 P----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 235 ~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
. .+|+++++||.+||+.||.+|||++++++||||+....
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 3 58999999999999999999999999999999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=402.04 Aligned_cols=261 Identities=35% Similarity=0.639 Sum_probs=228.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+...++|++++.||+|+||+||+|.+..+++.||||++....... .....+.+|+.+++.++||||+++++++.....+
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 345688999999999999999999999999999999997654322 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe---cCCCeEEeeccchhcccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~a~~~~~ 163 (334)
|+|||||.+++|.+.+...+++++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888999999999999999999999999999999999999995 456799999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (334)
.......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+.......+....+.++ ..+|+
T Consensus 177 ---~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 177 ---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp ---C----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred ---CCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 2223456799999999999763 4 5899999999999999999999999998888888877655433 35899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
++++||.+||+.||.+|||+.++|+||||+....
T Consensus 252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999999999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-53 Score=400.12 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=211.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+|+.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3688999999999999999999999999999999997643 3344467888999999999999999999999654
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..+|+||||+.+ +|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 467999999987 5666664 359999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC---------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 233 (334)
. .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 2234556899999999999987764 89999999999999999999999988777766653321100
Q ss_pred ----------------------CCC-----------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 234 ----------------------PPW-----------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 234 ----------------------~~~-----------~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|.. .+.++++||.+||..||.+|||++|+|+||||....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 000 146799999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=383.98 Aligned_cols=257 Identities=36% Similarity=0.661 Sum_probs=209.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++......|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34577999999999999999999999999999999997542 2356789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~Dfg~a~~~~~~ 164 (334)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999988888999999999999999999999999999999999999975 78999999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCccCC----CCCCCH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTC----PPWLSF 239 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~-~~~~~~~~~~~~----~~~~~~ 239 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ....+....... .+.++.
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 122345678999999999987766 589999999999999999999997655443 555555544432 245899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
++++||.+||+.||.+|||+.++|+||||.....
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 9999999999999999999999999999986544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=370.67 Aligned_cols=257 Identities=32% Similarity=0.588 Sum_probs=218.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++......
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 4456889999999999999999999999999999999976542 22256788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE---ecCCCeEEeeccchh
Q 019904 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSA 159 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~a~ 159 (334)
|+||||+++++|.+.+.. ...+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999998854 3679999999999999999999999999999999999999 456789999999987
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC---CC
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---PW 236 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~ 236 (334)
..... .......||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+ ..
T Consensus 176 ~~~~~---~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T 3is5_A 176 LFKSD---EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250 (285)
T ss_dssp C-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred ecCCc---ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence 54321 22345578999999999864 34 5899999999999999999999999888777766655443332 34
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 7899999999999999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=392.90 Aligned_cols=263 Identities=27% Similarity=0.388 Sum_probs=212.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4578999999999999999999999999999999997532 3344467889999999999999999999999776
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
...|+||||+.+ +|.+.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 579999999875 9999999888899999999999999999999999999999999999999999999999999876433
Q ss_pred ccCC--------------------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-----------CC
Q 019904 164 VRDD--------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-----------YL 212 (334)
Q Consensus 164 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-----------~~ 212 (334)
.... ......+||+.|+|||++.....++.++|||||||++|+|++| ..
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 1235668999999999986555557999999999999999984 44
Q ss_pred CCCCCc-----------------HHHHHHHhh------------------------cCccCC-------CCCCCHHHHHH
Q 019904 213 PFDDSN-----------------LMNLYKKIS------------------------AAEFTC-------PPWLSFTARKL 244 (334)
Q Consensus 213 pf~~~~-----------------~~~~~~~~~------------------------~~~~~~-------~~~~~~~~~~l 244 (334)
+|.+.+ ..+.+..+. ...... .+.+++++.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 444432 111111111 101111 14589999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 245 IARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
|.+||+.||.+|||++|+|+||||.....
T Consensus 342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 342 LESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999987543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=383.10 Aligned_cols=259 Identities=26% Similarity=0.409 Sum_probs=212.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||+||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999999999999999999754321 1122345799999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 999985 8888887754 5999999999999999999999999999999999999999999999999998743321 22
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------------
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------------- 231 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------------- 231 (334)
......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 234457899999999998755557899999999999999999999999887776665533111
Q ss_pred -------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 -------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 -------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
..++.++.++.+||.+||+.||.+|||++|+|+||||.....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 012347889999999999999999999999999999986543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=376.80 Aligned_cols=259 Identities=29% Similarity=0.425 Sum_probs=211.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHHHhC---CCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLV---KHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||+|+||+||+|.+..+|+.||+|++....... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4589999999999999999999999999999999987433111 11123455666666665 499999999999876
Q ss_pred C-----eEEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 84 T-----KIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 84 ~-----~~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
. ..++||||+.+ +|.+++..... +++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 58999999985 99999987654 9999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---- 232 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~---- 232 (334)
++..... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......
T Consensus 166 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 166 LARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875432 223345688999999999988776 58999999999999999999999998877776665331100
Q ss_pred -----------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 233 -----------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 233 -----------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..+.++..+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 1135788999999999999999999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=384.87 Aligned_cols=254 Identities=34% Similarity=0.625 Sum_probs=219.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+... ...+|+.++..+ +||||+++++++.+....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 346789999999999999999999999999999999976532 234677777777 799999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC----CCeEEeeccchhccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQ 162 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~----~~~kl~Dfg~a~~~~ 162 (334)
|+|||||.||+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||+... +.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999998899999999999999999999999999999999999998543 349999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC---CcHHHHHHHhhcCccCCC----C
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTCP----P 235 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~---~~~~~~~~~~~~~~~~~~----~ 235 (334)
.. .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+..++...+....+.++ +
T Consensus 172 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 172 AE--NGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp CT--TCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CC--CCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 21 223345688999999999987666 4889999999999999999999985 456677777776665544 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+|.++++||.+||+.||.+|||++++++||||...
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 689999999999999999999999999999999754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=398.48 Aligned_cols=261 Identities=28% Similarity=0.354 Sum_probs=200.8
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-----CC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 84 (334)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ......+++.+|+.+|+.++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999996532 333446788899999999999999999999843 35
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 7999999985 599999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred cCC-------------------------CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh----------
Q 019904 165 RDD-------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA---------- 209 (334)
Q Consensus 165 ~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~---------- 209 (334)
... ......+||+.|+|||++.....++.++|||||||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 110 123455789999999998655555699999999999999998
Q ss_pred -CCCCCCCCcH--------------------HHHHHHhhcC-------------------------------ccCCCCCC
Q 019904 210 -GYLPFDDSNL--------------------MNLYKKISAA-------------------------------EFTCPPWL 237 (334)
Q Consensus 210 -g~~pf~~~~~--------------------~~~~~~~~~~-------------------------------~~~~~~~~ 237 (334)
|..+|.+.+. .+.+..+... .....+.+
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 7777776541 1111111100 00112346
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+.++.+||.+||..||.+|||++|+|+||||....
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 89999999999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=384.89 Aligned_cols=266 Identities=30% Similarity=0.415 Sum_probs=221.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-----
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 82 (334)
..+++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence 4689999999999999999999999999999999998654322 2223567789999999999999999999877
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 83 ---KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 83 ---~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
.+.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 4568999999986 777776654 57999999999999999999999999999999999999999999999999998
Q ss_pred hcccccc--CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCC
Q 019904 159 ALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236 (334)
Q Consensus 159 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 236 (334)
....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......++.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7543221 12223455789999999999876655799999999999999999999999988777766654432222211
Q ss_pred --------------------------------CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 237 --------------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 237 --------------------------------~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
.++.+.+||.+||+.||.+|||++|+|+||||.....+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 322 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCC
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcc
Confidence 267799999999999999999999999999998765443
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=400.68 Aligned_cols=256 Identities=36% Similarity=0.647 Sum_probs=221.8
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++++.||+|+||+||+|.+..++..||+|++........ ....+.+|+.+++.++||||+++++++.....+|+
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34579999999999999999999999999999999986543222 24678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEeeccchhcccccc
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~~~ 165 (334)
|||||.+|+|.+.+....++++..++.++.||+.||+|||++||+||||||+|||++.. +.+||+|||++.....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-- 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-- 191 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT--
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC--
Confidence 99999999999999988899999999999999999999999999999999999999764 4599999999875432
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 241 (334)
.......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+..++...+....+.++ ..+|..+
T Consensus 192 -~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 192 -QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp -TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred -CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 223345679999999999864 34 5899999999999999999999999999998888877765543 3589999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++||.+||+.||.+|||++++|+||||+.
T Consensus 269 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred HHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 99999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=386.26 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=223.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH-----HHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----KMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
...++|++.+.||+|+||.||+|.+..+++.||||++........ ...+.+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 345789999999999999999999999999999999986542211 123456789999999999999999999999
Q ss_pred CCeEEEEEeccCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
.+.+++||||+.+| +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999999776 99999999889999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHH
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (334)
.. ........||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|..++.++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHH
Confidence 32 2233456799999999999988776788999999999999999999997632 22334455667799999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.+||.+||+.||.+|||++++++||||....
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=385.94 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=214.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
..++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3578999999999999999999999999999999986532 33444677889999999999999999999997763
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
.+|+||||+ +++|.+++.. .++++..+..++.||+.||+|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 469999999 7799988876 579999999999999999999999999999999999999999999999999987533
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------- 231 (334)
. ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 234467899999999998755556999999999999999999999999887766655432111
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 --------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 --------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
...+.+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 123457899999999999999999999999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=380.86 Aligned_cols=258 Identities=34% Similarity=0.602 Sum_probs=225.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhh-----hhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK-----VLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 468999999999999999999999899999999997543 12233456788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
...|+||||+.|++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.+|.++|+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999998865432
Q ss_pred ccCCCcccccccCCcccChHhhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 234 (334)
........||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+.........+.......+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2223456799999999998743 2345889999999999999999999999888777777766555443
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..++..+.+||.+||+.||.+|||++++|+||||++
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 468899999999999999999999999999999963
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=374.25 Aligned_cols=265 Identities=32% Similarity=0.617 Sum_probs=227.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh-HHHHHHHHHHHHHHHhCCCCCeeeEEEEE--eeCC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVM--GSKT 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~ 84 (334)
+..++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|+.+++.++||||+++++++ ....
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35689999999999999999999999999999999998654332 23457789999999999999999999998 4456
Q ss_pred eEEEEEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+.++ |.+.+.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999986 7777765 3569999999999999999999999999999999999999999999999999987544
Q ss_pred cccCCCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHH
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (334)
............||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.+.+.......+.......+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 332333334567899999999998643 2356899999999999999999999999988888888888888888999999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+||.+||+.||.+|||++++++||||.....
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999987554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=375.20 Aligned_cols=262 Identities=31% Similarity=0.557 Sum_probs=215.8
Q ss_pred cccccceEEe-eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 019904 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (334)
Q Consensus 7 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 84 (334)
++..++|++. +.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 4556789995 789999999999999999999999999975432 2246788999999885 7999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEeeccchhcc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~a~~~ 161 (334)
.+|+||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999998889999999999999999999999999999999999999988776 999999998643
Q ss_pred ccccC-----CCcccccccCCcccChHhhhcC----CCCCCccchhhHHHHHHHHHhCCCCCCCCc--------------
Q 019904 162 QQVRD-----DGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSN-------------- 218 (334)
Q Consensus 162 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~e~~~g~~pf~~~~-------------- 218 (334)
..... ........||+.|+|||++.+. ...+.++|||||||++|+|++|..||.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32111 1122345699999999999751 223588999999999999999999998653
Q ss_pred -HHHHHHHhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 219 -LMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 219 -~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...+...+......+| ..++..+++||.+||+.||.+|||++|+|+||||+..
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2345555555555555 3589999999999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=379.64 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=219.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
-..+++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 457899999999999999999999999999999999986543 2333456678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||||+.+++|.+++.....+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999999888887788999999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------------
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---------------- 230 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---------------- 230 (334)
........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 1223445789999999999876555789999999999999999999999887666554432110
Q ss_pred ---cCC------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 231 ---FTC------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 231 ---~~~------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
... .+.++..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 001 1357899999999999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=381.03 Aligned_cols=266 Identities=34% Similarity=0.549 Sum_probs=221.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
....++|++.+.||+|+||.||+|.+..+++.||+|++...... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34457899999999999999999999999999999999865432 2344678899999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHH
Q 019904 85 KIFIVLEFVTGGELFDKIVN----------------------------------------HGRMKEDEARRYFQQLINAV 124 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qil~~l 124 (334)
..|+|||||++|+|.+++.. ...+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998852 11236778899999999999
Q ss_pred HHHHhCCcEEeecCCCCEEEecCC--CeEEeeccchhccccccCCC--cccccccCCcccChHhhhcC-CCCCCccchhh
Q 019904 125 DYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDR-GYDGSTADLWS 199 (334)
Q Consensus 125 ~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~Diws 199 (334)
+|||++||+||||||+||+++.++ .+||+|||++.......... ......||+.|+|||++.+. ...+.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 89999999987543322211 23456799999999999752 34468999999
Q ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 200 lG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|||++|+|++|..||.+.+.......+......++. .+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999998888777776655543332 3799999999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-52 Score=378.40 Aligned_cols=257 Identities=26% Similarity=0.390 Sum_probs=222.3
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.+|++.+.||+|+||+||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++......|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 56999999999999999999999999999999997654444555678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+.| +|.+.+.. ..++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 99985 78777754 56799999999999999999999999999999999999999999999999999875332
Q ss_pred ccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--CCCCCCCHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLI 245 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li 245 (334)
.....||+.|+|||++.+ ....+.++|||||||++|+|++|..||.+.+.......+..... ..+..++..+++||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 234579999999999963 23345899999999999999999999998877666655544432 23456899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.+||+.||.+|||++++++||||.....+
T Consensus 287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp HHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred HHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999875543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=371.23 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=221.0
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
.|...+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48888999999999999999998999999999975432 224668899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
|+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--ccccc
Confidence 9999999998765 46999999999999999999999999999999999999999999999999998754321 12234
Q ss_pred ccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHHHHHHHHHh
Q 019904 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARI 248 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~ 248 (334)
...||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..... ..+..++..+++||.+|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 5679999999999987666 4899999999999999999999998887777666654432 22345889999999999
Q ss_pred cCCCCCCCCCHhHHhcCccccCCC
Q 019904 249 LDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 249 L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|+.||.+|||++++++||||....
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=379.97 Aligned_cols=266 Identities=28% Similarity=0.403 Sum_probs=214.6
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
.++...++|++.+.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 35678899999999999999999999999999999999997543221 1223467799999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
.+..|+||||+.+ +|.+.+.... .+++..+..++.|++.||+|||++||+||||||+||+++.+|.+||+|||++...
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999987 8888887653 6899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC---------
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--------- 232 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~--------- 232 (334)
... ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 163 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 322 222345678999999999987655568999999999999999999999998877766655331100
Q ss_pred -------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 233 -------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 233 -------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
....++.++++||.+||+.||.+|||++|+|+||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~ 300 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence 01346789999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=366.89 Aligned_cols=258 Identities=36% Similarity=0.637 Sum_probs=224.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.++|++.+.||+|+||.||+|.+..+|+.||+|++........ ...+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3689999999999999999999999999999999976433221 1256788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC----CeEEeeccchhccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~a~~~~ 162 (334)
|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998888899999999999999999999999999999999999998877 79999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCC
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 238 (334)
.. .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ +.++
T Consensus 164 ~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 164 AG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp -----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred CC---CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCC
Confidence 21 22234568999999999987666 5899999999999999999999999888887777766555443 5689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=366.28 Aligned_cols=264 Identities=31% Similarity=0.521 Sum_probs=227.4
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhh------hhhHHHHHHHHHHHHHHHhCC-CCCeeeEEE
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK------VLKHKMAEQIKREVATMKLVK-HPNVVRLYE 78 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~ 78 (334)
.....++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+.+|+.+++.+. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 3456799999999999999999999999999999999997543 112334567889999999996 999999999
Q ss_pred EEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 79 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
++......|+||||+++++|.+++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence 99999999999999999999999998888999999999999999999999999999999999999999999999999988
Q ss_pred hccccccCCCcccccccCCcccChHhhhc-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~ 233 (334)
..... ........|++.|+|||++.+ ....+.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred hhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 65332 222344578999999999862 2334588999999999999999999999988877777766655443
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 234 P----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 234 ~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+ ..++..+.+||.+||+.||.+|||++++++||||....
T Consensus 249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 3 34789999999999999999999999999999998643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=379.01 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=214.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-----CCCeeeEEEEEee
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLYEVMGS 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~ 82 (334)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.+. ||||+++++++..
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence 34578999999999999999999999999999999997432 22456678999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--------------
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------------- 146 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-------------- 146 (334)
.+..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 99999999999 889999998764 5999999999999999999999999999999999999964
Q ss_pred -----------CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 019904 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (334)
Q Consensus 147 -----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~ 215 (334)
++.+||+|||++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCC
Confidence 78899999999875332 2234578999999999998776 489999999999999999999999
Q ss_pred CCcHHHHHHHhhcCccCCCC----------------------------------------------CCCHHHHHHHHHhc
Q 019904 216 DSNLMNLYKKISAAEFTCPP----------------------------------------------WLSFTARKLIARIL 249 (334)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~li~~~L 249 (334)
+.+..+....+.....+.|. ..++.+.+||.+||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 88777666555432222221 12367889999999
Q ss_pred CCCCCCCCCHhHHhcCcccc
Q 019904 250 DPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+.||.+|||++|+|+||||+
T Consensus 341 ~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 341 QIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CSSGGGSCCHHHHTTSGGGC
T ss_pred cCChhhCCCHHHHhcCcccC
Confidence 99999999999999999995
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=378.43 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=221.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC--
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-- 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 84 (334)
....++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 456789999999999999999999999999999999998765556666778999999999999999999999987654
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+++++|.+++...+++++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 349999999999999999988899999999999999999999999999999999999999999999999999987543
Q ss_pred cccC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC----CCCC
Q 019904 163 QVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWL 237 (334)
Q Consensus 163 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~ 237 (334)
.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+............... +..+
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp --------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred ccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 3211 122234568999999999988766 489999999999999999999999988777665554443322 3458
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+.++.+||.+||+.||.+||++.++|.|+|+..
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=382.36 Aligned_cols=253 Identities=32% Similarity=0.552 Sum_probs=215.3
Q ss_pred cceEE--eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 11 GKYEV--GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 11 ~~y~~--~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+.|.+ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 6789999999999999999999999999976432 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE--ecCCCeEEeeccchhcccccc
Q 019904 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~--~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
||||+++++|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999999988764 469999999999999999999999999999999999999 45678999999998754322
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 241 (334)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++ +.+++++
T Consensus 243 --~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 319 (373)
T 2x4f_A 243 --EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319 (373)
T ss_dssp --CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred --cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence 22334579999999999986655 5899999999999999999999999988888877766654443 4689999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++||.+||+.||.+|||++|+|+||||..
T Consensus 320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 320 KEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 99999999999999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=372.66 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=204.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++.+.||+|+||+||+|.+..+|+.||||++.............+.++..+.+..+||||+++++++...+..|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999986543333333344444444445558999999999999999999999
Q ss_pred eccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+ +++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---AGA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---CCC
Confidence 999 55888887764 4699999999999999999999999999999999999999999999999999765432 222
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cCCCCCCCHHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~ 247 (334)
.....||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+..... .+.... ...+..++.++.+||.+
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~ 287 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQGYLPPEFTAGLSSELRSVLVM 287 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhccCCCcccccCCCHHHHHHHHH
Confidence 344568999999999876 44 589999999999999999977665543322 222221 12345689999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
||+.||.+|||++|+|+||||++
T Consensus 288 ~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 288 MLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HcCCChhhCcCHHHHHhCccccC
Confidence 99999999999999999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=375.48 Aligned_cols=264 Identities=25% Similarity=0.433 Sum_probs=216.3
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEeeC
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSK 83 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~ 83 (334)
+...-++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+|+.++| |||+++++++...
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 4456678999999999999999999984 588999999976543 33445778999999999986 9999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..+|+||| +.+++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999999 56779999999999999999999999999999999999999999999999997 58899999999876543
Q ss_pred ccCCCcccccccCCcccChHhhhc----------CCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhc--Cc
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLND----------RGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA--AE 230 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~--~~ 230 (334)
...........||+.|+|||++.+ ....+.++|||||||++|+|++|+.||.... .......+.. ..
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 239 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence 322223345679999999999975 1334588999999999999999999998643 2233333332 33
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 231 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
...|...+.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 4567778899999999999999999999999999999986543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=366.93 Aligned_cols=259 Identities=22% Similarity=0.390 Sum_probs=218.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.+|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 34789999999999999999999999999999999976555556667889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||++|++|.+++...+++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 167 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LT 167 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-cc
Confidence 99999999999999998899999999999999999999999999999999999999999999999999987543221 11
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----CCCCCCCHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTARK 243 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 243 (334)
......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+......+...... ..++.++..+.+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN 246 (294)
T ss_dssp -------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred ccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence 2234578999999999988776 5889999999999999999999998887665544443322 234668999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+|.+||++||.+||+..+.+.+.|..
T Consensus 247 li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 247 VILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999999665555555543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=369.94 Aligned_cols=257 Identities=36% Similarity=0.673 Sum_probs=225.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.....+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 3457899999999999999999999999999999999754322 2356789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE---ecCCCeEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+||||+++++|.+.+...+.+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 999999999999999888899999999999999999999999999999999999999 7788999999998864322
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC----CCCCCHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFT 240 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~ 240 (334)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+ +..++.+
T Consensus 162 ---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (304)
T 2jam_A 162 ---GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237 (304)
T ss_dssp ---BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred ---CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence 22344578999999999987666 489999999999999999999999988888877776665433 3568999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+.+||.+||+.||.+|||++++++||||....
T Consensus 238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=387.83 Aligned_cols=256 Identities=35% Similarity=0.617 Sum_probs=208.4
Q ss_pred cccccceEEe-eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEee--
Q 019904 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS-- 82 (334)
Q Consensus 7 ~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~-- 82 (334)
...+++|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3467889887 7899999999999999999999999998642 2455777776 55689999999999876
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEeec
Q 019904 83 --KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDF 155 (334)
Q Consensus 83 --~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~Df 155 (334)
...+|+|||||.||+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 667999999999999999998754 5999999999999999999999999999999999999987 788999999
Q ss_pred cchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCcc
Q 019904 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEF 231 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~----~~~~~~~~~~ 231 (334)
|++..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..... ....+....+
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99874332 222345688999999999987666 489999999999999999999997654221 3334444444
Q ss_pred CCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 232 TCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 232 ~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.++ ..++.++++||.+||+.||.+|||++|+++||||......
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 331 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCC
Confidence 333 4589999999999999999999999999999999865443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=377.66 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=219.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++++.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 3469999999999999999999999999999999997432 333457788999999999999999999999765
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
...|+||||+.+ +|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 468999999985 89988866 4699999999999999999999999999999999999999999999999999875543
Q ss_pred ccC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Q 019904 164 VRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (334)
Q Consensus 164 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------- 231 (334)
... ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 222 22234558999999999987666556899999999999999999999998776555544421100
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 --------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 --------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
...+.++.++.+||.+||+.||.+|||++|+|+||||.....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 012457899999999999999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=381.67 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=211.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS---- 82 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 82 (334)
....++|++++.||+|+||.||+|.+..+|+.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 4456899999999999999999999999999999999865432 22379999999999999999999844
Q ss_pred ----------------------------------CCeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 019904 83 ----------------------------------KTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAV 124 (334)
Q Consensus 83 ----------------------------------~~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l 124 (334)
....++||||+++ +|.+.+. ....+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3448999999986 7666554 456899999999999999999
Q ss_pred HHHHhCCcEEeecCCCCEEEe-cCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHH
Q 019904 125 DYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 203 (334)
Q Consensus 125 ~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 203 (334)
+|||++||+||||||+||+++ .++.+||+|||++..... ........||+.|+|||++.+....+.++|||||||+
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 999999999999999999998 678999999999875432 2233456789999999999876655799999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHhhcCc-----------------c------------CCCCCCCHHHHHHHHHhcCCCCC
Q 019904 204 LFVLLAGYLPFDDSNLMNLYKKISAAE-----------------F------------TCPPWLSFTARKLIARILDPNPM 254 (334)
Q Consensus 204 l~e~~~g~~pf~~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~L~~dp~ 254 (334)
+|+|++|+.||.+.+..+....+.... . .+|..++.++.+||.+||+.||.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999988777665553210 0 13456889999999999999999
Q ss_pred CCCCHhHHhcCccccC
Q 019904 255 TRITIPEILEDEWFKK 270 (334)
Q Consensus 255 ~Rpt~~e~l~h~~~~~ 270 (334)
+|||+.|+|+||||..
T Consensus 312 ~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDH 327 (383)
T ss_dssp GSCCHHHHHTSGGGHH
T ss_pred hCCCHHHHhcCHHHHH
Confidence 9999999999999974
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=381.53 Aligned_cols=257 Identities=26% Similarity=0.386 Sum_probs=202.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 3479999999999999999999999999999999996532 2334457788999999999999999999999654
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..+|+|||++ +++|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 5799888865 579999999999999999999999999999999999999999999999999987533
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----------- 231 (334)
. ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 133467899999999998755556899999999999999999999999887766655432110
Q ss_pred ------------C--------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 ------------T--------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 ------------~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
. ..+..++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 0 01246889999999999999999999999999999986543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=380.83 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=216.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEeeCCeE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~ 86 (334)
...+|++.+.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+|+.+. ||||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 89999999976543 3344678899999999997 59999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|+||| +.+++|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 56779999999988999999999999999999999999999999999999995 58999999999875543222
Q ss_pred CCcccccccCCcccChHhhhcC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcC--ccCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA--EFTC 233 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~--~~~~ 233 (334)
.......+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.... .......+... ....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 2223456799999999999752 234588999999999999999999998643 33344444333 3456
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 234 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
|...+.++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 7778999999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=361.80 Aligned_cols=257 Identities=24% Similarity=0.455 Sum_probs=218.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS---- 82 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 82 (334)
......|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCC
Confidence 33455699999999999999999999999999999999865433 3346788999999999999999999999865
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEe-cCCCeEEeeccchh
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSA 159 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~a~ 159 (334)
...+|+||||+++++|.+++...+.+++..++.++.||+.||+|||++| ++||||||+||+++ .++.++|+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 4668999999999999999998888999999999999999999999999 99999999999997 78999999999986
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCc--cCCCCC
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAE--FTCPPW 236 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~~--~~~~~~ 236 (334)
.... .......||+.|+|||++.+ . .+.++|||||||++|+|++|..||.... .......+.... ...+..
T Consensus 181 ~~~~----~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (290)
T 1t4h_A 181 LKRA----SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCCT----TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred cccc----cccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCC
Confidence 4322 23345678999999998874 3 4589999999999999999999998744 444444443332 234556
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.++++.+||.+||+.||.+|||++++++||||+.
T Consensus 255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 7899999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=363.00 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=214.7
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (334)
+..++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++...+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 456889999999999999999999999999999999976433322 346677899999998 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---------------
Q 019904 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--------------- 147 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~--------------- 147 (334)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999775 679999999999999999999999999999999999999844
Q ss_pred ----CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHH
Q 019904 148 ----GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (334)
Q Consensus 148 ----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~ 223 (334)
..++|+|||.+..... .....||+.|+|||++.+....+.++|||||||++|+|++|..|+.........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 4799999998875432 123458999999999987655557899999999999999999887655433222
Q ss_pred HHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 224 KKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
. .......|..++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 241 ~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 R--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp H--TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred H--cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 2 222345667899999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=367.48 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=216.5
Q ss_pred CcccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 2 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
+.+.+....++|++.+.||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3455666788999999999999999999987 578899999976543 3334577889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCCeEEeecc
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
.....|+||||+.+++|.+++...+. +++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 99999999999999999999987653 999999999999999999999999 9999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhh--cCccCCC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCP 234 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~--~~~~~~~ 234 (334)
++...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+. ......|
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 185 LSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred CCcccccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 98753321 122345679999999999988776 589999999999999999999999988777766653 3455677
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc--CccccC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKK 270 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~--h~~~~~ 270 (334)
..+++.+.+||.+||+.||.+|||++++++ .+++..
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 889999999999999999999999999987 455543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=379.63 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=208.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
..++|++++.||+|+||.||+|.+..+++.||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4689999999999999999999999999999999997543 23344577889999999999999999999997665
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999986 7888775 468999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC---------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~--------- 233 (334)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 122345678999999999998766 489999999999999999999999988777666654321110
Q ss_pred ---------------------------CC------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 234 ---------------------------PP------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 234 ---------------------------~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
|. ..+.++++||.+||+.||.+|||++|+|+||||....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 00 0156789999999999999999999999999998644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=363.80 Aligned_cols=262 Identities=33% Similarity=0.541 Sum_probs=225.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe--eCC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKT 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~ 84 (334)
....++|++.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++. ...
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 45789999999999999999999999999999999999765432 334677899999999999999999999874 467
Q ss_pred eEEEEEeccCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEEeecCCCCEEEecCCCeEEeec
Q 019904 85 KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDF 155 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~~l~~LH~~~-----i~H~dlkp~NIl~~~~~~~kl~Df 155 (334)
..|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.| ++||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999998764 34999999999999999999999999 999999999999999999999999
Q ss_pred cchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCC
Q 019904 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCP 234 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~ 234 (334)
|++...... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..... ..|
T Consensus 161 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 161 GLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp CHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred chheeeccc--cccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 998754321 112234578999999999987766 4899999999999999999999999888777777766554 566
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..++.++.++|.+||+.||.+|||++++++|+|+....
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 78999999999999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=377.88 Aligned_cols=261 Identities=31% Similarity=0.554 Sum_probs=222.0
Q ss_pred cccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
.+++|++.+.||+|+||.||+|++. .+|+.||||++...... .....+.+.+|+.+++.+ .||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4579999999999999999999984 57899999998754321 112234566899999999 699999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..+|+||||+.+++|.+++....++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 211 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999875332
Q ss_pred ccCCCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCC----cHHHHHHHhhcCccCCCCCCC
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLS 238 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~~ 238 (334)
.. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... ....+...+.......|..++
T Consensus 212 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (355)
T 1vzo_A 212 DE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 290 (355)
T ss_dssp GG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence 11 1123345799999999999853 33458899999999999999999999743 345556666666777888899
Q ss_pred HHHHHHHHHhcCCCCCCCC-----CHhHHhcCccccC
Q 019904 239 FTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
..+.+||.+||+.||.+|| |++++++||||..
T Consensus 291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 9999999999999999999 9999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=371.08 Aligned_cols=261 Identities=31% Similarity=0.513 Sum_probs=221.9
Q ss_pred ccccceEEe-eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCe
Q 019904 8 RRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (334)
Q Consensus 8 ~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (334)
...++|.+. +.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 445678888 89999999999999999999999999997644322 23467889999999996 6999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEeeccchhc
Q 019904 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSAL 160 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~Dfg~a~~ 160 (334)
.|+||||+.+|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999988553 57999999999999999999999999999999999999987 78999999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC----CCC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPW 236 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~ 236 (334)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....... +..
T Consensus 184 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 184 IGHA---CELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp C------------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred cCCc---cccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 4322 22334579999999999987766 489999999999999999999999988887777665544333 345
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
++..+.+||.+||+.||.+|||++++|+||||+....
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 8999999999999999999999999999999986543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=375.30 Aligned_cols=258 Identities=25% Similarity=0.422 Sum_probs=208.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC---
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 84 (334)
+.+++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 45789999999999999999999999999999999997543 2334577899999999999999999999985543
Q ss_pred ------------------------------------------------------eEEEEEeccCCCchHHHHHhcCC---
Q 019904 85 ------------------------------------------------------KIFIVLEFVTGGELFDKIVNHGR--- 107 (334)
Q Consensus 85 ------------------------------------------------------~~~~v~e~~~~~~L~~~l~~~~~--- 107 (334)
..|+|||||++++|.+++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 38999999999999999987653
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC----------CcccccccCC
Q 019904 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTP 177 (334)
Q Consensus 108 l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~ 177 (334)
.++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++......... .......||+
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 455678999999999999999999999999999999999999999999998754432111 1223457999
Q ss_pred cccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-CCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 178 ~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
.|+|||++.+..+ +.++|||||||++|+|++|..|+.. .......+.....+ .+...++++.+||.+||+.||.+|
T Consensus 241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 9999999988776 5899999999999999998877532 12222222222211 112356788999999999999999
Q ss_pred CCHhHHhcCccccC
Q 019904 257 ITIPEILEDEWFKK 270 (334)
Q Consensus 257 pt~~e~l~h~~~~~ 270 (334)
||++|+|+||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=375.07 Aligned_cols=256 Identities=24% Similarity=0.414 Sum_probs=218.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 4578999999999999999999999999999999997642 33445778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+++++|.+++...+.+++..+..++.|++.||+|||+. ||+||||||+||+++.++.++|+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999999999888999999999999999999999996 9999999999999999999999999998644321
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHh---------------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--------------------- 226 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~--------------------- 226 (334)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1234578999999999988766 48999999999999999999999876654432211
Q ss_pred ---------------------hcCc-cC-CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 227 ---------------------SAAE-FT-CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 227 ---------------------~~~~-~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.... .. .+..++.++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 1111 11 123478899999999999999999999999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=386.30 Aligned_cols=257 Identities=36% Similarity=0.663 Sum_probs=207.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.+|+.++||||+++++++. .+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 57899999999999999999999999999999999865432 1222345789999999999999999999985 45
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEeeccchhcc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALS 161 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~Dfg~a~~~ 161 (334)
.+|+||||+.+|+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 6899999999999999998888999999999999999999999999999999999999997544 5999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCccCCC----
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTCP---- 234 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~~~~~~~~~~~~~---- 234 (334)
.. .......+||+.|+|||++.+ ...++.++|||||||++|+|++|..||..... ......+.......+
T Consensus 293 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred CC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 32 223345679999999999864 23335789999999999999999999976432 233334444443332
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..++..+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 458999999999999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=382.56 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=211.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC------CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV------KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~ 83 (334)
.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ .|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 467999999999999999999999999999999997543 2234566777777776 577999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC--eEEeeccchh
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 159 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~a~ 159 (334)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999997 48999988764 4999999999999999999999999999999999999999887 9999999986
Q ss_pred ccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-------
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------- 232 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~------- 232 (334)
.... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 251 YEHQ-----RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ecCC-----cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 4322 2335678999999999998776 58999999999999999999999998876665544321000
Q ss_pred ----------------------------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHh
Q 019904 233 ----------------------------------------------------CPPWLSFTARKLIARILDPNPMTRITIP 260 (334)
Q Consensus 233 ----------------------------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 260 (334)
++...++.+.+||.+||+.||.+|||++
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~ 404 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG 404 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence 0112378899999999999999999999
Q ss_pred HHhcCccccCCCC
Q 019904 261 EILEDEWFKKDYK 273 (334)
Q Consensus 261 e~l~h~~~~~~~~ 273 (334)
|+|+||||+....
T Consensus 405 e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 405 QALRHPWLRRRLP 417 (429)
T ss_dssp HHHTSTTTC----
T ss_pred HHhCChhhccCCC
Confidence 9999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-51 Score=362.52 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=204.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567899999999999999999999999999999999976432 223344555666678889999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
|+||||+.+ +|.+++.. ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999986 87776653 46799999999999999999999998 9999999999999999999999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhh---cCCCCCCccchhhHHHHHHHHHhCCCCCCCC-cHHH-HHHHhhcCccCC-CC
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMN-LYKKISAAEFTC-PP 235 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-~~~~-~~~~~~~~~~~~-~~ 235 (334)
... .......||+.|+|||++. .....+.++|||||||++|+|++|..||... .... ....+....... +.
T Consensus 161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 322 2223447899999999973 3333458899999999999999999999852 3333 333333333333 34
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.++.++.+||.+||+.||.+|||++|+++||||+.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 68999999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=366.71 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=210.8
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEee--CCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--~~~ 85 (334)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999987433 356889999999998 9999999999987 677
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 164 (334)
.++||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT-
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC-
Confidence 999999999999988874 389999999999999999999999999999999999999777 799999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-cHHHHHHHh-------------hcCc
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKI-------------SAAE 230 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-~~~~~~~~~-------------~~~~ 230 (334)
........||+.|+|||++.+....+.++|||||||++|+|++|..||... +.......+ ....
T Consensus 184 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 222345578999999999987555579999999999999999999999532 222222211 1111
Q ss_pred cC------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 FT------------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 ~~------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.. .+..++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11 1122789999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-53 Score=388.58 Aligned_cols=251 Identities=17% Similarity=0.215 Sum_probs=206.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHH---HHHHhCCCCCeeeEE-------
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV---ATMKLVKHPNVVRLY------- 77 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~iv~~~------- 77 (334)
...++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+ .+++.++||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 3458899999999999999999999989999999999865444444567888999 455556799999988
Q ss_pred EEEeeCCe-----------------EEEEEeccCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCcE
Q 019904 78 EVMGSKTK-----------------IFIVLEFVTGGELFDKIVNHGRMKE-------DEARRYFQQLINAVDYCHSRGVY 133 (334)
Q Consensus 78 ~~~~~~~~-----------------~~~v~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~qil~~l~~LH~~~i~ 133 (334)
+++...+. .|+||||+ +|+|.+++...+.+++ ..+..++.||+.||+|||++||+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 77766643 89999999 5799999987665665 78888999999999999999999
Q ss_pred EeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcC-----------CCCCCccchhhHHH
Q 019904 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----------GYDGSTADLWSCGV 202 (334)
Q Consensus 134 H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~ 202 (334)
||||||+|||++.+|.+||+|||++..... ......| +.|+|||++.+. .+ +.++|||||||
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~ 301 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGL 301 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHH
Confidence 999999999999999999999999874222 2344567 999999999876 45 58999999999
Q ss_pred HHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 203 ILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 203 il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++|+|++|+.||.+.+.......+ ...++.++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 999999999999875544333222 2334678999999999999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=363.18 Aligned_cols=259 Identities=28% Similarity=0.454 Sum_probs=217.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++++.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 4578999999999999999999999999999999987542 2235678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 172 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ- 172 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-
Confidence 9999999999998876 46799999999999999999999999999999999999999999999999998754322111
Q ss_pred CcccccccCCcccChHhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc---CCCCCCCHH
Q 019904 168 GLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFT 240 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~ 240 (334)
......||+.|+|||++. .....+.++|||||||++|+|++|..||...+.......+..... ..+..++..
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 2j7t_A 173 -KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE 251 (302)
T ss_dssp -C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred -ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence 123457899999999985 233345899999999999999999999998887776665544432 235568999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+.+||.+||+.||.+|||++++++||||....
T Consensus 252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred HHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 99999999999999999999999999998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=368.45 Aligned_cols=264 Identities=28% Similarity=0.473 Sum_probs=197.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 456799999999999999999999998999999999875432 223567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 88 IVLEFVTGGELFDKIVN--------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
+||||+++++|.+++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999999874 4569999999999999999999999999999999999999999999999999987
Q ss_pred cccccc---CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-----
Q 019904 160 LSQQVR---DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----- 231 (334)
Q Consensus 160 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~----- 231 (334)
...... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 249 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence 543221 111223457899999999997633346899999999999999999999987665544433322211
Q ss_pred -----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 -----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 -----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
..+..++.++.+||.+||+.||.+|||++++++||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 123457899999999999999999999999999999986543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=368.36 Aligned_cols=258 Identities=36% Similarity=0.660 Sum_probs=211.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 457899999999999999999999999999999999764321 122234678999999999999999999999766
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEeeccchhc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSAL 160 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~a~~ 160 (334)
. +|+||||+.+++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 5 8999999999999999988889999999999999999999999999999999999999987664 99999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCccCC----
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTC---- 233 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~~~~---- 233 (334)
... ........||+.|+|||++.. ....+.++|||||||++|+|++|..||...... .....+.......
T Consensus 167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (322)
T 2ycf_A 167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243 (322)
T ss_dssp CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred ccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence 432 122234578999999999853 333458999999999999999999999764322 2233333333322
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 234 ~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+..++..+.+||.+||+.||.+|||++++|+||||..
T Consensus 244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 2458999999999999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=360.94 Aligned_cols=259 Identities=35% Similarity=0.630 Sum_probs=225.5
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+...++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++......
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34567999999999999999999999999999999999764432 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEeeccchhcccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQ 163 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~Dfg~a~~~~~ 163 (334)
|+||||+.+++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999999888889999999999999999999999999999999999999754 4699999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (334)
. .......||+.|+|||++.+. .+.++||||||+++|+|++|..||.+.+.......+.......+ ..++.
T Consensus 177 ~---~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 177 N---TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp C---SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred C---CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 2 222344688999999998764 45899999999999999999999999888887777766654332 46899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 240 TARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
++.+||.+||+.||.+|||++++++||||...
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999999999999999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=377.37 Aligned_cols=263 Identities=24% Similarity=0.349 Sum_probs=205.8
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
+.....+++|++.+.||+|+||.||+|.+..+|+.||||++...... .....+++..++.++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 34567789999999999999999999999999999999998654322 23455778888889999999999998654
Q ss_pred Ce-------EEEEEeccCCCchHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCcEEeecCCCCEEEec-CCC
Q 019904 84 TK-------IFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLDA-YGN 149 (334)
Q Consensus 84 ~~-------~~~v~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~qil~~l~~LH--~~~i~H~dlkp~NIl~~~-~~~ 149 (334)
.. .++||||+.+ +|...+ .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 33 8899999997 444433 34567999999999999999999999 999999999999999997 899
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~ 229 (334)
+||+|||++..... ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 171 ~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99999999875432 222345578999999999987665579999999999999999999999998877666655321
Q ss_pred cc--------------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 230 EF--------------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 230 ~~--------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.. ..+...+.++.+||.+||+.||.+|||+.|+|+||||.....+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 10 1112256789999999999999999999999999999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=376.69 Aligned_cols=258 Identities=24% Similarity=0.498 Sum_probs=224.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHH--------------HHHHHHHHHHHHHhCCCCCe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--------------MAEQIKREVATMKLVKHPNV 73 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~h~~i 73 (334)
...++|++.+.||+|+||.||+|.+ +|+.||+|++......... ..+.+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999999999 7999999999865433221 12678899999999999999
Q ss_pred eeEEEEEeeCCeEEEEEeccCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEE
Q 019904 74 VRLYEVMGSKTKIFIVLEFVTGGELFDK------IVN--HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLL 144 (334)
Q Consensus 74 v~~~~~~~~~~~~~~v~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~ 144 (334)
+++++++...+..|+||||+++++|.++ +.. ...+++..++.++.|++.||+|||+ +|++||||||+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999988 665 5679999999999999999999999 999999999999999
Q ss_pred ecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHH
Q 019904 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNL 222 (334)
Q Consensus 145 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~ 222 (334)
+.++.++|+|||++...... ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||..... ...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999998754321 23445789999999999876 3432389999999999999999999998766 777
Q ss_pred HHHhhcCccCCC-------------------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 223 YKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 223 ~~~~~~~~~~~~-------------------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...+.......| ..++.++.+||.+||+.||.+|||++|+++||||...
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 777776666665 6689999999999999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=368.14 Aligned_cols=263 Identities=28% Similarity=0.424 Sum_probs=217.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC---
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--- 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 83 (334)
....++|++.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 34568999999999999999999999999999999999643 2333456788999999999999999999987654
Q ss_pred --CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 84 --TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 84 --~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
...|+||||+.+ +|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 85 NFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp TCCCEEEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 679999999985 89888876 56999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCC--------cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---
Q 019904 162 QQVRDDG--------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--- 230 (334)
Q Consensus 162 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--- 230 (334)
....... ......||+.|+|||++......+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 3221110 12234789999999998765555689999999999999999999999887665544332100
Q ss_pred -----------------------c------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 231 -----------------------F------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 231 -----------------------~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
. ..++.++.++.+||.+||+.||.+|||++|+++||||+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 0 012468899999999999999999999999999999986544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=368.33 Aligned_cols=270 Identities=23% Similarity=0.359 Sum_probs=202.7
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
.+....++|++.+.||+|+||.||+|.+..++. .||+|++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 344556789999999999999999999877665 7999999764332 233678899999999999999999999998
Q ss_pred eCCeE------EEEEeccCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 82 SKTKI------FIVLEFVTGGELFDKIVNHG------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 82 ~~~~~------~~v~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
..... ++||||+.+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77665 99999999999999986543 5999999999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~ 228 (334)
+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 99999999875443322222334456788999999988776 489999999999999999 9999998877777666554
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCC-------HhHHhcCccccCCCCCCc
Q 019904 229 A-EFTCPPWLSFTARKLIARILDPNPMTRIT-------IPEILEDEWFKKDYKPPV 276 (334)
Q Consensus 229 ~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt-------~~e~l~h~~~~~~~~~~~ 276 (334)
. ....++.++.++.+||.+||+.||.+||| +++++.|+|+......|.
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 4 35667789999999999999999999999 777889999987665553
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=361.64 Aligned_cols=259 Identities=28% Similarity=0.467 Sum_probs=225.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++......|+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 446799999999999999999999999999999999765322 235778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||+.+++|.+++.. +++++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 9999999999998865 569999999999999999999999999999999999999999999999999986543221 1
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 247 (334)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.... ...+..++..+.+||.+
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 2234578999999999987766 489999999999999999999999887776665554433 34566789999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
||+.||.+|||++++++||||.....
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99999999999999999999986544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=372.51 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=213.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE---
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI--- 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--- 86 (334)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 478999999999999999999999999999999997643 3344467888999999999999999999999877654
Q ss_pred ---EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 87 ---FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 87 ---~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
|+||||+.+ +|.+.+ ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQT-DLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCCE-EHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEccccc-cHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 999999985 887776 34599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------ 231 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------ 231 (334)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 223457899999999998755556899999999999999999999998877666555432110
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 232 -------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..++.+++.+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 11245789999999999999999999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=372.97 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=218.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEEC-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 79 (334)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34689999999999999999999874 345679999997542 334467789999999999 89999999999
Q ss_pred EeeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEE
Q 019904 80 MGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (334)
Q Consensus 80 ~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl 143 (334)
+...+.+|+||||+.+|+|.+++.... .++...+..++.||+.||+|||++||+||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999998753 4788999999999999999999999999999999999
Q ss_pred EecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHH
Q 019904 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNL 222 (334)
Q Consensus 144 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~ 222 (334)
++.+|.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~ 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999999875443222222334467889999999988766 589999999999999999 9999998887777
Q ss_pred HHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 223 YKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 223 ~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...+.... ...|..++.++.+||.+||+.||.+|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 76665543 4567789999999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=362.06 Aligned_cols=257 Identities=28% Similarity=0.477 Sum_probs=216.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.++||||+++++++......|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 445789999999999999999999999999999999975432 356789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+||||+.+++|.+++. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 9999999999999987 45679999999999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARK 243 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 243 (334)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+... ....+..++..+.+
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred -cccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 12334578999999999987766 48899999999999999999999987766555444332 23345568999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
||.+||+.||.+|||++++++||||....
T Consensus 258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 258 FVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99999999999999999999999998643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=367.47 Aligned_cols=255 Identities=23% Similarity=0.406 Sum_probs=209.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC--e
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 85 (334)
..-++|++.+.||+|+||+||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34678999999999999999999999999999999997644322 2466789999999999999999999998765 7
Q ss_pred EEEEEeccCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE----ecCCCeEEeeccch
Q 019904 86 IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~----~~~~~~kl~Dfg~a 158 (334)
.|+||||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999987543 9999999999999999999999999999999999999 67778999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhc-------CCCCCCccchhhHHHHHHHHHhCCCCCCCC----cHHHHHHHhh
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND-------RGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKIS 227 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~e~~~g~~pf~~~----~~~~~~~~~~ 227 (334)
..... ........||+.|+|||++.. ....+.++|||||||++|+|++|..||... .......++.
T Consensus 164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 75432 222345579999999999873 234468999999999999999999999642 2233333333
Q ss_pred cCcc---------------------C----CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 228 AAEF---------------------T----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 228 ~~~~---------------------~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
.... + .+..++..+.+||.+||+.||.+|||++|+|+||-
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2211 1 11224567889999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-51 Score=380.74 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=196.5
Q ss_pred ccccceEE-eeeeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--
Q 019904 8 RRVGKYEV-GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (334)
Q Consensus 8 ~~~~~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 82 (334)
+..+.|.+ ++.||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHA 91 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence 34466887 568999999999999965 5688999999975432 2357789999999999999999999954
Q ss_pred CCeEEEEEeccCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE----ecCCC
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGN 149 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~----~~~~~ 149 (334)
...+|+||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred CCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 7789999999976 888877532 249999999999999999999999999999999999999 67789
Q ss_pred eEEeeccchhcccccc-CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH--------
Q 019904 150 LKVSDFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-------- 220 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-------- 220 (334)
+||+|||++....... ........+||+.|+|||++.+...++.++|||||||++|+|++|..||.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 9999999987543321 1122345678999999999988665678999999999999999999999765431
Q ss_pred -HHHHHhhcCc-cC-------------------------------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhH
Q 019904 221 -NLYKKISAAE-FT-------------------------------------CPPWLSFTARKLIARILDPNPMTRITIPE 261 (334)
Q Consensus 221 -~~~~~~~~~~-~~-------------------------------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 261 (334)
+.+..+.... .+ .....+..+.+||.+||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 2222221110 00 00112778999999999999999999999
Q ss_pred HhcCccccCCCCC
Q 019904 262 ILEDEWFKKDYKP 274 (334)
Q Consensus 262 ~l~h~~~~~~~~~ 274 (334)
+|+||||.....+
T Consensus 331 ~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 331 AMQDPYFLEDPLP 343 (405)
T ss_dssp HHTSGGGTSSSCC
T ss_pred HhcChhhccCCCC
Confidence 9999999875543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=378.24 Aligned_cols=252 Identities=29% Similarity=0.404 Sum_probs=208.1
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 83 (334)
...+|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999865421 234799999999999999999988432
Q ss_pred -CeEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccc
Q 019904 84 -TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGL 157 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~ 157 (334)
..+++||||+.+ ++.+.+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 246799999987 6665554 34679999999999999999999999999999999999999965 5689999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--------
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------- 229 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-------- 229 (334)
++.... ........||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+..+.+.++...
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 875432 222345678999999999987655568999999999999999999999988766655444321
Q ss_pred ---------ccC------------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 230 ---------EFT------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 230 ---------~~~------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.+. +++.++.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 111 234578999999999999999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=376.54 Aligned_cols=252 Identities=31% Similarity=0.420 Sum_probs=207.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
...+|++.+.||+|+||.||+|++..+++ ||+|++..... ...+|+.+++.++||||+++++++....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 45689999999999999999999977665 88888764332 1237999999999999999999985443
Q ss_pred --eEEEEEeccCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe-cCCCeEEeeccc
Q 019904 85 --KIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~ 157 (334)
.+|+||||+.++ +...+. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+
T Consensus 110 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 388999999875 433332 356799999999999999999999999999999999999999 789999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------- 230 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------- 230 (334)
+..... ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 189 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 189 AKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 875432 2223456789999999999876655799999999999999999999999988766655443210
Q ss_pred ----------c------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 ----------F------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 ----------~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
. .+++.+++++.+||.+||+.||.+|||+.|+++||||....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 12345889999999999999999999999999999998643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=374.15 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=220.9
Q ss_pred ccceEEeeeeeccCceEEEEEE-----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.++|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 4789999999999999999999 44567889999986432 2233457889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC---CeEEee
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSD 154 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~---~~kl~D 154 (334)
..|+||||+.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999999998753 489999999999999999999999999999999999998555 499999
Q ss_pred ccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cC
Q 019904 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FT 232 (334)
Q Consensus 155 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~ 232 (334)
||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... ..
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~ 306 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD 306 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999975443333333445678999999999988776 489999999999999998 999999998888887776554 45
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 233 CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 233 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.+..++..+.+||.+||+.||.+|||+++++++.++..
T Consensus 307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 66779999999999999999999999999999877653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=363.09 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=217.4
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEe
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 81 (334)
...+....++|++.+.||+|+||.||+|.+..+|+.||||++...... .+.+.+|+.+++.+ +||||+++++++.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 345667789999999999999999999999999999999999754321 35678899999998 7999999999997
Q ss_pred e------CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 82 S------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 82 ~------~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
. ....|+||||+.+++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 7 56899999999999999999875 479999999999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~ 229 (334)
|||++...... ........||+.|+|||++.. ....+.++|||||||++|+|++|..||.+.........+...
T Consensus 172 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 172 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred eCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 99998754321 112234578999999999963 223458899999999999999999999887776665555443
Q ss_pred cc--CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 230 EF--TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 230 ~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.. ..+..++..+.+||.+||+.||.+|||++++++||||+..
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 32 2245689999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=371.16 Aligned_cols=265 Identities=25% Similarity=0.395 Sum_probs=213.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh--------hhHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--------LKHKMAEQIKREVATMKLVKHPNVVRLY 77 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (334)
+....++|++.+.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+.+++.++||||++++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 45567899999999999999999999865 89999999864321 2334457889999999999999999999
Q ss_pred EEEee-----CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 78 EVMGS-----KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 78 ~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
+++.. ...+|+||||+.+ +|.+.+.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+|
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 174 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT 174 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred eeEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence 99843 3478999999985 8888776543 699999999999999999999999999999999999999999999
Q ss_pred EeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-
Q 019904 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 230 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~- 230 (334)
|+|||++..... ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 175 l~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 251 (362)
T 3pg1_A 175 ICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVG 251 (362)
T ss_dssp ECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999874332 2223445789999999999875555699999999999999999999999987766655543210
Q ss_pred -------------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 231 -------------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 231 -------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
...++..++.+.+||.+||+.||.+|||++|+|+||||+....+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 327 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence 011235688999999999999999999999999999999765543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-50 Score=362.02 Aligned_cols=260 Identities=26% Similarity=0.408 Sum_probs=210.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe-------
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG------- 81 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------- 81 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 3579999999999999999999999999999999987542 334577889999999999999999999873
Q ss_pred -------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe-cCCCeEEe
Q 019904 82 -------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVS 153 (334)
Q Consensus 82 -------~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~ 153 (334)
.....|+||||+.+ +|.+++.. +++++..++.++.|++.||+|||++||+||||||+||+++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 44689999999984 99988864 5699999999999999999999999999999999999997 56789999
Q ss_pred eccchhcccccc-CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-
Q 019904 154 DFGLSALSQQVR-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (334)
Q Consensus 154 Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~- 231 (334)
|||++....... .........+|+.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999987543221 112233456799999999998755556899999999999999999999998877665554432110
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 232 -----------------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 232 -----------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
..++.++.++++||.+||+.||.+|||++++|+||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 112458999999999999999999999999999999986443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=362.28 Aligned_cols=266 Identities=31% Similarity=0.434 Sum_probs=217.3
Q ss_pred CCcccccccccceEEeeeeeccCceEEEEEEEC-CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeE
Q 019904 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRL 76 (334)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~ 76 (334)
|..+.+....++|++.+.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+ .||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 667777888899999999999999999999995 678899999987543221 1122344666666655 89999999
Q ss_pred EEEEe-----eCCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 77 YEVMG-----SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 77 ~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
++++. .....++||||+.+ +|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99987 56779999999985 9999998754 4999999999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~ 229 (334)
++|+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...
T Consensus 159 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCC---CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 999999998754321 12334578999999999987766 58999999999999999999999988877666554321
Q ss_pred c---------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 E---------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 ~---------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
. ...++.++..+++||.+||+.||.+|||+.++++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0 012345889999999999999999999999999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=361.94 Aligned_cols=254 Identities=24% Similarity=0.370 Sum_probs=217.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCe---EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~---vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
...++|++.+.||+|+||.||+|.+..+++. ||||++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3467899999999999999999999866654 9999997532 2334577889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..|+||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999999765 5799999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCC-cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 019904 164 VRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (334)
Q Consensus 164 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (334)
..... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+... ..+.+..++..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 22111 1223345778999999987766 489999999999999999 99999998888877776654 45667789999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 241 ARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||.+||+.||.+|||+.++++
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=361.98 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=221.5
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (334)
.+...-..++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 3455566789999999999999999999873 455889999997542 234457789999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcE
Q 019904 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------------MKEDEARRYFQQLINAVDYCHSRGVY 133 (334)
Q Consensus 78 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~qil~~l~~LH~~~i~ 133 (334)
+++...+..|+||||+++++|.+++..... +++..++.++.||+.||+|||++||+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999987543 88999999999999999999999999
Q ss_pred EeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCC
Q 019904 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 212 (334)
Q Consensus 134 H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~ 212 (334)
||||||+||+++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875433222112233456788999999987666 489999999999999999 999
Q ss_pred CCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 213 PFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 213 pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
||.+.........+... ....+..++.++.++|.+||+.||.+|||+.+++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99988777766665544 345667899999999999999999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=364.02 Aligned_cols=251 Identities=28% Similarity=0.450 Sum_probs=211.2
Q ss_pred ccceEEeeeeeccCceEEEEEEE-CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC------CeeeEEEEEee
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARN-SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP------NVVRLYEVMGS 82 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~iv~~~~~~~~ 82 (334)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 47999999999999999999998 5578999999997532 2346678899999888765 49999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--------------
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------------- 146 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-------------- 146 (334)
.+..|+||||+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999999 779999998765 6899999999999999999999999999999999999987
Q ss_pred -----CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH
Q 019904 147 -----YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (334)
Q Consensus 147 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~ 221 (334)
++.+||+|||++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred cccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999875332 2234578999999999988776 489999999999999999999999877666
Q ss_pred HHHHhhcCccCC--------------------------------------------CCCCCHHHHHHHHHhcCCCCCCCC
Q 019904 222 LYKKISAAEFTC--------------------------------------------PPWLSFTARKLIARILDPNPMTRI 257 (334)
Q Consensus 222 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~li~~~L~~dp~~Rp 257 (334)
....+.....+. +...+.++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 544432221111 112346789999999999999999
Q ss_pred CHhHHhcCccccCC
Q 019904 258 TIPEILEDEWFKKD 271 (334)
Q Consensus 258 t~~e~l~h~~~~~~ 271 (334)
|++|+++||||+..
T Consensus 322 t~~ell~hp~f~~~ 335 (339)
T 1z57_A 322 TLREALKHPFFDLL 335 (339)
T ss_dssp CHHHHTTSGGGGGG
T ss_pred CHHHHhcCHHHHHH
Confidence 99999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=365.91 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=213.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe----
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---- 85 (334)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997643 334446778899999999999999999999987654
Q ss_pred --EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 86 --IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 86 --~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
+|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEeccccC-CHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 5999999985 8877763 3599999999999999999999999999999999999999999999999999875332
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--------------
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------- 229 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~-------------- 229 (334)
......||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 1234578999999999987555568999999999999999999999988766655443221
Q ss_pred -----------------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 -----------------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 -----------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
....++.++.++.+||.+||+.||.+|||++++|+||||....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0112346789999999999999999999999999999998643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=375.94 Aligned_cols=256 Identities=18% Similarity=0.200 Sum_probs=195.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC--CCCCeeeEE-------E
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLY-------E 78 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~-------~ 78 (334)
....+|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+ +||||++++ +
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138 (371)
T ss_dssp CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence 3445699999999999999999999999999999999876554555567788885544444 699988755 5
Q ss_pred EEeeC-----------------CeEEEEEeccCCCchHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCcEE
Q 019904 79 VMGSK-----------------TKIFIVLEFVTGGELFDKIVNHG-RMKEDEA------RRYFQQLINAVDYCHSRGVYH 134 (334)
Q Consensus 79 ~~~~~-----------------~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~------~~i~~qil~~l~~LH~~~i~H 134 (334)
++... ..+|+||||+. |+|.+++...+ .++.... ..++.||+.||+|||++||+|
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH 217 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH 217 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence 55433 34899999999 79999998743 3444445 577799999999999999999
Q ss_pred eecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCC
Q 019904 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYL 212 (334)
Q Consensus 135 ~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~ 212 (334)
|||||+|||++.+|.+||+|||++..... ......+|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999875432 1224567799999999976 445 589999999999999999999
Q ss_pred CCCCCcHHHH--HHH-----hhcCc--cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 213 PFDDSNLMNL--YKK-----ISAAE--FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 213 pf~~~~~~~~--~~~-----~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
||.+...... +.. ..... .+.++.++..+.+||.+||+.||.+|||++++|+||||..
T Consensus 292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 9987632210 000 01111 2233578999999999999999999999999999999974
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=360.73 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=213.5
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
.|...-..++|++.+.||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 2 ~p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp CCCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CcceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 344445678999999999999999999999999999999988542 23446778999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
.+..++||||+.+++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999999999987 467999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCC------------cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH---Hh
Q 019904 162 QQVRDDG------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KI 226 (334)
Q Consensus 162 ~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~---~~ 226 (334)
....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 237 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence 3221110 1124579999999999988766 489999999999999999999986532110000 00
Q ss_pred hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 227 SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 227 ~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.......|+.+++.+.++|.+||+.||.+|||++++++
T Consensus 238 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 238 GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00112346778999999999999999999999999976
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-50 Score=364.20 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=220.5
Q ss_pred cccccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 445689999999999999999999986 345889999997543 2334577899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeec
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dl 137 (334)
..+..|+||||+++++|.+++... .++++..++.++.||+.||+|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999874 56899999999999999999999999999999
Q ss_pred CCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q 019904 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216 (334)
Q Consensus 138 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~ 216 (334)
||+||+++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999875443322222334567889999999988776 489999999999999999 9999999
Q ss_pred CcHHHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 217 SNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 217 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+.......+.... ...|..++.++.++|.+||+.||.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88888777766554 3567789999999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=356.48 Aligned_cols=258 Identities=25% Similarity=0.384 Sum_probs=211.8
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 45678899999999999999999999999999999999998765555666688999999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..|+||||+++++|.+++...+++++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998754322
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 241 (334)
. ........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.... ...++.+|..+
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred c-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 1 112234578999999999987665 489999999999999999999999877665444443322 23456789999
Q ss_pred HHHHHHhcCCCCCCCC-CHhHHhc
Q 019904 242 RKLIARILDPNPMTRI-TIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rp-t~~e~l~ 264 (334)
.++|.+||+.||.+|| |++++++
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999999999999999 8888775
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=350.91 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=217.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++.+....|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 34579999999999999999999986 4778999999765432 256889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 999999999999999764 4689999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
.......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..++..+.++
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (269)
T 4hcu_A 162 -TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 239 (269)
T ss_dssp -HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred -ccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHH
Confidence 11233456778999999987776 489999999999999999 99999999888888777665 345567789999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcC
Q 019904 245 IARILDPNPMTRITIPEILED 265 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h 265 (334)
+.+||+.||.+|||+.+++++
T Consensus 240 i~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 240 MNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=369.46 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=214.1
Q ss_pred cccccceEEeeeeeccCceEEEEEE-----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 80 (334)
....++|++.+.||+|+||.||+|. +..+++.||||++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 3456899999999999999999998 55677899999997543 223356788999999999 689999999999
Q ss_pred eeCCe-EEEEEeccCCCchHHHHHhcCC----------------------------------------------------
Q 019904 81 GSKTK-IFIVLEFVTGGELFDKIVNHGR---------------------------------------------------- 107 (334)
Q Consensus 81 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~---------------------------------------------------- 107 (334)
...+. +++|||||++|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 87654 8999999999999999987543
Q ss_pred --------------CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccccc
Q 019904 108 --------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (334)
Q Consensus 108 --------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 173 (334)
+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...............
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 899999999999999999999999999999999999999999999999998754332222233445
Q ss_pred ccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH-HHHHhh-cCccCCCCCCCHHHHHHHHHhcC
Q 019904 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKIS-AAEFTCPPWLSFTARKLIARILD 250 (334)
Q Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~~L~ 250 (334)
.||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+..... ....+. ......|..+++++.++|.+||+
T Consensus 256 ~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 334 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH 334 (359)
T ss_dssp EECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 68899999999988776 489999999999999998 999998765333 333332 23456677899999999999999
Q ss_pred CCCCCCCCHhHHhcC
Q 019904 251 PNPMTRITIPEILED 265 (334)
Q Consensus 251 ~dp~~Rpt~~e~l~h 265 (334)
.||.+|||++|+++|
T Consensus 335 ~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 335 GEPSQRPTFSELVEH 349 (359)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCCCHHHHHHH
Confidence 999999999999875
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=367.08 Aligned_cols=256 Identities=23% Similarity=0.410 Sum_probs=221.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 78 (334)
....++|.+.+.||+|+||.||+|.+.. .+..||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 3455899999999999999999999753 33579999997542 233457788999999999 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCE
Q 019904 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (334)
Q Consensus 79 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NI 142 (334)
++...+..|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 9999999999999999999999998754 489999999999999999999999999999999999
Q ss_pred EEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH
Q 019904 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (334)
Q Consensus 143 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~ 221 (334)
|++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999875543322233344567889999999987666 489999999999999999 999999988888
Q ss_pred HHHHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 222 ~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
....+... ....+..++.++.+||.+||+.||.+|||+++++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87776654 445677899999999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=355.60 Aligned_cols=256 Identities=30% Similarity=0.523 Sum_probs=208.0
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee------
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 82 (334)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4578999999999999999999999999999999996432 335678899999999999999999998754
Q ss_pred -------CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEee
Q 019904 83 -------KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (334)
Q Consensus 83 -------~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~D 154 (334)
....|+||||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 457899999999999999998654 578899999999999999999999999999999999999999999999
Q ss_pred ccchhcccccc------------CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC-CcHHH
Q 019904 155 FGLSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMN 221 (334)
Q Consensus 155 fg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~-~~~~~ 221 (334)
||++....... .........||+.|+|||++.+....+.++|||||||++|+|++ ||.. .+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99987543211 01122345789999999999876555689999999999999998 5543 23344
Q ss_pred HHHHhhcCccCCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 222 LYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 222 ~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
....+......+| ...+..++++|.+||+.||.+|||++++++||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5555554444433 4466779999999999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=364.40 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=220.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhCC--CCCeeeEEEEEee
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVK--HPNVVRLYEVMGS 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 82 (334)
...++|++.+.||+|+||.||+|.+..+++.||||++........ ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 456789999999999999999999999999999999976543221 11244667999999996 5999999999999
Q ss_pred CCeEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe-cCCCeEEeeccchhc
Q 019904 83 KTKIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSAL 160 (334)
Q Consensus 83 ~~~~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~a~~ 160 (334)
.+..++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9999999999986 89999999888999999999999999999999999999999999999999 778999999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHH
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (334)
... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .+.......+..++.+
T Consensus 200 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 269 (320)
T 3a99_A 200 LKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 269 (320)
T ss_dssp CCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred ccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHH
Confidence 432 223345789999999999887776688999999999999999999997632 2233445567789999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+.+||.+||+.||.+|||++++++||||....
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 99999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=370.25 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=217.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+.+|+.+|+.++||||+++++++...+..|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 34578999999999999999999999899999999987532 2333567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999999998754 699999999999999999999999999999999999999999999999999874322111
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
........+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+.......+... ..+.|..++.++.+|
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL 347 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 111112234678999999987666 489999999999999998 99999988877766665443 456677899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc
Q 019904 245 IARILDPNPMTRITIPEILE 264 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~ 264 (334)
|.+||+.||.+|||++++++
T Consensus 348 i~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 348 MEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=356.25 Aligned_cols=267 Identities=25% Similarity=0.431 Sum_probs=214.9
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--CCCeeeEEEEEe
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMG 81 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~ 81 (334)
..+....++|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.+++.++ ||||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 345566788999999999999999999985 488999999976433 2334677899999999997 599999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
.....|+||| +.+++|.+++...+.+++..++.++.|++.||+|||++||+||||||+||++++ +.+||+|||++...
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred cCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999999999 567799999999889999999999999999999999999999999999999965 89999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhhcC----------CCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhc--
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA-- 228 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~-- 228 (334)
.............||+.|+|||++.+. ...+.++|||||||++|+|++|..||.... .......+..
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 433222223455789999999999752 234578999999999999999999998643 2233333332
Q ss_pred CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 229 AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 229 ~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.....+...+.++.+||.+||+.||.+|||++|+++||||+....+
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 2345667789999999999999999999999999999999865443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=371.05 Aligned_cols=249 Identities=25% Similarity=0.416 Sum_probs=204.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC--------CCCeeeEEEEEe
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--------HPNVVRLYEVMG 81 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~~~~~~~ 81 (334)
.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 478999999999999999999999999999999997532 23466788999999886 788999999987
Q ss_pred ----eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCC------
Q 019904 82 ----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYG------ 148 (334)
Q Consensus 82 ----~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~------ 148 (334)
....+|+||||+. ++|.+.+... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 5568999999995 5666666554 4699999999999999999999998 999999999999998775
Q ss_pred -------------------------------------------CeEEeeccchhccccccCCCcccccccCCcccChHhh
Q 019904 149 -------------------------------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185 (334)
Q Consensus 149 -------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~ 185 (334)
.+||+|||++..... ......||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChhh
Confidence 799999999875432 12345789999999999
Q ss_pred hcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCc-----------------------------
Q 019904 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN------LMNLYKKISAAE----------------------------- 230 (334)
Q Consensus 186 ~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~------~~~~~~~~~~~~----------------------------- 230 (334)
.+..+ +.++|||||||++|+|++|+.||.+.+ .......+....
T Consensus 266 ~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 98776 489999999999999999999997643 222222211100
Q ss_pred -------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 231 -------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 231 -------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
...+...+..+.+||.+||+.||.+|||++|+|+||||+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 011122346788999999999999999999999999996
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=348.08 Aligned_cols=252 Identities=24% Similarity=0.390 Sum_probs=217.1
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.-..++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456789999999999999999999886 4678999999764432 35678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998754 59999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (334)
. .......+|+.|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+.... ...|..+++.+.+
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 236 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ 236 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence 1 11223345678999999987766 489999999999999999 999999888877777665554 3456678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 019904 244 LIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+|.+||+.||.+|||+.+++++
T Consensus 237 li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 237 IMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=352.46 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=211.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|.....||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 97 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF 97 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence 344555559999999999999999999999999987542 23356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-CCCeEEeeccchhcccccc
Q 019904 90 LEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++. ++.++|+|||++......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~- 176 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI- 176 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC-
Confidence 99999999999998753 4678899999999999999999999999999999999987 899999999998754321
Q ss_pred CCCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCcHH-H-HHH-HhhcCccCCCCCCCHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLM-N-LYK-KISAAEFTCPPWLSFTA 241 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~-~~~-~~~~~~~~~~~~~~~~~ 241 (334)
........||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...... . ... .........|..++.++
T Consensus 177 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (295)
T 2clq_A 177 -NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred -CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence 11223457899999999997643 2358899999999999999999999754322 1 111 12233456677899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 242 RKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.+||.+||+.||.+|||++++|+||||+...
T Consensus 256 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=358.53 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=207.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeE----EEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..++|++.+.||+|+||+||+|.+..+++.+ |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 4578999999999999999999998777654 777765322 2333567889999999999999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
.++|++|+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 77899999999999999874 5799999999999999999999999999999999999999999999999999986544
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...........+|+.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....++.++.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 333223334456889999999998776 489999999999999999 99999987776666655444 356677899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 242 RKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+++.+||+.||.+|||+.+++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=350.17 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=207.4
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV 79 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 79 (334)
.+......++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 344566778999999999999999999998654 4569999986532 33446778899999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 80 MGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 80 ~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
+. ++..|+||||+.+++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 84 567889999999999999998654 6999999999999999999999999999999999999999999999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCC
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 236 (334)
........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+... ..+.++.
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 164 RYMEDSTY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cccCcccc-cccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence 75433211 11223456788999999987766 489999999999999996 99999988777666666544 3466778
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++..+.++|.+||+.||.+|||+.++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=359.69 Aligned_cols=256 Identities=33% Similarity=0.567 Sum_probs=210.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhC----CCCCeeeEEEE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLV----KHPNVVRLYEV 79 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~~iv~~~~~ 79 (334)
....++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3456789999999999999999999999999999999976443221 1233456789999888 89999999999
Q ss_pred EeeCCeEEEEEec-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe-cCCCeEEeeccc
Q 019904 80 MGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (334)
Q Consensus 80 ~~~~~~~~~v~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~-~~~~~kl~Dfg~ 157 (334)
+...+..++|||+ +.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++ .++.++|+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78899999999888899999999999999999999999999999999999999 789999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCC
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 237 (334)
+..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+......++..+
T Consensus 187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~ 256 (312)
T 2iwi_A 187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHV 256 (312)
T ss_dssp CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTS
T ss_pred hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccC
Confidence 875432 223445689999999999887776568999999999999999999997632 2333455677889
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+..+.+||.+||+.||.+|||++|+++||||+...
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 99999999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=365.29 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=210.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CC-----CeeeEEEEEe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HP-----NVVRLYEVMG 81 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~ 81 (334)
...++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+. |+ +|+++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 34689999999999999999999999999999999997532 23456677888888775 44 4999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEEeecCCCCEEEe--cCCCeEEeec
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD--AYGNLKVSDF 155 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH--~~~i~H~dlkp~NIl~~--~~~~~kl~Df 155 (334)
.....|+||||+.+ +|.+++... ..+++..++.++.|++.||.||| +.||+||||||+|||++ .++.+||+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999975 999999875 46999999999999999999999 57999999999999995 4678999999
Q ss_pred cchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC-
Q 019904 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP- 234 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~- 234 (334)
|++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.......|
T Consensus 206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCceeccc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99875432 2334678999999999998776 4899999999999999999999999887776655532111000
Q ss_pred -----------------------------------CC----------------------------CCHHHHHHHHHhcCC
Q 019904 235 -----------------------------------PW----------------------------LSFTARKLIARILDP 251 (334)
Q Consensus 235 -----------------------------------~~----------------------------~~~~~~~li~~~L~~ 251 (334)
+. .+.++++||.+||+.
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 00 013789999999999
Q ss_pred CCCCCCCHhHHhcCccccCC
Q 019904 252 NPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 252 dp~~Rpt~~e~l~h~~~~~~ 271 (334)
||.+|||++|+|+||||+..
T Consensus 360 dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC-
T ss_pred ChhhCCCHHHHhcCcccccC
Confidence 99999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=360.75 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=209.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCC-CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC------eeeEEEEEee
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN------VVRLYEVMGS 82 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------iv~~~~~~~~ 82 (334)
.++|++.+.||+|+||.||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 478999999999999999999998777 689999997532 22456778999999887665 8999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE----------------
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---------------- 144 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---------------- 144 (334)
.+..|+||||+ ++++.+.+.... ++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 557777776653 69999999999999999999999999999999999999
Q ss_pred ---ecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH
Q 019904 145 ---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (334)
Q Consensus 145 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~ 221 (334)
+.++.+||+|||++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 6678999999999875322 2234578999999999987776 489999999999999999999999877665
Q ss_pred HHHHhhcCccCCC--------------------------------------------CCCCHHHHHHHHHhcCCCCCCCC
Q 019904 222 LYKKISAAEFTCP--------------------------------------------PWLSFTARKLIARILDPNPMTRI 257 (334)
Q Consensus 222 ~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~li~~~L~~dp~~Rp 257 (334)
....+.......| ...+.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 5444332211111 11245788999999999999999
Q ss_pred CHhHHhcCccccCC
Q 019904 258 TIPEILEDEWFKKD 271 (334)
Q Consensus 258 t~~e~l~h~~~~~~ 271 (334)
|++|+|+||||...
T Consensus 327 t~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 327 TLAEALLHPFFAGL 340 (355)
T ss_dssp CHHHHTTSGGGGGC
T ss_pred CHHHHhcChhhcCC
Confidence 99999999999853
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=360.42 Aligned_cols=253 Identities=19% Similarity=0.353 Sum_probs=212.5
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCe----EEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..++|++.+.||+|+||.||+|.+..+++. ||+|.+..... ......+.+|+.+++.++||||+++++++. .+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 457899999999999999999999888876 67777653321 122345678999999999999999999986 45
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..++||||+.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 688999999999999999875 4799999999999999999999999999999999999999999999999999986544
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+... ....|..++.++
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred ccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence 333333445567889999999988776 489999999999999999 99999987766666666554 455677789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 242 RKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.++|.+||+.||.+|||+.+++++
T Consensus 247 ~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999875
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=352.57 Aligned_cols=248 Identities=23% Similarity=0.287 Sum_probs=211.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCC-------CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (334)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 35689999999999999999999988776 469999986543 23356788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC--------eE
Q 019904 81 GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LK 151 (334)
Q Consensus 81 ~~~~~~~~v~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~--------~k 151 (334)
...+..|+||||+.+++|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999998887 99
Q ss_pred EeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcCc
Q 019904 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE 230 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~~~~ 230 (334)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|++| ..||...+...... .....
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-Hhhcc
Confidence 999998764321 23456889999999998744456899999999999999995 55555555444333 33445
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 231 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
...|...+.++.+||.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 56667788999999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=348.95 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=215.3
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++......
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 445679999999999999999999886 5778999999765432 25678999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+||||+.+++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999999999977 4579999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (334)
. .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.... ...|..+++.+.+
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 252 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT 252 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred c-ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence 1 11223456788999999997776 589999999999999998 999999988887777776553 4556678999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 019904 244 LIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+|.+||+.||.+|||++++++|
T Consensus 253 li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 253 IMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhHCcCHHHHHHH
Confidence 9999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=360.60 Aligned_cols=256 Identities=20% Similarity=0.326 Sum_probs=213.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEE-----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEe
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 81 (334)
...++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 3457899999999999999999997 3456789999997532 223356788999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecC
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlk 138 (334)
..+..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999999999998653 27899999999999999999999999999999
Q ss_pred CCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCC
Q 019904 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217 (334)
Q Consensus 139 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~ 217 (334)
|+||+++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999875543322222334567889999999988766 489999999999999998 99999876
Q ss_pred cHHHHHHHhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCc
Q 019904 218 NLMNLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (334)
Q Consensus 218 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 266 (334)
............ ....|..++.++.+||.+||+.||.+|||+.+++++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 544333333222 3455677899999999999999999999999998854
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=346.23 Aligned_cols=251 Identities=27% Similarity=0.454 Sum_probs=205.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
....++|++.+.||+|+||.||+|.+. |+.||+|++....... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999984 7889999987543222 2335778899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cEEeecCCCCEEEec--------CCCeEEee
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDA--------YGNLKVSD 154 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~---i~H~dlkp~NIl~~~--------~~~~kl~D 154 (334)
.|+||||+++++|.+++. .+++++..++.++.|++.||+|||++| ++||||||+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988885 457999999999999999999999999 999999999999986 67899999
Q ss_pred ccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc--cC
Q 019904 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FT 232 (334)
Q Consensus 155 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~--~~ 232 (334)
||++...... ......||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+.......+.... ..
T Consensus 160 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 160 FGLAREWHRT----TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred CCcccccccc----cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence 9998754322 1234578999999999988766 489999999999999999999999887776666554443 45
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 233 CPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 233 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+..++..+.++|.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 667899999999999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=357.58 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=218.5
Q ss_pred cccccccceEEeeeeeccCceEEEEEEEC-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeE
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRL 76 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 76 (334)
......++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 34445689999999999999999999975 456789999997543 233457788999999999 89999999
Q ss_pred EEEEeeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCC
Q 019904 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (334)
Q Consensus 77 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~ 140 (334)
++++...+..|+||||+.+++|.+++.... .+++..++.++.||+.||+|||++||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999998754 3889999999999999999999999999999999
Q ss_pred CEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcH
Q 019904 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (334)
Q Consensus 141 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~ 219 (334)
||+++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 99999999999999999875433221112233456788999999987665 489999999999999999 9999999888
Q ss_pred HHHHHHhhcCc-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 220 MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+....+.... ...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 266 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 87776665543 45667799999999999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=355.36 Aligned_cols=257 Identities=19% Similarity=0.278 Sum_probs=220.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (334)
.....++|++.+.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 3455689999999999999999999876 357889999997543 223346788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCe
Q 019904 81 GSKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (334)
Q Consensus 81 ~~~~~~~~v~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~ 150 (334)
...+..|+||||+.+++|.+++... .++++..+..++.||+.||+|||++||+||||||+||+++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 9999999999999999999998753 357899999999999999999999999999999999999999999
Q ss_pred EEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC
Q 019904 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (334)
Q Consensus 151 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~ 229 (334)
||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 256 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence 9999999875443222222234467889999999987766 489999999999999999 89999998887777766554
Q ss_pred c-cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 230 E-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 230 ~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
. ...+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 3 35667899999999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=363.52 Aligned_cols=255 Identities=32% Similarity=0.576 Sum_probs=185.9
Q ss_pred cccccceEEee-eeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee---
Q 019904 7 KRRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (334)
Q Consensus 7 ~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 82 (334)
....++|.+.+ .||+|+||.||+|.+..+|+.||||++..... ...+....++.+.||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 34568999965 59999999999999999999999999965321 12233344677899999999999876
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEeecc
Q 019904 83 -KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFG 156 (334)
Q Consensus 83 -~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~Dfg 156 (334)
....|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998764 6999999999999999999999999999999999999976 4559999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCccC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFT 232 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~----~~~~~~~~~~ 232 (334)
++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ...+......
T Consensus 177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp TCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cceeccc----cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 9874332 22345578999999999976665 4889999999999999999999977654433 2222222222
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 233 CP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 233 ~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+ ..++.++++||.+||+.||.+|||++|+|+||||+....
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 296 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV 296 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence 22 468999999999999999999999999999999986543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=354.50 Aligned_cols=255 Identities=22% Similarity=0.356 Sum_probs=214.5
Q ss_pred cccccceEEeeeeeccCceEEEEEEE-----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 80 (334)
.-..++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34457999999999999999999985 45678999999975432 23357788999999999 899999999999
Q ss_pred eeCCeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCE
Q 019904 81 GSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (334)
Q Consensus 81 ~~~~~~~~v~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NI 142 (334)
...+..++||||+++|+|.+++.... ++++..++.++.|++.||+|||++|++||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999998754 489999999999999999999999999999999999
Q ss_pred EEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHH
Q 019904 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (334)
Q Consensus 143 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~ 221 (334)
+++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 999999999999999875543322222334457889999999988766 489999999999999998 999998765433
Q ss_pred HHHHhh-c-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 222 LYKKIS-A-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 222 ~~~~~~-~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...... . .....+..++..+.++|.+||+.||.+|||++++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 333222 2 233446678999999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=356.80 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=215.5
Q ss_pred cccceEEeeeeeccCceEEEEEE-----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
..++|++.+.||+|+||.||+|. +..+++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 45799999999999999999999 55678899999996432 233356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC---CCeEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVS 153 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---~~~kl~ 153 (334)
...|+||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.+ +.++|+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999999998763 48899999999999999999999999999999999999844 469999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-cc
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~ 231 (334)
|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+... ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 9999875443322222334567899999999988766 489999999999999998 99999988877777766554 34
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..+..++..+.++|.+||+.||.+|||+.+++++.|+..
T Consensus 265 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 265 DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 566779999999999999999999999999999988753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=350.40 Aligned_cols=261 Identities=24% Similarity=0.371 Sum_probs=200.5
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
.....+++|++.+.||+|+||.||+|.+..+|+.||||++...... ....+.+.++..+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 3456788999999999999999999999999999999999765322 223344556666788899999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+ ++.+...... ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++....
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 4455554443 46799999999999999999999995 99999999999999999999999999886433
Q ss_pred cccCCCcccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCcc-CC--C
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEF-TC--P 234 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~-~~~~~~~~~~~~~~~-~~--~ 234 (334)
. ........||+.|+|||++.. ....+.++|||||||++|+|++|..||.. .........+..... .. .
T Consensus 177 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 253 (318)
T 2dyl_A 177 D---DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGH 253 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSS
T ss_pred C---CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCcc
Confidence 2 122334578999999999952 23345889999999999999999999986 344455554444332 22 2
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..++.++.+||.+||+.||.+|||++++++||||+.
T Consensus 254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 358999999999999999999999999999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=348.98 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=221.2
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
.......++|++.+.||+|+||.||+|.+..++..||+|++..... ..+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3445577899999999999999999999999999999999975432 246788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
...|+||||+.+++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999999998743 5999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (334)
.... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....|..+++
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 3221 112233456889999999988776 489999999999999999 99999987776666655544 4456778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 240 TARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+.+||.+||+.||.+|||++++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHHHH
Confidence 9999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=349.80 Aligned_cols=253 Identities=22% Similarity=0.372 Sum_probs=206.8
Q ss_pred ccccceEEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
-..++|++++.||+|+||+||+|+ +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 356899999999999999999998 56788999999987532 33456788999999999999999999998553
Q ss_pred --CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 84 --TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 84 --~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..+++||||+++++|.+++...+ ++++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 56899999999999999998764 599999999999999999999999999999999999999999999999999875
Q ss_pred cccccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH----------------HHH
Q 019904 161 SQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLY 223 (334)
Q Consensus 161 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~----------------~~~ 223 (334)
....... .......++..|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 4332111 12223456778999999998776 48999999999999999999998653221 111
Q ss_pred HHh-hcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 224 KKI-SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 224 ~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+ .....+.|..++.++.+||.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 112 22344567789999999999999999999999999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=343.39 Aligned_cols=248 Identities=19% Similarity=0.317 Sum_probs=214.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--C
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--T 84 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--~ 84 (334)
....++|++.+.||+|+||.||+|.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 457889999999999999999999984 788999999765432 33356789999999999999999999999887 7
Q ss_pred eEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||++| ++||||||+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8899999999999999998765 4899999999999999999999999 99999999999999999999999987653
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCC--CccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--ccCCCCC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG--STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW 236 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~ 236 (334)
.. .....||+.|+|||++.+..... .++|||||||++|+|++|..||.+.+.......+... ....|..
T Consensus 163 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 163 FQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp TS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred ec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence 11 22356899999999998765432 2799999999999999999999988877766555433 3456778
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.++.++|.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=354.99 Aligned_cols=252 Identities=22% Similarity=0.365 Sum_probs=215.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeE--EEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV--ALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 84 (334)
...++|++.+.||+|+||.||+|.+..++..+ |+|.+.... .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45689999999999999999999998888765 999886422 233356788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~ 148 (334)
..|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997754 699999999999999999999999999999999999999999
Q ss_pred CeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhh
Q 019904 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (334)
Q Consensus 149 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~ 227 (334)
.+||+|||++...... .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998643221 11233456889999999987666 489999999999999998 999999998888877776
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 228 ~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.. ....+..++..+.+||.+||+.||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54 345667789999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=346.94 Aligned_cols=249 Identities=21% Similarity=0.268 Sum_probs=209.7
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ .|+|++++++++......|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 45679999999999999999999999999999999865432 23577899999999 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC-----eEEeeccchhcc
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~-----~kl~Dfg~a~~~ 161 (334)
+||||+ +++|.+++...+ ++++..+..++.||+.||+|||++||+||||||+||+++.++. +||+|||++...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 889999998754 5999999999999999999999999999999999999987776 999999998754
Q ss_pred ccccCC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcCc---
Q 019904 162 QQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAE--- 230 (334)
Q Consensus 162 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---~~~~~~~~~~~~~--- 230 (334)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+. ........+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 432221 12345579999999999987766 58999999999999999999999873 3333333332221
Q ss_pred --cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 231 --FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 231 --~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...++.++.++.++|.+||+.||.+|||++++++
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1223468999999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=346.25 Aligned_cols=254 Identities=31% Similarity=0.542 Sum_probs=205.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 35789999999999999999999999999999999998654444555678899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.+|.++|+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999998865 45699999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC--cHHHHHHHhhcCccC--CCCCCCH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKKISAAEFT--CPPWLSF 239 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~--~~~~~~~~~~~~~~~--~~~~~~~ 239 (334)
. ........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+. ........+.....+ .+..++.
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred C--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 1 112234578999999999987666 48999999999999999999999764 333444444443332 2356899
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 240 TARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.+||.+||+.||.+|||++++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=357.76 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=208.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 87 (334)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .+.+.+|+.+++.+ +||||+++++++......|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34789999999999999999999999999999999875432 23577899999999 8999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC-----eEEeeccchhcc
Q 019904 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~-----~kl~Dfg~a~~~ 161 (334)
+||||+ +++|.+++... +.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 88999999874 67999999999999999999999999999999999999998887 999999998754
Q ss_pred ccccCCC-----cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcCccCC
Q 019904 162 QQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTC 233 (334)
Q Consensus 162 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---~~~~~~~~~~~~~~~~ 233 (334)
....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+. .....+..+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 3322111 1245679999999999998776 58999999999999999999999873 4444444443332222
Q ss_pred C-----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 234 P-----PWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 234 ~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+ ..++ ++.++|.+||+.||.+||+++++++
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2 2345 9999999999999999999998875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=362.55 Aligned_cols=254 Identities=24% Similarity=0.441 Sum_probs=206.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-----------CCCeeeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLY 77 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~ 77 (334)
..++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.+++.+. ||||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 45799999999999999999999999999999999975432 2456778898888876 89999999
Q ss_pred EEEeeCC----eEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecC---
Q 019904 78 EVMGSKT----KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAY--- 147 (334)
Q Consensus 78 ~~~~~~~----~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~--- 147 (334)
+++...+ .+++|||++ +++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9987654 789999999 78999999874 4599999999999999999999998 99999999999999543
Q ss_pred ---CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-----
Q 019904 148 ---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----- 219 (334)
Q Consensus 148 ---~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~----- 219 (334)
+.+||+|||++..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 3799999999875432 1234578999999999998776 5899999999999999999999986431
Q ss_pred -HHHHHHhhc------------------------------------------CccCCCCCCCHHHHHHHHHhcCCCCCCC
Q 019904 220 -MNLYKKISA------------------------------------------AEFTCPPWLSFTARKLIARILDPNPMTR 256 (334)
Q Consensus 220 -~~~~~~~~~------------------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~R 256 (334)
......+.. ....++..++.++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 111111111 1112333456788999999999999999
Q ss_pred CCHhHHhcCccccCCCC
Q 019904 257 ITIPEILEDEWFKKDYK 273 (334)
Q Consensus 257 pt~~e~l~h~~~~~~~~ 273 (334)
||++|+|+||||.....
T Consensus 326 pt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp BCHHHHHTCGGGTTCTT
T ss_pred CCHHHHhhChhhhcccC
Confidence 99999999999987543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=354.02 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=207.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeE----EEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..++|++++.||+|+||.||+|.+..+++.| |+|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4578999999999999999999998888765 566554322 2233567889999999999999999999998765
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
.++|++++.+|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 78899999999999999874 5799999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
...........+|+.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..+.++.++.++
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 333323334456888999999998776 489999999999999999 99999988777766665544 356677899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++|.+||+.||.+|||+.|+++
T Consensus 249 ~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=345.76 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=214.8
Q ss_pred ccccccceEEee-eeeccCceEEEEEE--ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 6 IKRRVGKYEVGR-TIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 6 ~~~~~~~y~~~~-~lG~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
+....++|++.+ .||+|+||.||+|. ...+++.||+|++.... ......+.+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-E 88 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C
Confidence 344567899998 99999999999995 45667899999997643 2334467789999999999999999999999 5
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
.+..|+||||+.+++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 67789999999999999999998889999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 019904 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (334)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (334)
..... .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..++.
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCCCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 22111 11122346788999999987666 488999999999999999 99999998887777666554 3456778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 240 TARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+.++|.+||+.||.+|||+.++++
T Consensus 248 ~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=341.46 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=217.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.+++.++||||+++++++...+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 35679999999999999999999986 5778999999765432 256889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+||||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l 244 (334)
........+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+.... ...|..++..+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 237 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 237 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence 111223456788999999987766 489999999999999999 999999988888777776553 44566789999999
Q ss_pred HHHhcCCCCCCCCCHhHHhcC
Q 019904 245 IARILDPNPMTRITIPEILED 265 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~h 265 (334)
+.+||+.||.+|||+.+++++
T Consensus 238 i~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 238 MNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=345.04 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=214.5
Q ss_pred CCcccccccccceEEeeeeeccCceEEEEEEECC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 019904 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77 (334)
Q Consensus 1 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (334)
|..+......++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 5566778888999999999999999999998654 33469999987642 233357788999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeecc
Q 019904 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (334)
Q Consensus 78 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg 156 (334)
+++... ..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 998654 5689999999999999997754 59999999999999999999999999999999999999999999999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCP 234 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~ 234 (334)
++........ .......+++.|+|||++.+..+ +.++|||||||++|+|++ |+.||...........+... ..+.+
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 159 LSRYIEDEDY-YKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCcccccccc-cccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 9875433211 11233456788999999987766 489999999999999998 99999876665555554433 34567
Q ss_pred CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 235 PWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 235 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
..+++.+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 7799999999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=351.33 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=213.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEE-----CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 80 (334)
....++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 34567999999999999999999984 4567899999997543 233356788999999999 699999999998
Q ss_pred eeCC-eEEEEEeccCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEE
Q 019904 81 GSKT-KIFIVLEFVTGGELFDKIVNHGR----------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (334)
Q Consensus 81 ~~~~-~~~~v~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl 143 (334)
...+ .+|+||||+++++|.+++..... +++..++.++.|++.||+|||++||+||||||+||+
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7754 58999999999999999987654 889999999999999999999999999999999999
Q ss_pred EecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHH-H
Q 019904 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-N 221 (334)
Q Consensus 144 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~-~ 221 (334)
++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.... .
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 99999999999999875433222222334567889999999988776 489999999999999998 99999876533 3
Q ss_pred HHHHhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 222 LYKKISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 222 ~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
....+.. .....+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3333332 3355677799999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=354.24 Aligned_cols=256 Identities=21% Similarity=0.348 Sum_probs=214.6
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCC-----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 79 (334)
.....++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 34456789999999999999999999876654 79999997543 223357788999999999 89999999999
Q ss_pred EeeCCeEEEEEeccCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe
Q 019904 80 MGSKTKIFIVLEFVTGGELFDKIVNH--------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (334)
Q Consensus 80 ~~~~~~~~~v~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~ 145 (334)
+...+..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999999999998753 3579999999999999999999999999999999999999
Q ss_pred cCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 019904 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK 224 (334)
Q Consensus 146 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~ 224 (334)
.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 999999999999875443222222234457889999999988776 489999999999999998 999998765443333
Q ss_pred Hhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 225 KISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 225 ~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+.. .....|...+..+.++|.+||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 278 KLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3322 233456778999999999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=353.49 Aligned_cols=254 Identities=21% Similarity=0.254 Sum_probs=203.1
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
+.+--..++|++.+.||+|+||+||+|.+. ++.||||++..... ......+|+.+++.++||||+++++++...
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 344556789999999999999999999885 78999999975432 234456699999999999999999999774
Q ss_pred C----eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEEeecCCCCEEEecCCC
Q 019904 84 T----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------GVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 84 ~----~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~----------~i~H~dlkp~NIl~~~~~~ 149 (334)
. .+|+||||+++|+|.+++... .+++..++.++.|++.||+|||+. ||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 3 479999999999999999764 599999999999999999999999 9999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCC----CCCccchhhHHHHHHHHHhCCCCCCCCc-------
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTADLWSCGVILFVLLAGYLPFDDSN------- 218 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~e~~~g~~pf~~~~------- 218 (334)
+||+|||++................||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+..
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999876544333333444679999999999986422 2357899999999999999999997532
Q ss_pred ---------HHHHHHHhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 219 ---------LMNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 219 ---------~~~~~~~~~~~~~--~~~~~-----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.......+..... ..+.. .+.++.+||.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2222222222111 11111 2345999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=350.51 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=207.8
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (334)
..+....++|++.+.||+|+||.||+|.+.. ++..||+|++..... .....+.+.+|+.+++.++||||+++++++
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3445566899999999999999999998765 455899999975432 233457788999999999999999999998
Q ss_pred eeCC-----eEEEEEeccCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC
Q 019904 81 GSKT-----KIFIVLEFVTGGELFDKIVN------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (334)
Q Consensus 81 ~~~~-----~~~~v~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~ 149 (334)
.... ..|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7765 35999999999999999853 346999999999999999999999999999999999999999999
Q ss_pred eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc
Q 019904 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~ 228 (334)
+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 99999999875433222222233457889999999987766 489999999999999999 9999998877766666554
Q ss_pred C-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 229 A-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 229 ~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
. ....+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4 345677899999999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=359.19 Aligned_cols=253 Identities=22% Similarity=0.357 Sum_probs=205.7
Q ss_pred cccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..++|++.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 3468999999999999999999876 457789999997542 23345778999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999999998754 6999999999999999999999999999999999999999999999999998754432
Q ss_pred cCCC-cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 165 RDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 165 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
.... ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..+.+..++..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 1111 1122345678999999988776 489999999999999998 99999988887777766554 345566789999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++|.+||+.||.+|||++++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHH
Confidence 99999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=344.54 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=217.2
Q ss_pred cccccccceEEee-eeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 5 KIKRRVGKYEVGR-TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 5 ~~~~~~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
++....++|.+.+ .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 3455678888887 9999999999999864 467789999997642 334467789999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..+..|+||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 556789999999999999998654 4699999999999999999999999999999999999999999999999999875
Q ss_pred cccccC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCC
Q 019904 161 SQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWL 237 (334)
Q Consensus 161 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~ 237 (334)
...... ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... ...|+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence 432211 111223456889999999987666 489999999999999998 999999887777776665543 4667789
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcCc
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILEDE 266 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 266 (334)
++++.++|.+||+.||.+|||+.+++++.
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999999999999999999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=359.98 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=212.0
Q ss_pred cccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 3 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
...+....++|++.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 3456677899999999999999999999974 68999999986542 2235678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence 999999999999999999886543 5899999999999999999999999999999999999999999999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH---H----HHhhcCc-
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL---Y----KKISAAE- 230 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~---~----~~~~~~~- 230 (334)
................||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+...... . .......
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 75443333333344568999999999987766 4899999999999999999999976432111 0 0111110
Q ss_pred -----c----CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCc
Q 019904 231 -----F----TCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (334)
Q Consensus 231 -----~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 266 (334)
. ..++..+..+.+++.+||+.||.+|||+.+++++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0 11222456789999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=342.16 Aligned_cols=250 Identities=27% Similarity=0.406 Sum_probs=208.2
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHH----HHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM----AEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
...++|++.+.||+|+||.||+|.+..+++.||+|++.......... .+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 34689999999999999999999999999999999986543322211 26788999999999999999999999766
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCC-----eEEeec
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGN-----LKVSDF 155 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~-----~kl~Df 155 (334)
. ++||||+++++|.+.+... .++++..+..++.|++.||+|||++| |+||||||+||+++.++. +||+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6 6899999999998888665 47999999999999999999999999 999999999999988776 999999
Q ss_pred cchhccccccCCCcccccccCCcccChHhhhcC-CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH--HHHHhhc--Cc
Q 019904 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--LYKKISA--AE 230 (334)
Q Consensus 156 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~--~~~~~~~--~~ 230 (334)
|++..... ......||+.|+|||++... ...+.++|||||||++|+|++|..||....... ....+.. ..
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 98864222 23446789999999998432 233578999999999999999999998654322 2333322 23
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 231 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...+..+++.+.+||.+||+.||.+|||++++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4567789999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=348.85 Aligned_cols=253 Identities=22% Similarity=0.330 Sum_probs=209.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
...+|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++...+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4578999999999999999999876543 359999997543 2333567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..|+||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999999765 5799999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCC-cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 019904 164 VRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (334)
Q Consensus 164 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (334)
..... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..+.+..++..
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred ccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence 21111 1122345778999999987766 489999999999999998 99999988887777776554 34556779999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 241 ARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.++|.+||+.||.+||++.++++
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=351.85 Aligned_cols=258 Identities=21% Similarity=0.343 Sum_probs=191.7
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEeeCCe
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
.-..++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 3456899999999999999999999999999999999976432 122334445555 7888899999999999999999
Q ss_pred EEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 86 IFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~-~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999986 78777763 56799999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccCCCcccccccCCcccChHhhh----cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCcc-CC
Q 019904 160 LSQQVRDDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEF-TC 233 (334)
Q Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~~~~~~~~~~-~~ 233 (334)
..... .......||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+... ......+..... ..
T Consensus 175 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 175 QLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp C---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred ecccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 54321 1223347899999999984 3334 5899999999999999999999986432 222222222211 11
Q ss_pred ----CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 234 ----PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 234 ----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+..++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 23589999999999999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=363.36 Aligned_cols=244 Identities=25% Similarity=0.451 Sum_probs=210.7
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-eE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-KI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~ 86 (334)
...++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 45688999999999999999999985 6799999997543 2467889999999999999999999986655 79
Q ss_pred EEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
|+||||+++|+|.+++...+. +++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999999999987653 799999999999999999999999999999999999999999999999998743221
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
.....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|..+++.+.
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 416 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 416 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred -----ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 123356889999999988776 489999999999999998 99999987766666665544 4566788999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+||.+||+.||.+|||+.++++
T Consensus 417 ~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 417 DVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=354.65 Aligned_cols=253 Identities=15% Similarity=0.198 Sum_probs=200.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECC---CCCeEEEEEeehhhhhh--------HHHHHHHHHHHHHHHhCCCCCeeeEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLK--------HKMAEQIKREVATMKLVKHPNVVRLYE 78 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 78 (334)
.++|++.+.||+|+||.||+|.+.. ++..||+|++....... ......+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 78899999987543211 111234667889999999999999999
Q ss_pred EEee----CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC--CeEE
Q 019904 79 VMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKV 152 (334)
Q Consensus 79 ~~~~----~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~--~~kl 152 (334)
++.. ....|+||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 78899999999 899999998877899999999999999999999999999999999999999887 9999
Q ss_pred eeccchhccccccC-----CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC--CcHHHHHHH
Q 019904 153 SDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKK 225 (334)
Q Consensus 153 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~--~~~~~~~~~ 225 (334)
+|||++........ ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+ .+.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999875433211 112245579999999999987765 5899999999999999999999965 232222222
Q ss_pred hhcCccCCC---------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 226 ISAAEFTCP---------PWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 226 ~~~~~~~~~---------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
........| ..++.++.++|.+||+.||.+|||++++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 111111122 268999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=344.24 Aligned_cols=254 Identities=22% Similarity=0.408 Sum_probs=197.6
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
....-++|++.+.||+|+||+||+|.+.. .||+|++..... .....+.+.+|+.+++.++||||++++++. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 34556889999999999999999998643 599999975432 334467889999999999999999999965 5667
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.++||||+.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999999999654 46999999999999999999999999999999999999999999999999998754433
Q ss_pred cCCCcccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCcc-----CCCCC
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEF-----TCPPW 236 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~-~~~~~~~~~~-----~~~~~ 236 (334)
..........||+.|+|||++.. ....+.++|||||||++|+|++|..||.+..... ....+..... ..+..
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN 253 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence 33333445679999999999962 2233578999999999999999999998754443 3333333222 22346
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++..+.+||.+||+.||.+|||++++++
T Consensus 254 ~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 254 CPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8899999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=344.98 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=206.4
Q ss_pred ccceEEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC--
Q 019904 10 VGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 83 (334)
..+|++.+.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3569999999999999999999 56789999999997543 223356788999999999999999999999877
Q ss_pred CeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
..+|+||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence 678999999999999999955 4579999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC---------------cHHHHHHHh
Q 019904 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------------NLMNLYKKI 226 (334)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~---------------~~~~~~~~~ 226 (334)
..... .......||..|+|||++.+..+. .++|||||||++|+|++|..|+... ........+
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 32111 122345678889999999887664 8899999999999999999886432 111222222
Q ss_pred h-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 227 S-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 227 ~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
. ......|+.+++.+.+||.+||+.||.+|||++++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 2 2234567789999999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.78 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=213.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+|+.++||||+++++++. ....
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345578999999999999999999986 467899999976432 2567889999999999999999999986 6678
Q ss_pred EEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
|+||||+.+|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999999999754 36899999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
.. .......+++.|+|||++....+ +.++|||||||++|||++ |..||.+.+..+....+... ..+.|..++.++.
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 415 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY 415 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHH
T ss_pred ce-eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 11123345778999999987776 489999999999999999 99999998888777766554 3456778999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+||.+||+.||.+|||++++++
T Consensus 416 ~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 416 NIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCChhHCcCHHHHHH
Confidence 9999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=340.18 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=209.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-------
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------- 82 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------- 82 (334)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... +.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 478999999999999999999999999999999997543 245689999999999999999998854
Q ss_pred ---------CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeE
Q 019904 83 ---------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 83 ---------~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~k 151 (334)
...+|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45589999999999999999764 5799999999999999999999999999999999999999999999
Q ss_pred EeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Q 019904 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~ 231 (334)
|+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ......+.. .
T Consensus 163 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~--~ 234 (284)
T 2a19_B 163 IGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRD--G 234 (284)
T ss_dssp ECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT--T
T ss_pred ECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc--c
Confidence 9999988754322 22334578999999999987766 58999999999999999999987532 222333322 2
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
..+..++..++++|.+||+.||.+|||+.|++++.+...
T Consensus 235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 345678999999999999999999999999999887654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=341.73 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=210.4
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM- 80 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~- 80 (334)
.+.....+|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 35566788999999999999999999975433 35899988653 2334457788999999999999999999985
Q ss_pred eeCCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 81 GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 81 ~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
..++..|+||||+.+++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 5567889999999999999999764 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccccC--CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCC
Q 019904 160 LSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPP 235 (334)
Q Consensus 160 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~ 235 (334)
....... ........+|+.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+.... ...|.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence 5432221 122234467889999999988776 489999999999999999 677887766655555554443 34567
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++..+.++|.+||+.||.+|||+.++++
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=360.15 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=196.1
Q ss_pred CCcccccccccceEE-eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEE
Q 019904 1 MSQPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (334)
Q Consensus 1 ~~~~~~~~~~~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 78 (334)
|++|.+...++++.+ .+.||+|+||+||.+. ..+|+.||||++.... .+.+.+|+.+++.+ +||||+++++
T Consensus 4 ~~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~ 76 (434)
T 2rio_A 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYC 76 (434)
T ss_dssp ----CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccccchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEE
Confidence 456777777777665 5789999999998754 4579999999987543 34567899999876 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCchHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC----
Q 019904 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---- 147 (334)
Q Consensus 79 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~-------~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~---- 147 (334)
++.+....|+|||||. |+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 77 ~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~ 155 (434)
T 2rio_A 77 SETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFT 155 (434)
T ss_dssp EEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHH
T ss_pred EEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccc
Confidence 9999999999999996 59999998765332 23456799999999999999999999999999999754
Q ss_pred ---------CCeEEeeccchhccccccCC--CcccccccCCcccChHhhhc------CCCCCCccchhhHHHHHHHHHh-
Q 019904 148 ---------GNLKVSDFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVILFVLLA- 209 (334)
Q Consensus 148 ---------~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~e~~~- 209 (334)
+.+||+|||++......... .......||+.|+|||++.+ ....+.++|||||||++|+|++
T Consensus 156 ~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~ 235 (434)
T 2rio_A 156 ADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235 (434)
T ss_dssp SCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence 37999999998754332111 11234579999999999975 2334689999999999999999
Q ss_pred CCCCCCCCcHHHHHHHhhcCccCCC-------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 210 GYLPFDDSNLMNLYKKISAAEFTCP-------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 210 g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
|..||........ .+.......+ ..++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 236 g~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 236 GKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp SCCTTCSTTTHHH--HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCCCchhhHH--HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9999976543331 1222222111 124578999999999999999999999999999974
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=368.50 Aligned_cols=251 Identities=25% Similarity=0.366 Sum_probs=216.6
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~ 292 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence 345679999999999999999999998899999999975432 2467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999999999874 358999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..++..+.+
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 450 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 450 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111223345678999999987766 489999999999999999 99999988776666655443 34567789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
||.+||+.||.+|||+.++++
T Consensus 451 li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 451 LMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999999976
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=340.06 Aligned_cols=256 Identities=22% Similarity=0.347 Sum_probs=211.8
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (334)
+....-.|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 16 i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 34455578888999999999999999755444 79999986432 33446778899999999999999999999987
Q ss_pred CCeE-EEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 83 KTKI-FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 83 ~~~~-~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.+.. ++||||+.+++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 6665 999999999999999987 35689999999999999999999999999999999999999999999999999864
Q ss_pred ccccc--CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCC
Q 019904 161 SQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (334)
Q Consensus 161 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 236 (334)
..... .........+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+... ....+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence 33221 1122334567889999999987766 489999999999999999 55666666666655555444 3456777
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++..+.++|.+||+.||.+|||++++++
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999999999999999999999976
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=353.86 Aligned_cols=253 Identities=15% Similarity=0.200 Sum_probs=200.0
Q ss_pred ccceEEeeeeeccCceEEEEEEECCC-----CCeEEEEEeehhhhhhH--------HHHHHHHHHHHHHHhCCCCCeeeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKH--------KMAEQIKREVATMKLVKHPNVVRL 76 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~ 76 (334)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........ ........|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34899999999999999999998764 58899999875432111 111234456677888999999999
Q ss_pred EEEEeeC----CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe--cCCC
Q 019904 77 YEVMGSK----TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGN 149 (334)
Q Consensus 77 ~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~--~~~~ 149 (334)
++++... ...|+||||+ +++|.+++... +++++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 5589999999 89999999876 5799999999999999999999999999999999999999 8899
Q ss_pred eEEeeccchhccccccCC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH-HHHH
Q 019904 150 LKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLY 223 (334)
Q Consensus 150 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~-~~~~ 223 (334)
+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ....
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999998754332211 11234469999999999988776 5899999999999999999999985321 1111
Q ss_pred HHhh----cC------ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 224 KKIS----AA------EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 224 ~~~~----~~------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.... .. ....+..++.++.+++..||+.||.+||+++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110 00 01122568999999999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=339.61 Aligned_cols=245 Identities=24% Similarity=0.443 Sum_probs=205.8
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-Ce
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-TK 85 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~ 85 (334)
....++|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+.+++.++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 456789999999999999999999874 7899999987543 246788999999999999999999987554 57
Q ss_pred EEEEEeccCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
.|+||||+++++|.+++..... +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999977543 89999999999999999999999999999999999999999999999998874332
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
. .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ....+..+++.+
T Consensus 170 ~-----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (278)
T 1byg_A 170 T-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV 243 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred c-----ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence 1 223457889999999987766 489999999999999998 99999987776666665443 345677899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++|.+||+.||.+|||+.++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 244 YEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcCChhhCCCHHHHHH
Confidence 99999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=347.01 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=206.0
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe----e
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----S 82 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~ 82 (334)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 345678999999999999999999999999999999986532 234567889999999999999999999986 3
Q ss_pred CCeEEEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
....|+||||+.+++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4578999999999999998876 467999999999999999999999999999999999999999999999999987
Q ss_pred hccccccCCC-------cccccccCCcccChHhhhcCCC--CCCccchhhHHHHHHHHHhCCCCCCCC-----cHHHHHH
Q 019904 159 ALSQQVRDDG-------LLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYK 224 (334)
Q Consensus 159 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~e~~~g~~pf~~~-----~~~~~~~ 224 (334)
.......... ......||+.|+|||++.+... .+.++|||||||++|+|++|..||... .......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 6432211110 0123457999999999875432 358999999999999999999999531 1111111
Q ss_pred HhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCc
Q 019904 225 KISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDE 266 (334)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~ 266 (334)
.....+.++.++..+.++|.+||+.||.+|||+++++++-
T Consensus 262 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 262 --NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp --CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 1223344567899999999999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=342.68 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=206.2
Q ss_pred cccccceEEeeeeeccCceEEEEEEECC-CCC--eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
....++|++.+.||+|+||.||+|.+.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3456789999999999999999998643 333 6899999766544555678899999999999999999999999876
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
. .++||||+.+++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999999764 569999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc--cCCCCCCC
Q 019904 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLS 238 (334)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (334)
..... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .+.+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 22111 11223457788999999987666 488999999999999999 999999988888777775543 34556799
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 239 FTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++.++|.+||+.||.+|||+.++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=340.70 Aligned_cols=249 Identities=20% Similarity=0.268 Sum_probs=204.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEE-EEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-VMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~ 87 (334)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.++|++++..+. +.......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 45789999999999999999999999999999999875432 235778999999999887665554 446778899
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe---cCCCeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~a~~~~~ 163 (334)
+||||+ +++|.+++.. ..++++..+..++.|++.||+|||++||+||||||+||+++ .++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 999999 8899999974 45799999999999999999999999999999999999994 788999999999875443
Q ss_pred ccCC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccC---
Q 019904 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFT--- 232 (334)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~~~~--- 232 (334)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. .......+......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 2221 11245578999999999988776 589999999999999999999998632 12222222222222
Q ss_pred --CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 233 --CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 233 --~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+..+|+++.+||.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 23678999999999999999999999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=337.64 Aligned_cols=249 Identities=21% Similarity=0.353 Sum_probs=212.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+. ++..||+|++...... .+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 34579999999999999999999985 4678999999754322 456889999999999999999999986 45688
Q ss_pred EEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||||+.+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999999987543 69999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....+..++..+.+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 241 (279)
T 1qpc_A 164 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ 241 (279)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence 111223456788999999987665 488999999999999999 99999998887777766554 34556779999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+|.+||+.||.+|||++++++
T Consensus 242 li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 242 LMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccChhhCCCHHHHHH
Confidence 999999999999999999976
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=359.66 Aligned_cols=252 Identities=23% Similarity=0.402 Sum_probs=204.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC--e
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~ 85 (334)
..-++|++.+.||+|+||.||+|.+..+|+.||||++....... ..+.+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34578999999999999999999999999999999997644322 2466789999999999999999999998765 7
Q ss_pred EEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE----ecCCCeEEeeccch
Q 019904 86 IFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~----~~~~~~kl~Dfg~a 158 (334)
.|+|||||++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997644 39999999999999999999999999999999999999 66677999999998
Q ss_pred hccccccCCCcccccccCCcccChHhhhcC-------CCCCCccchhhHHHHHHHHHhCCCCCCC----CcHHHHHHHhh
Q 019904 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-------GYDGSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKIS 227 (334)
Q Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~e~~~g~~pf~~----~~~~~~~~~~~ 227 (334)
...... .......||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.. ....+...++.
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 754322 222345799999999998752 2224789999999999999999999964 22334444433
Q ss_pred cCcc---------------------CCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 228 AAEF---------------------TCP----PWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 228 ~~~~---------------------~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.... +.+ ..++..+.++|.+||+.||.+|||++++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 3221 111 124457889999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=346.51 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=210.3
Q ss_pred cccceEEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe--e
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--S 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~ 82 (334)
..++|++.+.||+|+||.||+|. +..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 34789999999999999999999 56788999999997543 233567889999999999999999999886 4
Q ss_pred CCeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
....|+||||+++++|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 56799999999999999999874 46999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH---------------HHHHH
Q 019904 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKK 225 (334)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~---------------~~~~~ 225 (334)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 322111 11233457888999999987766 48999999999999999999998654322 12222
Q ss_pred hh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 226 IS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 226 ~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+. ......+..+++.+.+||.+||+.||.+|||+++++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22 22345677899999999999999999999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=340.48 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=200.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEE-EEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-VMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~ 87 (334)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+. ++......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 45789999999999999999999999999999998765432 234678999999999877666555 457788899
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE---ecCCCeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~ 163 (334)
+||||+ +++|.+++.. ..++++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999 8899999985 4579999999999999999999999999999999999999 7889999999999875443
Q ss_pred ccCC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH---HHHHHHhhcCccC---
Q 019904 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFT--- 232 (334)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~---~~~~~~~~~~~~~--- 232 (334)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+. ......+......
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence 2221 12235578999999999998776 5899999999999999999999976322 1222222222222
Q ss_pred --CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 233 --CPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 233 --~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....+|.++.+||.+||+.||.+|||++++++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 22668999999999999999999999999976
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=359.37 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=209.7
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.. +..|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 345789999999999999999999865 567999999764322 3568899999999999999999999876 6789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 999999999999999753 469999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+... ..+.|+.++..+.+
T Consensus 335 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 335 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred -eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 111233456788999999987766 489999999999999999 99999998887777776554 34667789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
||.+||+.||.+|||++++++
T Consensus 413 li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 413 LMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=342.87 Aligned_cols=237 Identities=32% Similarity=0.589 Sum_probs=195.4
Q ss_pred ccccccceEEe-eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHH-HhCCCCCeeeEEEEEee-
Q 019904 6 IKRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS- 82 (334)
Q Consensus 6 ~~~~~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~- 82 (334)
....+++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++..
T Consensus 12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 35577899998 7899999999999999999999999998642 2455788877 66789999999999887
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEee
Q 019904 83 ---KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSD 154 (334)
Q Consensus 83 ---~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~D 154 (334)
...+|+||||+++++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.++|+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 678999999999999999998764 6999999999999999999999999999999999999998 78899999
Q ss_pred ccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHh----hcCc
Q 019904 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAE 230 (334)
Q Consensus 155 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~----~~~~ 230 (334)
||++..... ..+ +.++|||||||++|+|++|..||.+.......... ....
T Consensus 164 fg~a~~~~~------------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 164 FGFAKETTG------------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CTTCEECTT------------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred ccccccccc------------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 998753211 112 47899999999999999999999876544433221 1222
Q ss_pred cCCC----CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCCC
Q 019904 231 FTCP----PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275 (334)
Q Consensus 231 ~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~~ 275 (334)
...+ ..++.++.+||.+||+.||.+|||++|+++||||......+
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 2333 46899999999999999999999999999999998765443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=348.12 Aligned_cols=245 Identities=15% Similarity=0.175 Sum_probs=201.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECC--------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeee------
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR------ 75 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~------ 75 (334)
.++|++.+.||+|+||.||+|.+.. .++.||+|++... +.+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4799999999999999999999987 4889999998754 35678999999999999887
Q ss_pred ---------EEEEEee-CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEE
Q 019904 76 ---------LYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (334)
Q Consensus 76 ---------~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl 143 (334)
+++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 78899999999 89999999886 68999999999999999999999999999999999999
Q ss_pred EecCC--CeEEeeccchhccccccCC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 019904 144 LDAYG--NLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216 (334)
Q Consensus 144 ~~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~ 216 (334)
++.++ .+||+|||++......... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 8999999998754332211 12234479999999999987766 5899999999999999999999986
Q ss_pred Cc--HHHHHHHh---hcCccCCC------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 217 SN--LMNLYKKI---SAAEFTCP------PWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 217 ~~--~~~~~~~~---~~~~~~~~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.. ........ ......++ ..++.++.+||.+||+.||.+|||++++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 53 22222222 11211111 246899999999999999999999999976
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.66 Aligned_cols=242 Identities=29% Similarity=0.473 Sum_probs=199.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+. ++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 35689999999999999999999984 7889999986432 24678899999999999999999998763 478
Q ss_pred EEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEEeecCCCCEEEecCCC-eEEeeccchhc
Q 019904 88 IVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS---RGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~---~~i~H~dlkp~NIl~~~~~~-~kl~Dfg~a~~ 160 (334)
+||||+++++|.+++.... .++...+..++.|++.||+|||+ +||+||||||+||+++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998765 37889999999999999999999 89999999999999998887 79999999864
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc--HHHHHHHh-hcCccCCCCCC
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKI-SAAEFTCPPWL 237 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~--~~~~~~~~-~~~~~~~~~~~ 237 (334)
... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... .......+ .......+..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred ccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 332 1233468999999999987666 589999999999999999999997532 22333222 22334556779
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+..+.++|.+||+.||.+|||++++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=342.95 Aligned_cols=246 Identities=24% Similarity=0.367 Sum_probs=200.8
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhh-hhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEecc
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEK-VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 93 (334)
..+.||+|+||.||+|.+ +++.||+|++.... .......+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 112 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence 348999999999999987 57899999987532 223344678899999999999999999999999999999999999
Q ss_pred CCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 94 TGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 94 ~~~~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
++++|.+++.. ..++++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++............
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 99999999874 346999999999999999999999999999999999999999999999999998754432222223
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH----HHHHHhhcCc-----------cCCCC
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAE-----------FTCPP 235 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~----~~~~~~~~~~-----------~~~~~ 235 (334)
....||+.|+|||++.+. + +.++|||||||++|+|++|..||...... .+...+.... ...+.
T Consensus 193 ~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADS 270 (307)
T ss_dssp SSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCH
T ss_pred cccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccch
Confidence 345789999999998753 3 58999999999999999999999864422 2222221111 11122
Q ss_pred CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 236 WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 236 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+..+.+++.+||+.||.+|||+.++++
T Consensus 271 ~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 271 TSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 34567899999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=359.06 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=196.5
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v 89 (334)
.+|.+.+.||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 4699999999999999764 3345789999999975432 2345799999999 799999999999999999999
Q ss_pred EeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CC--CeEEeeccchhcccc
Q 019904 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALSQQ 163 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~--~~kl~Dfg~a~~~~~ 163 (334)
||||.+ +|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++. ++ .+||+|||++.....
T Consensus 97 ~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 97 IELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp EECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred EECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 999975 9999997754 4566677899999999999999999999999999999953 23 478999999875432
Q ss_pred ccC-CCcccccccCCcccChHhhhcC--CCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCccCC---CCC
Q 019904 164 VRD-DGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC---PPW 236 (334)
Q Consensus 164 ~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~~~~---~~~ 236 (334)
... ........||+.|+|||++.+. ...+.++|||||||++|+|++ |..||................... +..
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 211 1223446799999999999742 233578999999999999999 999997665444433333222221 222
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.+..+++||.+||+.||.+|||++++++||||+.
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 4566899999999999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=348.77 Aligned_cols=247 Identities=16% Similarity=0.213 Sum_probs=199.8
Q ss_pred cccccceEEeeeeeccCceEEEEE-----EECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC---CCCeeeEEE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYE 78 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~ 78 (334)
....++|++.+.||+|+||+||+| .+..+++.||+|++.... ...+.+|+.+++.++ |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 344578999999999999999999 467789999999997543 345677888888887 899999999
Q ss_pred EEeeCCeEEEEEeccCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-------
Q 019904 79 VMGSKTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA------- 146 (334)
Q Consensus 79 ~~~~~~~~~~v~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~------- 146 (334)
++...+..|+|||||++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 457999999999999999999999999999999999999998
Q ss_pred ----CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHH
Q 019904 147 ----YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222 (334)
Q Consensus 147 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~ 222 (334)
++.+||+|||+|...............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 89999999999975443333334456689999999999998776 5899999999999999999999964322100
Q ss_pred HHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 223 YKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...........++...+++..||+.+|.+|++..+.+.
T Consensus 294 ----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 294 ----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp ----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred ----eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 00011111235678899999999999999976544443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=346.47 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=209.0
Q ss_pred CcccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Q 019904 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (334)
Q Consensus 2 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (334)
+...+....++|++.+.||+|+||.||+|.+. +|+.||+|++....... ....+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45566677899999999999999999999864 68899999997643221 1235789999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEEeecCCCCEEEecCCCeEEee
Q 019904 82 SKTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSD 154 (334)
Q Consensus 82 ~~~~~~~v~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~~l~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~D 154 (334)
.....++||||+.+|+|.+++.... ++++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998653 489999999999999999999999 999999999999999999999999
Q ss_pred ccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc--------HHHHHHHh
Q 019904 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------LMNLYKKI 226 (334)
Q Consensus 155 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~--------~~~~~~~~ 226 (334)
||++...... .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ........
T Consensus 178 fg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 178 FGLAKLMDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CSSCEECCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred CccccccCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9998754322 1222334568999999999987766 589999999999999999999995211 11111111
Q ss_pred hcCc-----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 227 SAAE-----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 227 ~~~~-----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
.... ...+...+..+.+++.+||+.||.+|||+.++++|-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0000 0111123467999999999999999999999998654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=342.12 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=205.0
Q ss_pred ccce-EEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--
Q 019904 10 VGKY-EVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (334)
Q Consensus 10 ~~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 82 (334)
.++| ++++.||+|+||+||++. +..+++.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 3455 999999999999998775 34578899999997642 23345778999999999999999999999987
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
...+|+||||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 46889999999999999998765 49999999999999999999999999999999999999999999999999987543
Q ss_pred cccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH---------------HHHHHh
Q 019904 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKKI 226 (334)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~---------------~~~~~~ 226 (334)
..... .......+|+.|+|||++.+..+. .++|||||||++|+|++|..||...... .....+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 32111 122344578889999999877664 8899999999999999999999754321 111111
Q ss_pred h-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 227 S-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 227 ~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
. ......+..++.++.+||.+||+.||.+|||++++++
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 2234567789999999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=336.20 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=195.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEee---
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGS--- 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~--- 82 (334)
...++|++.+.||+|+||+||+|.+ +|+.||||++.... ...+.+|..++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3567999999999999999999988 58899999997543 2344556666666 789999999998644
Q ss_pred -CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEEeecCCCCEEEecCCCeEEe
Q 019904 83 -KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 83 -~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
....|+||||+++|+|.+++.. ..+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3568999999999999999954 56999999999999999999999 9999999999999999999999999
Q ss_pred eccchhccccccCC--CcccccccCCcccChHhhhcCCCC-----CCccchhhHHHHHHHHHhC----------CCCCCC
Q 019904 154 DFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFDD 216 (334)
Q Consensus 154 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~e~~~g----------~~pf~~ 216 (334)
|||++......... .......||+.|+|||++.+.... +.++|||||||++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99998654322111 112334799999999999875332 2589999999999999999 888854
Q ss_pred C----cHHHHHHHhhcC---ccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 217 S----NLMNLYKKISAA---EFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 217 ~----~~~~~~~~~~~~---~~~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
. ............ ....|. ..+..+.+||.+||+.||.+|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 122222222211 112221 14467999999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=366.85 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=207.5
Q ss_pred eeeeccCceEEEEEEE--CCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
+.||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+|+.++||||+++++++.. +.+++||||+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999954 4567889999997643 333445789999999999999999999999965 45889999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC-CCccccc
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTT 173 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 173 (334)
+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .......
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~ 532 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 532 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence 999999999888999999999999999999999999999999999999999999999999999875433211 1122233
Q ss_pred ccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 019904 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 251 (334)
.+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....|..++.++.+||.+||+.
T Consensus 533 ~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~ 611 (635)
T 4fl3_A 533 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 611 (635)
T ss_dssp --CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 56788999999988776 489999999999999998 99999998888877777655 3466788999999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019904 252 NPMTRITIPEILE 264 (334)
Q Consensus 252 dp~~Rpt~~e~l~ 264 (334)
||.+|||++++++
T Consensus 612 dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 612 DVENRPGFAAVEL 624 (635)
T ss_dssp STTTSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=343.44 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=189.5
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEe---
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG--- 81 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~--- 81 (334)
+.....+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.+. ||||+++++++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 3344568999999999999999999999999999999986532 233567889999999996 999999999983
Q ss_pred -----eCCeEEEEEeccCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEecCCCeE
Q 019904 82 -----SKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLK 151 (334)
Q Consensus 82 -----~~~~~~~v~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~~~~~~k 151 (334)
....+++||||+. |+|.+++.. .+++++..++.++.||+.||+|||++| |+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 4456899999997 588888865 457999999999999999999999999 99999999999999999999
Q ss_pred EeeccchhccccccCCC----------cccccccCCcccChHhhh--cCCCCCCccchhhHHHHHHHHHhCCCCCCCCcH
Q 019904 152 VSDFGLSALSQQVRDDG----------LLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219 (334)
Q Consensus 152 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~ 219 (334)
|+|||++.......... ......||+.|+|||++. .....+.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999987543321110 112446899999999984 222335899999999999999999999987655
Q ss_pred HHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCcc
Q 019904 220 MNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEW 267 (334)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~ 267 (334)
....... .....+...+..+.+||.+||+.||.+|||++|++++-+
T Consensus 259 ~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 259 LRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ---------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 4443322 223345567889999999999999999999999998643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=350.40 Aligned_cols=256 Identities=23% Similarity=0.303 Sum_probs=202.1
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe-e
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-S 82 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 82 (334)
.....+|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.+++.++||||+++++++. .
T Consensus 85 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 162 (373)
T 3c1x_A 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162 (373)
T ss_dssp CSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC
T ss_pred ChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC
Confidence 344557899999999999999999875433 45899988642 22334678899999999999999999999864 4
Q ss_pred CCeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
++..|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 163 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 568899999999999999997654 5889999999999999999999999999999999999999999999999998754
Q ss_pred ccccCC--CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCC
Q 019904 162 QQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWL 237 (334)
Q Consensus 162 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~ 237 (334)
...... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~ 321 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC 321 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence 322111 11223456788999999988776 489999999999999999 78888876655544444433 34556779
Q ss_pred CHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 238 SFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 238 ~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+..+.++|.+||+.||.+|||+.+++++
T Consensus 322 ~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 322 PDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=363.70 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=207.4
Q ss_pred ccceEEee-eeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGR-TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
-+++.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 34556666 8999999999999875 345679999997542 22235778899999999999999999999976 568
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+|||||.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999999999754 469999999999999999999999999999999999999999999999999987543221
Q ss_pred C-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHH
Q 019904 166 D-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 242 (334)
. ........+++.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..+....+... ....|..++.++.
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~ 569 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 569 (613)
T ss_dssp -----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence 1 111122345688999999987776 489999999999999998 99999998877777776554 3566788999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+||.+||+.||.+|||++++++
T Consensus 570 ~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 570 ALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=338.35 Aligned_cols=248 Identities=21% Similarity=0.364 Sum_probs=194.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEeeC---
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSK--- 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~--- 83 (334)
..++|++.+.||+|+||.||+|.+. |+.||||++.... .....+|..++.. ++||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 4578999999999999999999985 8899999986543 1233445555554 4899999999999887
Q ss_pred -CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEEeecCCCCEEEecCCCeEEee
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSD 154 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~--------~i~H~dlkp~NIl~~~~~~~kl~D 154 (334)
...|+||||+++|+|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred CCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 7899999999999999999764 699999999999999999999999 999999999999999999999999
Q ss_pred ccchhccccccCC--CcccccccCCcccChHhhhcCCCCCC-----ccchhhHHHHHHHHHhC----------CCCCCCC
Q 019904 155 FGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGS-----TADLWSCGVILFVLLAG----------YLPFDDS 217 (334)
Q Consensus 155 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~e~~~g----------~~pf~~~ 217 (334)
||++......... .......||+.|+|||++.+...... ++|||||||++|+|++| ..||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 9998643322111 11234579999999999987665422 38999999999999999 7777542
Q ss_pred -----cHHHHHHHhhc--CccCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 218 -----NLMNLYKKISA--AEFTCPP-----WLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 218 -----~~~~~~~~~~~--~~~~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
........+.. .....|. .++.++.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11222222211 1222222 345679999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=360.84 Aligned_cols=249 Identities=23% Similarity=0.367 Sum_probs=213.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||.||+|.+.. +..||||++...... .+.+.+|+.+|+.++||||+++++++.. ..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 445789999999999999999999865 567999999764322 3568899999999999999999999866 6789
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+||||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999999753 469999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
. .......++..|+|||++....+ +.++|||||||++|+|++ |..||.+....+....+... ....+..++..+.+
T Consensus 418 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 418 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp H-HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred e-ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 0 11123346778999999987766 489999999999999999 99999998887777776554 34567789999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
||.+||+.||++|||++++++
T Consensus 496 li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 496 LMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=338.05 Aligned_cols=252 Identities=22% Similarity=0.378 Sum_probs=207.1
Q ss_pred cccceEEeeeeeccCceEEEEEE----ECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
..++|++++.||+|+||.||+|. +..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 45679999999999999999998 4668899999999753 2334577899999999999999999999986654
Q ss_pred --eEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
.+++||||+++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 789999999999999999876 46999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH----------------HHHH
Q 019904 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLYK 224 (334)
Q Consensus 162 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~----------------~~~~ 224 (334)
...... .......++..|+|||.+.+..+ +.++|||||||++|+|++|..||...... .+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 332111 11223456778999999987666 48899999999999999999998643110 1112
Q ss_pred Hhh-cCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 225 KIS-AAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 225 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+. ....+.+..++.++.++|.+||+.||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222 2234567789999999999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=340.68 Aligned_cols=262 Identities=20% Similarity=0.298 Sum_probs=192.8
Q ss_pred cccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--
Q 019904 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (334)
Q Consensus 5 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 82 (334)
.....+++|++.+.||+|+||.||+|.+ +++.||||++....... .....++..+..++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh----HHHHHHHHHHHhccCcchhhheecccccc
Confidence 3456789999999999999999999987 67899999997543211 112234444556899999999985532
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEEeecCCCCEEEecCCCe
Q 019904 83 ---KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---------GVYHRDLKPENLLLDAYGNL 150 (334)
Q Consensus 83 ---~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~---------~i~H~dlkp~NIl~~~~~~~ 150 (334)
...+|+||||+++|+|.+++.... .++..+..++.||+.||+|||+. ||+||||||+|||++.++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 346799999999999999997654 58899999999999999999999 99999999999999999999
Q ss_pred EEeeccchhcccccc------CCCcccccccCCcccChHhhhcCC------CCCCccchhhHHHHHHHHHhCCCCCCC-C
Q 019904 151 KVSDFGLSALSQQVR------DDGLLHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLAGYLPFDD-S 217 (334)
Q Consensus 151 kl~Dfg~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~e~~~g~~pf~~-~ 217 (334)
||+|||++....... .........||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.. .
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999987543211 111223457999999999997631 223678999999999999999776532 1
Q ss_pred c-----------------HHHHHHHh--hcCccCCCCC------CCHHHHHHHHHhcCCCCCCCCCHhHHhc------Cc
Q 019904 218 N-----------------LMNLYKKI--SAAEFTCPPW------LSFTARKLIARILDPNPMTRITIPEILE------DE 266 (334)
Q Consensus 218 ~-----------------~~~~~~~~--~~~~~~~~~~------~~~~~~~li~~~L~~dp~~Rpt~~e~l~------h~ 266 (334)
. ........ ......+|.. ++..+.+||.+||+.||.+|||+.|+++ ++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1 11111111 1112233333 3347999999999999999999999954 56
Q ss_pred cccCCCC
Q 019904 267 WFKKDYK 273 (334)
Q Consensus 267 ~~~~~~~ 273 (334)
|-++...
T Consensus 320 ~~~~~~~ 326 (336)
T 3g2f_A 320 WERNKSV 326 (336)
T ss_dssp CCC----
T ss_pred HHhcccC
Confidence 6665443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=371.09 Aligned_cols=259 Identities=28% Similarity=0.403 Sum_probs=206.0
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee---
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 82 (334)
.+..+++|++.+.||+|+||.||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK 86 (676)
T ss_dssp --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence 3556799999999999999999999999999999999987532 23345778899999999999999999998765
Q ss_pred ---CCeEEEEEeccCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCC---eEEe
Q 019904 83 ---KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVS 153 (334)
Q Consensus 83 ---~~~~~~v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~ 153 (334)
.+..|+|||||+||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++. ++|+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 677899999999999999998754 5899999999999999999999999999999999999997765 8999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHH--------
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK-------- 225 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~-------- 225 (334)
|||++..... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......+..
T Consensus 167 DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 167 DLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp SCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 9999875432 222345678999999999987766 4899999999999999999999976432221100
Q ss_pred -h-----hcCcc------C----CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 226 -I-----SAAEF------T----CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 226 -~-----~~~~~------~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+ ..... + .+..++..+.+||.+||..||.+|||+.++++||||..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 00111 1 11225678999999999999999999999999999973
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=361.37 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=212.6
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34567899999999999999999998643 4569999886432 3344577889999999999999999999984 5
Q ss_pred CeEEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
+..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 66899999999999999998654 68999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHH
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (334)
.... .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+....+....+... ..+.|+.+++.
T Consensus 543 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C-----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCcc-eeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 2211 11223456789999999987766 489999999999999997 99999998888877776554 35677889999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 241 ARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+.+||.+||+.||.+|||+.++++
T Consensus 621 l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.74 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=208.6
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
.....++|++.+.||+|+||.||+|.+.. .||+|++...... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 34567899999999999999999999853 5999998754321 2223556789999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+++||||+.+++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+||+++ ++.++|+|||++......
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999999997755 699999999999999999999999999999999999998 689999999987654321
Q ss_pred c---CCCcccccccCCcccChHhhhcC--------CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC
Q 019904 165 R---DDGLLHTTCGTPNYVAPEVLNDR--------GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (334)
Q Consensus 165 ~---~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~ 233 (334)
. .........|++.|+|||++.+. ...+.++|||||||++|+|++|..||...........+.....+.
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 262 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN 262 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence 1 11223345689999999999752 233578999999999999999999999988877777665543322
Q ss_pred --CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 234 --PPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 234 --~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+..++.++.++|.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2358899999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=347.78 Aligned_cols=249 Identities=21% Similarity=0.275 Sum_probs=205.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeeCCeEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 87 (334)
..++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+.| ++|..+..++......|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999998754322 346789999999987 56666777778888999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE---ecCCCeEEeeccchhcccc
Q 019904 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~ 163 (334)
+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8899999985 4579999999999999999999999999999999999999 5889999999999875443
Q ss_pred ccCC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCc-----
Q 019904 164 VRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAE----- 230 (334)
Q Consensus 164 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~~----- 230 (334)
.... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. ....+.++....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 2221 11235679999999999998776 489999999999999999999998643 233333332221
Q ss_pred cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 231 FTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 231 ~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
...+..++.++.+||.+||+.||.+||+++++++
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1223568999999999999999999999998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=332.04 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=200.0
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHh--CCCCCeeeEEEEEeeCC---
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSKT--- 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~--- 84 (334)
.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|..+++. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46899999999999999999998 48899999996542 3456788888887 78999999999998876
Q ss_pred -eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEEeecCCCCEEEecCCCeEEeec
Q 019904 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKVSDF 155 (334)
Q Consensus 85 -~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH--------~~~i~H~dlkp~NIl~~~~~~~kl~Df 155 (334)
..|+||||+++|+|.+++... ++++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 899999999999999999764 6999999999999999999999 899999999999999999999999999
Q ss_pred cchhccccccCC--CcccccccCCcccChHhhhcCCCCC-----CccchhhHHHHHHHHHhC----------CCCCCCC-
Q 019904 156 GLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDG-----STADLWSCGVILFVLLAG----------YLPFDDS- 217 (334)
Q Consensus 156 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~e~~~g----------~~pf~~~- 217 (334)
|++......... .......||+.|+|||++.+..... .++|||||||++|+|++| ..||...
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 998654332111 0123457899999999998653321 578999999999999999 7898653
Q ss_pred ----cHHHHHHHhhcCc--cCCCC-----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 218 ----NLMNLYKKISAAE--FTCPP-----WLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 218 ----~~~~~~~~~~~~~--~~~~~-----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
........+.... ...|. ..+..+.+||.+||+.||.+|||+++++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2233333332222 22222 133578999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=350.27 Aligned_cols=253 Identities=18% Similarity=0.219 Sum_probs=195.9
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCe---------ee-
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNV---------VR- 75 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i---------v~- 75 (334)
......|+..+.||+|+||.||+|.+..+|+.||||++...........+.+++|+.+++.+.| +|. +.
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3445569999999999999999999999999999999875443333445778999999999987 221 11
Q ss_pred -----------EEEEEee-----CCeEEEEEeccCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019904 76 -----------LYEVMGS-----KTKIFIVLEFVTGGELFDKIVN-------HGRMKEDEARRYFQQLINAVDYCHSRGV 132 (334)
Q Consensus 76 -----------~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qil~~l~~LH~~~i 132 (334)
+..++.. ...++++|+++. ++|.+++.. ...+++..+..++.||+.||+|||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 232 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 232 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 1111111 234678888764 689888842 2347788899999999999999999999
Q ss_pred EEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhc---------CCCCCCccchhhHHHH
Q 019904 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND---------RGYDGSTADLWSCGVI 203 (334)
Q Consensus 133 ~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~~DiwslG~i 203 (334)
+||||||+|||++.++.+||+|||++...... ....+| +.|+|||++.. ....+.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998754322 344567 99999999942 2223478999999999
Q ss_pred HHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 204 LFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 204 l~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+|+|++|+.||.+.+.......+ +.....+|.++.+||.+||+.||.+|||+.++++||||..
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHCCCCCCCcchhhhHHHH----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999876644333322 2233468899999999999999999999999999999974
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=323.53 Aligned_cols=222 Identities=19% Similarity=0.248 Sum_probs=188.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
.++|++.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 37899999999999999999999999999999999876555555668889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||++|++|.+++.. + .....+..++.|++.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~------------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-------------
T ss_pred EEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-------------
Confidence 999999999999854 3 4566788999999999999999999999999999999999999998554
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH---HhhcCcc----CCCCCCCHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEF----TCPPWLSFTAR 242 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~---~~~~~~~----~~~~~~~~~~~ 242 (334)
|++| .+.++|||||||++|+|++|+.||.+.+...... +...... ..++.++.++.
T Consensus 175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 2222 3588999999999999999999998765332110 1111111 12356899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+||.+||+.||.+| |+.|+++
T Consensus 238 ~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHHHHH
T ss_pred HHHHHHcccCCccC-CHHHHHH
Confidence 99999999999999 9999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=345.94 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=194.4
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHHHhCC---------CCCeee
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVK---------HPNVVR 75 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~~iv~ 75 (334)
.++|++.+.||+|+||+||+|++ +|+.||||++...... .....+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 57899999999999999999998 6799999999865321 2223467788999988885 888888
Q ss_pred EEEEEe------------------------------eCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 019904 76 LYEVMG------------------------------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125 (334)
Q Consensus 76 ~~~~~~------------------------------~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~ 125 (334)
+.+++. .....|+|||||.+|++.+.+.+ +.+++..++.++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 877643 26889999999999977776644 56899999999999999999
Q ss_pred HHH-hCCcEEeecCCCCEEEecCC--------------------CeEEeeccchhccccccCCCcccccccCCcccChHh
Q 019904 126 YCH-SRGVYHRDLKPENLLLDAYG--------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184 (334)
Q Consensus 126 ~LH-~~~i~H~dlkp~NIl~~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 184 (334)
||| ++||+||||||+|||++.+| .+||+|||+|+.... ...+||+.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999987 899999999875432 23579999999999
Q ss_pred hhcCCCCCCccchhhHHHH-HHHHHhCCCCCCCCcH-HHHHHHhh-cCcc--CC----CCCCCHHHHHHHHHhcCCCCCC
Q 019904 185 LNDRGYDGSTADLWSCGVI-LFVLLAGYLPFDDSNL-MNLYKKIS-AAEF--TC----PPWLSFTARKLIARILDPNPMT 255 (334)
Q Consensus 185 ~~~~~~~~~~~DiwslG~i-l~e~~~g~~pf~~~~~-~~~~~~~~-~~~~--~~----~~~~~~~~~~li~~~L~~dp~~ 255 (334)
+.+.. +.++||||||++ .+++++|..||.+... ......+. .... .. ++.+|+++++||.+||+.|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 98765 589999998877 6788999999965322 11222222 1111 11 1236789999999999977
Q ss_pred CCCHhHHh-cCcccc
Q 019904 256 RITIPEIL-EDEWFK 269 (334)
Q Consensus 256 Rpt~~e~l-~h~~~~ 269 (334)
|++|+| +||||+
T Consensus 324 --sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 --SATDLLCQHSLFK 336 (336)
T ss_dssp --SHHHHHHHCGGGC
T ss_pred --CHHHHHhcCCCcC
Confidence 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=358.96 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=198.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECC-CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe---
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK--- 85 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 85 (334)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 3899999999999999999999976 78999999986532 23345678899999999999999999999987655
Q ss_pred --EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 86 --IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 86 --~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
.|+||||++|++|.+.+.. ++++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++.....
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS 233 (681)
T ss_dssp EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SCEEECCCTTCEETTC
T ss_pred ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-CcEEEEecccchhccc
Confidence 7999999999999987754 7999999999999999999999999999999999999987 4999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHH
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (334)
. ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+.....+ .........++.+.+
T Consensus 234 ~------~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~~l~~ 299 (681)
T 2pzi_A 234 F------GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYDSYGR 299 (681)
T ss_dssp C------SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCHHHHH
T ss_pred C------CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCHHHHH
Confidence 1 3457999999999998654 5899999999999999999999875321000 000000114578999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 244 LIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
||.+||+.||.+||+..+.+.|+|+.
T Consensus 300 li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 300 LLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHhhhccCChhhCCCHHHHHHHHHHH
Confidence 99999999999999999988888774
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=296.76 Aligned_cols=189 Identities=15% Similarity=0.143 Sum_probs=137.2
Q ss_pred eeeccCceEEEEEEECCCCCeEEEEEeehhh-------hhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCCeEEEE
Q 019904 18 TIGEGTFAKVKFARNSETGEPVALKILDKEK-------VLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 18 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v 89 (334)
..+.|++|.+..++..-.|+.|++|++.+.. ...+...+.+.+|+.+|+++ .|+||++++++++++...|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4567777777777776789999999997542 12344457799999999999 599999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||++|++|.++|...+++++. .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Ccc
Confidence 9999999999999998888875 47899999999999999999999999999999999999999998754322 223
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCC
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP 213 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~p 213 (334)
..+.+||+.|+|||++.+.. ..++|+||+|++++++.++..+
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccch
Confidence 45678999999999998643 3678999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=251.60 Aligned_cols=188 Identities=22% Similarity=0.232 Sum_probs=143.0
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh-----hhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
...+.||+|+||.||+|.. .++.+++|....... ......+++.+|+.+++.++||||+++..++...+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3456899999999999944 578899998654222 222335668999999999999999955444446677799
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||+++++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999998865 5689999999999999999999999999999998 99999999988654321111
Q ss_pred -----cccccccCCcccChHhhhc--CCCCCCccchhhHHHHHHHHHhCCCCC
Q 019904 169 -----LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPF 214 (334)
Q Consensus 169 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~e~~~g~~pf 214 (334)
......||+.|+|||++.. ..| +..+|+||.++-..+.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhcccc
Confidence 1235689999999999986 444 36789999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=210.35 Aligned_cols=146 Identities=17% Similarity=0.231 Sum_probs=116.5
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---------------HHHHHHHHHHHHHHhCCCCCeeeEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---------------KMAEQIKREVATMKLVKHPNVVRLY 77 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (334)
|.+++.||+|+||.||+|.+ .+|+.||+|+++....... .....+.+|+.+|+.++| +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 34449999999999999999 7899999999965322111 235678899999999994 5555
Q ss_pred EEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 78 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
+++.. +..|+||||++|++|.+ +. . .....++.|++.||.|||++||+||||||+|||++ +|.++|+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 55543 45699999999999987 42 1 23557999999999999999999999999999999 99999999998
Q ss_pred hhccccccCCCcccccccCCcccChHhhh
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLN 186 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 186 (334)
|.. +..+.|||.+.
T Consensus 239 a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE---------------VGEEGWREILE 252 (282)
T ss_dssp CEE---------------TTSTTHHHHHH
T ss_pred CeE---------------CCCCCHHHHHH
Confidence 752 44678999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-23 Score=181.08 Aligned_cols=141 Identities=23% Similarity=0.290 Sum_probs=109.6
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCe--EEEEEeehhhhh---------------------hHHHHHHHHHHHHHHHh
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVL---------------------KHKMAEQIKREVATMKL 67 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~ 67 (334)
--|.+.+.||+|+||.||+|.+..+|+. ||||+++..... .......+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3478999999999999999998778888 999997543211 01122467899999999
Q ss_pred CCCCCe--eeEEEEEeeCCeEEEEEeccCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEEeecCC
Q 019904 68 VKHPNV--VRLYEVMGSKTKIFIVLEFVTG-G----ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKP 139 (334)
Q Consensus 68 l~h~~i--v~~~~~~~~~~~~~~v~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH-~~~i~H~dlkp 139 (334)
+.|+++ +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 988764 444443 356899999942 3 66655432 335577889999999999999 99999999999
Q ss_pred CCEEEecCCCeEEeeccchhc
Q 019904 140 ENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 140 ~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+|||++. .++|+|||+|..
T Consensus 200 ~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS--SEEECCCTTCEE
T ss_pred HHEEEcC--cEEEEECccccc
Confidence 9999988 999999998864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.81 E-value=7.6e-20 Score=166.56 Aligned_cols=139 Identities=18% Similarity=0.201 Sum_probs=102.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh-----------------h--HHHHHHHHHHHHHHHhCCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----------------K--HKMAEQIKREVATMKLVKH 70 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------~--~~~~~~~~~e~~~l~~l~h 70 (334)
-.=|.+++.||.|++|.||+|.+. +|+.||||+++..... . ........+|...|.++.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 334999999999999999999985 6999999997642110 0 0011223467788888865
Q ss_pred CCee--eEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC
Q 019904 71 PNVV--RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (334)
Q Consensus 71 ~~iv--~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~ 148 (334)
.++. ..++.. ..++||||+.|++|.... .......++.||+.+|.+||+.|||||||||.|||++.+|
T Consensus 173 ~gv~vp~p~~~~----~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 173 EGFPVPEPIAQS----RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp TTCSCCCEEEEE----TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred cCCCCCeeeecc----CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 5543 333322 236999999998875432 1234567889999999999999999999999999998876
Q ss_pred C----------eEEeeccchh
Q 019904 149 N----------LKVSDFGLSA 159 (334)
Q Consensus 149 ~----------~kl~Dfg~a~ 159 (334)
. +.|+||+.+-
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCE
T ss_pred CcccccccccceEEEEeCCcc
Confidence 3 7899999643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-14 Score=125.43 Aligned_cols=145 Identities=17% Similarity=0.144 Sum_probs=115.5
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCC
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 84 (334)
+...++.|++...+|.|+.+.||++... ++.+++|+........ ...+.+|+.+++.+. +..+.+++++....+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 4566788999999999999999999753 6789999987532111 235778999999885 677889999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----------------------------------- 129 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~----------------------------------- 129 (334)
..|+|||+++|.+|.+.+. +......++.++..+|+.||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred ceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999988876521 122344688899999999998
Q ss_pred ------------------------CCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 130 ------------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 130 ------------------------~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
.+++|+|++|.||++++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998755567999997653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=117.01 Aligned_cols=140 Identities=14% Similarity=0.128 Sum_probs=104.4
Q ss_pred ccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEEEEeeC
Q 019904 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSK 83 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~ 83 (334)
+...+..|.+....+.|..+.||++.. .+|..+++|+..... ...+.+|+.+++.+.+.+ +.+++.+....
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 456677788765555666799999965 457789999976431 235678888888886544 56688888888
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-------------------------------- 131 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~-------------------------------- 131 (334)
+..|+|||+++|.++. . .... ...++.++...|+.||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 8899999999998873 1 1122 2256777888888888643
Q ss_pred --------------------------cEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 132 --------------------------VYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 132 --------------------------i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
++|+|++|.||++++++.+.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766677999997653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.28 E-value=9.7e-12 Score=113.20 Aligned_cols=143 Identities=22% Similarity=0.340 Sum_probs=106.9
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEee--hhhhhhHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEeeC---Ce
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSK---TK 85 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~---~~ 85 (334)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+++.+.. ..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345678999999999998864 4678999876 32211 113467789999999874 4578889888766 45
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------ 129 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~------------------------------------ 129 (334)
.|+|||+++|..+.+.. -..++......++.++..+|+.||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 89999999997764321 2346788888999999999999997
Q ss_pred ----------------------CCcEEeecCCCCEEEecCCC--eEEeeccchhcc
Q 019904 130 ----------------------RGVYHRDLKPENLLLDAYGN--LKVSDFGLSALS 161 (334)
Q Consensus 130 ----------------------~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~a~~~ 161 (334)
.+++|+|++|.||+++.++. +.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999987754 689999987643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=4.6e-12 Score=112.70 Aligned_cols=185 Identities=18% Similarity=0.201 Sum_probs=122.2
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCC--eeeEEEEEeeCC---eEEEE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPN--VVRLYEVMGSKT---KIFIV 89 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--iv~~~~~~~~~~---~~~~v 89 (334)
++.++.|....||++. ..+++|+.... .....+.+|+.+|+.+. +.. +.+++....... ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999763 46899986532 23467889999998874 333 445555443333 34889
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------------------------------------- 129 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~---------------------------------------- 129 (334)
|++++|..+..... ..++......++.++...++.||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865433 246777788888888888888886
Q ss_pred ------------------CCcEEeecCCCCEEEec--CCCeEEeeccchhccccccCCCccccc---cc---------CC
Q 019904 130 ------------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTT---CG---------TP 177 (334)
Q Consensus 130 ------------------~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~---~g---------t~ 177 (334)
..++|+|++|.||+++. .+.+.++||+.+.......+-...... .+ ..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 23799999999999998 456889999987653321110000000 00 00
Q ss_pred cccC-hHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 019904 178 NYVA-PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (334)
Q Consensus 178 ~y~a-PE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~ 215 (334)
.... |+...... .-.+.|++|.++|.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHHH
Confidence 0111 22222111 11589999999999999988864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=2.1e-08 Score=87.19 Aligned_cols=141 Identities=14% Similarity=0.168 Sum_probs=101.1
Q ss_pred cccceEEeeeeeccCce-EEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeCCeE
Q 019904 9 RVGKYEVGRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 86 (334)
.+..|+.. .+..|..+ .||+......+..+++|+-.... ...+.+|...|+.+. +--|.+++.+..+.+..
T Consensus 23 ~l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~ 95 (272)
T 4gkh_A 23 DLYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA 95 (272)
T ss_dssp HHTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred cccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence 34445543 34445444 79998887778889999876432 356778999888775 32367888888899999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------- 129 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~------------------------------------- 129 (334)
|+|||+++|.++.+..... ......+..++...|+.||+
T Consensus 96 ~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (272)
T 4gkh_A 96 WLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDER 171 (272)
T ss_dssp EEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGG
T ss_pred EEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccc
Confidence 9999999998876655332 12233456666666777763
Q ss_pred ---------------------CCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 130 ---------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 130 ---------------------~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus 172 ~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 172 NGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1278999999999999877778999997654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.84 E-value=6.6e-08 Score=85.85 Aligned_cols=135 Identities=19% Similarity=0.251 Sum_probs=95.3
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC---CeeeEEEEEe-eCCeEEEEEe
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMG-SKTKIFIVLE 91 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~-~~~~~~~v~e 91 (334)
++.++.|....||+. |..+++|+-... .....+.+|+.+|+.+.+. .|.+++.+.. ..+..|+||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 466888999999987 567899985321 2346788999999998752 3566666664 4556789999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------------------------------------- 130 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~----------------------------------------- 130 (334)
+++|..+..... ..++......++.++...|+.||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988765321 2345555555566666666655532
Q ss_pred -------------------CcEEeecCCCCEEEec---CCC-eEEeeccchhccc
Q 019904 131 -------------------GVYHRDLKPENLLLDA---YGN-LKVSDFGLSALSQ 162 (334)
Q Consensus 131 -------------------~i~H~dlkp~NIl~~~---~~~-~kl~Dfg~a~~~~ 162 (334)
.++|+|++|.||+++. ++. +.|+||+.+....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999987 455 5899999876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=1.3e-07 Score=86.99 Aligned_cols=80 Identities=15% Similarity=0.150 Sum_probs=50.2
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhh-hhH---HHHHHHHHHHHHHHhCCC--C-CeeeEEEEEeeCCeEE
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKH---KMAEQIKREVATMKLVKH--P-NVVRLYEVMGSKTKIF 87 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~---~~~~~~~~e~~~l~~l~h--~-~iv~~~~~~~~~~~~~ 87 (334)
..+.||.|..+.||++....+++.+++|....... ..+ ....++..|..+++.+.. | .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997665678899998653211 000 112455678888887642 3 34456654 344568
Q ss_pred EEEeccCCC
Q 019904 88 IVLEFVTGG 96 (334)
Q Consensus 88 ~v~e~~~~~ 96 (334)
+|||++++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.28 E-value=9e-06 Score=72.69 Aligned_cols=30 Identities=23% Similarity=0.299 Sum_probs=27.2
Q ss_pred CCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 689999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=2.8e-06 Score=76.80 Aligned_cols=86 Identities=10% Similarity=0.154 Sum_probs=54.9
Q ss_pred eEEeeee-eccCceEEEEEEEC--C----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEee
Q 019904 13 YEVGRTI-GEGTFAKVKFARNS--E----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGS 82 (334)
Q Consensus 13 y~~~~~l-G~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~ 82 (334)
....+.| +.|....+|+.... . ++..+++|+..............+.+|+.+++.+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88888999987653 1 156789998654320000001345678888877752 346778877765
Q ss_pred C---CeEEEEEeccCCCch
Q 019904 83 K---TKIFIVLEFVTGGEL 98 (334)
Q Consensus 83 ~---~~~~~v~e~~~~~~L 98 (334)
. +..|+|||+++|..+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp STTTSSCEEEEECCCCBCC
T ss_pred CCccCCceEEEEecCCCCh
Confidence 5 356899999988554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.13 E-value=2.6e-05 Score=69.07 Aligned_cols=77 Identities=17% Similarity=0.258 Sum_probs=59.9
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC---CCCeeeEEEEEeeCCeEEEEE
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~v~ 90 (334)
.-.+.|+.|....+|+... ++..+++|+..... ...+..|+..|+.+. ...+++++.+....+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457789999999999875 46778999876432 456778888888774 356788888888888999999
Q ss_pred eccCCCch
Q 019904 91 EFVTGGEL 98 (334)
Q Consensus 91 e~~~~~~L 98 (334)
|+++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.4e-05 Score=73.86 Aligned_cols=81 Identities=14% Similarity=0.061 Sum_probs=45.8
Q ss_pred HhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCC--CCccchhhHHHHHH
Q 019904 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILF 205 (334)
Q Consensus 128 H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~ 205 (334)
+...++|+|++|.||+++.++ +.++||+.+.......+-...-.. -...|++|+........ ....++.+++..+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN-LILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH-HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH-HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 456899999999999998876 999999987653322111000000 01235555544311100 01234456677777
Q ss_pred HHHhC
Q 019904 206 VLLAG 210 (334)
Q Consensus 206 e~~~g 210 (334)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.05 E-value=3.1e-05 Score=64.05 Aligned_cols=121 Identities=18% Similarity=0.114 Sum_probs=80.8
Q ss_pred chHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccccc
Q 019904 97 ELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (334)
Q Consensus 97 ~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 174 (334)
+|.+.|.. ..+++|+++|.++.|.+.+|.-+-. ..-..+=+.|..|++..+|.|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 78888875 5689999999999999999888721 1212344567899999999988774 2111 1
Q ss_pred cCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhcCC
Q 019904 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 251 (334)
....+.|||... ...+.+.=|||||+++|.-+--..|- .-+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 123466787753 22246678999999999888644441 11345899999999999866
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=2.3e-05 Score=68.98 Aligned_cols=74 Identities=15% Similarity=0.074 Sum_probs=45.9
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEEEEe
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e 91 (334)
+.-++.|+.|....+|++ ..+++|+....... .-...+|+.+++.+...++ .+++.+ +.+.-++++|
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e 87 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR 87 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence 444788999999999998 45899987643211 1122457777776653333 455554 3334568999
Q ss_pred cc-CCCch
Q 019904 92 FV-TGGEL 98 (334)
Q Consensus 92 ~~-~~~~L 98 (334)
|+ +|..+
T Consensus 88 ~i~~g~~l 95 (301)
T 3dxq_A 88 YIAGAQTM 95 (301)
T ss_dssp CCTTCEEC
T ss_pred ecCCCccC
Confidence 99 66444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.68 E-value=5.8e-05 Score=66.93 Aligned_cols=139 Identities=15% Similarity=0.134 Sum_probs=76.6
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEEE------EeeCCeE
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTKI 86 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~------~~~~~~~ 86 (334)
-.+.|+.|....+|++.... | .+++|+..... . .+.+..|..+++.+...+ +.+++.. ....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-E----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-C----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 45667788889999987642 3 68999887521 1 133455666666654212 2333311 1234677
Q ss_pred EEEEeccCCCchH--------------HHHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 019904 87 FIVLEFVTGGELF--------------DKIVNH-GRM--------KEDEARRY---------------FQQLINAVDYCH 128 (334)
Q Consensus 87 ~~v~e~~~~~~L~--------------~~l~~~-~~l--------~~~~~~~i---------------~~qil~~l~~LH 128 (334)
+++|++++|..+. ..++.. ..+ ....-... ...+...++.+.
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 8999999985431 011111 011 10000000 011333444554
Q ss_pred h-------CCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 129 S-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 129 ~-------~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
. .+++|+|++|.||+++.++.+.++||+.+..
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 2 4799999999999998866668999997653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.67 E-value=6.5e-05 Score=67.05 Aligned_cols=137 Identities=15% Similarity=0.196 Sum_probs=71.0
Q ss_pred eeeeeccCceE-EEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC--CCeeeEEEEEeeCCeEEEEEec
Q 019904 16 GRTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 16 ~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
.+.|+.|.... +|+... .+|+.+++|....... ..+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 45566554444 666653 2366788886543210 223456666665542 23556666543333 689999
Q ss_pred cCCCchHHHHHhc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 019904 93 VTGGELFDKIVNH--------------------------GRMKEDEAR-------RYF-------------QQLINAVDY 126 (334)
Q Consensus 93 ~~~~~L~~~l~~~--------------------------~~l~~~~~~-------~i~-------------~qil~~l~~ 126 (334)
+.+..+.+.+... ..+...... .+. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776654433211 011121110 000 011112222
Q ss_pred H------HhCCcEEeecCCCCEEEecC----CCeEEeeccchhcc
Q 019904 127 C------HSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALS 161 (334)
Q Consensus 127 L------H~~~i~H~dlkp~NIl~~~~----~~~kl~Dfg~a~~~ 161 (334)
+ +...++|||+.+.||+++.+ +.+.++||+.+...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2 23579999999999999874 67899999987643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00076 Score=58.73 Aligned_cols=78 Identities=12% Similarity=0.088 Sum_probs=53.7
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC---CCeeeEEEEEeeCCeEEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~ 88 (334)
+..-++.+|.|..+.||++... +|+.|++|+-....... ...+..|+..|+.|.. --+++++.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 4566888999999999999864 58899999865432111 2346788888887742 1245555542 2368
Q ss_pred EEeccCCCc
Q 019904 89 VLEFVTGGE 97 (334)
Q Consensus 89 v~e~~~~~~ 97 (334)
|||+..++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 999988754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00016 Score=67.08 Aligned_cols=73 Identities=16% Similarity=0.217 Sum_probs=48.7
Q ss_pred EeeeeeccCceEEEEEEECC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeE
Q 019904 15 VGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKI 86 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~ 86 (334)
-++.|+.|-...||++.... .++.+++|+..... . ...+.+|..+++.+...++ +++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678888889999998643 25789999884321 1 1234468888887763333 567766542
Q ss_pred EEEEeccCCC
Q 019904 87 FIVLEFVTGG 96 (334)
Q Consensus 87 ~~v~e~~~~~ 96 (334)
.+|+||++|.
T Consensus 148 g~v~e~l~G~ 157 (429)
T 1nw1_A 148 GRLEEYIPSR 157 (429)
T ss_dssp EEEECCCCEE
T ss_pred CEEEEEeCCc
Confidence 2899999863
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00018 Score=65.52 Aligned_cols=137 Identities=16% Similarity=0.178 Sum_probs=80.9
Q ss_pred eeeeeccCceEEEEEEECC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeeCCeEE
Q 019904 16 GRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIF 87 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~ 87 (334)
++.|..|-...+|++.... +++.|++|+..... .....+.+|..+++.+...+ ..++++.+.. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567668788899988642 35789999864311 11345568888888776322 3566666543 2
Q ss_pred EEEeccCCCchH--------------HHH---HhcC-C----CC--HHHHHHHHHHHHH-------------------HH
Q 019904 88 IVLEFVTGGELF--------------DKI---VNHG-R----MK--EDEARRYFQQLIN-------------------AV 124 (334)
Q Consensus 88 ~v~e~~~~~~L~--------------~~l---~~~~-~----l~--~~~~~~i~~qil~-------------------~l 124 (334)
+||||++|..|. +.+ +... + .. ...+..++.++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 899999875432 111 1111 1 11 2445555554422 12
Q ss_pred HHHH----h----CCcEEeecCCCCEEEecC----CCeEEeeccchhc
Q 019904 125 DYCH----S----RGVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 160 (334)
Q Consensus 125 ~~LH----~----~~i~H~dlkp~NIl~~~~----~~~kl~Dfg~a~~ 160 (334)
..|. . ..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 3332 2 359999999999999876 7899999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00031 Score=62.37 Aligned_cols=136 Identities=17% Similarity=0.107 Sum_probs=77.3
Q ss_pred eeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC--eeeEEEE-----EeeCCeEEEE
Q 019904 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV-----MGSKTKIFIV 89 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~-----~~~~~~~~~v 89 (334)
..++ |....||++.. .+|+.+++|........ ...+..|..+++.+...+ +++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~----~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCC----HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998765 34667999998643211 234556777776664222 3333332 2235667899
Q ss_pred EeccCCCchH-----------HH---HHh---cCC------CCHHH----------------------HHHHHHHHHHHH
Q 019904 90 LEFVTGGELF-----------DK---IVN---HGR------MKEDE----------------------ARRYFQQLINAV 124 (334)
Q Consensus 90 ~e~~~~~~L~-----------~~---l~~---~~~------l~~~~----------------------~~~i~~qil~~l 124 (334)
|++++|..+. .. ++. ..+ ..... ....+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999874321 11 111 000 11111 011122222222
Q ss_pred HHH----HhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 125 DYC----HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 125 ~~L----H~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..+ ....++|+|++|.||+++ + .+.++||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234689999999999998 4 899999987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00028 Score=63.93 Aligned_cols=75 Identities=15% Similarity=0.055 Sum_probs=44.5
Q ss_pred EeeeeeccCceEEEEEEECC--------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeeCCe
Q 019904 15 VGRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTK 85 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~ 85 (334)
-.+.++.|....+|++.... .+..+++|+....... ......|..+++.+...+ +.++++.. .+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~- 109 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG- 109 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence 35678888888999988643 1367999987643211 112356777777775333 44666554 22
Q ss_pred EEEEEeccCCCc
Q 019904 86 IFIVLEFVTGGE 97 (334)
Q Consensus 86 ~~~v~e~~~~~~ 97 (334)
++||+|++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 68999998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0034 Score=56.04 Aligned_cols=32 Identities=19% Similarity=0.320 Sum_probs=28.0
Q ss_pred CCcEEeecCCCCEEEecCCCeEEeeccchhcc
Q 019904 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~ 161 (334)
.+++|+|+.|.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999876543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0066 Score=56.57 Aligned_cols=75 Identities=12% Similarity=0.184 Sum_probs=48.3
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-eeEEEEEeeCCeEEEEEecc
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV 93 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~v~e~~ 93 (334)
-++.|+.|-...+|++.....+..+++|+..... .... +..+|..+++.+...++ .++++++. +. .||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence 3567888888999999875445789999875421 1111 12478888888875554 56777663 22 499999
Q ss_pred CCCc
Q 019904 94 TGGE 97 (334)
Q Consensus 94 ~~~~ 97 (334)
+|..
T Consensus 184 ~G~~ 187 (458)
T 2qg7_A 184 DGYA 187 (458)
T ss_dssp CSEE
T ss_pred CCcc
Confidence 8743
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0061 Score=56.16 Aligned_cols=75 Identities=15% Similarity=0.119 Sum_probs=47.2
Q ss_pred EeeeeeccCceEEEEEEECCC-------CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeeCCeE
Q 019904 15 VGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKI 86 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~ 86 (334)
-++.+..|-...+|++..... ++.|++|+..... .. .-+..+|..+++.+...+ ..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 346677788889999886521 5789999875422 11 112346788777775323 455665432 2
Q ss_pred EEEEeccCCCc
Q 019904 87 FIVLEFVTGGE 97 (334)
Q Consensus 87 ~~v~e~~~~~~ 97 (334)
+.||+|++|..
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 68999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.67 E-value=0.12 Score=47.06 Aligned_cols=30 Identities=30% Similarity=0.347 Sum_probs=25.2
Q ss_pred CcEEeecCCCCEEEe------cCCCeEEeeccchhc
Q 019904 131 GVYHRDLKPENLLLD------AYGNLKVSDFGLSAL 160 (334)
Q Consensus 131 ~i~H~dlkp~NIl~~------~~~~~kl~Dfg~a~~ 160 (334)
.++|+|+.+.||++. .++.+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 378999999999993 456799999998764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.24 E-value=1.3 Score=36.43 Aligned_cols=84 Identities=18% Similarity=0.141 Sum_probs=63.2
Q ss_pred CCCCeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC
Q 019904 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (334)
Q Consensus 69 ~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~ 148 (334)
.||++ -..+-.+++.+.+.++.-+++.-+..++ .++..+.++++.+|+.... -|...-+|--|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence 47888 5556678888888888765554455553 4788888888888887555 1235667778999999999999
Q ss_pred CeEEeeccch
Q 019904 149 NLKVSDFGLS 158 (334)
Q Consensus 149 ~~kl~Dfg~a 158 (334)
.+++.-.|+-
T Consensus 122 ~p~i~hRGi~ 131 (219)
T 4ano_A 122 EPFFLHVGVK 131 (219)
T ss_dssp CEEESCCEET
T ss_pred cEEEEEcCCc
Confidence 9999988853
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.81 E-value=0.72 Score=37.89 Aligned_cols=117 Identities=19% Similarity=0.239 Sum_probs=79.1
Q ss_pred CCCCCeeeEEEEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC
Q 019904 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (334)
Q Consensus 68 l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~ 147 (334)
..||+.+.. .+-..++.+.+.++.-+.+.-+..+ +.++....++++.+|+....+ ...-+|--|+|+|++++.+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEV--NRTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGG--GGSSEECCCSGGGEEECTT
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHH--hcCceEEEEecceEEEcCC
Confidence 358888876 6777778877777765533223333 347888999999999887733 3455777899999999999
Q ss_pred CCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 019904 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215 (334)
Q Consensus 148 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~ 215 (334)
+.+++.-.|+-....+ .=..+|- =.-..=|++..+++++..|.
T Consensus 116 ~~p~i~~RGik~~l~P--------------~~~~ee~-----------fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 116 GLPIAKTRGLQNVVDP--------------LPVSEAE-----------FLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SCEEESCCEETTTBSC--------------CCCCHHH-----------HHHHHHHHHHHHHCTTCCHH
T ss_pred CCEEEEEccCccCCCC--------------CCCCHHH-----------HHHHHHHHHHHHHcCCCCHH
Confidence 9999998885332111 0011121 12256678888999988873
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.09 E-value=0.04 Score=51.36 Aligned_cols=63 Identities=11% Similarity=0.156 Sum_probs=17.2
Q ss_pred EEeeeeeccCceEEEEEEECCCCCeEEE------EEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Q 019904 14 EVGRTIGEGTFAKVKFARNSETGEPVAL------KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (334)
Q Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 80 (334)
.+.+.|| ||.||++.......+||+ |....... ..+....+.+|..+++.++|||+++.+.+.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceE
Confidence 3445666 999999988765567888 65543222 223345677889999999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 334 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-93 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-90 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-87 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-83 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-83 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-83 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-82 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-82 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-79 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-79 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-79 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-78 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-78 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-75 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-75 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-75 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-75 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-74 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-74 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-73 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-72 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-71 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-69 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-68 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-67 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-66 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-64 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-61 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-61 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-61 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 275 bits (705), Expect = 6e-93
Identities = 96/260 (36%), Positives = 150/260 (57%), Gaps = 5/260 (1%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLY T+++++LE+ G ++ ++ + E Y +L NA+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+KPENLLL + G LK++DFG S + T CGT +Y+ PE++ R +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR LI+R+L
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 252 NPMTRITIPEILEDEWFKKD 271
NP R + E+LE W +
Sbjct: 242 NPSQRPMLREVLEHPWITAN 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (688), Expect = 2e-90
Identities = 107/267 (40%), Positives = 157/267 (58%), Gaps = 5/267 (1%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
V +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+E+ K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL+ V Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCPPW--LSFTARKLIA 246
+ D+WSCG++L +LAG LP+D S+ Y + PW + L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 247 RILDPNPMTRITIPEILEDEWFKKDYK 273
+IL NP RITIP+I +D W+ K K
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (672), Expect = 1e-87
Identities = 85/287 (29%), Positives = 146/287 (50%), Gaps = 8/287 (2%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
QP+ K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 1 QPR-KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN 122
M + HP V+LY K++ L + GEL I G E R Y ++++
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P AR
Sbjct: 180 ELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 243 KLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L+ ++L + R+ E+ K P F + +++
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAH---PFF---ESVTWENLH 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 254 bits (651), Expect = 1e-83
Identities = 72/280 (25%), Positives = 132/280 (47%), Gaps = 14/280 (5%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ K Y++ +G G F V TG K ++ L +K E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEI 77
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLI 121
+ M + HP ++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ + H + H D+KPEN++ + ++K+ DFG L+ ++ D ++ T T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEF 194
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235
APE+++ D+W+ GV+ +VLL+G PF + + + + ++
Sbjct: 195 AAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 236 WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+S A+ I +L P R+T+ + LE W K D+
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 252 bits (646), Expect = 2e-83
Identities = 70/282 (24%), Positives = 120/282 (42%), Gaps = 10/282 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N ++ + ++V+E+ G V+ ++E E + + Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ HRD+K N+LL G +K+ DFG +++ ++ GTP ++APEV+ D G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--LSFTARKLIAR 247
D+WS G+ L P + N M+ I+ E S R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVE 289
L P R T +L+ + ++ P V + D V
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 251 bits (642), Expect = 4e-83
Identities = 80/285 (28%), Positives = 140/285 (49%), Gaps = 18/285 (6%)
Query: 6 IKRRVG---KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ R + +E+ +G+G F KV A+N ET A K++D + + E E+
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEI 60
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLI 121
+ HPN+V+L + + ++I++EF GG + ++ R + E + + +Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H + HRDLK N+L G++K++DFG+SA + R + GTP ++A
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMA 178
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTC 233
PEV+ DR YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 179 PEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFE 278
P S + + + L+ N R T ++L+ + D P+ E
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (638), Expect = 2e-82
Identities = 76/279 (27%), Positives = 135/279 (48%), Gaps = 14/279 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
KY IG+G V A + TG+ VA++ ++ ++ E I E+ M+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKN 76
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRD+K +N+LL G++K++DFG A + T GTP ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 248 ILDPNPMTRITIPEILEDEWFKK----DYKPPVFEEKKD 282
LD + R + E+L+ ++ K P+ K+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKE 291
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 251 bits (641), Expect = 4e-82
Identities = 81/303 (26%), Positives = 140/303 (46%), Gaps = 14/303 (4%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ K + Y++ +G G F V TG A K + E +++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKE 73
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQL 120
+ TM +++HP +V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 121 INAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + H H DLKPEN++ LK+ DFGL+A + + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAE 190
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CP 234
+ APEV + G D+WS GV+ ++LL+G PF N + + + ++
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKD 294
+S + I ++L +P TR+TI + LE W P + + + K
Sbjct: 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 309
Query: 295 SEE 297
+
Sbjct: 310 KYD 312
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 241 bits (615), Expect = 3e-79
Identities = 87/275 (31%), Positives = 138/275 (50%), Gaps = 19/275 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH------KMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 -KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
K+ HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 185 L-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
+ ++ G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 237 -LSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
S T + L++R L P R T E L +F++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (617), Expect = 4e-79
Identities = 97/271 (35%), Positives = 149/271 (54%), Gaps = 13/271 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ +G G F++V A + T + VA+K + K+ + ++ E+A + +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S ++++++ V+GGELFD+IV G E +A R Q+++AV Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL D + +SDFG LS+ +L T CGTP YVAPEVL +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFG---LSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
Y + D WS GVI ++LL GY PF D N L+++I AE+ +S +A+
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
I +++ +P R T + L+ W D
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 6e-79
Identities = 86/271 (31%), Positives = 135/271 (49%), Gaps = 16/271 (5%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + + + EV ++ +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLIN 122
KHPN+VR Y+ + +T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D GTP
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 237 LSFTARKLIARILDPNPMTRITIPEILEDEW 267
S ++I R+L+ R ++ EILE+
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 2e-78
Identities = 66/271 (24%), Positives = 125/271 (46%), Gaps = 15/271 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + K +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
+ D+WS G +++VLL+G PF + + I AE+T +S A
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNPMTRITIPEILEDEWFKKDYKPP 275
+ R+L +R+T E L+ W K+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 4e-78
Identities = 85/285 (29%), Positives = 145/285 (50%), Gaps = 15/285 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHP 71
+ + + +G+G+F KV A +T + A+K L K+ VL E E + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ ++ +K +F V+E++ GG+L I + + A Y ++I + + HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLK +N+LLD G++K++DFG+ + D +T CGTP+Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
S D WS GV+L+ +L G PF + L+ I P WL A+ L+ ++
Sbjct: 182 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 252 NPMTRITIP-EILEDEWFK---------KDYKPPVFEEKKDTNLD 286
P R+ + +I + F+ K+ PP F K + D
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWEELERKEIDPP-FRPKVKSPFD 284
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 238 bits (608), Expect = 1e-77
Identities = 101/317 (31%), Positives = 170/317 (53%), Gaps = 31/317 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ RT+G G+F +V R+ G A+K+L KE V++ K E E + +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R++ +IF++++++ GGELF + R A+ Y ++ A++Y HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG + V +T CGTP+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
S D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + + L++R++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 253 PMTRI-----TIPEILEDEWFKKD-------------YKPPVFEEKKDT-NLDDVEAVFK 293
R+ ++ WFK+ Y+PP+ + + DT D
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYP---- 295
Query: 294 DSEEHHVTEQKEEQPVA 310
EE + E P A
Sbjct: 296 --EEDINYGVQGEDPYA 310
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 2e-75
Identities = 66/310 (21%), Positives = 117/310 (37%), Gaps = 52/310 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR- 130
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN-------------------------------- 218
+D+WS G+ L + G P +
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 219 ----------LMNLYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDE 266
+ L I P S + + + L NP R + +++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 267 WFKKDYKPPV 276
+ K+ V
Sbjct: 300 FIKRSDAEEV 309
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 2e-75
Identities = 97/287 (33%), Positives = 144/287 (50%), Gaps = 24/287 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 129 SRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSFT 240
+N AD+WS GVI ++LL+G PF +SA + S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 241 ARKLIARILDPNPMTRITIPEILEDEWFK---------KDYKPPVFE 278
A+ I R+L +P R+TI + L+ W K + P FE
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 234 bits (598), Expect = 2e-75
Identities = 83/295 (28%), Positives = 137/295 (46%), Gaps = 24/295 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--- 69
+ V R IG G F +V R ++TG+ A+K LDK+++ + E + LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
P +V + + K+ +L+ + GG+L + HG E + R Y ++I +++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R V +RDLKP N+LLD +G++++SD GL+ H + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIA 246
S+AD +S G +LF LL G+ PF + + P S R L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 247 RILDPNPMTRITIP-----EILEDEWFK---------KDYKPPVFEEKKDTNLDD 287
+L + R+ E+ E +F+ + Y PP+ + + N D
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAAD 296
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 7e-75
Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 20/282 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM---AEQIKREVATMKL 67
+Y+VG +G G F V PVA+K ++K+++ ++ EV +K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 68 VK--HPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAV 124
V V+RL + ++LE +LFD I G ++E+ AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 125 DYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+CH+ GV HRD+K EN+L+D G LK+ DFG AL D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
+ Y G +A +WS G++L+ ++ G +PF+ +I + +S +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 244 LIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 285
LI L P R T EI W + P +E + +L
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 1e-74
Identities = 68/270 (25%), Positives = 128/270 (47%), Gaps = 18/270 (6%)
Query: 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ + IG G+F V ++ET VA L K+ K + ++ K E +K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 70 HPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y+ S K I +V E +T G L + MK R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 126 YCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAA--EFTCPPWLSF 239
E+ YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 183 EMYE-EKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 240 TARKLIARILDPNPMTRITIPEILEDEWFK 269
+++I + N R +I ++L +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 4e-74
Identities = 94/299 (31%), Positives = 150/299 (50%), Gaps = 21/299 (7%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + ++ + +G+GTF KV R TG A+KIL KE ++ E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+HP + L + ++ V+E+ GGELF + E+ AR Y ++++A++Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D Y + D W GV+++ ++ G LPF + + L++ I E P LS A+ L+A
Sbjct: 179 DNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 247 RILDPNPMTRI-----TIPEILEDEWFKK-------------DYKPPVFEEKKDTNLDD 287
+L +P R+ E++E +F +KP V E DD
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDD 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (584), Expect = 8e-74
Identities = 94/321 (29%), Positives = 145/321 (45%), Gaps = 25/321 (7%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 54
Query: 62 VATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEAR 114
V + + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174
+ + A+ Y HS + HRD+KPENLL + + +++ L T C
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----- 229
TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +
Sbjct: 175 YTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 230 -EFTCPPW--LSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNLD 286
EF P W +S + LI +L P R+TI E + W + K P L
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLK 293
Query: 287 DVEAVFKDSEEHHVTEQKEEQ 307
+ + ++D +E + +
Sbjct: 294 EDKERWEDVKEEMTSALATMR 314
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 224 bits (572), Expect = 9e-73
Identities = 65/268 (24%), Positives = 119/268 (44%), Gaps = 10/268 (3%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 71 PNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y+ ++T +IV+E+V G L D + G M A A+++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ ++ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241
D +D++S G +L+ +L G PF + +++ + + P LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 242 RKLIARILDPNPMTRITIPEILEDEWFK 269
++ + L NP R + + +
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 7e-72
Identities = 58/263 (22%), Positives = 119/263 (45%), Gaps = 14/263 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+ VG+ IG G+F V + VA+K+L+ ++ + K EV ++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
N++ + ++ IV ++ G L+ + + + + + +Q +DY H+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDLK N+ L +K+ DFGL+ + + G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 190 YDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF------TA 241
+ + +D+++ G++L+ L+ G LP+ + N + + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 242 RKLIARILDPNPMTRITIPEILE 264
++L+A L R P+IL
Sbjct: 243 KRLMAECLKKKRDERPLFPQILA 265
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (570), Expect = 1e-71
Identities = 92/306 (30%), Positives = 156/306 (50%), Gaps = 24/306 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY+ + D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNPMTRI-----TIPEILEDEWFKKD-------------YKPPVFEEKKDT 283
+ L+ +L + R + +I +WF + P +
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325
Query: 284 NLDDVE 289
N DD E
Sbjct: 326 NFDDYE 331
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 5e-69
Identities = 79/309 (25%), Positives = 118/309 (38%), Gaps = 43/309 (13%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
V KYE IG+GTF +V AR+ +TG+ VALK + E K RE+ ++L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 65
Query: 68 VKHPNVVRLYEV--------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+KH NVV L E+ K I++V +F + E +R Q
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTP 177
L+N + Y H + HRD+K N+L+ G LK++DFGL+ ++ T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235
Y PE+L G DLW G I+ + + + IS + P
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
Query: 236 ------------------------------WLSFTARKLIARILDPNPMTRITIPEILED 265
A LI ++L +P RI + L
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305
Query: 266 EWFKKDYKP 274
++F D P
Sbjct: 306 DFFWSDPMP 314
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-68
Identities = 73/337 (21%), Positives = 136/337 (40%), Gaps = 42/337 (12%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K + + ++ RE+ + +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 71 PNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + T K ++ + G +L+ ++ + D + Q++ + Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL 185
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------- 234
+ + D+WS G IL +L+ F + ++ I +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 235 --------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
P A L+ ++L NP RI + + L + ++ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 275 ---PVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 308
P+ E +++ + + +E E QP
Sbjct: 305 SDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 341
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-67
Identities = 73/291 (25%), Positives = 113/291 (38%), Gaps = 32/291 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--MAEQIKREVATMKLVKHP 71
E +GEG FA V AR+ T + VA+K + + K + RE+ ++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++ L + G K+ I +V +F+ N + + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLKP NLLLD G LK++DFGL+ + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------------- 234
G D+W+ G IL LL + ++ +I T
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 235 -----------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
LI + NP RIT + L+ ++F P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-66
Identities = 60/258 (23%), Positives = 116/258 (44%), Gaps = 18/258 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ ++ +TIG+G F V G VA+K + + A+ E + M ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHS 60
Query: 72 NVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCH 128
N+V+L V + K ++IV E++ G L D + + GR + D ++ + A++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRDL N+L+ KVSDFGL+ + +D T + APE L ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246
+ +D+WS G++L+ + + G +P+ L ++ ++ P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 247 RILDPNPMTRITIPEILE 264
+ R + ++ E
Sbjct: 235 NCWHLDAAMRPSFLQLRE 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-65
Identities = 88/294 (29%), Positives = 134/294 (45%), Gaps = 34/294 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE IGEGT+ V A+N ET E VALK + + + RE+ +K +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++V+ S K+ +V EF +G + + + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK+++FGL+ T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 192 GSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFT------------------ 232
++ D+WS G I L P F +++ + K+I T
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 233 -----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKPP 275
P L+ T R L+ +L NP+ RI+ E L+ +F D+ PP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCPP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 204 bits (520), Expect = 8e-65
Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 33/288 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IGEGT+ V A+N+ GE ALK + EK + RE++ +K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+LY+V+ +K ++ +V E + V G ++ A+ + QL+N + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK++DFGL+ T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------------- 232
+T D+WS G I ++ G F + + +I T
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 233 ----------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270
L + L++++L +P RIT + LE +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-64
Identities = 79/293 (26%), Positives = 129/293 (44%), Gaps = 33/293 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IGEGT+ V ARN TGE VALK + + + RE++ +K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+L +V+ ++ K+++V EF+ + F + + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRDLKP+NLL++ G +K++DFGL+ T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---------------- 234
+ D+WS G I ++ F + ++ +I T
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 235 -------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274
P L R L++++L +P RI+ L +F+ KP
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-64
Identities = 65/260 (25%), Positives = 103/260 (39%), Gaps = 10/260 (3%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +G+G+F V+ S VA+K L + + + + + REV M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
H N++RLY V + +V E G L D++ H G RY Q+ + Y
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLND 187
S+ HRDL NLLL +K+ DFGL Q D ++ + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKL 244
R + + +D W GV L+ + G P+ N + KI P +
Sbjct: 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 245 IARILDPNPMTRITIPEILE 264
+ + P R T + +
Sbjct: 248 MVQCWAHKPEDRPTFVALRD 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 4e-64
Identities = 55/261 (21%), Positives = 103/261 (39%), Gaps = 11/261 (4%)
Query: 17 RTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F VK + + + VA+KIL E + +++ E M+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
R+ + ++ +V+E G L + + +K+ Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGS 193
RDL N+LL K+SDFGLS + + T + APE +N +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDP 251
+D+WS GV+++ + G P+ + + E CP L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 252 NPMTRITIPEI---LEDEWFK 269
+ R + L + ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 7e-64
Identities = 83/336 (24%), Positives = 142/336 (42%), Gaps = 47/336 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +G G + V A + TG VA+K L + A++ RE+ +K ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHE 77
Query: 72 NVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + T ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--------- 236
+ T D+WS G I+ ++ G F S+ ++ K+I T P
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 237 ----------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFKK--DY 272
S A L+ ++L + R+T E L +F+ D
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310
Query: 273 KPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQP 308
+ +K D + DDV+ + + E +P
Sbjct: 311 EDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 2e-63
Identities = 80/336 (23%), Positives = 131/336 (38%), Gaps = 53/336 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y + IG G+F V A+ ++GE VA+K + ++K RE+ M+ + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74
Query: 73 VVRLYEVM------GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINA 123
+VRL + + +VL++V + + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRD+KP+NLLLD LK+ DFG ++Q+ + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRYYRAP 191
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------- 234
E++ S+ D+WS G +L LL G F + ++ +I T
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 235 ---------------------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273
P A L +R+L+ P R+T E +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 274 PPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKEEQPV 309
P V K N D A+F + + + +
Sbjct: 312 PNV----KLPNGRDTPALFNFTTQELSSNPPLATIL 343
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-62
Identities = 61/260 (23%), Positives = 100/260 (38%), Gaps = 13/260 (5%)
Query: 19 IGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ R + VA+K+L + + E++ RE M + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 75 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DL N+LL K+SDFGLS AL + APE +N R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 195 ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252
+D+WS GV ++ L+ G P+ + I + CPP L++
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 253 PMTRITIPEI---LEDEWFK 269
R + + ++
Sbjct: 253 WEDRPDFLTVEQRMRACYYS 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-61
Identities = 56/256 (21%), Positives = 107/256 (41%), Gaps = 10/256 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK+ + VA+K++ + + + ++ E M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
HRDL N L++ G +KVSDFGLS + + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARIL 249
+D+W+ GV+++ + + G +P++ + I P S ++
Sbjct: 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 250 DPNPMTRITIPEILED 265
R T +L +
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-61
Identities = 52/285 (18%), Positives = 110/285 (38%), Gaps = 35/285 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATM- 65
E G+ +G G F KV A + VA+K+L ++ E + E+ M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------------------- 105
+L H N+V L I+++ E+ G+L + + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ ++ + Q+ +++ + HRDL N+L+ +K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+ + ++APE L + Y +D+WS G++L+ + + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 222 LYKKI--SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ K+ + + P + + ++ + R + P +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-61
Identities = 77/280 (27%), Positives = 136/280 (48%), Gaps = 16/280 (5%)
Query: 7 KRRVG--KYEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKR 60
+VG +E+ + +G G + KV R +TG+ A+K+L K ++ K K E +
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 61 EVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
E ++ ++ P +V L+ ++TK+ ++L+++ GGELF + R E E + Y +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ A+++ H G+ +RD+K EN+LLD+ G++ ++DFGLS +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPP 235
V D WS GV+++ LL G PF + ++I +E P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 236 WLSFTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270
+S A+ LI R+L +P R+ EI E +F+K
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 2e-61
Identities = 59/261 (22%), Positives = 103/261 (39%), Gaps = 12/261 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
++ + IG G F +V G+ VA+K L K E + M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPNV+ L V+ T + I+ EF+ G L N G+ + + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPEVL 185
HRDL N+L+++ KVSDFGLS + D + + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
R + + +D+WS G++++ +++ G P+ D ++ I P +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 244 LIARILDPNPMTRITIPEILE 264
L+ + R +I+
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVN 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-61
Identities = 81/299 (27%), Positives = 124/299 (41%), Gaps = 42/299 (14%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +YE IGEG + KV AR+ + G VALK + + + M REVA ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62
Query: 67 L---VKHPNVVRLYEVM-----GSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYF 117
+HPNVVRL++V +TK+ +V E V + V + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + + T
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTL 179
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----- 232
Y APEVL Y DLWS G I + F S+ ++ KI
Sbjct: 180 WYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 233 ----------------------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
+ + L+ + L NP RI+ L +F+
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 6e-61
Identities = 62/272 (22%), Positives = 113/272 (41%), Gaps = 17/272 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F +V + T VA+K L + E +E MK ++H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
+V+LY V+ S+ I+IV E+++ G L D + ++ + Q+ + + Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRDL+ N+L+ KV+DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L L G +P+ + ++ CPP + L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 248 ILDPNPMTRITIPEILE--DEWFKK---DYKP 274
P R T + +++F Y+P
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 6e-61
Identities = 56/264 (21%), Positives = 105/264 (39%), Gaps = 6/264 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE--KVLKHKMAEQIKREVATMKLVKH 70
++ + +G G F V GE V + + KE + K ++I E M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P+V RL + + T I G L + + + Q+ ++Y R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRDL N+L+ ++K++DFGL+ L + ++A E + R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 191 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARI 248
+D+WS GV ++ L+ G P+D + + E PP + ++ +
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 249 LDPNPMTRITIPEILED-EWFKKD 271
+ +R E++ + +D
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARD 273
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 75/333 (22%), Positives = 130/333 (39%), Gaps = 51/333 (15%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ +G G + V A +++TG VA+K L + A++ RE+ +K +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 72 NVVRLYEVMGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
NV+ L +V + + L G + IV ++ +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL---------- 237
+ T D+WS G I+ LL G F ++ ++ K I T L
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 238 ---------------------SFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP-- 274
+ A L+ ++L + RIT + L +F + + P
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 275 --------PVFEEKKDTNLDDVEAVFKDSEEHH 299
FE + + + +
Sbjct: 313 EPVADPYDQSFESRDLLIDEWKSLTYDEVISFV 345
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-60
Identities = 55/263 (20%), Positives = 108/263 (41%), Gaps = 14/263 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G F +V VA+K L + + + E MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
+VRLY V ++ I+I+ E++ G L D + +K ++ Q+ + +
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRDL+ N+L+ + K++DFGL+ L + + + APE +N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L ++ G +P+ + + + P +L+
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 248 ILDPNPMTRITIPEILE--DEWF 268
P R T + +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 5e-60
Identities = 59/255 (23%), Positives = 100/255 (39%), Gaps = 10/255 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG G F V + VA+K + + + + E E M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + I +V EF+ G L D G + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDL N L+ +KVSDFG++ T + +PEV + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARIL 249
S +D+WS GV+++ + + G +P+++ + + + IS P S +++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 250 DPNPMTRITIPEILE 264
P R +L
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-59
Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 28/300 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ IGEG F +V AR + G + I ++ E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARR 115
N++ L + +++ +E+ G L D + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + +DY + HRDL N+L+ K++DFG LS+
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 188
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTC 233
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 189 PVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 234 PPWLSFTARKLIARILDPNPMTRITIPEILED-EWFKKDYKPPV----FEEKKDTNLDDV 288
P L+ + P R + +IL ++ K V +E+ +D
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 1e-59
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 12/278 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G + +V + VA+K L ++ E+ +E A MK +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
N+V+L V + +I+ EF+T G L D + R + Q+ +A++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRDL N L+ +KV+DFGLS L + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 190 YDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTARKLIAR 247
+ + W+ GV+L+ + G P+ +L +Y+ + P +L+
Sbjct: 193 FSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 248 ILDPNPMTRITIPEILEDEWFKKDYKPPVFEEKKDTNL 285
NP R + EI + F+ ++ ++ + L
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVEKEL 287
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-59
Identities = 68/262 (25%), Positives = 115/262 (43%), Gaps = 15/262 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ E+GR IGEG F V VA+K + E+ +E TM+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL V + Y QL A+ Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--GTPNYVAPEVL 185
S+ HRD+ N+L+ + +K+ DFG LS+ + D + ++APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 186 NDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
N R + + +D+W GV ++ +L+ G PF ++ +I E PP T
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 244 LIARILDPNPMTRITIPEILED 265
L+ + +P R E+
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 4e-58
Identities = 61/284 (21%), Positives = 101/284 (35%), Gaps = 34/284 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
E R IGEG F +V AR E VA+K+L +E M +RE A M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------- 107
+PN+V+L V + ++ E++ G+L + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 108 -----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ E +Q+ + Y R HRDL N L+ +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMN 221
++ PE + Y +D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 222 LYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
+ + CP L+ P R + I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (468), Expect = 6e-57
Identities = 51/287 (17%), Positives = 94/287 (32%), Gaps = 27/287 (9%)
Query: 9 RVG-KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
RVG +Y +GR IG G+F + + GE VA+K+ + Q+ E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKM 58
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++ + G+ +V+E + + Q+I+ ++Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 127 CHSRGVYHRDLKPENLL---LDAYGNLKVSDFGLS-----ALSQQVRDDGLLHTTCGTPN 178
HS+ HRD+KP+N L + + DFGL+ A + Q GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231
Y + DL S G +L G LP+ +K
Sbjct: 179 YASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 232 -TCPPWLSFTARKLIARILDPNPMTRIT---IPEILEDEWFKKDYKP 274
+ + + ++ + + ++ +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 184 bits (468), Expect = 1e-56
Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 54/300 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 71 PNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
PN++ L +++ +V E V + + + + R Y +++ A+DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 129 SRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
S G+ HRD+KP N+++D L++ D+GL+ + + + PE+L D
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSN--------------LMNLYKKISAAEFTC 233
+ D+WS G +L ++ PF + +LY I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 234 PPW------------------------LSFTARKLIARILDPNPMTRITIPEILEDEWFK 269
P +S A + ++L + +R+T E +E +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-56
Identities = 56/280 (20%), Positives = 109/280 (38%), Gaps = 30/280 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM- 65
+ G+T+G G F KV A S+ VA+K+L L + E + E+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------------VNHGR 107
L H N+V L ++ E+ G+L + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ ++ + Q+ + + S+ HRDL N+LL K+ DFGL+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
+ ++APE + + +D+WS G+ L+ L + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 227 --SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
P ++ D +P+ R T +I++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-56
Identities = 59/280 (21%), Positives = 113/280 (40%), Gaps = 29/280 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVAT 64
+ +G+ +GEG F +V A + VA+K+L + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------R 107
MK + KH N++ L +++++E+ + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ + Q+ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++APE L DR Y +D+WS GV+L+ + G P+ + L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265
P + ++ P R T +++ED
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-54
Identities = 74/343 (21%), Positives = 132/343 (38%), Gaps = 60/343 (17%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNH 75
Query: 71 PNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
N++ L V + +++V+E + + + Q++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS G+ HRDLKP N+++ + LK+ DFGL+ + ++ T Y APEV
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPEV 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW-------- 236
+ GY + D+WS G I+ ++ + F + ++ + K+ T P
Sbjct: 190 ILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 237 ----------------------------------LSFTARKLIARILDPNPMTRITIPEI 262
+ AR L++++L +P RI++ +
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 263 LEDEWFKKDYKPPVFEEKKDTNLDDVEAVFKDSEEHHVTEQKE 305
L+ + Y P E D D EH + E KE
Sbjct: 309 LQHPYINVWYDPAEVEAPPPQIYDKQ----LDEREHTIEEWKE 347
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-54
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 11/260 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V + PVA+K L K E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
H N++RL V+ + I+ E++ G L + G + + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN 186
+ HRDL N+L+++ KVSDFGLS + + + + + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244
R + + +D+WS G++++ ++ G P+ + + + K I+ P +L
Sbjct: 187 YRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 245 IARILDPNPMTRITIPEILE 264
+ + R +I+
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-53
Identities = 59/268 (22%), Positives = 104/268 (38%), Gaps = 12/268 (4%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L++ Q E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEG 79
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + + + Q+
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPN 178
+ + S+ HRDL N +LD +KV+DFGL+ D + + T
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPW 236
++A E L + + +D+WS GV+L+ L+ G P+ D N ++ + P +
Sbjct: 200 WMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 237 LSFTARKLIARILDPNPMTRITIPEILE 264
+++ + P R + E++
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 174 bits (443), Expect = 3e-53
Identities = 50/281 (17%), Positives = 95/281 (33%), Gaps = 27/281 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y+VGR IGEG+F + N + VA+K + A Q++ E T KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ +Y +V++ + + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 130 RGVYHRDLKPENLLLDAY-----GNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNY 179
+ + +RD+KP+N L+ + V DFG+ ++Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL---YKKISAAEFTCPPW 236
++ R DL + G + L G LP+ Y++I + + P
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 237 -----LSFTARKLIARILDPNPMTRITIPEILE--DEWFKK 270
K + + + + ++
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-51
Identities = 52/285 (18%), Positives = 109/285 (38%), Gaps = 22/285 (7%)
Query: 12 KYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V K E VA+K +++ ++ + + E + MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----------MKEDEARRY 116
+VVRL V+ +++E +T G+L + + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + + Y ++ HRDL N ++ +K+ DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE-FTCP 234
+++PE L D + + WS GV+L+ + P+ + + + + P
Sbjct: 199 VRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 235 PWLSFTARKLIARILDPNPMTRITIPEILE--DEWFKKDYKPPVF 277
+L+ NP R + EI+ E + ++ F
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSF 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 6e-51
Identities = 58/279 (20%), Positives = 108/279 (38%), Gaps = 29/279 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ ++G+ +G G F +V A + T VA+K+L + H + E+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILI 71
Query: 67 LVKH-PNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGR----------------M 108
+ H NVV L + +++EF G L + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ Y Q+ +++ SR HRDL N+LL +K+ DFGL+ + D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKI- 226
++APE + DR Y +D+WS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
P + + + + P R T E++E
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 6e-50
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 48/295 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ +IG+G F +V + GE VA+KI + + + + E+ +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 71 PNVVRLYEVM----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ G+ T++++V ++ G LFD + N + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 127 CHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGT 176
H + HRDLK +N+L+ G ++D GL+ D D + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 177 PNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFD---------------D 216
Y+APEVL+D AD+++ G++ + + D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 217 SNLMNLYKKISAAEF-------TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264
++ + K + + K++ N R+T I +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (380), Expect = 3e-43
Identities = 54/327 (16%), Positives = 107/327 (32%), Gaps = 63/327 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------REVA 63
+Y + R +G G F+ V A++ VA+KI+ +KV ++IK +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT-----GGELFDKIVNHGRMKEDEARRYFQ 118
+ ++++L + K + + V K H + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 119 QLINAVDYC-HSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGT 176
QL+ +DY G+ H D+KPEN+L++ + ++ L D + T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK------------ 224
Y +PEVL + AD+WS ++F L+ G F+ + K
Sbjct: 193 REYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 225 ------------------------------------KISAAEFTCPPWLSFTARKLIARI 248
+ ++ + ++ +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 249 LDPNPMTRITIPEILEDEWFKKDYKPP 275
L +P R ++ W K
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 1e-23
Identities = 33/213 (15%), Positives = 69/213 (32%), Gaps = 42/213 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---------------EQ 57
+G+ +GEG + V + E +K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
++ V + RG+ H DL N+L+ G + + DF S + +L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--- 165
Query: 178 NYVAPEVLND---RGYDGSTADLWSCGVILFVL 207
+ R Y + D+ S I +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.45 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.33 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.41 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.26 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-67 Score=461.59 Aligned_cols=256 Identities=37% Similarity=0.711 Sum_probs=238.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 67899999999999999999999999999999999877666666677889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||||++|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----CC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----Cc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999874332 22
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 249 (334)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+....+.+|+.+|+++++||.+||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 345689999999999998777 4899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHhHHhcCccccC
Q 019904 250 DPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 250 ~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
++||++|||++|+|+||||+.
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCC
Confidence 999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-67 Score=461.43 Aligned_cols=262 Identities=31% Similarity=0.579 Sum_probs=236.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999988766666667889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.........
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998654433333
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (334)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++....+.+|..+|+++++||.+|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 4455689999999999998777 489999999999999999999999999999999998888899999999999999999
Q ss_pred cCCCCCCCCCHhHH------hcCccccCC
Q 019904 249 LDPNPMTRITIPEI------LEDEWFKKD 271 (334)
Q Consensus 249 L~~dp~~Rpt~~e~------l~h~~~~~~ 271 (334)
|++||++|||++|+ ++||||+..
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 99999999999984 778998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-67 Score=460.45 Aligned_cols=263 Identities=40% Similarity=0.696 Sum_probs=225.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
.+++|++++.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 467899999999999999999999999999999999765432 234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998654433333
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH-HHHHHhhcCc--cCCCCCCCHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAE--FTCPPWLSFTARKLI 245 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~li 245 (334)
.....+||+.|+|||++.+..+++.++|||||||++|+|++|+.||...... .......... ...++.+|+++++||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 4456789999999999998888778899999999999999999999765432 2222222222 222346899999999
Q ss_pred HHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 246 ARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 246 ~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
.+||+.||++|||++|+|+||||++..+
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 9999999999999999999999986543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-65 Score=458.30 Aligned_cols=260 Identities=34% Similarity=0.620 Sum_probs=241.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..++.|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 35789999999999999999999999999999999998876655556788899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999875332 22
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
......+||+.|+|||++.+.++ +.++|||||||++|+|++|+.||.+.+..++...+....+.+|..+|+++++||.+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 33456789999999999998887 58999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCC-----HhHHhcCccccC
Q 019904 248 ILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
||++||.+|++ ++|+++||||..
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred hccCCchhhcccccccHHHHHcCccccc
Confidence 99999999994 899999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-64 Score=448.33 Aligned_cols=253 Identities=30% Similarity=0.512 Sum_probs=224.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
++|++++.||+|+||+||+|++..+|+.||||++....... .+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 58999999999999999999999999999999997654322 467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcc
Q 019904 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (334)
Q Consensus 91 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 170 (334)
|||+||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... .....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCCB
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--ccccc
Confidence 99999999987765 4699999999999999999999999999999999999999999999999999875432 22234
Q ss_pred cccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC---ccCCCCCCCHHHHHHHHH
Q 019904 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~ 247 (334)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+... ....|+.+|.++++||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 55689999999999998777 48999999999999999999999988877666555433 344567799999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
||++||.+|||++|+|+||||+.
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999975
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.6e-64 Score=449.09 Aligned_cols=256 Identities=34% Similarity=0.719 Sum_probs=238.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
++.|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 56899999999999999999999999999999999877666666678899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||||.||+|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999875432 2
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHhc
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 249 (334)
..+.+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+...++......+|+.+|++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 3456899999999999887775 899999999999999999999999999999999988888999999999999999999
Q ss_pred CCCCCCCC-----CHhHHhcCccccCC
Q 019904 250 DPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 250 ~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
++||.+|+ |++++++||||+..
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hhCHHhccccchhhHHHHHcCcccccC
Confidence 99999996 99999999999763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-64 Score=448.03 Aligned_cols=256 Identities=38% Similarity=0.689 Sum_probs=213.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
-++|++.+.||+|+||+||+|++..+|+.||||++.+..... ....+.+|+.+|+.++||||+++++++.+++.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999998654332 235678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe---cCCCeEEeeccchhccccccC
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
||||+||+|.+++...+++++..+..++.||+.||+|||++||+||||||+||++. .+|.+||+|||+|.....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999988999999999999999999999999999999999999995 478999999999875432
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC----CCCCCHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTAR 242 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 242 (334)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....+...+......+ ++.+|++++
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 223445689999999999998777 489999999999999999999999998888888887665543 356899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+||.+||++||++|||++|+|+||||+..
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.6e-64 Score=447.51 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=228.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEe
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 91 (334)
+|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999987665555667889999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCccc
Q 019904 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (334)
Q Consensus 92 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 171 (334)
||.+|+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999999988888888999999999999999999999999999999999999999999999999999875332 23
Q ss_pred ccccCCcccChHhhhcC--CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC--CCCCCCHHHHHHHHH
Q 019904 172 TTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLIAR 247 (334)
Q Consensus 172 ~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 247 (334)
...||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+.+..+.....+ .+..+|+++++||.+
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 46799999999999743 23458999999999999999999999988887777766555432 344689999999999
Q ss_pred hcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 248 ILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
||+.||.+|||++|+|+||||.+...
T Consensus 250 ~L~~dP~~Rpt~~ell~Hp~~~~~~~ 275 (309)
T d1u5ra_ 250 CLQKIPQDRPTSEVLLKHRFVLRERP 275 (309)
T ss_dssp HTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred HCcCChhHCcCHHHHHhCHHhcCCCC
Confidence 99999999999999999999986543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-64 Score=439.69 Aligned_cols=256 Identities=33% Similarity=0.557 Sum_probs=216.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee--CCeE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 86 (334)
+.+.|++++.||+|+||+||+|++..+|+.||+|++...... +...+.+.+|+.+|+.++|||||++++++.+ ...+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 357899999999999999999999999999999999876543 3346778999999999999999999999864 4568
Q ss_pred EEEEeccCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEEeecCCCCEEEecCCCeEEeeccc
Q 019904 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~~l~~LH~~~-----i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
|+|||||++|+|.+++.+ ...+++..++.++.||+.||+|||++| |+||||||+|||++.+|.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998864 457999999999999999999999976 99999999999999999999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-CCCCC
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 236 (334)
|+..... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..++..++..... ..|..
T Consensus 161 a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNHD--TSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeecccC--CCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 9864432 223345789999999999988776 4899999999999999999999999998888888876654 46778
Q ss_pred CCHHHHHHHHHhcCCCCCCCCCHhHHhcCccc
Q 019904 237 LSFTARKLIARILDPNPMTRITIPEILEDEWF 268 (334)
Q Consensus 237 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~ 268 (334)
+|+++++||.+||+.||++|||++|+|+|||+
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999999999999999995
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-63 Score=451.38 Aligned_cols=258 Identities=33% Similarity=0.648 Sum_probs=239.3
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.....+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34789999999999999999999999999999999998776666566778899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
+||||+.+|+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999999989999999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHH
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (334)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...+...+....+.+|..+|+++.+||.+
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 23456899999999999987774 8999999999999999999999999999999999998889999999999999999
Q ss_pred hcCCCCCCCC-----CHhHHhcCccccCC
Q 019904 248 ILDPNPMTRI-----TIPEILEDEWFKKD 271 (334)
Q Consensus 248 ~L~~dp~~Rp-----t~~e~l~h~~~~~~ 271 (334)
||++||.+|+ |++++++||||+..
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HhhhCHHhccccccccHHHHHcCccccCC
Confidence 9999999995 99999999999753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-64 Score=445.03 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=223.1
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++++.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999976432 22467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|||++|+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....... ..
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 99999999998765 4579999999999999999999999999999999999999999999999999986433211 12
Q ss_pred ccccccCCcccChHhhhc----CCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---cCCCCCCCHHHH
Q 019904 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTAR 242 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 242 (334)
....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+.++.... ...|..+|++++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 235679999999999853 2223589999999999999999999999988777777766554 334567899999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+||.+||++||++|||++|+|+||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-63 Score=450.22 Aligned_cols=259 Identities=28% Similarity=0.552 Sum_probs=231.0
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4567899999999999999999999999999999999765432 2456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe--cCCCeEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~--~~~~~kl~Dfg~a~~~~~~ 164 (334)
+|||||+||+|.+.+...+ ++++..++.++.||+.||+|||++||+||||||+|||++ .+|.+||+|||+|.....
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~- 181 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP- 181 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC-
Confidence 9999999999998876654 699999999999999999999999999999999999997 568999999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (334)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+....+.++ +.+|++
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 258 (352)
T d1koba_ 182 --DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258 (352)
T ss_dssp --TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHH
T ss_pred --CCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 334556789999999999988777 4899999999999999999999999999998888877765544 468999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+++||.+||++||.+|||++|+|+||||+....
T Consensus 259 ~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 999999999999999999999999999986543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.9e-63 Score=448.55 Aligned_cols=259 Identities=30% Similarity=0.575 Sum_probs=230.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 346799999999999999999999999999999999976433 23467889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec--CCCeEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~--~~~~kl~Dfg~a~~~~~~ 164 (334)
+|||||+||+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~- 178 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP- 178 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT-
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc-
Confidence 99999999999999854 457999999999999999999999999999999999999964 57899999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (334)
........||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+.+..+......++ +.+|++
T Consensus 179 --~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 179 --KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp --TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred --ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 2334567899999999999987774 899999999999999999999999999998888877765544 358999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCCCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKDYK 273 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~ 273 (334)
+++||.+||+.||++|||++|+|+||||+....
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-63 Score=439.59 Aligned_cols=258 Identities=37% Similarity=0.618 Sum_probs=230.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.++|++++.||+|+||+||+|++..+|+.||||++.+..... ....+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 468999999999999999999999999999999997644322 12357789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC----CeEEeeccchhccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~----~~kl~Dfg~a~~~~ 162 (334)
|+|||||+||+|.+++...+++++..++.++.|++.||+|||++||+||||||+|||++.+| .+||+|||+|....
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999988999999999999999999999999999999999999998776 49999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCC
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLS 238 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~ 238 (334)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+.+..+......++ +.+|
T Consensus 169 ~---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 244 (293)
T d1jksa_ 169 F---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 244 (293)
T ss_dssp T---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred C---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence 2 223345678999999999987766 5899999999999999999999999999998888877766544 5689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
.++++||.+||+.||++|||++|+|+||||+..
T Consensus 245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-63 Score=431.97 Aligned_cols=253 Identities=25% Similarity=0.498 Sum_probs=218.3
Q ss_pred ccce-EEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee----CC
Q 019904 10 VGKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KT 84 (334)
Q Consensus 10 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 84 (334)
.+|| ++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+.+|+++|+.++|||||++++++.+ ..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 3556 6788999999999999999999999999999875543 3345778999999999999999999999865 45
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEEeecCCCCEEEe-cCCCeEEeeccchhcc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALS 161 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~a~~~ 161 (334)
.+|+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 68999999999999999999889999999999999999999999999 99999999999996 4789999999998753
Q ss_pred ccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhcCcc--CCCCCCC
Q 019904 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAAEF--TCPPWLS 238 (334)
Q Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~~~~--~~~~~~~ 238 (334)
. .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.. ...+...+..... .++..++
T Consensus 166 ~----~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 166 R----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp C----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred c----CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 2 223456789999999999875 44 589999999999999999999997654 4555555544332 3445689
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcCcccc
Q 019904 239 FTARKLIARILDPNPMTRITIPEILEDEWFK 269 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~ 269 (334)
+++++||.+||++||++|||++|+|+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999999999999999999999999995
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-63 Score=443.15 Aligned_cols=258 Identities=30% Similarity=0.576 Sum_probs=234.7
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEeeCCeEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
+++|++++.||+|+||+||+|++..+|+.||||++.++........+.+.+|..++. .++||||+++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 478999999999999999999999999999999998766555555566667777665 7899999999999999999999
Q ss_pred EEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
|||||++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ..
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--cc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998754322 22
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHHHHHHHh
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 248 (334)
......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+...+..++....+.+|..+|+++++||.+|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 33456899999999999988775 89999999999999999999999999999999998888899999999999999999
Q ss_pred cCCCCCCCCCHh-HHhcCccccC
Q 019904 249 LDPNPMTRITIP-EILEDEWFKK 270 (334)
Q Consensus 249 L~~dp~~Rpt~~-e~l~h~~~~~ 270 (334)
|++||.+|||+. ++++||||+.
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999996 8999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-63 Score=446.90 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=218.4
Q ss_pred cccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
....++|++++.||+|+||+||+|++..+|+.||+|++.... .....+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 346789999999999999999999999999999999997542 233356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999998899999999999999999999997 59999999999999999999999999998854332
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH---------------------
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK--------------------- 224 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~--------------------- 224 (334)
...+.+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.+......
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---ccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2345689999999999998777 489999999999999999999997654322100
Q ss_pred ---------------------HhhcCc-cCCC-CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 225 ---------------------KISAAE-FTCP-PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 225 ---------------------~~~~~~-~~~~-~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
.+.... ...| ..+|.++++||.+||..||.+|||++|+|+||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000000 0111 236889999999999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.4e-62 Score=429.35 Aligned_cols=258 Identities=32% Similarity=0.538 Sum_probs=229.1
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh------hHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEee
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL------KHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 82 (334)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.... .....+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57999999999999999999999999999999999765322 1334467889999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
++..|+|||||++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC---
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 234 (334)
. ........||+.|+|||.+.+. ...+.++||||+||++|+|++|+.||.+.+.......+.......+
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 2233456899999999999742 2346789999999999999999999999998888887776655433
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 235 -PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 235 -~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
+.+|+++++||.+||++||.+|||++|+|+||||++
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 368999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-62 Score=445.30 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=225.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHH---HHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
.+++|++++.||+|+||.||+|++..+|+.||||++.+...........+ .+++.+++.++|||||++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 46789999999999999999999999999999999987554433323333 345777888889999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|+|||||+||+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccCCCCCCCHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTAR 242 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 242 (334)
......+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+ ...+...+.......|+.+|++++
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 223456899999999999765555699999999999999999999997643 344555556666777888999999
Q ss_pred HHHHHhcCCCCCCCCC-----HhHHhcCccccC
Q 019904 243 KLIARILDPNPMTRIT-----IPEILEDEWFKK 270 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt-----~~e~l~h~~~~~ 270 (334)
+||.+||++||.+||| ++|+++||||+.
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-62 Score=437.67 Aligned_cols=256 Identities=25% Similarity=0.491 Sum_probs=229.5
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
..+++|++++.||+|+||+||+|.+..+|+.||||++...... ...+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 4579999999999999999999999999999999999765432 345789999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC--CCeEEeeccchhccccc
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQV 164 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~--~~~kl~Dfg~a~~~~~~ 164 (334)
+|||||+||+|.+++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 9999999999999998765 79999999999999999999999999999999999999854 479999999987532
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCC----CCCCHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (334)
.........||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+.+..+....+.++ +.+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 2233455689999999999988776 4899999999999999999999999999999998888776665 368999
Q ss_pred HHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 241 ARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 241 ~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
+++||.+||.+||.+|||++|+|+||||.+.
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-61 Score=430.56 Aligned_cols=256 Identities=27% Similarity=0.361 Sum_probs=215.5
Q ss_pred EeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEec
Q 019904 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (334)
Q Consensus 15 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 92 (334)
.++.||+|+||+||+|++..+|+.||||++....... ....+.+.+|+.+|+.++|||||++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4688999999999999999999999999997644322 22235688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCcccc
Q 019904 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (334)
Q Consensus 93 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 172 (334)
|.++++.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...... ......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence 999887777666778999999999999999999999999999999999999999999999999998754332 223345
Q ss_pred cccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC--------------------
Q 019904 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-------------------- 232 (334)
Q Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~-------------------- 232 (334)
.+||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+.++......
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 689999999999987666679999999999999999999999998888777665421100
Q ss_pred --------CCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 233 --------CPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 233 --------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
..+.+++++++||.+||+.||++|||++|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0124688999999999999999999999999999998643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=425.29 Aligned_cols=253 Identities=31% Similarity=0.542 Sum_probs=220.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHHHhCC--CCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVK--HPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~ 84 (334)
-++|++.+.||+|+||+||+|++..+|+.||||++.+...... ....++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4789999999999999999999999999999999986543221 11234568999999987 899999999999999
Q ss_pred eEEEEEeccCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecC-CCeEEeeccchhccc
Q 019904 85 KIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 ~~~~v~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~a~~~~ 162 (334)
..|+||||+.+ +++.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999986 6888888888899999999999999999999999999999999999999854 789999999987533
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCCCCCHHHH
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (334)
. .......||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+ .+......+++.+|++++
T Consensus 163 ~----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 163 D----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp S----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHH
T ss_pred c----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHH
Confidence 2 233456899999999999988877778999999999999999999998632 344556678889999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 243 KLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
+||.+||++||++|||++|+|+||||+...
T Consensus 233 ~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999997643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-60 Score=423.05 Aligned_cols=261 Identities=30% Similarity=0.470 Sum_probs=219.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||+||+|.+..+|+.||||++..... .+...+.+.+|+.+|++++|||||++++++.+...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 4799999999999999999999999999999999976542 233356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCC
Q 019904 90 LEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 167 (334)
||||.++ +.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ..
T Consensus 80 ~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 80 FEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp EECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred EeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence 9999875 4444433 35699999999999999999999999999999999999999999999999999975433 22
Q ss_pred CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc----------------
Q 019904 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------------- 231 (334)
Q Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~---------------- 231 (334)
.......||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+..+...++.....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3344568999999999998888878999999999999999999999998887766555422100
Q ss_pred --CC-----------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 232 --TC-----------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 232 --~~-----------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
.. .+.+|.++++||.+||+.||++|||++|+|+||||+...+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 00 12467899999999999999999999999999999876543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-59 Score=416.51 Aligned_cols=257 Identities=32% Similarity=0.472 Sum_probs=218.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||+||+|++. +|+.||||++..... .+...+++.+|+.+|++++||||+++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 479999999999999999999995 789999999976543 333457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||++.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999998777777676788999999999999999999999999999999999999999999999999998764332 122
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------------- 230 (334)
.....|++.|+|||.+.+..+.+.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3445789999999999887777899999999999999999999999887776665543210
Q ss_pred ----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccC
Q 019904 231 ----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKK 270 (334)
Q Consensus 231 ----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~ 270 (334)
...++.+++++++||.+||++||++|||++|+|+||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0123457889999999999999999999999999999973
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-60 Score=426.88 Aligned_cols=255 Identities=35% Similarity=0.602 Sum_probs=214.3
Q ss_pred ccccceEEee-eeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEee---
Q 019904 8 RRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGS--- 82 (334)
Q Consensus 8 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~--- 82 (334)
..+++|.++. .||+|+||+||+|++..+|+.||||+++.. ..+.+|+.++. ..+|||||+++++|++
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 4578999875 599999999999999999999999999643 34668998865 5589999999999876
Q ss_pred -CCeEEEEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEeecc
Q 019904 83 -KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFG 156 (334)
Q Consensus 83 -~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~Dfg 156 (334)
...+|+|||||+||+|.+++... .++++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999874 36999999999999999999999999999999999999975 4679999999
Q ss_pred chhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCccC
Q 019904 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFT 232 (334)
Q Consensus 157 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~----~~~~~~~~~~~ 232 (334)
+|+.... .......+||+.|+|||++.+..+. .++|||||||++|+|+||+.||.+.+... +...+....+.
T Consensus 160 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 160 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp TCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred eeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 9875432 2234556899999999999887774 89999999999999999999998765333 33344444555
Q ss_pred CCC----CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 233 CPP----WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 233 ~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
+|. .+|+++++||.+||+.||++|||++|+|+||||....+.
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 281 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence 543 489999999999999999999999999999999865543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-59 Score=410.91 Aligned_cols=258 Identities=26% Similarity=0.437 Sum_probs=216.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
..++|++.+.||+|+||+||+|.+..+|+.||||++..+........+.+.+|+.+|+.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 3578999999999999999999999999999999998776666666788999999999999999999999987654
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|+|||||+|++|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 48999999999999999999999999999999999999999999999999999999999999999999999987643322
Q ss_pred c-CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC----CCCCCCH
Q 019904 165 R-DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSF 239 (334)
Q Consensus 165 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~ 239 (334)
. ........+||+.|+|||++.+..++ .++|||||||++|+|+||+.||.+.+..+...++...... .++.+|+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred cccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 1 22234456899999999999887764 8999999999999999999999998888877666554433 3456899
Q ss_pred HHHHHHHHhcCCCCCCCC-CHhHHhcCccc
Q 019904 240 TARKLIARILDPNPMTRI-TIPEILEDEWF 268 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rp-t~~e~l~h~~~ 268 (334)
++.+||.+||++||.+|| |++++ .|+|.
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred HHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 999999999999999999 55554 46654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=414.90 Aligned_cols=262 Identities=29% Similarity=0.382 Sum_probs=216.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee------
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 82 (334)
.++||++++.||+|+||+||+|++..+|+.||||++..+... +....++.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 479999999999999999999999999999999998765432 3334667899999999999999999998755
Q ss_pred --CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 83 --KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 83 --~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
+..+|+|||||.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 456899999999877665555567899999999999999999999999999999999999999999999999999865
Q ss_pred ccccc--CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCCCC---
Q 019904 161 SQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--- 235 (334)
Q Consensus 161 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 235 (334)
..... ........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+......+++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 43221 1223345679999999999987765679999999999999999999999988877766655432221111
Q ss_pred -----------------------------CCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 236 -----------------------------WLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 236 -----------------------------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
..++++++||.+||+.||++|||++|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 036778999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-58 Score=410.96 Aligned_cols=259 Identities=31% Similarity=0.422 Sum_probs=212.1
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCC-CCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC---CCCCeeeEEEEEee-
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS- 82 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~- 82 (334)
+..++|++++.||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 4568999999999999999999999765 5679999997543221 1123345677666655 79999999999853
Q ss_pred ----CCeEEEEEeccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 83 ----KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 83 ----~~~~~~v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
...+|++|||+.++++...... ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence 3578999999998776544433 35699999999999999999999999999999999999999999999999999
Q ss_pred hhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-------
Q 019904 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------- 230 (334)
Q Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------- 230 (334)
+..... ........||+.|+|||++.+..+. .++|||||||++|||++|+.||.+.+..+.+..+....
T Consensus 163 ~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 163 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 875432 2234566899999999999988774 89999999999999999999999988777766553210
Q ss_pred --------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 --------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 --------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...+..+|+.+++||.+||+.||++|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 11234578999999999999999999999999999999854
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-58 Score=407.00 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=216.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||+||+|.+..+|+.||||++..+... .+++.+|+.+|++++|||||++++++.+.+.+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3557899999999999999999999999999999999754322 456889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999999999764 468999999999999999999999999999999999999999999999999997543221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCC-CCCCcHHHHHHHhhcC-ccCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~p-f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 243 (334)
........|++.|+|||++.+..+ +.++|||||||++|||++|..| |.+.+...+...+... ....|+.+|+++++
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 247 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -ceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence 112233468899999999998777 4899999999999999996554 5666666666655443 45677889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhc
Q 019904 244 LIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~ 264 (334)
||.+||+.||++|||++|+++
T Consensus 248 li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 248 LMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-58 Score=415.09 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=213.0
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCC-----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 84 (334)
++|++++.||+|+||+||+|++...++ .||+|.+..... ......+.+|+.+|+++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999866544 699999865432 22346788999999988 8999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCC
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~N 141 (334)
.+|+|||||++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 9999999999999999997642 48899999999999999999999999999999999
Q ss_pred EEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHH
Q 019904 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM 220 (334)
Q Consensus 142 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~ 220 (334)
||++.++.+||+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986554333333345678999999999998777 489999999999999997 89999886655
Q ss_pred HHHHHhhcC--ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 221 NLYKKISAA--EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 221 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
..+.++... .++.|..+|+++++||.+||+.||++|||++|+++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 444444333 345677899999999999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=403.54 Aligned_cols=259 Identities=32% Similarity=0.469 Sum_probs=223.5
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
+++|++++.||+|+||+||+|.+..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++......++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4799999999999999999999999999999999976543 344567889999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
|+++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|...... ...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~--~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC--CSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC--Ccc
Confidence 999999999988888889999999999999999999999999999999999999999999999999998754432 223
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCC-CCCcHHHHHHHhhcCc------------------
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAE------------------ 230 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf-~~~~~~~~~~~~~~~~------------------ 230 (334)
.....+++.|+|||++....+.+.++|||||||++|+|++|+.|| .+.+..+....+....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 334567889999999988777679999999999999999999985 5556555555442211
Q ss_pred -----------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCC
Q 019904 231 -----------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKD 271 (334)
Q Consensus 231 -----------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~ 271 (334)
...++.+++.+++||.+||+.||.+|||++|+|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 11223478899999999999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-58 Score=406.25 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=206.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (334)
...++|++.+.||+|+||+||+|+.. ..||||++...... ....+.+.+|+.+|++++|||||++++++. ...+|
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence 34678999999999999999999863 35999999764433 334678999999999999999999999875 45689
Q ss_pred EEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||||++|+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999999765 5699999999999999999999999999999999999999999999999999976554333
Q ss_pred CCcccccccCCcccChHhhhcCC--CCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHH-HhhcCc-----cCCCCCCC
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK-KISAAE-----FTCPPWLS 238 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~-~~~~~~-----~~~~~~~~ 238 (334)
........||+.|+|||++.+.. .++.++|||||||++|||+||+.||.+.+...... .+.... ...+..+|
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 239 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence 33445668999999999997532 34689999999999999999999998865544333 332221 13456789
Q ss_pred HHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 239 FTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+++.+||.+||+.||++|||++|++++
T Consensus 240 ~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 240 KAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999999999876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=405.81 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=210.3
Q ss_pred eeeeccCceEEEEEEEC--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEEeccC
Q 019904 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (334)
Q Consensus 17 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 94 (334)
+.||+|+||+||+|.+. .+++.||||++.... ......+.+.+|+.+|++++|||||++++++..+ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 47999999999999754 455789999997543 3344467899999999999999999999998654 5789999999
Q ss_pred CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC-CCccccc
Q 019904 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-DGLLHTT 173 (334)
Q Consensus 95 ~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 173 (334)
+|+|.+++....++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999875432211 1122345
Q ss_pred ccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHHhcCC
Q 019904 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (334)
Q Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~ 251 (334)
.||+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+..++...+... ..+.|..+|+++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 68999999999988776 489999999999999998 99999998888887777654 4567788999999999999999
Q ss_pred CCCCCCCHhHHh---cCccc
Q 019904 252 NPMTRITIPEIL---EDEWF 268 (334)
Q Consensus 252 dp~~Rpt~~e~l---~h~~~ 268 (334)
||++|||+++++ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 56554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-58 Score=416.49 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=213.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 84 (334)
.-++|++++.||+|+||+||+|.+..+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 3579999999999999999999999999999999997643 34445678899999999999999999999997665
Q ss_pred --eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 85 --~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
.+|+||||| +++|...+ +..++++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 44666655 45679999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc------------
Q 019904 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (334)
Q Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~------------ 230 (334)
. ......||+.|+|||++.+..+.+.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 173 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 173 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred C-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 2 23456799999999999887777799999999999999999999999887666554432211
Q ss_pred -------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 -------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 -------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
....+.+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 112345789999999999999999999999999999998643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-57 Score=405.60 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=208.2
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
..++|++.+.||+|+||+||+|.+..+|+ .||||.+.... .....+.+.+|+.+|++++|||||++++++...+.
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 35789999999999999999999987665 48888876432 23345678999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+|+|||||++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999999988774 46999999999999999999999999999999999999999999999999999765432
Q ss_pred cCCC---cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 019904 165 RDDG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (334)
Q Consensus 165 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (334)
.... ......||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+... ..+.|..++.
T Consensus 182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (299)
T d1jpaa_ 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPS 260 (299)
T ss_dssp --------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchH
Confidence 2211 1122457899999999988766 489999999999999998 89999999888888777654 3566778999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 240 TARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
++.+||.+||+.||++|||+.|++++
T Consensus 261 ~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999998763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=398.05 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=208.0
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 89 (334)
-++|++++.||+|+||+||+|.+. +++.||||++...... .+.+.+|+.++++++||||+++++++..++.+|+|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 358999999999999999999986 5678999999764332 35688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCC
Q 019904 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (334)
Q Consensus 90 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 168 (334)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~ 157 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 157 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc-e
Confidence 9999999999988765 4688999999999999999999999999999999999999999999999999875443221 2
Q ss_pred cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHH
Q 019904 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (334)
Q Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 246 (334)
......||+.|+|||++.+..+ +.++|||||||++|||+| |..||...+..++...+... ....|..+++++.+||.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 236 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 236 (263)
T ss_dssp -------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred eecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 2234578999999999998776 489999999999999999 67788888887877777654 34567778999999999
Q ss_pred HhcCCCCCCCCCHhHHhcC
Q 019904 247 RILDPNPMTRITIPEILED 265 (334)
Q Consensus 247 ~~L~~dp~~Rpt~~e~l~h 265 (334)
+||+.||++|||++|+++|
T Consensus 237 ~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 237 HCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCHhHCcCHHHHHHH
Confidence 9999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=401.28 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=217.4
Q ss_pred cccceEEeee-eeccCceEEEEEEECC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCe
Q 019904 9 RVGKYEVGRT-IGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (334)
Q Consensus 9 ~~~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (334)
.-++|.+.+. ||+|+||+||+|.+.. ++..||||++.... .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3467888884 9999999999998754 34579999997543 23346788999999999999999999999865 45
Q ss_pred EEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 78999999999999988654 57999999999999999999999999999999999999999999999999998754432
Q ss_pred cC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHH
Q 019904 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (334)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 241 (334)
.. ........||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++...+..+ ....|+.+|+++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 241 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 241 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 21 112234568899999999988776 489999999999999998 99999988877777777654 356788899999
Q ss_pred HHHHHHhcCCCCCCCCCHhHH---hcCcccc
Q 019904 242 RKLIARILDPNPMTRITIPEI---LEDEWFK 269 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~---l~h~~~~ 269 (334)
.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999999888 5677764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-57 Score=409.01 Aligned_cols=261 Identities=26% Similarity=0.453 Sum_probs=214.2
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC-----
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 84 (334)
.+||++++.||+|+||+||+|.+..+|+.||||++.+.. .....+.+.+|+.+|+.++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 368999999999999999999999999999999997543 3444677889999999999999999999997653
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
.+|++ +++.+|+|.+++... ++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 85 ~~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CEEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 35555 556688999998764 6999999999999999999999999999999999999999999999999998754332
Q ss_pred cC-CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------------
Q 019904 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------------ 231 (334)
Q Consensus 165 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~------------ 231 (334)
.. .......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+.............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 22 22335567999999999997666667899999999999999999999998776554443321000
Q ss_pred -------------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCCCC
Q 019904 232 -------------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDYKP 274 (334)
Q Consensus 232 -------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~~~ 274 (334)
...+.+|.++++||.+||+.||.+|||++|+|+||||+....+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 1123578899999999999999999999999999999865543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=394.48 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=219.3
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 90 (334)
+.|++++.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 67899999999999999999985 6788999999865433 356889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccCCCc
Q 019904 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (334)
Q Consensus 91 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 169 (334)
||+.+|+|..++.. ...+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999988665 4579999999999999999999999999999999999999999999999999987544322 222
Q ss_pred ccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHHHHH
Q 019904 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIAR 247 (334)
Q Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 247 (334)
.....||+.|+|||++.+..++ .++|||||||++|||+| |+.||.+.+..++..++... ....|...++++.+||.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3345789999999999987774 89999999999999998 89999999988888877665 446677899999999999
Q ss_pred hcCCCCCCCCCHhHHhcC
Q 019904 248 ILDPNPMTRITIPEILED 265 (334)
Q Consensus 248 ~L~~dp~~Rpt~~e~l~h 265 (334)
||+.||++|||++++++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=398.72 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=215.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++++.||+|+||+||+|.+. +++.||||++...... .+.+.+|+.+|++++|||||++++++.+ +..|+
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 4478999999999999999999985 5778999999754322 3568899999999999999999998754 56789
Q ss_pred EEeccCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|||||++|+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-
Confidence 99999999999877543 369999999999999999999999999999999999999999999999999997643221
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
........||+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+..+....+... ....|..+++++.+|
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l 242 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence 112334578999999999987766 489999999999999999 56667777777777777654 456678899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc--Ccccc
Q 019904 245 IARILDPNPMTRITIPEILE--DEWFK 269 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~--h~~~~ 269 (334)
|.+||+.||++|||++++++ ++||.
T Consensus 243 i~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 243 MRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999999999999988 77775
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=409.50 Aligned_cols=252 Identities=29% Similarity=0.381 Sum_probs=210.1
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee------CC
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~ 84 (334)
-+|+.++.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 379999999999999999999999999999999976432 23479999999999999999999854 33
Q ss_pred eEEEEEeccCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhc
Q 019904 85 KIFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSAL 160 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~ 160 (334)
++|+|||||+++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 58999999987643322 23455799999999999999999999999999999999999999776 899999999875
Q ss_pred cccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC-----------
Q 019904 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------- 229 (334)
Q Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~----------- 229 (334)
... ........||+.|+|||.+.+...++.++||||+||++|||++|+.||...+..+.+..+...
T Consensus 173 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 432 233455689999999999987666679999999999999999999999988776665554311
Q ss_pred ------cc------------CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 230 ------EF------------TCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 230 ------~~------------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
.. ...+.+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 01234789999999999999999999999999999998643
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=406.68 Aligned_cols=261 Identities=31% Similarity=0.560 Sum_probs=223.4
Q ss_pred cccceEEeeeeeccCceEEEEEEEC---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~ 83 (334)
.+++|++++.||+|+||+||+|.+. .+|+.||||++.+.... +....+.+.+|+.+|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 4588999999999999999999874 46899999998754322 22234567899999999987 8999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..+|+||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCCcccChHhhhcCC-CCCCccchhhHHHHHHHHHhCCCCCCCCc----HHHHHHHhhcCccCCCCCCC
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLS 238 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~e~~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~ 238 (334)
. .........|++.|+|||.+.+.. ..+.++|||||||++|+|++|+.||.+.+ ...+.........+.|..+|
T Consensus 182 ~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 182 D-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp G-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred c-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 2 222344568999999999998654 34678999999999999999999997643 33444555556677788899
Q ss_pred HHHHHHHHHhcCCCCCCCC-----CHhHHhcCccccC
Q 019904 239 FTARKLIARILDPNPMTRI-----TIPEILEDEWFKK 270 (334)
Q Consensus 239 ~~~~~li~~~L~~dp~~Rp-----t~~e~l~h~~~~~ 270 (334)
+++++||.+||++||++|| |++|+++||||+.
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999999999 5899999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=407.34 Aligned_cols=256 Identities=27% Similarity=0.366 Sum_probs=214.5
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC-----C
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~ 84 (334)
.+||++++.||+|+||+||+|++..+|+.||||++.+... .....+++.+|+.+|+.++||||+++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4789999999999999999999999999999999986543 333356788999999999999999999998643 2
Q ss_pred eEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
..+++|+++.+|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 34556677789999998854 5799999999999999999999999999999999999999999999999999865332
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccCC-----------
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----------- 233 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 233 (334)
......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 23456789999999999887777799999999999999999999999988776665553221111
Q ss_pred --------------------CCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 234 --------------------PPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 234 --------------------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
...+|+++++||.+||..||.+|||++|+|+||||+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 134789999999999999999999999999999998654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-56 Score=399.58 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=209.3
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeC--Ce
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TK 85 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--~~ 85 (334)
..++|++++.||+|+||+||+|++..+|+.||||++.... .+++.+|+.+|+.++ ||||+++++++... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999997543 356789999999996 99999999999754 56
Q ss_pred EEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC-CeEEeeccchhccccc
Q 019904 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (334)
Q Consensus 86 ~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 164 (334)
+|+|||||.+++|.... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence 99999999999987653 5699999999999999999999999999999999999998765 589999999875432
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc-HHHHHHHhhc-------------Cc
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA-------------AE 230 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~-~~~~~~~~~~-------------~~ 230 (334)
........||+.|+|||.+.+...++.++||||+||++|+|++|..||.... .......+.. ..
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 2233456789999999999887766799999999999999999999997543 2222111100 00
Q ss_pred ------------------------cCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 231 ------------------------FTCPPWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 231 ------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
......+|+++++||.+||..||.+|||++|+|+||||+.-.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 001123788999999999999999999999999999998643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-56 Score=398.55 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=209.8
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
+.|++++.||+|+||+||+|.+..+|+ +||+|.+.... .....+.+.+|+.+|++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 569999999999999999999988776 57888876432 233357789999999999999999999999765 56
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
+++||++.+|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 7788999999998887765 579999999999999999999999999999999999999999999999999998654433
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (334)
.........||+.|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..++...+..+. .+.|+.+++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 3333344568999999999998776 589999999999999998 899999887777776665543 5677889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcCc
Q 019904 244 LIARILDPNPMTRITIPEILEDE 266 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h~ 266 (334)
||.+||+.||.+|||+.|+++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=391.68 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=205.9
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
-++|++++.||+|+||.||+|.+..++ ..||||.+... ......+.+.+|+.+|++++||||+++++++. ++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 368999999999999999999986543 45888887543 23444678899999999999999999999985 5678
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
|+|||||++|+|.+++... .++++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+|+......
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999999999887654 479999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc-cCCCCCCCHHHHH
Q 019904 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (334)
Q Consensus 166 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 243 (334)
........||+.|+|||++.+..+. .++|||||||++|||++ |..||.+.+..++...+.... .+.|+.+|+++.+
T Consensus 163 -~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 163 -YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred -ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1222345688999999999987774 89999999999999998 899999988888877776554 5678889999999
Q ss_pred HHHHhcCCCCCCCCCHhHHhcC
Q 019904 244 LIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 244 li~~~L~~dp~~Rpt~~e~l~h 265 (334)
||.+||+.||++|||++|+++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=387.59 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=207.4
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
.....|++.+.||+|+||+||+|.+..++ ..||||++..... ......+.+|+.+|++++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 34567999999999999999999976654 3699999975432 23346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 162 (334)
+..++|||||.++++.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999999999887765 579999999999999999999999999999999999999999999999999997644
Q ss_pred cccCC-CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcC-ccCCCCCCCH
Q 019904 163 QVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (334)
Q Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (334)
..... .......||+.|+|||++.+..+ +.++|||||||++|||++| ..|+.+.+..++...+... ..+.|..++.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 240 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS 240 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence 32221 12234568999999999988766 4899999999999999995 5556666777777666554 3466777999
Q ss_pred HHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 240 TARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 240 ~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+.+||.+||+.||++|||+.|+++
T Consensus 241 ~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 241 AIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 9999999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=388.21 Aligned_cols=255 Identities=22% Similarity=0.370 Sum_probs=212.4
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (334)
..++|++.+.||+|+||+||+|++.. ++.||||++...... .+.+.+|+.+|++++|||||++++++.+ +.+|+
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 45899999999999999999999865 467999999755432 3568899999999999999999999854 56789
Q ss_pred EEeccCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 89 VLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
|||||++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~- 167 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 167 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-
Confidence 9999999999988864 3579999999999999999999999999999999999999999999999999997543321
Q ss_pred CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcC-ccCCCCCCCHHHHHH
Q 019904 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (334)
Q Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 244 (334)
........||+.|+|||++....+ +.++|||||||++|||++| ..|+.+....++...+... ..+.++.+|+++++|
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 246 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246 (285)
T ss_dssp --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence 122334578999999999998777 4899999999999999995 5666777777777766544 456788899999999
Q ss_pred HHHhcCCCCCCCCCHhHHhc--CccccCC
Q 019904 245 IARILDPNPMTRITIPEILE--DEWFKKD 271 (334)
Q Consensus 245 i~~~L~~dp~~Rpt~~e~l~--h~~~~~~ 271 (334)
|.+||+.||++|||++++++ ++||...
T Consensus 247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 247 MCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 99999999999999999987 7888754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-56 Score=403.91 Aligned_cols=255 Identities=26% Similarity=0.441 Sum_probs=204.3
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee------C
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------K 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 83 (334)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ......++.+|+.+|+.++||||++++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999986543 34445678899999999999999999999964 4
Q ss_pred CeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccc
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 163 (334)
..+|+|||||.++ +.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 6899999999875 44444 35699999999999999999999999999999999999999999999999998775443
Q ss_pred ccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccC-----------
Q 019904 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----------- 232 (334)
Q Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~~~~~~~----------- 232 (334)
........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+......++......
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 223345678999999999998766 58999999999999999999999988766655443211100
Q ss_pred -----------C--------------C------CCCCHHHHHHHHHhcCCCCCCCCCHhHHhcCccccCCC
Q 019904 233 -----------C--------------P------PWLSFTARKLIARILDPNPMTRITIPEILEDEWFKKDY 272 (334)
Q Consensus 233 -----------~--------------~------~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h~~~~~~~ 272 (334)
. + ...|+++++||.+||..||++|||++|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0 0 01356789999999999999999999999999998644
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-55 Score=389.26 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=218.0
Q ss_pred ccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (334)
-++|++++.||+|+||+||+|++. .+++.||||++.... .....+++.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 467999999999999999999874 356789999987543 2334577899999999999999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCC
Q 019904 85 KIFIVLEFVTGGELFDKIVNHG------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~ 140 (334)
..++||||+.+|+|.+++.... .++...+..++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996532 3788899999999999999999999999999999
Q ss_pred CEEEecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCC-CCCCCCcH
Q 019904 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNL 219 (334)
Q Consensus 141 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~-~pf~~~~~ 219 (334)
|||++.++.+||+|||+|+...............||+.|+|||.+.+..++ .++|||||||++|||++|. .||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999865444333344456789999999999987775 8999999999999999985 68999988
Q ss_pred HHHHHHhhcCcc-CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 220 MNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.++...+..... ..|..+++++.+||.+||+.||++|||+.|+++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 888888776654 457789999999999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=387.79 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=205.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECC-CC--CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCCeE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSE-TG--EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (334)
.++|++.+.||+|+||+||+|+... ++ ..||||++.+.........+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 4679999999999999999998643 33 3689999987666566667889999999999999999999999965 467
Q ss_pred EEEEeccCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhcccccc
Q 019904 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 165 (334)
++|||||++|++.+.+... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 8999999999999877654 479999999999999999999999999999999999999999999999999988654332
Q ss_pred CCC-cccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhcCc--cCCCCCCCHHH
Q 019904 166 DDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTA 241 (334)
Q Consensus 166 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 241 (334)
... ......|+..|+|||++.+..+ +.++|||||||++|||+| |..||.+.+..+....+.... ++.++.+|.++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 221 2233457889999999998666 588999999999999998 899999999999888876554 35567799999
Q ss_pred HHHHHHhcCCCCCCCCCHhHHhc
Q 019904 242 RKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 242 ~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.+||.+||+.||++|||++++++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=383.01 Aligned_cols=244 Identities=24% Similarity=0.433 Sum_probs=206.9
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-CCeE
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKI 86 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 86 (334)
...++|++++.||+|+||.||+|++ .|..||||++..+. ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 3567899999999999999999998 47789999997543 24678899999999999999999998854 5678
Q ss_pred EEEEeccCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccc
Q 019904 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 164 (334)
|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence 99999999999999997643 589999999999999999999999999999999999999999999999999875332
Q ss_pred cCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHHHhhc-CccCCCCCCCHHHH
Q 019904 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTAR 242 (334)
Q Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 242 (334)
......+|+.|+|||++.+..+ +.++|||||||++|||+| |+.||...+..++...+.. ...+.|+.++++++
T Consensus 156 ----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (262)
T d1byga_ 156 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 2234567899999999988776 599999999999999998 7999998888887777754 34577888999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhc
Q 019904 243 KLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
+||.+||+.||.+|||+.++++
T Consensus 231 ~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 231 EVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcccCHhHCcCHHHHHH
Confidence 9999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=386.54 Aligned_cols=253 Identities=23% Similarity=0.413 Sum_probs=215.9
Q ss_pred cccceEEeeeeeccCceEEEEEEECCCC-------CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEE
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~ 80 (334)
-.++|++++.||+|+||.||+|++..++ ..||||++..... ......+.+|...+.++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 4589999999999999999999876544 3699999976432 23356778888888887 799999999999
Q ss_pred eeCCeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEE
Q 019904 81 GSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (334)
Q Consensus 81 ~~~~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~ 144 (334)
.+++..|+|||||.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 99999999999999999999997553 48999999999999999999999999999999999999
Q ss_pred ecCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHH
Q 019904 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY 223 (334)
Q Consensus 145 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~ 223 (334)
+.++.+||+|||++................||+.|+|||.+.+..+ +.++|||||||++|||++ |..||.+.+...+.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 9999999999999987665544444556678999999999998777 489999999999999998 79999998888887
Q ss_pred HHhhcC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 224 KKISAA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 224 ~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..+... .+..|..+|+++.+||.+||+.||.+|||+.|+++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 776554 45677889999999999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-55 Score=389.12 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=201.0
Q ss_pred ccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
-++|++++.||+|+||.||+|.+.. +++.||||++..... ....+.+.+|..++.++ +|+||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3789999999999999999999754 446899999875432 22245666777777666 689999999987654
Q ss_pred -CeEEEEEeccCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec
Q 019904 84 -TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (334)
Q Consensus 84 -~~~~~v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~ 146 (334)
..+++|||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 56899999999999999997532 4889999999999999999999999999999999999999
Q ss_pred CCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHH-HHH
Q 019904 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMN-LYK 224 (334)
Q Consensus 147 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~-~~~ 224 (334)
++.+||+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|||++| ..||.+..... ...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999976544333333445679999999999998776 5899999999999999986 56887755433 333
Q ss_pred Hhhc-CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 225 KISA-AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 225 ~~~~-~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.+.. ..+..|+.+++++++||.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3333 3456677899999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=390.43 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=214.8
Q ss_pred ccccceEEeeeeeccCceEEEEEEECCCCCe--EEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeCC
Q 019904 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (334)
Q Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 84 (334)
...++|++.+.||+|+||+||+|.+..+|.. ||||.+... ......+.+.+|+.+|+++ +|||||++++++...+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4678999999999999999999999888765 667776532 2233356789999999998 6999999999999999
Q ss_pred eEEEEEeccCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCC
Q 019904 85 KIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (334)
Q Consensus 85 ~~~~v~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~ 148 (334)
..|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 4689999999999999999999999999999999999999999
Q ss_pred CeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhh
Q 019904 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKIS 227 (334)
Q Consensus 149 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~ 227 (334)
.+||+|||+|+...... ......||..|+|||.+.+..+ +.++|||||||++|||++| ..||.+.+..++...+.
T Consensus 165 ~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEccccccccccccc---cccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999987543322 2234568999999999998776 4899999999999999996 56899989888888876
Q ss_pred cC-ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhcC
Q 019904 228 AA-EFTCPPWLSFTARKLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 228 ~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
.. .+..|..+++++++||.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 54 456677899999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=382.73 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=219.6
Q ss_pred cccceEEeeeeeccCceEEEEEEECC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeC
Q 019904 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (334)
Q Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 83 (334)
.-++|++++.||+|+||+||+|.+.. ++..||||++.... .......+.+|+.++++++||||+++++++..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 34899999999999999999998752 35789999997543 233456789999999999999999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~ 153 (334)
...++|||||.+|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++.++++||+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence 9999999999999999988653 246888999999999999999999999999999999999999999999
Q ss_pred eccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcCc-c
Q 019904 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE-F 231 (334)
Q Consensus 154 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g-~~pf~~~~~~~~~~~~~~~~-~ 231 (334)
|||+|+...............||+.|+|||.+.+..+. .++|||||||++|||+|| ..||.+.+..+.+..+.... .
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999865544333333445789999999999987775 899999999999999998 58899988888887776544 4
Q ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 232 TCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 232 ~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
..|+.+|+.+.++|.+||+.||++|||++++++
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 567789999999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=381.39 Aligned_cols=252 Identities=21% Similarity=0.358 Sum_probs=213.8
Q ss_pred ccceEEeeeeeccCceEEEEEEEC-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeC
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 83 (334)
-++|++++.||+|+||.||+|.+. .+++.||||++..... ......+.+|+.+++.+ +|||||++++++.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 379999999999999999999853 4667899999976432 33356788999999999 599999999999999
Q ss_pred CeEEEEEeccCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEe
Q 019904 84 TKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD 145 (334)
Q Consensus 84 ~~~~~v~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~ 145 (334)
...|+|||||++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 99999999999999999997643 588999999999999999999999999999999999999
Q ss_pred cCCCeEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHh-CCCCCCCCcHHHHHH
Q 019904 146 AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK 224 (334)
Q Consensus 146 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~-g~~pf~~~~~~~~~~ 224 (334)
.++.++++|||.++...............||+.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+....+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999986554333333445678999999999988766 589999999999999998 677777765544444
Q ss_pred Hhhc--CccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 225 KISA--AEFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 225 ~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
++.. .....|..+|..+.+||.+||+.||++|||++++++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3322 234556678999999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=370.57 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=204.1
Q ss_pred ceEEeeeeeccCceEEEEEEECCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee-CCeEE
Q 019904 12 KYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIF 87 (334)
Q Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 87 (334)
.+.+.+.||+|+||+||+|.+..++ ..||||.+... ......+++.+|+.+|++++||||+++++++.. +...+
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 105 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 105 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred eeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence 3344788999999999999986644 25899998642 234446889999999999999999999999765 56899
Q ss_pred EEEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccchhccccccC
Q 019904 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (334)
Q Consensus 88 ~v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 166 (334)
+|||||++|+|.+++.... .++...+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 106 lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999999999887544 577888999999999999999999999999999999999999999999999875433211
Q ss_pred --CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCC-cHHHHHHHhhc-CccCCCCCCCHHHH
Q 019904 167 --DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISA-AEFTCPPWLSFTAR 242 (334)
Q Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~ 242 (334)
........||+.|+|||.+....+ +.++|||||||++|||++|..||... +..+....+.. .....|+.+++++.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~ 264 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence 122234568999999999988776 58999999999999999977777543 33344444433 34566778999999
Q ss_pred HHHHHhcCCCCCCCCCHhHHhcC
Q 019904 243 KLIARILDPNPMTRITIPEILED 265 (334)
Q Consensus 243 ~li~~~L~~dp~~Rpt~~e~l~h 265 (334)
+||.+||+.||++|||+.|+++|
T Consensus 265 ~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 265 EVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-51 Score=367.51 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=201.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeeCCeEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIFIV 89 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~v 89 (334)
++|++++.||+|+||.||+|++..+|+.||||++..+.. ...+.+|+.+++.++|++ |+.+..++......++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999876432 234678999999998766 55666777888999999
Q ss_pred EeccCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec---CCCeEEeeccchhcccccc
Q 019904 90 LEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQVR 165 (334)
Q Consensus 90 ~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~---~~~~kl~Dfg~a~~~~~~~ 165 (334)
|||+.+ ++.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++. +..++|+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999965 5655554 4568999999999999999999999999999999999999853 4579999999998654322
Q ss_pred CC-----CcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHHHHHHHh---h-----cCccC
Q 019904 166 DD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---S-----AAEFT 232 (334)
Q Consensus 166 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~~~~~~~---~-----~~~~~ 232 (334)
.. .......||+.|+|||++.+..+ +.++|||||||++|||++|..||...........+ . .....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 21 12344579999999999998777 48999999999999999999999875543322211 1 11112
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCCCCHhH---HhcCccccCC
Q 019904 233 CPPWLSFTARKLIARILDPNPMTRITIPE---ILEDEWFKKD 271 (334)
Q Consensus 233 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e---~l~h~~~~~~ 271 (334)
.++.+|+++.+||.+||+.||++||++++ +|+|+|.+..
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 34568999999999999999999999875 4677766543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-50 Score=356.63 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=204.6
Q ss_pred ccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeeCCeEEE
Q 019904 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 88 (334)
-++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++.++.+.| +|++.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3689999999999999999999999999999999865432 2346788899999975 899999999999999999
Q ss_pred EEeccCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEec-----CCCeEEeeccchhccc
Q 019904 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-----YGNLKVSDFGLSALSQ 162 (334)
Q Consensus 89 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~-----~~~~kl~Dfg~a~~~~ 162 (334)
||||+ +++|.+.+...+ .++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 579998887654 6999999999999999999999999999999999999964 5789999999997644
Q ss_pred cccC-----CCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcC-----
Q 019904 163 QVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAA----- 229 (334)
Q Consensus 163 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~---~~~~~~~~~~~----- 229 (334)
.... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. .......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 3211 122345679999999999998776 489999999999999999999997543 22222222211
Q ss_pred ccCCCCCCCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 230 EFTCPPWLSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 230 ~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
....++.+|+++.+++..|+..+|++||+++.+.+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11233568899999999999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=357.15 Aligned_cols=247 Identities=21% Similarity=0.315 Sum_probs=191.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeCC----eE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~ 86 (334)
..|.+.+.||+|+||+||+|+. +|+.||||++..+... ....+.|+..++.++||||+++++++..++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4789999999999999999986 5889999999754321 122334666667789999999999987654 68
Q ss_pred EEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEEeecCCCCEEEecCCCeEEeeccch
Q 019904 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (334)
Q Consensus 87 ~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~--------~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a 158 (334)
|+|||||++|+|.+++.+. +++...+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999875 58999999999999999999996 69999999999999999999999999998
Q ss_pred hccccccC--CCcccccccCCcccChHhhhcCCC-----CCCccchhhHHHHHHHHHhCCCCCCCC--------------
Q 019904 159 ALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDS-------------- 217 (334)
Q Consensus 159 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~e~~~g~~pf~~~-------------- 217 (334)
........ ........||+.|+|||++.+... .+.++|||||||++|||+||..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 76543221 112345679999999999876432 246789999999999999998877421
Q ss_pred -cHHHHHHHhhcCcc--CCCCC-----CCHHHHHHHHHhcCCCCCCCCCHhHHhc
Q 019904 218 -NLMNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTRITIPEILE 264 (334)
Q Consensus 218 -~~~~~~~~~~~~~~--~~~~~-----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 264 (334)
.............. .+|.. .+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 12222222222222 22221 2235889999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-48 Score=355.63 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=193.4
Q ss_pred cceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-----------CCCeeeEEEE
Q 019904 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLYEV 79 (334)
Q Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~~~~~ 79 (334)
+||++++.||+|+||+||+|++..+|+.||||++++.... .+.+.+|+.+++.+. |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 5799999999999999999999999999999999865422 345677888887775 5789999988
Q ss_pred Eee--CCeEEEEEeccCCCchHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEeecCCCCEEEecCCC----
Q 019904 80 MGS--KTKIFIVLEFVTGGELFDK-I--VNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGN---- 149 (334)
Q Consensus 80 ~~~--~~~~~~v~e~~~~~~L~~~-l--~~~~~l~~~~~~~i~~qil~~l~~LH~-~~i~H~dlkp~NIl~~~~~~---- 149 (334)
+.. ....+.+|+++..+..... . .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 4566777777665443222 2 233578999999999999999999998 89999999999999987654
Q ss_pred --eEEeeccchhccccccCCCcccccccCCcccChHhhhcCCCCCCccchhhHHHHHHHHHhCCCCCCCCcHH------H
Q 019904 150 --LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM------N 221 (334)
Q Consensus 150 --~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e~~~g~~pf~~~~~~------~ 221 (334)
++++|||.|..... ......||+.|+|||++.+..++ .++||||+||++++|++|+.||...... .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 89999998764322 23456799999999999987774 8999999999999999999999753311 1
Q ss_pred HHHHhh---c---------------------------------------CccCCCCCCCHHHHHHHHHhcCCCCCCCCCH
Q 019904 222 LYKKIS---A---------------------------------------AEFTCPPWLSFTARKLIARILDPNPMTRITI 259 (334)
Q Consensus 222 ~~~~~~---~---------------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 259 (334)
...... . .....+...+.++++||.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 111000 0 0001112245789999999999999999999
Q ss_pred hHHhcCccccCC
Q 019904 260 PEILEDEWFKKD 271 (334)
Q Consensus 260 ~e~l~h~~~~~~ 271 (334)
+|+|+||||+..
T Consensus 323 ~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 323 GGLVNHPWLKDT 334 (362)
T ss_dssp HHHHTCGGGTTC
T ss_pred HHHhcCcccCCC
Confidence 999999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5e-27 Score=193.88 Aligned_cols=135 Identities=19% Similarity=0.288 Sum_probs=107.9
Q ss_pred eEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhh---------------hHHHHHHHHHHHHHHHhCCCCCeeeEE
Q 019904 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL---------------KHKMAEQIKREVATMKLVKHPNVVRLY 77 (334)
Q Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~~iv~~~ 77 (334)
+.+++.||+|+||+||+|.+. +|+.||||+++..... .........+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468899999999999999985 6899999987642111 112234456789999999999999988
Q ss_pred EEEeeCCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEEeecCCCCEEEecCCCeEEeeccc
Q 019904 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (334)
Q Consensus 78 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 157 (334)
++.. .+++|||++++.+. .++...+..++.|++.+|+|||++||+||||||+|||++++ .++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7642 26899999986543 25556677899999999999999999999999999999874 589999998
Q ss_pred hhc
Q 019904 158 SAL 160 (334)
Q Consensus 158 a~~ 160 (334)
|..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=2.1e-09 Score=91.03 Aligned_cols=147 Identities=17% Similarity=0.158 Sum_probs=101.4
Q ss_pred ccccccccceEEeeeeeccCceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEee
Q 019904 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (334)
Q Consensus 4 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 82 (334)
|.+.+.++.|+..+..+.++.+.||+... +++.+++|......... ...+.+|...++.+. +--+.+++.+...
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~ 81 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERH 81 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEec
Confidence 56777888999988876666789998763 46678889876543222 234567888877664 3336778888888
Q ss_pred CCeEEEEEeccCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 019904 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--------------------------------- 129 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~~l~~LH~--------------------------------- 129 (334)
++..|+||++.+|..+.+..... .....++.++...++.||+
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred CCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 99999999999997765433211 1122234444444444542
Q ss_pred --------------------------CCcEEeecCCCCEEEecCCCeEEeeccchhc
Q 019904 130 --------------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (334)
Q Consensus 130 --------------------------~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~~ 160 (334)
..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1379999999999999866667999997654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.45 E-value=2e-07 Score=78.02 Aligned_cols=85 Identities=15% Similarity=0.139 Sum_probs=57.8
Q ss_pred ccccccceEEeeeeeccC-ceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCC--CeeeEEEEEee
Q 019904 6 IKRRVGKYEVGRTIGEGT-FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVMGS 82 (334)
Q Consensus 6 ~~~~~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~ 82 (334)
+..++..++... +..|. .+.||+... .++..+++|...... ...+..|...++.+... .+.+++.+..+
T Consensus 6 ~~~~l~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 6 WVERLFGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp GTTTTTTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred HHHhccCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 445566666644 44444 478998876 346678999865443 22356677777766532 35678888888
Q ss_pred CCeEEEEEeccCCCch
Q 019904 83 KTKIFIVLEFVTGGEL 98 (334)
Q Consensus 83 ~~~~~~v~e~~~~~~L 98 (334)
.+..++||++++|.++
T Consensus 78 ~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SSCEEEEEECCSSEET
T ss_pred ccceEEEEEeeecccc
Confidence 8899999999988554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.33 E-value=6e-07 Score=80.25 Aligned_cols=81 Identities=16% Similarity=0.151 Sum_probs=49.9
Q ss_pred eeeeeccCceEEEEEEECCCCCeEEEEEeehhh-h-hh--HHHHHHHHHHHHHHHhCC-C--CCeeeEEEEEeeCCeEEE
Q 019904 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEK-V-LK--HKMAEQIKREVATMKLVK-H--PNVVRLYEVMGSKTKIFI 88 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~-~~--~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 88 (334)
.+.||.|....||++.+..+++.|++|.-.... . .. +....+...|...|+.+. + ..+++++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999987778899999754211 0 00 111234556777777653 2 345666654 4455678
Q ss_pred EEeccCCCch
Q 019904 89 VLEFVTGGEL 98 (334)
Q Consensus 89 v~e~~~~~~L 98 (334)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.46 E-value=0.00028 Score=62.41 Aligned_cols=74 Identities=18% Similarity=0.216 Sum_probs=49.6
Q ss_pred eeeeeccCceEEEEEEECC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeEEEEEeeCCeEE
Q 019904 16 GRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIF 87 (334)
Q Consensus 16 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~ 87 (334)
++.|+.|---.+|++.... ..+.|.+++..... . .-...+|..+++.+.-.+ ..++++++.. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888888999988643 34668888875321 1 224557888888876334 4577777643 5
Q ss_pred EEEeccCCCch
Q 019904 88 IVLEFVTGGEL 98 (334)
Q Consensus 88 ~v~e~~~~~~L 98 (334)
+|+||++|..+
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.41 E-value=0.00019 Score=61.74 Aligned_cols=68 Identities=19% Similarity=0.157 Sum_probs=43.8
Q ss_pred ceEEEEEEECCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe--eeEE-----EEEeeCCeEEEEEeccCCC
Q 019904 24 FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV--VRLY-----EVMGSKTKIFIVLEFVTGG 96 (334)
Q Consensus 24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~-----~~~~~~~~~~~v~e~~~~~ 96 (334)
--.||++.. .+|..|++|+.+..... .+.+..|...+..|...++ +... ..+...+..+.++++..|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 467999886 46888999998764321 3456678877777653222 1111 1234567788999998873
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.26 E-value=0.00027 Score=60.29 Aligned_cols=30 Identities=27% Similarity=0.330 Sum_probs=26.9
Q ss_pred CCcEEeecCCCCEEEecCCCeEEeeccchh
Q 019904 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (334)
Q Consensus 130 ~~i~H~dlkp~NIl~~~~~~~kl~Dfg~a~ 159 (334)
.|+||+|+.+.||+++.++..-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988777899999764
|